country,term,count
DZ,CARDIO-RESPIRATORY ARREST,2
DZ,HEPATIC FAILURE,2
DZ,ABDOMINAL PAIN UPPER,1
DZ,ACUTE ABDOMEN,1
DZ,AGITATION,1
DZ,ANXIETY DISORDER,1
DZ,APPLICATION SITE ERYTHEMA,1
DZ,CARDIAC FAILURE,1
DZ,EJECTION FRACTION DECREASED,1
DZ,EYE PAIN,1
DZ,FACIAL PARALYSIS,1
DZ,GASTROINTESTINAL TOXICITY,1
DZ,HERPES ZOSTER,1
DZ,LEUKOPENIA,1
DZ,LYMPHOCYTE COUNT DECREASED,1
DZ,MUCOSAL INFLAMMATION,1
DZ,NERVE COMPRESSION,1
DZ,NEUTROPENIA,1
DZ,OVERDOSE,1
DZ,PANCREATIC CARCINOMA,1
DZ,PARAESTHESIA,1
DZ,PNEUMOBILIA,1
DZ,SOCIAL FEAR,1
DZ,THINKING ABNORMAL,1
DZ,THROMBOCYTOPENIA,1
DZ,ULCER,1
DZ,VOMITING,1
AR,ANAEMIA,13
AR,PNEUMONIA,13
AR,PAIN IN EXTREMITY,12
AR,HYPERTENSION,11
AR,MALAISE,11
AR,URINARY TRACT INFECTION,11
AR,CARDIO-RESPIRATORY ARREST,10
AR,PAIN,10
AR,ARTHRALGIA,9
AR,PYREXIA,9
AR,DYSPNOEA,8
AR,FALL,8
AR,FATIGUE,8
AR,DRUG INEFFECTIVE,7
AR,GAIT DISTURBANCE,7
AR,INFECTION,7
AR,BACK PAIN,6
AR,BLOOD PRESSURE INCREASED,6
AR,CELLULITIS,6
AR,DISEASE PROGRESSION,6
AR,THROMBOSIS,6
AR,ABDOMINAL PAIN UPPER,5
AR,ASTHENIA,5
AR,BLOOD PRESSURE DECREASED,5
AR,CARDIAC DISORDER,5
AR,COUGH,5
AR,DEEP VEIN THROMBOSIS,5
AR,DEHYDRATION,5
AR,DIABETES MELLITUS,5
AR,HYPOTENSION,5
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
AR,PULMONARY OEDEMA,5
AR,VOMITING,5
AR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
AR,ABASIA,4
AR,ACUTE MYOCARDIAL INFARCTION,4
AR,ARTHROPATHY,4
AR,BLOOD PRESSURE FLUCTUATION,4
AR,CARDIAC FAILURE,4
AR,COMA,4
AR,DEATH,4
AR,DIARRHOEA,4
AR,DIZZINESS,4
AR,GENERAL PHYSICAL HEALTH DETERIORATION,4
AR,HAEMATOCRIT DECREASED,4
AR,HAEMORRHAGE,4
AR,IMPAIRED HEALING,4
AR,INFLUENZA,4
AR,LOSS OF CONSCIOUSNESS,4
AR,MUSCLE SPASMS,4
AR,MYOCARDIAL INFARCTION,4
AR,RENAL FAILURE,4
AR,RHEUMATOID ARTHRITIS,4
AR,SEIZURE,4
AR,VISUAL IMPAIRMENT,4
AR,WEIGHT DECREASED,4
AR,ABDOMINAL PAIN,3
AR,ALANINE AMINOTRANSFERASE INCREASED,3
AR,ARTERIAL OCCLUSIVE DISEASE,3
AR,ASPARTATE AMINOTRANSFERASE INCREASED,3
AR,ATRIAL FIBRILLATION,3
AR,BLOOD PRESSURE ABNORMAL,3
AR,BLOOD PRESSURE SYSTOLIC INCREASED,3
AR,BLOOD URINE PRESENT,3
AR,BONE PAIN,3
AR,BREAST CANCER,3
AR,BRONCHOSPASM,3
AR,CARDIOMYOPATHY,3
AR,CATARACT,3
AR,CHOLELITHIASIS,3
AR,CONDITION AGGRAVATED,3
AR,DECREASED APPETITE,3
AR,DYSPHAGIA,3
AR,GASTRIC DISORDER,3
AR,HEADACHE,3
AR,HEPATIC ENZYME INCREASED,3
AR,HEPATOMEGALY,3
AR,HIP FRACTURE,3
AR,INFARCTION,3
AR,JOINT SWELLING,3
AR,METASTASES TO LIVER,3
AR,MUSCULAR WEAKNESS,3
AR,MYALGIA,3
AR,NERVOUS SYSTEM DISORDER,3
AR,NODULE,3
AR,OEDEMA PERIPHERAL,3
AR,OSTEOARTHRITIS,3
AR,PERIPHERAL SWELLING,3
AR,PLATELET COUNT DECREASED,3
AR,PLEURAL EFFUSION,3
AR,PRODUCT USE ISSUE,3
AR,PRURITUS,3
AR,PULMONARY MASS,3
AR,SWELLING,3
AR,TACHYCARDIA,3
AR,THROMBOCYTOPENIA,3
AR,ABDOMINAL DISCOMFORT,2
AR,ABDOMINAL DISTENSION,2
AR,ACUTE KIDNEY INJURY,2
AR,AGITATION,2
AR,ALOPECIA,2
AR,ANXIETY,2
AR,APPARENT DEATH,2
AR,ARRHYTHMIA,2
AR,ARRHYTHMIA SUPRAVENTRICULAR,2
AR,ARTHRITIS,2
AR,BLINDNESS,2
AR,BLOOD ALKALINE PHOSPHATASE INCREASED,2
AR,BLOOD BILIRUBIN INCREASED,2
AR,BLOOD CREATININE INCREASED,2
AR,BLOOD GLUCOSE INCREASED,2
AR,BLOOD SODIUM DECREASED,2
AR,BRONCHIAL DISORDER,2
AR,BRONCHITIS,2
AR,CEREBROVASCULAR ACCIDENT,2
AR,CHEST PAIN,2
AR,CONTUSION,2
AR,DEAFNESS UNILATERAL,2
AR,DEPRESSED MOOD,2
AR,DEPRESSION,2
AR,DEVICE RELATED INFECTION,2
AR,DIPLEGIA,2
AR,DISORIENTATION,2
AR,DRUG INTOLERANCE,2
AR,DYSPHONIA,2
AR,EMOTIONAL DISTRESS,2
AR,EYE DISORDER,2
AR,FEAR,2
AR,FEMUR FRACTURE,2
AR,FLUID OVERLOAD,2
AR,GAIT INABILITY,2
AR,GASTROINTESTINAL HAEMORRHAGE,2
AR,GASTROOESOPHAGEAL REFLUX DISEASE,2
AR,HAEMATOMA,2
AR,HAEMORRHAGIC STROKE,2
AR,HEPATITIS,2
AR,HEPATITIS E,2
AR,HYPERSENSITIVITY,2
AR,HYPERTHYROIDISM,2
AR,HYPOGLYCAEMIA,2
AR,IMMUNODEFICIENCY,2
AR,IMMUNOSUPPRESSION,2
AR,INFLAMMATION OF WOUND,2
AR,INJECTION SITE HAEMATOMA,2
AR,INTERNATIONAL NORMALISED RATIO INCREASED,2
AR,LIGAMENT SPRAIN,2
AR,LOCALISED INFECTION,2
AR,LUMBAR VERTEBRAL FRACTURE,2
AR,LUNG DISORDER,2
AR,MACULOPATHY,2
AR,MALIGNANT NEOPLASM PROGRESSION,2
AR,MALNUTRITION,2
AR,MEMORY IMPAIRMENT,2
AR,MULTI-ORGAN FAILURE,2
AR,MUSCULOSKELETAL DISCOMFORT,2
AR,MUSCULOSKELETAL STIFFNESS,2
AR,NAUSEA,2
AR,NEOPLASM,2
AR,NEUROPATHY PERIPHERAL,2
AR,NOSOCOMIAL INFECTION,2
AR,OEDEMA,2
AR,OSTEOMYELITIS SALMONELLA,2
AR,PARAESTHESIA,2
AR,PARKINSON^S DISEASE,2
AR,PERICARDIAL EFFUSION,2
AR,PITUITARY TUMOUR,2
AR,PLASMA CELL MYELOMA,2
AR,PNEUMONIA PNEUMOCOCCAL,2
AR,PSORIASIS,2
AR,RED BLOOD CELL COUNT DECREASED,2
AR,RENAL IMPAIRMENT,2
AR,SENSORY DISTURBANCE,2
AR,SEPSIS,2
AR,SEPTIC SHOCK,2
AR,SKIN DISCOLOURATION,2
AR,SPINAL PAIN,2
AR,SUBDURAL HAEMATOMA,2
AR,SYNOVIAL CYST,2
AR,THROAT IRRITATION,2
AR,TUBERCULOSIS,2
AR,VASCULITIS,2
AR,VENA CAVA THROMBOSIS,2
AR,WEIGHT INCREASED,2
AR,WHITE BLOOD CELL COUNT INCREASED,2
AR,ABDOMINAL RIGIDITY,1
AR,ACCIDENT AT HOME,1
AR,ACCIDENTAL EXPOSURE TO PRODUCT,1
AR,ACUTE ABDOMEN,1
AR,ACUTE CORONARY SYNDROME,1
AR,ACUTE HEPATIC FAILURE,1
AR,ACUTE LEUKAEMIA,1
AR,ACUTE RESPIRATORY FAILURE,1
AR,AGEUSIA,1
AR,AMENORRHOEA,1
AR,AMYLASE INCREASED,1
AR,ANAL FISSURE,1
AR,ANGER,1
AR,ANGINA UNSTABLE,1
AR,ANGIOEDEMA,1
AR,ANKLE FRACTURE,1
AR,AORTIC ANEURYSM,1
AR,APLASTIC ANAEMIA,1
AR,APPENDICITIS,1
AR,ARTERIAL STENOSIS,1
AR,ASTHMA,1
AR,ASTIGMATISM,1
AR,AZOTAEMIA,1
AR,BACTERIAL TRANSLOCATION,1
AR,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
AR,BILIRUBIN CONJUGATED INCREASED,1
AR,BLADDER PROLAPSE,1
AR,BLISTER INFECTED,1
AR,BLOOD CALCIUM DECREASED,1
AR,BLOOD CHOLESTEROL ABNORMAL,1
AR,BLOOD CHOLESTEROL INCREASED,1
AR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
AR,BLOOD TRIGLYCERIDES INCREASED,1
AR,BLOOD UREA INCREASED,1
AR,BODY TEMPERATURE INCREASED,1
AR,BONE MARROW FAILURE,1
AR,BRAIN NEOPLASM,1
AR,BREAST CALCIFICATIONS,1
AR,BREAST CYST,1
AR,BRONCHOPULMONARY ASPERGILLOSIS,1
AR,C-REACTIVE PROTEIN INCREASED,1
AR,CANDIDA INFECTION,1
AR,CARDIAC ARREST,1
AR,CARDIAC DEATH,1
AR,CARDIAC FAILURE CONGESTIVE,1
AR,CARDIAC SIDEROSIS,1
AR,CARDIOMEGALY,1
AR,CARTILAGE INJURY,1
AR,CATARACT OPERATION,1
AR,CEREBRAL ATROPHY,1
AR,CEREBRAL ISCHAEMIA,1
AR,CEREBROSPINAL FISTULA,1
AR,CERVIX CARCINOMA STAGE 0,1
AR,CHEST DISCOMFORT,1
AR,CHOLESTASIS,1
AR,CHROMATURIA,1
AR,CHRONIC ALLOGRAFT NEPHROPATHY,1
AR,CHRONIC HEPATITIS,1
AR,CHRONIC KIDNEY DISEASE,1
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AR,COAGULATION TIME PROLONGED,1
AR,COELIAC DISEASE,1
AR,COGNITIVE DISORDER,1
AR,COLITIS,1
AR,COLITIS ULCERATIVE,1
AR,COLON CANCER,1
AR,CONCOMITANT DISEASE AGGRAVATED,1
AR,CONCOMITANT DISEASE PROGRESSION,1
AR,CONGENITAL NEUROLOGICAL DISORDER,1
AR,CORONARY ARTERY DISEASE,1
AR,CORONARY ARTERY OCCLUSION,1
AR,CRANIOSYNOSTOSIS,1
AR,CRITICAL ILLNESS,1
AR,CRITICAL ILLNESS MYOPATHY,1
AR,CRITICAL ILLNESS POLYNEUROPATHY,1
AR,CROHN^S DISEASE,1
AR,CRYING,1
AR,CYANOSIS,1
AR,CYSTITIS,1
AR,DECREASED IMMUNE RESPONSIVENESS,1
AR,DEFORMITY,1
AR,DENGUE FEVER,1
AR,DERMAL CYST,1
AR,DERMATITIS,1
AR,DERMATITIS ALLERGIC,1
AR,DERMATITIS DIAPER,1
AR,DEVICE ISSUE,1
AR,DIABETES INSIPIDUS,1
AR,DIABETIC FOOT,1
AR,DISCOMFORT,1
AR,DIVERTICULITIS,1
AR,DIVERTICULUM,1
AR,DRUG DISPENSING ERROR,1
AR,DRUG HYPERSENSITIVITY,1
AR,DRUG LEVEL DECREASED,1
AR,DRUG-INDUCED LIVER INJURY,1
AR,DRY MOUTH,1
AR,DYSPEPSIA,1
AR,DYSPNOEA AT REST,1
AR,DYSURIA,1
AR,EAR PAIN,1
AR,ECCHYMOSIS,1
AR,ECZEMA,1
AR,ECZEMA INFECTED,1
AR,ELECTROCARDIOGRAM T WAVE INVERSION,1
AR,ELECTROENCEPHALOGRAM ABNORMAL,1
AR,EMOTIONAL DISORDER,1
AR,EMPHYSEMA,1
AR,ENDOCRINE DISORDER,1
AR,ENTEROCOLITIS,1
AR,EPISTAXIS,1
AR,ERYSIPELAS,1
AR,ERYTHEMA,1
AR,ESCHERICHIA URINARY TRACT INFECTION,1
AR,EXTREMITY NECROSIS,1
AR,FAILURE TO THRIVE,1
AR,FEEDING INTOLERANCE,1
AR,FEELING ABNORMAL,1
AR,FEELING COLD,1
AR,FIBULA FRACTURE,1
AR,FINGER DEFORMITY,1
AR,FLATULENCE,1
AR,FLUID INTAKE REDUCED,1
AR,FLUID RETENTION,1
AR,FOLLICULITIS,1
AR,FOOD INTOLERANCE,1
AR,FOOT DEFORMITY,1
AR,FOREIGN BODY,1
AR,FRACTURE,1
AR,FRACTURE PAIN,1
AR,FUNGAL OESOPHAGITIS,1
AR,FUNGAL PERITONITIS,1
AR,FURUNCLE,1
AR,GASTRIC ULCER,1
AR,GASTRIC ULCER HAEMORRHAGE,1
AR,GASTRITIS,1
AR,GASTROENTERITIS,1
AR,GASTROINTESTINAL CARCINOMA,1
AR,GASTROINTESTINAL DISORDER,1
AR,GASTROINTESTINAL DYSPLASIA,1
AR,GASTROINTESTINAL INFLAMMATION,1
AR,GASTROINTESTINAL MUCOSAL EXFOLIATION,1
AR,GASTROINTESTINAL OEDEMA,1
AR,GASTROINTESTINAL PAIN,1
AR,GASTROLITHIASIS,1
AR,GAZE PALSY,1
AR,GENERALISED TONIC-CLONIC SEIZURE,1
AR,GLAUCOMA,1
AR,GRAFT VERSUS HOST DISEASE,1
AR,HAEMATEMESIS,1
AR,HAEMOCHROMATOSIS,1
AR,HAEMODIALYSIS COMPLICATION,1
AR,HAEMODYNAMIC INSTABILITY,1
AR,HAEMOGLOBIN DECREASED,1
AR,HAEMOPHILIA,1
AR,HAEMOPTYSIS,1
AR,HAEMORRHAGE URINARY TRACT,1
AR,HAEMORRHOIDS,1
AR,HAIR DISORDER,1
AR,HAPTOGLOBIN DECREASED,1
AR,HEAD INJURY,1
AR,HEART VALVE INCOMPETENCE,1
AR,HEART VALVE STENOSIS,1
AR,HEPATIC FUNCTION ABNORMAL,1
AR,HEPATIC STEATOSIS,1
AR,HEPATITIS A,1
AR,HEPATITIS B,1
AR,HEPATOTOXICITY,1
AR,HERPES VIRUS INFECTION,1
AR,HERPES ZOSTER,1
AR,HIATUS HERNIA,1
AR,HISTOPLASMOSIS,1
AR,HORMONE LEVEL ABNORMAL,1
AR,HOSPITALISATION,1
AR,HOT FLUSH,1
AR,HYPERBILIRUBINAEMIA,1
AR,HYPERCHLORHYDRIA,1
AR,HYPERHIDROSIS,1
AR,HYPERSOMNIA,1
AR,HYPERTENSIVE CRISIS,1
AR,HYPERTRANSAMINASAEMIA,1
AR,HYPOACUSIS,1
AR,HYPOAESTHESIA,1
AR,HYPOAESTHESIA ORAL,1
AR,HYPOKINESIA,1
AR,HYPOTHYROIDISM,1
AR,HYPOVOLAEMIC SHOCK,1
AR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
AR,INFECTED SKIN ULCER,1
AR,INFLAMMATORY BOWEL DISEASE,1
AR,INFLUENZA LIKE ILLNESS,1
AR,INJECTION SITE ABSCESS,1
AR,INJECTION SITE DISCOMFORT,1
AR,INJECTION SITE HAEMORRHAGE,1
AR,INJECTION SITE INFLAMMATION,1
AR,INJECTION SITE PAIN,1
AR,INSOMNIA,1
AR,INTERVERTEBRAL DISC PROTRUSION,1
AR,INTESTINAL PERFORATION,1
AR,INTESTINAL PROLAPSE,1
AR,INTRAOCULAR PRESSURE INCREASED,1
AR,IRRITABILITY,1
AR,ISCHAEMIA,1
AR,ISCHAEMIC CEREBRAL INFARCTION,1
AR,JOINT EFFUSION,1
AR,LARGE INTESTINE PERFORATION,1
AR,LARGE INTESTINE POLYP,1
AR,LETHARGY,1
AR,LEUKOCYTOSIS,1
AR,LEUKOPENIA,1
AR,LIGAMENT INJURY,1
AR,LIP DRY,1
AR,LIP SWELLING,1
AR,LIPASE INCREASED,1
AR,LIVER DISORDER,1
AR,LOCAL SWELLING,1
AR,LOSS OF CONTROL OF LEGS,1
AR,LUNG NEOPLASM,1
AR,MALABSORPTION,1
AR,MANTLE CELL LYMPHOMA,1
AR,MENINGITIS,1
AR,MENISCUS OPERATION,1
AR,METASTATIC NEOPLASM,1
AR,MOBILITY DECREASED,1
AR,MOTOR DYSFUNCTION,1
AR,MOUTH INJURY,1
AR,MOUTH ULCERATION,1
AR,MULTIPLE SCLEROSIS,1
AR,MULTIPLE SCLEROSIS RELAPSE,1
AR,MUSCLE NECROSIS,1
AR,MUSCULOSKELETAL PAIN,1
AR,MYOPATHY,1
AR,NASAL INJURY,1
AR,NECK PAIN,1
AR,NEGATIVISM,1
AR,NEOPLASM PROGRESSION,1
AR,NEPHROCALCINOSIS,1
AR,NEPHROLITHIASIS,1
AR,NERVOUSNESS,1
AR,NEUROTOXICITY,1
AR,NEUTROPENIA,1
AR,NEUTROPHIL COUNT INCREASED,1
AR,NEUTROPHILIA,1
AR,NO THERAPEUTIC RESPONSE,1
AR,NOSE DEFORMITY,1
AR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
AR,OCULAR DISCOMFORT,1
AR,OEDEMA DUE TO HEPATIC DISEASE,1
AR,OESOPHAGEAL DISCOMFORT,1
AR,OESOPHAGEAL PAIN,1
AR,ONYCHOCLASIS,1
AR,ONYCHOMADESIS,1
AR,ORAL FUNGAL INFECTION,1
AR,OSTEITIS,1
AR,OSTEONECROSIS,1
AR,OTITIS EXTERNA,1
AR,OVARIAN CYST,1
AR,PALLOR,1
AR,PALPITATIONS,1
AR,PANCREATIC CARCINOMA,1
AR,PANCREATITIS,1
AR,PANCREATITIS ACUTE,1
AR,PANCYTOPENIA,1
AR,PARALYSIS,1
AR,PATELLA FRACTURE,1
AR,PELVIC NEOPLASM,1
AR,PERIPHERAL VASCULAR DISORDER,1
AR,PERITONITIS,1
AR,PERITONITIS BACTERIAL,1
AR,PETECHIAE,1
AR,PHARYNGEAL HAEMORRHAGE,1
AR,PHARYNGITIS,1
AR,PHLEBITIS,1
AR,PNEUMONITIS,1
AR,PNEUMOTHORAX,1
AR,POLLAKIURIA,1
AR,POLYMYOSITIS,1
AR,POOR PERIPHERAL CIRCULATION,1
AR,POST PROCEDURAL COMPLICATION,1
AR,POSTOPERATIVE THROMBOSIS,1
AR,PRESCRIBED UNDERDOSE,1
AR,PROCEDURAL COMPLICATION,1
AR,PRODUCT DIFFICULT TO SWALLOW,1
AR,PRODUCT PHYSICAL ISSUE,1
AR,PRODUCT QUALITY ISSUE,1
AR,PRODUCT USE IN UNAPPROVED INDICATION,1
AR,PRODUCTIVE COUGH,1
AR,PROSTATIC DISORDER,1
AR,PRURIGO,1
AR,PRURITUS GENERALISED,1
AR,PSEUDOMONAS INFECTION,1
AR,PSORIATIC ARTHROPATHY,1
AR,PULMONARY ARTERIAL HYPERTENSION,1
AR,PULMONARY CAVITATION,1
AR,PULMONARY EMBOLISM,1
AR,PULMONARY FIBROSIS,1
AR,PULMONARY THROMBOSIS,1
AR,PYELONEPHRITIS,1
AR,PYELONEPHRITIS ACUTE,1
AR,QUADRIPARESIS,1
AR,RASH,1
AR,RED BLOOD CELL COUNT INCREASED,1
AR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
AR,RENAL CYST,1
AR,RENAL FAILURE ACUTE,1
AR,RESPIRATORY TRACT INFECTION,1
AR,RETINAL DEGENERATION,1
AR,RETINAL VEIN THROMBOSIS,1
AR,SCIATIC NERVE INJURY,1
AR,SCIATICA,1
AR,SERUM FERRITIN INCREASED,1
AR,SHOCK,1
AR,SINUS BRADYCARDIA,1
AR,SKIN ULCER,1
AR,SKULL FRACTURE,1
AR,SOMNOLENCE,1
AR,SPEECH DISORDER,1
AR,SPINAL COLUMN INJURY,1
AR,SPINAL CORD COMPRESSION,1
AR,SPINAL CORD DISORDER,1
AR,SPINAL FRACTURE,1
AR,SPLENECTOMY,1
AR,SPLENITIS,1
AR,SPLENOMEGALY,1
AR,STATUS EPILEPTICUS,1
AR,STENOSIS,1
AR,STOMATITIS,1
AR,STRESS,1
AR,STRESS ECHOCARDIOGRAM ABNORMAL,1
AR,SUDDEN DEATH,1
AR,SUPERIOR SAGITTAL SINUS THROMBOSIS,1
AR,SUPRAVENTRICULAR TACHYCARDIA,1
AR,SWELLING FACE,1
AR,SWOLLEN TONGUE,1
AR,SYNCOPE,1
AR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
AR,TACHYPNOEA,1
AR,TALIPES,1
AR,TENDINOUS CONTRACTURE,1
AR,TENSION,1
AR,THERAPY CESSATION,1
AR,THROAT TIGHTNESS,1
AR,THYROID DISORDER,1
AR,THYROID NEOPLASM,1
AR,TINEA PEDIS,1
AR,TONGUE BITING,1
AR,TOXICITY TO VARIOUS AGENTS,1
AR,TRANSFERRIN INCREASED,1
AR,TREMOR,1
AR,TUBULOINTERSTITIAL NEPHRITIS,1
AR,TUMOUR INVASION,1
AR,TUMOUR MARKER INCREASED,1
AR,TYPE 2 DIABETES MELLITUS,1
AR,URINARY RETENTION,1
AR,URINARY TRACT INFECTION BACTERIAL,1
AR,URINARY TRACT OBSTRUCTION,1
AR,URINE OSMOLARITY INCREASED,1
AR,UROSEPSIS,1
AR,VAGINAL HAEMORRHAGE,1
AR,VARICELLA,1
AR,VARICOSE VEIN,1
AR,VASCULITIS NECROTISING,1
AR,VENOUS THROMBOSIS,1
AR,VERTEBRAL ARTERY THROMBOSIS,1
AR,VISION BLURRED,1
AR,VISUAL ACUITY REDUCED,1
AR,VITAMIN D DECREASED,1
AR,VITH NERVE PARALYSIS,1
AR,VOLVULUS,1
AR,WEIGHT LOSS POOR,1
AR,WHITE BLOOD CELL COUNT DECREASED,1
AR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
AM,CARDIAC FAILURE,2
AM,CARDIAC FAILURE CONGESTIVE,1
AM,COR PULMONALE,1
AM,RESPIRATORY FAILURE,1
AU,HYPOTENSION,30
AU,PYREXIA,20
AU,HYPOCALCAEMIA,19
AU,DRUG-INDUCED LIVER INJURY,18
AU,NAUSEA,17
AU,VOMITING,17
AU,MALAISE,16
AU,SEPSIS,16
AU,FATIGUE,15
AU,HYPOGLYCAEMIA,14
AU,HYPOMAGNESAEMIA,14
AU,PNEUMONIA,14
AU,DRUG INEFFECTIVE,13
AU,ELECTROCARDIOGRAM QT PROLONGED,13
AU,NEUTROPENIA,13
AU,HYPERKALAEMIA,12
AU,TOXIC EPIDERMAL NECROLYSIS,12
AU,ACIDOSIS,11
AU,ACUTE KIDNEY INJURY,11
AU,FALL,11
AU,HYPERLACTACIDAEMIA,11
AU,PSYCHOTIC DISORDER,11
AU,AGGRESSION,10
AU,ANAEMIA,10
AU,DIARRHOEA,10
AU,DYSPNOEA,10
AU,LETHARGY,10
AU,RHABDOMYOLYSIS,10
AU,ABDOMINAL PAIN,9
AU,FEBRILE NEUTROPENIA,9
AU,HAEMOGLOBIN DECREASED,9
AU,HYPERTENSION,9
AU,LIVER FUNCTION TEST ABNORMAL,9
AU,MYOCARDIAL INFARCTION,9
AU,OEDEMA PERIPHERAL,9
AU,PNEUMONIA HAEMOPHILUS,9
AU,RENAL IMPAIRMENT,9
AU,ARTHRALGIA,8
AU,ATRIAL FIBRILLATION,8
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,8
AU,DEATH,8
AU,DEHYDRATION,8
AU,OVERDOSE,8
AU,TOXICITY TO VARIOUS AGENTS,8
AU,APPENDICITIS PERFORATED,7
AU,BLOOD CREATININE INCREASED,7
AU,CHEST PAIN,7
AU,HEPATIC FAILURE,7
AU,HYPONATRAEMIA,7
AU,INTENTIONAL OVERDOSE,7
AU,METABOLIC ACIDOSIS,7
AU,PANCYTOPENIA,7
AU,PARAESTHESIA,7
AU,PULMONARY EMBOLISM,7
AU,CARDIAC FAILURE,6
AU,CONDITION AGGRAVATED,6
AU,CONTUSION,6
AU,PAIN,6
AU,PANCREATITIS,6
AU,PLATELET COUNT DECREASED,6
AU,PLEURISY,6
AU,PRURITUS,6
AU,RASH,6
AU,THROMBOCYTOPENIA,6
AU,TREMOR,6
AU,WHITE BLOOD CELL COUNT DECREASED,6
AU,ASCITES,5
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,5
AU,C-REACTIVE PROTEIN INCREASED,5
AU,CHRONIC KIDNEY DISEASE,5
AU,CONVULSION,5
AU,DELIRIUM,5
AU,DISEASE PROGRESSION,5
AU,DIZZINESS,5
AU,EJECTION FRACTION DECREASED,5
AU,ERYTHEMA,5
AU,HAEMATOCRIT DECREASED,5
AU,HAEMORRHAGE,5
AU,HEPATOTOXICITY,5
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,5
AU,LEUKOPENIA,5
AU,MELAENA,5
AU,MENTAL IMPAIRMENT,5
AU,NEUTROPHIL COUNT DECREASED,5
AU,PERSONALITY CHANGE,5
AU,RECTAL HAEMORRHAGE,5
AU,RED BLOOD CELL COUNT DECREASED,5
AU,RENAL FAILURE,5
AU,STEVENS-JOHNSON SYNDROME,5
AU,TUBULOINTERSTITIAL NEPHRITIS,5
AU,UROSEPSIS,5
AU,ALANINE AMINOTRANSFERASE INCREASED,4
AU,CONFUSIONAL STATE,4
AU,CONSTIPATION,4
AU,DECREASED APPETITE,4
AU,DRUG HYPERSENSITIVITY,4
AU,GENERAL PHYSICAL HEALTH DETERIORATION,4
AU,HEADACHE,4
AU,INFECTION,4
AU,OSTEOMYELITIS,4
AU,PAIN IN EXTREMITY,4
AU,PNEUMONIA ASPIRATION,4
AU,POLYP,4
AU,PULMONARY HYPERTENSION,4
AU,SCHIZOPHRENIA,4
AU,SKIN EXFOLIATION,4
AU,THROMBOTIC MICROANGIOPATHY,4
AU,UPPER GASTROINTESTINAL HAEMORRHAGE,4
AU,UPPER RESPIRATORY TRACT INFECTION,4
AU,WHITE BLOOD CELL COUNT INCREASED,4
AU,ABDOMINAL DISTENSION,3
AU,ACUTE MYOCARDIAL INFARCTION,3
AU,ANTIPSYCHOTIC DRUG LEVEL INCREASED,3
AU,ASPARTATE AMINOTRANSFERASE INCREASED,3
AU,ASTHENIA,3
AU,BACK PAIN,3
AU,BLOOD ALBUMIN DECREASED,3
AU,BLOOD BILIRUBIN INCREASED,3
AU,BLOOD GLUCOSE INCREASED,3
AU,BLOOD PARATHYROID HORMONE INCREASED,3
AU,BLOOD UREA INCREASED,3
AU,BONE PAIN,3
AU,CARDIAC ARREST,3
AU,CARDIOMYOPATHY,3
AU,CHILLS,3
AU,COLON CANCER,3
AU,COMPLETED SUICIDE,3
AU,COMPLICATIONS OF TRANSPLANTED KIDNEY,3
AU,DEPRESSION,3
AU,DERMATITIS EXFOLIATIVE,3
AU,DYSGEUSIA,3
AU,DYSPNOEA EXERTIONAL,3
AU,EOSINOPHILIA,3
AU,EPIGLOTTITIS,3
AU,FOOT FRACTURE,3
AU,GASTROOESOPHAGEAL REFLUX DISEASE,3
AU,HAEMATEMESIS,3
AU,HAEMATOMA,3
AU,HALLUCINATION_ AUDITORY,3
AU,HEPATIC ENCEPHALOPATHY,3
AU,HYPERTHYROIDISM,3
AU,HYPOKALAEMIA,3
AU,HYPOTHYROIDISM,3
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
AU,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,3
AU,JAUNDICE,3
AU,LICHENOID KERATOSIS,3
AU,LIVER DISORDER,3
AU,LOSS OF CONSCIOUSNESS,3
AU,MALIGNANT NEOPLASM PROGRESSION,3
AU,MITRAL VALVE INCOMPETENCE,3
AU,MYALGIA,3
AU,MYOCARDIAL ISCHAEMIA,3
AU,MYOCARDITIS,3
AU,MYOPATHY,3
AU,NON-CARDIAC CHEST PAIN,3
AU,PARANOIA,3
AU,RASH MACULO-PAPULAR,3
AU,RESPIRATORY FAILURE,3
AU,SEDATION,3
AU,SEPTIC SHOCK,3
AU,SINUS TACHYCARDIA,3
AU,SPINAL CORD COMPRESSION,3
AU,SPLENIC INFARCTION,3
AU,SYSTOLIC DYSFUNCTION,3
AU,TROPONIN I INCREASED,3
AU,URINARY TRACT INFECTION,3
AU,WEIGHT DECREASED,3
AU,WITHDRAWAL SYNDROME,3
AU,ABDOMINAL PAIN UPPER,2
AU,ABNORMAL BEHAVIOUR,2
AU,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
AU,ADVERSE DRUG REACTION,2
AU,AGITATION,2
AU,ALOPECIA,2
AU,ANAL PRURITUS,2
AU,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,2
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,2
AU,ANURIA,2
AU,ANXIETY,2
AU,ASTHMA,2
AU,BACTERAEMIA,2
AU,BACTERIAL SEPSIS,2
AU,BLINDNESS UNILATERAL,2
AU,BLOOD CREATININE ABNORMAL,2
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,2
AU,BLOOD POTASSIUM ABNORMAL,2
AU,BLOOD POTASSIUM DECREASED,2
AU,BLOOD SODIUM DECREASED,2
AU,BLOOD TEST ABNORMAL,2
AU,BODY TEMPERATURE INCREASED,2
AU,BRADYCARDIA,2
AU,BRONCHOPNEUMONIA,2
AU,BURNING SENSATION,2
AU,CARDIAC FAILURE CONGESTIVE,2
AU,CARDIOGENIC SHOCK,2
AU,CARDIOMEGALY,2
AU,CARDIOVASCULAR INSUFFICIENCY,2
AU,CHEST DISCOMFORT,2
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
AU,CLOSTRIDIAL INFECTION,2
AU,CLOSTRIDIUM DIFFICILE COLITIS,2
AU,COGNITIVE DISORDER,2
AU,COLITIS,2
AU,COMA HEPATIC,2
AU,COMPARTMENT SYNDROME,2
AU,COUGH,2
AU,CUTANEOUS VASCULITIS,2
AU,CYANOSIS,2
AU,DELUSION,2
AU,DELUSIONAL PERCEPTION,2
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,2
AU,DILATATION ATRIAL,2
AU,DILATATION VENTRICULAR,2
AU,DISEASE RECURRENCE,2
AU,DISSOCIATION,2
AU,DUODENAL ULCER HAEMORRHAGE,2
AU,DYSPHONIA,2
AU,ELECTROCARDIOGRAM ABNORMAL,2
AU,ENTEROBACTER BACTERAEMIA,2
AU,EXOPHTHALMOS,2
AU,FEELING ABNORMAL,2
AU,GAIT DISTURBANCE,2
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
AU,GENITAL LESION,2
AU,GLOMERULAR FILTRATION RATE DECREASED,2
AU,HAEMATOCHEZIA,2
AU,HAEMATURIA,2
AU,HEART RATE INCREASED,2
AU,HEPATIC FUNCTION ABNORMAL,2
AU,HEPATIC STEATOSIS,2
AU,HEPATITIS,2
AU,HEPATITIS C,2
AU,HEPATORENAL SYNDROME,2
AU,HEPATOSPLENOMEGALY,2
AU,HYPERGLYCAEMIA,2
AU,HYPERHIDROSIS,2
AU,HYPOAESTHESIA,2
AU,HYPOPARATHYROIDISM,2
AU,HYPOPHOSPHATAEMIA,2
AU,ILEUS,2
AU,INFLAMMATION,2
AU,INFLUENZA LIKE ILLNESS,2
AU,INFUSION RELATED REACTION,2
AU,INJURY,2
AU,INTESTINAL DILATATION,2
AU,INTESTINAL HAEMORRHAGE,2
AU,INTESTINAL PERFORATION,2
AU,IRON DEFICIENCY ANAEMIA,2
AU,ISCHAEMIA,2
AU,KIDNEY TRANSPLANT REJECTION,2
AU,LEUKOCYTOSIS,2
AU,LIPASE INCREASED,2
AU,LOWER RESPIRATORY TRACT INFECTION,2
AU,LYMPHOCYTE COUNT DECREASED,2
AU,LYMPHOCYTE COUNT INCREASED,2
AU,METASTASES TO CENTRAL NERVOUS SYSTEM,2
AU,METASTATIC MALIGNANT MELANOMA,2
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
AU,MUSCULOSKELETAL PAIN,2
AU,MUSCULOSKELETAL STIFFNESS,2
AU,NASOPHARYNGITIS,2
AU,NECK PAIN,2
AU,NEPHROTIC SYNDROME,2
AU,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
AU,OCULAR HYPERAEMIA,2
AU,OLIGURIA,2
AU,ORAL DISORDER,2
AU,PALMOPLANTAR KERATODERMA,2
AU,PERIPHERAL VASCULAR DISORDER,2
AU,PERSECUTORY DELUSION,2
AU,PHARYNGEAL HAEMATOMA,2
AU,PLASMABLASTIC LYMPHOMA,2
AU,POLYDIPSIA,2
AU,PORTAL VEIN THROMBOSIS,2
AU,POST PROCEDURAL COMPLICATION,2
AU,PRODUCT USE ISSUE,2
AU,PROTEIN TOTAL DECREASED,2
AU,PROTHROMBIN TIME PROLONGED,2
AU,PSORIASIS,2
AU,PULMONARY OEDEMA,2
AU,PYELONEPHRITIS,2
AU,RETCHING,2
AU,SALIVARY HYPERSECRETION,2
AU,SECRETION DISCHARGE,2
AU,SEIZURE,2
AU,SQUAMOUS CELL CARCINOMA OF SKIN,2
AU,STATUS EPILEPTICUS,2
AU,SUICIDE ATTEMPT,2
AU,SWELLING,2
AU,TACHYCARDIA,2
AU,TENDERNESS,2
AU,TETANY,2
AU,TRANSIENT ISCHAEMIC ATTACK,2
AU,TREATMENT FAILURE,2
AU,TREATMENT NONCOMPLIANCE,2
AU,TROPONIN INCREASED,2
AU,TYPE 2 DIABETES MELLITUS,2
AU,ULCER,2
AU,URINE OUTPUT DECREASED,2
AU,URTICARIA,2
AU,UVEITIS,2
AU,VENTRICULAR HYPOKINESIA,2
AU,VITAMIN D DECREASED,2
AU,ABDOMINAL DISCOMFORT,1
AU,ABDOMINAL SEPSIS,1
AU,ABNORMAL FAECES,1
AU,ABNORMAL LOSS OF WEIGHT,1
AU,ABORTION INCOMPLETE,1
AU,ABORTION INDUCED,1
AU,ACARODERMATITIS,1
AU,ACUTE MYELOID LEUKAEMIA,1
AU,ACUTE PULMONARY OEDEMA,1
AU,ADENOCARCINOMA OF COLON,1
AU,AFFECTIVE DISORDER,1
AU,AGRANULOCYTOSIS,1
AU,AKATHISIA,1
AU,ALTERED STATE OF CONSCIOUSNESS,1
AU,ANAL SQUAMOUS CELL CARCINOMA,1
AU,ANAPHYLACTIC REACTION,1
AU,ANISOCYTOSIS,1
AU,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,1
AU,AORTIC DILATATION,1
AU,AORTIC VALVE INCOMPETENCE,1
AU,ARRHYTHMIA,1
AU,ARTHROPATHY,1
AU,ASOCIAL BEHAVIOUR,1
AU,ATAXIA,1
AU,ATRIOVENTRICULAR BLOCK COMPLETE,1
AU,ATROPHY,1
AU,AUTOIMMUNE HEPATITIS,1
AU,BALANCE DISORDER,1
AU,BASAL CELL CARCINOMA,1
AU,BILIARY DILATATION,1
AU,BILIRUBIN CONJUGATED INCREASED,1
AU,BLEEDING TIME PROLONGED,1
AU,BLOOD ALUMINIUM DECREASED,1
AU,BLOOD BICARBONATE DECREASED,1
AU,BLOOD CHLORIDE DECREASED,1
AU,BLOOD CHLORIDE INCREASED,1
AU,BLOOD CREATINE INCREASED,1
AU,BLOOD CREATININE DECREASED,1
AU,BLOOD DISORDER,1
AU,BLOOD ELECTROLYTES ABNORMAL,1
AU,BLOOD FIBRINOGEN INCREASED,1
AU,BLOOD IRON DECREASED,1
AU,BLOOD OSMOLARITY DECREASED,1
AU,BLOOD OSMOLARITY INCREASED,1
AU,BLOOD PHOSPHORUS INCREASED,1
AU,BLOOD PRESSURE INCREASED,1
AU,BLOOD UREA DECREASED,1
AU,BLOOD UREA NITROGEN/CREATININE RATIO DECREASED,1
AU,BONE MARROW FAILURE,1
AU,BRACHIOCEPHALIC VEIN THROMBOSIS,1
AU,BRAIN NATRIURETIC PEPTIDE INCREASED,1
AU,BRONCHITIS,1
AU,BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC,1
AU,BRONCHOSPASM,1
AU,BURSITIS,1
AU,CALCINOSIS,1
AU,CALCIUM DEFICIENCY,1
AU,CANCER PAIN,1
AU,CANDIDA INFECTION,1
AU,CARDIAC DISORDER,1
AU,CARDIAC ENZYMES INCREASED,1
AU,CARDIO-RESPIRATORY ARREST,1
AU,CARDIOPULMONARY FAILURE,1
AU,CATHETER SITE CELLULITIS,1
AU,CATHETER SITE DISCHARGE,1
AU,CENTRAL NERVOUS SYSTEM LESION,1
AU,CEREBRAL DISORDER,1
AU,CEREBRAL HAEMORRHAGE,1
AU,CEREBRAL INFARCTION,1
AU,CHEST X-RAY ABNORMAL,1
AU,CHOKING,1
AU,CHOLANGIOCARCINOMA,1
AU,CHOLECYSTITIS,1
AU,CHOLELITHIASIS,1
AU,CHROMATURIA,1
AU,CHRONIC HEPATIC FAILURE,1
AU,CIRCULATORY COLLAPSE,1
AU,CIRRHOSIS ALCOHOLIC,1
AU,CLONIC CONVULSION,1
AU,COLONIC ABSCESS,1
AU,CONGESTIVE CARDIOMYOPATHY,1
AU,CONJUNCTIVAL OEDEMA,1
AU,CONJUNCTIVITIS INFECTIVE,1
AU,CORONARY ARTERY DISEASE,1
AU,CRYING,1
AU,CYST,1
AU,CYTOKINE RELEASE SYNDROME,1
AU,CYTOMEGALOVIRUS INFECTION,1
AU,DEEP VEIN THROMBOSIS,1
AU,DELUSIONS_ MIXED,1
AU,DEMENTIA,1
AU,DEVICE DIFFICULT TO USE,1
AU,DEVICE RELATED INFECTION,1
AU,DIFFUSE LARGE B-CELL LYMPHOMA,1
AU,DISTAL INTESTINAL OBSTRUCTION SYNDROME,1
AU,DISTURBANCE IN ATTENTION,1
AU,DIVERTICULAR PERFORATION,1
AU,DIVERTICULITIS,1
AU,DIVERTICULUM,1
AU,DRUG ABUSE,1
AU,DRUG DOSE OMISSION,1
AU,DRUG ERUPTION,1
AU,DRUG INTOLERANCE,1
AU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
AU,DRY EYE,1
AU,DRY MOUTH,1
AU,DYSAESTHESIA,1
AU,DYSARTHRIA,1
AU,DYSGRAPHIA,1
AU,DYSKINESIA,1
AU,DYSPHAGIA,1
AU,DYSTONIA,1
AU,ELECTROCARDIOGRAM QT INTERVAL ABNORMAL,1
AU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
AU,ELECTROCARDIOGRAM ST-T CHANGE,1
AU,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
AU,ELEVATED MOOD,1
AU,EMBOLIC STROKE,1
AU,EMBOLISM,1
AU,EMOTIONAL DISORDER,1
AU,EMOTIONAL DISTRESS,1
AU,ENTERITIS,1
AU,EOSINOPHILIC COLITIS,1
AU,EPILEPSY,1
AU,EPSTEIN-BARR VIRUS INFECTION,1
AU,ESCHERICHIA BACTERAEMIA,1
AU,EXERCISE TEST ABNORMAL,1
AU,EXTRAPYRAMIDAL DISORDER,1
AU,EYE PAIN,1
AU,EYELID OEDEMA,1
AU,FAECAL INCONTINENCE,1
AU,FAECALOMA,1
AU,FAECES DISCOLOURED,1
AU,FAMILY STRESS,1
AU,FEELING COLD,1
AU,FEMUR FRACTURE,1
AU,FIBULA FRACTURE,1
AU,FLANK PAIN,1
AU,FULL BLOOD COUNT DECREASED,1
AU,FUNGAL INFECTION,1
AU,GALLBLADDER ENLARGEMENT,1
AU,GALLBLADDER POLYP,1
AU,GAMMA-GLUTAMYLTRANSFERASE DECREASED,1
AU,GASTRIC ANTRAL VASCULAR ECTASIA,1
AU,GASTRIC DILATATION,1
AU,GASTRIC ULCER,1
AU,GASTRITIS EROSIVE,1
AU,GASTROENTERITIS,1
AU,GASTROENTERITIS VIRAL,1
AU,GASTROINTESTINAL CARCINOMA,1
AU,GASTROINTESTINAL DISORDER,1
AU,GASTROINTESTINAL HAEMORRHAGE,1
AU,GASTROINTESTINAL MUCOSAL DISORDER,1
AU,GASTROINTESTINAL PERFORATION,1
AU,GASTROINTESTINAL STOMA COMPLICATION,1
AU,GENITAL NEOPLASM MALIGNANT FEMALE,1
AU,GLOBULINS DECREASED,1
AU,GLUCOSE TOLERANCE IMPAIRED,1
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
AU,HAEMANGIOMA OF BONE,1
AU,HAEMATOLOGY TEST ABNORMAL,1
AU,HAEMODYNAMIC INSTABILITY,1
AU,HAEMOGLOBINURIA,1
AU,HAEMOLYSIS,1
AU,HAEMOPTYSIS,1
AU,HAEMORRHAGE URINARY TRACT,1
AU,HAEMORRHAGIC STROKE,1
AU,HAEMORRHOIDS,1
AU,HAIR COLOUR CHANGES,1
AU,HEAD INJURY,1
AU,HEAT STROKE,1
AU,HEMIPARESIS,1
AU,HEPATIC CIRRHOSIS,1
AU,HIP FRACTURE,1
AU,HISTIOCYTOSIS HAEMATOPHAGIC,1
AU,HOSTILITY,1
AU,HUMERUS FRACTURE,1
AU,HYDRONEPHROSIS,1
AU,HYPERBILIRUBINAEMIA,1
AU,HYPERSPLENISM,1
AU,HYPERTHERMIA,1
AU,HYPOCHROMIC ANAEMIA,1
AU,HYPOPERFUSION,1
AU,HYPOPHAGIA,1
AU,HYPOPHYSITIS,1
AU,HYPOPITUITARISM,1
AU,HYPOVOLAEMIA,1
AU,HYPOXIA,1
AU,ILL-DEFINED DISORDER,1
AU,IMMUNISATION,1
AU,IMMUNODEFICIENCY,1
AU,INCORRECT PRODUCT STORAGE,1
AU,INFECTED SEROMA,1
AU,INFLUENZA,1
AU,INFUSION SITE PAIN,1
AU,INITIAL INSOMNIA,1
AU,INJECTION SITE REACTION,1
AU,INJECTION SITE URTICARIA,1
AU,INSOMNIA,1
AU,INTENTIONAL PRODUCT MISUSE,1
AU,INTERNATIONAL NORMALISED RATIO DECREASED,1
AU,INTERNATIONAL NORMALISED RATIO INCREASED,1
AU,INTERVERTEBRAL DISC DEGENERATION,1
AU,INTESTINAL ISCHAEMIA,1
AU,INTESTINAL OBSTRUCTION,1
AU,INTRAOCULAR PRESSURE DECREASED,1
AU,IRITIS,1
AU,ISCHAEMIC STROKE,1
AU,JAUNDICE CHOLESTATIC,1
AU,JOB DISSATISFACTION,1
AU,JOINT DISLOCATION,1
AU,JOINT DISLOCATION PATHOLOGICAL,1
AU,JOINT STIFFNESS,1
AU,JOINT SWELLING,1
AU,KIDNEY FIBROSIS,1
AU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
AU,LACTIC ACIDOSIS,1
AU,LARGE INTESTINAL OBSTRUCTION,1
AU,LARGE INTESTINAL ULCER,1
AU,LEFT VENTRICULAR DYSFUNCTION,1
AU,LEFT VENTRICULAR HYPERTROPHY,1
AU,LEUKOCYTOCLASTIC VASCULITIS,1
AU,LIMB DISCOMFORT,1
AU,LIMB INJURY,1
AU,LIP INJURY,1
AU,LIP SQUAMOUS CELL CARCINOMA,1
AU,LIP SWELLING,1
AU,LISTLESS,1
AU,LOBAR PNEUMONIA,1
AU,LOCALISED INFECTION,1
AU,LOWER LIMB FRACTURE,1
AU,LUNG CANCER METASTATIC,1
AU,LUNG CONSOLIDATION,1
AU,LUNG DISORDER,1
AU,LUNG INFECTION,1
AU,LUNG INFILTRATION,1
AU,LUNG NEOPLASM MALIGNANT,1
AU,LYMPHADENOPATHY,1
AU,MALNUTRITION,1
AU,MANIA,1
AU,MASTICATION DISORDER,1
AU,MEDIAL TIBIAL STRESS SYNDROME,1
AU,MEDICATION ERROR,1
AU,MEMORY IMPAIRMENT,1
AU,MENORRHAGIA,1
AU,MENTAL DISORDER,1
AU,MESENTERIC NEOPLASM,1
AU,METASTASES TO BONE,1
AU,METASTASES TO BONE MARROW,1
AU,METASTASES TO KIDNEY,1
AU,METASTASES TO LUNG,1
AU,METASTASES TO LYMPH NODES,1
AU,METASTASES TO PANCREAS,1
AU,METASTASES TO THE MEDIASTINUM,1
AU,METASTATIC NEOPLASM,1
AU,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,1
AU,MOOD SWINGS,1
AU,MOUTH ULCERATION,1
AU,MOVEMENT DISORDER,1
AU,MUCOSAL INFLAMMATION,1
AU,MULTI-ORGAN FAILURE,1
AU,MUSCLE RIGIDITY,1
AU,MUSCLE SPASMS,1
AU,MUSCULAR WEAKNESS,1
AU,MYOGLOBIN BLOOD INCREASED,1
AU,MYOGLOBIN URINE,1
AU,MYOSITIS,1
AU,NAIL BED BLEEDING,1
AU,NEPHRITIS,1
AU,NEPHROPATHY,1
AU,NERVE COMPRESSION,1
AU,NERVE INJURY,1
AU,NERVOUS SYSTEM DISORDER,1
AU,NEUTROPENIC SEPSIS,1
AU,NEUTROPHIL COUNT INCREASED,1
AU,NEUTROPHILIA,1
AU,NIGHT BLINDNESS,1
AU,NIGHT SWEATS,1
AU,OBSESSIVE-COMPULSIVE DISORDER,1
AU,OCCULT BLOOD POSITIVE,1
AU,OCULAR TOXICITY,1
AU,OESOPHAGEAL ADENOCARCINOMA,1
AU,OESOPHAGITIS,1
AU,ONYCHOMADESIS,1
AU,OPHTHALMIC HERPES ZOSTER,1
AU,OPPORTUNISTIC INFECTION,1
AU,OPTIC NEURITIS,1
AU,OPTIC NEUROPATHY,1
AU,ORAL CANDIDIASIS,1
AU,ORAL DISCOMFORT,1
AU,ORAL PAIN,1
AU,ORTHOSTATIC HYPOTENSION,1
AU,OSTEOARTHRITIS,1
AU,OSTEOPOROSIS,1
AU,OSTEOSCLEROSIS,1
AU,OXYGEN SATURATION DECREASED,1
AU,PAIN IN JAW,1
AU,PALPITATIONS,1
AU,PARAINFLUENZAE VIRUS INFECTION,1
AU,PARKINSONISM,1
AU,PELVIC FLUID COLLECTION,1
AU,PELVIC FRACTURE,1
AU,PERIORBITAL OEDEMA,1
AU,PERIPHERAL MOTOR NEUROPATHY,1
AU,PERONEAL NERVE PALSY,1
AU,PERSONAL RELATIONSHIP ISSUE,1
AU,PHARYNGEAL OEDEMA,1
AU,PLASMA CELL MYELOMA,1
AU,PLATELET COUNT ABNORMAL,1
AU,PLEURAL EFFUSION,1
AU,PLEURITIC PAIN,1
AU,PNEUMONIA MYCOPLASMAL,1
AU,PNEUMOPERITONEUM,1
AU,POLYARTHRITIS,1
AU,POLYCHROMASIA,1
AU,POLYNEUROPATHY,1
AU,PORTAL SHUNT,1
AU,PORTAL VEIN DILATATION,1
AU,POST HERPETIC NEURALGIA,1
AU,POST PROCEDURAL INFECTION,1
AU,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
AU,PRESYNCOPE,1
AU,PROCTALGIA,1
AU,PRODUCT SUBSTITUTION ISSUE,1
AU,PROSTATE CANCER,1
AU,PROSTATE CANCER METASTATIC,1
AU,PSYCHOPATHIC PERSONALITY,1
AU,PSYCHOTIC BEHAVIOUR,1
AU,PUBIS FRACTURE,1
AU,PULMONARY ARTERIAL HYPERTENSION,1
AU,PULMONARY MASS,1
AU,PULMONARY VALVE INCOMPETENCE,1
AU,PURULENT DISCHARGE,1
AU,PURULENT PERICARDITIS,1
AU,RADIATION PROCTITIS,1
AU,RASH ERYTHEMATOUS,1
AU,RASH PRURITIC,1
AU,RECTAL ADENOCARCINOMA,1
AU,RECTAL CANCER,1
AU,RENAL ARTERIOSCLEROSIS,1
AU,RENAL CANCER,1
AU,RENAL CELL CARCINOMA,1
AU,RENAL FAILURE ACUTE,1
AU,RENAL FAILURE CHRONIC,1
AU,RENAL GRAFT INFECTION,1
AU,RENAL TRANSPLANT,1
AU,RENAL TUBULAR ATROPHY,1
AU,RENAL TUBULAR NECROSIS,1
AU,RESPIRATION ABNORMAL,1
AU,RESPIRATORY DISTRESS,1
AU,RESPIRATORY TRACT INFECTION,1
AU,RETINAL INJURY,1
AU,RHEUMATOID ARTHRITIS,1
AU,RIB FRACTURE,1
AU,ROAD TRAFFIC ACCIDENT,1
AU,SALMONELLA BACTERAEMIA,1
AU,SCHIZOAFFECTIVE DISORDER,1
AU,SEROMA,1
AU,SEROTONIN SYNDROME,1
AU,SERUM FERRITIN DECREASED,1
AU,SEXUALLY TRANSMITTED DISEASE,1
AU,SHOCK,1
AU,SIALOADENITIS,1
AU,SINUS ARREST,1
AU,SINUSITIS,1
AU,SKIN BURNING SENSATION,1
AU,SKIN CANCER,1
AU,SKIN ULCER,1
AU,SLUGGISHNESS,1
AU,SOCIAL AVOIDANT BEHAVIOUR,1
AU,SOCIAL PROBLEM,1
AU,SOMATIC DELUSION,1
AU,SOMNOLENCE,1
AU,SPEECH DISORDER,1
AU,SPINAL COMPRESSION FRACTURE,1
AU,SPINAL OSTEOARTHRITIS,1
AU,SQUAMOUS CELL CARCINOMA OF LUNG,1
AU,STAPHYLOCOCCUS TEST POSITIVE,1
AU,STEM CELL TRANSPLANT,1
AU,STERILE PYURIA,1
AU,STILL^S DISEASE ADULT ONSET,1
AU,STRIDOR,1
AU,SUBDURAL EMPYEMA,1
AU,SUBSTANCE ABUSE,1
AU,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
AU,SUICIDAL IDEATION,1
AU,SUNBURN,1
AU,SUPRAVENTRICULAR EXTRASYSTOLES,1
AU,SUPRAVENTRICULAR TACHYCARDIA,1
AU,SWELLING FACE,1
AU,SWOLLEN TONGUE,1
AU,SYNCOPE,1
AU,SYSTEMIC LUPUS ERYTHEMATOSUS,1
AU,TACHYARRHYTHMIA,1
AU,TESTICULAR TORSION,1
AU,THINKING ABNORMAL,1
AU,THROAT TIGHTNESS,1
AU,THROMBOSIS,1
AU,THYROID MASS,1
AU,TIBIA FRACTURE,1
AU,TONGUE DISCOLOURATION,1
AU,TONGUE DISORDER,1
AU,TOOTHACHE,1
AU,TRANSPLANT DYSFUNCTION,1
AU,TRANSPLANT REJECTION,1
AU,TRAUMATIC HAEMATOMA,1
AU,TRICUSPID VALVE INCOMPETENCE,1
AU,TRISMUS,1
AU,TROPONIN T INCREASED,1
AU,TUMOUR HAEMORRHAGE,1
AU,UNEVALUABLE EVENT,1
AU,URETERIC OBSTRUCTION,1
AU,URINARY TRACT INFECTION PSEUDOMONAL,1
AU,VASCULAR PSEUDOANEURYSM,1
AU,VASCULAR STENT THROMBOSIS,1
AU,VENTRICULAR EXTRASYSTOLES,1
AU,VENTRICULAR HYPERTROPHY,1
AU,VENTRICULAR INTERNAL DIAMETER ABNORMAL,1
AU,VENTRICULAR TACHYCARDIA,1
AU,VIRAL INFECTION,1
AU,VIRAL MYOCARDITIS,1
AU,VISION BLURRED,1
AU,VISUAL ACUITY REDUCED,1
AU,VITAMIN D DEFICIENCY,1
AU,VULVOVAGINAL PRURITUS,1
AU,WHEEZING,1
AU,WHITE BLOOD CELL COUNT ABNORMAL,1
AU,WOUND,1
AU,WOUND COMPLICATION,1
AU,WOUND DEHISCENCE,1
AU,WOUND INFECTION,1
AT,CENTRAL NERVOUS SYSTEM LESION,2
AT,CLINICALLY ISOLATED SYNDROME,2
AT,DEMYELINATION,2
AT,ILEUS,2
AT,NAUSEA,2
AT,SMALL INTESTINE ADENOCARCINOMA,2
AT,ABDOMINAL PAIN,1
AT,ACUTE KIDNEY INJURY,1
AT,ARTHRALGIA,1
AT,BARRETT^S OESOPHAGUS,1
AT,BLOOD GLUCOSE INCREASED,1
AT,CONSTIPATION,1
AT,DEPRESSION,1
AT,DEPRESSION SUICIDAL,1
AT,DERMATITIS,1
AT,DIARRHOEA,1
AT,DIASTOLIC DYSFUNCTION,1
AT,DILATATION ATRIAL,1
AT,DIVERTICULITIS,1
AT,DYSPHONIA,1
AT,ENTERITIS,1
AT,EPISTAXIS,1
AT,ESCHERICHIA BACTERAEMIA,1
AT,FEBRILE INFECTION,1
AT,HAEMOGLOBIN ABNORMAL,1
AT,INTENSIVE CARE,1
AT,INTESTINAL HAEMORRHAGE,1
AT,IRIDOCYCLITIS,1
AT,LOSS OF CONSCIOUSNESS,1
AT,MESENTERIC ARTERY THROMBOSIS,1
AT,MESENTERIC VASCULAR OCCLUSION,1
AT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
AT,MYALGIA,1
AT,PANCREATITIS,1
AT,POLYNEUROPATHY,1
AT,PYREXIA,1
AT,RENAL CYST INFECTION,1
AT,RENAL CYST RUPTURED,1
AT,SEPSIS,1
AT,THROAT CLEARING,1
AT,THYROID MASS,1
AT,TRICUSPID VALVE INCOMPETENCE,1
BH,ANGIOEDEMA,1
BH,RASH,1
BD,INTENTIONAL PRODUCT USE ISSUE,5
BD,RESPIRATORY DISTRESS,5
BD,ARTHRALGIA,4
BD,ASTHENIA,3
BD,ELECTROLYTE IMBALANCE,3
BD,HAEMOGLOBIN DECREASED,3
BD,COUGH,2
BD,DECREASED APPETITE,2
BD,DYSPNOEA,2
BD,ELECTROCARDIOGRAM QT PROLONGED,2
BD,HYPOCALCAEMIA,2
BD,PYREXIA,2
BD,RENAL FAILURE,2
BD,VOMITING,2
BD,ADVERSE EVENT,1
BD,ANAEMIA OF CHRONIC DISEASE,1
BD,BLOOD ALBUMIN DECREASED,1
BD,BLOOD THYROID STIMULATING HORMONE INCREASED,1
BD,CEREBROVASCULAR ACCIDENT,1
BD,CONSTIPATION,1
BD,DEAFNESS,1
BD,DRUG INEFFECTIVE,1
BD,DYSPNOEA EXERTIONAL,1
BD,HAEMOPTYSIS,1
BD,HYPERTENSION,1
BD,HYPOACUSIS,1
BD,HYPOKALAEMIA,1
BD,INCORRECT DRUG ADMINISTRATION DURATION,1
BD,INFECTION,1
BD,KWASHIORKOR,1
BD,MENINGITIS TUBERCULOUS,1
BD,MOUTH ULCERATION,1
BD,MYCOBACTERIUM TEST POSITIVE,1
BD,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
BD,MYOCARDIAL INFARCTION,1
BD,MYOCARDIAL ISCHAEMIA,1
BD,NAUSEA,1
BD,NEUROPATHY PERIPHERAL,1
BD,OEDEMA,1
BD,OPTIC NERVE DISORDER,1
BD,PNEUMOTHORAX,1
BD,PRODUCT USE IN UNAPPROVED INDICATION,1
BD,PSYCHIATRIC SYMPTOM,1
BD,PULMONARY CAVITATION,1
BD,PULMONARY HAEMORRHAGE,1
BD,PURPURA,1
BD,RESPIRATORY FAILURE,1
BD,RICKETTSIOSIS,1
BD,SPUTUM ABNORMAL,1
BD,SUDDEN DEATH,1
BD,TINNITUS,1
BD,TUBERCULOSIS,1
BD,UNDERDOSE,1
BD,VISCERAL LEISHMANIASIS,1
BD,WEIGHT DECREASED,1
BY,ADVERSE EVENT,1
BY,ALANINE AMINOTRANSFERASE INCREASED,1
BY,ANAEMIA,1
BY,ARTHRALGIA,1
BY,ASCITES,1
BY,ASPARTATE AMINOTRANSFERASE INCREASED,1
BY,ASTHENIA,1
BY,BACK PAIN,1
BY,BLOOD DISORDER,1
BY,CALCULUS URINARY,1
BY,CIRCULATORY COLLAPSE,1
BY,CONDITION AGGRAVATED,1
BY,COUGH,1
BY,CYTOMEGALOVIRUS TEST POSITIVE,1
BY,CYTOPENIA,1
BY,DEVICE RELATED INFECTION,1
BY,DUODENAL ULCER,1
BY,DYSPNOEA,1
BY,DYSPNOEA EXERTIONAL,1
BY,FEBRILE NEUTROPENIA,1
BY,HAEMOPTYSIS,1
BY,HEPATIC CONGESTION,1
BY,HEPATOMEGALY,1
BY,LEUKOPENIA,1
BY,NEUTROPENIA,1
BY,PERICARDIAL EFFUSION,1
BY,PERIPHERAL SENSORY NEUROPATHY,1
BY,PNEUMONIA,1
BY,PULMONARY ARTERIAL HYPERTENSION,1
BY,PYELONEPHRITIS ACUTE,1
BY,RESPIRATORY DISTRESS,1
BY,THROMBOCYTOPENIA,1
BY,UPPER RESPIRATORY TRACT INFECTION,1
BY,WEIGHT INCREASED,1
BE,FATIGUE,18
BE,DIARRHOEA,16
BE,NAUSEA,16
BE,DECREASED APPETITE,14
BE,NEUTROPENIA,14
BE,VOMITING,14
BE,ANAEMIA,13
BE,GENERAL PHYSICAL HEALTH DETERIORATION,13
BE,PYREXIA,12
BE,DYSPNOEA,11
BE,PNEUMONIA,11
BE,HEADACHE,10
BE,MALAISE,10
BE,ASTHENIA,9
BE,BACK PAIN,9
BE,HYPOKALAEMIA,9
BE,LUPUS-LIKE SYNDROME,9
BE,DEHYDRATION,8
BE,MYALGIA,8
BE,PRURITUS,8
BE,THROMBOCYTOPENIA,8
BE,ABDOMINAL PAIN,7
BE,ARTHRALGIA,7
BE,C-REACTIVE PROTEIN INCREASED,7
BE,CARDIAC ARREST,7
BE,HAEMATURIA,7
BE,RASH,7
BE,RENAL FAILURE,7
BE,SEPTIC SHOCK,7
BE,WEIGHT DECREASED,7
BE,ATRIAL FIBRILLATION,6
BE,BRONCHOPNEUMOPATHY,6
BE,CARDIAC FAILURE,6
BE,DEATH,6
BE,HYPOTENSION,6
BE,LYMPHANGITIS,6
BE,NECROSIS,6
BE,OSTEITIS,6
BE,SEPSIS,6
BE,URINARY TRACT INFECTION,6
BE,ARRHYTHMIA,5
BE,ASCITES,5
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
BE,CONFUSIONAL STATE,5
BE,DIZZINESS,5
BE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
BE,ENCEPHALOPATHY,5
BE,HEMIPARESIS,5
BE,HYPERSENSITIVITY,5
BE,HYPERTENSION,5
BE,HYPOCALCAEMIA,5
BE,INSOMNIA,5
BE,INTESTINAL OBSTRUCTION,5
BE,LOSS OF CONSCIOUSNESS,5
BE,METABOLIC ACIDOSIS,5
BE,OEDEMA PERIPHERAL,5
BE,PAIN IN EXTREMITY,5
BE,PLASMA CELL MYELOMA,5
BE,RENAL FAILURE ACUTE,5
BE,SYSTEMIC LUPUS ERYTHEMATOSUS,5
BE,TORSADE DE POINTES,5
BE,ABDOMINAL PAIN UPPER,4
BE,ACUTE KIDNEY INJURY,4
BE,BRONCHITIS,4
BE,CONJUNCTIVITIS,4
BE,CONSTIPATION,4
BE,CONTUSION,4
BE,DISEASE PROGRESSION,4
BE,DRUG HYPERSENSITIVITY,4
BE,DRUG INEFFECTIVE,4
BE,EPILEPSY,4
BE,EPISTAXIS,4
BE,FEBRILE NEUTROPENIA,4
BE,GASTRITIS,4
BE,HAEMATOMA,4
BE,HEPATIC ENZYME INCREASED,4
BE,HEPATITIS TOXIC,4
BE,HYPOMAGNESAEMIA,4
BE,INFLUENZA LIKE ILLNESS,4
BE,INTERNATIONAL NORMALISED RATIO INCREASED,4
BE,JOINT SWELLING,4
BE,LARGE INTESTINE PERFORATION,4
BE,LEUKOPENIA,4
BE,MALIGNANT NEOPLASM PROGRESSION,4
BE,MYOCARDIAL INFARCTION,4
BE,PANCREATITIS,4
BE,ABDOMINAL DISTENSION,3
BE,ACUTE MYOCARDIAL INFARCTION,3
BE,ALANINE AMINOTRANSFERASE INCREASED,3
BE,ANAPHYLACTIC SHOCK,3
BE,ASPARTATE AMINOTRANSFERASE INCREASED,3
BE,BLOOD ALBUMIN DECREASED,3
BE,BLOOD GLUCOSE INCREASED,3
BE,BLOOD LACTATE DEHYDROGENASE INCREASED,3
BE,BLOOD PRESSURE DECREASED,3
BE,BODY TEMPERATURE INCREASED,3
BE,BRADYCARDIA,3
BE,CHOLECYSTITIS,3
BE,COUGH,3
BE,CROHN^S DISEASE,3
BE,DISSEMINATED INTRAVASCULAR COAGULATION,3
BE,DYSARTHRIA,3
BE,DYSPEPSIA,3
BE,DYSPHAGIA,3
BE,DYSURIA,3
BE,ECCHYMOSIS,3
BE,HAEMOGLOBIN DECREASED,3
BE,HEMIPLEGIA,3
BE,HERPES ZOSTER,3
BE,HYPERKALAEMIA,3
BE,INTERSTITIAL LUNG DISEASE,3
BE,INTESTINAL ISCHAEMIA,3
BE,LONG QT SYNDROME,3
BE,LUNG INFECTION,3
BE,MOVEMENT DISORDER,3
BE,MULTI-ORGAN FAILURE,3
BE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
BE,OESOPHAGITIS,3
BE,OSTEONECROSIS OF JAW,3
BE,PAIN,3
BE,PARAESTHESIA,3
BE,PHARYNGITIS,3
BE,PNEUMOTHORAX,3
BE,PRURIGO,3
BE,PULMONARY EMBOLISM,3
BE,RECTAL HAEMORRHAGE,3
BE,RENAL IMPAIRMENT,3
BE,SOMNOLENCE,3
BE,TACHYCARDIA,3
BE,TOXICITY TO VARIOUS AGENTS,3
BE,TRANSIENT ISCHAEMIC ATTACK,3
BE,VERTIGO,3
BE,YELLOW SKIN,3
BE,ACUTE MYELOID LEUKAEMIA,2
BE,AGITATION,2
BE,ANXIETY,2
BE,APHASIA,2
BE,APNOEA,2
BE,ATAXIA,2
BE,ATRIOVENTRICULAR BLOCK,2
BE,BENIGN NEOPLASM,2
BE,BLOOD ALKALINE PHOSPHATASE INCREASED,2
BE,BLOOD CREATININE INCREASED,2
BE,BLOOD POTASSIUM INCREASED,2
BE,BRONCHOPNEUMONIA,2
BE,BRONCHOPULMONARY ASPERGILLOSIS,2
BE,BURNING SENSATION,2
BE,CARDIOMYOPATHY,2
BE,CEREBROVASCULAR ACCIDENT,2
BE,COLITIS,2
BE,CONVULSION,2
BE,CYTOMEGALOVIRUS INFECTION,2
BE,DELIRIUM,2
BE,DEPRESSION,2
BE,DERMATITIS,2
BE,DERMATITIS BULLOUS,2
BE,DERMATITIS CONTACT,2
BE,DIVERTICULITIS,2
BE,DYSGEUSIA,2
BE,DYSKINESIA,2
BE,ECZEMA,2
BE,ELECTROCARDIOGRAM QT PROLONGED,2
BE,ERYSIPELAS,2
BE,EYE PAIN,2
BE,FACIAL PARALYSIS,2
BE,FALL,2
BE,FEELING HOT,2
BE,FLUID RETENTION,2
BE,GAIT DISTURBANCE,2
BE,GASTROINTESTINAL DISORDER,2
BE,GASTROINTESTINAL HAEMORRHAGE,2
BE,GASTROINTESTINAL INFLAMMATION,2
BE,GASTROOESOPHAGEAL REFLUX DISEASE,2
BE,HAEMOPTYSIS,2
BE,HAEMORRHAGE SUBCUTANEOUS,2
BE,HALLUCINATION,2
BE,HEART RATE INCREASED,2
BE,HEPATIC FAILURE,2
BE,HEPATITIS,2
BE,HYPERAMMONAEMIC ENCEPHALOPATHY,2
BE,HYPERHIDROSIS,2
BE,HYPOKINESIA,2
BE,HYPONATRAEMIA,2
BE,HYPOVOLAEMIA,2
BE,IMMUNE THROMBOCYTOPENIC PURPURA,2
BE,INFECTION,2
BE,INFLUENZA,2
BE,INGUINAL HERNIA,2
BE,ISCHAEMIC STROKE,2
BE,LUNG ADENOCARCINOMA,2
BE,LUNG DISORDER,2
BE,LYMPHOPENIA,2
BE,METASTASES TO LUNG,2
BE,MOBILITY DECREASED,2
BE,MUCOSAL INFLAMMATION,2
BE,NASOPHARYNGITIS,2
BE,NEPHROLITHIASIS,2
BE,OCULAR ICTERUS,2
BE,OEDEMA,2
BE,PARKINSON^S DISEASE,2
BE,PERIPHERAL SWELLING,2
BE,PLEURAL EFFUSION,2
BE,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
BE,PNEUMONIA BACTERIAL,2
BE,PNEUMONITIS,2
BE,POOR QUALITY SLEEP,2
BE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
BE,PROCTALGIA,2
BE,RENAL CELL CARCINOMA,2
BE,RESPIRATORY FAILURE,2
BE,SERUM FERRITIN INCREASED,2
BE,SHOCK,2
BE,SKIN ATROPHY,2
BE,SKIN ULCER,2
BE,SMALL INTESTINAL OBSTRUCTION,2
BE,SPINAL PAIN,2
BE,SQUAMOUS CELL CARCINOMA,2
BE,STAPHYLOCOCCAL INFECTION,2
BE,SUDDEN DEATH,2
BE,SUICIDE ATTEMPT,2
BE,SYNCOPE,2
BE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
BE,THERAPY NON-RESPONDER,2
BE,TUBULOINTERSTITIAL NEPHRITIS,2
BE,UROSEPSIS,2
BE,VAGINAL ULCERATION,2
BE,VISION BLURRED,2
BE,WEIGHT INCREASED,2
BE,WHITE BLOOD CELL COUNT DECREASED,2
BE,ABDOMINAL DISCOMFORT,1
BE,ABDOMINAL WALL HAEMATOMA,1
BE,ABNORMAL FAECES,1
BE,ABORTION SPONTANEOUS,1
BE,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
BE,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
BE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
BE,ACUTE HEPATIC FAILURE,1
BE,ACUTE PULMONARY OEDEMA,1
BE,ADENOCARCINOMA OF COLON,1
BE,ADENOVIRUS INFECTION,1
BE,AGGRESSION,1
BE,ALOPECIA,1
BE,ALTERED STATE OF CONSCIOUSNESS,1
BE,AMYLOIDOSIS SENILE,1
BE,ANAL SPHINCTER HYPERTONIA,1
BE,ANAL SQUAMOUS CELL CARCINOMA,1
BE,ANAL STENOSIS,1
BE,ANOGENITAL WARTS,1
BE,ANORECTAL HUMAN PAPILLOMA VIRUS INFECTION,1
BE,ANOSMIA,1
BE,APHTHOUS ULCER,1
BE,APPENDICITIS,1
BE,ARTHRITIS,1
BE,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
BE,ASTHMA,1
BE,ATELECTASIS,1
BE,ATRIAL SEPTAL DEFECT,1
BE,AUTOIMMUNE HYPOTHYROIDISM,1
BE,B PRECURSOR TYPE ACUTE LEUKAEMIA,1
BE,BACTERAEMIA,1
BE,BILIARY COLIC,1
BE,BILIRUBIN CONJUGATED INCREASED,1
BE,BLADDER DISORDER,1
BE,BLINDNESS UNILATERAL,1
BE,BLOOD BILIRUBIN INCREASED,1
BE,BLOOD GLUCOSE ABNORMAL,1
BE,BLOOD PRESSURE INCREASED,1
BE,BRADYPHRENIA,1
BE,BREAST CANCER,1
BE,BREAST PAIN,1
BE,BREATH ODOUR,1
BE,BRONCHIAL CARCINOMA,1
BE,BRONCHIOLITIS,1
BE,BRONCHITIS CHRONIC,1
BE,BUBONIC PLAGUE,1
BE,CAFE AU LAIT SPOTS,1
BE,CALCIPHYLAXIS,1
BE,CARDIAC FLUTTER,1
BE,CARDIAC TAMPONADE,1
BE,CARDIOMEGALY,1
BE,CARDIOTOXICITY,1
BE,CAROTID ARTERY THROMBOSIS,1
BE,CATHETER SITE HAEMORRHAGE,1
BE,CEREBRAL HAEMORRHAGE,1
BE,CERVICAL SPINAL STENOSIS,1
BE,CHEST DISCOMFORT,1
BE,CHEST PAIN,1
BE,CHILLS,1
BE,CHOLANGIOCARCINOMA,1
BE,CHOLANGITIS,1
BE,CHOLECYSTITIS ACUTE,1
BE,CHOLELITHIASIS,1
BE,CHROMATURIA,1
BE,CHRONIC SINUSITIS,1
BE,CLOSTRIDIUM DIFFICILE INFECTION,1
BE,COAGULOPATHY,1
BE,COMA,1
BE,COMA HEPATIC,1
BE,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
BE,CONDITION AGGRAVATED,1
BE,CONJUNCTIVAL IRRITATION,1
BE,CRANIAL NERVE DISORDER,1
BE,CRYPTORCHISM,1
BE,CYSTITIS,1
BE,CYSTITIS NONINFECTIVE,1
BE,DACRYOSTENOSIS ACQUIRED,1
BE,DEFAECATION URGENCY,1
BE,DELUSION,1
BE,DEPRESSIVE SYMPTOM,1
BE,DEVICE DIFFICULT TO USE,1
BE,DIABETES MELLITUS,1
BE,DISORIENTATION,1
BE,DRUG DOSE OMISSION,1
BE,DRUG ERUPTION,1
BE,DRUG-INDUCED LIVER INJURY,1
BE,DRY MOUTH,1
BE,DRY SKIN,1
BE,DYSPNOEA EXERTIONAL,1
BE,DYSSTASIA,1
BE,EAR INFECTION,1
BE,EAR MALFORMATION,1
BE,ECZEMA EYELIDS,1
BE,EMBOLIC STROKE,1
BE,ENCEPHALITIS,1
BE,ENTEROBACTER INFECTION,1
BE,EOSINOPHILIC PNEUMONIA,1
BE,EPIDERMOLYSIS,1
BE,EPSTEIN-BARR VIRUS INFECTION,1
BE,ERYTHEMA INDURATUM,1
BE,ESCHERICHIA SEPSIS,1
BE,EYE MOVEMENT DISORDER,1
BE,EYE OEDEMA,1
BE,EYELID OEDEMA,1
BE,FAECALOMA,1
BE,FEELING ABNORMAL,1
BE,FEELING COLD,1
BE,FOETAL EXPOSURE DURING PREGNANCY,1
BE,FOLLICULITIS,1
BE,FREEZING PHENOMENON,1
BE,GAMMA-GLUTAMYLTRANSFERASE DECREASED,1
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
BE,GASTRIC CANCER RECURRENT,1
BE,GASTRIC ULCER,1
BE,GASTRIC ULCER PERFORATION,1
BE,GASTROENTERITIS,1
BE,GASTROINTESTINAL PAIN,1
BE,GASTROINTESTINAL SURGERY,1
BE,GENERALISED OEDEMA,1
BE,GINGIVAL BLEEDING,1
BE,GLOMERULONEPHRITIS MINIMAL LESION,1
BE,GOUTY ARTHRITIS,1
BE,GRAFT VERSUS HOST DISEASE,1
BE,GRAND MAL CONVULSION,1
BE,HAEMANGIOMA,1
BE,HAEMATEMESIS,1
BE,HAEMATOCRIT DECREASED,1
BE,HAEMORRHAGE,1
BE,HAEMORRHAGE INTRACRANIAL,1
BE,HAIRY CELL LEUKAEMIA,1
BE,HALLUCINATION_ VISUAL,1
BE,HEAD INJURY,1
BE,HEPATIC CANCER,1
BE,HEPATIC STEATOSIS,1
BE,HEPATITIS B,1
BE,HEPATITIS B REACTIVATION,1
BE,HEPATITIS FULMINANT,1
BE,HEPATOMEGALY,1
BE,HIATUS HERNIA,1
BE,HICCUPS,1
BE,HILAR LYMPHADENOPATHY,1
BE,HYDROCEPHALUS,1
BE,HYPERAESTHESIA,1
BE,HYPERALDOSTERONISM,1
BE,HYPERGLYCAEMIA,1
BE,HYPERNATRAEMIA,1
BE,HYPERPARATHYROIDISM,1
BE,HYPERSOMNIA,1
BE,HYPERTENSIVE ENCEPHALOPATHY,1
BE,HYPERTROPHIC CARDIOMYOPATHY,1
BE,HYPERVOLAEMIA,1
BE,HYPOALBUMINAEMIA,1
BE,HYPOGLYCAEMIA,1
BE,HYPOTHYROIDISM,1
BE,HYPOVITAMINOSIS,1
BE,HYPOXIA,1
BE,ILL-DEFINED DISORDER,1
BE,IMMOBILE,1
BE,INCISION SITE CELLULITIS,1
BE,INDURATION,1
BE,INFARCTION,1
BE,INFECTED SKIN ULCER,1
BE,INFECTION PARASITIC,1
BE,INFLAMMATION,1
BE,INJECTION SITE ERYTHEMA,1
BE,INJECTION SITE PAIN,1
BE,INJECTION SITE REACTION,1
BE,INJECTION SITE SWELLING,1
BE,INTENTIONAL OVERDOSE,1
BE,INTENTIONAL PRODUCT MISUSE,1
BE,INTERNATIONAL NORMALISED RATIO,1
BE,INTERTRIGO,1
BE,INTERVERTEBRAL DISC PROTRUSION,1
BE,IRON DEFICIENCY ANAEMIA,1
BE,IRRITABILITY,1
BE,ISCHAEMIA,1
BE,JAUNDICE,1
BE,JOINT DISLOCATION,1
BE,JUVENILE IDIOPATHIC ARTHRITIS,1
BE,KETOACIDOSIS,1
BE,KIDNEY DUPLEX,1
BE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
BE,LACERATION,1
BE,LACTIC ACIDOSIS,1
BE,LARYNGITIS,1
BE,LEIOMYOSARCOMA,1
BE,LEUKAEMIA,1
BE,LEUKAEMIC INFILTRATION EXTRAMEDULLARY,1
BE,LIP HAEMORRHAGE,1
BE,LIP SWELLING,1
BE,LIPIDS ABNORMAL,1
BE,LIVER FUNCTION TEST ABNORMAL,1
BE,LIVIDITY,1
BE,LOCAL SWELLING,1
BE,LOGORRHOEA,1
BE,LOW BIRTH WEIGHT BABY,1
BE,LOWER GASTROINTESTINAL HAEMORRHAGE,1
BE,LYMPHADENOPATHY,1
BE,LYMPHADENOPATHY MEDIASTINAL,1
BE,LYMPHOCYTE COUNT DECREASED,1
BE,LYMPHOCYTE COUNT INCREASED,1
BE,MALNUTRITION,1
BE,MATERNAL EXPOSURE DURING PREGNANCY,1
BE,MEDULLARY THYROID CANCER,1
BE,MENINGITIS,1
BE,MENINGITIS PNEUMOCOCCAL,1
BE,METASTASES TO BONE,1
BE,METASTASES TO NECK,1
BE,METASTASES TO PANCREAS,1
BE,METRORRHAGIA,1
BE,MIGRAINE,1
BE,MONOPARESIS,1
BE,MOOD ALTERED,1
BE,MOUTH HAEMORRHAGE,1
BE,MULTIPLE SCLEROSIS RELAPSE,1
BE,MUSCLE CONTRACTIONS INVOLUNTARY,1
BE,MUSCLE RIGIDITY,1
BE,MUSCLE SPASMS,1
BE,MUSCULAR WEAKNESS,1
BE,MUSCULOSKELETAL CHEST PAIN,1
BE,MUSCULOSKELETAL DISORDER,1
BE,MYOCARDITIS,1
BE,NASAL CONGESTION,1
BE,NEOPLASM MALIGNANT,1
BE,NEPHROGENIC DIABETES INSIPIDUS,1
BE,NEPHROTIC SYNDROME,1
BE,NERVE INJURY,1
BE,NERVOUS SYSTEM DISORDER,1
BE,NEUROGENIC BLADDER,1
BE,NEUROPATHY PERIPHERAL,1
BE,NEUTROPHIL COUNT DECREASED,1
BE,NYSTAGMUS,1
BE,OBESITY,1
BE,OBSTRUCTIVE UROPATHY,1
BE,OCCUPATIONAL EXPOSURE TO PRODUCT,1
BE,OESOPHAGEAL CANDIDIASIS,1
BE,OESOPHAGEAL HAEMORRHAGE,1
BE,OLIGURIA,1
BE,ON AND OFF PHENOMENON,1
BE,ONYCHOMYCOSIS,1
BE,OPTIC NEURITIS,1
BE,ORAL HERPES,1
BE,ORAL INFECTION,1
BE,OSTEOARTHRITIS,1
BE,OSTEOPENIA,1
BE,OVERDOSE,1
BE,OXYGEN SATURATION DECREASED,1
BE,PAIN IN JAW,1
BE,PAIN OF SKIN,1
BE,PALLOR,1
BE,PANCREATIC CARCINOMA,1
BE,PANCREATITIS NECROTISING,1
BE,PARAESTHESIA ORAL,1
BE,PATHOLOGICAL FRACTURE,1
BE,PELVIC PAIN,1
BE,PEPTIC ULCER,1
BE,PERFORMANCE STATUS DECREASED,1
BE,PERICARDIAL EFFUSION,1
BE,PERINEPHRIC COLLECTION,1
BE,PERITONITIS,1
BE,PHIMOSIS,1
BE,PHOTOPHOBIA,1
BE,PLATELET COUNT DECREASED,1
BE,PLEURAL FIBROSIS,1
BE,PLEURISY,1
BE,PNEUMONIA ASPIRATION,1
BE,POISONING,1
BE,POLYARTHRITIS,1
BE,POLYMYALGIA RHEUMATICA,1
BE,POLYURIA,1
BE,POST PROCEDURAL HAEMORRHAGE,1
BE,POST PROCEDURAL SEPSIS,1
BE,PREMATURE BABY,1
BE,PRESYNCOPE,1
BE,PRODUCT USE IN UNAPPROVED INDICATION,1
BE,PRODUCTIVE COUGH,1
BE,PROSTATE CANCER,1
BE,PROTEIN TOTAL INCREASED,1
BE,PROTEINURIA,1
BE,PROTHROMBIN LEVEL DECREASED,1
BE,PSEUDOGYNAECOMASTIA,1
BE,PSEUDOMONAS INFECTION,1
BE,PSYCHOMOTOR HYPERACTIVITY,1
BE,PULMONARY ALVEOLAR HAEMORRHAGE,1
BE,PULMONARY FIBROSIS,1
BE,PULMONARY HAEMORRHAGE,1
BE,PULMONARY OEDEMA,1
BE,PYELOCALIECTASIS,1
BE,PYELONEPHRITIS,1
BE,PYROGLUTAMATE INCREASED,1
BE,PYURIA,1
BE,RASH ERYTHEMATOUS,1
BE,RASH MACULO-PAPULAR,1
BE,RASH PAPULAR,1
BE,RECTAL ADENOCARCINOMA,1
BE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
BE,REGURGITATION,1
BE,RENAL PAIN,1
BE,RENAL TRANSPLANT,1
BE,RESPIRATORY DISORDER,1
BE,RESPIRATORY TRACT INFECTION,1
BE,RESTLESSNESS,1
BE,RHEUMATOID ARTHRITIS,1
BE,RHINITIS,1
BE,ROAD TRAFFIC ACCIDENT,1
BE,SALIVA ALTERED,1
BE,SALIVARY HYPERSECRETION,1
BE,SCLEROSING ENCAPSULATING PERITONITIS,1
BE,SEDATION,1
BE,SENSE OF OPPRESSION,1
BE,SERONEGATIVE ARTHRITIS,1
BE,SKIN DISCOLOURATION,1
BE,SKIN DISORDER,1
BE,SKIN NECROSIS,1
BE,SKIN ODOUR ABNORMAL,1
BE,SKIN SWELLING,1
BE,SMALL FOR DATES BABY,1
BE,SMALL INTESTINAL STENOSIS,1
BE,SPEECH DISORDER,1
BE,SPINAL COLUMN STENOSIS,1
BE,SPINAL COMPRESSION FRACTURE,1
BE,SPINAL DISORDER,1
BE,SPINAL FRACTURE,1
BE,SPINAL FUSION SURGERY,1
BE,SPUTUM DISCOLOURED,1
BE,SQUAMOUS CELL CARCINOMA OF SKIN,1
BE,STAPHYLOCOCCAL SEPSIS,1
BE,STOMA SITE DISCHARGE,1
BE,STOMA SITE ERYTHEMA,1
BE,STOMA SITE EXTRAVASATION,1
BE,STOMA SITE HYPERGRANULATION,1
BE,STOMA SITE INFECTION,1
BE,STOMA SITE INFLAMMATION,1
BE,STOMA SITE PAIN,1
BE,STOMATITIS,1
BE,STREPTOCOCCAL SEPSIS,1
BE,STRESS CARDIOMYOPATHY,1
BE,STUPOR,1
BE,SUBARACHNOID HAEMORRHAGE,1
BE,SUBCUTANEOUS ABSCESS,1
BE,SUBILEUS,1
BE,SWELLING FACE,1
BE,SYNOVIAL SARCOMA,1
BE,SYSTEMIC MASTOCYTOSIS,1
BE,TAKAYASU^S ARTERITIS,1
BE,TENDERNESS,1
BE,TENDON DISORDER,1
BE,TENDONITIS,1
BE,TETANY,1
BE,THERAPEUTIC RESPONSE UNEXPECTED,1
BE,THROMBOPHLEBITIS SUPERFICIAL,1
BE,THROMBOTIC MICROANGIOPATHY,1
BE,TINNITUS,1
BE,TONSILLITIS,1
BE,TOXIC EPIDERMAL NECROLYSIS,1
BE,TRACHEITIS,1
BE,TRANSPLANT DYSFUNCTION,1
BE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
BE,UPPER RESPIRATORY TRACT INFECTION,1
BE,URETERIC OBSTRUCTION,1
BE,URINARY RETENTION,1
BE,URINARY TRACT INFECTION PSEUDOMONAL,1
BE,URINE FLOW DECREASED,1
BE,URINE OUTPUT DECREASED,1
BE,URINE SODIUM ABNORMAL,1
BE,URTICARIA,1
BE,VAGINAL HAEMORRHAGE,1
BE,VAGINAL INFECTION,1
BE,VASCULAR CALCIFICATION,1
BE,VASCULAR PAIN,1
BE,VASCULITIS,1
BE,VEIN DISORDER,1
BE,VENTRICULAR SEPTAL DEFECT,1
BE,VENTRICULAR TACHYCARDIA,1
BE,VIITH NERVE PARALYSIS,1
BE,VIRAL INFECTION,1
BE,VISUAL FIELD DEFECT,1
BE,VOCAL CORD PARESIS,1
BE,WALDENSTROM^S MACROGLOBULINAEMIA,1
BE,WHITE MATTER LESION,1
BE,WOLFF-PARKINSON-WHITE SYNDROME,1
BE,WOUND DEHISCENCE,1
BE,WOUND SECRETION,1
BE,WRONG DEVICE USED,1
BE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
BO,GENERAL PHYSICAL HEALTH DETERIORATION,2
BO,MALIGNANT NEOPLASM PROGRESSION,2
BO,ACUTE LYMPHOCYTIC LEUKAEMIA,1
BO,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
BO,ANAEMIA,1
BO,BACK PAIN,1
BO,CENTRAL NERVOUS SYSTEM LEUKAEMIA,1
BO,FAECES DISCOLOURED,1
BO,GASTROINTESTINAL HAEMORRHAGE,1
BO,HAEMORRHAGE,1
BO,HYPOVOLAEMIC SHOCK,1
BO,INTERMITTENT CLAUDICATION,1
BO,LOSS OF CONSCIOUSNESS,1
BO,NEUTROPENIA,1
BO,NEUTROPHIL COUNT DECREASED,1
BO,SEPTIC SHOCK,1
BO,SYNCOPE,1
BO,THROMBOCYTOPENIA,1
BO,WHITE BLOOD CELL COUNT INCREASED,1
BR,PAIN,523
BR,ARTHRALGIA,393
BR,DRUG INEFFECTIVE,380
BR,MALAISE,379
BR,WEIGHT DECREASED,358
BR,PAIN IN EXTREMITY,354
BR,HEADACHE,346
BR,DYSPNOEA,340
BR,FATIGUE,284
BR,ASTHENIA,282
BR,GAIT DISTURBANCE,281
BR,NAUSEA,272
BR,VOMITING,258
BR,PNEUMONIA,257
BR,FALL,256
BR,DIARRHOEA,252
BR,DIZZINESS,247
BR,HYPERTENSION,247
BR,URINARY TRACT INFECTION,247
BR,PYREXIA,221
BR,ANAEMIA,198
BR,WEIGHT INCREASED,187
BR,INFLUENZA,184
BR,BLOOD PRESSURE INCREASED,165
BR,PERIPHERAL SWELLING,165
BR,DECREASED APPETITE,161
BR,DEPRESSION,161
BR,INSOMNIA,157
BR,COUGH,156
BR,BACK PAIN,149
BR,ABDOMINAL PAIN UPPER,148
BR,DIABETES MELLITUS,144
BR,MEMORY IMPAIRMENT,144
BR,ABDOMINAL PAIN,143
BR,PRURITUS,143
BR,SWELLING,141
BR,RHEUMATOID ARTHRITIS,136
BR,HYPERSENSITIVITY,124
BR,FEELING ABNORMAL,123
BR,CEREBROVASCULAR ACCIDENT,122
BR,BLOOD CHOLESTEROL INCREASED,117
BR,ERYTHEMA,117
BR,OSTEOARTHRITIS,116
BR,TREMOR,115
BR,NERVOUSNESS,110
BR,CHEST PAIN,107
BR,DRUG DOSE OMISSION,105
BR,CATARACT,104
BR,INJECTION SITE PAIN,103
BR,SOMNOLENCE,103
BR,IMMUNODEFICIENCY,101
BR,ARTHROPATHY,98
BR,CARDIAC DISORDER,98
BR,SYNCOPE,98
BR,ANXIETY,97
BR,BLOOD GLUCOSE INCREASED,97
BR,HYPOAESTHESIA,96
BR,VISUAL IMPAIRMENT,94
BR,JOINT SWELLING,92
BR,MYOCARDIAL INFARCTION,89
BR,SPINAL PAIN,89
BR,MUSCULAR WEAKNESS,86
BR,ABASIA,83
BR,ARTHRITIS,82
BR,ARRHYTHMIA,81
BR,ABDOMINAL DISTENSION,79
BR,ALOPECIA,79
BR,INFECTION,79
BR,CONSTIPATION,78
BR,VISION BLURRED,75
BR,MOBILITY DECREASED,74
BR,ASTHMA,71
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,71
BR,INJECTION SITE ERYTHEMA,69
BR,MUSCLE SPASMS,68
BR,GASTRITIS,66
BR,GASTROOESOPHAGEAL REFLUX DISEASE,66
BR,WOUND,66
BR,BURNING SENSATION,65
BR,HAEMORRHAGE,65
BR,NASOPHARYNGITIS,65
BR,OSTEOPOROSIS,64
BR,DEATH,63
BR,DYSSTASIA,63
BR,CONFUSIONAL STATE,62
BR,SPEECH DISORDER,62
BR,DYSPHAGIA,61
BR,OROPHARYNGEAL PAIN,60
BR,HYPERHIDROSIS,59
BR,INFARCTION,59
BR,INTERVERTEBRAL DISC PROTRUSION,59
BR,TACHYCARDIA,59
BR,BLOOD PRESSURE DECREASED,58
BR,PARAESTHESIA,57
BR,SINUSITIS,57
BR,SKIN DISCOLOURATION,57
BR,HYPERGLYCAEMIA,56
BR,INFLAMMATION,56
BR,PRODUCT USE ISSUE,56
BR,THROMBOSIS,56
BR,CHILLS,55
BR,DRY MOUTH,55
BR,FEMUR FRACTURE,55
BR,BONE PAIN,54
BR,LUNG DISORDER,54
BR,DYSPHONIA,53
BR,MUSCULOSKELETAL PAIN,53
BR,GASTRIC DISORDER,52
BR,HYPOTENSION,52
BR,NECK PAIN,52
BR,NEPHROLITHIASIS,52
BR,RENAL DISORDER,52
BR,BLISTER,50
BR,CONDITION AGGRAVATED,50
BR,CROHN^S DISEASE,49
BR,INJECTION SITE PRURITUS,49
BR,EATING DISORDER,48
BR,LUNG INFECTION,48
BR,MULTIPLE SCLEROSIS RELAPSE,48
BR,FOOT DEFORMITY,46
BR,LIVER DISORDER,46
BR,RENAL FAILURE,46
BR,CHOLELITHIASIS,45
BR,SPINAL DISORDER,45
BR,DISEASE PROGRESSION,44
BR,DYSPEPSIA,44
BR,NODULE,44
BR,OEDEMA PERIPHERAL,44
BR,AMNESIA,43
BR,BALANCE DISORDER,43
BR,DEHYDRATION,43
BR,DYSGEUSIA,43
BR,FEELING HOT,43
BR,HYPOPHAGIA,43
BR,RASH,43
BR,DRY SKIN,42
BR,FEEDING DISORDER,42
BR,LABYRINTHITIS,42
BR,RENAL IMPAIRMENT,42
BR,SEIZURE,42
BR,DECREASED IMMUNE RESPONSIVENESS,41
BR,FLATULENCE,41
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,41
BR,BLOOD CHOLESTEROL ABNORMAL,40
BR,HEART RATE INCREASED,40
BR,CRYING,39
BR,DEPRESSED MOOD,39
BR,EYE PAIN,39
BR,FLUID RETENTION,39
BR,PLATELET COUNT DECREASED,39
BR,MUSCULOSKELETAL STIFFNESS,38
BR,PSORIASIS,38
BR,TUBERCULOSIS,38
BR,ABDOMINAL DISCOMFORT,37
BR,BODY HEIGHT DECREASED,37
BR,COMA,37
BR,FIBROMYALGIA,37
BR,LOSS OF CONSCIOUSNESS,37
BR,RETCHING,37
BR,BLOOD PRESSURE ABNORMAL,36
BR,BLOOD PRESSURE FLUCTUATION,36
BR,BLOOD TRIGLYCERIDES INCREASED,36
BR,CORONARY ARTERY OCCLUSION,36
BR,DYSURIA,36
BR,GASTROINTESTINAL DISORDER,36
BR,HEPATIC STEATOSIS,36
BR,HYPOGLYCAEMIA,36
BR,LOCAL SWELLING,36
BR,MOVEMENT DISORDER,36
BR,SEPSIS,36
BR,THERAPEUTIC RESPONSE DECREASED,36
BR,BRONCHITIS,35
BR,CARDIAC ARREST,35
BR,MYALGIA,35
BR,PALPITATIONS,35
BR,PRURITUS GENERALISED,35
BR,PULMONARY EMBOLISM,35
BR,RESPIRATORY FAILURE,35
BR,ARTERIAL OCCLUSIVE DISEASE,34
BR,DENGUE FEVER,34
BR,SKIN EXFOLIATION,34
BR,HAEMATOCHEZIA,33
BR,HEAD DISCOMFORT,33
BR,INTENTIONAL PRODUCT MISUSE,33
BR,PULMONARY OEDEMA,33
BR,THROAT IRRITATION,33
BR,THYROID DISORDER,33
BR,UPPER LIMB FRACTURE,33
BR,GLAUCOMA,32
BR,INFUSION RELATED REACTION,32
BR,LIMB INJURY,32
BR,STRESS,32
BR,SWELLING FACE,32
BR,BEDRIDDEN,31
BR,DEVICE MALFUNCTION,31
BR,DRUG HYPERSENSITIVITY,31
BR,IRRITABILITY,31
BR,JOINT STIFFNESS,31
BR,PLEURAL EFFUSION,31
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,31
BR,BONE DISORDER,30
BR,GENERAL PHYSICAL HEALTH DETERIORATION,30
BR,HAEMOGLOBIN DECREASED,30
BR,HYPOTHYROIDISM,30
BR,INCORRECT DOSE ADMINISTERED,30
BR,INJECTION SITE DISCOLOURATION,30
BR,MASS,30
BR,VISUAL ACUITY REDUCED,30
BR,DISCOMFORT,29
BR,EMOTIONAL DISORDER,29
BR,EPISTAXIS,29
BR,RHINITIS,29
BR,VITAMIN D DEFICIENCY,29
BR,ANGINA PECTORIS,28
BR,HYPOKINESIA,28
BR,LOCALISED INFECTION,28
BR,WHEEZING,28
BR,AGITATION,27
BR,BLINDNESS,27
BR,BACTERIAL INFECTION,26
BR,EYE DISORDER,26
BR,FEBRILE NEUTROPENIA,26
BR,FEELING COLD,26
BR,HAEMATOMA,26
BR,RASH MACULAR,26
BR,APHASIA,25
BR,DIVERTICULITIS,25
BR,DRUG EFFECT INCOMPLETE,25
BR,EXOSTOSIS,25
BR,EYE SWELLING,25
BR,HEART RATE DECREASED,25
BR,PALLOR,25
BR,UNEVALUABLE EVENT,25
BR,VIRAL INFECTION,25
BR,BREAST CANCER,24
BR,CARDIOVASCULAR DISORDER,24
BR,DRUG ADMINISTRATION ERROR,24
BR,ERYSIPELAS,24
BR,FEAR,24
BR,HAND DEFORMITY,24
BR,HIATUS HERNIA,24
BR,OCULAR HYPERAEMIA,24
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,24
BR,VENOUS OCCLUSION,24
BR,ASTHMATIC CRISIS,23
BR,BLOOD CREATININE INCREASED,23
BR,BREAST MASS,23
BR,DEMENTIA ALZHEIMER^S TYPE,23
BR,HEAD INJURY,23
BR,INJECTION SITE SWELLING,23
BR,RENAL PAIN,23
BR,RESPIRATORY DISORDER,23
BR,RHEUMATIC DISORDER,23
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,22
BR,EMPHYSEMA,22
BR,FORMICATION,22
BR,HAEMORRHOIDS,22
BR,IMPAIRED HEALING,22
BR,INTESTINAL OBSTRUCTION,22
BR,JOINT INJURY,22
BR,KIDNEY INFECTION,22
BR,PHARYNGITIS,22
BR,PRODUCT QUALITY ISSUE,22
BR,SPINAL FRACTURE,22
BR,ACNE,21
BR,ANKYLOSING SPONDYLITIS,21
BR,CARDIOMEGALY,21
BR,GAIT INABILITY,21
BR,HERPES ZOSTER,21
BR,LEUKOPENIA,21
BR,LIMB DISCOMFORT,21
BR,NEUROPATHY PERIPHERAL,21
BR,SECRETION DISCHARGE,21
BR,SEPTIC SHOCK,21
BR,SLUGGISHNESS,21
BR,THROMBOCYTOPENIA,21
BR,VARICOSE VEIN,21
BR,YELLOW SKIN,21
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,20
BR,ASCITES,20
BR,CARDIAC FAILURE,20
BR,CONVULSION,20
BR,DIABETES MELLITUS INADEQUATE CONTROL,20
BR,FINGER DEFORMITY,20
BR,FOOT FRACTURE,20
BR,GLUCOSE TOLERANCE IMPAIRED,20
BR,LIGAMENT SPRAIN,20
BR,MALIGNANT NEOPLASM PROGRESSION,20
BR,OSTEOPENIA,20
BR,TOOTH DISORDER,20
BR,BLOOD GLUCOSE ABNORMAL,19
BR,CYST,19
BR,DRUG DEPENDENCE,19
BR,GALLBLADDER DISORDER,19
BR,GASTROINTESTINAL INFECTION,19
BR,HEPATIC NEOPLASM,19
BR,HYPERAEMIA,19
BR,INJECTION SITE HAEMATOMA,19
BR,INJECTION SITE WARMTH,19
BR,JOINT RANGE OF MOTION DECREASED,19
BR,NERVOUS SYSTEM DISORDER,19
BR,ORAL PAIN,19
BR,SERUM FERRITIN INCREASED,19
BR,APHONIA,18
BR,BURSITIS,18
BR,DEAFNESS,18
BR,DYSENTERY,18
BR,HALLUCINATION,18
BR,HELICOBACTER INFECTION,18
BR,HERPES VIRUS INFECTION,18
BR,HYPOACUSIS,18
BR,JOINT DISLOCATION,18
BR,MIGRAINE,18
BR,OESOPHAGITIS,18
BR,SKIN DISORDER,18
BR,SLEEP DISORDER,18
BR,TENDONITIS,18
BR,TINNITUS,18
BR,URINARY INCONTINENCE,18
BR,APHTHOUS ULCER,17
BR,CHEST DISCOMFORT,17
BR,CHONDROPATHY,17
BR,DRY EYE,17
BR,EAR PAIN,17
BR,HYPERTENSIVE CRISIS,17
BR,ILL-DEFINED DISORDER,17
BR,LIMB DEFORMITY,17
BR,NEOPLASM MALIGNANT,17
BR,NEUTROPENIA,17
BR,POLLAKIURIA,17
BR,PRODUCTIVE COUGH,17
BR,ROAD TRAFFIC ACCIDENT,17
BR,VITAMIN D DECREASED,17
BR,AGEUSIA,16
BR,BLOOD GLUCOSE DECREASED,16
BR,CARDIO-RESPIRATORY ARREST,16
BR,CHOKING,16
BR,DERMATITIS ALLERGIC,16
BR,DEVICE DISLOCATION,16
BR,DRUG EFFECT DECREASED,16
BR,DRUG-INDUCED LIVER INJURY,16
BR,GASTROINTESTINAL HAEMORRHAGE,16
BR,ISCHAEMIC STROKE,16
BR,LOWER LIMB FRACTURE,16
BR,MEDICATION ERROR,16
BR,MUSCULOSKELETAL DISORDER,16
BR,NOSOCOMIAL INFECTION,16
BR,PULMONARY MASS,16
BR,SPINAL OSTEOARTHRITIS,16
BR,TENDON RUPTURE,16
BR,THROAT TIGHTNESS,16
BR,URTICARIA,16
BR,CATARRH,15
BR,CONCOMITANT DISEASE AGGRAVATED,15
BR,EAR INFECTION,15
BR,HEMIPLEGIA,15
BR,HEPATIC CIRRHOSIS,15
BR,HYPOMAGNESAEMIA,15
BR,INFLUENZA LIKE ILLNESS,15
BR,LARYNGEAL OEDEMA,15
BR,MOUTH INJURY,15
BR,NASAL CONGESTION,15
BR,PARKINSON^S DISEASE,15
BR,RESPIRATORY ARREST,15
BR,RIB FRACTURE,15
BR,SKIN LESION,15
BR,TYPE 2 DIABETES MELLITUS,15
BR,AGGRESSION,14
BR,APPARENT DEATH,14
BR,ARTHRITIS INFECTIVE,14
BR,BLOOD POTASSIUM DECREASED,14
BR,BRONCHOSPASM,14
BR,CARPAL TUNNEL SYNDROME,14
BR,CELLULITIS,14
BR,COLITIS,14
BR,CONJUNCTIVITIS,14
BR,DISORIENTATION,14
BR,HAEMOPTYSIS,14
BR,HEARING IMPAIRED,14
BR,IMMUNE SYSTEM DISORDER,14
BR,INCORRECT PRODUCT STORAGE,14
BR,JOINT EFFUSION,14
BR,KNEE ARTHROPLASTY,14
BR,LACRIMATION INCREASED,14
BR,LUNG NEOPLASM MALIGNANT,14
BR,ORAL CANDIDIASIS,14
BR,OXYGEN SATURATION DECREASED,14
BR,PATIENT-DEVICE INCOMPATIBILITY,14
BR,PROCEDURAL PAIN,14
BR,THYROID NEOPLASM,14
BR,ULCER,14
BR,ATROPHY,13
BR,CONTUSION,13
BR,CYSTITIS,13
BR,DIARRHOEA HAEMORRHAGIC,13
BR,DISTURBANCE IN ATTENTION,13
BR,DRUG PRESCRIBING ERROR,13
BR,EYE IRRITATION,13
BR,GASTROINTESTINAL INFLAMMATION,13
BR,GASTROINTESTINAL PAIN,13
BR,GLOSSODYNIA,13
BR,HYPERKERATOSIS,13
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,13
BR,INJECTION SITE MASS,13
BR,MENTAL DISORDER,13
BR,MOOD ALTERED,13
BR,MUCOSAL INFLAMMATION,13
BR,MULTI-ORGAN FAILURE,13
BR,MUSCULOSKELETAL CHEST PAIN,13
BR,PARALYSIS,13
BR,POSTOPERATIVE WOUND INFECTION,13
BR,PRODUCT USE IN UNAPPROVED INDICATION,13
BR,PSYCHIATRIC SYMPTOM,13
BR,PULMONARY FIBROSIS,13
BR,SCIATICA,13
BR,SENSORY DISTURBANCE,13
BR,STOMATITIS,13
BR,SURGERY,13
BR,TONGUE DISORDER,13
BR,TOOTH INFECTION,13
BR,VERTIGO,13
BR,ACUTE KIDNEY INJURY,12
BR,ANKLE FRACTURE,12
BR,APATHY,12
BR,ASPARTATE AMINOTRANSFERASE INCREASED,12
BR,ATRIAL FIBRILLATION,12
BR,BLOOD GLUCOSE FLUCTUATION,12
BR,BONE EROSION,12
BR,C-REACTIVE PROTEIN INCREASED,12
BR,CHOLECYSTITIS,12
BR,EYE HAEMORRHAGE,12
BR,FUNGAL INFECTION,12
BR,HAEMATEMESIS,12
BR,HIP FRACTURE,12
BR,HOSPITALISATION,12
BR,HYPOCALCAEMIA,12
BR,INJECTION SITE HYPERSENSITIVITY,12
BR,KNEE DEFORMITY,12
BR,NEOPLASM,12
BR,OEDEMA,12
BR,OVERDOSE,12
BR,PANCREATITIS,12
BR,PIGMENTATION DISORDER,12
BR,POOR PERIPHERAL CIRCULATION,12
BR,PROSTATE CANCER,12
BR,RESPIRATORY TRACT INFECTION,12
BR,RHINORRHOEA,12
BR,SENSORY LOSS,12
BR,URINARY RETENTION,12
BR,ACUTE MYOCARDIAL INFARCTION,11
BR,APHAGIA,11
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,11
BR,BLOOD TRIGLYCERIDES ABNORMAL,11
BR,BLOOD URIC ACID INCREASED,11
BR,BREAST CANCER FEMALE,11
BR,DRY THROAT,11
BR,EMOTIONAL DISTRESS,11
BR,FISTULA,11
BR,FLUSHING,11
BR,FURUNCLE,11
BR,HEPATIC CANCER,11
BR,INGUINAL HERNIA,11
BR,INTESTINAL POLYP,11
BR,ISCHAEMIA,11
BR,LACTOSE INTOLERANCE,11
BR,LYMPHADENOPATHY,11
BR,MENISCUS INJURY,11
BR,METASTASES TO BONE,11
BR,METASTATIC RENAL CELL CARCINOMA,11
BR,NAIL DISORDER,11
BR,NEOPLASM PROGRESSION,11
BR,ORAL DISCOMFORT,11
BR,RASH PUSTULAR,11
BR,RESPIRATORY DISTRESS,11
BR,SUICIDAL IDEATION,11
BR,THIRST,11
BR,VEIN DISORDER,11
BR,WEIGHT FLUCTUATION,11
BR,WHITE BLOOD CELL COUNT DECREASED,11
BR,ABSCESS,10
BR,ALANINE AMINOTRANSFERASE INCREASED,10
BR,ANGIOPATHY,10
BR,BLOOD CALCIUM DECREASED,10
BR,CARTILAGE INJURY,10
BR,CHROMATURIA,10
BR,COGNITIVE DISORDER,10
BR,COLD SWEAT,10
BR,COLITIS ULCERATIVE,10
BR,CYANOSIS,10
BR,DEVICE RELATED INFECTION,10
BR,DRUG INTOLERANCE,10
BR,ENDOMETRIOSIS,10
BR,FEELING OF DESPAIR,10
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,10
BR,GENERALISED OEDEMA,10
BR,HEPATITIS,10
BR,HERNIA,10
BR,HOT FLUSH,10
BR,HYPERAESTHESIA,10
BR,HYPERSOMNIA,10
BR,HYPOVITAMINOSIS,10
BR,INJECTION SITE INDURATION,10
BR,INJECTION SITE REACTION,10
BR,INTESTINAL HAEMORRHAGE,10
BR,INTESTINAL STENOSIS,10
BR,MALNUTRITION,10
BR,OBESITY,10
BR,OBSTRUCTIVE AIRWAYS DISORDER,10
BR,ORAL DISORDER,10
BR,POST PROCEDURAL COMPLICATION,10
BR,PRODUCT AVAILABILITY ISSUE,10
BR,PULMONARY PAIN,10
BR,RASH ERYTHEMATOUS,10
BR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,10
BR,RENAL CANCER,10
BR,RESTLESSNESS,10
BR,SKIN BURNING SENSATION,10
BR,SKIN FISSURES,10
BR,SNEEZING,10
BR,SUFFOCATION FEELING,10
BR,THERAPEUTIC RESPONSE UNEXPECTED,10
BR,TOOTH FRACTURE,10
BR,TOOTH LOSS,10
BR,TOOTHACHE,10
BR,UVEITIS,10
BR,WHITE BLOOD CELL COUNT INCREASED,10
BR,WRIST FRACTURE,10
BR,ACCIDENT,9
BR,BONE MARROW DISORDER,9
BR,CATARACT OPERATION,9
BR,CENTRAL NERVOUS SYSTEM LESION,9
BR,CEREBRAL ISCHAEMIA,9
BR,DEEP VEIN THROMBOSIS,9
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,9
BR,DIPLOPIA,9
BR,DYSPNOEA EXERTIONAL,9
BR,EXPIRED PRODUCT ADMINISTERED,9
BR,EYE PRURITUS,9
BR,FIBROSIS,9
BR,FREQUENT BOWEL MOVEMENTS,9
BR,GASTROENTERITIS,9
BR,KNEE OPERATION,9
BR,LABORATORY TEST ABNORMAL,9
BR,LYMPHOMA,9
BR,MOUTH HAEMORRHAGE,9
BR,MUSCLE ATROPHY,9
BR,MUSCLE RIGIDITY,9
BR,OSTEOMYELITIS,9
BR,OVARIAN CYST,9
BR,PAIN IN JAW,9
BR,PANIC DISORDER,9
BR,PROTEINURIA,9
BR,PSORIATIC ARTHROPATHY,9
BR,RECTAL HAEMORRHAGE,9
BR,RENAL CELL CARCINOMA,9
BR,SCOLIOSIS,9
BR,SHOCK,9
BR,SKIN WOUND,9
BR,SYNOVIAL CYST,9
BR,TIBIA FRACTURE,9
BR,TRANSFUSION,9
BR,TRANSIENT ISCHAEMIC ATTACK,9
BR,WOUND SECRETION,9
BR,ABNORMAL BEHAVIOUR,8
BR,ACUTE RESPIRATORY FAILURE,8
BR,ADVERSE EVENT,8
BR,ANAL HAEMORRHAGE,8
BR,BACK DISORDER,8
BR,BLOOD SODIUM DECREASED,8
BR,BLOOD TEST ABNORMAL,8
BR,BLOOD UREA INCREASED,8
BR,BLOOD URINE PRESENT,8
BR,BRADYCARDIA,8
BR,DELIRIUM,8
BR,DERMATITIS,8
BR,DEVICE BREAKAGE,8
BR,ENCEPHALOPATHY,8
BR,EPILEPSY,8
BR,FLUID INTAKE REDUCED,8
BR,GASTRIC HAEMORRHAGE,8
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,8
BR,HEMIPARESIS,8
BR,HYPERTHYROIDISM,8
BR,INCORRECT DRUG ADMINISTRATION DURATION,8
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,8
BR,NIGHTMARE,8
BR,OVERWEIGHT,8
BR,PANCREATITIS ACUTE,8
BR,PANIC ATTACK,8
BR,PERIPHERAL VASCULAR DISORDER,8
BR,PULMONARY HYPERTENSION,8
BR,PULPITIS DENTAL,8
BR,PURULENCE,8
BR,RENAL COLIC,8
BR,SALIVARY HYPERSECRETION,8
BR,SKIN CANCER,8
BR,SKIN HAEMORRHAGE,8
BR,SKIN INJURY,8
BR,SKIN PAPILLOMA,8
BR,SKIN ULCER,8
BR,THROMBOPHLEBITIS,8
BR,THYROID MASS,8
BR,UMBILICAL HERNIA,8
BR,UNDERDOSE,8
BR,UTERINE LEIOMYOMA,8
BR,WOUND INFECTION,8
BR,ABDOMINAL HERNIA,7
BR,ABDOMINAL RIGIDITY,7
BR,ANAL FISTULA,7
BR,APHTHOUS STOMATITIS,7
BR,ARTHRITIS BACTERIAL,7
BR,BLINDNESS UNILATERAL,7
BR,BONE LOSS,7
BR,BRAIN HYPOXIA,7
BR,CAROTID ARTERY OCCLUSION,7
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,7
BR,COORDINATION ABNORMAL,7
BR,CORONARY ARTERY DISEASE,7
BR,CUSHING^S SYNDROME,7
BR,DEFORMITY,7
BR,DEMENTIA,7
BR,DENTAL CARIES,7
BR,DIABETIC NEUROPATHY,7
BR,DYSCHEZIA,7
BR,DYSKINESIA,7
BR,ELECTROCARDIOGRAM QT PROLONGED,7
BR,EXPOSURE DURING PREGNANCY,7
BR,FACE INJURY,7
BR,FACE OEDEMA,7
BR,FRACTURE,7
BR,GENERAL SYMPTOM,7
BR,GINGIVAL PAIN,7
BR,HAEMORRHAGIC STROKE,7
BR,HEPATIC ENZYME INCREASED,7
BR,HEPATIC PAIN,7
BR,HEPATOMEGALY,7
BR,HIP ARTHROPLASTY,7
BR,HORMONE LEVEL ABNORMAL,7
BR,HYPOKALAEMIA,7
BR,INJECTION SITE BRUISING,7
BR,INJECTION SITE HAEMORRHAGE,7
BR,INJURY,7
BR,JOINT LOCK,7
BR,LACERATION,7
BR,LEIOMYOMA,7
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,7
BR,METASTASES TO LIVER,7
BR,MOTOR DYSFUNCTION,7
BR,MULTIPLE SCLEROSIS,7
BR,MUSCLE TWITCHING,7
BR,NERVE COMPRESSION,7
BR,ONYCHOCLASIS,7
BR,PARAPLEGIA,7
BR,PHARYNGEAL INFLAMMATION,7
BR,PLATELET COUNT INCREASED,7
BR,POST PROCEDURAL INFECTION,7
BR,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,7
BR,REFLUX GASTRITIS,7
BR,RETINAL DISORDER,7
BR,RHEUMATIC FEVER,7
BR,RHEUMATOID FACTOR INCREASED,7
BR,SCAR,7
BR,SCIATIC NERVE NEUROPATHY,7
BR,SEDATION,7
BR,SKIN ATROPHY,7
BR,SKIN INFECTION,7
BR,SKIN IRRITATION,7
BR,SKIN MASS,7
BR,SPLENOMEGALY,7
BR,SUICIDE ATTEMPT,7
BR,THERAPY CESSATION,7
BR,URINE ABNORMALITY,7
BR,URINE OUTPUT DECREASED,7
BR,VASCULAR RUPTURE,7
BR,WOUND COMPLICATION,7
BR,ANEURYSM,6
BR,APPENDICITIS,6
BR,APPLICATION SITE ERYTHEMA,6
BR,BIPOLAR DISORDER,6
BR,BLADDER PAIN,6
BR,BONE DENSITY DECREASED,6
BR,BRAIN NEOPLASM,6
BR,CANDIDA INFECTION,6
BR,CHOKING SENSATION,6
BR,CHRONIC GASTRITIS,6
BR,COAGULOPATHY,6
BR,DEAFNESS UNILATERAL,6
BR,DRUG DISPENSING ERROR,6
BR,EYELID OEDEMA,6
BR,FAT TISSUE INCREASED,6
BR,FRACTURED COCCYX,6
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
BR,GASTRIC ULCER,6
BR,GASTRITIS EROSIVE,6
BR,GROIN PAIN,6
BR,H1N1 INFLUENZA,6
BR,HEART RATE ABNORMAL,6
BR,HEPATIC ENCEPHALOPATHY,6
BR,HEPATITIS C,6
BR,HUNGER,6
BR,HYPONATRAEMIA,6
BR,HYPOTONIA,6
BR,INJECTION SITE OEDEMA,6
BR,IRON DEFICIENCY ANAEMIA,6
BR,KYPHOSIS,6
BR,LEUKOCYTOSIS,6
BR,LIMB OPERATION,6
BR,LIPOMA,6
BR,LUMBAR VERTEBRAL FRACTURE,6
BR,MEDICAL DEVICE COMPLICATION,6
BR,MUCOUS STOOLS,6
BR,NEEDLE ISSUE,6
BR,NEURALGIA,6
BR,ONYCHOMADESIS,6
BR,ORAL HERPES,6
BR,OSTEONECROSIS,6
BR,PANCREATIC DISORDER,6
BR,PAPULE,6
BR,PELVIC FRACTURE,6
BR,PERICARDIAL EFFUSION,6
BR,PERITONITIS,6
BR,PITUITARY TUMOUR BENIGN,6
BR,PNEUMONIA ASPIRATION,6
BR,PNEUMONIA BACTERIAL,6
BR,PRODUCT PHYSICAL ISSUE,6
BR,PROSTATOMEGALY,6
BR,PULMONARY HAEMORRHAGE,6
BR,PYELONEPHRITIS,6
BR,RHINITIS ALLERGIC,6
BR,SKELETAL INJURY,6
BR,SKIN SENSITISATION,6
BR,SPLEEN DISORDER,6
BR,SUTURE RELATED COMPLICATION,6
BR,THYROID FUNCTION TEST ABNORMAL,6
BR,URINARY TRACT INFECTION BACTERIAL,6
BR,UTERINE DISORDER,6
BR,WRONG DRUG ADMINISTERED,6
BR,ACCIDENTAL EXPOSURE TO PRODUCT,5
BR,ANAPHYLACTIC SHOCK,5
BR,ANGER,5
BR,APNOEA,5
BR,APPLICATION SITE HYPERSENSITIVITY,5
BR,APPLICATION SITE PAIN,5
BR,ASPHYXIA,5
BR,BLOOD CREATININE ABNORMAL,5
BR,BLOOD IMMUNOGLOBULIN E INCREASED,5
BR,BLOOD POTASSIUM INCREASED,5
BR,BLOOD URIC ACID ABNORMAL,5
BR,BONE ATROPHY,5
BR,BONE CYST,5
BR,BREAST PAIN,5
BR,CALCINOSIS,5
BR,CARDIOMYOPATHY,5
BR,CEREBRAL ATROPHY,5
BR,CEREBRAL THROMBOSIS,5
BR,CHIKUNGUNYA VIRUS INFECTION,5
BR,CLAVICLE FRACTURE,5
BR,DISEASE RECURRENCE,5
BR,DIVERTICULUM,5
BR,DRUG EFFECT DELAYED,5
BR,DYSARTHRIA,5
BR,EAR DISORDER,5
BR,EAR HAEMORRHAGE,5
BR,ELBOW DEFORMITY,5
BR,ELECTROLYTE IMBALANCE,5
BR,EYE ALLERGY,5
BR,EYELID DISORDER,5
BR,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,5
BR,GASTROINTESTINAL CARCINOMA,5
BR,GASTROINTESTINAL MOTILITY DISORDER,5
BR,GENERAL PHYSICAL CONDITION ABNORMAL,5
BR,GINGIVAL BLEEDING,5
BR,GOUT,5
BR,HAEMATOCRIT DECREASED,5
BR,HAEMODIALYSIS,5
BR,HEART RATE IRREGULAR,5
BR,HEPATIC FAILURE,5
BR,HEPATIC FUNCTION ABNORMAL,5
BR,HUMERUS FRACTURE,5
BR,HYPOAESTHESIA ORAL,5
BR,HYPOPARATHYROIDISM,5
BR,INCREASED APPETITE,5
BR,INCREASED BRONCHIAL SECRETION,5
BR,INTESTINAL FISTULA,5
BR,INTESTINAL PERFORATION,5
BR,INTRAOCULAR PRESSURE INCREASED,5
BR,IRRITABLE BOWEL SYNDROME,5
BR,LIP SWELLING,5
BR,LIVER TRANSPLANT,5
BR,MENINGITIS,5
BR,MOUTH ULCERATION,5
BR,NECK MASS,5
BR,NEPHRITIS,5
BR,NEUTROPHIL COUNT DECREASED,5
BR,NO ADVERSE EVENT,5
BR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,5
BR,ODYNOPHAGIA,5
BR,OESOPHAGEAL DISORDER,5
BR,OESOPHAGEAL PAIN,5
BR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,5
BR,PANCYTOPENIA,5
BR,PANIC REACTION,5
BR,PARAESTHESIA ORAL,5
BR,PELVIC PAIN,5
BR,PERIPHERAL COLDNESS,5
BR,PERITONITIS BACTERIAL,5
BR,PHARYNGEAL DISORDER,5
BR,PHARYNGEAL OEDEMA,5
BR,PHOTOPHOBIA,5
BR,PLASMA CELL MYELOMA,5
BR,PROTEIN URINE PRESENT,5
BR,RED BLOOD CELL COUNT DECREASED,5
BR,RENAL CYST,5
BR,RESPIRATORY RATE INCREASED,5
BR,RESTLESS LEGS SYNDROME,5
BR,RHEUMATOID NODULE,5
BR,ROTATOR CUFF SYNDROME,5
BR,SCREAMING,5
BR,SJOGREN^S SYNDROME,5
BR,SKIN REACTION,5
BR,SPINAL COLUMN INJURY,5
BR,SPINAL CORD COMPRESSION,5
BR,SPUTUM DISCOLOURED,5
BR,STAPHYLOCOCCAL INFECTION,5
BR,SUBCUTANEOUS ABSCESS,5
BR,SUTURE RUPTURE,5
BR,SWOLLEN TONGUE,5
BR,TACHYPNOEA,5
BR,TEETH BRITTLE,5
BR,TOOTH EXTRACTION,5
BR,TOTAL LUNG CAPACITY DECREASED,5
BR,TREATMENT NONCOMPLIANCE,5
BR,TUMOUR PAIN,5
BR,UNRESPONSIVE TO STIMULI,5
BR,URINE ANALYSIS ABNORMAL,5
BR,VARICES OESOPHAGEAL,5
BR,VARICOSE ULCERATION,5
BR,VASCULITIS,5
BR,VENOUS THROMBOSIS,5
BR,WEIGHT LOSS POOR,5
BR,ABNORMAL FAECES,4
BR,ABSCESS LIMB,4
BR,ACUTE PULMONARY OEDEMA,4
BR,ANGIOEDEMA,4
BR,ANGIOPLASTY,4
BR,ANTIPHOSPHOLIPID SYNDROME,4
BR,AORTIC ANEURYSM,4
BR,AORTIC DISORDER,4
BR,APPETITE DISORDER,4
BR,APPLICATION SITE PRURITUS,4
BR,ARTERIOSCLEROSIS CORONARY ARTERY,4
BR,ASPIRATION,4
BR,ASTHENOPIA,4
BR,BENIGN PROSTATIC HYPERPLASIA,4
BR,BLEPHARITIS,4
BR,BLOOD DISORDER,4
BR,BLOOD GROWTH HORMONE INCREASED,4
BR,BLOOD IRON DECREASED,4
BR,BLOOD MAGNESIUM DECREASED,4
BR,BODY TEMPERATURE DECREASED,4
BR,BONE DECALCIFICATION,4
BR,BONE FISSURE,4
BR,BRADYPHRENIA,4
BR,BRAIN OEDEMA,4
BR,BREAST DISORDER,4
BR,BREATH ODOUR,4
BR,BRONCHIECTASIS,4
BR,BRONCHITIS CHRONIC,4
BR,BRONCHOPNEUMONIA,4
BR,C-REACTIVE PROTEIN ABNORMAL,4
BR,CARDIAC OPERATION,4
BR,CARDIOGENIC SHOCK,4
BR,CEREBRAL DISORDER,4
BR,CEREBRAL HAEMORRHAGE,4
BR,COELIAC DISEASE,4
BR,CORONARY ARTERY RESTENOSIS,4
BR,CYTOMEGALOVIRUS INFECTION,4
BR,DECUBITUS ULCER,4
BR,DEMYELINATION,4
BR,DERMATOMYOSITIS,4
BR,DEVICE ISSUE,4
BR,DIABETIC COMPLICATION,4
BR,DIABETIC RETINOPATHY,4
BR,DIZZINESS POSTURAL,4
BR,DYSGRAPHIA,4
BR,DYSLIPIDAEMIA,4
BR,EAR DISCOMFORT,4
BR,EMBOLISM,4
BR,ENTERITIS INFECTIOUS,4
BR,ERUCTATION,4
BR,ESCHAR,4
BR,EYE DISCHARGE,4
BR,EYE INFLAMMATION,4
BR,FAECES DISCOLOURED,4
BR,FOOD INTOLERANCE,4
BR,GASTROINTESTINAL NECROSIS,4
BR,GENERALISED ERYTHEMA,4
BR,GINGIVAL DISORDER,4
BR,GINGIVITIS,4
BR,HEPATIC CYST,4
BR,HEPATIC ENZYME ABNORMAL,4
BR,HEPATOTOXICITY,4
BR,HYPOTHERMIA,4
BR,IMMUNOSUPPRESSION,4
BR,INJECTION SITE NODULE,4
BR,INJECTION SITE RASH,4
BR,INTERNATIONAL NORMALISED RATIO INCREASED,4
BR,INTERVERTEBRAL DISC DEGENERATION,4
BR,LARGE INTESTINE POLYP,4
BR,LEG AMPUTATION,4
BR,LEPROSY,4
BR,LIVER FUNCTION TEST ABNORMAL,4
BR,LYMPHOPENIA,4
BR,MASTICATION DISORDER,4
BR,MATERNAL EXPOSURE DURING PREGNANCY,4
BR,MEDICAL DEVICE IMPLANTATION,4
BR,MELAENA,4
BR,MENORRHAGIA,4
BR,METABOLIC ACIDOSIS,4
BR,METASTASES TO LUNG,4
BR,METASTASIS,4
BR,MIDDLE INSOMNIA,4
BR,MYOCARDIAL ISCHAEMIA,4
BR,NAIL DISCOLOURATION,4
BR,NASAL DISCOMFORT,4
BR,NASAL DRYNESS,4
BR,NECROSIS,4
BR,NIGHT SWEATS,4
BR,OCULAR VASCULAR DISORDER,4
BR,OESOPHAGEAL CARCINOMA,4
BR,ONYCHOMYCOSIS,4
BR,OSTEITIS,4
BR,OVARIAN CANCER,4
BR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,4
BR,PERIPHERAL EMBOLISM,4
BR,PETECHIAE,4
BR,PETIT MAL EPILEPSY,4
BR,PHARYNGEAL ERYTHEMA,4
BR,PHOTOSENSITIVITY REACTION,4
BR,POLYARTHRITIS,4
BR,POST PROCEDURAL DISCHARGE,4
BR,POSTURE ABNORMAL,4
BR,PRESCRIBED UNDERDOSE,4
BR,PRESYNCOPE,4
BR,PRURITUS ALLERGIC,4
BR,PSEUDOMONAS INFECTION,4
BR,PULMONARY THROMBOSIS,4
BR,QUALITY OF LIFE DECREASED,4
BR,RASH MACULO-PAPULAR,4
BR,RASH PAPULAR,4
BR,RECTAL POLYP,4
BR,RENAL TRANSPLANT,4
BR,SALIVA ALTERED,4
BR,SCRATCH,4
BR,SECOND PRIMARY MALIGNANCY,4
BR,SENILE DEMENTIA,4
BR,SICKLE CELL ANAEMIA WITH CRISIS,4
BR,SKIN HYPERTROPHY,4
BR,SKIN PLAQUE,4
BR,SNORING,4
BR,SPINAL DEFORMITY,4
BR,SPONDYLITIS,4
BR,SYNOVITIS,4
BR,TENDON DISORDER,4
BR,TENDON INJURY,4
BR,THINKING ABNORMAL,4
BR,TOXICITY TO VARIOUS AGENTS,4
BR,TRANSAMINASES INCREASED,4
BR,TRANSPLANT REJECTION,4
BR,UNDERWEIGHT,4
BR,UPPER GASTROINTESTINAL HAEMORRHAGE,4
BR,UROSEPSIS,4
BR,VASCULAR OCCLUSION,4
BR,VASODILATATION,4
BR,VIRAL LOAD INCREASED,4
BR,VIRAL UPPER RESPIRATORY TRACT INFECTION,4
BR,VOCAL CORD DISORDER,4
BR,X-RAY ABNORMAL,4
BR,ABDOMINAL ADHESIONS,3
BR,ABDOMINAL INFECTION,3
BR,ABORTION SPONTANEOUS,3
BR,ADRENAL INSUFFICIENCY,3
BR,ALLERGIC COUGH,3
BR,AMENORRHOEA,3
BR,ANAL SQUAMOUS CELL CARCINOMA,3
BR,ANIMAL SCRATCH,3
BR,ANORECTAL DISORDER,3
BR,ANURIA,3
BR,APPLICATION SITE BURN,3
BR,ARTERIOSCLEROSIS,3
BR,ARTHROPOD BITE,3
BR,ASPIRATION BRONCHIAL,3
BR,ATAXIA,3
BR,ATELECTASIS,3
BR,AUTOIMMUNE HEPATITIS,3
BR,BACK INJURY,3
BR,BACTERAEMIA,3
BR,BACTERIAL DISEASE CARRIER,3
BG,CARDIAC FAILURE,4
BG,DYSPNOEA,3
BG,ANGINA PECTORIS,2
BG,CYANOSIS,2
BG,FOAMING AT MOUTH,2
BG,RESPIRATORY ARREST,2
BG,SYNCOPE,2
BG,ABDOMINAL PAIN UPPER,1
BG,ACUTE KIDNEY INJURY,1
BG,ACUTE MYELOID LEUKAEMIA,1
BG,ANGIOEDEMA,1
BG,ATRIAL FIBRILLATION,1
BG,CARDIAC FAILURE CONGESTIVE,1
BG,CHEST DISCOMFORT,1
BG,CONDITION AGGRAVATED,1
BG,CYTOMEGALOVIRUS INFECTION,1
BG,DERMATITIS EXFOLIATIVE,1
BG,DRUG HYPERSENSITIVITY,1
BG,DYSPHAGIA,1
BG,ELECTROCARDIOGRAM QT PROLONGED,1
BG,EPILEPSY,1
BG,EROSIVE OESOPHAGITIS,1
BG,FAECES DISCOLOURED,1
BG,FATIGUE,1
BG,GASTRITIS EROSIVE,1
BG,GASTRITIS HAEMORRHAGIC,1
BG,GASTROINTESTINAL HAEMORRHAGE,1
BG,GLOMERULONEPHRITIS CHRONIC,1
BG,HAEMATEMESIS,1
BG,HAEMOGLOBIN DECREASED,1
BG,HYDRONEPHROSIS,1
BG,HYPERSENSITIVITY,1
BG,HYPOKALAEMIA,1
BG,HYPONATRAEMIA,1
BG,LEUKOPENIA,1
BG,MALAISE,1
BG,MEGACOLON,1
BG,NODAL RHYTHM,1
BG,PALLOR,1
BG,PERIPHERAL COLDNESS,1
BG,PLEURAL ADHESION,1
BG,PRURITUS,1
BG,PULMONARY FIBROSIS,1
BG,RENAL IMPAIRMENT,1
BG,THERAPY CESSATION,1
BG,THROMBOSIS IN DEVICE,1
BG,ULCER,1
BG,UPPER RESPIRATORY TRACT INFECTION,1
BG,URINARY TRACT INFECTION,1
BG,URTICARIA,1
KH,ASTHENIA,2
KH,PYREXIA,2
KH,ABDOMINAL MASS,1
KH,ANAEMIA,1
KH,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
KH,BONE MARROW FAILURE,1
KH,CARDIAC FAILURE,1
KH,CEREBRAL HAEMORRHAGE,1
KH,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
KH,DECREASED APPETITE,1
KH,DIZZINESS,1
KH,DRUG INTOLERANCE,1
KH,ELECTROCARDIOGRAM ABNORMAL,1
KH,ERYTHEMA NODOSUM,1
KH,FATIGUE,1
KH,FEELING HOT,1
KH,HAEMOGLOBIN DECREASED,1
KH,LOSS OF CONSCIOUSNESS,1
KH,MALAISE,1
KH,NAUSEA,1
KH,NEUTROPENIA,1
KH,ORAL DISCOMFORT,1
KH,PLATELET COUNT DECREASED,1
KH,THROMBOCYTOPENIA,1
KH,WHITE BLOOD CELL COUNT DECREASED,1
KH,WHITE BLOOD CELL COUNT INCREASED,1
CA,DIARRHOEA,124
CA,FATIGUE,114
CA,DRUG INEFFECTIVE,100
CA,ARTHRALGIA,94
CA,DYSPNOEA,91
CA,NAUSEA,87
CA,MALAISE,86
CA,PAIN,86
CA,FALL,80
CA,ASTHENIA,78
CA,PNEUMONIA,78
CA,VOMITING,75
CA,WEIGHT DECREASED,73
CA,NASOPHARYNGITIS,69
CA,COUGH,67
CA,HEADACHE,67
CA,PAIN IN EXTREMITY,63
CA,BLOOD PRESSURE INCREASED,60
CA,DIZZINESS,60
CA,DEATH,54
CA,WEIGHT INCREASED,51
CA,ABDOMINAL PAIN,49
CA,HAEMOGLOBIN DECREASED,48
CA,PERIPHERAL SWELLING,46
CA,PYREXIA,46
CA,BACK PAIN,43
CA,INFUSION RELATED REACTION,41
CA,JOINT SWELLING,41
CA,RASH,41
CA,HYPERTENSION,39
CA,HYPOTENSION,38
CA,DECREASED APPETITE,37
CA,GAIT DISTURBANCE,36
CA,INFLUENZA,36
CA,CONSTIPATION,35
CA,URINARY TRACT INFECTION,35
CA,INSOMNIA,34
CA,OXYGEN SATURATION DECREASED,34
CA,PRURITUS,34
CA,RHEUMATOID ARTHRITIS,34
CA,ARTHRITIS,32
CA,DEHYDRATION,30
CA,ABDOMINAL PAIN UPPER,28
CA,BLOOD PRESSURE SYSTOLIC INCREASED,25
CA,DEPRESSION,25
CA,LOWER RESPIRATORY TRACT INFECTION,25
CA,TOXICITY TO VARIOUS AGENTS,25
CA,ANXIETY,24
CA,CONTUSION,24
CA,HEART RATE INCREASED,24
CA,CONFUSIONAL STATE,23
CA,HYPOAESTHESIA,23
CA,OROPHARYNGEAL PAIN,23
CA,CHEST PAIN,22
CA,ARTHROPATHY,21
CA,ORTHOSTATIC HYPOTENSION,21
CA,ABDOMINAL DISCOMFORT,20
CA,BALANCE DISORDER,20
CA,CHEST DISCOMFORT,20
CA,CHILLS,20
CA,COGNITIVE DISORDER,20
CA,SWELLING,20
CA,ASTHMA,19
CA,CONDITION AGGRAVATED,19
CA,ERYTHEMA,18
CA,LOCALISED INFECTION,18
CA,MYALGIA,18
CA,RECTAL HAEMORRHAGE,18
CA,SEDATION,18
CA,BRONCHITIS,17
CA,HEART RATE DECREASED,17
CA,INFECTION,17
CA,MUSCULOSKELETAL PAIN,17
CA,CATARACT,16
CA,CYSTITIS,16
CA,INTESTINAL OBSTRUCTION,16
CA,PALPITATIONS,16
CA,SINUSITIS,16
CA,BLOOD PRESSURE FLUCTUATION,15
CA,INFLUENZA LIKE ILLNESS,15
CA,LIMB INJURY,15
CA,LOSS OF CONSCIOUSNESS,15
CA,PRODUCTIVE COUGH,15
CA,WHEEZING,15
CA,DYSPEPSIA,14
CA,GENERAL PHYSICAL HEALTH DETERIORATION,14
CA,HEPATIC ENZYME INCREASED,14
CA,MALIGNANT NEOPLASM PROGRESSION,14
CA,MIGRAINE,14
CA,MUSCLE SPASMS,14
CA,MUSCULAR WEAKNESS,14
CA,MYOCARDIAL INFARCTION,14
CA,STRESS,14
CA,BLOOD PRESSURE DECREASED,13
CA,CELLULITIS,13
CA,DYSPNOEA EXERTIONAL,13
CA,EPISTAXIS,13
CA,FEELING ABNORMAL,13
CA,FUNGAL INFECTION,13
CA,HERPES ZOSTER,13
CA,HYPERHIDROSIS,13
CA,WHITE BLOOD CELL COUNT DECREASED,13
CA,ANAEMIA,12
CA,ATRIAL FIBRILLATION,12
CA,BLOOD CREATININE INCREASED,12
CA,BLOOD GLUCOSE INCREASED,12
CA,BLOOD PRESSURE DIASTOLIC DECREASED,12
CA,BODY TEMPERATURE DECREASED,12
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,12
CA,FLUSHING,12
CA,HERNIA,12
CA,OEDEMA PERIPHERAL,12
CA,PULMONARY EMBOLISM,12
CA,ABDOMINAL DISTENSION,11
CA,BLOOD CALCIUM DECREASED,11
CA,CROHN^S DISEASE,11
CA,DRUG DOSE OMISSION,11
CA,GASTROOESOPHAGEAL REFLUX DISEASE,11
CA,HOT FLUSH,11
CA,INJECTION SITE PAIN,11
CA,MENIERE^S DISEASE,11
CA,NASAL CONGESTION,11
CA,SEIZURE,11
CA,SKIN ULCER,11
CA,SOMNOLENCE,11
CA,SYNCOPE,11
CA,THERAPEUTIC RESPONSE DECREASED,11
CA,THROMBOSIS,11
CA,TREMOR,11
CA,WOUND,11
CA,DEEP VEIN THROMBOSIS,10
CA,DRUG EFFECT DECREASED,10
CA,FREQUENT BOWEL MOVEMENTS,10
CA,HAEMORRHAGE,10
CA,MEMORY IMPAIRMENT,10
CA,MOBILITY DECREASED,10
CA,OSTEOARTHRITIS,10
CA,PSORIASIS,10
CA,RASH ERYTHEMATOUS,10
CA,RESPIRATORY DISTRESS,10
CA,SUICIDAL IDEATION,10
CA,TACHYCARDIA,10
CA,ALOPECIA,9
CA,BASAL CELL CARCINOMA,9
CA,CREATININE RENAL CLEARANCE DECREASED,9
CA,DELIRIUM,9
CA,DIABETES MELLITUS,9
CA,DRUG EFFECT INCOMPLETE,9
CA,DYSPHONIA,9
CA,FLATULENCE,9
CA,HOSPITALISATION,9
CA,HYPERAESTHESIA,9
CA,HYPOPHAGIA,9
CA,IMPAIRED HEALING,9
CA,JAUNDICE,9
CA,LUNG INFECTION,9
CA,NEPHROLITHIASIS,9
CA,OEDEMA,9
CA,PALLOR,9
CA,PANCREATITIS,9
CA,PLATELET COUNT DECREASED,9
CA,PRODUCT USE ISSUE,9
CA,PULMONARY CONGESTION,9
CA,PULMONARY FUNCTION TEST DECREASED,9
CA,VERTIGO,9
CA,VISUAL IMPAIRMENT,9
CA,WRIST FRACTURE,9
CA,BLOOD MAGNESIUM DECREASED,8
CA,BLOOD URINE PRESENT,8
CA,DISCOMFORT,8
CA,DRY SKIN,8
CA,DYSGEUSIA,8
CA,ECZEMA,8
CA,GASTROINTESTINAL DISORDER,8
CA,HIATUS HERNIA,8
CA,INFLAMMATION,8
CA,LETHARGY,8
CA,LOCAL SWELLING,8
CA,LUNG DISORDER,8
CA,MALIGNANT MELANOMA,8
CA,MUSCULOSKELETAL CHEST PAIN,8
CA,MUSCULOSKELETAL DISORDER,8
CA,MUSCULOSKELETAL STIFFNESS,8
CA,NECK PAIN,8
CA,NEUTROPHIL COUNT DECREASED,8
CA,OSTEOPOROSIS,8
CA,RASH GENERALISED,8
CA,SWELLING FACE,8
CA,TINNITUS,8
CA,URTICARIA,8
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,8
CA,ACUTE KIDNEY INJURY,7
CA,ALANINE AMINOTRANSFERASE INCREASED,7
CA,BLOOD IRON DECREASED,7
CA,BONE PAIN,7
CA,BURNING SENSATION,7
CA,CARDIAC ARREST,7
CA,CARDIAC DISORDER,7
CA,CEREBROVASCULAR ACCIDENT,7
CA,CHOLELITHIASIS,7
CA,DEMENTIA,7
CA,FLUID RETENTION,7
CA,GASTRITIS,7
CA,HAEMATOCHEZIA,7
CA,HYPERSENSITIVITY,7
CA,HYPOGLYCAEMIA,7
CA,HYPOTHYROIDISM,7
CA,IMPAIRED WORK ABILITY,7
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
CA,INJECTION SITE SWELLING,7
CA,INTENTIONAL OVERDOSE,7
CA,INTERNATIONAL NORMALISED RATIO INCREASED,7
CA,MENTAL STATUS CHANGES,7
CA,NEUTROPENIA,7
CA,OCCUPATIONAL DERMATITIS,7
CA,PANCYTOPENIA,7
CA,PARAESTHESIA,7
CA,POOR VENOUS ACCESS,7
CA,PRODUCT SUBSTITUTION ISSUE,7
CA,RASH PRURITIC,7
CA,RED BLOOD CELL COUNT DECREASED,7
CA,RENAL FAILURE,7
CA,RHINORRHOEA,7
CA,SEPSIS,7
CA,SEPTIC SHOCK,7
CA,SPEECH DISORDER,7
CA,STAPHYLOCOCCAL INFECTION,7
CA,THROAT IRRITATION,7
CA,WHITE BLOOD CELL COUNT INCREASED,7
CA,AGITATION,6
CA,ARRHYTHMIA,6
CA,ASPARTATE AMINOTRANSFERASE INCREASED,6
CA,BLADDER DISORDER,6
CA,BREAST CANCER,6
CA,CEREBRAL HAEMORRHAGE,6
CA,CLOSTRIDIUM DIFFICILE INFECTION,6
CA,COLITIS,6
CA,CONCUSSION,6
CA,DISEASE PROGRESSION,6
CA,DRUG HYPERSENSITIVITY,6
CA,DYSPHAGIA,6
CA,EXPOSURE DURING PREGNANCY,6
CA,EYE DISORDER,6
CA,FIBROMYALGIA,6
CA,FOOT FRACTURE,6
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
CA,GASTROENTERITIS,6
CA,GASTROENTERITIS VIRAL,6
CA,HAEMATOCRIT DECREASED,6
CA,HIP FRACTURE,6
CA,INJECTION SITE REACTION,6
CA,JOINT STIFFNESS,6
CA,OVERDOSE,6
CA,PERIPHERAL ISCHAEMIA,6
CA,POOR QUALITY SLEEP,6
CA,PULMONARY OEDEMA,6
CA,RENAL IMPAIRMENT,6
CA,RESPIRATORY FAILURE,6
CA,RESPIRATORY RATE INCREASED,6
CA,SKIN DISCOLOURATION,6
CA,SPLENOMEGALY,6
CA,STOMATITIS,6
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,6
CA,THROAT TIGHTNESS,6
CA,TRANSIENT ISCHAEMIC ATTACK,6
CA,UPPER RESPIRATORY TRACT INFECTION,6
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,5
CA,ADVERSE EVENT,5
CA,AORTIC ANEURYSM,5
CA,BLISTER,5
CA,BLOOD CHOLESTEROL INCREASED,5
CA,BLOOD GLUCOSE DECREASED,5
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,5
CA,BLOOD POTASSIUM DECREASED,5
CA,BLOOD PRESSURE DIASTOLIC INCREASED,5
CA,BODY TEMPERATURE INCREASED,5
CA,BONE DENSITY DECREASED,5
CA,CALCIUM DEFICIENCY,5
CA,CARPAL TUNNEL SYNDROME,5
CA,CHOLECYSTITIS,5
CA,DENTAL CARIES,5
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,5
CA,DERMATITIS CONTACT,5
CA,EAR INFECTION,5
CA,EJECTION FRACTION DECREASED,5
CA,EYE SWELLING,5
CA,FEBRILE NEUTROPENIA,5
CA,FISTULA,5
CA,FORCED EXPIRATORY VOLUME DECREASED,5
CA,HAEMORRHAGE URINARY TRACT,5
CA,HALLUCINATION,5
CA,HYPOACUSIS,5
CA,HYPOXIA,5
CA,ILL-DEFINED DISORDER,5
CA,INTERVERTEBRAL DISC PROTRUSION,5
CA,IRRITABILITY,5
CA,LACERATION,5
CA,LIGAMENT SPRAIN,5
CA,LYMPHADENOPATHY,5
CA,LYMPHOCYTE COUNT DECREASED,5
CA,MASS,5
CA,MELAENA,5
CA,MULTI-ORGAN FAILURE,5
CA,NEOPLASM MALIGNANT,5
CA,NEURALGIA,5
CA,NEUROTOXICITY,5
CA,ORAL PAIN,5
CA,PANIC ATTACK,5
CA,PELVIC FRACTURE,5
CA,PLEURAL EFFUSION,5
CA,PROSTATE CANCER,5
CA,PULMONARY FUNCTION TEST ABNORMAL,5
CA,PULMONARY MASS,5
CA,SCAR,5
CA,SHOCK,5
CA,SINUS CONGESTION,5
CA,SINUS DISORDER,5
CA,SNEEZING,5
CA,SPINAL FRACTURE,5
CA,SWOLLEN TONGUE,5
CA,THROMBOCYTOPENIA,5
CA,TOOTH DISORDER,5
CA,TOOTH EXTRACTION,5
CA,URINARY RETENTION,5
CA,ABASIA,4
CA,ACUTE MYOCARDIAL INFARCTION,4
CA,APHASIA,4
CA,APHONIA,4
CA,APHTHOUS ULCER,4
CA,ARTERIAL OCCLUSIVE DISEASE,4
CA,ARTHRITIS BACTERIAL,4
CA,ASPIRATION,4
CA,BLOOD TEST ABNORMAL,4
CA,BRONCHITIS CHRONIC,4
CA,C-REACTIVE PROTEIN INCREASED,4
CA,CARDIAC FAILURE,4
CA,CARDIAC FAILURE CONGESTIVE,4
CA,COLITIS ULCERATIVE,4
CA,DEPRESSED MOOD,4
CA,DIARRHOEA HAEMORRHAGIC,4
CA,DRUG INTOLERANCE,4
CA,DRY MOUTH,4
CA,ERYTHEMA OF EYELID,4
CA,EYE INFECTION,4
CA,EYE PAIN,4
CA,FEELING HOT,4
CA,FOETAL EXPOSURE DURING PREGNANCY,4
CA,FOOT DEFORMITY,4
CA,FURUNCLE,4
CA,GASTRIC HAEMORRHAGE,4
CA,GASTROINTESTINAL EROSION,4
CA,GASTROINTESTINAL HAEMORRHAGE,4
CA,HEAD INJURY,4
CA,HEART RATE IRREGULAR,4
CA,HEPATIC CIRRHOSIS,4
CA,HEPATIC LESION,4
CA,HEPATIC NEOPLASM,4
CA,HEPATIC STEATOSIS,4
CA,HYPONATRAEMIA,4
CA,INCORRECT DOSE ADMINISTERED,4
CA,INFLAMMATORY BOWEL DISEASE,4
CA,INJECTION SITE ERYTHEMA,4
CA,INJECTION SITE MASS,4
CA,INTESTINAL STENOSIS,4
CA,JOINT RANGE OF MOTION DECREASED,4
CA,LIMB DISCOMFORT,4
CA,LUNG NEOPLASM MALIGNANT,4
CA,METABOLIC ACIDOSIS,4
CA,MOVEMENT DISORDER,4
CA,MUSCLE STRAIN,4
CA,MUSCLE TWITCHING,4
CA,MUSCULOSKELETAL DISCOMFORT,4
CA,NEUTROPHIL COUNT INCREASED,4
CA,OCCUPATIONAL EXPOSURE TO AIR CONTAMINANTS,4
CA,OESOPHAGEAL ULCER,4
CA,ORAL CANDIDIASIS,4
CA,PAIN OF SKIN,4
CA,PERICARDIAL EFFUSION,4
CA,PERIPHERAL COLDNESS,4
CA,PERIPHERAL VASCULAR DISORDER,4
CA,PNEUMOTHORAX,4
CA,POLLAKIURIA,4
CA,POLYMYOSITIS,4
CA,PREGNANCY,4
CA,PRURITUS GENERALISED,4
CA,RALES,4
CA,RENAL DISORDER,4
CA,RENAL FAILURE ACUTE,4
CA,RESPIRATORY TRACT CONGESTION,4
CA,ROAD TRAFFIC ACCIDENT,4
CA,SKIN BURNING SENSATION,4
CA,SKIN LESION,4
CA,SUICIDE ATTEMPT,4
CA,TENDERNESS,4
CA,TENDON DISORDER,4
CA,TENDONITIS,4
CA,TOOTH INFECTION,4
CA,TYPE 2 DIABETES MELLITUS,4
CA,URINARY BLADDER HAEMORRHAGE,4
CA,URINARY INCONTINENCE,4
CA,VAGINAL HAEMORRHAGE,4
CA,VIRAL INFECTION,4
CA,ARTHRITIS INFECTIVE,3
CA,ARTHROPOD BITE,3
CA,ASCITES,3
CA,BLINDNESS,3
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,3
CA,BLOOD POTASSIUM INCREASED,3
CA,BLOOD PRESSURE ABNORMAL,3
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,3
CA,BLOOD PRESSURE SYSTOLIC DECREASED,3
CA,BLOOD TRIGLYCERIDES INCREASED,3
CA,BRADYCARDIA,3
CA,BRAIN OEDEMA,3
CA,BREAST MASS,3
CA,BREAST PAIN,3
CA,CANDIDA INFECTION,3
CA,CARDIAC PACEMAKER INSERTION,3
CA,CEREBRAL VASOCONSTRICTION,3
CA,CHOLECYSTITIS INFECTIVE,3
CA,COLON CANCER,3
CA,CONGENITAL CYSTIC LUNG,3
CA,CREPITATIONS,3
CA,CRYING,3
CA,CYST,3
CA,DEVICE OCCLUSION,3
CA,DEVICE RELATED INFECTION,3
CA,DIVERTICULITIS,3
CA,DRUG-INDUCED LIVER INJURY,3
CA,EAR DISCOMFORT,3
CA,ELECTROCARDIOGRAM QT PROLONGED,3
CA,ELECTROLYTE IMBALANCE,3
CA,EMPHYSEMA,3
CA,ENCEPHALOPATHY,3
CA,ERUCTATION,3
CA,EYE ALLERGY,3
CA,FAECES DISCOLOURED,3
CA,FAECES SOFT,3
CA,FEMUR FRACTURE,3
CA,GAIT INABILITY,3
CA,GALLBLADDER DISORDER,3
CA,GASTRIC ULCER,3
CA,GASTROINTESTINAL CARCINOMA,3
CA,GASTROINTESTINAL INFLAMMATION,3
CA,GINGIVAL ULCERATION,3
CA,GLOMERULAR FILTRATION RATE DECREASED,3
CA,GLOSSITIS,3
CA,HAEMATOMA,3
CA,HELICOBACTER INFECTION,3
CA,HEPATIC ENCEPHALOPATHY,3
CA,HIP DEFORMITY,3
CA,HYPERGLYCAEMIA,3
CA,HYPOKALAEMIA,3
CA,INCISION SITE INFECTION,3
CA,INFUSION SITE ERYTHEMA,3
CA,INJECTION SITE PRURITUS,3
CA,INTENTIONAL PRODUCT USE ISSUE,3
CA,INTESTINAL PERFORATION,3
CA,INTESTINAL RESECTION,3
CA,JOINT INJURY,3
CA,KIDNEY INFECTION,3
CA,KNEE ARTHROPLASTY,3
CA,LACRIMATION INCREASED,3
CA,LIP SWELLING,3
CA,LOWER RESPIRATORY TRACT CONGESTION,3
CA,MATERNAL EXPOSURE DURING PREGNANCY,3
CA,MEDICATION ERROR,3
CA,METASTASES TO LIVER,3
CA,METASTASIS,3
CA,MOOD ALTERED,3
CA,MOUTH ULCERATION,3
CA,MULTIPLE SCLEROSIS,3
CA,MYELODYSPLASTIC SYNDROME,3
CA,MYOCLONUS,3
CA,NEOPLASM,3
CA,NEURODERMATITIS,3
CA,NEUROLEPTIC MALIGNANT SYNDROME,3
CA,NEUROPATHY PERIPHERAL,3
CA,NIGHT SWEATS,3
CA,OCULAR HYPERAEMIA,3
CA,ORAL HERPES,3
CA,ORGAN FAILURE,3
CA,OSTEONECROSIS OF JAW,3
CA,PHARYNGEAL OEDEMA,3
CA,PHARYNGITIS,3
CA,PIGMENTATION DISORDER,3
CA,PLATELET COUNT INCREASED,3
CA,PNEUMONIA ASPIRATION,3
CA,POLYP,3
CA,POOR PERIPHERAL CIRCULATION,3
CA,PRODUCT USE IN UNAPPROVED INDICATION,3
CA,PSYCHOTIC DISORDER,3
CA,PULMONARY FIBROSIS,3
CA,RASH MACULAR,3
CA,REACTION TO DRUG EXCIPIENTS,3
CA,RESPIRATORY DEPRESSION,3
CA,RESPIRATORY TRACT INFECTION,3
CA,RETINAL DETACHMENT,3
CA,SEASONAL ALLERGY,3
CA,SEROTONIN SYNDROME,3
CA,SINUS HEADACHE,3
CA,SINUS TACHYCARDIA,3
CA,SKIN CANCER,3
CA,SKIN EXFOLIATION,3
CA,SKIN PLAQUE,3
CA,SLEEP DISORDER,3
CA,SPINAL PAIN,3
CA,SPUTUM DISCOLOURED,3
CA,SURGERY,3
CA,TACHYPNOEA,3
CA,TENDON RUPTURE,3
CA,TONGUE ULCERATION,3
CA,TOOTH ABSCESS,3
CA,TOOTH FRACTURE,3
CA,UNEVALUABLE EVENT,3
CA,VISION BLURRED,3
CA,VISUAL ACUITY REDUCED,3
CA,VOLVULUS,3
CA,VULVOVAGINAL MYCOTIC INFECTION,3
CA,WALKING DISABILITY,3
CA,WEIGHT FLUCTUATION,3
CA,WOUND INFECTION,3
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
CA,ABNORMAL DREAMS,2
CA,ABSCESS,2
CA,ACCIDENT,2
CA,ACUTE PULMONARY OEDEMA,2
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,2
CA,ADENOCARCINOMA OF COLON,2
CA,ADRENAL MASS,2
CA,ADVERSE DRUG REACTION,2
CA,ALLERGIC EOSINOPHILIA,2
CA,AMNESIA,2
CA,ANAL FISSURE,2
CA,ANAL INCONTINENCE,2
CA,ANAPHYLACTIC REACTION,2
CA,ANGINA PECTORIS,2
CA,ATRIAL TACHYCARDIA,2
CA,B-CELL LYMPHOMA,2
CA,BACTERIAL INFECTION,2
CA,BLOOD BILIRUBIN INCREASED,2
CA,BLOOD GLUCOSE ABNORMAL,2
CA,BLOOD GLUCOSE FLUCTUATION,2
CA,BLOOD LACTIC ACID INCREASED,2
CA,BLOOD PHOSPHORUS INCREASED,2
CA,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
CA,BLOOD UREA INCREASED,2
CA,BREAST FEEDING,2
CA,BREATH SOUNDS ABNORMAL,2
CA,BRUXISM,2
CA,BURSITIS,2
CA,CARDIAC VALVE DISEASE,2
CA,CARDIOMEGALY,2
CA,CATARACT OPERATION,2
CA,CENTRAL NERVOUS SYSTEM LESION,2
CA,CEREBRAL DISORDER,2
CA,CHOLECYSTITIS ACUTE,2
CA,CHOLESTASIS OF PREGNANCY,2
CA,CLAUSTROPHOBIA,2
CA,CLOSTRIDIUM DIFFICILE COLITIS,2
CA,COCCIDIOIDOMYCOSIS,2
CA,COELIAC DISEASE,2
CA,COLITIS ISCHAEMIC,2
CA,COMPARTMENT SYNDROME,2
CA,CONJUNCTIVITIS,2
CA,CORNEAL TRANSPLANT,2
CA,CORONARY ARTERY DISEASE,2
CA,CYTOMEGALOVIRUS CHORIORETINITIS,2
CA,DEAFNESS UNILATERAL,2
CA,DELUSION,2
CA,DEVICE BREAKAGE,2
CA,DIABETIC KETOACIDOSIS,2
CA,DISEASE RECURRENCE,2
CA,DISTURBANCE IN ATTENTION,2
CA,DIVERTICULAR PERFORATION,2
CA,DIZZINESS POSTURAL,2
CA,DRUG ADMINISTRATION ERROR,2
CA,DRUG EFFECT DELAYED,2
CA,DYSSTASIA,2
CA,DYSURIA,2
CA,EAR PAIN,2
CA,ECCHYMOSIS,2
CA,ENTERITIS,2
CA,ENTERITIS INFECTIOUS,2
CA,EOSINOPHIL COUNT INCREASED,2
CA,EPIGASTRIC DISCOMFORT,2
CA,EPILEPSY,2
CA,EUPHORIC MOOD,2
CA,EXTREMITY NECROSIS,2
CA,EYE MOVEMENT DISORDER,2
CA,FACIAL BONES FRACTURE,2
CA,FACIAL PAIN,2
CA,FEELING COLD,2
CA,FEELING OF BODY TEMPERATURE CHANGE,2
CA,FEMORAL NECK FRACTURE,2
CA,FINE MOTOR SKILL DYSFUNCTION,2
CA,FINGER DEFORMITY,2
CA,FOAMING AT MOUTH,2
CA,FORCED VITAL CAPACITY DECREASED,2
CA,FRACTURE,2
CA,GASTROINTESTINAL STROMAL TUMOUR,2
CA,GESTATIONAL DIABETES,2
CA,GINGIVAL DISORDER,2
CA,GLAUCOMA,2
CA,GOUT,2
CA,HAEMATEMESIS,2
CA,HAEMOGLOBINURIA,2
CA,HAEMOPTYSIS,2
CA,HAEMORRHOIDAL HAEMORRHAGE,2
CA,HALLUCINATION_ VISUAL,2
CA,HALLUCINATIONS_ MIXED,2
CA,HEART RATE ABNORMAL,2
CA,HEMIPARESIS,2
CA,HEPATIC ENZYME ABNORMAL,2
CA,HEPATIC INFECTION,2
CA,HEPATITIS,2
CA,HEPATOCELLULAR CARCINOMA,2
CA,HERPES ZOSTER DISSEMINATED,2
CA,HYPERSOMNIA,2
CA,HYPOMAGNESAEMIA,2
CA,IMMUNE THROMBOCYTOPENIC PURPURA,2
CA,IMMUNOSUPPRESSION,2
CA,INCREASED APPETITE,2
CA,INCREASED UPPER AIRWAY SECRETION,2
CA,INFECTED SKIN ULCER,2
CA,INFUSION SITE SWELLING,2
CA,INGROWING NAIL,2
CA,INGUINAL HERNIA,2
CA,INJECTION SITE BRUISING,2
CA,INJECTION SITE EXTRAVASATION,2
CA,INTENTIONAL PRODUCT MISUSE,2
CA,INTESTINAL POLYP,2
CA,IRITIS,2
CA,ISCHAEMIC STROKE,2
CA,JOINT DISLOCATION,2
CA,JOINT EFFUSION,2
CA,LABYRINTHITIS,2
CA,LARYNGITIS,2
CA,LIMB OPERATION,2
CA,LIP INJURY,2
CA,LIPASE INCREASED,2
CA,LIVER DISORDER,2
CA,LOOSE TOOTH,2
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
CA,LOWER LIMB FRACTURE,2
CA,LYMPHOMA,2
CA,MACULAR DEGENERATION,2
CA,MALNUTRITION,2
CA,MASTITIS FUNGAL,2
CA,MEAN CELL HAEMOGLOBIN INCREASED,2
CA,MEAN CELL VOLUME INCREASED,2
CA,MICTURITION DISORDER,2
CA,MIDDLE INSOMNIA,2
CA,MULTIPLE DRUG THERAPY,2
CA,MULTIPLE FRACTURES,2
CA,MYCOBACTERIUM TEST POSITIVE,2
CA,NASAL DRYNESS,2
CA,NEEDLE ISSUE,2
CA,NEOPLASM PROGRESSION,2
CA,NEPHROPATHY,2
CA,NEPHROTIC SYNDROME,2
CA,NERVOUSNESS,2
CA,NO THERAPEUTIC RESPONSE,2
CA,NOCTURIA,2
CA,NODULE,2
CA,OESOPHAGEAL HAEMORRHAGE,2
CA,ORAL DISORDER,2
CA,ORGANISING PNEUMONIA,2
CA,PAIN IN JAW,2
CA,PARANOIA,2
CA,PAROSMIA,2
CA,PHARYNGEAL ULCERATION,2
CA,PHOTOSENSITIVITY REACTION,2
CA,PLASMA CELL MYELOMA,2
CA,PNEUMONITIS,2
CA,POST PROCEDURAL COMPLICATION,2
CA,POST PROCEDURAL INFECTION,2
CA,PRE-ECLAMPSIA,2
CA,PRESYNCOPE,2
CA,PRODUCT TASTE ABNORMAL,2
CA,PROTEINURIA,2
CA,PULMONARY HYPERTENSION,2
CA,PULSE ABSENT,2
CA,RASH PAPULAR,2
CA,RASH VESICULAR,2
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
CA,RENAL MASS,2
CA,RENAL PAIN,2
CA,RENAL TUBULAR NECROSIS,2
CA,RESPIRATORY ARREST,2
CA,RESPIRATORY DISORDER,2
CA,RETINAL TOXICITY,2
CA,RIB FRACTURE,2
CA,ROTATOR CUFF SYNDROME,2
CA,SCHIZOPHRENIA,2
CA,SCIATICA,2
CA,SCLERODERMA,2
CA,SCRATCH,2
CA,SKIN ABRASION,2
CA,SKIN ATROPHY,2
CA,SKIN DISORDER,2
CA,SKIN HAEMORRHAGE,2
CA,SKIN INFECTION,2
CA,SKIN ODOUR ABNORMAL,2
CA,SKIN REACTION,2
CA,SMALL CELL CARCINOMA,2
CA,SMALL INTESTINAL OBSTRUCTION,2
CA,SOFT TISSUE NECROSIS,2
CA,SPINAL COMPRESSION FRACTURE,2
CA,SPINAL CORD COMPRESSION,2
CA,SPINAL DISORDER,2
CA,SPINAL OPERATION,2
CA,STREPTOCOCCAL BACTERAEMIA,2
CA,STRESS CARDIOMYOPATHY,2
CA,SYNOVIAL CYST,2
CA,SYNOVITIS,2
CA,TENDON INJURY,2
CA,TENSION HEADACHE,2
CA,THYROID DISORDER,2
CA,THYROID NEOPLASM,2
CA,TOOTHACHE,2
CA,TOXIC ENCEPHALOPATHY,2
CA,TRANSAMINASES INCREASED,2
CA,TREATMENT FAILURE,2
CA,TREATMENT NONCOMPLIANCE,2
CA,TUBULOINTERSTITIAL NEPHRITIS,2
CA,ULCER,2
CA,UMBILICAL HERNIA,2
CA,UNDERDOSE,2
CA,UTERINE HAEMORRHAGE,2
CA,UTERINE LEIOMYOMA,2
CA,VAGINAL INFECTION,2
CA,VEIN DISORDER,2
CA,VENTRICULAR TACHYCARDIA,2
CA,WEIGHT ABNORMAL,2
CA,WEIGHT BEARING DIFFICULTY,2
CA,WOUND COMPLICATION,2
CA,ABDOMINAL ADHESIONS,1
CA,ABDOMINAL HERNIA,1
CA,ABDOMINAL INFECTION,1
CA,ABDOMINAL PAIN LOWER,1
CA,ABNORMAL CLOTTING FACTOR,1
CA,ABORTION MISSED,1
CA,ABORTION SPONTANEOUS,1
CA,ABSCESS JAW,1
CA,ABSCESS LIMB,1
CA,ABSCESS ORAL,1
CA,ACCIDENT AT HOME,1
CA,ACNE,1
CA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
CA,ACUTE CORONARY SYNDROME,1
CA,ACUTE HEPATIC FAILURE,1
CA,ACUTE LEUKAEMIA,1
CA,ACUTE LYMPHOCYTIC LEUKAEMIA,1
CA,ADNEXA UTERI MASS,1
CA,ADRENAL INSUFFICIENCY,1
CA,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
CA,ADVERSE REACTION,1
CA,AFFECT LABILITY,1
CA,AGEUSIA,1
CA,ALCOHOL PROBLEM,1
CA,ALVEOLAR OSTEITIS,1
CA,AMMONIA INCREASED,1
CA,ANEURYSM,1
CA,ANGER,1
CA,ANGIODYSPLASIA,1
CA,ANIMAL BITE,1
CA,ANKLE DEFORMITY,1
CA,ANKLE FRACTURE,1
CA,ANKYLOSING SPONDYLITIS,1
CA,ANOSMIA,1
CA,ANOXIA,1
CA,ANTIBIOTIC THERAPY,1
CA,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
CA,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,1
CA,ANTIPSYCHOTIC DRUG LEVEL DECREASED,1
CA,ANURIA,1
CA,AORTIC VALVE STENOSIS,1
CA,APATHY,1
CA,APLASIA PURE RED CELL,1
CA,APNOEA,1
CA,APPARENT DEATH,1
CA,APPENDICITIS,1
CA,ARM AMPUTATION,1
CA,ARRHYTHMIA SUPRAVENTRICULAR,1
CA,ARTERIOGRAM CORONARY,1
CA,ARTERIOSCLEROSIS CORONARY ARTERY,1
CA,ARTHROPOD STING,1
CA,ASBESTOSIS,1
CA,ASPIRATION JOINT,1
CA,ASPIRATION PLEURAL CAVITY,1
CA,ATAXIA,1
CA,ATELECTASIS,1
CA,ATRIAL FLUTTER,1
CA,ATYPICAL PNEUMONIA,1
CA,AUTONOMIC NEUROPATHY,1
CA,AXILLARY MASS,1
CA,B-CELL TYPE ACUTE LEUKAEMIA,1
CA,BACK DISORDER,1
CA,BACTERIAL TEST,1
CA,BACTERIAL TEST POSITIVE,1
CA,BENIGN NEOPLASM OF BLADDER,1
CA,BENIGN PROSTATIC HYPERPLASIA,1
CA,BILIRUBIN URINE,1
CA,BLADDER CATHETERISATION,1
CA,BLADDER NEOPLASM,1
CA,BLADDER REPAIR,1
CA,BLADDER TRANSITIONAL CELL CARCINOMA,1
CA,BLINDNESS UNILATERAL,1
CA,BLOOD BICARBONATE ABNORMAL,1
CA,BLOOD BILIRUBIN DECREASED,1
CA,BLOOD BLISTER,1
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CA,BLOOD DISORDER,1
CA,BLOOD ELECTROLYTES DECREASED,1
CA,BLOOD GASTRIN DECREASED,1
CA,BLOOD HIV RNA DECREASED,1
CA,BLOOD IMMUNOGLOBULIN E INCREASED,1
CA,BLOOD IMMUNOGLOBULIN G DECREASED,1
CA,BLOOD IMMUNOGLOBULIN G INCREASED,1
CA,BLOOD IRON INCREASED,1
CA,BLOOD PH DECREASED,1
CA,BLOOD PRODUCT TRANSFUSION DEPENDENT,1
CA,BLOOD SODIUM DECREASED,1
CA,BLOOD SODIUM INCREASED,1
CA,BONE CANCER,1
CA,BONE CYST,1
CA,BONE LESION,1
CA,BONE MARROW FAILURE,1
CA,BONE OPERATION,1
CA,BORDERLINE PERSONALITY DISORDER,1
CA,BOWEL MOVEMENT IRREGULARITY,1
CA,BOWEN^S DISEASE,1
CA,BRAIN ABSCESS,1
CA,BRAIN CONTUSION,1
CA,BREAST CALCIFICATIONS,1
CA,BREAST CANCER METASTATIC,1
CA,BREAST DISCHARGE,1
CA,BREAST TENDERNESS,1
CA,BREAST ULCERATION,1
CA,BREECH PRESENTATION,1
CA,BUNION,1
CA,CAESAREAN SECTION,1
CA,CALCIUM PHOSPHATE PRODUCT INCREASED,1
CA,CAMPYLOBACTER GASTROENTERITIS,1
CA,CAMPYLOBACTER INFECTION,1
CA,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
CA,CARDIAC FAILURE ACUTE,1
CA,CARDIAC INFECTION,1
CA,CARDIOVASCULAR DISORDER,1
CA,CARDIOVASCULAR INSUFFICIENCY,1
CA,CARPAL TUNNEL DECOMPRESSION,1
CA,CARTILAGE INJURY,1
CA,CATHETER SITE DISCHARGE,1
CA,CATHETER SITE ERYTHEMA,1
CA,CATHETER SITE EXTRAVASATION,1
CA,CATHETER SITE INFECTION,1
CA,CATHETER SITE PAIN,1
CA,CATHETER SITE SWELLING,1
CA,CD4 LYMPHOCYTES DECREASED,1
CA,CENTRAL VENOUS CATHETERISATION,1
CA,CEREBELLAR SYNDROME,1
CA,CEREBRAL OEDEMA MANAGEMENT,1
CA,CERVIX ENLARGEMENT,1
CA,CHEILITIS,1
CA,CHEST INJURY,1
CA,CHEST X-RAY ABNORMAL,1
CA,CHOKING,1
CA,CHOLECYSTECTOMY,1
CA,CHROMATURIA,1
CA,CHRONIC HEPATIC FAILURE,1
CA,CHRONIC KIDNEY DISEASE,1
CA,CIRCULATORY COLLAPSE,1
CA,CLUSTER HEADACHE,1
CA,COAGULATION TIME PROLONGED,1
CA,COAGULOPATHY,1
CA,COLECTOMY,1
CA,COLON CANCER METASTATIC,1
CA,COMA,1
CA,CONJUNCTIVAL HYPERAEMIA,1
CA,CONSCIOUSNESS FLUCTUATING,1
CA,CONTINUOUS POSITIVE AIRWAY PRESSURE,1
CA,COORDINATION ABNORMAL,1
CA,CORNEAL PERFORATION,1
CA,CORONARY ARTERIAL STENT INSERTION,1
CA,CORONARY ARTERY OCCLUSION,1
CA,COSTOCHONDRITIS,1
CA,CSF GLUCOSE DECREASED,1
CA,CULTURE URINE POSITIVE,1
CA,CYANOSIS,1
CA,CYSTIC FIBROSIS,1
CA,CYSTIC FIBROSIS LUNG,1
CA,CYTOMEGALOVIRUS INFECTION,1
CA,CYTOMEGALOVIRUS VIRAEMIA,1
CA,DEAFNESS,1
CA,DECREASED ACTIVITY,1
CA,DEFAECATION URGENCY,1
CA,DELUSIONAL DISORDER_ UNSPECIFIED TYPE,1
CA,DEPRESSIVE SYMPTOM,1
CA,DERMATITIS,1
CA,DERMATITIS ALLERGIC,1
CA,DEVELOPMENTAL DELAY,1
CA,DEVICE FAILURE,1
CA,DEVICE LEAKAGE,1
CA,DEVICE LOOSENING,1
CA,DIABETES MELLITUS INADEQUATE CONTROL,1
CA,DIABETIC RETINOPATHY,1
CA,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,1
CA,DIPLOPIA,1
CA,DISORIENTATION,1
CA,DISSEMINATED INTRAVASCULAR COAGULATION,1
CA,DISSOCIATION,1
CA,DIVERTICULUM,1
CA,DROOLING,1
CA,DRUG DISPENSING ERROR,1
CA,DRUG EFFECT INCREASED,1
CA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CA,DRUG LEVEL INCREASED,1
CA,DRUG WITHDRAWAL SYNDROME,1
CA,DRY EYE,1
CA,DRY THROAT,1
CA,DUODENITIS,1
CA,DUPUYTREN^S CONTRACTURE,1
CA,DYSARTHRIA,1
CA,DYSPHEMIA,1
CA,DYSPNOEA AT REST,1
CA,DYSPNOEA PAROXYSMAL NOCTURNAL,1
CA,EAR DISORDER,1
CA,EAR INFECTION VIRAL,1
CA,EAR SWELLING,1
CA,EATING DISORDER,1
CA,ELBOW DEFORMITY,1
CA,ELECTROCARDIOGRAM ABNORMAL,1
CA,EMBOLISM VENOUS,1
CA,EMOTIONAL DISTRESS,1
CA,ENCEPHALITIS,1
CA,END STAGE RENAL DISEASE,1
CA,ENDOMETRIAL HYPERTROPHY,1
CA,ENDOMETRIOSIS,1
CA,ENTEROCOCCAL INFECTION,1
CA,ENTEROCOLITIS,1
CA,ENTEROCOLITIS HAEMORRHAGIC,1
CA,ENTROPION,1
CA,ENZYME ABNORMALITY,1
CA,ERECTION INCREASED,1
CA,ESCHERICHIA INFECTION,1
CA,ESCHERICHIA URINARY TRACT INFECTION,1
CA,EXCORIATION,1
CA,EXERCISE TOLERANCE DECREASED,1
CA,EXPOSED BONE IN JAW,1
CA,EXPOSURE DURING BREAST FEEDING,1
CA,EXPOSURE VIA BODY FLUID,1
CA,EYE DEGENERATIVE DISORDER,1
CA,EYE DISCHARGE,1
CA,EYE HAEMORRHAGE,1
CA,EYE LASER SURGERY,1
CA,EYE OEDEMA,1
CA,EYE OPERATION,1
CA,EYELID INFECTION,1
CA,EYELID OEDEMA,1
CA,EYELID TUMOUR,1
CA,FACE OEDEMA,1
CA,FACTOR VII DEFICIENCY,1
CA,FAECAL INCONTINENCE,1
CA,FAECES HARD,1
CA,FAMILIAL HYPOCALCIURIC HYPERCALCAEMIA,1
CA,FEAR,1
CA,FEBRILE CONVULSION,1
CA,FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION,1
CA,FEEDING DISORDER,1
CA,FINGER AMPUTATION,1
CA,FOOD AVERSION,1
CA,FOOD POISONING,1
CA,FOOT OPERATION,1
CA,FULL BLOOD COUNT DECREASED,1
CA,FUNCTIONAL GASTROINTESTINAL DISORDER,1
CA,FUNGAL RHINITIS,1
CA,FUNGAL TEST POSITIVE,1
CA,GASTRIC DILATATION,1
CA,GASTRIC DISORDER,1
CA,GASTRIC FISTULA,1
CA,GASTRIC INFECTION,1
CA,GASTRIC MUCOSAL LESION,1
CA,GASTRIC VARICES,1
CA,GASTRITIS EROSIVE,1
CA,GASTROINTESTINAL ANASTOMOTIC LEAK,1
CA,GASTROINTESTINAL INFECTION,1
CA,GASTROINTESTINAL PERFORATION,1
CA,GASTROINTESTINAL SOUNDS ABNORMAL,1
CA,GASTROINTESTINAL STOMA COMPLICATION,1
CA,GENITOURINARY SYMPTOM,1
CA,GILBERT^S SYNDROME,1
CA,GINGIVAL BLEEDING,1
CA,GINGIVITIS,1
CA,GLOSSODYNIA,1
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
CA,GOITRE,1
CA,GRANULOMATOSIS WITH POLYANGIITIS,1
CL,PNEUMONIA,13
CL,PAIN,12
CL,DRUG INEFFECTIVE,10
CL,DIARRHOEA,9
CL,DIZZINESS,9
CL,VOMITING,9
CL,DYSPNOEA,8
CL,FATIGUE,8
CL,HEADACHE,8
CL,MALAISE,8
CL,NAUSEA,8
CL,HYPOTENSION,7
CL,IMMUNE SYSTEM DISORDER,7
CL,ASTHENIA,6
CL,DRUG DOSE OMISSION,6
CL,NASOPHARYNGITIS,6
CL,ABDOMINAL PAIN UPPER,5
CL,CHEST PAIN,5
CL,DEPRESSED MOOD,5
CL,GASTRITIS,5
CL,HYPERTENSION,5
CL,HYPOAESTHESIA,5
CL,PYREXIA,5
CL,ABDOMINAL PAIN,4
CL,ANAEMIA,4
CL,ARTHRALGIA,4
CL,BACK PAIN,4
CL,BRONCHITIS,4
CL,DECREASED APPETITE,4
CL,DISEASE PROGRESSION,4
CL,ERYTHEMA,4
CL,HYPERSENSITIVITY,4
CL,INFECTION,4
CL,INFLAMMATION,4
CL,MALIGNANT NEOPLASM PROGRESSION,4
CL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
CL,PARAESTHESIA,4
CL,PHARYNGITIS,4
CL,PULMONARY HYPERTENSION,4
CL,SJOGREN^S SYNDROME,4
CL,SKIN DISCOLOURATION,4
CL,SWELLING,4
CL,TACHYCARDIA,4
CL,WEIGHT DECREASED,4
CL,ABASIA,3
CL,ARRHYTHMIA,3
CL,BONE DISORDER,3
CL,BREAST PAIN,3
CL,CHOKING SENSATION,3
CL,COUGH,3
CL,DEATH,3
CL,DEEP VEIN THROMBOSIS,3
CL,FALL,3
CL,INSOMNIA,3
CL,MUSCULAR WEAKNESS,3
CL,NERVOUSNESS,3
CL,PAIN IN EXTREMITY,3
CL,RASH,3
CL,SEPTIC SHOCK,3
CL,URINARY TRACT INFECTION,3
CL,ACUTE MYOCARDIAL INFARCTION,2
CL,ARTHROPATHY,2
CL,ATRIAL FIBRILLATION,2
CL,BLOOD TEST ABNORMAL,2
CL,BREAST DISCOMFORT,2
CL,BREAST DISORDER,2
CL,BREAST MASS,2
CL,BURNING SENSATION,2
CL,CARDIAC DISORDER,2
CL,CARDIAC FAILURE,2
CL,CATARACT,2
CL,CHILLS,2
CL,CONSTIPATION,2
CL,CUSHING^S SYNDROME,2
CL,DEAFNESS,2
CL,DEHYDRATION,2
CL,DEPRESSION,2
CL,DRY MOUTH,2
CL,DYSPHONIA,2
CL,ECHOCARDIOGRAM ABNORMAL,2
CL,EYE DISORDER,2
CL,FEBRILE NEUTROPENIA,2
CL,FLUID RETENTION,2
CL,FOOT DEFORMITY,2
CL,GASTROINTESTINAL STROMAL TUMOUR,2
CL,GENERAL PHYSICAL HEALTH DETERIORATION,2
CL,HIP FRACTURE,2
CL,INTENTIONAL PRODUCT USE ISSUE,2
CL,INTESTINAL OBSTRUCTION,2
CL,ISCHAEMIC STROKE,2
CL,LOSS OF CONSCIOUSNESS,2
CL,MEMORY IMPAIRMENT,2
CL,MENSTRUATION IRREGULAR,2
CL,METASTASES TO PERITONEUM,2
CL,MULTIPLE GATED ACQUISITION SCAN ABNORMAL,2
CL,MUSCLE SPASMS,2
CL,MYALGIA,2
CL,OROPHARYNGEAL PAIN,2
CL,PANCREATITIS,2
CL,PARKINSON^S DISEASE,2
CL,PERIPHERAL SWELLING,2
CL,PNEUMONIA ASPIRATION,2
CL,PULMONARY EMBOLISM,2
CL,PYELONEPHRITIS ACUTE,2
CL,SYNCOPE,2
CL,SYSTEMIC LUPUS ERYTHEMATOSUS,2
CL,THROAT IRRITATION,2
CL,THROMBOSIS,2
CL,UPPER RESPIRATORY TRACT INFECTION,2
CL,UROSEPSIS,2
CL,VERTIGO,2
CL,WOUND,2
CL,ABDOMINAL DISCOMFORT,1
CL,ABDOMINAL DISTENSION,1
CL,ABDOMINAL INJURY,1
CL,ABDOMINAL MASS,1
CL,ABNORMAL BEHAVIOUR,1
CL,ACNE,1
CL,ADNEXA UTERI CYST,1
CL,AFFECTIVE DISORDER,1
CL,AGITATION,1
CL,ALOPECIA,1
CL,AMENORRHOEA,1
CL,ANAEMIA OF MALIGNANT DISEASE,1
CL,ANGINA PECTORIS,1
CL,ANGIOEDEMA,1
CL,ANXIETY,1
CL,ARTERIAL INSUFFICIENCY,1
CL,ARTHRITIS,1
CL,ASCITES,1
CL,ASPHYXIA,1
CL,AZOTAEMIA,1
CL,BALANCE DISORDER,1
CL,BEDRIDDEN,1
CL,BENIGN NEOPLASM OF THYROID GLAND,1
CL,BLINDNESS,1
CL,BLISTER,1
CL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CL,BLOOD CREATININE INCREASED,1
CL,BLOOD GASES ABNORMAL,1
CL,BLOOD PRESSURE ABNORMAL,1
CL,BLOOD PRESSURE INCREASED,1
CL,BLOOD UREA INCREASED,1
CL,BONE SCAN ABNORMAL,1
CL,BRAIN OEDEMA,1
CL,BREAST ABSCESS,1
CL,BREAST CALCIFICATIONS,1
CL,BREAST NEOPLASM,1
CL,BREAST SWELLING,1
CL,BREATH ODOUR,1
CL,BRONCHOSPASM,1
CL,CAMPYLOBACTER INFECTION,1
CL,CARDIAC ARREST,1
CL,CARDIAC FLUTTER,1
CL,CARDIO-RESPIRATORY ARREST,1
CL,CARPAL TUNNEL SYNDROME,1
CL,CAT SCRATCH DISEASE,1
CL,CELLULITIS,1
CL,CEREBRAL ARTERY EMBOLISM,1
CL,CEREBROVASCULAR ACCIDENT,1
CL,CERVIX DISORDER,1
CL,CHEMICAL PERITONITIS,1
CL,CHEST DISCOMFORT,1
CL,CHOKING,1
CL,CHOLECYSTITIS ACUTE,1
CL,CHOLELITHIASIS,1
CL,CIRCULATORY COLLAPSE,1
CL,CLOSTRIDIUM DIFFICILE INFECTION,1
CL,COLITIS,1
CL,CONTUSION,1
CL,CONVULSION,1
CL,DEMENTIA ALZHEIMER^S TYPE,1
CL,DERMATITIS ALLERGIC,1
CL,DEVICE RELATED INFECTION,1
CL,DIABETES MELLITUS,1
CL,DISCOMFORT,1
CL,DISEASE COMPLICATION,1
CL,DISORIENTATION,1
CL,DIVERTICULITIS,1
CL,DRUG HYPERSENSITIVITY,1
CL,DRUG LEVEL INCREASED,1
CL,DRUG PRESCRIBING ERROR,1
CL,DRUG-INDUCED LIVER INJURY,1
CL,DRY EYE,1
CL,DYSARTHRIA,1
CL,DYSPHAGIA,1
CL,DYSSTASIA,1
CL,ELECTRIC SHOCK,1
CL,ENDOCARDITIS,1
CL,ENERGY INCREASED,1
CL,EPICONDYLITIS,1
CL,ESCHERICHIA TEST POSITIVE,1
CL,EUPHORIC MOOD,1
CL,EXPIRED PRODUCT ADMINISTERED,1
CL,FACE OEDEMA,1
CL,FAECAL CALPROTECTIN ABNORMAL,1
CL,FEELING ABNORMAL,1
CL,FEELING COLD,1
CL,FEMUR FRACTURE,1
CL,FLATULENCE,1
CL,FLUID OVERLOAD,1
CL,FOOD INTOLERANCE,1
CL,FUNGAL PERITONITIS,1
CL,FUNGAL SEPSIS,1
CL,GAIT DISTURBANCE,1
CL,GALLBLADDER DISORDER,1
CL,GASTRITIS EROSIVE,1
CL,GASTROINTESTINAL NECROSIS,1
CL,GASTROINTESTINAL PAIN,1
CL,GASTROINTESTINAL SOUNDS ABNORMAL,1
CL,GASTROOESOPHAGEAL REFLUX DISEASE,1
CL,GINGIVAL BLEEDING,1
CL,GINGIVAL INFECTION,1
CL,GLUCOSE TOLERANCE IMPAIRED,1
CL,HAEMATOLOGY TEST ABNORMAL,1
CL,HAEMOLYTIC URAEMIC SYNDROME,1
CL,HAEMORRHAGIC STROKE,1
CL,HEART RATE DECREASED,1
CL,HEART RATE INCREASED,1
CL,HEART RATE NORMAL,1
CL,HEMIPARESIS,1
CL,HEMIPLEGIA,1
CL,HEPATIC FAILURE,1
CL,HEPATITIS ACUTE,1
CL,HEPATITIS B,1
CL,HERPES ZOSTER,1
CL,HOSPITALISATION,1
CL,HYPERCAPNIA,1
CL,HYPERHIDROSIS,1
CL,HYPERKALAEMIA,1
CL,HYPERPARATHYROIDISM,1
CL,HYPERTENSIVE CRISIS,1
CL,HYPERTHERMIA MALIGNANT,1
CL,HYPERTRIGLYCERIDAEMIA,1
CL,HYPOACUSIS,1
CL,HYPOKALAEMIA,1
CL,HYPOPERFUSION,1
CL,IMMUNODEFICIENCY,1
CL,IMPAIRED HEALING,1
CL,IMPLANTABLE DEFIBRILLATOR INSERTION,1
CL,INCORRECT DOSAGE ADMINISTERED,1
CL,INCORRECT DOSE ADMINISTERED,1
CL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CL,INFLUENZA,1
CL,INGUINAL HERNIA,1
CL,INJECTION SITE PAIN,1
CL,INTERNAL HAEMORRHAGE,1
CL,INTERVERTEBRAL DISC PROTRUSION,1
CL,INTESTINAL PERFORATION,1
CL,LARYNGITIS,1
CL,LENS DISORDER,1
CL,LETHARGY,1
CL,LIVER DISORDER,1
CL,LIVER FUNCTION TEST ABNORMAL,1
CL,LIVER INJURY,1
CL,LOCAL SWELLING,1
CL,LOOSE TOOTH,1
CL,LUMBAR RADICULOPATHY,1
CL,LUNG NEOPLASM,1
CL,LYMPHADENITIS,1
CL,LYMPHADENOPATHY,1
CL,MACULAR DEGENERATION,1
CL,MALARIA,1
CL,MASS,1
CL,MELAENA,1
CL,MENINGITIS,1
CL,MENOMETRORRHAGIA,1
CL,MENTAL DISORDER,1
CL,METASTASES TO LIVER,1
CL,METASTASIS,1
CL,MICROENCEPHALY,1
CL,MICTURITION DISORDER,1
CL,MITRAL VALVE DISEASE,1
CL,MOOD ALTERED,1
CL,MOVEMENT DISORDER,1
CL,MUCOSAL INFLAMMATION,1
CL,MULTIPLE INJURIES,1
CL,MUSCLE ATROPHY,1
CL,MUSCLE FIBROSIS,1
CL,MUSCULOSKELETAL PAIN,1
CL,MUSCULOSKELETAL STIFFNESS,1
CL,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
CL,MYOCARDIAL NECROSIS,1
CL,NAIL DISORDER,1
CL,NECK PAIN,1
CL,NECK SURGERY,1
CL,NEOPLASM MALIGNANT,1
CL,NEURALGIA,1
CL,NEUTROPENIC SEPSIS,1
CL,NO THERAPEUTIC RESPONSE,1
CL,NODULE,1
CL,NOSOCOMIAL INFECTION,1
CL,OBSTRUCTIVE AIRWAYS DISORDER,1
CL,OCULAR HYPERAEMIA,1
CL,OEDEMA PERIPHERAL,1
CL,OEDEMATOUS PANCREATITIS,1
CL,OESOPHAGEAL OBSTRUCTION,1
CL,OSTEOARTHRITIS,1
CL,OSTEOMA,1
CL,OSTEOMYELITIS,1
CL,OXYGEN SATURATION DECREASED,1
CL,OXYGEN SATURATION NORMAL,1
CL,PALLOR,1
CL,PANCREATIC CARCINOMA,1
CL,PANCREATIC NECROSIS,1
CL,PANIC ATTACK,1
CL,PARESIS,1
CL,PELVIC PAIN,1
CL,PERICARDIAL EFFUSION,1
CL,PERIODONTITIS,1
CL,PERIPHERAL EMBOLISM,1
CL,PERIPHERAL ISCHAEMIA,1
CL,PERITONEAL DISORDER,1
CL,PERITONEAL EFFLUENT ABNORMAL,1
CL,PERITONITIS,1
CL,PHOTOPHOBIA,1
CL,PLASMA CELL MYELOMA,1
CL,PLATELET COUNT DECREASED,1
CL,PNEUMOTHORAX,1
CL,POLYARTHRITIS,1
CL,POOR QUALITY SLEEP,1
CL,POST PROCEDURAL HAEMORRHAGE,1
CL,POSTOPERATIVE WOUND INFECTION,1
CL,PRESYNCOPE,1
CL,PROCEDURAL COMPLICATION,1
CL,PROCEDURAL PAIN,1
CL,PRODUCT USE ISSUE,1
CL,PROTEIN TOTAL DECREASED,1
CL,PROTEINURIA,1
CL,PRURITUS,1
CL,PSYCHIATRIC DECOMPENSATION,1
CL,PYELONEPHRITIS,1
CL,PYRAMIDAL TRACT SYNDROME,1
CL,RECURRENT CANCER,1
CL,RED BLOOD CELL COUNT DECREASED,1
CL,RENAL DISORDER,1
CL,RENAL FAILURE,1
CL,RENAL IMPAIRMENT,1
CL,RENAL INJURY,1
CL,RESPIRATORY DISORDER,1
CL,RESPIRATORY DISTRESS,1
CL,RESPIRATORY FAILURE,1
CL,RESPIRATORY TRACT INFECTION,1
CL,ROAD TRAFFIC ACCIDENT,1
CL,SEIZURE,1
CL,SENILE DEMENTIA,1
CL,SEPSIS,1
CL,SKIN IRRITATION,1
CL,SKIN WARM,1
CL,SLEEP APNOEA SYNDROME,1
CL,SOMNOLENCE,1
CL,SPEECH DISORDER,1
CL,SPINAL CORD DISORDER,1
CL,SPINAL DEFORMITY,1
CL,SPINAL DISORDER,1
CL,SPINAL FRACTURE,1
CL,STEVENS-JOHNSON SYNDROME,1
CL,STOMA SITE PAIN,1
CL,STRESS,1
CL,STRIDOR,1
CL,SUBACUTE ENDOCARDITIS,1
CL,SUBARACHNOID HAEMORRHAGE,1
CL,SWELLING FACE,1
CL,SWOLLEN TONGUE,1
CL,TACHYARRHYTHMIA,1
CL,TERMINAL STATE,1
CL,THIRST,1
CL,TONSILLITIS,1
CL,TOOTH INJURY,1
CL,TOOTHACHE,1
CL,TREATMENT FAILURE,1
CL,TUMOUR PAIN,1
CL,UPPER GASTROINTESTINAL HAEMORRHAGE,1
CL,UPPER LIMB FRACTURE,1
CL,URINARY TRACT DISORDER,1
CL,URINARY TRACT INFECTION PSEUDOMONAL,1
CL,UTERINE LEIOMYOMA,1
CL,VASCULAR PAIN,1
CL,VIITH NERVE PARALYSIS,1
CL,VIRAL INFECTION,1
CL,VIRAL PHARYNGITIS,1
CL,VISUAL IMPAIRMENT,1
CL,WALKING DISABILITY,1
CL,WALKING DISTANCE TEST NORMAL,1
CL,WITHDRAWAL SYNDROME,1
CL,WRIST FRACTURE,1
CN,HAEMOGLOBIN DECREASED,19
CN,LYMPHOCYTE COUNT DECREASED,18
CN,ALANINE AMINOTRANSFERASE INCREASED,15
CN,BLOOD GLUCOSE INCREASED,14
CN,NEUTROPHIL COUNT INCREASED,14
CN,BLOOD UREA INCREASED,13
CN,INCISION SITE PAIN,12
CN,WHITE BLOOD CELL COUNT INCREASED,12
CN,LUNG INFECTION,11
CN,WHITE BLOOD CELL COUNT DECREASED,11
CN,DIARRHOEA,10
CN,NAUSEA,10
CN,PYREXIA,10
CN,BLOOD CREATININE INCREASED,9
CN,HEPATIC FUNCTION ABNORMAL,9
CN,PLATELET COUNT DECREASED,9
CN,DERMATITIS EXFOLIATIVE,8
CN,RED BLOOD CELLS URINE POSITIVE,8
CN,ABDOMINAL DISTENSION,7
CN,DECREASED APPETITE,7
CN,VOMITING,7
CN,WEIGHT DECREASED,7
CN,ACUTE KIDNEY INJURY,6
CN,ANAEMIA,6
CN,ASPARTATE AMINOTRANSFERASE INCREASED,6
CN,ASTHENIA,6
CN,BLOOD TRIGLYCERIDES INCREASED,6
CN,C-REACTIVE PROTEIN INCREASED,6
CN,CHEST DISCOMFORT,6
CN,DYSPNOEA,6
CN,FEBRILE NEUTROPENIA,6
CN,GASTRIC HAEMORRHAGE,6
CN,HAEMOPTYSIS,6
CN,PNEUMONIA,6
CN,PROTEIN URINE PRESENT,6
CN,THROMBOCYTOPENIA,6
CN,UPPER RESPIRATORY TRACT INFECTION,6
CN,VIRAL MUTATION IDENTIFIED,6
CN,ABDOMINAL DISCOMFORT,5
CN,ATRIAL FIBRILLATION,5
CN,BLOOD ALBUMIN DECREASED,5
CN,CLOSTRIDIUM DIFFICILE COLITIS,5
CN,DIZZINESS,5
CN,HAEMATEMESIS,5
CN,INFECTION,5
CN,MULTI-ORGAN FAILURE,5
CN,NEUTROPENIA,5
CN,RENAL IMPAIRMENT,5
CN,URINARY TRACT INFECTION,5
CN,CARDIOMYOPATHY,4
CN,COMA,4
CN,COMPLICATIONS OF TRANSPLANTED KIDNEY,4
CN,DISEASE PROGRESSION,4
CN,DRUG INEFFECTIVE,4
CN,GASTROOESOPHAGEAL REFLUX DISEASE,4
CN,INTERSTITIAL LUNG DISEASE,4
CN,INTESTINAL OBSTRUCTION,4
CN,KIDNEY TRANSPLANT REJECTION,4
CN,LEUKOPENIA,4
CN,LIVER INJURY,4
CN,NEUTROPHIL COUNT DECREASED,4
CN,OVERDOSE,4
CN,PNEUMONITIS,4
CN,RASH,4
CN,VIRAL INFECTION,4
CN,ANAPHYLACTIC SHOCK,3
CN,BILIRUBIN CONJUGATED INCREASED,3
CN,BLOOD BILIRUBIN INCREASED,3
CN,BLOOD CHOLESTEROL INCREASED,3
CN,BLOOD CREATININE DECREASED,3
CN,BLOOD PRESSURE DECREASED,3
CN,BONE MARROW FAILURE,3
CN,CONFUSIONAL STATE,3
CN,DEATH,3
CN,DIABETES MELLITUS,3
CN,DRUG LEVEL INCREASED,3
CN,GASTROINTESTINAL HAEMORRHAGE,3
CN,HAEMATOCHEZIA,3
CN,HAEMATURIA,3
CN,HAEMORRHAGE,3
CN,HEPATITIS B DNA INCREASED,3
CN,HEPATOCELLULAR INJURY,3
CN,HIGH DENSITY LIPOPROTEIN DECREASED,3
CN,HYPERAMMONAEMIC ENCEPHALOPATHY,3
CN,HYPOALBUMINAEMIA,3
CN,LIVER DISORDER,3
CN,LOW DENSITY LIPOPROTEIN INCREASED,3
CN,METABOLIC ACIDOSIS,3
CN,PLASMA CELL MYELOMA,3
CN,PORTAL HYPERTENSION,3
CN,PROCEDURAL PAIN,3
CN,PROTEINURIA,3
CN,SINUS BRADYCARDIA,3
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,3
CN,ABDOMINAL INFECTION,2
CN,APPETITE DISORDER,2
CN,ARRHYTHMIA,2
CN,ASCITES,2
CN,CARDIAC FAILURE,2
CN,CHEST PAIN,2
CN,CHRONIC KIDNEY DISEASE,2
CN,CLOSTRIDIUM DIFFICILE INFECTION,2
CN,CONSTIPATION,2
CN,DELIRIUM,2
CN,ELECTROLYTE IMBALANCE,2
CN,FALL,2
CN,FATIGUE,2
CN,FEELING ABNORMAL,2
CN,HAEMORRHAGE INTRACRANIAL,2
CN,HEADACHE,2
CN,HEPATIC ENZYME INCREASED,2
CN,HIGH DENSITY LIPOPROTEIN INCREASED,2
CN,HYPERGLYCAEMIA,2
CN,HYPERHIDROSIS,2
CN,HYPOAESTHESIA,2
CN,HYPOKALAEMIA,2
CN,INFUSION RELATED REACTION,2
CN,LOW DENSITY LIPOPROTEIN DECREASED,2
CN,MYOCARDIAL NECROSIS MARKER INCREASED,2
CN,OEDEMA PERIPHERAL,2
CN,PAIN IN EXTREMITY,2
CN,PANCREATIC FISTULA,2
CN,PERICARDIAL FIBROSIS,2
CN,PLASMA CELL LEUKAEMIA,2
CN,PLASMA CELL MYELOMA RECURRENT,2
CN,PLEURAL EFFUSION,2
CN,PRURITUS,2
CN,PULMONARY ARTERIAL HYPERTENSION,2
CN,RALES,2
CN,RASH PRURITIC,2
CN,RENAL CYST,2
CN,RENAL FAILURE,2
CN,RESPIRATORY FAILURE,2
CN,SEIZURE,2
CN,SEPTIC SHOCK,2
CN,SINUS TACHYCARDIA,2
CN,SUICIDE ATTEMPT,2
CN,SYSTEMIC LUPUS ERYTHEMATOSUS,2
CN,THROMBOCYTOPENIC PURPURA,2
CN,TRANSAMINASES ABNORMAL,2
CN,TRAUMATIC LUNG INJURY,2
CN,VASCULAR STENT THROMBOSIS,2
CN,ABDOMINAL PAIN,1
CN,ABDOMINAL PAIN UPPER,1
CN,ABDOMINAL WALL HAEMORRHAGE,1
CN,ACUTE LEFT VENTRICULAR FAILURE,1
CN,AGRANULOCYTOSIS,1
CN,ALTERED STATE OF CONSCIOUSNESS,1
CN,AMMONIA INCREASED,1
CN,ANAL ABSCESS,1
CN,ANAPHYLACTIC REACTION,1
CN,ANOXIA,1
CN,APOPTOSIS,1
CN,APPENDICEAL ABSCESS,1
CN,ARTHRALGIA,1
CN,ASTHMA,1
CN,ATELECTASIS,1
CN,ATRIAL TACHYCARDIA,1
CN,BACK PAIN,1
CN,BK VIRUS INFECTION,1
CN,BLINDNESS,1
CN,BLOOD CHLORIDE DECREASED,1
CN,BLOOD CHOLESTEROL DECREASED,1
CN,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CN,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
CN,BLOOD GLUCOSE DECREASED,1
CN,BLOOD PHOSPHORUS DECREASED,1
CN,BLOOD POTASSIUM DECREASED,1
CN,BLOOD POTASSIUM INCREASED,1
CN,BLOOD PRESSURE ABNORMAL,1
CN,BLOOD SODIUM DECREASED,1
CN,BLOOD TRIGLYCERIDES DECREASED,1
CN,BLOOD UREA DECREASED,1
CN,BLOOD URIC ACID INCREASED,1
CN,BODY TEMPERATURE INCREASED,1
CN,BRAIN HERNIATION,1
CN,BREATH HOLDING,1
CN,BUNDLE BRANCH BLOCK RIGHT,1
CN,C-REACTIVE PROTEIN DECREASED,1
CN,CARDIOTOXICITY,1
CN,CATARACT,1
CN,CEREBRAL HAEMORRHAGE,1
CN,CEREBRAL INFARCTION,1
CN,CHILLS,1
CN,CHROMATURIA,1
CN,CHRONIC GASTRITIS,1
CN,CIRCULATORY COLLAPSE,1
CN,COAGULOPATHY,1
CN,COLITIS,1
CN,COLON NEOPLASM,1
CN,COMPLICATIONS OF TRANSPLANT SURGERY,1
CN,CONDITION AGGRAVATED,1
CN,CONTUSION,1
CN,CORONARY ARTERY DISEASE,1
CN,CORONARY ARTERY OCCLUSION,1
CN,CORONARY ARTERY STENOSIS,1
CN,COUGH,1
CN,CYANOSIS,1
CN,CYTOMEGALOVIRUS INFECTION,1
CN,DEAFNESS,1
CN,DERMATITIS ALLERGIC,1
CN,DERMATITIS BULLOUS,1
CN,DISCOMFORT,1
CN,DISORGANISED SPEECH,1
CN,DRUG CLEARANCE DECREASED,1
CN,DRUG DOSE OMISSION,1
CN,DRUG ERUPTION,1
CN,DRUG HYPERSENSITIVITY,1
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
CN,DRUG-INDUCED LIVER INJURY,1
CN,DUODENAL NEOPLASM,1
CN,DUODENAL ULCER HAEMORRHAGE,1
CN,DYSKINESIA,1
CN,DYSPEPSIA,1
CN,DYSPHONIA,1
CN,DYSPHORIA,1
CN,DYSURIA,1
CN,EFFUSION,1
CN,ELECTROCARDIOGRAM ABNORMAL,1
CN,ENCEPHALOPATHY,1
CN,EPIDERMOLYSIS BULLOSA,1
CN,EPIDIDYMAL DISORDER,1
CN,EPILEPSY,1
CN,EPSTEIN-BARR VIRUS INFECTION,1
CN,ESCHERICHIA INFECTION,1
CN,FAECES DISCOLOURED,1
CN,FEMORAL NECK FRACTURE,1
CN,FISTULA,1
CN,FLANK PAIN,1
CN,FLUSHING,1
CN,FREQUENT BOWEL MOVEMENTS,1
CN,FUNGAL INFECTION,1
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CN,GASTRIC CANCER,1
CN,GASTRIC ULCER,1
CN,GASTRITIS,1
CN,GASTROINTESTINAL TOXICITY,1
CN,GASTROPLEURAL FISTULA,1
CN,GINGIVAL BLEEDING,1
CN,GINGIVAL PAIN,1
CN,GRANULOCYTE COUNT DECREASED,1
CN,HAEMOGLOBIN INCREASED,1
CN,HEAD DISCOMFORT,1
CN,HEART RATE DECREASED,1
CN,HEART RATE INCREASED,1
CN,HEPATIC CYST,1
CN,HEPATIC ENCEPHALOPATHY,1
CN,HEPATITIS ACUTE,1
CN,HEPATITIS CHOLESTATIC,1
CN,HEPATOTOXICITY,1
CN,HERPES ZOSTER,1
CN,HYDROCEPHALUS,1
CN,HYDRONEPHROSIS,1
CN,HYPERCALCAEMIA,1
CN,HYPERPARATHYROIDISM SECONDARY,1
CN,HYPOGLYCAEMIA,1
CN,HYPOPROTEINAEMIA,1
CN,HYPOTENSION,1
CN,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
CN,IMPAIRED HEALING,1
CN,INCISION SITE HAEMORRHAGE,1
CN,INFECTIOUS THYROIDITIS,1
CN,INFLUENZA LIKE ILLNESS,1
CN,INSOMNIA,1
CN,INTENTIONAL PRODUCT MISUSE,1
CN,INTESTINAL PERFORATION,1
CN,IRON DEFICIENCY ANAEMIA,1
CN,IRRITABILITY,1
CN,JAUNDICE CHOLESTATIC,1
CN,KIDNEY ENLARGEMENT,1
CN,KIDNEY INFECTION,1
CN,LARGE INTESTINAL STENOSIS,1
CN,LINEAR IGA DISEASE,1
CN,LUPUS-LIKE SYNDROME,1
CN,LYMPHOPROLIFERATIVE DISORDER,1
CN,MALIGNANT NEOPLASM PROGRESSION,1
CN,MALNUTRITION,1
CN,MARROW HYPERPLASIA,1
CN,MASTICATION DISORDER,1
CN,MENTAL DISORDER,1
CN,MENTAL IMPAIRMENT,1
CN,METABOLIC ALKALOSIS,1
CN,MIOSIS,1
CN,MOUTH HAEMORRHAGE,1
CN,MOUTH ULCERATION,1
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CN,MUSCLE TIGHTNESS,1
CN,MUSCULOSKELETAL PAIN,1
CN,MYALGIA,1
CN,MYDRIASIS,1
CN,MYELODYSPLASTIC SYNDROME,1
CN,MYOCARDIAL INFARCTION,1
CN,MYOCARDIAL RUPTURE,1
CN,MYOPATHY,1
CN,NASOPHARYNGITIS,1
CN,NEPHROLITHIASIS,1
CN,NEPHROTIC SYNDROME,1
CN,NERVE INJURY,1
CN,NEURITIS,1
CN,NEUROPATHY PERIPHERAL,1
CN,OCULAR ICTERUS,1
CN,OEDEMA,1
CN,OEDEMATOUS KIDNEY,1
CN,OESOPHAGEAL HAEMORRHAGE,1
CN,OLIGURIA,1
CN,ORGANISING PNEUMONIA,1
CN,OXYGEN SATURATION DECREASED,1
CN,PAIN,1
CN,PALPITATIONS,1
CN,PAPILLARY THYROID CANCER,1
CN,PARAESTHESIA,1
CN,PARATHYROID TUMOUR BENIGN,1
CN,PARKINSON^S DISEASE,1
CN,PELVIC PROLAPSE,1
CN,PERINEPHRIC ABSCESS,1
CN,PERITONITIS,1
CN,PLATELET COUNT INCREASED,1
CN,PNEUMOTHORAX,1
CN,POLLAKIURIA,1
CN,POST PROCEDURAL URINE LEAK,1
CN,POSTOPERATIVE WOUND INFECTION,1
CN,PRODUCT USE IN UNAPPROVED INDICATION,1
CN,PRODUCT USE ISSUE,1
CN,PULMONARY FIBROSIS,1
CN,PULMONARY HAEMORRHAGE,1
CN,RASH ERYTHEMATOUS,1
CN,RENAL ATROPHY,1
CN,RENAL FAILURE ACUTE,1
CN,RENAL HAEMORRHAGE,1
CN,RESPIRATORY ACIDOSIS,1
CN,RESPIRATORY DEPRESSION,1
CN,RESPIRATORY TRACT INFECTION,1
CN,RESPIRATORY TRACT INFECTION FUNGAL,1
CN,RESTLESSNESS,1
CN,RHABDOMYOLYSIS,1
CN,SECONDARY HYPOTHYROIDISM,1
CN,SEPSIS,1
CN,SHOCK HAEMORRHAGIC,1
CN,SKIN EXFOLIATION,1
CN,SLEEP DISORDER,1
CN,SOMNOLENCE,1
CN,STAPHYLOCOCCAL INFECTION,1
CN,STEVENS-JOHNSON SYNDROME,1
CN,SUBARACHNOID HAEMORRHAGE,1
CN,SUBDURAL HAEMATOMA,1
CN,SUBDURAL HAEMORRHAGE,1
CN,SUPRAVENTRICULAR EXTRASYSTOLES,1
CN,SUPRAVENTRICULAR TACHYCARDIA,1
CN,SYNCOPE,1
CN,TACHYCARDIA,1
CN,TACHYPNOEA,1
CN,TOXIC EPIDERMAL NECROLYSIS,1
CN,TRACHEAL INJURY,1
CN,TREMOR,1
CN,TROPONIN T INCREASED,1
CN,TUBERCULOUS PLEURISY,1
CN,TUMOUR HAEMORRHAGE,1
CN,TUMOUR LYSIS SYNDROME,1
CN,URETEROLITHIASIS,1
CN,URINE ANALYSIS ABNORMAL,1
CN,VENTRICULAR EXTRASYSTOLES,1
CN,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
CN,VISION BLURRED,1
CN,WEIGHT INCREASED,1
CN,WHEEZING,1
CN,WHITE BLOOD CELL COUNT ABNORMAL,1
CN,WOUND COMPLICATION,1
CN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
CN,YELLOW SKIN,1
CO,CARDIO-RESPIRATORY ARREST,84
CO,MALAISE,79
CO,DEATH,74
CO,ABDOMINAL PAIN,67
CO,ACUTE MYOCARDIAL INFARCTION,67
CO,HEADACHE,67
CO,PYREXIA,67
CO,DIZZINESS,64
CO,PAIN IN EXTREMITY,59
CO,DIARRHOEA,58
CO,ASTHENIA,50
CO,GENERAL PHYSICAL HEALTH DETERIORATION,48
CO,PNEUMONIA,47
CO,VOMITING,47
CO,PAIN,44
CO,DYSPNOEA,43
CO,PLATELET COUNT DECREASED,43
CO,FATIGUE,39
CO,HAEMOGLOBIN DECREASED,37
CO,ABDOMINAL PAIN UPPER,36
CO,ARTHRALGIA,36
CO,URINARY TRACT INFECTION,36
CO,COUGH,35
CO,HYPOTENSION,35
CO,INFLAMMATION,35
CO,DECREASED APPETITE,34
CO,NAUSEA,34
CO,GAIT DISTURBANCE,30
CO,CHEST PAIN,28
CO,DRUG INEFFECTIVE,27
CO,INFLUENZA,27
CO,FALL,25
CO,WEIGHT DECREASED,25
CO,GASTRITIS,24
CO,PULMONARY OEDEMA,24
CO,SEPSIS,24
CO,ANAEMIA,23
CO,DIABETIC FOOT,21
CO,OEDEMA PERIPHERAL,21
CO,BACK PAIN,20
CO,CEREBROVASCULAR ACCIDENT,20
CO,HYPERHIDROSIS,19
CO,MYOCARDIAL INFARCTION,19
CO,CARDIAC FAILURE,18
CO,ERYTHEMA,18
CO,FEELING ABNORMAL,18
CO,RESPIRATORY DISTRESS,18
CO,ASPHYXIA,17
CO,CARDIAC DISORDER,17
CO,CONTUSION,17
CO,HYPERTENSION,17
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,17
CO,TACHYCARDIA,17
CO,CHOLELITHIASIS,16
CO,DEPRESSION,16
CO,INSOMNIA,16
CO,SYNCOPE,16
CO,BONE PAIN,15
CO,PERIPHERAL SWELLING,15
CO,ABDOMINAL DISTENSION,14
CO,DYSURIA,14
CO,HAEMORRHAGE,14
CO,MOBILITY DECREASED,14
CO,BLOOD GLUCOSE INCREASED,13
CO,DEPRESSED MOOD,13
CO,FLUID RETENTION,13
CO,LOSS OF CONSCIOUSNESS,13
CO,MOUTH HAEMORRHAGE,13
CO,RASH,13
CO,RENAL TRANSPLANT,13
CO,SEIZURE,13
CO,DISCOMFORT,12
CO,FEELING OF DESPAIR,12
CO,HYPERSENSITIVITY,12
CO,LUNG DISORDER,12
CO,MALIGNANT NEOPLASM PROGRESSION,12
CO,PLATELET COUNT INCREASED,12
CO,RESPIRATORY FAILURE,12
CO,THROMBOSIS,12
CO,ARTHRITIS,11
CO,BLOOD CREATININE INCREASED,11
CO,CONDITION AGGRAVATED,11
CO,EPISTAXIS,11
CO,HYPOGLYCAEMIA,11
CO,OSTEOARTHRITIS,11
CO,PRODUCTIVE COUGH,11
CO,PRURITUS,11
CO,BLOOD PRESSURE INCREASED,10
CO,MUSCULAR WEAKNESS,10
CO,NECK PAIN,10
CO,VISION BLURRED,10
CO,VISUAL IMPAIRMENT,10
CO,ARRHYTHMIA,9
CO,CHOKING,9
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,9
CO,CONSTIPATION,9
CO,EYE PAIN,9
CO,HAEMATURIA,9
CO,HEPATITIS,9
CO,MULTI-ORGAN FAILURE,9
CO,OEDEMA,9
CO,PALLOR,9
CO,PERITONITIS,9
CO,SOMNOLENCE,9
CO,SPEECH DISORDER,9
CO,SWELLING,9
CO,THROMBOCYTOPENIA,9
CO,ANXIETY,8
CO,BLINDNESS,8
CO,BLOOD PRESSURE DECREASED,8
CO,CELLULITIS,8
CO,CHILLS,8
CO,GASTROINTESTINAL HAEMORRHAGE,8
CO,HYPERTENSIVE CRISIS,8
CO,JOINT INJURY,8
CO,LIMB INJURY,8
CO,MUSCULOSKELETAL PAIN,8
CO,PERITONITIS BACTERIAL,8
CO,RENAL DISORDER,8
CO,SWELLING FACE,8
CO,ABASIA,7
CO,AGITATION,7
CO,ALOPECIA,7
CO,BLOOD CHOLESTEROL INCREASED,7
CO,BRONCHITIS,7
CO,COAGULOPATHY,7
CO,CYANOSIS,7
CO,DISEASE COMPLICATION,7
CO,DISORIENTATION,7
CO,FOOT DEFORMITY,7
CO,HAEMATEMESIS,7
CO,HAEMORRHAGIC STROKE,7
CO,HYPERGLYCAEMIA,7
CO,INTESTINAL OBSTRUCTION,7
CO,JOINT RANGE OF MOTION DECREASED,7
CO,MEMORY IMPAIRMENT,7
CO,MOVEMENT DISORDER,7
CO,NASOPHARYNGITIS,7
CO,NEPHROLITHIASIS,7
CO,PLEURAL EFFUSION,7
CO,RESPIRATORY ARREST,7
CO,SKIN ULCER,7
CO,SPLENOMEGALY,7
CO,WHITE BLOOD CELL COUNT INCREASED,7
CO,BLISTER,6
CO,BRAIN NEOPLASM,6
CO,CARDIAC ARREST,6
CO,CARDIOMEGALY,6
CO,CARDIOVASCULAR DISORDER,6
CO,CATARACT,6
CO,CHRONIC MYELOID LEUKAEMIA,6
CO,DRUG INTOLERANCE,6
CO,EATING DISORDER,6
CO,GASTROINTESTINAL DISORDER,6
CO,HAEMATOCHEZIA,6
CO,HYPOAESTHESIA,6
CO,IMMUNODEFICIENCY,6
CO,INCORRECT ROUTE OF DRUG ADMINISTRATION,6
CO,INFECTION,6
CO,LEUKOPENIA,6
CO,LUNG INFECTION,6
CO,MASS,6
CO,MUSCLE SPASMS,6
CO,MYALGIA,6
CO,OXYGEN SATURATION DECREASED,6
CO,PETECHIAE,6
CO,PRODUCT USE ISSUE,6
CO,PRURITUS GENERALISED,6
CO,PULMONARY HYPERTENSION,6
CO,RENAL FAILURE,6
CO,ROAD TRAFFIC ACCIDENT,6
CO,SKIN DISCOLOURATION,6
CO,UPPER GASTROINTESTINAL HAEMORRHAGE,6
CO,VAGINAL HAEMORRHAGE,6
CO,ABDOMINAL DISCOMFORT,5
CO,ARTERIAL OCCLUSIVE DISEASE,5
CO,BACTERAEMIA,5
CO,BLOOD GLUCOSE ABNORMAL,5
CO,BLOOD POTASSIUM DECREASED,5
CO,BLOOD TRIGLYCERIDES INCREASED,5
CO,CEREBRAL HAEMORRHAGE,5
CO,CHOLECYSTITIS,5
CO,COMA,5
CO,CONVULSION,5
CO,DECREASED IMMUNE RESPONSIVENESS,5
CO,DEHYDRATION,5
CO,DEVICE RELATED INFECTION,5
CO,DISEASE RECURRENCE,5
CO,DRUG DOSE OMISSION,5
CO,DRY SKIN,5
CO,EAR PAIN,5
CO,GASTROINTESTINAL INFECTION,5
CO,HEAD INJURY,5
CO,HEPATIC CIRRHOSIS,5
CO,HERPES ZOSTER,5
CO,INCORRECT DOSE ADMINISTERED,5
CO,INFARCTION,5
CO,JOINT SWELLING,5
CO,KIDNEY INFECTION,5
CO,LACRIMATION INCREASED,5
CO,OSTEOPOROSIS,5
CO,PARAESTHESIA,5
CO,PELVIC PAIN,5
CO,PERIPHERAL COLDNESS,5
CO,PERITONEAL DIALYSIS COMPLICATION,5
CO,PLATELET COUNT ABNORMAL,5
CO,POSTOPERATIVE WOUND INFECTION,5
CO,PSYCHIATRIC SYMPTOM,5
CO,PULMONARY SEPSIS,5
CO,SLEEP DISORDER,5
CO,SOFT TISSUE INFECTION,5
CO,TUBERCULOSIS,5
CO,WEIGHT INCREASED,5
CO,ABDOMINAL MASS,4
CO,ABDOMINAL SEPSIS,4
CO,AMNESIA,4
CO,ASCITES,4
CO,BLOOD URINE PRESENT,4
CO,BRADYCARDIA,4
CO,CARDIAC FAILURE CONGESTIVE,4
CO,CARDIOGENIC SHOCK,4
CO,CHROMATURIA,4
CO,CONTRAINDICATED PRODUCT ADMINISTERED,4
CO,CORONARY ARTERY OCCLUSION,4
CO,DIABETES MELLITUS,4
CO,DIARRHOEA HAEMORRHAGIC,4
CO,DYSPHONIA,4
CO,DYSSTASIA,4
CO,ENCEPHALOPATHY,4
CO,EYE IRRITATION,4
CO,FEEDING DISORDER,4
CO,GAIT INABILITY,4
CO,GASTROENTERITIS,4
CO,GENERALISED OEDEMA,4
CO,HAEMATOMA,4
CO,HAEMOPTYSIS,4
CO,HIATUS HERNIA,4
CO,HIP FRACTURE,4
CO,IMMUNOSUPPRESSION,4
CO,INTERNATIONAL NORMALISED RATIO INCREASED,4
CO,INTESTINAL PERFORATION,4
CO,ISCHAEMIC STROKE,4
CO,LIVER DISORDER,4
CO,LOCALISED INFECTION,4
CO,MALNUTRITION,4
CO,MENINGITIS,4
CO,METASTASES TO BONE,4
CO,METASTASES TO LIVER,4
CO,MULTIMORBIDITY,4
CO,NERVOUS SYSTEM DISORDER,4
CO,OROPHARYNGEAL PAIN,4
CO,PARALYSIS,4
CO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,4
CO,PRIMARY MYELOFIBROSIS,4
CO,PROCEDURAL COMPLICATION,4
CO,PULMONARY MASS,4
CO,RASH GENERALISED,4
CO,RECTAL HAEMORRHAGE,4
CO,TERMINAL STATE,4
CO,UMBILICAL HERNIA,4
CO,UNEVALUABLE EVENT,4
CO,URINARY RETENTION,4
CO,URTICARIA,4
CO,UTERINE LEIOMYOMA,4
CO,YELLOW SKIN,4
CO,ABNORMAL BEHAVIOUR,3
CO,ALTERED STATE OF CONSCIOUSNESS,3
CO,ANGINA PECTORIS,3
CO,ANKLE FRACTURE,3
CO,APATHY,3
CO,APHASIA,3
CO,APHONIA,3
CO,APPENDICITIS,3
CO,ATRIAL FIBRILLATION,3
CO,BLOOD CREATININE ABNORMAL,3
CO,BLOOD GLUCOSE DECREASED,3
CO,BLOOD UREA INCREASED,3
CO,BONE DISORDER,3
CO,BRAIN DEATH,3
CO,BREAST PAIN,3
CO,BURNING SENSATION,3
CO,CALCULUS URINARY,3
CO,CEREBRAL HAEMATOMA,3
CO,CHRONIC MYELOID LEUKAEMIA RECURRENT,3
CO,COLITIS,3
CO,CONCOMITANT DISEASE AGGRAVATED,3
CO,CRANIOCEREBRAL INJURY,3
CO,DEEP VEIN THROMBOSIS,3
CO,DELIRIUM,3
CO,DIABETES MELLITUS INADEQUATE CONTROL,3
CO,DIABETIC COMA,3
CO,DISEASE PROGRESSION,3
CO,DRUG DISPENSING ERROR,3
CO,DRY EYE,3
CO,ELECTROLYTE IMBALANCE,3
CO,EOSINOPHIL COUNT INCREASED,3
CO,FACE OEDEMA,3
CO,FACIAL PAIN,3
CO,FEBRILE NEUTROPENIA,3
CO,FLATULENCE,3
CO,GENERAL PHYSICAL CONDITION ABNORMAL,3
CO,GENERALISED ERYTHEMA,3
CO,GINGIVAL BLEEDING,3
CO,GLAUCOMA,3
CO,HEART RATE DECREASED,3
CO,HEMIPARESIS,3
CO,HEPATIC ENCEPHALOPATHY,3
CO,HEPATIC FAILURE,3
CO,HEPATIC LESION,3
CO,HEPATIC STEATOSIS,3
CO,HYDRONEPHROSIS,3
CO,HYPERSOMNIA,3
CO,HYPOKALAEMIA,3
CO,HYPOPHAGIA,3
CO,HYPOVOLAEMIC SHOCK,3
CO,INGUINAL HERNIA,3
CO,INTENTIONAL PRODUCT MISUSE,3
CO,JOINT DISLOCATION,3
CO,JOINT STIFFNESS,3
CO,KIDNEY TRANSPLANT REJECTION,3
CO,LACERATION,3
CO,MELAENA,3
CO,MENINGITIS BACTERIAL,3
CO,MULTIPLE SCLEROSIS,3
CO,MUSCULOSKELETAL CHEST PAIN,3
CO,MUSCULOSKELETAL STIFFNESS,3
CO,MYELOFIBROSIS,3
CO,MYOCARDIAL ISCHAEMIA,3
CO,NECK MASS,3
CO,NEOPLASM,3
CO,NEOPLASM MALIGNANT,3
CO,NEPHROPATHY,3
CO,OCULAR HYPERAEMIA,3
CO,OESOPHAGITIS,3
CO,ORAL DISORDER,3
CO,PANCREATITIS,3
CO,PARKINSON^S DISEASE,3
CO,PERIPHERAL VENOUS DISEASE,3
CO,POST PROCEDURAL COMPLICATION,3
CO,POST PROCEDURAL INFECTION,3
CO,PRODUCT USE IN UNAPPROVED INDICATION,3
CO,PULMONARY EMBOLISM,3
CO,PULMONARY THROMBOSIS,3
CO,RESPIRATORY DISORDER,3
CO,RHINITIS,3
CO,SCRATCH,3
CO,SECOND PRIMARY MALIGNANCY,3
CO,SENSORY LOSS,3
CO,SERUM FERRITIN INCREASED,3
CO,SKIN LESION,3
CO,SUDDEN DEATH,3
CO,TIBIA FRACTURE,3
CO,TINNITUS,3
CO,UNDERWEIGHT,3
CO,UPPER LIMB FRACTURE,3
CO,URETHRAL OBSTRUCTION,3
CO,URINE OUTPUT DECREASED,3
CO,VARICOSE VEIN,3
CO,VENOUS OCCLUSION,3
CO,VIRAL INFECTION,3
CO,WHITE BLOOD CELL COUNT DECREASED,3
CO,WOUND,3
CO,ABDOMINAL PAIN LOWER,2
CO,ACCIDENT AT HOME,2
CO,ACNE,2
CO,ACTIVITIES OF DAILY LIVING IMPAIRED,2
CO,ACUTE CORONARY SYNDROME,2
CO,ACUTE LYMPHOCYTIC LEUKAEMIA,2
CO,AGGRESSION,2
CO,ANAL FISTULA,2
CO,AORTIC VALVE INCOMPETENCE,2
CO,APLASTIC ANAEMIA,2
CO,ARTERIOSCLEROSIS,2
CO,ARTHROPATHY,2
CO,ATELECTASIS,2
CO,BACTERIAL INFECTION,2
CO,BACTERIAL SEPSIS,2
CO,BALANCE DISORDER,2
CO,BENIGN PROSTATIC HYPERPLASIA,2
CO,BLOOD CALCIUM DECREASED,2
CO,BLOOD CHOLESTEROL ABNORMAL,2
CO,BLOOD DISORDER,2
CO,BLOOD SODIUM DECREASED,2
CO,BREAST CANCER,2
CO,BREAST MASS,2
CO,CANDIDA INFECTION,2
CO,CARDIAC MURMUR,2
CO,CARDIAC VALVE DISEASE,2
CO,CATHETER SITE INFECTION,2
CO,CATHETERISATION CARDIAC,2
CO,CENTRAL NERVOUS SYSTEM LEUKAEMIA,2
CO,CEREBRAL INFARCTION,2
CO,CEREBRAL THROMBOSIS,2
CO,CEREBROVASCULAR DISORDER,2
CO,CHEST DISCOMFORT,2
CO,CHIKUNGUNYA VIRUS INFECTION,2
CO,CHOKING SENSATION,2
CO,CHOLECYSTECTOMY,2
CO,CHOLURIA,2
CO,CHRONIC KIDNEY DISEASE,2
CO,COCCYDYNIA,2
CO,COLD SWEAT,2
CO,COLITIS ULCERATIVE,2
CO,COLON NEOPLASM,2
CO,CONFUSIONAL STATE,2
CO,CORONARY ARTERY DISEASE,2
CO,DERMATITIS ALLERGIC,2
CO,DIABETIC COMPLICATION,2
CO,DIVERTICULITIS,2
CO,DRUG HYPERSENSITIVITY,2
CO,DYSKINESIA,2
CO,DYSPEPSIA,2
CO,DYSPHAGIA,2
CO,ECZEMA,2
CO,EMBOLISM,2
CO,ERUCTATION,2
CO,ESCHERICHIA BACTERAEMIA,2
CO,EYE HAEMORRHAGE,2
CO,EYE PRURITUS,2
CO,EYELID OEDEMA,2
CO,FACIAL PARALYSIS,2
CO,FEELING HOT,2
CO,FEMUR FRACTURE,2
CO,FISTULA,2
CO,FOETAL CARDIAC DISORDER,2
CO,FOETAL EXPOSURE TIMING UNSPECIFIED,2
CO,FOOT FRACTURE,2
CO,FOREIGN BODY SENSATION IN EYES,2
CO,FREQUENT BOWEL MOVEMENTS,2
CO,GASTRIC CANCER,2
CO,GASTRIC ULCER,2
CO,GASTRIC ULCER HAEMORRHAGE,2
CO,GASTROINTESTINAL INFLAMMATION,2
CO,GASTROOESOPHAGEAL REFLUX DISEASE,2
CO,HAEMANGIOMA,2
CO,HAEMATOCRIT DECREASED,2
CO,HAEMODYNAMIC INSTABILITY,2
CO,HAEMORRHAGIC DISORDER,2
CO,HAND DEFORMITY,2
CO,HEMIPLEGIA,2
CO,HEPATECTOMY,2
CO,HEPATIC MASS,2
CO,HEPATIC PAIN,2
CO,HEPATOCELLULAR CARCINOMA,2
CO,HEPATOMEGALY,2
CO,HEPATOTOXICITY,2
CO,HOSPITALISATION,2
CO,HUMERUS FRACTURE,2
CO,HYDROCEPHALUS,2
CO,HYPOCALCAEMIA,2
CO,HYPOKINESIA,2
CO,HYPOTHYROIDISM,2
CO,HYPOTONIA,2
CO,IMMUNE SYSTEM DISORDER,2
CO,INCOHERENT,2
CO,INFLUENZA LIKE ILLNESS,2
CO,INTENTIONAL PRODUCT USE ISSUE,2
CO,INVESTIGATION ABNORMAL,2
CO,IRON DEFICIENCY,2
CO,IRON OVERLOAD,2
CO,ISCHAEMIA,2
CO,JAUNDICE,2
CO,LABORATORY TEST ABNORMAL,2
CO,LIMB DISCOMFORT,2
CO,LOCAL SWELLING,2
CO,LOWER GASTROINTESTINAL HAEMORRHAGE,2
CO,LYMPHOCYTE COUNT ABNORMAL,2
CO,LYMPHOCYTE COUNT DECREASED,2
CO,MENINGOENCEPHALITIS HERPETIC,2
CO,MENISCUS INJURY,2
CO,METASTASES TO LUNG,2
CO,METASTASES TO SPINE,2
CO,MONOPLEGIA,2
CO,MOUTH ULCERATION,2
CO,MUCOSAL INFLAMMATION,2
CO,MULTI-ORGAN DISORDER,2
CO,MULTIPLE SCLEROSIS RELAPSE,2
CO,MUSCLE DISORDER,2
CO,MYOSITIS,2
CO,NEUTROPENIA,2
CO,NODULE,2
CO,NOSOCOMIAL INFECTION,2
CO,OBSTRUCTIVE AIRWAYS DISORDER,2
CO,OLIGURIA,2
CO,OPTIC NERVE DISORDER,2
CO,OSTEOCHONDROSIS,2
CO,OVARIAN MASS,2
CO,PAIN OF SKIN,2
CO,PALPITATIONS,2
CO,PARATHYROIDECTOMY,2
CO,PERICARDITIS,2
CO,PERIPHERAL ISCHAEMIA,2
CO,PERITONEAL CLOUDY EFFLUENT,2
CO,PHLEBITIS,2
CO,PITUITARY TUMOUR BENIGN,2
CO,PLATELET DISORDER,2
CO,PNEUMONIA BACTERIAL,2
CO,POLLAKIURIA,2
CO,POLYNEUROPATHY,2
CO,POST PROCEDURAL FISTULA,2
CO,POST PROCEDURAL OEDEMA,2
CO,PROCEDURAL PAIN,2
CO,PRODUCT SUPPLY ISSUE,2
CO,PTERYGIUM,2
CO,PURULENT DISCHARGE,2
CO,RECTAL ABSCESS,2
CO,RED BLOOD CELL COUNT DECREASED,2
CO,RENAL CYST,2
CO,RENAL IMPAIRMENT,2
CO,ROTATOR CUFF SYNDROME,2
CO,SALIVARY HYPERSECRETION,2
CO,SECRETION DISCHARGE,2
CO,SEPTIC SHOCK,2
CO,SKIN BURNING SENSATION,2
CO,SKIN INFECTION,2
CO,SKIN TOXICITY,2
CO,SKIN WARM,2
CO,SPINAL CORD COMPRESSION,2
CO,SPINAL PAIN,2
CO,SPLENITIS,2
CO,SUPERINFECTION,2
CO,SYSTEMIC LUPUS ERYTHEMATOSUS,2
CO,THERMAL BURN,2
CO,THROAT IRRITATION,2
CO,THROMBOPHLEBITIS,2
CO,THROMBOTIC STROKE,2
CO,THYROID FUNCTION TEST ABNORMAL,2
CO,THYROID NEOPLASM,2
CO,TRAUMATIC LUNG INJURY,2
CO,TREMOR,2
CO,UNDERDOSE,2
CO,UNRESPONSIVE TO STIMULI,2
CO,URAEMIC ENCEPHALOPATHY,2
CO,UROSEPSIS,2
CO,VAGINAL INFECTION,2
CO,VARICOSE ULCERATION,2
CO,VASCULAR RUPTURE,2
CO,VENOUS THROMBOSIS,2
CO,VERTIGO,2
CO,VISUAL ACUITY REDUCED,2
CO,WHEELCHAIR USER,2
CO,WOUND SECRETION,2
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CO,ABDOMINAL ADHESIONS,1
CO,ABDOMINAL COMPARTMENT SYNDROME,1
CO,ABDOMINAL INFECTION,1
CO,ABDOMINAL NEOPLASM,1
CO,ABDOMINAL RIGIDITY,1
CO,ABDOMINAL WALL ABSCESS,1
CO,ABSCESS,1
CO,ABSCESS LIMB,1
CO,ACCIDENT,1
CO,ACETABULUM FRACTURE,1
CO,ACUTE LEUKAEMIA,1
CO,ACUTE PULMONARY OEDEMA,1
CO,ACUTE RESPIRATORY FAILURE,1
CO,ADVERSE DRUG REACTION,1
CO,ADVERSE EVENT,1
CO,AFFECT LABILITY,1
CO,AIRWAY BURNS,1
CO,ALANINE AMINOTRANSFERASE ABNORMAL,1
CO,ALANINE AMINOTRANSFERASE INCREASED,1
CO,ALCOHOL POISONING,1
CO,ALPHA 1 FOETOPROTEIN INCREASED,1
CO,AMPUTATION,1
CO,ANAL INCONTINENCE,1
CO,ANAL PRURITUS,1
CO,ANAL SPHINCTER ATONY,1
CO,ANAPHYLACTIC SHOCK,1
CO,ANGINA BULLOSA HAEMORRHAGICA,1
CO,ANGINA UNSTABLE,1
CO,ANGIOSCLEROSIS,1
CO,ANGLE CLOSURE GLAUCOMA,1
CO,ANORECTAL DISCOMFORT,1
CO,ANORECTAL SWELLING,1
CO,ANTIPHOSPHOLIPID SYNDROME,1
CO,AORTIC ANEURYSM,1
CO,AORTIC DILATATION,1
CO,APPENDICECTOMY,1
CO,APPLICATION SITE PAIN,1
CO,APPLICATION SITE RASH,1
CO,ARTERIAL THROMBOSIS,1
CO,ARTERIOVENOUS FISTULA,1
CO,ARTERIOVENOUS FISTULA SITE INFECTION,1
CO,ARTHRITIS BACTERIAL,1
CO,ARTHRODESIS,1
CO,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
CO,ASPARTATE AMINOTRANSFERASE INCREASED,1
CO,ASPIRATION,1
CO,ASPIRATION BRONCHIAL,1
CO,ASTHMA,1
CO,ASTHMATIC CRISIS,1
CO,ATAXIA,1
CO,ATRIAL FLUTTER,1
CO,ATRIOVENTRICULAR BLOCK COMPLETE,1
CO,AXILLARY MASS,1
CO,BACK INJURY,1
CO,BACTERIAL DIARRHOEA,1
CO,BACTERIAL TEST POSITIVE,1
CO,BASOPHIL COUNT INCREASED,1
CO,BENIGN NEOPLASM OF CERVIX UTERI,1
CO,BILE DUCT STENOSIS,1
CO,BILE DUCT STONE,1
CO,BIOPSY,1
CO,BIOPSY VAGINA ABNORMAL,1
CO,BLADDER DISORDER,1
CO,BLADDER NECK OBSTRUCTION,1
CO,BLADDER OUTLET OBSTRUCTION,1
CO,BLEPHARITIS,1
CO,BLISTER RUPTURE,1
CO,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CO,BLOOD BILIRUBIN ABNORMAL,1
CO,BLOOD CALCIUM ABNORMAL,1
CO,BLOOD CHROMOGRANIN A INCREASED,1
CO,BLOOD CORTISOL INCREASED,1
CO,BLOOD COUNT ABNORMAL,1
CO,BLOOD CULTURE POSITIVE,1
CO,BLOOD ELECTROLYTES DECREASED,1
CO,BLOOD GLUCOSE FLUCTUATION,1
CO,BLOOD GROWTH HORMONE INCREASED,1
CO,BLOOD IRON DECREASED,1
CO,BLOOD IRON INCREASED,1
CO,BLOOD LACTATE DEHYDROGENASE ABNORMAL,1
CO,BLOOD LACTATE DEHYDROGENASE DECREASED,1
CO,BLOOD POTASSIUM ABNORMAL,1
CO,BLOOD POTASSIUM INCREASED,1
CO,BLOOD PRESSURE ABNORMAL,1
CO,BLOOD PRESSURE DIASTOLIC DECREASED,1
CO,BLOOD PRESSURE FLUCTUATION,1
CO,BLOOD TEST ABNORMAL,1
CO,BLOOD TRIGLYCERIDES ABNORMAL,1
CO,BLOOD URINE,1
CO,BLOODY DISCHARGE,1
CO,BODY MASS INDEX INCREASED,1
CO,BODY SURFACE AREA DECREASED,1
CO,BONE CANCER,1
CO,BONE CYST,1
CO,BONE DEFORMITY,1
CO,BONE DENSITY DECREASED,1
CO,BONE EROSION,1
CO,BONE MARROW FAILURE,1
CO,BONE NEOPLASM,1
CO,BRADYPHRENIA,1
CO,BRAIN NEOPLASM BENIGN,1
CO,BREAST CANCER FEMALE,1
CO,BREAST CANCER RECURRENT,1
CO,BREAST CELLULITIS,1
CO,BREAST OEDEMA,1
CO,BREATH ODOUR,1
CO,BREATHING-RELATED SLEEP DISORDER,1
CO,BRONCHIECTASIS,1
CO,BRONCHITIS BACTERIAL,1
CO,BRONCHITIS CHRONIC,1
CO,BRONCHOPNEUMONIA,1
CO,BUNION,1
CO,BURN OF INTERNAL ORGANS,1
CO,BURNING SENSATION MUCOSAL,1
CO,BURSITIS,1
CO,CACHEXIA,1
CO,CARCINOEMBRYONIC ANTIGEN INCREASED,1
CO,CARDIOMYOPATHY,1
CO,CAROTID ARTERY OCCLUSION,1
CO,CARTILAGE INJURY,1
CO,CATARACT OPERATION,1
CO,CATHETER SITE HAEMORRHAGE,1
CO,CD8 LYMPHOCYTES ABNORMAL,1
CO,CENTRAL NERVOUS SYSTEM LESION,1
CO,CEREBELLAR ISCHAEMIA,1
CO,CEREBRAL ARTERY THROMBOSIS,1
CO,CEREBRAL ISCHAEMIA,1
CO,CERVICAL SPINAL STENOSIS,1
CO,CHEST EXPANSION DECREASED,1
CO,CHEST X-RAY ABNORMAL,1
CO,CHOLANGITIS,1
CO,CHONDROPATHY,1
CO,CHRONIC GASTRITIS,1
CO,COLECTOMY,1
CO,COLON CANCER,1
CO,COLONIC ABSCESS,1
CO,COMMINUTED FRACTURE,1
CO,COMPLICATION ASSOCIATED WITH DEVICE,1
CO,CONCOMITANT DISEASE PROGRESSION,1
CO,CONJUNCTIVAL ULCER,1
CO,CONJUNCTIVITIS,1
CO,CONNECTIVE TISSUE DISORDER,1
CO,CORONARY OSTIAL STENOSIS,1
CO,CREATININE RENAL CLEARANCE DECREASED,1
CO,CREATININE URINE INCREASED,1
CO,CRITICAL ILLNESS,1
CO,CRYING,1
CO,CSF TEST ABNORMAL,1
CO,CYANOSIS CENTRAL,1
CO,CYST,1
CO,CYSTITIS,1
CO,CYTOGENETIC ANALYSIS ABNORMAL,1
CO,CYTOMEGALOVIRUS INFECTION,1
CO,CYTOPENIA,1
CO,DEAFNESS,1
CO,DEAFNESS UNILATERAL,1
CO,DECREASED ACTIVITY,1
CO,DEFICIENCY OF BILE SECRETION,1
CO,DENTAL CARIES,1
CO,DERMAL CYST,1
CO,DERMATITIS,1
CO,DERMATITIS ACNEIFORM,1
CO,DERMATITIS CONTACT,1
CO,DEVICE DISLOCATION,1
CO,DEVICE MATERIAL ISSUE,1
CO,DEVICE OCCLUSION,1
CO,DIABETIC NEPHROPATHY,1
CO,DIABETIC NEUROPATHY,1
CO,DIABETIC RETINOPATHY,1
CO,DIABETIC VASCULAR DISORDER,1
CO,DIET REFUSAL,1
CO,DIPLOPIA,1
CO,DISABILITY,1
CO,DISCOLOURED VOMIT,1
CO,DISLOCATION OF VERTEBRA,1
CO,DIVERTICULAR PERFORATION,1
CO,DIVERTICULUM,1
CO,DIVERTICULUM INTESTINAL,1
CO,DRUG ADMINISTRATION ERROR,1
CO,DRUG MONITORING PROCEDURE NOT PERFORMED,1
CO,DRUG RESISTANCE,1
CO,DRY MOUTH,1
CO,DRY THROAT,1
CO,DYSAESTHESIA,1
CO,DYSARTHRIA,1
CO,DYSCHEZIA,1
CO,DYSMENORRHOEA,1
CO,DYSPNOEA EXERTIONAL,1
CO,EAR DISORDER,1
CO,EAR HAEMORRHAGE,1
CO,ECONOMIC PROBLEM,1
CO,EJECTION FRACTION DECREASED,1
CO,ELBOW DEFORMITY,1
CO,EMOTIONAL DISORDER,1
CO,ENDOCARDITIS,1
CO,ENDOMETRIAL HYPERPLASIA,1
CO,ENTERITIS INFECTIOUS,1
CO,EOSINOPHIL COUNT ABNORMAL,1
CO,EOSINOPHIL PERCENTAGE INCREASED,1
CO,EOSINOPHILIC COLITIS,1
CO,EPILEPSY,1
CO,ERYSIPELAS,1
CO,ESCHAR,1
CO,EXCORIATION,1
CO,EXOPHTHALMOS,1
CO,EXOSTOSIS,1
CO,EXPOSURE DURING PREGNANCY,1
CO,EXTREMITY NECROSIS,1
CO,EYE DISORDER,1
CO,EYE INFECTION,1
CO,EYE INFLAMMATION,1
CO,EYE MOVEMENT DISORDER,1
CO,EYE SWELLING,1
CO,FACE INJURY,1
CO,FACE LIFT,1
CO,FACIAL ASYMMETRY,1
CO,FACIAL BONES FRACTURE,1
CO,FACTOR XI DEFICIENCY,1
CO,FAECES DISCOLOURED,1
CO,FEELING COLD,1
CO,FEELING DRUNK,1
CO,FEMORAL ARTERY OCCLUSION,1
CO,FIBROMYALGIA,1
CO,FIBULA FRACTURE,1
CO,FINGER DEFORMITY,1
CO,FLANK PAIN,1
CO,FLUSHING,1
CO,FOLATE DEFICIENCY,1
CO,FOLLICULITIS,1
CO,FOOD INTOLERANCE,1
CO,FUNGAL INFECTION,1
CO,FUNGAL PERITONITIS,1
CO,FURUNCLE,1
CO,GALLBLADDER EMPYEMA,1
CO,GALLBLADDER OBSTRUCTION,1
CO,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
CO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CO,GANGRENE,1
CO,GASTRIC HAEMORRHAGE,1
CO,GASTRIC INFECTION,1
CO,GASTRIC ULCER PERFORATION,1
CO,GASTRITIS BACTERIAL,1
CO,GASTRITIS EROSIVE,1
CO,GASTROINTESTINAL AMYLOIDOSIS,1
CO,GASTROINTESTINAL PERFORATION,1
CO,GASTROINTESTINAL ULCER,1
CO,GASTROSTOMY,1
CO,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
CO,GENITAL HERPES,1
CO,GINGIVAL ABSCESS,1
CO,GLOMERULAR FILTRATION RATE DECREASED,1
CO,GOITRE,1
CO,GROIN PAIN,1
CO,HAEMANGIOMA OF BONE,1
CO,HAEMATOCRIT ABNORMAL,1
CO,HAEMOGLOBIN INCREASED,1
CO,HAEMORRHAGIC OVARIAN CYST,1
CO,HAEMORRHOIDS,1
CO,HALLUCINATION,1
CO,HALLUCINATION_ AUDITORY,1
CO,HAND FRACTURE,1
CO,HEAD DISCOMFORT,1
CO,HEART RATE INCREASED,1
CO,HEART VALVE STENOSIS,1
CO,HEPATIC CYST,1
CO,HEPATIC FIBROSIS,1
CO,HEPATIC FUNCTION ABNORMAL,1
CO,HEPATIC INFECTION BACTERIAL,1
CO,HEPATIC NECROSIS,1
CO,HEPATIC NEOPLASM,1
CO,HEPATIC VEIN OCCLUSION,1
CO,HEPATOCELLULAR INJURY,1
CO,HERNIA,1
CO,HERNIA PAIN,1
CO,HERNIA REPAIR,1
CO,HERNIAL EVENTRATION,1
CO,HERPES VIRUS INFECTION,1
CO,HISTOPLASMOSIS,1
CO,HORDEOLUM,1
CO,HYPERCALCAEMIA,1
CO,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,1
CO,HYPERKALAEMIA,1
CO,HYPERLIPIDAEMIA,1
CO,HYPERPHAGIA,1
CO,HYPERPYREXIA,1
CO,HYPERTENSIVE ENCEPHALOPATHY,1
CO,HYPERTHERMIA,1
CO,HYPERTRIGLYCERIDAEMIA,1
CO,HYPOACUSIS,1
CO,HYPOMAGNESAEMIA,1
CO,HYPONATRAEMIA,1
CO,HYPOPERFUSION,1
CO,HYPOPHOSPHATAEMIA,1
CO,HYPOPITUITARISM,1
CO,HYPOTHERMIA,1
CO,ILL-DEFINED DISORDER,1
CO,IMMUNE THROMBOCYTOPENIC PURPURA,1
CO,IMMUNOGLOBULIN THERAPY,1
CO,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
CO,IMPAIRED HEALING,1
CO,INAPPROPRIATE PRESCRIBING,1
CO,INCISION SITE COMPLICATION,1
CO,INCISION SITE INFECTION,1
CO,INCORRECT DRUG ADMINISTRATION DURATION,1
CO,INCORRECT DRUG ADMINISTRATION RATE,1
CO,INDURATION,1
CO,INFECTED SKIN ULCER,1
CO,INFECTED VARICOSE VEIN,1
CO,INFLAMMATION OF WOUND,1
CO,INFLAMMATORY BOWEL DISEASE,1
CO,INFUSION RELATED REACTION,1
CO,INGROWING NAIL,1
CO,INJECTION SITE BRUISING,1
CO,INJECTION SITE MASS,1
CO,INJECTION SITE PAIN,1
CO,INJECTION SITE URTICARIA,1
CO,INTERNAL HAEMORRHAGE,1
CO,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
CO,INTERVERTEBRAL DISC DEGENERATION,1
CO,INTERVERTEBRAL DISC DISORDER,1
CO,INTERVERTEBRAL DISCITIS,1
CO,INTESTINAL MASS,1
CO,INTESTINAL POLYP,1
CO,INTESTINAL RESECTION,1
CO,INTRA-ABDOMINAL FLUID COLLECTION,1
CO,INTRA-ABDOMINAL HAEMATOMA,1
CO,INTRACRANIAL ANEURYSM,1
CO,INTRACRANIAL HAEMATOMA,1
CO,INTRAOCULAR LENS IMPLANT,1
CO,INTRAOCULAR PRESSURE TEST ABNORMAL,1
CO,IRON DEFICIENCY ANAEMIA,1
CO,JAUNDICE CHOLESTATIC,1
CO,JOINT EFFUSION,1
CO,JOINT INSTABILITY,1
CO,JOINT WARMTH,1
CO,KIDNEY ENLARGEMENT,1
CO,KYPHOSIS,1
CO,LACRIMATION DECREASED,1
CO,LAGOPHTHALMOS,1
CO,LARGE INTESTINAL ULCER,1
CO,LARGE INTESTINE POLYP,1
CO,LARYNGEAL MASS,1
CO,LARYNGITIS,1
CO,LEFT VENTRICULAR DILATATION,1
CO,LEFT VENTRICULAR DYSFUNCTION,1
CO,LEIOMYOMA,1
CO,LEMIERRE SYNDROME,1
CO,LEUKAEMIC INFILTRATION HEPATIC,1
CO,LEUKOCYTOSIS,1
CO,LIMB FRACTURE,1
CO,LIP SWELLING,1
CO,LIPOMA,1
CO,LIVER FUNCTION TEST ABNORMAL,1
CO,LIVER FUNCTION TEST INCREASED,1
CO,LIVER OPERATION,1
CO,LIVER TRANSPLANT REJECTION,1
CO,LOOSE TOOTH,1
CO,LOW DENSITY LIPOPROTEIN INCREASED,1
CO,LOWER LIMB FRACTURE,1
CO,LYMPHADENOPATHY,1
CO,LYMPHOMA,1
CO,MEDICATION ERROR,1
CO,MELANOCYTIC NAEVUS,1
CO,MENINGITIS VIRAL,1
CO,MENINGOENCEPHALITIS VIRAL,1
CO,MENISCAL DEGENERATION,1
CO,MENORRHAGIA,1
CO,METABOLIC ACIDOSIS,1
CO,METABOLIC ALKALOSIS,1
CO,METASTASES TO BILIARY TRACT,1
CO,METASTASES TO CENTRAL NERVOUS SYSTEM,1
CO,METASTASES TO SKIN,1
CO,METASTASIS,1
CO,METRORRHAGIA,1
CO,MICTURITION URGENCY,1
CO,MIGRAINE,1
CO,MITRAL VALVE DISEASE,1
CO,MITRAL VALVE INCOMPETENCE,1
CO,MONOCYTE COUNT INCREASED,1
CO,MONOCYTE PERCENTAGE INCREASED,1
CO,MOOD ALTERED,1
CO,MOUTH INJURY,1
CO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CO,MUSCLE TIGHTNESS,1
CO,MUSCULOSKELETAL DISCOMFORT,1
CO,MYASTHENIA GRAVIS,1
CO,NASAL CAVITY MASS,1
CO,NASAL CONGESTION,1
CO,NASAL NEOPLASM,1
CO,NASAL OBSTRUCTION,1
CO,NASAL POLYPS,1
CO,NECROSIS,1
CO,NEOPLASM PROGRESSION,1
CO,NEOPLASM RECURRENCE,1
CO,NEPHRITIS,1
CO,NERVE CONDUCTION STUDIES ABNORMAL,1
CO,NERVOUSNESS,1
CO,NEUROLOGICAL INFECTION,1
CO,NEUROMYELITIS OPTICA,1
CO,NEUROMYELITIS OPTICA SPECTRUM DISORDER,1
CO,NEUROPATHY PERIPHERAL,1
CO,NEUROTOXICITY,1
CO,NEUTROPHIL COUNT ABNORMAL,1
CO,NIGHT SWEATS,1
CO,NITRITE URINE PRESENT,1
CO,NO ADVERSE EVENT,1
CO,NOCTURIA,1
CO,NONINFECTIOUS PERITONITIS,1
CO,NONINFECTIVE ENCEPHALITIS,1
CO,OBSTRUCTION GASTRIC,1
CO,OCULAR DISCOMFORT,1
CO,OCULAR NEOPLASM,1
CO,ODYNOPHAGIA,1
CO,OESOPHAGEAL ADENOCARCINOMA,1
CO,OESOPHAGEAL DISCOMFORT,1
CO,OESOPHAGEAL HAEMORRHAGE,1
CO,OESOPHAGEAL OBSTRUCTION,1
CO,OESOPHAGEAL PROSTHESIS INSERTION,1
CO,OESOPHAGEAL VARICES HAEMORRHAGE,1
CO,ONCOLOGIC COMPLICATION,1
CO,OPTIC NEURITIS,1
CO,ORAL HERPES,1
CO,ORAL INFECTION,1
CO,ORAL MUCOSAL BLISTERING,1
CO,OROPHARYNGEAL SQUAMOUS CELL CARCINOMA,1
CO,OSTEOMYELITIS CHRONIC,1
CO,OVARIAN CYST,1
CO,OVARIAN NEOPLASM,1
CO,OVERDOSE,1
CO,PACKED RED BLOOD CELL TRANSFUSION,1
CO,PANCREATIC CARCINOMA,1
CO,PANCREATITIS ACUTE,1
CO,PAPILLARY THYROID CANCER,1
CO,PAPILLOEDEMA,1
CO,PARAESTHESIA ORAL,1
CO,PARANEOPLASTIC PLEURAL EFFUSION,1
CO,PARATHYROID CYST,1
CO,PARATHYROID DISORDER,1
CO,PARONYCHIA,1
CO,PATELLOFEMORAL PAIN SYNDROME,1
CO,PATHOGEN RESISTANCE,1
CO,PERIPHERAL ARTERY THROMBOSIS,1
CO,PERIPHERAL VASCULAR DISORDER,1
CO,PERITONEAL CYST,1
CO,PHANTOM PAIN,1
CO,PIGMENTATION DISORDER,1
CO,PLASMA CELL MYELOMA,1
CO,PLEURAL DISORDER,1
CO,PLEURISY,1
CO,PNEUMONIA ASPIRATION,1
CO,PNEUMONIA KLEBSIELLA,1
CO,PNEUMONIA NECROTISING,1
CO,PNEUMONIA STREPTOCOCCAL,1
CO,POLYMYALGIA RHEUMATICA,1
CO,POLYP,1
CR,DIZZINESS,2
CR,DYSPHAGIA,2
CR,DYSPNOEA,2
CR,ABDOMINAL DISTENSION,1
CR,ACUTE KIDNEY INJURY,1
CR,ANXIETY,1
CR,ASCITES,1
CR,ASPARTATE AMINOTRANSFERASE INCREASED,1
CR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CR,BLOOD CHOLESTEROL INCREASED,1
CR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CR,BLOOD TRIGLYCERIDES INCREASED,1
CR,BLOOD UREA INCREASED,1
CR,CHRONIC GASTRITIS,1
CR,CHRONIC HEPATIC FAILURE,1
CR,COLORECTAL CANCER METASTATIC,1
CR,DECREASED APPETITE,1
CR,DIARRHOEA,1
CR,DRUG HYPERSENSITIVITY,1
CR,DRY MOUTH,1
CR,DYSARTHRIA,1
CR,ERYTHEMA,1
CR,FURUNCLE,1
CR,HAEMATOCRIT DECREASED,1
CR,HAEMOGLOBIN DECREASED,1
CR,HAEMORRHOIDS,1
CR,HEADACHE,1
CR,HELICOBACTER INFECTION,1
CR,HEPATIC CANCER,1
CR,HIGH DENSITY LIPOPROTEIN DECREASED,1
CR,HYPERAEMIA,1
CR,LEUKOENCEPHALOPATHY,1
CR,LYMPHOCYTE PERCENTAGE INCREASED,1
CR,MALAISE,1
CR,MONOCYTE PERCENTAGE INCREASED,1
CR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CR,MUSCLE DISORDER,1
CR,OCCULT BLOOD POSITIVE,1
CR,PERIPHERAL SWELLING,1
CR,RENAL FAILURE,1
CR,SEIZURE,1
CR,SWELLING FACE,1
CR,TRANSPLANT REJECTION,1
CR,WHITE BLOOD CELL COUNT DECREASED,1
CI,DIZZINESS,1
CI,DYSPNOEA,1
CI,HICCUPS,1
CI,SWELLING FACE,1
HR,HEPATIC ENZYME INCREASED,2
HR,ERYTHEMA,1
HR,HYPERSENSITIVITY,1
HR,PAPULE,1
HR,PRURITUS,1
HR,PRURITUS GENERALISED,1
HR,SCLERAL DISORDER,1
HR,TACHYCARDIA,1
CY,HEART RATE INCREASED,8
CY,LOSS OF CONSCIOUSNESS,7
CY,ATYPICAL FEMUR FRACTURE,1
CY,BLOOD CREATININE INCREASED,1
CY,BLOOD UREA INCREASED,1
CY,CANDIDIASIS,1
CY,CIRCULATORY COLLAPSE,1
CY,DEVICE RELATED INFECTION,1
CY,DYSPNOEA,1
CY,HAEMOGLOBIN DECREASED,1
CY,HYPERTENSION,1
CY,MUSCULOSKELETAL PAIN,1
CY,OEDEMA PERIPHERAL,1
CY,PENILE SQUAMOUS CELL CARCINOMA,1
CY,PNEUMONITIS,1
CY,PSEUDOMONAS INFECTION,1
CY,PULMONARY HYPERTENSION,1
CY,PYREXIA,1
CY,RESORPTION BONE INCREASED,1
CY,RESPIRATORY FAILURE,1
CY,RESPIRATORY TRACT INFECTION,1
CY,SEPTIC SHOCK,1
CY,STATUS EPILEPTICUS,1
CZ,DYSPNOEA,6
CZ,CARDIAC ARREST,5
CZ,CONDITION AGGRAVATED,5
CZ,DRUG-INDUCED LIVER INJURY,5
CZ,EPISTAXIS,5
CZ,ANAEMIA,4
CZ,ANAPHYLACTIC SHOCK,4
CZ,CIRCULATORY COLLAPSE,4
CZ,COAGULOPATHY,4
CZ,OXYGEN SATURATION DECREASED,4
CZ,PARAESTHESIA,4
CZ,PNEUMONIA,4
CZ,PYREXIA,4
CZ,RESPIRATORY ARREST,4
CZ,ALTERED STATE OF CONSCIOUSNESS,3
CZ,DRUG LEVEL INCREASED,3
CZ,FATIGUE,3
CZ,HEPATIC CIRRHOSIS,3
CZ,LEUKOPENIA,3
CZ,MALAISE,3
CZ,RENAL FAILURE,3
CZ,SEPSIS,3
CZ,SEPTIC SHOCK,3
CZ,TOXICITY TO VARIOUS AGENTS,3
CZ,UROSEPSIS,3
CZ,ACUTE KIDNEY INJURY,2
CZ,ACUTE RESPIRATORY DISTRESS SYNDROME,2
CZ,ALANINE AMINOTRANSFERASE INCREASED,2
CZ,ALPHA 1 FOETOPROTEIN INCREASED,2
CZ,ASPARTATE AMINOTRANSFERASE INCREASED,2
CZ,AUTOIMMUNE HEPATITIS,2
CZ,BLOOD ALKALINE PHOSPHATASE INCREASED,2
CZ,C-REACTIVE PROTEIN INCREASED,2
CZ,CHEST WALL HAEMATOMA,2
CZ,CHOLESTASIS,2
CZ,CLOSTRIDIUM TEST POSITIVE,2
CZ,COLITIS,2
CZ,CRYPTOCOCCOSIS,2
CZ,DEHYDRATION,2
CZ,ENCEPHALITIS,2
CZ,FALL,2
CZ,FEBRILE NEUTROPENIA,2
CZ,FLUSHING,2
CZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CZ,GENERALISED TONIC-CLONIC SEIZURE,2
CZ,HAEMATEMESIS,2
CZ,HEADACHE,2
CZ,HEMIPARESIS,2
CZ,HERPES VIRUS INFECTION,2
CZ,HYPONATRAEMIA,2
CZ,HYPOTENSION,2
CZ,IMMUNOGLOBULINS INCREASED,2
CZ,INFECTION,2
CZ,JAUNDICE,2
CZ,LIVER DISORDER,2
CZ,LOSS OF CONSCIOUSNESS,2
CZ,MENINGITIS ASEPTIC,2
CZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
CZ,NAUSEA,2
CZ,NOSOCOMIAL INFECTION,2
CZ,OEDEMA PERIPHERAL,2
CZ,PALPITATIONS,2
CZ,PANCREATIC MASS,2
CZ,PERITONITIS,2
CZ,PLEOCYTOSIS,2
CZ,PNEUMOTHORAX,2
CZ,POLYARTERITIS NODOSA,2
CZ,PSEUDOMONAS INFECTION,2
CZ,PSYCHOMOTOR RETARDATION,2
CZ,PULMONARY HAEMORRHAGE,2
CZ,RENAL CYST HAEMORRHAGE,2
CZ,SPINAL FRACTURE,2
CZ,SYNCOPE,2
CZ,THIRST,2
CZ,VOMITING,2
CZ,WEIGHT DECREASED,2
CZ,ABASIA,1
CZ,ABDOMINAL PAIN,1
CZ,ACUTE ON CHRONIC LIVER FAILURE,1
CZ,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,1
CZ,ANTINUCLEAR ANTIBODY POSITIVE,1
CZ,APPENDICITIS,1
CZ,ASCITES,1
CZ,B-CELL LYMPHOMA,1
CZ,BLEEDING VARICOSE VEIN,1
CZ,BLOOD COUNT ABNORMAL,1
CZ,BLOOD THYROID STIMULATING HORMONE DECREASED,1
CZ,BONE MARROW FAILURE,1
CZ,BRONCHIAL OBSTRUCTION,1
CZ,CARDIAC FAILURE,1
CZ,CARDIOVASCULAR DISORDER,1
CZ,CAUDA EQUINA SYNDROME,1
CZ,CHEST DISCOMFORT,1
CZ,CHEST PAIN,1
CZ,CHROMATURIA,1
CZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CZ,COLITIS ULCERATIVE,1
CZ,CONJUNCTIVITIS,1
CZ,CSF CELL COUNT INCREASED,1
CZ,DECREASED APPETITE,1
CZ,DEEP VEIN THROMBOSIS,1
CZ,DEPRESSION,1
CZ,DERMATITIS ALLERGIC,1
CZ,DIABETIC METABOLIC DECOMPENSATION,1
CZ,DIARRHOEA,1
CZ,DIZZINESS,1
CZ,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CZ,DRUG INEFFECTIVE,1
CZ,DYSPEPSIA,1
CZ,DYSPHAGIA,1
CZ,ELECTROLYTE IMBALANCE,1
CZ,ENCEPHALITIS FUNGAL,1
CZ,ENCEPHALOPATHY,1
CZ,EPILEPSY,1
CZ,ERYSIPELAS,1
CZ,FAECES DISCOLOURED,1
CZ,FEELING HOT,1
CZ,GAIT DISTURBANCE,1
CZ,GENERAL PHYSICAL HEALTH DETERIORATION,1
CZ,GLIOBLASTOMA MULTIFORME,1
CZ,GOITRE,1
CZ,HAEMATOSPERMIA,1
CZ,HEPATIC ENCEPHALOPATHY,1
CZ,HEPATIC FIBROSIS,1
CZ,HEPATIC NECROSIS,1
CZ,HEPATORENAL FAILURE,1
CZ,HYDROCEPHALUS,1
CZ,HYPERSENSITIVITY,1
CZ,HYPERTHYROIDISM,1
CZ,HYPOALBUMINAEMIA,1
CZ,HYPOKALAEMIA,1
CZ,HYPOTHYROIDISM,1
CZ,ILEUS PARALYTIC,1
CZ,IMPAIRED HEALING,1
CZ,INFLAMMATION,1
CZ,INFLUENZA,1
CZ,INFUSION RELATED REACTION,1
CZ,INTESTINAL HAEMORRHAGE,1
CZ,INTRACRANIAL PRESSURE INCREASED,1
CZ,INTRACRANIAL TUMOUR HAEMORRHAGE,1
CZ,LEUKOCYTOSIS,1
CZ,LISTERIA SEPSIS,1
CZ,LIVER FUNCTION TEST INCREASED,1
CZ,LIVER INJURY,1
CZ,LOWER GASTROINTESTINAL HAEMORRHAGE,1
CZ,MEGACOLON,1
CZ,MENINGEAL DISORDER,1
CZ,MENINGISM,1
CZ,MENINGITIS,1
CZ,METRORRHAGIA,1
CZ,MUCOSAL INFLAMMATION,1
CZ,MUSCULAR WEAKNESS,1
CZ,MYDRIASIS,1
CZ,NON-CARDIAC CHEST PAIN,1
CZ,NON-SMALL CELL LUNG CANCER,1
CZ,OESOPHAGEAL VARICES HAEMORRHAGE,1
CZ,OLIGURIA,1
CZ,ORAL CANDIDIASIS,1
CZ,ORAL FUNGAL INFECTION,1
CZ,OSTEONECROSIS OF JAW,1
CZ,PANCYTOPENIA,1
CZ,PATHOLOGICAL FRACTURE,1
CZ,PERIPHERAL SWELLING,1
CZ,PLASMA CELL MYELOMA,1
CZ,PNEUMOCOCCAL SEPSIS,1
CZ,PNEUMONIA FUNGAL,1
CZ,POLYNEUROPATHY,1
CZ,PRESYNCOPE,1
CZ,PRODUCT USE IN UNAPPROVED INDICATION,1
CZ,PSYCHOMOTOR SKILLS IMPAIRED,1
CZ,PULMONARY EMBOLISM,1
CZ,PULMONARY OEDEMA,1
CZ,PUPILS UNEQUAL,1
CZ,PUSTULAR PSORIASIS,1
CZ,QUALITY OF LIFE DECREASED,1
CZ,RASH,1
CZ,RENAL NEOPLASM,1
CZ,RESPIRATORY DISTRESS,1
CZ,RHEUMATOID ARTHRITIS,1
CZ,SEXUAL DYSFUNCTION,1
CZ,SINUSITIS,1
CZ,SLEEP APNOEA SYNDROME,1
CZ,SPLENOMEGALY,1
CZ,STEATOHEPATITIS,1
CZ,STOMATITIS,1
CZ,SWELLING FACE,1
CZ,THROMBOCYTOPENIA,1
CZ,TONGUE OEDEMA,1
CZ,TONSILLAR HYPERTROPHY,1
CZ,TOXIC EPIDERMAL NECROLYSIS,1
CZ,TOXIC NODULAR GOITRE,1
CZ,TYPE 1 DIABETES MELLITUS,1
CZ,UPPER GASTROINTESTINAL HAEMORRHAGE,1
CZ,UPPER RESPIRATORY TRACT INFECTION,1
DK,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,18
DK,DIZZINESS,12
DK,LUPUS-LIKE SYNDROME,12
DK,DYSPNOEA,11
DK,RASH,8
DK,SWOLLEN TONGUE,7
DK,ANAPHYLACTIC REACTION,6
DK,HEADACHE,6
DK,HEART RATE INCREASED,5
DK,NAUSEA,5
DK,CARDIAC FAILURE,4
DK,CROSS SENSITIVITY REACTION,4
DK,CYANOSIS,4
DK,DYSURIA,4
DK,EYE PAIN,4
DK,SYSTEMIC LUPUS ERYTHEMATOSUS,4
DK,VOMITING,4
DK,ABDOMINAL PAIN,3
DK,EYE HAEMORRHAGE,3
DK,GASTRIC ULCER,3
DK,HEMIANOPIA HOMONYMOUS,3
DK,HEMIPARESIS,3
DK,PAIN,3
DK,SKIN EXFOLIATION,3
DK,ALOPECIA,2
DK,ANAEMIA,2
DK,BRAIN MIDLINE SHIFT,2
DK,BRAIN OEDEMA,2
DK,CEREBRAL HAEMATOMA,2
DK,CUTANEOUS LUPUS ERYTHEMATOSUS,2
DK,DEATH,2
DK,DRUG HYPERSENSITIVITY,2
DK,DRY EYE,2
DK,EOSINOPHILIA,2
DK,FATIGUE,2
DK,HERPES ZOSTER,2
DK,HYPOACUSIS,2
DK,INJURY CORNEAL,2
DK,LIP SWELLING,2
DK,MOTOR DYSFUNCTION,2
DK,MYALGIA,2
DK,NEURALGIA,2
DK,ORAL MUCOSAL BLISTERING,2
DK,PAIN IN EXTREMITY,2
DK,PALPITATIONS,2
DK,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
DK,PULMONARY FUNCTION TEST DECREASED,2
DK,TOOTH EROSION,2
DK,VASCULAR MALFORMATION,2
DK,VISION BLURRED,2
DK,ABDOMINAL DISTENSION,1
DK,ACTIVITIES OF DAILY LIVING IMPAIRED,1
DK,ALANINE AMINOTRANSFERASE INCREASED,1
DK,ALCOHOL INTOLERANCE,1
DK,ANGIOEDEMA,1
DK,ARTHRALGIA,1
DK,ATRIAL FIBRILLATION,1
DK,BACTERAEMIA,1
DK,BILIRUBIN EXCRETION DISORDER,1
DK,BLINDNESS,1
DK,BLISTER,1
DK,BLISTER INFECTED,1
DK,BLOOD ALKALINE PHOSPHATASE INCREASED,1
DK,BLOOD BILIRUBIN INCREASED,1
DK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
DK,BLOOD CREATININE INCREASED,1
DK,BLOOD PRESSURE INCREASED,1
DK,BONE PAIN,1
DK,CEREBRAL HAEMORRHAGE,1
DK,CHOLESTASIS,1
DK,COGNITIVE DISORDER,1
DK,CONDITION AGGRAVATED,1
DK,DENTAL CARIES,1
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,1
DK,DISTURBANCE IN ATTENTION,1
DK,DRUG WITHDRAWAL SYNDROME,1
DK,DRY MOUTH,1
DK,DRY SKIN,1
DK,DYSPHAGIA,1
DK,DYSPNOEA EXERTIONAL,1
DK,DYSTONIA,1
DK,EAR PAIN,1
DK,ERYSIPELAS,1
DK,ERYTHEMA,1
DK,ERYTHEMA ANNULARE,1
DK,EXPOSED BONE IN JAW,1
DK,EYE MOVEMENT DISORDER,1
DK,FACIAL PARALYSIS,1
DK,GAIT DISTURBANCE,1
DK,GENERAL PHYSICAL HEALTH DETERIORATION,1
DK,GINGIVAL BLEEDING,1
DK,GINGIVAL PAIN,1
DK,HAEMORRHAGE,1
DK,HEPATIC CIRRHOSIS,1
DK,HEPATIC FIBROSIS,1
DK,HYPERBILIRUBINAEMIA,1
DK,HYPERHIDROSIS,1
DK,HYPERPYREXIA,1
DK,HYPERSENSITIVITY,1
DK,HYPERTONIA,1
DK,HYPOMAGNESAEMIA,1
DK,HYPOXIA,1
DK,ILEUS,1
DK,IMPAIRED HEALING,1
DK,INCREASED APPETITE,1
DK,INFLAMMATION,1
DK,INTENTIONAL PRODUCT USE ISSUE,1
DK,INTERNATIONAL NORMALISED RATIO INCREASED,1
DK,INTERSTITIAL LUNG DISEASE,1
DK,IRON DEFICIENCY ANAEMIA,1
DK,MALAISE,1
DK,MELAENA,1
DK,MUCOUS MEMBRANE DISORDER,1
DK,MUSCLE RIGIDITY,1
DK,NEUROLEPTIC MALIGNANT SYNDROME,1
DK,OSTEONECROSIS OF JAW,1
DK,OVERDOSE,1
DK,PATHOLOGICAL FRACTURE,1
DK,PERFUME SENSITIVITY,1
DK,PERIODONTITIS,1
DK,PERIPHERAL SWELLING,1
DK,PLANTAR FASCIITIS,1
DK,PRODUCT USE ISSUE,1
DK,PRURITUS,1
DK,PUSTULAR PSORIASIS,1
DK,RENAL IMPAIRMENT,1
DK,SEIZURE,1
DK,SEROTONIN SYNDROME,1
DK,SINUS BRADYCARDIA,1
DK,SKIN HAEMORRHAGE,1
DK,SKIN LESION,1
DK,SLEEP DISORDER,1
DK,STENT PLACEMENT,1
DK,STEVENS-JOHNSON SYNDROME,1
DK,SWELLING FACE,1
DK,TARDIVE DYSKINESIA,1
DK,THIRST,1
DK,TINNITUS,1
DK,TOOTH ABSCESS,1
DK,TOOTH FRACTURE,1
DK,TOXICITY TO VARIOUS AGENTS,1
DK,TUBULOINTERSTITIAL NEPHRITIS,1
DK,URTICARIA,1
DK,VISUAL ACUITY REDUCED,1
DK,VISUAL IMPAIRMENT,1
DK,WEIGHT INCREASED,1
DK,WOUND SECRETION,1
DO,CHOLECYSTITIS ACUTE,3
DO,HYDROCHOLECYSTIS,3
DO,ABDOMINAL DISTENSION,2
DO,CHOLELITHIASIS,2
DO,DIARRHOEA,2
DO,HEADACHE,2
DO,ABDOMINAL PAIN UPPER,1
DO,ANAL FISSURE,1
DO,ARTHRALGIA,1
DO,BLOOD CREATININE DECREASED,1
DO,CARDIAC ARREST,1
DO,CHOLECYSTITIS,1
DO,COLITIS ULCERATIVE,1
DO,DEHYDRATION,1
DO,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,1
DO,DIZZINESS,1
DO,DRUG HYPERSENSITIVITY,1
DO,DYSCHEZIA,1
DO,DYSPEPSIA,1
DO,DYSURIA,1
DO,ELECTROPHORESIS PROTEIN ABNORMAL,1
DO,FALL,1
DO,FREQUENT BOWEL MOVEMENTS,1
DO,GASTROINTESTINAL DISORDER,1
DO,HAEMORRHOIDS,1
DO,INFLUENZA,1
DO,LARGE INTESTINE POLYP,1
DO,LOSS OF CONSCIOUSNESS,1
DO,LYMPHOCYTE COUNT INCREASED,1
DO,NEUTROPHIL COUNT DECREASED,1
DO,PAINFUL DEFAECATION,1
DO,PARAESTHESIA,1
DO,PARAESTHESIA ORAL,1
DO,PATHOGEN RESISTANCE,1
DO,PERIPHERAL SWELLING,1
DO,PHARYNGITIS STREPTOCOCCAL,1
DO,POST PROCEDURAL COMPLICATION,1
DO,PROCTALGIA,1
DO,PSEUDOPOLYPOSIS,1
DO,RECTAL HAEMORRHAGE,1
DO,RECTAL NEOPLASM,1
DO,RECTAL POLYP,1
DO,RECTAL PROLAPSE,1
DO,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
DO,SERUM FERRITIN INCREASED,1
DO,TACHYCARDIA,1
DO,TRANSIENT ISCHAEMIC ATTACK,1
DO,UPPER LIMB FRACTURE,1
DO,VIRAL INFECTION,1
DO,VOMITING,1
EC,CARDIO-RESPIRATORY ARREST,9
EC,ABDOMINAL PAIN,5
EC,HYPOTENSION,5
EC,ACUTE MYOCARDIAL INFARCTION,3
EC,ASTHENIA,3
EC,HEADACHE,3
EC,PYREXIA,3
EC,ABASIA,2
EC,ABDOMINAL DISTENSION,2
EC,ABDOMINAL PAIN UPPER,2
EC,CHOLELITHIASIS,2
EC,DIARRHOEA,2
EC,GENERAL PHYSICAL HEALTH DETERIORATION,2
EC,MALAISE,2
EC,NECK PAIN,2
EC,PAIN,2
EC,PERIPHERAL SWELLING,2
EC,PLATELET COUNT DECREASED,2
EC,SEPSIS,2
EC,VOMITING,2
EC,ANAEMIA,1
EC,ANGER,1
EC,ARTHRALGIA,1
EC,ARTHROPATHY,1
EC,BEDRIDDEN,1
EC,BLOOD PRESSURE FLUCTUATION,1
EC,BLOOD PRESSURE INCREASED,1
EC,CARDIOMEGALY,1
EC,CARDIOVASCULAR DISORDER,1
EC,CEREBRAL INFARCTION,1
EC,CEREBROVASCULAR ACCIDENT,1
EC,CHILLS,1
EC,CHOLANGITIS,1
EC,CHRONIC MYELOID LEUKAEMIA,1
EC,COMA,1
EC,COUGH,1
EC,DECREASED APPETITE,1
EC,DECREASED IMMUNE RESPONSIVENESS,1
EC,DEPRESSION,1
EC,DIABETES MELLITUS,1
EC,DIABETIC COMPLICATION,1
EC,DROWNING,1
EC,DRUG DOSE OMISSION,1
EC,DRUG INEFFECTIVE,1
EC,DYSPEPSIA,1
EC,ELECTROLYTE IMBALANCE,1
EC,EXTREMITY NECROSIS,1
EC,FACE OEDEMA,1
EC,FATIGUE,1
EC,FLATULENCE,1
EC,FLUID RETENTION,1
EC,FOOD INTERACTION,1
EC,GASTROINTESTINAL HAEMORRHAGE,1
EC,GASTROINTESTINAL MOTILITY DISORDER,1
EC,GINGIVAL PAIN,1
EC,GLAUCOMA,1
EC,HEART RATE DECREASED,1
EC,HEPATIC CIRRHOSIS,1
EC,HYPERTENSION,1
EC,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
EC,INFECTION,1
EC,INFLUENZA,1
EC,INSOMNIA,1
EC,INTERVERTEBRAL DISC DISPLACEMENT,1
EC,LIP AND/OR ORAL CAVITY CANCER,1
EC,MALIGNANT NEOPLASM PROGRESSION,1
EC,NEOPLASM MALIGNANT,1
EC,NEOPLASM PROGRESSION,1
EC,NO THERAPEUTIC RESPONSE,1
EC,OEDEMA PERIPHERAL,1
EC,ORAL MUCOSAL BLISTERING,1
EC,PANCYTOPENIA,1
EC,PERITONEAL EFFLUENT ABNORMAL,1
EC,PHOTOSENSITIVITY REACTION,1
EC,POSTOPERATIVE WOUND INFECTION,1
EC,PROCEDURAL PAIN,1
EC,PROTEINURIA,1
EC,PULMONARY OEDEMA,1
EC,RED BLOOD CELL COUNT DECREASED,1
EC,RENAL DISORDER,1
EC,RESPIRATORY DISORDER,1
EC,SEIZURE,1
EC,SPINAL PAIN,1
EC,SWELLING FACE,1
EC,SYNOVIAL CYST,1
EC,THYROID MASS,1
EC,TONIC CLONIC MOVEMENTS,1
EC,URINARY TRACT INFECTION,1
EC,VASODILATATION,1
EC,WEIGHT DECREASED,1
EG,BLOOD ALKALINE PHOSPHATASE INCREASED,2
EG,ADVERSE EVENT,1
EG,ANGIOEDEMA,1
EG,ARTHROPOD BITE,1
EG,CHEST PAIN,1
EG,DRUG INEFFECTIVE,1
EG,DRUG RESISTANCE,1
EG,OROPHARYNGEAL PAIN,1
EG,PAPILLARY MUSCLE RUPTURE,1
EG,PRODUCT QUALITY ISSUE,1
EG,PRURITUS GENITAL,1
EG,PURULENT DISCHARGE,1
EG,PYREXIA,1
EG,STAPHYLOCOCCAL INFECTION,1
EG,TREATMENT FAILURE,1
EG,WOUND COMPLICATION,1
EE,SUDDEN DEATH,3
EE,PYREXIA,2
EE,RENAL FAILURE,2
EE,SEPSIS,2
EE,ATRIAL FIBRILLATION,1
EE,BLOOD CREATININE INCREASED,1
EE,BLOOD PRESSURE INCREASED,1
EE,CYANOSIS,1
EE,DIARRHOEA,1
EE,DRUG INEFFECTIVE,1
EE,DRUG INTOLERANCE,1
EE,FATIGUE,1
EE,GROIN PAIN,1
EE,HAEMORRHAGIC ANAEMIA,1
EE,HAEMORRHAGIC EROSIVE GASTRITIS,1
EE,HEPATIC FAILURE,1
EE,HYPERBILIRUBINAEMIA,1
EE,INTERSTITIAL LUNG DISEASE,1
EE,JAUNDICE,1
EE,LUNG INFILTRATION,1
EE,NEUTROPHIL COUNT DECREASED,1
EE,OBSTRUCTIVE SHOCK,1
EE,OVERDOSE,1
EE,PRODUCT USE ISSUE,1
EE,PULMONARY EMBOLISM,1
EE,RECTAL HAEMORRHAGE,1
EE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
EE,VOMITING,1
FI,DYSPNOEA,4
FI,FATIGUE,4
FI,PYREXIA,4
FI,VOMITING,4
FI,CONFUSIONAL STATE,3
FI,GAIT DISTURBANCE,3
FI,HEADACHE,3
FI,MUSCULAR WEAKNESS,3
FI,NAUSEA,3
FI,PNEUMONIA,3
FI,ABDOMINAL DISCOMFORT,2
FI,C-REACTIVE PROTEIN INCREASED,2
FI,CEREBRAL HAEMORRHAGE,2
FI,DECREASED APPETITE,2
FI,DIARRHOEA,2
FI,DIZZINESS,2
FI,DRUG INEFFECTIVE,2
FI,ERYTHEMA,2
FI,GENERAL PHYSICAL HEALTH DETERIORATION,2
FI,HEMIPARESIS,2
FI,LUNG INFECTION,2
FI,MEMORY IMPAIRMENT,2
FI,NEUTROPHIL COUNT DECREASED,2
FI,PAIN,2
FI,PRURITUS,2
FI,RASH,2
FI,SEPSIS,2
FI,TOOTH INFECTION,2
FI,URTICARIA,2
FI,WEIGHT DECREASED,2
FI,ABDOMINAL PAIN,1
FI,ABDOMINAL PAIN UPPER,1
FI,ADENOCARCINOMA,1
FI,ALANINE AMINOTRANSFERASE INCREASED,1
FI,ALOPECIA,1
FI,AMYOTROPHIC LATERAL SCLEROSIS,1
FI,ANAEMIA,1
FI,ANGIOEDEMA,1
FI,APPLICATION SITE ERYTHEMA,1
FI,ARTHRALGIA,1
FI,ASPARTATE AMINOTRANSFERASE INCREASED,1
FI,ASTHENIA,1
FI,BACK DISORDER,1
FI,BENIGN NEOPLASM OF THYROID GLAND,1
FI,BLOOD ALKALINE PHOSPHATASE INCREASED,1
FI,BLOOD PHOSPHORUS DECREASED,1
FI,BLOOD PRESSURE INCREASED,1
FI,BLOOD URINE,1
FI,BODY TEMPERATURE DECREASED,1
FI,BORRELIA INFECTION,1
FI,BRAIN STEM SYNDROME,1
FI,CARDIOMYOPATHY,1
FI,CLOSTRIDIUM DIFFICILE INFECTION,1
FI,COMA,1
FI,COMPLETED SUICIDE,1
FI,CONDITION AGGRAVATED,1
FI,CONTUSION,1
FI,DEEP VEIN THROMBOSIS,1
FI,DELUSION,1
FI,DEREALISATION,1
FI,DIALYSIS,1
FI,DIAPHRAGMATIC HERNIA,1
FI,DIARRHOEA HAEMORRHAGIC,1
FI,DISORIENTATION,1
FI,DYSARTHRIA,1
FI,ELECTROCARDIOGRAM QT PROLONGED,1
FI,ENTERITIS,1
FI,ENTERITIS INFECTIOUS,1
FI,ENTEROCOLITIS,1
FI,EPIGASTRIC DISCOMFORT,1
FI,ERUCTATION,1
FI,ERYSIPELAS,1
FI,EXPOSURE DURING PREGNANCY,1
FI,EYELID OEDEMA,1
FI,FACIAL PARALYSIS,1
FI,FACIAL PARESIS,1
FI,FEBRILE NEUTROPENIA,1
FI,FEELING ABNORMAL,1
FI,FEELING HOT,1
FI,FOLATE DEFICIENCY,1
FI,FRACTURE,1
FI,GAIT INABILITY,1
FI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FI,GASTRIC ULCER,1
FI,GASTROINTESTINAL HYPOMOTILITY,1
FI,GASTROINTESTINAL NEOPLASM,1
FI,GESTATIONAL DIABETES,1
FI,HAEMOGLOBIN DECREASED,1
FI,HEART RATE INCREASED,1
FI,HEPATIC CIRRHOSIS,1
FI,HEPATIC NECROSIS,1
FI,HEPATORENAL SYNDROME,1
FI,HERPES ZOSTER,1
FI,HIP ARTHROPLASTY,1
FI,HYPERCAPNIA,1
FI,HYPERHIDROSIS,1
FI,HYPERPARATHYROIDISM,1
FI,HYPERREFLEXIA,1
FI,HYPERTENSION,1
FI,HYPOAESTHESIA,1
FI,HYPOCALCAEMIA,1
FI,HYPONATRAEMIA,1
FI,INCORRECT DOSE ADMINISTERED,1
FI,INFECTION,1
FI,INTERSTITIAL LUNG DISEASE,1
FI,JEJUNAL PERFORATION,1
FI,JOINT STIFFNESS,1
FI,KYPHOSIS,1
FI,LEUKAEMIA,1
FI,LIP SWELLING,1
FI,LYMPHADENOPATHY,1
FI,MATERNAL EXPOSURE DURING PREGNANCY,1
FI,MEDICATION ERROR,1
FI,MENINGITIS,1
FI,METABOLIC ACIDOSIS,1
FI,METASTASES TO BONE,1
FI,METASTASES TO LIVER,1
FI,MUSCLE ATROPHY,1
FI,MUSCLE FATIGUE,1
FI,MUSCLE SPASMS,1
FI,MUSCULOSKELETAL STIFFNESS,1
FI,MYALGIA,1
FI,MYOCARDIAL INFARCTION,1
FI,NASOPHARYNGITIS,1
FI,NEUROLEPTIC MALIGNANT SYNDROME,1
FI,NEUTROPHILIA,1
FI,NOCTURNAL DYSPNOEA,1
FI,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
FI,OESOPHAGITIS,1
FI,OSTEONECROSIS,1
FI,PAIN IN EXTREMITY,1
FI,PAIN OF SKIN,1
FI,PANCREATIC CYST,1
FI,PANCYTOPENIA,1
FI,PARAESTHESIA ORAL,1
FI,PERIPHERAL SWELLING,1
FI,PETECHIAE,1
FI,PLATELET COUNT DECREASED,1
FI,PLEURAL EFFUSION,1
FI,POOR QUALITY SLEEP,1
FI,PRODUCT QUALITY ISSUE,1
FI,PROTEINURIA,1
FI,PSYCHOTIC DISORDER,1
FI,PYELONEPHRITIS,1
FI,RASH MACULAR,1
FI,RESPIRATORY FAILURE,1
FI,RESPIRATORY TRACT INFECTION,1
FI,RESTLESS LEGS SYNDROME,1
FI,RETICULOCYTE COUNT DECREASED,1
FI,RHEUMATOID ARTHRITIS,1
FI,ROAD TRAFFIC ACCIDENT,1
FI,SERUM SICKNESS,1
FI,SLEEP DISORDER,1
FI,SMALL INTESTINAL OBSTRUCTION,1
FI,SOMNOLENCE,1
FI,SPEECH DISORDER,1
FI,SPINAL OSTEOARTHRITIS,1
FI,STAPHYLOCOCCAL SKIN INFECTION,1
FI,SUICIDAL IDEATION,1
FI,SWELLING,1
FI,SYNCOPE,1
FI,TENDERNESS,1
FI,TOE AMPUTATION,1
FI,TONGUE ATROPHY,1
FI,TOOTHACHE,1
FI,TRANSFUSION,1
FI,UPPER RESPIRATORY TRACT INFECTION,1
FI,URINARY RETENTION,1
FI,URINARY TRACT INFECTION,1
FI,URINARY TRACT INFECTION PSEUDOMONAL,1
FI,URINE ANALYSIS ABNORMAL,1
FI,UROSEPSIS,1
FI,URTICARIAL VASCULITIS,1
FI,VIRAL TEST POSITIVE,1
FI,WHITE BLOOD CELL COUNT INCREASED,1
FR,ACUTE KIDNEY INJURY,129
FR,FALL,113
FR,ANAEMIA,111
FR,HYPONATRAEMIA,84
FR,ASTHENIA,80
FR,DIARRHOEA,78
FR,CHOLESTASIS,74
FR,VOMITING,73
FR,THROMBOCYTOPENIA,70
FR,HEPATOCELLULAR INJURY,64
FR,DYSPNOEA,63
FR,NAUSEA,63
FR,PYREXIA,63
FR,HEADACHE,62
FR,CONFUSIONAL STATE,60
FR,HYPOTENSION,59
FR,GENERAL PHYSICAL HEALTH DETERIORATION,58
FR,FATIGUE,53
FR,PANCYTOPENIA,53
FR,NEUTROPENIA,52
FR,ABDOMINAL PAIN,51
FR,RENAL FAILURE,51
FR,MALAISE,50
FR,PANCREATITIS ACUTE,46
FR,COMA,40
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,40
FR,HYPERKALAEMIA,40
FR,WEIGHT DECREASED,40
FR,PRURITUS,38
FR,DECREASED APPETITE,37
FR,SEPTIC SHOCK,37
FR,ARTHRALGIA,36
FR,CARDIAC FAILURE,36
FR,DRUG INEFFECTIVE,36
FR,HYPOKALAEMIA,36
FR,RENAL FAILURE ACUTE,36
FR,DEATH,34
FR,CARDIO-RESPIRATORY ARREST,33
FR,HAEMATOMA,33
FR,PULMONARY EMBOLISM,33
FR,RASH,33
FR,AGRANULOCYTOSIS,32
FR,LUNG DISORDER,32
FR,SOMNOLENCE,31
FR,LOSS OF CONSCIOUSNESS,30
FR,PARAESTHESIA,30
FR,VERTIGO,30
FR,DEHYDRATION,29
FR,TOXICITY TO VARIOUS AGENTS,28
FR,ABDOMINAL PAIN UPPER,27
FR,DIZZINESS,27
FR,LEUKOPENIA,27
FR,OEDEMA PERIPHERAL,27
FR,RASH MACULO-PAPULAR,27
FR,ERYTHEMA,26
FR,INTERSTITIAL LUNG DISEASE,26
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,25
FR,INSOMNIA,25
FR,INTERNATIONAL NORMALISED RATIO INCREASED,25
FR,ISCHAEMIC STROKE,25
FR,MUSCULAR WEAKNESS,25
FR,RECTAL HAEMORRHAGE,25
FR,SEPSIS,25
FR,DEPRESSION,24
FR,COUGH,23
FR,HYPERTENSION,23
FR,MYALGIA,23
FR,OVERDOSE,23
FR,AGITATION,22
FR,HYPOGLYCAEMIA,22
FR,RHABDOMYOLYSIS,22
FR,HYPERTHERMIA,21
FR,HYPOMAGNESAEMIA,21
FR,INFLAMMATION,21
FR,PAIN,21
FR,CHILLS,20
FR,HEAD INJURY,20
FR,TREMOR,20
FR,BLOOD CREATININE INCREASED,19
FR,CONSTIPATION,19
FR,EOSINOPHILIA,19
FR,HEPATITIS,19
FR,HYPOCALCAEMIA,19
FR,MELAENA,19
FR,RESPIRATORY DISTRESS,19
FR,DISTURBANCE IN ATTENTION,18
FR,HOT FLUSH,18
FR,MUCOSAL INFLAMMATION,18
FR,TOXIC SKIN ERUPTION,18
FR,BRADYCARDIA,17
FR,CHEST PAIN,17
FR,METABOLIC ACIDOSIS,17
FR,SEIZURE,17
FR,URTICARIA,17
FR,ALTERED STATE OF CONSCIOUSNESS,16
FR,CARDIAC ARREST,16
FR,EPISTAXIS,16
FR,FEBRILE NEUTROPENIA,16
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,16
FR,PRODUCT USE ISSUE,16
FR,RENAL IMPAIRMENT,16
FR,TACHYCARDIA,16
FR,CEREBROVASCULAR ACCIDENT,15
FR,COLITIS,15
FR,DEEP VEIN THROMBOSIS,15
FR,DISORIENTATION,15
FR,DYSPHAGIA,15
FR,FEBRILE BONE MARROW APLASIA,15
FR,LACTIC ACIDOSIS,15
FR,MUSCLE SPASMS,15
FR,ORTHOSTATIC HYPOTENSION,15
FR,SYNCOPE,15
FR,URINARY RETENTION,15
FR,ALOPECIA,14
FR,ANXIETY,14
FR,C-REACTIVE PROTEIN INCREASED,14
FR,DIFFUSE LARGE B-CELL LYMPHOMA,14
FR,ENCEPHALOPATHY,14
FR,FACE OEDEMA,14
FR,GASTROINTESTINAL HAEMORRHAGE,14
FR,HAEMORRHAGE,14
FR,HALLUCINATION,14
FR,LINEAR IGA DISEASE,14
FR,PANCREATITIS,14
FR,PURPURA,14
FR,SHOCK HAEMORRHAGIC,14
FR,ABNORMAL BEHAVIOUR,13
FR,BACK PAIN,13
FR,BALANCE DISORDER,13
FR,GAIT DISTURBANCE,13
FR,GASTROINTESTINAL DISORDER,13
FR,HYPOGLYCAEMIC UNCONSCIOUSNESS,13
FR,LEFT VENTRICULAR FAILURE,13
FR,PEMPHIGOID,13
FR,TUBULOINTERSTITIAL NEPHRITIS,13
FR,URINARY TRACT INFECTION,13
FR,ATRIAL FIBRILLATION,12
FR,CELL DEATH,12
FR,CEREBRAL HAEMATOMA,12
FR,CONDITION AGGRAVATED,12
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,12
FR,HYPERGLYCAEMIA,12
FR,HYPERSENSITIVITY,12
FR,LEUKOCYTOSIS,12
FR,PLEURAL EFFUSION,12
FR,PNEUMONIA ASPIRATION,12
FR,SKIN LESION,12
FR,SUBDURAL HAEMATOMA,12
FR,TRANSAMINASES INCREASED,12
FR,ANGIOEDEMA,11
FR,ARRHYTHMIA,11
FR,DRY MOUTH,11
FR,ELECTROCARDIOGRAM QT PROLONGED,11
FR,LYMPHADENOPATHY,11
FR,OEDEMA,11
FR,PAIN IN EXTREMITY,11
FR,PNEUMONIA,11
FR,ANAPHYLACTIC REACTION,10
FR,BASAL CELL CARCINOMA,10
FR,HEPATOCELLULAR CARCINOMA,10
FR,HYPERCHOLESTEROLAEMIA,10
FR,HYPOXIA,10
FR,INTENTIONAL OVERDOSE,10
FR,INTESTINAL OBSTRUCTION,10
FR,LUNG INFECTION,10
FR,MALIGNANT NEOPLASM PROGRESSION,10
FR,ORAL CANDIDIASIS,10
FR,PRODUCT USE IN UNAPPROVED INDICATION,10
FR,PRURITUS GENERALISED,10
FR,RESPIRATORY FAILURE,10
FR,SUPRAVENTRICULAR TACHYCARDIA,10
FR,AGGRESSION,9
FR,ASCITES,9
FR,BRONCHITIS,9
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,9
FR,DYSPEPSIA,9
FR,ECZEMA,9
FR,EPILEPSY,9
FR,HAEMOGLOBIN DECREASED,9
FR,HEPATIC FAILURE,9
FR,HYPERBILIRUBINAEMIA,9
FR,HYPERTRIGLYCERIDAEMIA,9
FR,OSTEONECROSIS OF JAW,9
FR,PALPITATIONS,9
FR,PANCREATIC CARCINOMA,9
FR,PSORIASIS,9
FR,SCIATICA,9
FR,ACUTE CORONARY SYNDROME,8
FR,ACUTE PULMONARY OEDEMA,8
FR,BONE MARROW FAILURE,8
FR,DERMATITIS EXFOLIATIVE,8
FR,DERMATITIS EXFOLIATIVE GENERALISED,8
FR,DRUG-INDUCED LIVER INJURY,8
FR,GASTRITIS,8
FR,HAEMATEMESIS,8
FR,INFUSION RELATED REACTION,8
FR,JAUNDICE,8
FR,MANIA,8
FR,MUSCLE HAEMORRHAGE,8
FR,PERICARDIAL EFFUSION,8
FR,PERITONITIS,8
FR,POLYNEUROPATHY,8
FR,PRODUCTIVE COUGH,8
FR,VISION BLURRED,8
FR,VISUAL ACUITY REDUCED,8
FR,WEIGHT INCREASED,8
FR,ASPHYXIA,7
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,7
FR,CHEILITIS,7
FR,COMPLETED SUICIDE,7
FR,DIABETES MELLITUS,7
FR,DYSARTHRIA,7
FR,FOETAL EXPOSURE DURING PREGNANCY,7
FR,HAEMATURIA,7
FR,HEPATIC ENCEPHALOPATHY,7
FR,HISTIOCYTOSIS HAEMATOPHAGIC,7
FR,HYPERHIDROSIS,7
FR,HYPOTHERMIA,7
FR,MEMORY IMPAIRMENT,7
FR,MYOCARDIAL INFARCTION,7
FR,NEUROPATHY PERIPHERAL,7
FR,OSTEOARTHRITIS,7
FR,PANCREATIC CARCINOMA METASTATIC,7
FR,POISONING DELIBERATE,7
FR,QUADRIPARESIS,7
FR,RIB FRACTURE,7
FR,SINUS NODE DYSFUNCTION,7
FR,SPEECH DISORDER,7
FR,STATUS EPILEPTICUS,7
FR,TETANY,7
FR,TONGUE OEDEMA,7
FR,TOXIC EPIDERMAL NECROLYSIS,7
FR,VISUAL IMPAIRMENT,7
FR,WHITE BLOOD CELL COUNT DECREASED,7
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,6
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,6
FR,ALANINE AMINOTRANSFERASE INCREASED,6
FR,AMNESIA,6
FR,ANURIA,6
FR,ASPARTATE AMINOTRANSFERASE INCREASED,6
FR,ASPIRATION,6
FR,ASTHMA,6
FR,BICYTOPENIA,6
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,6
FR,BLOOD THYROID STIMULATING HORMONE NORMAL,6
FR,CARDIOGENIC SHOCK,6
FR,CEREBRAL HAEMORRHAGE,6
FR,CONVULSION,6
FR,DERMATOMYOSITIS,6
FR,DIABETES MELLITUS INADEQUATE CONTROL,6
FR,DISEASE PROGRESSION,6
FR,DRUG ERUPTION,6
FR,DYSKINESIA,6
FR,DYSPHONIA,6
FR,HAEMOLYTIC ANAEMIA,6
FR,HAEMOPTYSIS,6
FR,HAEMORRHAGIC STROKE,6
FR,HALLUCINATION_ VISUAL,6
FR,HEART RATE INCREASED,6
FR,HEMIPLEGIA,6
FR,HEPATITIS ACUTE,6
FR,HYPOAESTHESIA ORAL,6
FR,INFECTION,6
FR,ISCHAEMIC CEREBRAL INFARCTION,6
FR,LEUKOCYTURIA,6
FR,MIGRAINE,6
FR,MIOSIS,6
FR,MULTI-ORGAN FAILURE,6
FR,NEURALGIA,6
FR,OSTEOPOROSIS,6
FR,OXYGEN SATURATION DECREASED,6
FR,PALLOR,6
FR,PULMONARY OEDEMA,6
FR,SUICIDAL IDEATION,6
FR,TINNITUS,6
FR,TYPE I HYPERSENSITIVITY,6
FR,ABASIA,5
FR,ACUTE PRERENAL FAILURE,5
FR,AMYOTROPHY,5
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,5
FR,BLOOD PRESSURE DECREASED,5
FR,BLOOD PRESSURE INCREASED,5
FR,BLOOD PRESSURE SYSTOLIC INCREASED,5
FR,CEREBRAL VENOUS THROMBOSIS,5
FR,CHEST DISCOMFORT,5
FR,CHOLANGITIS,5
FR,CHOLELITHIASIS,5
FR,CONGESTIVE CARDIOMYOPATHY,5
FR,COORDINATION ABNORMAL,5
FR,CYTOMEGALOVIRUS INFECTION,5
FR,DELIRIUM,5
FR,DEPRESSED MOOD,5
FR,DERMATITIS BULLOUS,5
FR,DISSEMINATED INTRAVASCULAR COAGULATION,5
FR,DIVERTICULITIS,5
FR,DRUG LEVEL INCREASED,5
FR,DRY EYE,5
FR,DRY SKIN,5
FR,DYSURIA,5
FR,EAR INFECTION,5
FR,EPSTEIN-BARR VIRUS INFECTION,5
FR,ERYSIPELAS,5
FR,FOLATE DEFICIENCY,5
FR,GASTROOESOPHAGEAL REFLUX DISEASE,5
FR,HAEMATOTOXICITY,5
FR,HEPATIC FUNCTION ABNORMAL,5
FR,HEPATIC STEATOSIS,5
FR,HYPERSENSITIVITY VASCULITIS,5
FR,HYPOAESTHESIA,5
FR,HYPOPARATHYROIDISM,5
FR,HYPOPARATHYROIDISM SECONDARY,5
FR,HYPOTONIA,5
FR,INCORRECT DOSE ADMINISTERED,5
FR,INTRA-ABDOMINAL HAEMORRHAGE,5
FR,LIPASE INCREASED,5
FR,LYMPHOPENIA,5
FR,METASTASES TO LIVER,5
FR,MUSCLE RIGIDITY,5
FR,MYELODYSPLASTIC SYNDROME,5
FR,MYOCLONUS,5
FR,ORAL DISORDER,5
FR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,5
FR,PALMOPLANTAR KERATODERMA,5
FR,PAPULE,5
FR,PERIPHERAL SENSORY NEUROPATHY,5
FR,PETECHIAE,5
FR,PHOTOSENSITIVITY REACTION,5
FR,PLATELET COUNT DECREASED,5
FR,PSYCHOMOTOR HYPERACTIVITY,5
FR,PSYCHOMOTOR SKILLS IMPAIRED,5
FR,PYELONEPHRITIS,5
FR,RASH ERYTHEMATOUS,5
FR,RASH MACULAR,5
FR,RASH PUSTULAR,5
FR,SHOCK,5
FR,SINUS BRADYCARDIA,5
FR,SINUSITIS,5
FR,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,5
FR,SUBARACHNOID HAEMORRHAGE,5
FR,TRANSIENT ISCHAEMIC ATTACK,5
FR,WRONG DRUG ADMINISTERED,5
FR,ABDOMINAL DISTENSION,4
FR,ABNORMAL FAECES,4
FR,ACCIDENTAL OVERDOSE,4
FR,ACIDOSIS,4
FR,ALCOHOL WITHDRAWAL SYNDROME,4
FR,ANAEMIA MACROCYTIC,4
FR,ANAPHYLACTIC SHOCK,4
FR,APHTHOUS ULCER,4
FR,AXONAL NEUROPATHY,4
FR,BIPOLAR DISORDER,4
FR,BLISTER,4
FR,BLOOD PRESSURE FLUCTUATION,4
FR,BONE PAIN,4
FR,BRADYARRHYTHMIA,4
FR,CALCIPHYLAXIS,4
FR,CATARACT,4
FR,CHOLECYSTITIS,4
FR,CORONARY ARTERY STENOSIS,4
FR,CREATININE RENAL CLEARANCE DECREASED,4
FR,CYTOPENIA,4
FR,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,4
FR,DIPLOPIA,4
FR,DRUG HYPERSENSITIVITY,4
FR,DRUG WITHDRAWAL CONVULSIONS,4
FR,DYSPNOEA EXERTIONAL,4
FR,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,4
FR,EOSINOPHIL COUNT INCREASED,4
FR,EXPOSURE DURING PREGNANCY,4
FR,EXTENSOR PLANTAR RESPONSE,4
FR,EYE PAIN,4
FR,EYELID OEDEMA,4
FR,FACIAL BONES FRACTURE,4
FR,FLATULENCE,4
FR,FOETAL ARRHYTHMIA,4
FR,FUNGAL INFECTION,4
FR,GASTROENTERITIS,4
FR,GENERAL PHYSICAL CONDITION ABNORMAL,4
FR,GENERALISED TONIC-CLONIC SEIZURE,4
FR,GLAUCOMA,4
FR,HAEMODYNAMIC INSTABILITY,4
FR,HEAD DISCOMFORT,4
FR,HEART DISEASE CONGENITAL,4
FR,HEPATITIS CHOLESTATIC,4
FR,HYPERAMMONAEMIA,4
FR,HYPERTENSIVE CRISIS,4
FR,HYPOGAMMAGLOBULINAEMIA,4
FR,HYPOKINESIA,4
FR,HYPOTHYROIDISM,4
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
FR,INTESTINAL PERFORATION,4
FR,IRRITABILITY,4
FR,LIVER INJURY,4
FR,MALNUTRITION,4
FR,MATERNAL EXPOSURE DURING PREGNANCY,4
FR,MEDICATION ERROR,4
FR,MOTOR DYSFUNCTION,4
FR,MYOCARDIAL ISCHAEMIA,4
FR,NAIL PIGMENTATION,4
FR,NASOPHARYNGITIS,4
FR,NECK PAIN,4
FR,NEPHROLITHIASIS,4
FR,NEPHROPATHY TOXIC,4
FR,NERVOUS SYSTEM DISORDER,4
FR,NEUTROPHIL COUNT DECREASED,4
FR,NIGHT SWEATS,4
FR,NORMOCHROMIC NORMOCYTIC ANAEMIA,4
FR,ODYNOPHAGIA,4
FR,OLIGURIA,4
FR,OROPHARYNGEAL PAIN,4
FR,OSTEITIS,4
FR,PACKED RED BLOOD CELL TRANSFUSION,4
FR,PERICARDITIS,4
FR,PERIPHERAL ARTERY THROMBOSIS,4
FR,PERIPHERAL COLDNESS,4
FR,PHLEBITIS,4
FR,PLASMA CELL MYELOMA,4
FR,PLEURISY,4
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
FR,PSORIATIC ARTHROPATHY,4
FR,PULMONARY ARTERY ATRESIA,4
FR,PULMONARY FIBROSIS,4
FR,PYELONEPHRITIS ACUTE,4
FR,RALES,4
FR,RASH GENERALISED,4
FR,RENAL TUBULAR DISORDER,4
FR,RENAL TUBULAR NECROSIS,4
FR,RESPIRATORY DISORDER,4
FR,RHEUMATOID ARTHRITIS,4
FR,SKIN EXFOLIATION,4
FR,SKIN ULCER,4
FR,SLEEP APNOEA SYNDROME,4
FR,SUICIDE ATTEMPT,4
FR,THERAPEUTIC PRODUCT CROSS-REACTIVITY,4
FR,THROAT IRRITATION,4
FR,TIBIA FRACTURE,4
FR,TOOTH ABSCESS,4
FR,VASCULAR PURPURA,4
FR,WRIST FRACTURE,4
FR,ABDOMINAL WALL HAEMATOMA,3
FR,ACUTE MYELOID LEUKAEMIA,3
FR,ACUTE SINUSITIS,3
FR,ANAL FISSURE,3
FR,ANAPHYLACTOID REACTION,3
FR,APHASIA,3
FR,ATAXIA,3
FR,ATRIAL FLUTTER,3
FR,ATRIOVENTRICULAR BLOCK,3
FR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,3
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,3
FR,BLOOD BILIRUBIN INCREASED,3
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,3
FR,BLOOD UREA INCREASED,3
FR,BRONCHOPNEUMONIA,3
FR,BURNING SENSATION,3
FR,CANDIDA INFECTION,3
FR,CENTRAL NERVOUS SYSTEM LESION,3
FR,CEREBRAL ARTERY THROMBOSIS,3
FR,CEREBRAL ISCHAEMIA,3
FR,CHOLANGIOCARCINOMA,3
FR,COAGULOPATHY,3
FR,COGNITIVE DISORDER,3
FR,COLITIS ISCHAEMIC,3
FR,CONJUNCTIVITIS,3
FR,CONTRAINDICATION TO MEDICAL TREATMENT,3
FR,CRANIOCEREBRAL INJURY,3
FR,CROHN^S DISEASE,3
FR,DERMATITIS PSORIASIFORM,3
FR,DIFFUSE ALOPECIA,3
FR,DIPLEGIA,3
FR,DIVERTICULUM INTESTINAL,3
FR,DUODENITIS,3
FR,ECCHYMOSIS,3
FR,EJECTION FRACTION DECREASED,3
FR,ERYTHEMA MULTIFORME,3
FR,ESCHERICHIA INFECTION,3
FR,EXTRAPYRAMIDAL DISORDER,3
FR,EYE IRRITATION,3
FR,FACIAL PARALYSIS,3
FR,FAECALOMA,3
FR,FEELING DRUNK,3
FR,FEMUR FRACTURE,3
FR,FLUSHING,3
FR,GASTROINTESTINAL ANGIODYSPLASIA,3
FR,GASTROINTESTINAL MOTILITY DISORDER,3
FR,GENOTYPE DRUG RESISTANCE TEST POSITIVE,3
FR,HAEMATOCHEZIA,3
FR,HALLUCINATION_ AUDITORY,3
FR,HYDROCEPHALUS,3
FR,HYPERCALCAEMIA,3
FR,HYPERCAPNIA,3
FR,HYPERCREATININAEMIA,3
FR,HYPERLACTACIDAEMIA,3
FR,HYPERTHYROIDISM,3
FR,HYPOALBUMINAEMIA,3
FR,HYPOPHOSPHATAEMIA,3
FR,ILEUS PARALYTIC,3
FR,IMMUNOSUPPRESSION,3
FR,IMPAIRED HEALING,3
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
FR,INFLUENZA,3
FR,INJURY,3
FR,IRON DEFICIENCY ANAEMIA,3
FR,LARGE INTESTINE PERFORATION,3
FR,LARGE INTESTINE POLYP,3
FR,LARYNGEAL HAEMATOMA,3
FR,LEUKOENCEPHALOPATHY,3
FR,LICHENOID KERATOSIS,3
FR,LIGAMENT SPRAIN,3
FR,LUMBAR VERTEBRAL FRACTURE,3
FR,LYMPHOCYTE COUNT DECREASED,3
FR,MATERNAL DRUGS AFFECTING FOETUS,3
FR,MICROCYTIC ANAEMIA,3
FR,MIGRAINE WITH AURA,3
FR,MOUTH ULCERATION,3
FR,MUCOSAL HAEMORRHAGE,3
FR,MULTIPLE SCLEROSIS RELAPSE,3
FR,MYOSITIS,3
FR,NEOPLASM MALIGNANT,3
FR,NEUTROPHIL COUNT INCREASED,3
FR,NON-ALCOHOLIC STEATOHEPATITIS,3
FR,OESOPHAGEAL PAIN,3
FR,ORAL HERPES,3
FR,PARKINSONISM,3
FR,PELVIC PAIN,3
FR,PERIORBITAL HAEMATOMA,3
FR,PERIPHERAL ISCHAEMIA,3
FR,PERIPHERAL SWELLING,3
FR,PHOTOPHOBIA,3
FR,PNEUMOTHORAX,3
FR,POST PROCEDURAL HAEMORRHAGE,3
FR,PRESCRIBED UNDERDOSE,3
FR,PRESYNCOPE,3
FR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
FR,PROSTATITIS,3
FR,PULMONARY ARTERIAL HYPERTENSION,3
FR,RASH PRURITIC,3
FR,RECTAL ADENOCARCINOMA,3
FR,RENAL DISORDER,3
FR,RENAL NEOPLASM,3
FR,RESTLESS LEGS SYNDROME,3
FR,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,3
FR,SECOND PRIMARY MALIGNANCY,3
FR,SINOATRIAL BLOCK,3
FR,SINUS TACHYCARDIA,3
FR,SJOGREN^S SYNDROME,3
FR,SKIN DISCOLOURATION,3
FR,SKIN PLAQUE,3
FR,SKIN TEST POSITIVE,3
FR,SPLENOMEGALY,3
FR,STAPHYLOCOCCAL INFECTION,3
FR,STERNAL FRACTURE,3
FR,STOMATITIS,3
FR,SWOLLEN TONGUE,3
FR,SYNOVITIS,3
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,3
FR,TENDONITIS,3
FR,THROMBOSIS,3
FR,THROMBOTIC MICROANGIOPATHY,3
FR,TOXIC ENCEPHALOPATHY,3
FR,TRANSFUSION,3
FR,UNRESPONSIVE TO STIMULI,3
FR,UPPER LIMB FRACTURE,3
FR,VENTRICULAR FIBRILLATION,3
FR,VOCAL CORD DISORDER,3
FR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
FR,ABSCESS,2
FR,ACUTE MYOCARDIAL INFARCTION,2
FR,ACUTE RESPIRATORY FAILURE,2
FR,ADENOCARCINOMA OF COLON,2
FR,AKATHISIA,2
FR,ANGER,2
FR,ANHEDONIA,2
FR,ANKYLOSING SPONDYLITIS,2
FR,ANTIBIOTIC LEVEL ABOVE THERAPEUTIC,2
FR,APLASIA,2
FR,APLASTIC ANAEMIA,2
FR,ARTHRITIS,2
FR,ATELECTASIS,2
FR,AUTOIMMUNE HEPATITIS,2
FR,B-CELL LYMPHOMA,2
FR,BACTERAEMIA,2
FR,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
FR,BLOOD SODIUM INCREASED,2
FR,BLOOD THYROID STIMULATING HORMONE,2
FR,BLOOD URINE PRESENT,2
FR,BONE LESION,2
FR,BONE TUBERCULOSIS,2
FR,BRADYPNOEA,2
FR,BRAIN HERNIATION,2
FR,BRAIN HYPOXIA,2
FR,BRAIN OEDEMA,2
FR,BRONCHOPULMONARY ASPERGILLOSIS,2
FR,BRONCHOSPASM,2
FR,BROWN-SEQUARD SYNDROME,2
FR,BUNDLE BRANCH BLOCK RIGHT,2
FR,CACHEXIA,2
FR,CANDIDA SEPSIS,2
FR,CARDIAC FAILURE ACUTE,2
FR,CARDIAC TAMPONADE,2
FR,CARDIOACTIVE DRUG LEVEL INCREASED,2
FR,CARDIOPULMONARY FAILURE,2
FR,CEREBELLAR SYNDROME,2
FR,CHALAZION,2
FR,CHOLANGITIS ACUTE,2
FR,COLITIS MICROSCOPIC,2
FR,CONTRAINDICATED PRODUCT ADMINISTERED,2
FR,CORONARY ARTERY DISEASE,2
FR,CREATININE RENAL CLEARANCE ABNORMAL,2
FR,CREPITATIONS,2
FR,CUTANEOUS VASCULITIS,2
FR,CYANOSIS,2
FR,CYSTITIS,2
FR,DEATH NEONATAL,2
FR,DELUSION,2
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,2
FR,DERMATITIS,2
FR,DERMATITIS ACNEIFORM,2
FR,DEVICE OCCLUSION,2
FR,DIABETIC KETOACIDOSIS,2
FR,DISINHIBITION,2
FR,DRUG ABUSE,2
FR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
FR,DRUG ADMINISTRATION ERROR,2
FR,DRUG CROSS-REACTIVITY,2
FR,DRUG DISPENSING ERROR,2
FR,DRUG EFFECT INCOMPLETE,2
FR,DRUG PRESCRIBING ERROR,2
FR,DUODENAL ULCER,2
FR,DYSAESTHESIA,2
FR,DYSGEUSIA,2
FR,DYSPNOEA AT REST,2
FR,ECZEMA NUMMULAR,2
FR,EMBOLISM,2
FR,ESCHERICHIA SEPSIS,2
FR,ESSENTIAL HYPERTENSION,2
FR,EXECUTIVE DYSFUNCTION,2
FR,FAECES DISCOLOURED,2
FR,FAT EMBOLISM,2
FR,FEELING ABNORMAL,2
FR,FEELING HOT,2
FR,FEMORAL NECK FRACTURE,2
FR,FLUID OVERLOAD,2
FR,FRACTURED SACRUM,2
FR,FRONTOTEMPORAL DEMENTIA,2
FR,GENERALISED OEDEMA,2
FR,GINGIVITIS,2
FR,GRAND MAL CONVULSION,2
FR,GRANULOMATOUS LIVER DISEASE,2
FR,HAIR GROWTH ABNORMAL,2
FR,HEPATIC ENZYME INCREASED,2
FR,HEPATIC HAEMATOMA,2
FR,HEPATIC LESION,2
FR,HERPES ZOSTER,2
FR,HIGH DENSITY LIPOPROTEIN DECREASED,2
FR,HISTOPLASMOSIS,2
FR,HOSPITALISATION,2
FR,HUMERUS FRACTURE,2
FR,HYPERAESTHESIA,2
FR,HYPERSEXUALITY,2
FR,HYPOCHLORAEMIA,2
FR,HYPOFIBRINOGENAEMIA,2
FR,HYPOVOLAEMIC SHOCK,2
FR,IMMUNE THROMBOCYTOPENIC PURPURA,2
FR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
FR,IMPLANT SITE REACTION,2
FR,INFLUENZA LIKE ILLNESS,2
FR,INJECTION SITE PAIN,2
FR,INTENTIONAL PRODUCT USE ISSUE,2
FR,INTERMITTENT CLAUDICATION,2
FR,INTERVERTEBRAL DISC PROTRUSION,2
FR,INTESTINAL VILLI ATROPHY,2
FR,INTRACARDIAC THROMBUS,2
FR,INTRACRANIAL PRESSURE INCREASED,2
FR,INVASIVE DUCTAL BREAST CARCINOMA,2
FR,JAUNDICE CHOLESTATIC,2
FR,JUGULAR VEIN THROMBOSIS,2
FR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
FR,LABORATORY TEST ABNORMAL,2
FR,LARYNGITIS,2
FR,LEFT VENTRICULAR DYSFUNCTION,2
FR,LEUKOCYTOCLASTIC VASCULITIS,2
FR,LIMB INJURY,2
FR,LIP OEDEMA,2
FR,LIVER DISORDER,2
FR,LIVER FUNCTION TEST ABNORMAL,2
FR,LIVER TRANSPLANT,2
FR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
FR,LOW DENSITY LIPOPROTEIN DECREASED,2
FR,LYMPHOCYTIC HYPOPHYSITIS,2
FR,LYMPHOMA,2
FR,MENINGITIS,2
FR,MENINGORRHAGIA,2
FR,MENORRHAGIA,2
FR,METASTASES TO CENTRAL NERVOUS SYSTEM,2
FR,METASTASES TO PLEURA,2
FR,METRORRHAGIA,2
FR,MIXED LIVER INJURY,2
FR,MUSCLE CONTRACTURE,2
FR,MYDRIASIS,2
FR,MYOPATHY,2
FR,MYXOFIBROSARCOMA,2
FR,NEONATAL ANURIA,2
FR,NEOPLASM,2
FR,NEPHRITIS ALLERGIC,2
FR,NEUTROPHILIA,2
FR,NIGHTMARE,2
FR,NON-HODGKIN^S LYMPHOMA,2
FR,OCULAR HYPERAEMIA,2
FR,OESOPHAGEAL CANDIDIASIS,2
FR,OESOPHAGEAL CARCINOMA,2
FR,OESOPHAGEAL ULCER,2
FR,OESOPHAGITIS,2
FR,OPTIC ISCHAEMIC NEUROPATHY,2
FR,ORAL FUNGAL INFECTION,2
FR,ORGANISING PNEUMONIA,2
FR,OSTEOMYELITIS,2
FR,OSTEONECROSIS,2
FR,PAIN IN JAW,2
FR,PARALYSIS,2
FR,PARTIAL SEIZURES,2
FR,PELVIC FRACTURE,2
FR,PERFORMANCE STATUS DECREASED,2
FR,PERIODONTAL DISEASE,2
FR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
FR,PERIPHERAL ARTERY STENOSIS,2
FR,PERIPHERAL MOTOR NEUROPATHY,2
FR,PHARYNGEAL OEDEMA,2
FR,PHARYNGITIS,2
FR,PHOTOPSIA,2
FR,PIGMENTATION DISORDER,2
FR,PLATELET TRANSFUSION,2
FR,POST PROCEDURAL HAEMATOMA,2
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
FR,PRERENAL FAILURE,2
FR,PRESCRIBED OVERDOSE,2
FR,PRODUCT FORMULATION ISSUE,2
FR,PROSTATE CANCER,2
FR,PROSTATE CANCER METASTATIC,2
FR,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
FR,PROTEINURIA,2
FR,PROTHROMBIN LEVEL ABNORMAL,2
FR,PROTHROMBIN LEVEL DECREASED,2
FR,PSEUDOMONAS INFECTION,2
FR,PSYCHOMOTOR RETARDATION,2
FR,PULMONARY ALVEOLAR HAEMORRHAGE,2
FR,PUSTULAR PSORIASIS,2
FR,PYROGLUTAMATE INCREASED,2
FR,RASH PAPULAR,2
FR,RASH VESICULAR,2
FR,RED BLOOD CELL COUNT DECREASED,2
FR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
FR,RENAL ARTERY STENOSIS,2
FR,RENAL FAILURE NEONATAL,2
FR,RESPIRATORY ALKALOSIS,2
FR,RESPIRATORY TRACT CONGESTION,2
FR,RHINORRHOEA,2
FR,SARCOIDOSIS,2
FR,SEBORRHOEIC DERMATITIS,2
FR,SENSORY DISTURBANCE,2
FR,SEPSIS SYNDROME,2
FR,SKIN HAEMORRHAGE,2
FR,SLEEP DISORDER,2
FR,SPINAL FRACTURE,2
FR,SPINAL MUSCULAR ATROPHY,2
FR,SPONTANEOUS HAEMATOMA,2
FR,SQUAMOUS CELL CARCINOMA,2
FR,STAPHYLOCOCCAL SEPSIS,2
FR,STEVENS-JOHNSON SYNDROME,2
FR,STRESS,2
FR,STRESS CARDIOMYOPATHY,2
FR,SUBDURAL HAEMORRHAGE,2
FR,SUBILEUS,2
FR,SUDDEN DEATH,2
FR,SUDDEN HEARING LOSS,2
FR,SYSTEMIC CANDIDA,2
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,2
FR,THERAPEUTIC RESPONSE UNEXPECTED,2
FR,THERAPY CESSATION,2
FR,THIRST,2
FR,THROMBOCYTOPENIC PURPURA,2
FR,TOE AMPUTATION,2
FR,TONGUE DISCOLOURATION,2
FR,TONSILLITIS,2
FR,TOOTH INFECTION,2
FR,TRANSPLANT REJECTION,2
FR,TREATMENT FAILURE,2
FR,TUBERCULOSIS,2
FR,ULCER,2
FR,UPPER AIRWAY OBSTRUCTION,2
FR,URINARY TRACT INFECTION BACTERIAL,2
FR,URINE OUTPUT DECREASED,2
FR,UROSEPSIS,2
FR,URTICARIA PAPULAR,2
FR,VENTRICULAR HYPOKINESIA,2
FR,VENTRICULAR SEPTAL DEFECT,2
FR,WHITE BLOOD CELL COUNT INCREASED,2
FR,ABDOMINAL CAVITY DRAINAGE,1
FR,ABDOMINAL DISCOMFORT,1
FR,ABDOMINAL PAIN LOWER,1
FR,ABNORMAL LOSS OF WEIGHT,1
FR,ABNORMAL SENSATION IN EYE,1
FR,ABORTION INDUCED,1
FR,ABSCESS LIMB,1
FR,ACARODERMATITIS,1
FR,ACCIDENTAL EXPOSURE TO PRODUCT,1
FR,ACNE,1
FR,ACQUIRED EPIDERMOLYSIS BULLOSA,1
FR,ACTINIC KERATOSIS,1
FR,ACTINOMYCOSIS,1
FR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
FR,ACUTE ABDOMEN,1
FR,ACUTE LYMPHOCYTIC LEUKAEMIA,1
FR,ADENOCARCINOMA GASTRIC,1
FR,ADENOCARCINOMA PANCREAS,1
FR,ADENOMA BENIGN,1
FR,ADNEXA UTERI PAIN,1
FR,ADRENAL INSUFFICIENCY,1
FR,ADVERSE EVENT,1
FR,AFFECTIVE DISORDER,1
FR,AGE-RELATED MACULAR DEGENERATION,1
FR,AKINESIA,1
FR,ALANINE AMINOTRANSFERASE ABNORMAL,1
FR,ALCOHOL INTERACTION,1
FR,ALCOHOLISM,1
FR,ALKALOSIS,1
FR,ALLERGIC TRANSFUSION REACTION,1
FR,AMYOTROPHIC LATERAL SCLEROSIS,1
FR,ANAEMIA FOLATE DEFICIENCY,1
FR,ANAL ABSCESS,1
FR,ANAPHYLACTOID SHOCK,1
FR,ANASTOMOTIC STENOSIS,1
FR,ANGINA PECTORIS,1
FR,ANGIODYSPLASIA,1
FR,ANGIOPATHY,1
FR,ANOSMIA,1
FR,ANTEROGRADE AMNESIA,1
FR,ANTI-SS-A ANTIBODY POSITIVE,1
FR,ANTICOAGULATION DRUG LEVEL INCREASED,1
FR,ANTINUCLEAR ANTIBODY POSITIVE,1
FR,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
FR,AORTIC DILATATION,1
FR,APHONIA,1
FR,APHTHOUS STOMATITIS,1
FR,APICAL GRANULOMA,1
FR,APPLICATION SITE BURN,1
FR,APPLICATION SITE DISCOLOURATION,1
FR,APPLICATION SITE EXFOLIATION,1
FR,APPLICATION SITE SCAR,1
FR,APPLICATION SITE VESICLES,1
FR,APPLICATION SITE WARMTH,1
FR,AREFLEXIA,1
FR,ARTERIAL DISORDER,1
FR,ARTERIAL STENOSIS,1
FR,ARTERIOSCLEROSIS,1
FR,ARTHROPATHY,1
FR,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
FR,ATRIAL SEPTAL DEFECT,1
FR,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
FR,ATYPICAL MYCOBACTERIUM TEST POSITIVE,1
FR,AUDITORY DISORDER,1
FR,AUTOIMMUNE COLITIS,1
FR,AUTOIMMUNE DISORDER,1
FR,AUTOIMMUNE THYROIDITIS,1
FR,AUTONOMIC NEUROPATHY,1
FR,BACTERIAL SEPSIS,1
FR,BACTERIURIA,1
FR,BASAL GANGLIA HAEMATOMA,1
FR,BEDRIDDEN,1
FR,BENIGN PROSTATIC HYPERPLASIA,1
FR,BILE DUCT STENOSIS,1
FR,BILE DUCT STONE,1
FR,BILIARY CYST,1
FR,BLADDER DILATATION,1
FR,BLADDER DISORDER,1
FR,BLADDER SPHINCTER ATONY,1
FR,BLADDER TRANSITIONAL CELL CARCINOMA,1
FR,BLAST CELL PROLIFERATION,1
FR,BLINDNESS TRANSIENT,1
FR,BLISTER RUPTURE,1
FR,BLOOD ALBUMIN DECREASED,1
FR,BLOOD ALKALINE PHOSPHATASE ABNORMAL,1
FR,BLOOD CALCIUM DECREASED,1
FR,BLOOD CHROMOGRANIN A INCREASED,1
FR,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
FR,BLOOD CREATININE ABNORMAL,1
FR,BLOOD CULTURE POSITIVE,1
FR,BLOOD FOLATE INCREASED,1
FR,BLOOD GLUCOSE ABNORMAL,1
FR,BLOOD GLUCOSE INCREASED,1
FR,BLOOD LACTIC ACID INCREASED,1
FR,BLOOD PHOSPHORUS DECREASED,1
FR,BLOOD PHOSPHORUS INCREASED,1
FR,BLOOD POTASSIUM DECREASED,1
FR,BLOOD POTASSIUM INCREASED,1
FR,BLOOD PRESSURE ABNORMAL,1
FR,BLOOD PRESSURE DIASTOLIC INCREASED,1
FR,BLOOD PRESSURE SYSTOLIC DECREASED,1
FR,BLOOD SODIUM DECREASED,1
FR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
FR,BLOOD TRIGLYCERIDES INCREASED,1
FR,BLOOD URIC ACID DECREASED,1
FR,BODY TEMPERATURE DECREASED,1
FR,BONE DENSITY DECREASED,1
FR,BONE DISORDER,1
FR,BONE MARROW BASOPHILIC LEUKOCYTE COUNT INCREASED,1
FR,BOWEN^S DISEASE,1
FR,BRADYPHRENIA,1
FR,BRAIN CONTUSION,1
FR,BRAIN DEATH,1
FR,BRAIN SCAN ABNORMAL,1
FR,BREAST CANCER,1
FR,BREAST CANCER METASTATIC,1
FR,BREAST DISCOLOURATION,1
FR,BREAST HAEMATOMA,1
FR,BREAST HAEMORRHAGE,1
FR,BREAST PAIN,1
FR,BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS,1
FR,BRONCHIAL CARCINOMA,1
FR,BRONCHIAL DISORDER,1
FR,BRONCHIAL FISTULA,1
FR,BRONCHIAL HAEMORRHAGE,1
FR,BRONCHIAL OBSTRUCTION,1
FR,BRONCHOALVEOLAR LAVAGE ABNORMAL,1
FR,BRONCHOPNEUMOPATHY,1
FR,BURNS SECOND DEGREE,1
FR,BURSITIS,1
FR,CAESAREAN SECTION,1
FR,CALCULUS BLADDER,1
FR,CALCULUS URINARY,1
FR,CAMPYLOBACTER INFECTION,1
FR,CARDIAC DISORDER,1
FR,CARDIAC FAILURE CONGESTIVE,1
FR,CARDIAC MURMUR,1
FR,CARDIAC PACEMAKER INSERTION,1
FR,CARDIAC VALVE DISEASE,1
FR,CARDIOVASCULAR DISORDER,1
FR,CARPAL TUNNEL SYNDROME,1
FR,CATARACT NUCLEAR,1
FR,CATHETER PLACEMENT,1
FR,CELLULITIS,1
FR,CEREBELLAR ISCHAEMIA,1
FR,CEREBRAL ATROPHY,1
FR,CEREBRAL DISORDER,1
FR,CEREBRAL INFARCTION,1
FR,CEREBRAL TOXOPLASMOSIS,1
FR,CEREBROVASCULAR DISORDER,1
FR,CHEST X-RAY ABNORMAL,1
FR,CHOLECYSTITIS ACUTE,1
FR,CHOLELITHIASIS OBSTRUCTIVE,1
FR,CHONDROLYSIS,1
FR,CHROMATURIA,1
FR,CHRONIC KIDNEY DISEASE,1
FR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
FR,CHRONIC LYMPHOCYTIC LEUKAEMIA (IN REMISSION),1
FR,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
FR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
FR,CHVOSTEK^S SIGN,1
FR,CIRCADIAN RHYTHM SLEEP DISORDER,1
FR,CIRCULATORY COLLAPSE,1
FR,CLEFT LIP AND PALATE,1
FR,CLOSTRIDIUM DIFFICILE COLITIS,1
FR,CLOSTRIDIUM DIFFICILE SEPSIS,1
FR,COAGULATION FACTOR V LEVEL DECREASED,1
FR,COAGULATION TIME PROLONGED,1
FR,COARCTATION OF THE AORTA,1
FR,COCCIDIOIDOMYCOSIS,1
FR,COLD SWEAT,1
FR,COLD URTICARIA,1
FR,COLON ADENOMA,1
FR,COLONIC PSEUDO-OBSTRUCTION,1
FR,COMA SCALE ABNORMAL,1
FR,COMMUNITY ACQUIRED INFECTION,1
FR,COMPLEX REGIONAL PAIN SYNDROME,1
FR,CONCOMITANT DISEASE PROGRESSION,1
FR,CONJUNCTIVAL ABRASION,1
FR,CONJUNCTIVAL DISORDER,1
FR,CONJUNCTIVAL HAEMORRHAGE,1
FR,CONTUSION,1
FR,COOMBS TEST POSITIVE,1
FR,CORONARY ARTERY THROMBOSIS,1
FR,CRITICAL ILLNESS POLYNEUROPATHY,1
FR,CRYPTOCOCCOSIS,1
FR,CRYSTAL URINE PRESENT,1
FR,CUTANEOUS SARCOIDOSIS,1
FR,CYCLOTHYMIC DISORDER,1
FR,CYSTITIS ESCHERICHIA,1
FR,CYSTITIS HAEMORRHAGIC,1
FR,CYTOMEGALOVIRUS COLITIS,1
FR,DEAFNESS NEUROSENSORY,1
FR,DECUBITUS ULCER,1
FR,DELUSIONAL DISORDER_ UNSPECIFIED TYPE,1
FR,DEMYELINATION,1
FR,DERMATOFIBROSARCOMA PROTUBERANS,1
FR,DERMO-HYPODERMITIS,1
FR,DEVICE INEFFECTIVE,1
FR,DIABETIC METABOLIC DECOMPENSATION,1
FR,DIARRHOEA HAEMORRHAGIC,1
GE,ANAEMIA,1
GE,APPENDICITIS,1
GE,BACK PAIN,1
GE,DEATH,1
GE,EATING DISORDER,1
GE,ELECTROCARDIOGRAM QT PROLONGED,1
GE,GASTROINTESTINAL DISORDER,1
GE,GENERALISED OEDEMA,1
GE,HYPOALBUMINAEMIA,1
GE,HYPOPROTEINAEMIA,1
GE,NEPHROTIC SYNDROME,1
GE,PLATELET COUNT DECREASED,1
GE,RENAL FAILURE,1
GE,THROMBOCYTOPENIA,1
DE,NAUSEA,65
DE,DYSPNOEA,64
DE,DIARRHOEA,54
DE,FATIGUE,49
DE,PNEUMONIA,49
DE,ABDOMINAL PAIN,47
DE,GENERAL PHYSICAL HEALTH DETERIORATION,45
DE,VOMITING,43
DE,FOETAL EXPOSURE DURING PREGNANCY,42
DE,DIZZINESS,38
DE,PYREXIA,34
DE,DEATH,29
DE,EXPOSURE DURING PREGNANCY,29
DE,PAIN,29
DE,ASTHENIA,27
DE,HYPOTENSION,27
DE,SEPSIS,27
DE,ANAEMIA,26
DE,HEADACHE,26
DE,ATRIAL SEPTAL DEFECT,25
DE,FALL,25
DE,TYPE I HYPERSENSITIVITY,24
DE,WEIGHT DECREASED,24
DE,ATRIAL FIBRILLATION,23
DE,RASH,22
DE,ACUTE KIDNEY INJURY,21
DE,PAIN IN EXTREMITY,21
DE,ARTHRALGIA,20
DE,OVERDOSE,20
DE,DECREASED APPETITE,19
DE,GAIT DISTURBANCE,19
DE,PRURITUS,19
DE,RENAL FAILURE,19
DE,URTICARIA,19
DE,GASTROINTESTINAL HAEMORRHAGE,18
DE,VISUAL IMPAIRMENT,18
DE,BACK PAIN,17
DE,GASTRITIS,17
DE,THROMBOCYTOPENIA,17
DE,HYPERTENSION,16
DE,HYPOGLYCAEMIA,16
DE,PULMONARY EMBOLISM,16
DE,CEREBROVASCULAR ACCIDENT,15
DE,HEPATIC ENZYME INCREASED,15
DE,INFECTION,15
DE,OSTEOARTHRITIS,15
DE,URINARY TRACT INFECTION,15
DE,ABORTION MISSED,14
DE,DRUG INTOLERANCE,14
DE,LEUKOPENIA,14
DE,PARAESTHESIA,14
DE,PLEURAL EFFUSION,14
DE,ABDOMINAL PAIN UPPER,13
DE,BRONCHITIS,13
DE,CIRCULATORY COLLAPSE,13
DE,DEHYDRATION,13
DE,HYPOAESTHESIA,13
DE,PANCYTOPENIA,13
DE,THROMBOSIS,13
DE,CARDIAC FAILURE,12
DE,FLUSHING,12
DE,FOETAL GROWTH RESTRICTION,12
DE,HAEMORRHAGE,12
DE,HYPERTENSIVE CRISIS,12
DE,MYALGIA,12
DE,MYOCARDIAL INFARCTION,12
DE,OEDEMA PERIPHERAL,12
DE,SLEEP DISORDER,12
DE,SMALL FOR DATES BABY,12
DE,VISION BLURRED,12
DE,AORTIC VALVE INCOMPETENCE,11
DE,BLOOD CREATININE INCREASED,11
DE,CARDIOVASCULAR DISORDER,11
DE,CONFUSIONAL STATE,11
DE,DRUG INEFFECTIVE,11
DE,DYSMORPHISM,11
DE,DYSPHAGIA,11
DE,HAEMOGLOBIN DECREASED,11
DE,METABOLIC ACIDOSIS,11
DE,NEUTROPENIA,11
DE,OLIGOHYDRAMNIOS,11
DE,VENTRICULAR SEPTAL DEFECT,11
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,10
DE,CHEST PAIN,10
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,10
DE,GASTROENTERITIS,10
DE,HEPATIC FAILURE,10
DE,HERPES ZOSTER,10
DE,HYPERHIDROSIS,10
DE,IMPAIRED HEALING,10
DE,INTERVERTEBRAL DISC PROTRUSION,10
DE,LOSS OF CONSCIOUSNESS,10
DE,MULTIPLE SCLEROSIS RELAPSE,10
DE,PATENT DUCTUS ARTERIOSUS,10
DE,PREMATURE BABY,10
DE,TACHYCARDIA,10
DE,TALIPES,10
DE,ACUTE MYELOID LEUKAEMIA,9
DE,ARRHYTHMIA,9
DE,BRADYCARDIA NEONATAL,9
DE,CHOLELITHIASIS,9
DE,CONSTIPATION,9
DE,CROHN^S DISEASE,9
DE,DYSGEUSIA,9
DE,HEPATITIS,9
DE,MUSCLE SPASMS,9
DE,NASOPHARYNGITIS,9
DE,PANCREATITIS,9
DE,RENAL FAILURE ACUTE,9
DE,RESPIRATORY FAILURE,9
DE,RESTLESSNESS,9
DE,SOMNOLENCE,9
DE,SYNCOPE,9
DE,TRANSAMINASES INCREASED,9
DE,ABDOMINAL DISCOMFORT,8
DE,BLOOD GLUCOSE INCREASED,8
DE,C-REACTIVE PROTEIN INCREASED,8
DE,CARDIAC DISORDER,8
DE,CHOLANGITIS,8
DE,CHOLECYSTITIS,8
DE,CHROMATURIA,8
DE,COMPLETED SUICIDE,8
DE,COUGH,8
DE,DEPRESSION,8
DE,DIVERTICULITIS,8
DE,EPILEPSY,8
DE,GASTROINTESTINAL DISORDER,8
DE,HAEMORRHAGIC ANAEMIA,8
DE,HALLUCINATION_ AUDITORY,8
DE,HEPATIC STEATOSIS,8
DE,INFLAMMATION,8
DE,JAUNDICE,8
DE,LYMPHADENOPATHY,8
DE,MUSCULAR WEAKNESS,8
DE,MUSCULOSKELETAL PAIN,8
DE,SKIN DISORDER,8
DE,TOXICITY TO VARIOUS AGENTS,8
DE,TRANSIENT ISCHAEMIC ATTACK,8
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,8
DE,BLOOD PRESSURE INCREASED,7
DE,BONE MARROW FAILURE,7
DE,CARDIAC ARREST,7
DE,CHILLS,7
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,7
DE,COLITIS,7
DE,CYSTITIS,7
DE,DIABETES MELLITUS,7
DE,DRUG-INDUCED LIVER INJURY,7
DE,DYSPNOEA EXERTIONAL,7
DE,ENDOCARDITIS,7
DE,ERYSIPELAS,7
DE,FISTULA,7
DE,HAEMATOMA,7
DE,HYPOKALAEMIA,7
DE,HYPONATRAEMIA,7
DE,MALAISE,7
DE,PERITONITIS,7
DE,PRESBYACUSIS,7
DE,PRURITUS GENERALISED,7
DE,RASH PUSTULAR,7
DE,RESPIRATORY DISORDER NEONATAL,7
DE,SKIN LESION,7
DE,SPEECH DISORDER,7
DE,STAPHYLOCOCCAL INFECTION,7
DE,VISUAL ACUITY REDUCED,7
DE,ABDOMINAL DISTENSION,6
DE,ABDOMINAL SYMPTOM,6
DE,ALANINE AMINOTRANSFERASE INCREASED,6
DE,ASTHMA,6
DE,BUTTERFLY RASH,6
DE,CELLULITIS,6
DE,CEREBRAL ISCHAEMIA,6
DE,COAGULOPATHY,6
DE,COLD SWEAT,6
DE,DEPRESSED MOOD,6
DE,DISTURBANCE IN ATTENTION,6
DE,DYSPEPSIA,6
DE,ERYTHEMA,6
DE,EYELID OEDEMA,6
DE,FEBRILE NEUTROPENIA,6
DE,FEMUR FRACTURE,6
DE,HEMIPARESIS,6
DE,HEPATOMEGALY,6
DE,INSOMNIA,6
DE,MATERNAL EXPOSURE DURING PREGNANCY,6
DE,NEONATAL HYPOXIA,6
DE,NERVOUSNESS,6
DE,PERICARDIAL EFFUSION,6
DE,PERIPHERAL SWELLING,6
DE,PHOTOPHOBIA,6
DE,POST PROCEDURAL COMPLICATION,6
DE,PSORIASIS,6
DE,PULMONARY HYPERTENSION,6
DE,RASH GENERALISED,6
DE,RED BLOOD CELL COUNT DECREASED,6
DE,RESPIRATORY DISTRESS,6
DE,SPLENOMEGALY,6
DE,THERAPEUTIC PRODUCT CROSS-REACTIVITY,6
DE,VERTIGO,6
DE,VITAMIN D DEFICIENCY,6
DE,WEIGHT INCREASED,6
DE,ABNORMAL SENSATION IN EYE,5
DE,ACCIDENTAL EXPOSURE TO PRODUCT,5
DE,ACIDOSIS,5
DE,AGRANULOCYTOSIS,5
DE,ANAL ABSCESS,5
DE,ANAPHYLACTIC REACTION,5
DE,ANGINA PECTORIS,5
DE,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,5
DE,APHASIA,5
DE,ARTHROPATHY,5
DE,ASCITES,5
DE,ASPARTATE AMINOTRANSFERASE INCREASED,5
DE,ATRIAL FLUTTER,5
DE,BLOOD BILIRUBIN INCREASED,5
DE,BONE PAIN,5
DE,BUNDLE BRANCH BLOCK RIGHT,5
DE,CANDIDA INFECTION,5
DE,CARPAL TUNNEL SYNDROME,5
DE,CEREBRAL HAEMORRHAGE,5
DE,CEREBRAL INFARCTION,5
DE,CHOLESTASIS,5
DE,COLITIS ULCERATIVE,5
DE,CONDITION AGGRAVATED,5
DE,DEVICE DISLOCATION,5
DE,DRUG EFFECT DECREASED,5
DE,DRY MOUTH,5
DE,DUODENAL ULCER,5
DE,FEELING ABNORMAL,5
DE,FUNGAL SEPSIS,5
DE,GASTRIC ULCER,5
DE,GASTROINTESTINAL INFLAMMATION,5
DE,GASTROOESOPHAGEAL REFLUX DISEASE,5
DE,HAEMATOCHEZIA,5
DE,HYPERSENSITIVITY,5
DE,HYPOSPADIAS,5
DE,HYPOXIA,5
DE,ILEUS,5
DE,INTENTIONAL OVERDOSE,5
DE,JOINT SWELLING,5
DE,LIVER FUNCTION TEST ABNORMAL,5
DE,LIVER FUNCTION TEST INCREASED,5
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,5
DE,MENTAL DISORDER,5
DE,MICROCEPHALY,5
DE,MOBILITY DECREASED,5
DE,MUCOSAL INFLAMMATION,5
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
DE,NAEVUS FLAMMEUS,5
DE,NIGHT BLINDNESS,5
DE,OCULAR ICTERUS,5
DE,OEDEMA,5
DE,OSTEITIS,5
DE,PLEURISY,5
DE,PNEUMOTHORAX,5
DE,PROTEINURIA,5
DE,PULMONARY FIBROSIS,5
DE,PULMONARY VALVE STENOSIS,5
DE,RHEUMATOID ARTHRITIS,5
DE,SEIZURE,5
DE,SELF-MEDICATION,5
DE,SKIN EXFOLIATION,5
DE,SUICIDE ATTEMPT,5
DE,TINNITUS,5
DE,TREMOR,5
DE,TUNNEL VISION,5
DE,VENOUS THROMBOSIS LIMB,5
DE,WHITE BLOOD CELL COUNT INCREASED,5
DE,ABDOMINAL HERNIA,4
DE,ABDOMINAL PAIN LOWER,4
DE,ABSCESS LIMB,4
DE,ALOPECIA,4
DE,ANXIETY,4
DE,ARTERIAL OCCLUSIVE DISEASE,4
DE,BALANCE DISORDER,4
DE,BASAL CELL CARCINOMA,4
DE,BLOOD PRESSURE DECREASED,4
DE,BLOOD PRESSURE FLUCTUATION,4
DE,BLOOD UREA INCREASED,4
DE,BLOOD URIC ACID INCREASED,4
DE,BREAST ENLARGEMENT,4
DE,CHRONIC KIDNEY DISEASE,4
DE,CLEFT PALATE,4
DE,COGNITIVE DISORDER,4
DE,CONGENITAL CYSTIC LUNG,4
DE,CONTUSION,4
DE,CYTOMEGALOVIRUS INFECTION,4
DE,DELIRIUM,4
DE,DERMATITIS,4
DE,DEVELOPMENTAL HIP DYSPLASIA,4
DE,DISORIENTATION,4
DE,DISSEMINATED INTRAVASCULAR COAGULATION,4
DE,DIVERTICULUM INTESTINAL,4
DE,DRUG DEPENDENCE,4
DE,EPISTAXIS,4
DE,FAECES PALE,4
DE,GASTROENTERITIS CLOSTRIDIAL,4
DE,GASTROINTESTINAL CARCINOMA,4
DE,GASTROINTESTINAL PAIN,4
DE,GENERALISED TONIC-CLONIC SEIZURE,4
DE,GLOMERULAR FILTRATION RATE DECREASED,4
DE,HELLP SYNDROME,4
DE,HEPATIC FUNCTION ABNORMAL,4
DE,HEPATIC NECROSIS,4
DE,HEPATITIS CHOLESTATIC,4
DE,HEPATITIS FULMINANT,4
DE,HEPATITIS TOXIC,4
DE,HEPATOTOXICITY,4
DE,HYPERFERRITINAEMIA,4
DE,HYPERTHYROIDISM,4
DE,HYPOVOLAEMIC SHOCK,4
DE,INCORRECT DOSE ADMINISTERED,4
DE,INFLAMMATORY MARKER INCREASED,4
DE,INTESTINAL STENOSIS,4
DE,IRON DEFICIENCY,4
DE,LABORATORY TEST ABNORMAL,4
DE,LIMB REDUCTION DEFECT,4
DE,LIP SWELLING,4
DE,LIPASE INCREASED,4
DE,LISTLESS,4
DE,LUNG INFECTION,4
DE,MEDICATION ERROR,4
DE,MELAENA,4
DE,MYELODYSPLASTIC SYNDROME,4
DE,OCULAR DISCOMFORT,4
DE,OSTEONECROSIS OF JAW,4
DE,PANIC ATTACK,4
DE,PERICARDITIS,4
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,4
DE,PORTAL FIBROSIS,4
DE,PRESCRIBED UNDERDOSE,4
DE,PROTHROMBIN TIME PROLONGED,4
DE,RENAL FUNCTION TEST ABNORMAL,4
DE,RENAL IMPAIRMENT,4
DE,RENAL INJURY,4
DE,RENAL PAIN,4
DE,RHABDOMYOLYSIS,4
DE,RHINITIS,4
DE,ROTATOR CUFF SYNDROME,4
DE,SHOCK HAEMORRHAGIC,4
DE,STOMATITIS,4
DE,STRESS,4
DE,TACHYARRHYTHMIA,4
DE,TENDON RUPTURE,4
DE,URINARY INCONTINENCE,4
DE,URINARY RETENTION,4
DE,ABSCESS,3
DE,ACUTE MYOCARDIAL INFARCTION,3
DE,AMYLASE INCREASED,3
DE,ANAL FISTULA,3
DE,ANAL HAEMORRHAGE,3
DE,ANAPHYLACTIC SHOCK,3
DE,ARTERIOSCLEROSIS,3
DE,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,3
DE,ATYPICAL FEMUR FRACTURE,3
DE,BIPOLAR DISORDER,3
DE,BREAST CANCER,3
DE,BRONCHOPNEUMONIA,3
DE,BRONCHOSPASM,3
DE,BURSITIS,3
DE,CERVICAL DYSPLASIA,3
DE,CHEST DISCOMFORT,3
DE,CHOLECYSTITIS ACUTE,3
DE,CONGENITAL SKIN DIMPLES,3
DE,CONVULSION,3
DE,CORONARY ARTERY DISEASE,3
DE,CORONARY ARTERY STENOSIS,3
DE,DEAFNESS,3
DE,DEEP VEIN THROMBOSIS,3
DE,DEVICE OCCLUSION,3
DE,DIPLOPIA,3
DE,DISEASE PROGRESSION,3
DE,DIVERTICULUM,3
DE,DRUG ABUSE,3
DE,DRUG LEVEL BELOW THERAPEUTIC,3
DE,DYSARTHRIA,3
DE,DYSSTASIA,3
DE,EMOTIONAL DISTRESS,3
DE,ENCEPHALITIS,3
DE,ENTERITIS,3
DE,FAECALOMA,3
DE,FAECES DISCOLOURED,3
DE,GASTRIC ULCER HAEMORRHAGE,3
DE,GESTATIONAL DIABETES,3
DE,GLAUCOMA,3
DE,GOUT,3
DE,GRANULOCYTOPENIA NEONATAL,3
DE,HAEMARTHROSIS,3
DE,HAEMATOCRIT DECREASED,3
DE,HAEMOLYSIS,3
DE,HEPATIC CIRRHOSIS,3
DE,HISTIOCYTOSIS HAEMATOPHAGIC,3
DE,HYPERBILIRUBINAEMIA NEONATAL,3
DE,HYPERKINESIA,3
DE,HYPOCHROMIC ANAEMIA,3
DE,HYPOPHAGIA,3
DE,INFLUENZA,3
DE,INFUSION RELATED REACTION,3
DE,INTERNATIONAL NORMALISED RATIO INCREASED,3
DE,JUVENILE IDIOPATHIC ARTHRITIS,3
DE,LARGE FOR DATES BABY,3
DE,LEG AMPUTATION,3
DE,LIVER INJURY,3
DE,LYMPHOCYTE COUNT DECREASED,3
DE,LYMPHOCYTE COUNT INCREASED,3
DE,MALIGNANT NEOPLASM PROGRESSION,3
DE,MEMORY IMPAIRMENT,3
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,3
DE,MITRAL VALVE INCOMPETENCE,3
DE,MONOCYTE COUNT INCREASED,3
DE,MOUTH HAEMORRHAGE,3
DE,MUSCULOSKELETAL STIFFNESS,3
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,3
DE,NEUTROPHIL COUNT INCREASED,3
DE,ORAL HERPES,3
DE,OSTEOPOROSIS,3
DE,PALLOR,3
DE,PARESIS,3
DE,PATHOLOGICAL FRACTURE,3
DE,PERIODONTITIS,3
DE,PNEUMONIA BACTERIAL,3
DE,POLYARTHRITIS,3
DE,POOR QUALITY SLEEP,3
DE,POST PROCEDURAL HAEMATOMA,3
DE,PREMATURE RUPTURE OF MEMBRANES,3
DE,PRODUCT USE IN UNAPPROVED INDICATION,3
DE,PRODUCT USE ISSUE,3
DE,PULMONARY CONGESTION,3
DE,PYELONEPHRITIS,3
DE,RASH PRURITIC,3
DE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
DE,RENAL CYST,3
DE,RENAL DISORDER,3
DE,RESPIRATORY TRACT INFECTION,3
DE,ROAD TRAFFIC ACCIDENT,3
DE,SALIVARY GLAND CYST,3
DE,SKIN DISCOLOURATION,3
DE,SKIN FISSURES,3
DE,SKIN ULCER,3
DE,SLOW RESPONSE TO STIMULI,3
DE,SURGERY,3
DE,SWOLLEN TONGUE,3
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,3
DE,TETHERED CORD SYNDROME,3
DE,TOOTH DISORDER,3
DE,URINE OUTPUT DECREASED,3
DE,UROGENITAL INFECTION BACTERIAL,3
DE,UROSEPSIS,3
DE,VASCULITIS,3
DE,WHEEZING,3
DE,WOUND,3
DE,ABDOMINAL ADHESIONS,2
DE,ABDOMINAL WOUND DEHISCENCE,2
DE,ABNORMAL BEHAVIOUR,2
DE,ABORTION SPONTANEOUS INCOMPLETE,2
DE,ACCIDENTAL OVERDOSE,2
DE,ACTINIC KERATOSIS,2
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
DE,ACUTE CORONARY SYNDROME,2
DE,ACUTE HEPATIC FAILURE,2
DE,ACUTE RESPIRATORY FAILURE,2
DE,AGGRESSION,2
DE,AGITATION,2
DE,AKINESIA,2
DE,ALCOHOL ABUSE,2
DE,AMNESIA,2
DE,ANGIOEDEMA,2
DE,ANGIOPLASTY,2
DE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR FOETOPATHY,2
DE,ANTICONVULSANT DRUG LEVEL DECREASED,2
DE,ANXIETY DISORDER,2
DE,AORTIC ANEURYSM,2
DE,AORTIC VALVE SCLEROSIS,2
DE,APATHY,2
DE,APPENDICITIS,2
DE,APPENDICITIS PERFORATED,2
DE,ARTHRITIS,2
DE,ARTHRITIS BACTERIAL,2
DE,ARTHROSCOPY,2
DE,ATAXIA,2
DE,ATYPICAL PNEUMONIA,2
DE,AUTOIMMUNE THYROIDITIS,2
DE,BASAL GANGLIA HAEMORRHAGE,2
DE,BENIGN PROSTATIC HYPERPLASIA,2
DE,BICUSPID AORTIC VALVE,2
DE,BILE DUCT STONE,2
DE,BLADDER HYPERTROPHY,2
DE,BLIGHTED OVUM,2
DE,BLOOD CHOLINESTERASE INCREASED,2
DE,BLOOD CHROMOGRANIN A INCREASED,2
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
DE,BLOOD GLUCOSE FLUCTUATION,2
DE,BLOOD POTASSIUM INCREASED,2
DE,BLOOD TEST ABNORMAL,2
DE,BODY TEMPERATURE INCREASED,2
DE,BREAST ADENOMA,2
DE,BRONCHIAL CARCINOMA,2
DE,BRONCHITIS CHRONIC,2
DE,BRONCHOPULMONARY DYSPLASIA,2
DE,CAESAREAN SECTION,2
DE,CARDIAC FAILURE CONGESTIVE,2
DE,CARDIOGENIC SHOCK,2
DE,CARDIOMYOPATHY,2
DE,CARDIOVASCULAR INSUFFICIENCY,2
DE,CATARACT,2
DE,CHOLECYSTECTOMY,2
DE,COARCTATION OF THE AORTA,2
DE,COLECTOMY,2
DE,COLITIS ISCHAEMIC,2
DE,CONCOMITANT DISEASE PROGRESSION,2
DE,CONCUSSION,2
DE,CONGENITAL ANOMALY,2
DE,CONGENITAL ARTERIOVENOUS FISTULA,2
DE,CONGENITAL MUSCULOSKELETAL ANOMALY,2
DE,CONGENITAL PULMONARY HYPERTENSION,2
DE,CONTRAINDICATED PRODUCT ADMINISTERED,2
DE,CUSHING^S SYNDROME,2
DE,CUTIS LAXA,2
DE,CYST,2
DE,CYTOGENETIC ABNORMALITY,2
DE,DERMATITIS ALLERGIC,2
DE,DEVICE RELATED INFECTION,2
DE,DIARRHOEA HAEMORRHAGIC,2
DE,DISEASE RECURRENCE,2
DE,DRUG DOSE OMISSION,2
DE,DRUG SPECIFIC ANTIBODY,2
DE,DRUG WITHDRAWAL SYNDROME,2
DE,DRY SKIN,2
DE,ECZEMA,2
DE,EMPHYSEMA,2
DE,EOSINOPHILIA,2
DE,EXOSTOSIS,2
DE,FACIAL PARESIS,2
DE,FAECAL VOMITING,2
DE,FAMILIAL MEDITERRANEAN FEVER,2
DE,FEMORAL NECK FRACTURE,2
DE,FLATULENCE,2
DE,FOOT DEFORMITY,2
DE,FRACTURE,2
DE,FREQUENT BOWEL MOVEMENTS,2
DE,GALLBLADDER DISORDER,2
DE,GASTRIC MUCOSA ERYTHEMA,2
DE,GASTRITIS HAEMORRHAGIC,2
DE,GASTROINTESTINAL INFECTION,2
DE,GASTROINTESTINAL VIRAL INFECTION,2
DE,GENERAL PHYSICAL CONDITION ABNORMAL,2
DE,GENERALISED OEDEMA,2
DE,GENITOURINARY TRACT INFECTION,2
DE,GINGIVAL BLEEDING,2
DE,GOITRE,2
DE,HAEMOLYTIC ANAEMIA,2
DE,HAEMOPTYSIS,2
DE,HAEMORRHOIDS,2
DE,HAEMORRHOIDS THROMBOSED,2
DE,HEART RATE IRREGULAR,2
DE,HEPATIC CYST,2
DE,HEPATIC ENCEPHALOPATHY,2
DE,HIATUS HERNIA,2
DE,HIP ARTHROPLASTY,2
DE,HIP FRACTURE,2
DE,HOT FLUSH,2
DE,HYPERAEMIA,2
DE,HYPERAESTHESIA,2
DE,HYPERBILIRUBINAEMIA,2
DE,HYPERCHOLESTEROLAEMIA,2
DE,HYPERLIPIDAEMIA,2
DE,HYPERPLASIA,2
DE,HYPOACUSIS,2
DE,HYPOAESTHESIA EYE,2
DE,HYPOCALCAEMIA,2
DE,HYPOKINESIA,2
DE,HYPOMAGNESAEMIA,2
DE,HYPOTHERMIA NEONATAL,2
DE,HYPOTONIA NEONATAL,2
DE,IDIOPATHIC INTRACRANIAL HYPERTENSION,2
DE,ILEAL STENOSIS,2
DE,IMMUNOSUPPRESSION,2
DE,IMPAIRED GASTRIC EMPTYING,2
DE,INFANTILE APNOEA,2
DE,INFECTIOUS PLEURAL EFFUSION,2
DE,INJECTION SITE INDURATION,2
DE,INJECTION SITE PAIN,2
DE,INTERSTITIAL LUNG DISEASE,2
DE,INTERVERTEBRAL DISC OPERATION,2
DE,INTESTINAL HAEMORRHAGE,2
DE,INTRACRANIAL PRESSURE INCREASED,2
DE,IRRITABILITY,2
DE,ISCHAEMIC STROKE,2
DE,JOINT INJURY,2
DE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
DE,LACERATION,2
DE,LACRIMATION INCREASED,2
DE,LARGE INTESTINAL STENOSIS,2
DE,LARGE INTESTINE PERFORATION,2
DE,LARYNGITIS,2
DE,LEFT VENTRICULAR FAILURE,2
DE,LIMB INJURY,2
DE,LIPID METABOLISM DISORDER,2
DE,LIVE BIRTH,2
DE,LOCALISED INFECTION,2
DE,LOW BIRTH WEIGHT BABY,2
DE,LUMBAR SPINAL STENOSIS,2
DE,LUNG DISORDER,2
DE,LYMPHOCYTE COUNT ABNORMAL,2
DE,LYMPHOEDEMA,2
DE,MALIGNANT MELANOMA IN SITU,2
DE,MEAN CELL HAEMOGLOBIN DECREASED,2
DE,MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION,2
DE,METASTATIC NEOPLASM,2
DE,MICTURITION DISORDER,2
DE,MIGRAINE,2
DE,MOOD SWINGS,2
DE,MOTOR DEVELOPMENTAL DELAY,2
DE,MULTIPLE SCLEROSIS,2
DE,MUSCLE HAEMORRHAGE,2
DE,MUSCULOSKELETAL CHEST PAIN,2
DE,MYELITIS,2
DE,NAIL DISORDER,2
DE,NECROSIS,2
DE,NEOPLASM,2
DE,NEOPLASM PROGRESSION,2
DE,NEPHROLITHIASIS,2
DE,NERVOUS SYSTEM DISORDER,2
DE,NEUROENDOCRINE TUMOUR,2
DE,NEUTROPENIC SEPSIS,2
DE,NEUTROPHIL COUNT DECREASED,2
DE,NIGHT SWEATS,2
DE,NOCTURIA,2
DE,NODULE,2
DE,OESOPHAGEAL CANDIDIASIS,2
DE,OESOPHAGITIS,2
DE,OESOPHAGITIS ULCERATIVE,2
DE,ORAL CANDIDIASIS,2
DE,OROPHARYNGEAL SWELLING,2
DE,OTITIS MEDIA,2
DE,OVARIAN ADHESION,2
DE,OXYGEN SATURATION DECREASED,2
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
DE,PALPITATIONS,2
DE,PARTIAL SEIZURES,2
DE,PERFORMANCE STATUS DECREASED,2
DE,PERIPHERAL SENSORY NEUROPATHY,2
DE,PERSISTENT FOETAL CIRCULATION,2
DE,PERSONALITY CHANGE,2
DE,PILONIDAL CYST,2
DE,PLASMA CELL MYELOMA,2
DE,PLATELET COUNT INCREASED,2
DE,PNEUMONITIS,2
DE,POLYNEUROPATHY,2
DE,PREMATURE DELIVERY,2
DE,PROCEDURAL PAIN,2
DE,PROSTATE CANCER,2
DE,PULMONARY HYPOPLASIA,2
DE,RENAL COLIC,2
DE,RESPIRATORY ARREST,2
DE,RESPIRATORY DISORDER,2
DE,RESTLESS LEGS SYNDROME,2
DE,RHEUMATOID LUNG,2
DE,SECOND PRIMARY MALIGNANCY,2
DE,SENSORY DISTURBANCE,2
DE,SHOCK SYMPTOM,2
DE,SKIN BURNING SENSATION,2
DE,SOPOR,2
DE,SPLENIC INFARCTION,2
DE,SQUAMOUS CELL CARCINOMA OF SKIN,2
DE,SUBILEUS,2
DE,SUBSTANCE ABUSE,2
DE,SUICIDAL IDEATION,2
DE,SUPERINFECTION BACTERIAL,2
DE,SWELLING,2
DE,SYNOVITIS,2
DE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
DE,TENDON DISORDER,2
DE,TENOSYNOVITIS,2
DE,THORACIC VERTEBRAL FRACTURE,2
DE,THROAT IRRITATION,2
DE,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
DE,THYROID FUNCTION TEST ABNORMAL,2
DE,THYROID MASS,2
DE,TONGUE ULCERATION,2
DE,TONSILLITIS,2
DE,TOOTHACHE,2
DE,TREATMENT FAILURE,2
DE,TYPE 1 DIABETES MELLITUS,2
DE,UNDERDOSE,2
DE,VAGINAL DISCHARGE,2
DE,VARICELLA ZOSTER GASTRITIS,2
DE,VENTRICULAR FIBRILLATION,2
DE,VENTRICULAR HYPOKINESIA,2
DE,VERTIGO POSITIONAL,2
DE,VISUAL FIELD DEFECT,2
DE,WOUND INFECTION,2
DE,ABASIA,1
DE,ABDOMINAL LYMPHADENOPATHY,1
DE,ABORTION SPONTANEOUS,1
DE,ACCIDENT,1
DE,ACCIDENTAL POISONING,1
DE,ACCOMMODATION DISORDER,1
DE,ACINETOBACTER INFECTION,1
DE,ACNE,1
DE,ACTINOMYCOSIS,1
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,1
DE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
DE,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
DE,ACUTE GRAFT VERSUS HOST DISEASE,1
DE,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
DE,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
DE,ACUTE LYMPHOCYTIC LEUKAEMIA,1
DE,ACUTE MYELOID LEUKAEMIA RECURRENT,1
DE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
DE,ADENOCARCINOMA OF COLON,1
DE,ADENOCARCINOMA PANCREAS,1
DE,ADRENAL INSUFFICIENCY,1
DE,ADVERSE DRUG REACTION,1
DE,AFFECT LABILITY,1
DE,AGEUSIA,1
DE,ALPHA 1 GLOBULIN INCREASED,1
DE,ALPHA 2 GLOBULIN INCREASED,1
DE,ALTERED STATE OF CONSCIOUSNESS,1
DE,ALVEOLITIS,1
DE,ALVEOLITIS ALLERGIC,1
DE,ANAL INCONTINENCE,1
DE,ANASTOMOTIC ULCER,1
DE,ANGIOPATHY,1
DE,ANTI-THYROID ANTIBODY POSITIVE,1
DE,ANTINUCLEAR ANTIBODY INCREASED,1
DE,ANURIA,1
DE,AORTIC ARTERIOSCLEROSIS,1
DE,AORTIC STENOSIS,1
DE,AORTIC VALVE DISEASE MIXED,1
DE,AORTIC VALVE STENOSIS,1
DE,APHTHOUS STOMATITIS,1
DE,APNOEA,1
DE,APNOEA NEONATAL,1
DE,APPARENT DEATH,1
DE,APPENDICECTOMY,1
DE,APPLICATION SITE REACTION,1
DE,APRAXIA,1
DE,ARRHYTHMIA NEONATAL,1
DE,ARTERIAL RUPTURE,1
DE,ARTERIOSCLEROSIS CORONARY ARTERY,1
DE,ARTERITIS,1
DE,ARTHRODESIS,1
DE,ARTHROPOD STING,1
DE,ASPERGILLUS INFECTION,1
DE,ASPIRATION,1
DE,ASTERIXIS,1
DE,ASTROCYTOMA,1
DE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
DE,AUTOIMMUNE HEPATITIS,1
DE,AVULSION FRACTURE,1
DE,BACTERIAL ABDOMINAL INFECTION,1
DE,BASAL GANGLIA INFARCTION,1
DE,BASEDOW^S DISEASE,1
DE,BASOPHIL COUNT ABNORMAL,1
DE,BENIGN INTRACRANIAL HYPERTENSION,1
DE,BENIGN NEOPLASM,1
DE,BENIGN NEOPLASM OF ADRENAL GLAND,1
DE,BENIGN SALIVARY GLAND NEOPLASM,1
DE,BICYTOPENIA,1
DE,BILIARY DILATATION,1
DE,BIOPSY LIVER,1
DE,BLADDER DISORDER,1
DE,BLADDER DYSFUNCTION,1
DE,BLADDER PAIN,1
DE,BLADDER SPASM,1
DE,BLINDNESS,1
DE,BLISTER,1
DE,BLOOD CREATINE INCREASED,1
DE,BLOOD CREATININE ABNORMAL,1
DE,BLOOD GASTRIN INCREASED,1
DE,BLOOD GLUCOSE DECREASED,1
DE,BLOOD IMMUNOGLOBULIN A DECREASED,1
DE,BLOOD IMMUNOGLOBULIN E INCREASED,1
DE,BLOOD IMMUNOGLOBULIN G DECREASED,1
DE,BLOOD IRON DECREASED,1
DE,BLOOD LACTIC ACID INCREASED,1
DE,BLOOD MAGNESIUM DECREASED,1
DE,BLOOD PRESSURE ABNORMAL,1
DE,BLOOD THROMBOPLASTIN DECREASED,1
DE,BLOOD THYROID STIMULATING HORMONE DECREASED,1
DE,BLOOD UREA DECREASED,1
DE,BLOOD URINE PRESENT,1
DE,BONE DEFORMITY,1
DE,BONE DISORDER,1
DE,BONE FISTULA,1
DE,BONE GRAFT,1
DE,BONE LOSS,1
DE,BONE SWELLING,1
DE,BORDERLINE PERSONALITY DISORDER,1
DE,BOWEN^S DISEASE,1
DE,BRADYARRHYTHMIA,1
DE,BRADYCARDIA,1
DE,BRAIN HERNIATION,1
DE,BRAIN NEOPLASM,1
DE,BRAIN STEM STROKE,1
DE,BREAST CANCER FEMALE,1
DE,BREAST CANCER METASTATIC,1
DE,BREAST DISCOMFORT,1
DE,BREAST DISORDER,1
DE,BRONCHITIS BACTERIAL,1
DE,BURNING SENSATION,1
DE,BURNOUT SYNDROME,1
DE,CACHEXIA,1
DE,CALCINOSIS,1
DE,CALCIPHYLAXIS,1
DE,CALCIUM DEFICIENCY,1
DE,CAMPYLOBACTER INFECTION,1
DE,CARCINOMA IN SITU OF PENIS,1
DE,CARDIAC ABLATION,1
DE,CARDIAC FAILURE CHRONIC,1
DE,CARDIAC TAMPONADE,1
DE,CARDIAC VALVE DISEASE,1
DE,CARDIOPULMONARY FAILURE,1
DE,CAROTID SINUS SYNDROME,1
DE,CARTILAGE INJURY,1
DE,CATARACT OPERATION,1
DE,CATARACT OPERATION COMPLICATION,1
DE,CATHETER SITE DISCHARGE,1
DE,CATHETER SITE INFECTION,1
DE,CATHETER SITE INFLAMMATION,1
DE,CATHETERISATION CARDIAC,1
DE,CELL-MEDIATED IMMUNE DEFICIENCY,1
DE,CENTRAL NERVOUS SYSTEM INFECTION,1
DE,CENTRAL NERVOUS SYSTEM INFLAMMATION,1
DE,CENTRAL NERVOUS SYSTEM LESION,1
DE,CEREBRAL ARTERY EMBOLISM,1
DE,CEREBRAL ARTERY OCCLUSION,1
DE,CERVICAL VERTEBRAL FRACTURE,1
DE,CERVIX CARCINOMA STAGE 0,1
DE,CHOLANGIOLITIS,1
DE,CHONDROPATHY,1
DE,CHRONIC GASTRITIS,1
DE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
DE,CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS,1
DE,CHRONIC TONSILLITIS,1
DE,CIRCUMCISION,1
DE,CLAVICLE FRACTURE,1
DE,CLEAR CELL RENAL CELL CARCINOMA,1
DE,CLEFT LIP AND PALATE,1
DE,COAGULATION FACTOR DECREASED,1
DE,COLITIS MICROSCOPIC,1
DE,COLON ADENOMA,1
DE,COLON CANCER METASTATIC,1
DE,COLON NEOPLASM,1
DE,COLONOSCOPY,1
DE,COLOSTOMY,1
DE,COLOSTOMY CLOSURE,1
DE,COMA SCALE ABNORMAL,1
DE,COMPARTMENT SYNDROME,1
DE,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
DE,CONCOMITANT DISEASE AGGRAVATED,1
DE,CONTRAST MEDIA ALLERGY,1
DE,COORDINATION ABNORMAL,1
DE,CORONARY ARTERY EMBOLISM,1
DE,CREPITATIONS,1
DE,CSF CELL COUNT INCREASED,1
DE,CUSHINGOID,1
DE,CUTANEOUS LUPUS ERYTHEMATOSUS,1
DE,CYANOSIS,1
DE,CYSTIC LYMPHANGIOMA,1
DE,CYSTITIS NONINFECTIVE,1
DE,DAYDREAMING,1
DE,DEAFNESS UNILATERAL,1
DE,DECREASED EYE CONTACT,1
DE,DECREASED IMMUNE RESPONSIVENESS,1
DE,DECREASED INTEREST,1
DE,DECUBITUS ULCER,1
DE,DEEP VEIN THROMBOSIS POSTOPERATIVE,1
DE,DEFAECATION URGENCY,1
DE,DEMENTIA,1
DE,DEMENTIA ALZHEIMER^S TYPE,1
DE,DENTAL CARIES,1
DE,DENTAL OPERATION,1
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
DE,DEPRESSION SUICIDAL,1
DE,DERMAL CYST,1
DE,DERMATITIS PSORIASIFORM,1
DE,DEVICE RELATED SEPSIS,1
DE,DIABETES MELLITUS INADEQUATE CONTROL,1
DE,DIABETIC FOOT,1
DE,DIABETIC NEUROPATHY,1
DE,DIASTOLIC DYSFUNCTION,1
DE,DISABILITY,1
DE,DISSOCIATIVE DISORDER,1
DE,DIVERTICULAR PERFORATION,1
DE,DRUG ADMINISTRATION ERROR,1
DE,DRUG ERUPTION,1
DE,DRUG HYPERSENSITIVITY,1
DE,DRUG PRESCRIBING ERROR,1
DE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
DE,DRUG SPECIFIC ANTIBODY PRESENT,1
DE,DRUG USE DISORDER,1
DE,DRUG WITHDRAWAL SYNDROME NEONATAL,1
DE,DRY THROAT,1
DE,DUODENAL PERFORATION,1
DE,DUPUYTREN^S CONTRACTURE,1
DE,DYSKINESIA,1
DE,DYSPHONIA,1
DE,DYSPNOEA AT REST,1
DE,DYSURIA,1
DE,EAR DISCOMFORT,1
DE,ECZEMA HERPETICUM,1
DE,ECZEMA WEEPING,1
DE,EJECTION FRACTION DECREASED,1
DE,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
DE,EMBOLIC CEREBRAL INFARCTION,1
DE,EMBOLIC STROKE,1
DE,EMBOLISM ARTERIAL,1
DE,EMPYEMA,1
DE,ENDOCRINE NEOPLASM,1
DE,ENDOCRINE OPHTHALMOPATHY,1
DE,ENURESIS,1
DE,EPIDIDYMECTOMY,1
DE,EPIDIDYMITIS,1
DE,EPIGLOTTIC CYST,1
DE,EPSTEIN-BARR VIRUS INFECTION,1
DE,ERECTILE DYSFUNCTION,1
DE,EROSIVE DUODENITIS,1
DE,EROSIVE OESOPHAGITIS,1
DE,ERYTHEMA MULTIFORME,1
DE,EUPHORIC MOOD,1
DE,EXCESSIVE CERUMEN PRODUCTION,1
DE,EXFOLIATIVE RASH,1
DE,EXTRASYSTOLES,1
DE,EXTRAVASATION,1
DE,EYE HAEMORRHAGE,1
DE,EYE INFLAMMATION,1
DE,EYE OEDEMA,1
DE,EYE PAIN,1
DE,EYE PRURITUS,1
DE,EYELID PTOSIS,1
DE,FACIAL PAIN,1
DE,FACIAL PARALYSIS,1
DE,FACTOR V LEIDEN MUTATION,1
DE,FAECAL INCONTINENCE,1
DE,FAECAL VOLUME INCREASED,1
DE,FEBRILE INFECTION,1
DE,FEELING COLD,1
DE,FEELING DRUNK,1
DE,FELTY^S SYNDROME,1
DE,FEMALE GENITAL TRACT FISTULA,1
DE,FIBRIN D DIMER INCREASED,1
DE,FIXED BOWEL LOOP,1
DE,FLUID INTAKE REDUCED,1
DE,FLUID RETENTION,1
DE,FOETAL MALPOSITION,1
DE,FOOD INTOLERANCE,1
DE,FOOT FRACTURE,1
DE,FOREIGN BODY SENSATION IN EYES,1
DE,FULL BLOOD COUNT ABNORMAL,1
DE,FUNGAL INFECTION,1
DE,FUNGAL OESOPHAGITIS,1
DE,FURUNCLE,1
DE,GALLBLADDER OPERATION,1
DE,GALLBLADDER POLYP,1
DE,GANGRENE,1
DE,GASTRIC HAEMORRHAGE,1
DE,GASTRIC NEOPLASM,1
DE,GASTRIC POLYPS,1
DE,GASTRITIS EROSIVE,1
DE,GASTRITIS VIRAL,1
DE,GASTROENTERITIS ENTEROVIRAL,1
DE,GASTROENTERITIS EOSINOPHILIC,1
DE,GASTROENTERITIS NOROVIRUS,1
DE,GASTROENTERITIS YERSINIA,1
DE,GASTROINTESTINAL BACTERIAL INFECTION,1
DE,GASTROINTESTINAL NECROSIS,1
DE,GASTROINTESTINAL NEOPLASM,1
DE,GASTROINTESTINAL PERFORATION,1
DE,GASTROINTESTINAL SUBMUCOSAL TUMOUR,1
DE,GASTROINTESTINAL TELANGIECTASIA,1
DE,GASTROINTESTINAL ULCER,1
DE,GENE MUTATION,1
DE,GENERAL PHYSICAL CONDITION,1
DE,GENITAL HERPES ZOSTER,1
DE,GINGIVAL DISORDER,1
DE,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,1
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
DE,GRAFT VERSUS HOST DISEASE IN EYE,1
DE,GRAFT VERSUS HOST DISEASE IN LUNG,1
DE,GRAFT VERSUS HOST DISEASE IN SKIN,1
DE,GRANULOMATOSIS WITH POLYANGIITIS,1
DE,HAEMANGIOMA CONGENITAL,1
DE,HAEMATEMESIS,1
DE,HAEMOGLOBIN INCREASED,1
DE,HAEMOLYTIC URAEMIC SYNDROME,1
DE,HAEMOPHILIA,1
DE,HAEMORRHAGIC DIATHESIS,1
DE,HAEMORRHOIDAL HAEMORRHAGE,1
DE,HALLUCINATION,1
DE,HEAD DISCOMFORT,1
DE,HEARING IMPAIRED,1
DE,HEART RATE ABNORMAL,1
DE,HEART RATE DECREASED,1
DE,HEART RATE INCREASED,1
DE,HEPARIN-INDUCED THROMBOCYTOPENIA,1
DE,HEPATIC ECHINOCOCCIASIS,1
GH,DRUG INEFFECTIVE,1
GH,MALARIA,1
GR,SEPTIC SHOCK,9
GR,PYREXIA,8
GR,ANAEMIA,5
GR,SEROTONIN SYNDROME,5
GR,DRUG-INDUCED LIVER INJURY,4
GR,FEBRILE NEUTROPENIA,4
GR,PNEUMONITIS,4
GR,PULMONARY OEDEMA,4
GR,RESPIRATORY TRACT INFECTION,4
GR,ASTHENIA,3
GR,CARDIAC ARREST,3
GR,DECREASED APPETITE,3
GR,LOWER RESPIRATORY TRACT INFECTION,3
GR,MALIGNANT NEOPLASM PROGRESSION,3
GR,METASTASES TO BONE,3
GR,METASTASES TO LIVER,3
GR,MYDRIASIS,3
GR,NEUTROPENIA,3
GR,RASH,3
GR,RESPIRATORY FAILURE,3
GR,THROMBOCYTOPENIA,3
GR,TOXICITY TO VARIOUS AGENTS,3
GR,ARRHYTHMIA,2
GR,ATRIAL FIBRILLATION,2
GR,BACK PAIN,2
GR,BACTERAEMIA,2
GR,BLOOD CREATININE ABNORMAL,2
GR,BLOOD CREATININE INCREASED,2
GR,CONSTIPATION,2
GR,COUGH,2
GR,DEATH,2
GR,DEPRESSED LEVEL OF CONSCIOUSNESS,2
GR,DIARRHOEA,2
GR,DISEASE PROGRESSION,2
GR,ENTEROVESICAL FISTULA,2
GR,FATIGUE,2
GR,HAEMATOCRIT DECREASED,2
GR,HAEMOPTYSIS,2
GR,HYPERSENSITIVITY,2
GR,INFECTION,2
GR,MULTI-ORGAN FAILURE,2
GR,PNEUMONIA,2
GR,PROSTATE CANCER,2
GR,RENAL FAILURE ACUTE,2
GR,ABDOMINAL PAIN,1
GR,ABDOMINAL PAIN UPPER,1
GR,ALLERGIC  EPISODE,1
GR,ALLERGIC EPISODE,1
GR,ANGINA PECTORIS,1
GR,ARTHRITIS INFECTIVE,1
GR,AUTOIMMUNE COLITIS,1
GR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
GR,AUTOIMMUNE MYOCARDITIS,1
GR,BREAST CANCER,1
GR,BREAST CANCER METASTATIC,1
GR,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
GR,CEREBROVASCULAR ACCIDENT,1
GR,COGNITIVE DISORDER,1
GR,COLOSTOMY,1
GR,COMA,1
GR,CSF CELL COUNT ABNORMAL,1
GR,CYST,1
GR,CYSTITIS,1
GR,CYTOMEGALOVIRUS COLITIS,1
GR,DELIRIUM,1
GR,DERMATITIS ALLERGIC,1
GR,DISEASE RECURRENCE,1
GR,DIVERTICULAR PERFORATION,1
GR,DRUG EFFECT DECREASED,1
GR,DRUG RESISTANCE,1
GR,DYSARTHRIA,1
GR,DYSKINESIA,1
GR,DYSPHAGIA,1
GR,DYSPNOEA,1
GR,ENTERITIS,1
GR,EOSINOPHILIA,1
GR,ERYTHEMA,1
GR,ERYTHEMA NODOSUM,1
GR,FALL,1
GR,FEMUR FRACTURE,1
GR,FISTULA,1
GR,GASTRIC MUCOSAL HYPERTROPHY,1
GR,HAEMANGIOMA,1
GR,HAEMATOCHEZIA,1
GR,HAEMODYNAMIC INSTABILITY,1
GR,HAEMOGLOBIN DECREASED,1
GR,HAEMOLYSIS,1
GR,HAEMORRHAGE,1
GR,HALLUCINATION,1
GR,HEPATOMEGALY,1
GR,HIP FRACTURE,1
GR,HYPERTRANSAMINASAEMIA,1
GR,HYPOKALAEMIA,1
GR,HYPOMAGNESAEMIA,1
GR,HYPOPHAGIA,1
GR,HYPOVOLAEMIC SHOCK,1
GR,ILEUS,1
GR,INJECTION SITE PRURITUS,1
GR,ISCHAEMIC STROKE,1
GR,KERATINISING SQUAMOUS CELL CARCINOMA OF NASOPHARYNX,1
GR,LARGE INTESTINAL HAEMORRHAGE,1
GR,LIVER DISORDER,1
GR,LOSS OF CONSCIOUSNESS,1
GR,LUNG ABSCESS,1
GR,LUNG INFECTION,1
GR,LYMPHOPENIA,1
GR,MALIGNANT MELANOMA IN SITU,1
GR,METASTASES TO CENTRAL NERVOUS SYSTEM,1
GR,METASTASES TO LUNG,1
GR,METASTASES TO LYMPH NODES,1
GR,MUSCLE SPASMS,1
GR,MYELODYSPLASTIC SYNDROME,1
GR,MYOCARDIAL ISCHAEMIA,1
GR,NASAL CAVITY CANCER,1
GR,NEUROLOGICAL DECOMPENSATION,1
GR,NEUTROPHIL COUNT INCREASED,1
GR,NO THERAPEUTIC RESPONSE,1
GR,NON-HODGKIN^S LYMPHOMA,1
GR,OEDEMA PERIPHERAL,1
GR,ORAL FUNGAL INFECTION,1
GR,PALLOR,1
GR,PANCYTOPENIA,1
GR,PERICARDIAL EFFUSION,1
GR,PLASMA CELL MYELOMA,1
GR,PLEURAL EFFUSION,1
GR,PRODUCT USE ISSUE,1
GR,PROTHROMBIN TIME PROLONGED,1
GR,PRURITUS,1
GR,RASH MACULO-PAPULAR,1
GR,RECTAL PERFORATION,1
GR,RED MAN SYNDROME,1
GR,RENAL IMPAIRMENT,1
GR,RENAL TUBULAR NECROSIS,1
GR,RESPIRATORY DISTRESS,1
GR,SEPSIS,1
GR,SKIN INFECTION,1
GR,SPINAL DISORDER,1
GR,SQUAMOUS CELL CARCINOMA OF THE CERVIX,1
GR,SQUAMOUS CELL CARCINOMA OF THE VAGINA,1
GR,SURGERY,1
GR,THERAPEUTIC RESPONSE DECREASED,1
GR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
GR,VASCULAR STENT THROMBOSIS,1
GR,VERTIGO,1
GR,VOMITING,1
GR,WEIGHT DECREASED,1
GR,WHEEZING,1
GN,INTENTIONAL PRODUCT USE ISSUE,2
GN,RESPIRATORY DISTRESS,2
GN,CARDIO-RESPIRATORY ARREST,1
GN,EBOLA DISEASE,1
GN,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
GN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
GN,OVERDOSE,1
HT,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
HT,DECREASED APPETITE,1
HT,DRUG DOSE OMISSION,1
HT,HERBAL INTERACTION,1
HT,INTERNATIONAL NORMALISED RATIO INCREASED,1
HN,CARDIAC FAILURE CHRONIC,1
HN,DYSPNOEA EXERTIONAL,1
HN,GENERALISED OEDEMA,1
HN,OEDEMA PERIPHERAL,1
HN,ORTHOPNOEA,1
HN,WEIGHT INCREASED,1
HK,CONSTIPATION,4
HK,RETINOPATHY,3
HK,BLINDNESS,2
HK,EYE HAEMORRHAGE,1
HK,RETINAL HAEMORRHAGE,1
HK,RETINOPATHY HAEMORRHAGIC,1
HK,VISUAL FIELD DEFECT,1
HU,LICHEN PLANUS,2
HU,RASH,2
HU,SKIN EXFOLIATION,2
HU,ANAEMIA,1
HU,ATRIAL FIBRILLATION,1
HU,BONE MARROW FAILURE,1
HU,HAEMOGLOBIN DECREASED,1
HU,HAEMORRHAGE,1
HU,NAUSEA,1
HU,PANCYTOPENIA,1
HU,PERITONITIS,1
HU,PNEUMONIA,1
HU,PYREXIA,1
HU,SEPSIS,1
HU,STAPHYLOCOCCAL SEPSIS,1
IN,VOMITING,8
IN,DEATH,6
IN,SUICIDE ATTEMPT,6
IN,BRADYCARDIA,5
IN,ELECTROCARDIOGRAM QT PROLONGED,5
IN,LOSS OF CONSCIOUSNESS,5
IN,TACHYCARDIA,5
IN,ACUTE KIDNEY INJURY,4
IN,CIRCULATORY COLLAPSE,4
IN,FALL,4
IN,ANAEMIA,3
IN,HICCUPS,3
IN,INTENTIONAL OVERDOSE,3
IN,OVERDOSE,3
IN,URTICARIA,3
IN,ABDOMINAL DISTENSION,2
IN,ANAPHYLACTIC SHOCK,2
IN,BLOOD CHLORIDE DECREASED,2
IN,BLOOD SODIUM DECREASED,2
IN,DEEP VEIN THROMBOSIS,2
IN,DIARRHOEA,2
IN,DYSPNOEA,2
IN,ELECTROCARDIOGRAM T WAVE ABNORMAL,2
IN,HAEMORRHAGE,2
IN,LIPASE INCREASED,2
IN,PANCREATITIS ACUTE,2
IN,ACUTE RESPIRATORY DISTRESS SYNDROME,1
IN,AMYLASE INCREASED,1
IN,ANXIETY,1
IN,ASTHMA,1
IN,BLOOD ALBUMIN DECREASED,1
IN,BLOOD PRESSURE INCREASED,1
IN,CATHETER SITE DISCHARGE,1
IN,CHEST PAIN,1
IN,COUGH,1
IN,CYTOMEGALOVIRUS CHORIORETINITIS,1
IN,DEATH NEONATAL,1
IN,DENGUE FEVER,1
IN,DIPLOPIA,1
IN,DIZZINESS,1
IN,DRUG HYPERSENSITIVITY,1
IN,DRUG INEFFECTIVE,1
IN,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
IN,EXTRAPULMONARY TUBERCULOSIS,1
IN,FAECES DISCOLOURED,1
IN,GAIT DISTURBANCE,1
IN,GALACTORRHOEA,1
IN,GASTRITIS,1
IN,GASTROINTESTINAL DISORDER,1
IN,GASTROINTESTINAL INJURY,1
IN,GASTROINTESTINAL PAIN,1
IN,GENERAL PHYSICAL HEALTH DETERIORATION,1
IN,HEAD INJURY,1
IN,HEPATIC ENCEPHALOPATHY,1
IN,HEPATITIS,1
IN,HERNIA,1
IN,HIP FRACTURE,1
IN,HIV PERIPHERAL NEUROPATHY,1
IN,HYPOKALAEMIA,1
IN,HYPOMAGNESAEMIA,1
IN,INFECTION,1
IN,INTENTIONAL SELF-INJURY,1
IN,KIDNEY ENLARGEMENT,1
IN,LEFT VENTRICULAR DYSFUNCTION,1
IN,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
IN,LOWER RESPIRATORY TRACT INFECTION,1
IN,MATERNAL EXPOSURE DURING PREGNANCY,1
IN,MULTI-ORGAN FAILURE,1
IN,OLIGURIA,1
IN,PAIN OF SKIN,1
IN,PALPITATIONS,1
IN,PHARMACOPHOBIA,1
IN,PHOBIA,1
IN,POST PROCEDURAL DISCHARGE,1
IN,PRODUCT USE ISSUE,1
IN,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
IN,PROTEINURIA,1
IN,PULMONARY EMBOLISM,1
IN,PULMONARY TUBERCULOSIS,1
IN,PYREXIA,1
IN,RENAL FAILURE,1
IN,SEPTIC SHOCK,1
IN,SINUS TACHYCARDIA,1
IN,SLEEP DISORDER,1
IN,SOMNOLENCE,1
IN,STEVENS-JOHNSON SYNDROME,1
IN,SUBDURAL HAEMATOMA,1
IN,SYNCOPE,1
IN,TOOTH FRACTURE,1
IN,TOXIC EPIDERMAL NECROLYSIS,1
IN,TUBERCULOSIS,1
IN,TUBULOINTERSTITIAL NEPHRITIS,1
IN,VIRAL INFECTION,1
IN,VIROLOGIC FAILURE,1
IN,VISION BLURRED,1
IN,VULVAL CELLULITIS,1
ID,ACUTE CORONARY SYNDROME,1
ID,ACUTE HEPATIC FAILURE,1
ID,HEPATITIS B,1
ID,HEPATITIS FULMINANT,1
ID,PERITONEAL DISORDER,1
ID,WHEEZING,1
IR,STRONGYLOIDIASIS,5
IR,ABDOMINAL DISTENSION,2
IR,ABDOMINAL PAIN,1
IR,ALANINE AMINOTRANSFERASE INCREASED,1
IR,AMYLASE INCREASED,1
IR,ASPARTATE AMINOTRANSFERASE INCREASED,1
IR,BLOOD ALBUMIN DECREASED,1
IR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IR,BLOOD CORTISOL INCREASED,1
IR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IR,BLOOD POTASSIUM DECREASED,1
IR,BLOOD SODIUM DECREASED,1
IR,C-REACTIVE PROTEIN INCREASED,1
IR,CONSTIPATION,1
IR,DEATH,1
IR,DECREASED APPETITE,1
IR,DIARRHOEA,1
IR,DYSGEUSIA,1
IR,DYSPNOEA,1
IR,GASTRITIS EROSIVE,1
IR,HAEMATEMESIS,1
IR,HEADACHE,1
IR,HEART RATE INCREASED,1
IR,HYPERAESTHESIA,1
IR,HYPOTHERMIA,1
IR,LIPASE INCREASED,1
IR,LOCALISED OEDEMA,1
IR,NAUSEA,1
IR,NEURALGIA,1
IR,PRODUCT SUBSTITUTION ISSUE,1
IR,RESPIRATORY ALKALOSIS,1
IR,RESPIRATORY RATE DECREASED,1
IR,SKIN EXFOLIATION,1
IR,VOMITING,1
IR,WEIGHT DECREASED,1
IQ,NAUSEA,2
IQ,RASH,2
IQ,ANAEMIA,1
IQ,ANXIETY,1
IQ,BLOOD BILIRUBIN INCREASED,1
IQ,BREAST HAEMORRHAGE,1
IQ,CHEST X-RAY ABNORMAL,1
IQ,COUGH,1
IQ,DANDRUFF,1
IQ,DYSPNOEA,1
IQ,FATIGUE,1
IQ,HEPATIC ENZYME INCREASED,1
IQ,HYPERGLYCAEMIA,1
IQ,HYPERSENSITIVITY,1
IQ,INFLUENZA,1
IQ,INFUSION RELATED REACTION,1
IQ,INTERSTITIAL LUNG DISEASE,1
IQ,PRURITUS,1
IQ,PYREXIA,1
IQ,RASH ERYTHEMATOUS,1
IQ,RESPIRATORY DISTRESS,1
IQ,SKIN DISORDER,1
IQ,TACHYCARDIA,1
IQ,THROMBOCYTOPENIA,1
IQ,VISION BLURRED,1
IE,LOWER RESPIRATORY TRACT INFECTION,17
IE,DEATH,13
IE,DYSPNOEA,11
IE,COUGH,10
IE,URINARY TRACT INFECTION,10
IE,DIARRHOEA,9
IE,DRUG INEFFECTIVE,9
IE,HEADACHE,9
IE,NAUSEA,9
IE,VOMITING,9
IE,WHITE BLOOD CELL COUNT INCREASED,9
IE,FATIGUE,8
IE,ARTHRALGIA,7
IE,BACK PAIN,7
IE,FACIAL PARALYSIS,7
IE,NEUTROPHIL COUNT INCREASED,7
IE,ABDOMINAL PAIN,6
IE,ASTHENIA,6
IE,C-REACTIVE PROTEIN INCREASED,6
IE,CONSTIPATION,6
IE,INFECTION,6
IE,MALAISE,6
IE,PRODUCT USE ISSUE,6
IE,PYREXIA,6
IE,ASCITES,5
IE,CELLULITIS,5
IE,FALL,5
IE,PNEUMONIA,5
IE,SEPSIS,5
IE,VIRAL INFECTION,5
IE,ACUTE KIDNEY INJURY,4
IE,ERYTHEMA,4
IE,HAEMOGLOBIN DECREASED,4
IE,HYPOAESTHESIA,4
IE,HYPOTENSION,4
IE,KIDNEY INFECTION,4
IE,NEUTROPHIL COUNT DECREASED,4
IE,PAIN,4
IE,PALLOR,4
IE,PULMONARY EMBOLISM,4
IE,WHEEZING,4
IE,BLOOD GLUCOSE INCREASED,3
IE,CHEST PAIN,3
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
IE,CONDITION AGGRAVATED,3
IE,DECREASED APPETITE,3
IE,DRUG DOSE OMISSION,3
IE,DYSKINESIA,3
IE,ENCEPHALOPATHY,3
IE,GASTRITIS,3
IE,GASTROINTESTINAL HAEMORRHAGE,3
IE,HAEMATURIA,3
IE,HYPERHIDROSIS,3
IE,HYPERTENSION,3
IE,HYPOCALCAEMIA,3
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
IE,ORTHOSTATIC HYPOTENSION,3
IE,PLATELET COUNT DECREASED,3
IE,PNEUMONIA ASPIRATION,3
IE,RESPIRATORY RATE INCREASED,3
IE,RESPIRATORY TRACT CONGESTION,3
IE,RESPIRATORY TRACT INFECTION,3
IE,SWELLING,3
IE,SYNCOPE,3
IE,TRANSIENT ISCHAEMIC ATTACK,3
IE,TYPE 2 DIABETES MELLITUS,3
IE,UPPER RESPIRATORY TRACT INFECTION,3
IE,ABDOMINAL PAIN UPPER,2
IE,ANAPHYLACTIC REACTION,2
IE,ARRHYTHMIA,2
IE,ATRIAL FIBRILLATION,2
IE,AXILLARY LYMPHADENECTOMY,2
IE,BLOOD CREATININE INCREASED,2
IE,BLOOD SODIUM DECREASED,2
IE,BODY TEMPERATURE INCREASED,2
IE,BONE PAIN,2
IE,BRONCHIOLITIS,2
IE,CARDIAC DISORDER,2
IE,CARDIAC FAILURE CONGESTIVE,2
IE,CEREBELLAR HAEMORRHAGE,2
IE,CHEST DISCOMFORT,2
IE,CIRCULATORY COLLAPSE,2
IE,COGNITIVE DISORDER,2
IE,CONFUSIONAL STATE,2
IE,CROHN^S DISEASE,2
IE,CYANOSIS,2
IE,DEEP VEIN THROMBOSIS,2
IE,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,2
IE,DIVERTICULITIS,2
IE,DYSPHAGIA,2
IE,EYE PAIN,2
IE,GENERAL PHYSICAL HEALTH DETERIORATION,2
IE,HAEMOGLOBIN ABNORMAL,2
IE,HAEMORRHAGE,2
IE,HEAD INJURY,2
IE,HEPATITIS C,2
IE,HERPES ZOSTER,2
IE,HYDROCEPHALUS,2
IE,HYPOKALAEMIA,2
IE,HYPOMAGNESAEMIA,2
IE,HYPONATRAEMIA,2
IE,IMMUNE SYSTEM DISORDER,2
IE,INVASIVE DUCTAL BREAST CARCINOMA,2
IE,LOWER RESPIRATORY TRACT INFECTION VIRAL,2
IE,LUNG CONSOLIDATION,2
IE,MASTECTOMY,2
IE,MOBILITY DECREASED,2
IE,MUSCLE SPASMS,2
IE,MUSCULAR WEAKNESS,2
IE,OEDEMA PERIPHERAL,2
IE,OROPHARYNGEAL PAIN,2
IE,PANCREATIC CARCINOMA,2
IE,PARKINSON^S DISEASE,2
IE,PHARYNGITIS,2
IE,POLLAKIURIA,2
IE,PRODUCT USE IN UNAPPROVED INDICATION,2
IE,PULMONARY CONGESTION,2
IE,PULMONARY HYPERTENSION,2
IE,RASH,2
IE,RASH MACULAR,2
IE,RENAL FAILURE,2
IE,RENAL IMPAIRMENT,2
IE,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,2
IE,SKIN INFECTION,2
IE,STAPHYLOCOCCAL INFECTION,2
IE,SUBARACHNOID HAEMORRHAGE,2
IE,SWELLING FACE,2
IE,TEMPORAL ARTERITIS,2
IE,TREMOR,2
IE,UNRESPONSIVE TO STIMULI,2
IE,VISION BLURRED,2
IE,ABASIA,1
IE,ABDOMINAL DISCOMFORT,1
IE,ABDOMINAL DISTENSION,1
IE,ABNORMAL CLOTTING FACTOR,1
IE,ABNORMAL LOSS OF WEIGHT,1
IE,ABORTION SPONTANEOUS,1
IE,ADRENAL INSUFFICIENCY,1
IE,AGGRESSION,1
IE,AGITATION,1
IE,ALANINE AMINOTRANSFERASE INCREASED,1
IE,ALCOHOL ABUSE,1
IE,AMNESIA,1
IE,ANAEMIA,1
IE,ANGIOCENTRIC LYMPHOMA,1
IE,ANKLE FRACTURE,1
IE,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
IE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
IE,ANURIA,1
IE,AORTIC STENOSIS,1
IE,AORTIC VALVE REPAIR,1
IE,ASPHYXIA,1
IE,ASTHMA,1
IE,ATRIOVENTRICULAR SEPTAL DEFECT,1
IE,AUTOIMMUNE DISORDER,1
IE,AUTOIMMUNE PANCREATITIS,1
IE,BASAL CELL CARCINOMA,1
IE,BLISTER,1
IE,BLOOD ALBUMIN DECREASED,1
IE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IE,BLOOD CALCIUM DECREASED,1
IE,BLOOD CHOLESTEROL INCREASED,1
IE,BLOOD MAGNESIUM DECREASED,1
IE,BLOOD POTASSIUM INCREASED,1
IE,BLOOD PRESSURE INCREASED,1
IE,BLOOD PRESSURE SYSTOLIC INCREASED,1
IE,BLOOD UREA INCREASED,1
IE,BODY TEMPERATURE DECREASED,1
IE,BRAIN INJURY,1
IE,BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS,1
IE,BRONCHITIS,1
IE,CARDIAC FAILURE ACUTE,1
IE,CARDIAC FLUTTER,1
IE,CARDIAC OPERATION,1
IE,CARDIO-RESPIRATORY ARREST,1
IE,CARDIOPULMONARY FAILURE,1
IE,CEREBRAL HAEMORRHAGE,1
IE,CEREBRAL ISCHAEMIA,1
IE,CHEST X-RAY ABNORMAL,1
IE,CHOKING,1
IE,CLOSTRIDIUM DIFFICILE INFECTION,1
IE,COAGULOPATHY,1
IE,COLITIS ISCHAEMIC,1
IE,COMA SCALE ABNORMAL,1
IE,CONCOMITANT DISEASE PROGRESSION,1
IE,CONVULSION,1
IE,CORONAVIRUS TEST POSITIVE,1
IE,CSF WHITE BLOOD CELL COUNT INCREASED,1
IE,DEEP VEIN THROMBOSIS POSTOPERATIVE,1
IE,DEHYDRATION,1
IE,DELIRIUM,1
IE,DEMENTIA,1
IE,DEPRESSION,1
IE,DEVICE ISSUE,1
IE,DILATATION ATRIAL,1
IE,DISEASE PROGRESSION,1
IE,DIVERTICULUM,1
IE,DIZZINESS,1
IE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
IE,DRUG LEVEL ABOVE THERAPEUTIC,1
IE,DRUG RESISTANCE,1
IE,DRY MOUTH,1
IE,DRY SKIN,1
IE,DYSPHONIA,1
IE,DYSTONIA,1
IE,EAR INFECTION,1
IE,ECZEMA,1
IE,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
IE,EMBOLIC STROKE,1
IE,EMPHYSEMA,1
IE,EOSINOPHIL COUNT INCREASED,1
IE,EPILEPSY,1
IE,EUPHORIC MOOD,1
IE,EXPOSURE DURING PREGNANCY,1
IE,EYELID OEDEMA,1
IE,EYELID PTOSIS,1
IE,FAECES DISCOLOURED,1
IE,FEELING HOT,1
IE,FLUID OVERLOAD,1
IE,FOAMING AT MOUTH,1
IE,FRACTURE DISPLACEMENT,1
IE,FRACTURED SACRUM,1
IE,GAIT DISTURBANCE,1
IE,GASTROINTESTINAL NECROSIS,1
IE,GASTROINTESTINAL PERFORATION,1
IE,GASTROINTESTINAL STOMA COMPLICATION,1
IE,GASTROOESOPHAGEAL REFLUX DISEASE,1
IE,GENERALISED TONIC-CLONIC SEIZURE,1
IE,GINGIVAL ABSCESS,1
IE,GLIOBLASTOMA MULTIFORME,1
IE,GLOBULINS INCREASED,1
IE,GLOMERULAR FILTRATION RATE DECREASED,1
IE,GRAND MAL CONVULSION,1
IE,GRUNTING,1
IE,HAEMARTHROSIS,1
IE,HAEMATOCHEZIA,1
IE,HAEMOPTYSIS,1
IE,HALLUCINATION_ AUDITORY,1
IE,HALLUCINATION_ VISUAL,1
IE,HEART RATE DECREASED,1
IE,HEART RATE INCREASED,1
IE,HEMIPARESIS,1
IE,HEPATIC ENCEPHALOPATHY,1
IE,HOSPITALISATION,1
IE,HUMAN RHINOVIRUS TEST POSITIVE,1
IE,HYPERLIPIDAEMIA,1
IE,HYPOGLYCAEMIA,1
IE,HYPOTHERMIA,1
IE,HYPOXIA,1
IE,ILEOSTOMY,1
IE,INCREASED BRONCHIAL SECRETION,1
IE,INFLUENZA LIKE ILLNESS,1
IE,INFUSION RELATED REACTION,1
IE,INJECTION SITE HAEMORRHAGE,1
IE,INJECTION SITE PAIN,1
IE,INTENTIONAL DEVICE USE ISSUE,1
IE,INTENTIONAL OVERDOSE,1
IE,INTERVERTEBRAL DISC SPACE NARROWING,1
IE,INTESTINAL ISCHAEMIA,1
IE,INTESTINAL STENOSIS,1
IE,INTRAOCULAR LENS IMPLANT,1
IE,IRON DEFICIENCY ANAEMIA,1
IE,IRRITABILITY,1
IE,ISCHAEMIC STROKE,1
IE,LARYNGITIS,1
IE,LEFT VENTRICULAR HYPERTROPHY,1
IE,LETHARGY,1
IE,LIVEDO RETICULARIS,1
IE,LIVER DISORDER,1
IE,LIVER FUNCTION TEST ABNORMAL,1
IE,LOCAL SWELLING,1
IE,LOCALISED INFECTION,1
IE,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
IE,LUMBOSACRAL PLEXUS LESION,1
IE,LUNG DISORDER,1
IE,LUNG INFECTION,1
IE,MALABSORPTION,1
IE,MEDICATION ERROR,1
IE,MEDICATION RESIDUE PRESENT,1
IE,MEGACOLON,1
IE,MENINGITIS ASEPTIC,1
IE,MENINGITIS CRYPTOCOCCAL,1
IE,MENINGITIS TUBERCULOUS,1
IE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
IE,MITRAL VALVE INCOMPETENCE,1
IE,MONOPARESIS,1
IE,MOUTH HAEMORRHAGE,1
IE,MULTIPLE SCLEROSIS RELAPSE,1
IE,MUSCLE ATROPHY,1
IE,MUSCLE STRAIN,1
IE,MUSCULOSKELETAL PAIN,1
IE,MYOCARDIAL INFARCTION,1
IE,MYOCARDIAL ISCHAEMIA,1
IE,NASAL CONGESTION,1
IE,NASOPHARYNGITIS,1
IE,NECK PAIN,1
IE,NEOPLASM MALIGNANT,1
IE,NEPHROLITHIASIS,1
IE,NERVOUS SYSTEM DISORDER,1
IE,NEUROENDOCRINE TUMOUR,1
IE,NEUROGENIC BLADDER,1
IE,NEUROGENIC BOWEL,1
IE,NEUROLOGICAL SYMPTOM,1
IE,NEUROPATHY PERIPHERAL,1
IE,NEUTROPENIC SEPSIS,1
IE,NEUTROPHIL COUNT ABNORMAL,1
IE,NON-HODGKIN^S LYMPHOMA,1
IE,OBESITY,1
IE,OCULAR HYPERAEMIA,1
IE,OESOPHAGEAL VARICES HAEMORRHAGE,1
IE,ON AND OFF PHENOMENON,1
IE,ORAL HERPES,1
IE,ORGANISING PNEUMONIA,1
IE,OVERDOSE,1
IE,OVERWEIGHT,1
IE,PAIN IN EXTREMITY,1
IE,PAPILLOMA VIRAL INFECTION,1
IE,PARAESTHESIA,1
IE,PARAINFLUENZAE VIRUS INFECTION,1
IE,PATENT DUCTUS ARTERIOSUS,1
IE,PELVIC PAIN,1
IE,PERIPHERAL SWELLING,1
IE,PERITONITIS BACTERIAL,1
IE,PETIT MAL EPILEPSY,1
IE,PHARYNGEAL ERYTHEMA,1
IE,PLASMA CELL MYELOMA,1
IE,PLEURAL EFFUSION,1
IE,PLEURITIC PAIN,1
IE,PNEUMONITIS,1
IE,POST PROCEDURAL COMPLICATION,1
IE,POST PROCEDURAL CONTUSION,1
IE,POSTICTAL STATE,1
IE,POSTOPERATIVE WOUND INFECTION,1
IE,PRESCRIBED OVERDOSE,1
IE,PRODUCTIVE COUGH,1
IE,PRURITUS,1
IE,PUBIS FRACTURE,1
IE,RASH MACULO-PAPULAR,1
IE,RASH PRURITIC,1
IE,RECTAL HAEMORRHAGE,1
IE,RESPIRATORY ARREST,1
IE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
IE,RESPIRATORY TRACT IRRITATION,1
IE,RESPIROVIRUS TEST POSITIVE,1
IE,RESTLESS LEGS SYNDROME,1
IE,RETROPERITONEAL HAEMATOMA,1
IE,RHEUMATOID ARTHRITIS,1
IE,RHINORRHOEA,1
IE,SALIVARY GLAND DISORDER,1
IE,SCHIZOPHRENIA,1
IE,SEIZURE,1
IE,SENSATION OF FOREIGN BODY,1
IE,SENSORY DISTURBANCE,1
IE,SEPTIC SHOCK,1
IE,SINUS TACHYCARDIA,1
IE,SKIN DISCOLOURATION,1
IE,SKIN LESION,1
IE,SMALL INTESTINAL OBSTRUCTION,1
IE,SMALL INTESTINAL RESECTION,1
IE,SOMNOLENCE,1
IE,SPINAL OSTEOARTHRITIS,1
IE,SPONDYLOLISTHESIS,1
IE,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,1
IE,SQUAMOUS CELL CARCINOMA OF SKIN,1
IE,STOMA SITE DISCHARGE,1
IE,STOMA SITE ERYTHEMA,1
IE,STOMA SITE INFECTION,1
IE,STOMA SITE INFLAMMATION,1
IE,STREPTOCOCCAL INFECTION,1
IE,STRESS,1
IE,SUBSTANCE ABUSE,1
IE,SWOLLEN TONGUE,1
IE,SYNOVIAL CYST,1
IE,TACHYCARDIA,1
IE,TENDERNESS,1
IE,TERMINAL STATE,1
IE,TESTICULAR SWELLING,1
IE,THALAMUS HAEMORRHAGE,1
IE,THROAT IRRITATION,1
IE,THROAT TIGHTNESS,1
IE,THROMBOSIS,1
IE,THROMBOSIS IN DEVICE,1
IE,TINNITUS,1
IE,TONGUE BITING,1
IE,TOXIC EPIDERMAL NECROLYSIS,1
IE,TRANSAMINASES INCREASED,1
IE,TRICUSPID VALVE DISEASE,1
IE,TRICUSPID VALVE INCOMPETENCE,1
IE,TUBERCULOSIS,1
IE,UNDERWEIGHT,1
IE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
IE,UPPER-AIRWAY COUGH SYNDROME,1
IE,URINARY BLADDER HAEMORRHAGE,1
IE,UTERINE PROLAPSE,1
IE,VASCULAR STENT THROMBOSIS,1
IE,VEIN DISORDER,1
IE,VERTEBRAL OSTEOPHYTE,1
IE,VERTIGO,1
IE,VISUAL ACUITY REDUCED,1
IE,VOLVULUS,1
IE,WEIGHT DECREASED,1
IE,WRIST FRACTURE,1
IL,TOXICITY TO VARIOUS AGENTS,34
IL,PANCYTOPENIA,26
IL,MUCOSAL INFLAMMATION,18
IL,DIARRHOEA,13
IL,PNEUMONITIS,12
IL,RHABDOMYOLYSIS,10
IL,SEPSIS,10
IL,ABDOMINAL PAIN,9
IL,HEPATOTOXICITY,9
IL,NEUTROPENIA,7
IL,ASTHENIA,6
IL,DYSPNOEA,6
IL,VOMITING,6
IL,INFECTION,5
IL,ATAXIA,4
IL,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
IL,FALL,4
IL,MYALGIA,4
IL,PULMONARY EMBOLISM,4
IL,PYREXIA,4
IL,VERTIGO,4
IL,COLITIS,3
IL,GASTROENTERITIS,3
IL,HYPOKALAEMIA,3
IL,HYPONATRAEMIA,3
IL,MUSCULAR WEAKNESS,3
IL,PLASMA CELL MYELOMA,3
IL,ACUTE MYOCARDIAL INFARCTION,2
IL,ATRIAL FIBRILLATION,2
IL,BLOOD CREATININE INCREASED,2
IL,BONE PAIN,2
IL,CARDIOGENIC SHOCK,2
IL,CHEST PAIN,2
IL,CHILLS,2
IL,CLOSTRIDIAL INFECTION,2
IL,CONDITION AGGRAVATED,2
IL,CONFUSIONAL STATE,2
IL,DECREASED APPETITE,2
IL,FATIGUE,2
IL,FLUID RETENTION,2
IL,HAND FRACTURE,2
IL,HEPATIC ENZYME INCREASED,2
IL,HYPERCALCAEMIA,2
IL,HYPERKALAEMIA,2
IL,LOCALISED OEDEMA,2
IL,MALIGNANT NEOPLASM PROGRESSION,2
IL,NAUSEA,2
IL,OEDEMA PERIPHERAL,2
IL,OSTEONECROSIS OF JAW,2
IL,PNEUMONIA,2
IL,RENAL FAILURE ACUTE,2
IL,URINARY RETENTION,2
IL,ABDOMINAL DISTENSION,1
IL,ABDOMINAL PAIN UPPER,1
IL,ACUTE KIDNEY INJURY,1
IL,ADDISON^S DISEASE,1
IL,ADENOMA BENIGN,1
IL,AGITATION,1
IL,ALANINE AMINOTRANSFERASE INCREASED,1
IL,AMNESIA,1
IL,ANAEMIA,1
IL,ANGINA UNSTABLE,1
IL,ARTERIOVENOUS GRAFT SITE INFECTION,1
IL,ARTHRALGIA,1
IL,ASPARTATE AMINOTRANSFERASE INCREASED,1
IL,BACK PAIN,1
IL,BLOOD BILIRUBIN INCREASED,1
IL,BLOOD IRON DECREASED,1
IL,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IL,BRONCHITIS,1
IL,BURNING SENSATION,1
IL,CARDIAC FAILURE,1
IL,CELLULITIS,1
IL,CEREBRAL HAEMORRHAGE,1
IL,CEREBROVASCULAR ACCIDENT,1
IL,CHORIORETINOPATHY,1
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IL,COAGULATION TIME PROLONGED,1
IL,COLECTOMY,1
IL,CONSTIPATION,1
IL,CROHN^S DISEASE,1
IL,DEATH,1
IL,DEEP VEIN THROMBOSIS,1
IL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IL,DISEASE PROGRESSION,1
IL,DIZZINESS,1
IL,DRUG LEVEL INCREASED,1
IL,DRUG SPECIFIC ANTIBODY PRESENT,1
IL,DUODENAL ULCER,1
IL,ELECTROCARDIOGRAM T WAVE INVERSION,1
IL,EMBOLIC STROKE,1
IL,ENDOMETRIAL CANCER,1
IL,EPISTAXIS,1
IL,ERYTHEMA,1
IL,FACE OEDEMA,1
IL,FISTULA,1
IL,FLATULENCE,1
IL,FOREARM FRACTURE,1
IL,FOREIGN BODY ASPIRATION,1
IL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
IL,GASTRINOMA,1
IL,GASTROINTESTINAL HAEMORRHAGE,1
IL,GENERAL PHYSICAL HEALTH DETERIORATION,1
IL,GENERALISED OEDEMA,1
IL,HAEMODIALYSIS,1
IL,HAEMOGLOBIN DECREASED,1
IL,HEADACHE,1
IL,HEPATITIS B REACTIVATION,1
IL,HEPATOMEGALY,1
IL,HYPOCALCAEMIA,1
IL,HYPOGLYCAEMIA,1
IL,HYPOMAGNESAEMIA,1
IL,INCORRECT DOSE ADMINISTERED,1
IL,INFLUENZA,1
IL,INJECTION SITE BRUISING,1
IL,INTERNATIONAL NORMALISED RATIO INCREASED,1
IL,INTESTINAL OBSTRUCTION,1
IL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IL,LEUKAEMIA,1
IL,LEUKOCYTOSIS,1
IL,LIP SWELLING,1
IL,LIPASE INCREASED,1
IL,LIVER INJURY,1
IL,LOSS OF CONSCIOUSNESS,1
IL,LUMBAR VERTEBRAL FRACTURE,1
IL,MALAISE,1
IL,MASS,1
IL,METABOLIC DISORDER,1
IL,MYOPATHY,1
IL,NEUROENDOCRINE CARCINOMA,1
IL,OLIGURIA,1
IL,PANCREATITIS,1
IL,PELVI-URETERIC OBSTRUCTION,1
IL,PERIPHERAL MOTOR NEUROPATHY,1
IL,PERIPHERAL SENSORY NEUROPATHY,1
IL,PNEUMONIA ASPIRATION,1
IL,PNEUMONIA LEGIONELLA,1
IL,PRODUCT USE ISSUE,1
IL,PROTHROMBIN TIME PROLONGED,1
IL,PULMONARY CONGESTION,1
IL,PULMONARY HYPERTENSION,1
IL,PULMONARY OEDEMA,1
IL,RADIAL PULSE ABNORMAL,1
IL,RENAL FAILURE,1
IL,RESPIRATORY DISORDER,1
IL,RETINAL SCAR,1
IL,RETINITIS,1
IL,RETINOPATHY,1
IL,RICHTER^S SYNDROME,1
IL,ROAD TRAFFIC ACCIDENT,1
IL,SEIZURE,1
IL,SEPTIC SHOCK,1
IL,SINUS TACHYCARDIA,1
IL,SPINAL COLUMN INJURY,1
IL,SPINAL COMPRESSION FRACTURE,1
IL,SUBARACHNOID HAEMORRHAGE,1
IL,SYNCOPE,1
IL,THERAPEUTIC PRODUCT INEFFECTIVE,1
IL,THERAPEUTIC RESPONSE DECREASED,1
IL,THROMBOCYTOPENIA,1
IL,TUMOUR LYSIS SYNDROME,1
IL,UPPER LIMB FRACTURE,1
IL,URINARY TRACT DISORDER,1
IL,URINARY TRACT INFECTION,1
IL,VASCULAR CALCIFICATION,1
IL,VISION BLURRED,1
IL,WEIGHT DECREASED,1
IL,WHITE MATTER LESION,1
IT,ANAEMIA,104
IT,ASTHENIA,90
IT,DIARRHOEA,78
IT,PYREXIA,74
IT,HYPOGLYCAEMIA,72
IT,DYSPNOEA,70
IT,HYPOTENSION,68
IT,DRUG ABUSE,63
IT,VOMITING,60
IT,NEUTROPENIA,57
IT,SOPOR,56
IT,CONFUSIONAL STATE,55
IT,HYPOKALAEMIA,55
IT,NAUSEA,53
IT,HYPOMAGNESAEMIA,51
IT,ACUTE KIDNEY INJURY,50
IT,ERYTHEMA,49
IT,THROMBOCYTOPENIA,46
IT,RENAL FAILURE ACUTE,45
IT,HYPOCALCAEMIA,42
IT,SYNCOPE,41
IT,INTERNATIONAL NORMALISED RATIO INCREASED,40
IT,FEBRILE NEUTROPENIA,39
IT,ELECTROCARDIOGRAM QT PROLONGED,38
IT,ABDOMINAL PAIN,34
IT,DECREASED APPETITE,34
IT,HYPERKALAEMIA,34
IT,MALAISE,33
IT,RENAL FAILURE,33
IT,HYPONATRAEMIA,32
IT,PRURITUS,31
IT,ATRIAL FIBRILLATION,30
IT,LOSS OF CONSCIOUSNESS,30
IT,PNEUMONIA,30
IT,COMA,28
IT,DEHYDRATION,27
IT,HYPOGLYCAEMIC COMA,27
IT,ABDOMINAL PAIN UPPER,26
IT,CARDIAC FAILURE,26
IT,BRADYCARDIA,25
IT,LACTIC ACIDOSIS,25
IT,BRADYPHRENIA,24
IT,FALL,24
IT,RENAL IMPAIRMENT,24
IT,URTICARIA,24
IT,FACE OEDEMA,23
IT,ACUTE RESPIRATORY FAILURE,22
IT,FATIGUE,22
IT,RHABDOMYOLYSIS,22
IT,HAEMATOMA,21
IT,HYPERHIDROSIS,21
IT,LEUKOPENIA,21
IT,PLEURAL EFFUSION,21
IT,PRESYNCOPE,21
IT,HYPERTENSIVE CRISIS,20
IT,OEDEMA PERIPHERAL,20
IT,PAIN,20
IT,PRURITUS GENERALISED,20
IT,SOMNOLENCE,20
IT,INTENTIONAL SELF-INJURY,19
IT,PANCYTOPENIA,19
IT,RASH,19
IT,TACHYCARDIA,19
IT,VERTIGO,19
IT,AGITATION,18
IT,OVERDOSE,18
IT,PULMONARY EMBOLISM,18
IT,RECTAL HAEMORRHAGE,18
IT,APHASIA,17
IT,CONDITION AGGRAVATED,17
IT,HAEMATURIA,17
IT,SEPTIC SHOCK,17
IT,CARDIAC ARREST,16
IT,CHEST PAIN,16
IT,COUGH,16
IT,HEADACHE,16
IT,HEMIPLEGIA,16
IT,HYPERGLYCAEMIA,16
IT,HYPERSENSITIVITY,16
IT,ARTHRALGIA,15
IT,BLOOD CREATININE INCREASED,15
IT,GAIT DISTURBANCE,15
IT,PETECHIAE,15
IT,RESPIRATORY FAILURE,15
IT,WEIGHT DECREASED,15
IT,DEATH,14
IT,INFUSION RELATED REACTION,14
IT,MYALGIA,14
IT,PARAESTHESIA,14
IT,SEPSIS,14
IT,TETANY,14
IT,BRADYKINESIA,13
IT,CEREBRAL HAEMORRHAGE,13
IT,DROP ATTACKS,13
IT,DRUG INEFFECTIVE,13
IT,DYSARTHRIA,13
IT,EPISTAXIS,13
IT,IRON DEFICIENCY ANAEMIA,13
IT,ALANINE AMINOTRANSFERASE INCREASED,12
IT,LUPUS-LIKE SYNDROME,12
IT,PSYCHOMOTOR RETARDATION,12
IT,TREMOR,12
IT,WERNICKE^S ENCEPHALOPATHY,12
IT,AGGRESSION,11
IT,BRONCHOSPASM,11
IT,CHILLS,11
IT,DEEP VEIN THROMBOSIS,11
IT,DYSPHAGIA,11
IT,HYPERPYREXIA,11
IT,HYPOPARATHYROIDISM,11
IT,MELAENA,11
IT,SEIZURE,11
IT,SELF INJURIOUS BEHAVIOUR,11
IT,SINUS BRADYCARDIA,11
IT,SUICIDE ATTEMPT,11
IT,ASPARTATE AMINOTRANSFERASE INCREASED,10
IT,ATRIAL FLUTTER,10
IT,CAROTID ARTERIOSCLEROSIS,10
IT,CHOLELITHIASIS,10
IT,DERMATITIS EXFOLIATIVE,10
IT,DIZZINESS,10
IT,HAEMOGLOBIN DECREASED,10
IT,HEAD INJURY,10
IT,HYPONATRAEMIC SYNDROME,10
IT,INTENTIONAL OVERDOSE,10
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,10
IT,METABOLIC ACIDOSIS,10
IT,OEDEMA,10
IT,PAIN IN EXTREMITY,10
IT,PSYCHOMOTOR HYPERACTIVITY,10
IT,ACUTE MYOCARDIAL INFARCTION,9
IT,BACK PAIN,9
IT,BRONCHOSTENOSIS,9
IT,CEREBRAL ARTERY OCCLUSION,9
IT,DRUG LEVEL INCREASED,9
IT,DYSGEUSIA,9
IT,HEMIPARESIS,9
IT,HYPERCHOLESTEROLAEMIA,9
IT,HYPERCREATININAEMIA,9
IT,HYPERTRANSAMINASAEMIA,9
IT,MYOCARDIAL INFARCTION,9
IT,NIH STROKE SCALE SCORE INCREASED,9
IT,PSYCHOMOTOR SKILLS IMPAIRED,9
IT,SPEECH DISORDER,9
IT,SUBARACHNOID HAEMORRHAGE,9
IT,VENTRICULAR FLUTTER,9
IT,AGRANULOCYTOSIS,8
IT,ALTERED STATE OF CONSCIOUSNESS,8
IT,ANGIOEDEMA,8
IT,CARDIOTOXICITY,8
IT,CONSTIPATION,8
IT,DUODENAL ULCER,8
IT,GENERAL PHYSICAL HEALTH DETERIORATION,8
IT,HEPATIC FAILURE,8
IT,HYPOKINESIA,8
IT,ILEUS PARALYTIC,8
IT,JAUNDICE,8
IT,MUSCLE SPASMS,8
IT,PNEUMONITIS,8
IT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,8
IT,SKIN EXFOLIATION,8
IT,SWELLING,8
IT,ACUTE PULMONARY OEDEMA,7
IT,AMYLOIDOSIS,7
IT,ASCITES,7
IT,BLOOD PRESSURE INCREASED,7
IT,BONE MARROW TOXICITY,7
IT,COGNITIVE DISORDER,7
IT,ELECTROLYTE IMBALANCE,7
IT,GASTROINTESTINAL HAEMORRHAGE,7
IT,HAEMORRHAGE,7
IT,HEPATIC ENZYME INCREASED,7
IT,INJURY,7
IT,INTERSTITIAL LUNG DISEASE,7
IT,OSTEONECROSIS OF JAW,7
IT,PORPHYRIA NON-ACUTE,7
IT,THROAT TIGHTNESS,7
IT,TRANSAMINASES INCREASED,7
IT,TRANSFUSION,7
IT,ABDOMINAL DISTENSION,6
IT,ABDOMINAL PAIN LOWER,6
IT,ATAXIA,6
IT,COLITIS,6
IT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,6
IT,ENTERITIS,6
IT,GASTRITIS EROSIVE,6
IT,GENERALISED OEDEMA,6
IT,HALLUCINATION_ VISUAL,6
IT,HEPATOTOXICITY,6
IT,HYPERAMYLASAEMIA,6
IT,HYPERLIPASAEMIA,6
IT,HYPERTENSION,6
IT,INTENTIONAL PRODUCT MISUSE,6
IT,LIVER INJURY,6
IT,MUCOSAL INFLAMMATION,6
IT,NORMOCHROMIC NORMOCYTIC ANAEMIA,6
IT,ORTHOSTATIC HYPOTENSION,6
IT,OXYGEN SATURATION DECREASED,6
IT,PALATAL OEDEMA,6
IT,PALPITATIONS,6
IT,PANCREATITIS,6
IT,PERICARDIAL EFFUSION,6
IT,POISONING,6
IT,RESPIRATORY DISTRESS,6
IT,STEVENS-JOHNSON SYNDROME,6
IT,SUBDURAL HAEMATOMA,6
IT,SUDDEN DEATH,6
IT,TOXIC EPIDERMAL NECROLYSIS,6
IT,TOXICITY TO VARIOUS AGENTS,6
IT,TRANSIENT ISCHAEMIC ATTACK,6
IT,WEIGHT INCREASED,6
IT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,5
IT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,5
IT,BALANCE DISORDER,5
IT,BLISTER,5
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
IT,BLOOD GLUCOSE INCREASED,5
IT,BONE MARROW FAILURE,5
IT,CEREBELLAR SYNDROME,5
IT,CEREBRAL ISCHAEMIA,5
IT,CHEST DISCOMFORT,5
IT,COLD SWEAT,5
IT,DEPRESSION,5
IT,DYSKINESIA,5
IT,ENCEPHALOPATHY,5
IT,EXTRASYSTOLES,5
IT,FLUSHING,5
IT,FUNGAL INFECTION,5
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
IT,HAEMATOCHEZIA,5
IT,HELICOBACTER INFECTION,5
IT,HEPATITIS ACUTE,5
IT,HIATUS HERNIA,5
IT,HYPERBILIRUBINAEMIA,5
IT,HYPERTRIGLYCERIDAEMIA,5
IT,HYPOSIDERAEMIA,5
IT,INCORRECT DOSE ADMINISTERED,5
IT,INSOMNIA,5
IT,INTESTINAL HAEMORRHAGE,5
IT,LIP OEDEMA,5
IT,MALIGNANT NEOPLASM PROGRESSION,5
IT,MICROCYTIC ANAEMIA,5
IT,MIXED LIVER INJURY,5
IT,MUSCULOSKELETAL PAIN,5
IT,PLATELET COUNT DECREASED,5
IT,POLYNEUROPATHY,5
IT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
IT,PRODUCT USE ISSUE,5
IT,RASH MACULO-PAPULAR,5
IT,STOMATITIS,5
IT,THROMBOSIS,5
IT,TONGUE COATED,5
IT,TUBULOINTERSTITIAL NEPHRITIS,5
IT,VASCULITIS,5
IT,VENOUS THROMBOSIS,5
IT,VITAMIN B1 DECREASED,5
IT,ANAPHYLACTIC REACTION,4
IT,ANXIETY,4
IT,BLOOD BILIRUBIN INCREASED,4
IT,C-REACTIVE PROTEIN INCREASED,4
IT,CARDIAC FAILURE ACUTE,4
IT,CARDIAC FAILURE CONGESTIVE,4
IT,CHROMATURIA,4
IT,DELIRIUM,4
IT,DIABETIC METABOLIC DECOMPENSATION,4
IT,DISEASE PROGRESSION,4
IT,DIVERTICULITIS,4
IT,DRUG PRESCRIBING ERROR,4
IT,DRY SKIN,4
IT,EPILEPSY,4
IT,GASTRIC HAEMORRHAGE,4
IT,GASTROINTESTINAL OBSTRUCTION,4
IT,GASTROINTESTINAL TOXICITY,4
IT,GENERALISED ERYTHEMA,4
IT,GINGIVAL BLEEDING,4
IT,GRAVITATIONAL OEDEMA,4
IT,HAEMORRHAGIC STROKE,4
IT,HALLUCINATION,4
IT,HEAD TITUBATION,4
IT,HEPATIC ENCEPHALOPATHY,4
IT,HOT FLUSH,4
IT,HYPOCOAGULABLE STATE,4
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
IT,INFLAMMATION,4
IT,MIOSIS,4
IT,MYELODYSPLASTIC SYNDROME,4
IT,MYOPATHY,4
IT,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,4
IT,OSCILLOPSIA,4
IT,OSTEONECROSIS,4
IT,PALLOR,4
IT,PEMPHIGOID,4
IT,PERICARDITIS,4
IT,PLASMA CELL MYELOMA,4
IT,RENAL TUBULAR DISORDER,4
IT,RETCHING,4
IT,ROMBERG TEST POSITIVE,4
IT,SLEEP DISORDER,4
IT,SPINAL FRACTURE,4
IT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,4
IT,SYSTEMIC LUPUS ERYTHEMATOSUS,4
IT,AMYLASE INCREASED,3
IT,ANGINA PECTORIS,3
IT,ANURIA,3
IT,AORTIC DILATATION,3
IT,APATHY,3
IT,AZOTAEMIA,3
IT,BASAL CELL CARCINOMA,3
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,3
IT,BLOOD MAGNESIUM DECREASED,3
IT,BLOODY DISCHARGE,3
IT,BREATH SOUNDS ABNORMAL,3
IT,BRONCHITIS,3
IT,CACHEXIA,3
IT,CARDIO-RESPIRATORY ARREST,3
IT,CEREBROVASCULAR ACCIDENT,3
IT,CHOLESTASIS,3
IT,COMPENSATORY SWEATING,3
IT,CYSTITIS,3
IT,DERMATITIS BULLOUS,3
IT,DRUG ERUPTION,3
IT,DRUG HYPERSENSITIVITY,3
IT,DRUG-INDUCED LIVER INJURY,3
IT,DYSPEPSIA,3
IT,DYSURIA,3
IT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
IT,EYELID OEDEMA,3
IT,FEELING HOT,3
IT,FLUID RETENTION,3
IT,GASTRITIS,3
IT,HAEMATEMESIS,3
IT,HAEMOPTYSIS,3
IT,HAEMORRHAGIC ANAEMIA,3
IT,HAEMORRHOIDS,3
IT,HEPATIC FUNCTION ABNORMAL,3
IT,HEPATITIS,3
IT,HEPATITIS C,3
IT,HEPATITIS CHOLESTATIC,3
IT,HEPATOCELLULAR INJURY,3
IT,HYPERAEMIA,3
IT,HYPERCAPNIA,3
IT,HYPERTHERMIA,3
IT,HYPOALBUMINAEMIA,3
IT,HYPOTHYROIDISM,3
IT,HYPOTONIA,3
IT,INFECTION,3
IT,INTERNATIONAL NORMALISED RATIO ABNORMAL,3
IT,JEALOUS DELUSION,3
IT,JOINT SWELLING,3
IT,LARYNGEAL OEDEMA,3
IT,LEUKOCYTOSIS,3
IT,LICHENOID KERATOSIS,3
IT,LUNG INFECTION,3
IT,LUNG NEOPLASM MALIGNANT,3
IT,LYMPHOPENIA,3
IT,MALNUTRITION,3
IT,MENOMETRORRHAGIA,3
IT,METAPNEUMOVIRUS INFECTION,3
IT,METRORRHAGIA,3
IT,MOBILITY DECREASED,3
IT,NEGATIVISM,3
IT,NEOPLASM MALIGNANT,3
IT,NEPHROPATHY TOXIC,3
IT,NEUROPATHY PERIPHERAL,3
IT,NEUROTOXICITY,3
IT,NON-HODGKIN^S LYMPHOMA,3
IT,NORMOCYTIC ANAEMIA,3
IT,OEDEMA MOUTH,3
IT,ORGANISING PNEUMONIA,3
IT,ORTHOPNOEA,3
IT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
IT,PERIPHERAL SWELLING,3
IT,PORTAL VEIN THROMBOSIS,3
IT,PRODUCT USE IN UNAPPROVED INDICATION,3
IT,PROSTATE CANCER,3
IT,PULMONARY HYPERTENSION,3
IT,RASH MORBILLIFORM,3
IT,RENAL PAIN,3
IT,SKIN LESION,3
IT,SPONTANEOUS HAEMATOMA,3
IT,SQUAMOUS CELL CARCINOMA OF SKIN,3
IT,SUSPICIOUSNESS,3
IT,SWELLING FACE,3
IT,SWOLLEN TONGUE,3
IT,TACHYPNOEA,3
IT,TENDONITIS,3
IT,THROMBOCYTOPENIC PURPURA,3
IT,TONGUE OEDEMA,3
IT,TREATMENT NONCOMPLIANCE,3
IT,TRICUSPID VALVE INCOMPETENCE,3
IT,URINARY INCONTINENCE,3
IT,URINARY TRACT INFECTION,3
IT,VITAMIN B1 DEFICIENCY,3
IT,WHITE BLOOD CELL COUNT DECREASED,3
IT,ABDOMINAL TENDERNESS,2
IT,ACARODERMATITIS,2
IT,ACTINIC KERATOSIS,2
IT,ACUTE LYMPHOCYTIC LEUKAEMIA,2
IT,ACUTE MYELOID LEUKAEMIA,2
IT,ADENOCARCINOMA OF COLON,2
IT,AMPUTATION,2
IT,ANAPHYLACTIC SHOCK,2
IT,AORTIC STENOSIS,2
IT,AREFLEXIA,2
IT,ARRHYTHMIA,2
IT,ATELECTASIS,2
IT,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
IT,ATRIOVENTRICULAR DISSOCIATION,2
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,2
IT,BLOOD PRESSURE DECREASED,2
IT,BRAIN STEM HAEMORRHAGE,2
IT,CARDIAC TAMPONADE,2
IT,CARDIOACTIVE DRUG LEVEL INCREASED,2
IT,CEREBELLAR HAEMORRHAGE,2
IT,CEREBRAL ARTERIOVENOUS MALFORMATION HAEMORRHAGIC,2
IT,CEREBRAL HAEMATOMA,2
IT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
IT,CLOSTRIDIUM DIFFICILE COLITIS,2
IT,COLITIS ULCERATIVE,2
IT,CONTRAINDICATED PRODUCT ADMINISTERED,2
IT,COORDINATION ABNORMAL,2
IT,CYTOMEGALOVIRUS INFECTION,2
IT,CYTOMEGALOVIRUS TEST POSITIVE,2
IT,DECUBITUS ULCER,2
IT,DERMATITIS,2
IT,DIABETES MELLITUS,2
IT,DIALYSIS,2
IT,DIASTOLIC DYSFUNCTION,2
IT,DIFFUSE VASCULITIS,2
IT,DIVERTICULAR PERFORATION,2
IT,DRUG DOSE OMISSION,2
IT,DRUG EFFECT INCOMPLETE,2
IT,DRY MOUTH,2
IT,DYSPHONIA,2
IT,DYSTONIA,2
IT,ECCHYMOSIS,2
IT,ELECTROCARDIOGRAM ABNORMAL,2
IT,ELECTROCARDIOGRAM T WAVE BIPHASIC,2
IT,ENCEPHALOMYELITIS,2
IT,ERYTHEMA MULTIFORME,2
IT,ESCHERICHIA INFECTION,2
IT,EXTRAVASATION,2
IT,FASTING,2
IT,FEELING COLD,2
IT,GAMBLING DISORDER,2
IT,GASTRIC CANCER,2
IT,GASTRIC DISORDER,2
IT,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
IT,H1N1 INFLUENZA,2
IT,HAEMATIDROSIS,2
IT,HAEMATOCRIT DECREASED,2
IT,HAEMATOTOXICITY,2
IT,HAEMORRHAGE INTRACRANIAL,2
IT,HAEMOTHORAX,2
IT,HEPATITIS C RNA INCREASED,2
IT,HEPATOCELLULAR CARCINOMA,2
IT,HYPERCALCAEMIA,2
IT,HYPERCREATINAEMIA,2
IT,HYPOAESTHESIA,2
IT,HYPOGLYCAEMIC UNCONSCIOUSNESS,2
IT,HYPOPARATHYROIDISM SECONDARY,2
IT,HYPOVOLAEMIC SHOCK,2
IT,INCORRECT DRUG ADMINISTRATION DURATION,2
IT,INFUSION SITE OEDEMA,2
IT,INTESTINAL ISCHAEMIA,2
IT,INTESTINAL OBSTRUCTION,2
IT,INTESTINAL PERFORATION,2
IT,INTRACRANIAL ANEURYSM,2
IT,INTRACRANIAL MASS,2
IT,ISCHAEMIC STROKE,2
IT,KLEBSIELLA INFECTION,2
IT,LARYNGOSPASM,2
IT,LIP SWELLING,2
IT,LIPASE INCREASED,2
IT,LOCAL SWELLING,2
IT,LOCALISED OEDEMA,2
IT,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,2
IT,MEDICATION ERROR,2
IT,MENORRHAGIA,2
IT,MESENTERITIS,2
IT,METASTATIC MALIGNANT MELANOMA,2
IT,MICROLITHIASIS,2
IT,MONOCYTE COUNT INCREASED,2
IT,MOVEMENT DISORDER,2
IT,MUCOSAL DISCOLOURATION,2
IT,MULTI-ORGAN FAILURE,2
IT,MULTIPLE SCLEROSIS,2
IT,MUSCULAR WEAKNESS,2
IT,MYOGLOBIN BLOOD INCREASED,2
IT,NECK PAIN,2
IT,NEOPLASM PROGRESSION,2
IT,NEUTROPHILIA,2
IT,OESOPHAGEAL CANDIDIASIS,2
IT,OESOPHAGITIS,2
IT,OROPHARYNGEAL PAIN,2
IT,PANCREATIC ENZYMES INCREASED,2
IT,PANCREATITIS ACUTE,2
IT,PARADOXICAL DRUG REACTION,2
IT,PARALYSIS,2
IT,PARAPARESIS,2
IT,PERITONITIS,2
IT,PERITONITIS BACTERIAL,2
IT,PHOTOPSIA,2
IT,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
IT,PNEUMONIA LEGIONELLA,2
IT,PNEUMONIA PNEUMOCOCCAL,2
IT,POSTURE ABNORMAL,2
IT,PRIMARY FAMILIAL HYPOMAGNESAEMIA,2
IT,PROTEINURIA,2
IT,PSEUDOMONAL SEPSIS,2
IT,PULMONARY OEDEMA,2
IT,PULMONARY TOXICITY,2
IT,RASH ERYTHEMATOUS,2
IT,RASH PAPULAR,2
IT,RASH PRURITIC,2
IT,RASH PUSTULAR,2
IT,RESPIRATORY DISORDER,2
IT,RETINAL DETACHMENT,2
IT,SEBORRHOEIC KERATOSIS,2
IT,SHOCK,2
IT,SHOCK HAEMORRHAGIC,2
IT,SKIN HYPERPIGMENTATION,2
IT,SUBCUTANEOUS ABSCESS,2
IT,SUBILEUS,2
IT,SURGERY,2
IT,THROMBOPHLEBITIS,2
IT,TOOTH ABSCESS,2
IT,TORSADE DE POINTES,2
IT,TRANSIENT ACANTHOLYTIC DERMATOSIS,2
IT,TROPONIN INCREASED,2
IT,URINARY RETENTION,2
IT,UTERINE POLYP,2
IT,VISION BLURRED,2
IT,VISUAL ACUITY REDUCED,2
IT,VISUAL IMPAIRMENT,2
IT,ABDOMINAL WALL HAEMATOMA,1
IT,ABNORMAL FAECES,1
IT,ABNORMAL LOSS OF WEIGHT,1
IT,ABSCESS,1
IT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
IT,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IT,ACUTE CORONARY SYNDROME,1
IT,ACUTE HEPATIC FAILURE,1
IT,ACUTE RESPIRATORY DISTRESS SYNDROME,1
IT,ADVERSE DRUG REACTION,1
IT,ADVERSE EVENT,1
IT,AMAUROSIS,1
IT,AMNESIA,1
IT,ANAEMIA MACROCYTIC,1
IT,ANAL ABSCESS,1
IT,ANAPHYLACTOID REACTION,1
IT,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,1
IT,ANTINUCLEAR ANTIBODY POSITIVE,1
IT,AORTIC ANEURYSM,1
IT,AORTIC ANEURYSM RUPTURE,1
IT,AORTIC ARTERIOSCLEROSIS,1
IT,APLASIA,1
IT,APLASIA PURE RED CELL,1
IT,APRAXIA,1
IT,ARTERIAL THROMBOSIS,1
IT,ARTERIOSCLEROSIS CORONARY ARTERY,1
IT,ARTERIOVENOUS FISTULA,1
IT,ARTHRITIS BACTERIAL,1
IT,ASPIRATION,1
IT,ASTHMA,1
IT,ASTRINGENT THERAPY,1
IT,ATRIAL TACHYCARDIA,1
IT,ATRIOVENTRICULAR BLOCK,1
IT,BENIGN PROSTATIC HYPERPLASIA,1
IT,BLOOD CHOLINESTERASE DECREASED,1
IT,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,1
IT,BLOOD ELECTROLYTES DECREASED,1
IT,BLOOD GLUCOSE ABNORMAL,1
IT,BLOOD PH DECREASED,1
IT,BLOOD POTASSIUM DECREASED,1
IT,BLOOD PRESSURE DIASTOLIC INCREASED,1
IT,BLOOD PRESSURE FLUCTUATION,1
IT,BLOOD UREA INCREASED,1
IT,BLOOD URIC ACID INCREASED,1
IT,BONE PAIN,1
IT,BRAIN INJURY,1
IT,BRAIN NEOPLASM,1
IT,BRAIN OEDEMA,1
IT,BREAST CANCER,1
IT,BREAST CANCER METASTATIC,1
IT,BREAST INFLAMMATION,1
IT,BREAST SWELLING,1
IT,BREATH SOUNDS,1
IT,BRONCHOPNEUMONIA,1
IT,BRONCHOPULMONARY ASPERGILLOSIS,1
IT,BUNDLE BRANCH BLOCK RIGHT,1
IT,BUTTERFLY RASH,1
IT,CANDIDA INFECTION,1
IT,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
IT,CARDIAC DISORDER,1
IT,CARDIAC PACEMAKER INSERTION,1
IT,CARDIOMEGALY,1
IT,CARDIOVASCULAR DISORDER,1
IT,CAUDA EQUINA SYNDROME,1
IT,CENTRAL NERVOUS SYSTEM INFLAMMATION,1
IT,CEREBELLAR STROKE,1
IT,CERVICAL DYSPLASIA,1
IT,CHEST X-RAY ABNORMAL,1
IT,CHOKING SENSATION,1
IT,CHOLECYSTITIS,1
IT,CHOLECYSTITIS ACUTE,1
IT,CHRONIC GASTRITIS,1
IT,CHRONIC GASTROINTESTINAL BLEEDING,1
IT,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
IT,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
IT,CIRCULATORY COLLAPSE,1
IT,CLOSTRIDIUM COLITIS,1
IT,COAGULOPATHY,1
IT,COLON ADENOMA,1
IT,COLON NEOPLASM,1
IT,COMPLETED SUICIDE,1
IT,CONDUCTION DISORDER,1
IT,CONJUNCTIVITIS,1
IT,CONTUSION,1
IT,CORONARY ARTERY STENOSIS,1
IT,CRANIOCEREBRAL INJURY,1
IT,CREATININE RENAL CLEARANCE DECREASED,1
IT,CREATININE URINE INCREASED,1
IT,CROHN^S DISEASE,1
IT,CYANOSIS,1
IT,CYTOKINE RELEASE SYNDROME,1
IT,CYTOPENIA,1
IT,DEAFNESS BILATERAL,1
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IT,DEPRESSED MOOD,1
IT,DERMAL CYST,1
IT,DERMATOMYOSITIS,1
IT,DIABETIC NEUROPATHY,1
IT,DIABETIC RETINAL OEDEMA,1
IT,DIASTOLIC HYPERTENSION,1
IT,DIPLOPIA,1
IT,DISORIENTATION,1
IT,DISSEMINATED INTRAVASCULAR COAGULATION,1
IT,DISSOCIATIVE DISORDER,1
IT,DIVERTICULUM INTESTINAL,1
IT,DRUG ADMINISTRATION ERROR,1
IT,DRUG RESISTANCE,1
IT,DRY EYE,1
IT,DYSMETRIA,1
IT,DYSPHORIA,1
IT,DYSSTASIA,1
IT,EAR HAEMORRHAGE,1
IT,EAR PAIN,1
IT,ECHOCARDIOGRAM ABNORMAL,1
IT,ECTROPION,1
IT,EMBOLISM,1
IT,EMPHYSEMA,1
IT,ENANTHEMA,1
IT,ENCAPSULATING PERITONEAL SCLEROSIS,1
IT,ENDOMETRIAL ADENOCARCINOMA,1
IT,ENDOMETRIAL CANCER,1
IT,ENTEROCOLITIS INFECTIOUS,1
IT,ERECTILE DYSFUNCTION,1
IT,EROSIVE DUODENITIS,1
IT,EROSIVE OESOPHAGITIS,1
IT,ERYTHEMA INFECTIOSUM,1
IT,ESCHERICHIA SEPSIS,1
IT,EXOPHTHALMOS,1
IT,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,1
IT,EXPOSURE DURING PREGNANCY,1
IT,EXTRA DOSE ADMINISTERED,1
IT,EXTRADURAL HAEMATOMA,1
IT,EYE OEDEMA,1
IT,EYE PAIN,1
IT,EYELID PTOSIS,1
IT,FACIAL BONES FRACTURE,1
IT,FACIAL PAIN,1
IT,FAECES DISCOLOURED,1
IT,FEBRILE INFECTION,1
IT,FEELING ABNORMAL,1
IT,FEMORAL HERNIA STRANGULATED,1
IT,FEMORAL NECK FRACTURE,1
IT,FEMUR FRACTURE,1
IT,FISTULA,1
IT,FLATULENCE,1
IT,FOLLICLE CENTRE LYMPHOMA_ FOLLICULAR GRADE I_ II_ III STAGE I,1
IT,FOLLICULITIS,1
IT,FUNGAL PERITONITIS,1
IT,GASTRIC ANTRAL VASCULAR ECTASIA,1
IT,GASTRIC ULCER,1
IT,GASTRIC ULCER PERFORATION,1
IT,GASTRODUODENAL ULCER,1
IT,GASTROENTERITIS,1
IT,GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC,1
IT,GASTROINTESTINAL PAIN,1
IT,GASTROINTESTINAL PERFORATION,1
IT,GINGIVAL SWELLING,1
IT,GINGIVITIS,1
IT,GLOMERULONEPHROPATHY,1
IT,GLOSSITIS,1
IT,GLUCOSE TOLERANCE IMPAIRED,1
IT,GLYCOSURIA,1
IT,GOITRE,1
IT,GYNAECOMASTIA,1
IT,HAEMANGIOMA OF LIVER,1
IT,HAEMOGLOBINAEMIA,1
IT,HAEMOLYTIC URAEMIC SYNDROME,1
IT,HAEMORRHAGIC EROSIVE GASTRITIS,1
IT,HAND-EYE COORDINATION IMPAIRED,1
IT,HEARING IMPAIRED,1
IT,HEART RATE INCREASED,1
IT,HELICOBACTER GASTRITIS,1
IT,HEPATIC CANCER,1
IT,HEPATIC CIRRHOSIS,1
IT,HEPATIC CYST,1
IT,HEPATIC ENZYME ABNORMAL,1
IT,HEPATIC FIBROSIS,1
IT,HEPATIC LESION,1
IT,HEPATIC STEATOSIS,1
IT,HEPATITIS TOXIC,1
IT,HEPATORENAL SYNDROME,1
IT,HEPATOSPLENOMEGALY,1
IT,HERPES ZOSTER,1
IT,HERPES ZOSTER CUTANEOUS DISSEMINATED,1
IT,HIP FRACTURE,1
IT,HYDROCELE,1
IT,HYDROCEPHALUS,1
IT,HYPERAMMONAEMIA,1
IT,HYPERCHLORHYDRIA,1
IT,HYPERCOAGULATION,1
IT,HYPERGAMMAGLOBULINAEMIA,1
IT,HYPERHOMOCYSTEINAEMIA,1
IT,HYPERLACTACIDAEMIA,1
IT,HYPERTENSIVE ENCEPHALOPATHY,1
IT,HYPERURICAEMIA,1
IT,HYPOACUSIS,1
IT,HYPOCHROMIC ANAEMIA,1
IT,HYPOKALAEMIC SYNDROME,1
IT,HYPOREFLEXIA,1
IT,HYPOTHERMIA,1
IT,HYPOVOLAEMIA,1
IT,HYPOXIA,1
IT,IATROGENIC INJURY,1
IT,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
IT,IMMUNE THROMBOCYTOPENIC PURPURA,1
IT,IMMUNODEFICIENCY,1
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
IT,INFECTIOUS COLITIS,1
IT,INFECTIOUS PLEURAL EFFUSION,1
IT,INFLUENZA,1
IT,INFLUENZA LIKE ILLNESS,1
IT,INGUINAL HERNIA,1
IT,INJECTION SITE EXTRAVASATION,1
IT,INJECTION SITE PAIN,1
IT,INTERNATIONAL NORMALISED RATIO DECREASED,1
IT,INTESTINAL ADENOCARCINOMA,1
IT,INTESTINAL INFARCTION,1
IT,INTUSSUSCEPTION,1
IT,INVESTIGATION,1
IT,LANGUAGE DISORDER,1
IT,LARGE INTESTINAL ULCER,1
IT,LEFT VENTRICULAR FAILURE,1
IT,LEUKOCYTURIA,1
IT,LIP AND/OR ORAL CAVITY CANCER,1
IT,LIP EROSION,1
IT,LISTERIOSIS,1
IT,LIVER DISORDER,1
IT,LIVER TRANSPLANT REJECTION,1
IT,LOWER RESPIRATORY TRACT INFECTION,1
IT,LOWER RESPIRATORY TRACT INFLAMMATION,1
IT,LUNG ADENOCARCINOMA,1
IT,LUNG ADENOCARCINOMA METASTATIC,1
IT,LUNG CONSOLIDATION,1
IT,LUNG DISORDER,1
IT,LUNG INFILTRATION,1
IT,LYMPHADENOPATHY,1
IT,LYMPHOCYTE COUNT DECREASED,1
IT,LYMPHOCYTIC LEUKAEMIA,1
IT,MACULAR OEDEMA,1
IT,MAJOR DEPRESSION,1
IT,MALIGNANT MELANOMA,1
IT,MASTITIS,1
IT,MATERNAL EXPOSURE DURING PREGNANCY,1
IT,MEDICAL DEVICE SITE HAEMATOMA,1
IT,MENINGIOMA,1
IT,METASTASES TO SKIN,1
IT,METASTASES TO SPINE,1
IT,METASTASIS,1
IT,METASTATIC NEOPLASM,1
IT,MICROEMBOLISM,1
IT,MIGRAINE,1
IT,MILLER FISHER SYNDROME,1
IT,MITRAL VALVE INCOMPETENCE,1
IT,MONOCYTOSIS,1
IT,MONOPARESIS,1
IT,MOOD SWINGS,1
IT,MULTIPLE INJURIES,1
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IT,MUSCLE ATROPHY,1
IT,MUSCLE INJURY,1
IT,MUSCLE RIGIDITY,1
IT,MYOCARDIAL ISCHAEMIA,1
IT,MYOCARDIAL NECROSIS,1
IT,MYOCARDITIS INFECTIOUS,1
IT,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
IT,NERVOUSNESS,1
IT,NEUTROPENIC INFECTION,1
IT,NEUTROPHIL COUNT DECREASED,1
IT,NO THERAPEUTIC RESPONSE,1
IT,NOCTURIA,1
IT,NOCTURNAL DYSPNOEA,1
IT,NODAL ARRHYTHMIA,1
IT,NODULE,1
IT,NONINFECTIOUS PERITONITIS,1
IT,NYSTAGMUS,1
IT,OCCULT BLOOD POSITIVE,1
IT,ODYNOPHAGIA,1
IT,OESOPHAGEAL DISORDER,1
IT,OESOPHAGEAL PERFORATION,1
IT,OESOPHAGEAL ULCER,1
IT,OESOPHAGEAL VARICES HAEMORRHAGE,1
IT,ONYCHALGIA,1
IT,OPSOCLONUS MYOCLONUS,1
IT,OPTIC NEURITIS,1
IT,ORAL CANDIDIASIS,1
IT,ORCHITIS,1
IT,OSTEOPOROSIS,1
IT,OTORRHOEA,1
IT,PAIN IN JAW,1
IT,PANCREATIC DISORDER,1
IT,PANCREATIC TOXICITY,1
IT,PANIC ATTACK,1
IT,PANNICULITIS,1
IT,PAPULE,1
IT,PARATHYROID TUMOUR BENIGN,1
IT,PARESIS,1
IT,PAROSMIA,1
IT,PARTIAL SEIZURES,1
IT,PELVIC FRACTURE,1
IT,PERIODONTITIS,1
IT,PERIORBITAL HAEMORRHAGE,1
IT,PERIORBITAL OEDEMA,1
IT,PERIPHERAL ISCHAEMIA,1
IT,PERIPHERAL SENSORY NEUROPATHY,1
IT,PERNICIOUS ANAEMIA,1
IT,PERSISTENT GENERALISED LYMPHADENOPATHY,1
IT,PETIT MAL EPILEPSY,1
IT,PHARYNGEAL OEDEMA,1
IT,PHOTOPHOBIA,1
IT,PHOTOSENSITIVITY REACTION,1
IT,PLASMACYTOMA,1
IT,PNEUMONIA FUNGAL,1
IT,PNEUMONIA PSEUDOMONAL,1
IT,PNEUMOPERITONEUM,1
IT,POLLAKIURIA,1
IT,POLYMERASE CHAIN REACTION POSITIVE,1
IT,POLYMORPHIC LIGHT ERUPTION,1
IT,POLYMYOSITIS,1
IT,PORTAL HYPERTENSIVE GASTROPATHY,1
IT,POST PROCEDURAL HAEMORRHAGE,1
IT,POSTURAL TREMOR,1
IT,PREMATURE BABY,1
IT,PREMATURE DELIVERY,1
IT,PRESCRIBED OVERDOSE,1
IT,PRODUCT MEASURED POTENCY ISSUE,1
IT,PRODUCTIVE COUGH,1
IT,PROLONGED EXPIRATION,1
IT,PULMONARY ARTERIAL HYPERTENSION,1
IT,PULMONARY ARTERY THROMBOSIS,1
IT,PULMONARY CONGESTION,1
IT,PULMONARY FIBROSIS,1
IT,PULMONARY FUNCTION TEST DECREASED,1
IT,PULMONARY MYCOSIS,1
IT,PULMONARY SEPSIS,1
IT,PUPILS UNEQUAL,1
IT,PURPURA,1
IT,PURULENT DISCHARGE,1
IT,PUSTULAR PSORIASIS,1
IT,PYRAMIDAL TRACT SYNDROME,1
IT,QUADRIPARESIS,1
IT,QUADRIPLEGIA,1
IT,RAPID CORRECTION OF HYPONATRAEMIA,1
IT,RASH GENERALISED,1
IT,RECURRENT CANCER,1
IT,RED BLOOD CELL COUNT DECREASED,1
IT,RENAL CANCER,1
IT,RENAL FAILURE CHRONIC,1
IT,RENAL HAEMATOMA,1
IT,RENAL INJURY,1
IT,RESPIRATORY TRACT INFECTION,1
IT,RETINAL TEAR,1
IT,SALIVARY HYPERSECRETION,1
IT,SCIATICA,1
IT,SECONDARY HYPOTHYROIDISM,1
IT,SECRETION DISCHARGE,1
IT,SELF-INJURIOUS IDEATION,1
IT,SELF-MEDICATION,1
IT,SENSORY DISTURBANCE,1
IT,SEXUAL DYSFUNCTION,1
IT,SHOCK HYPOGLYCAEMIC,1
IT,SIALOADENITIS,1
IT,SICKLE CELL ANAEMIA,1
IT,SICKLE CELL TRAIT,1
IT,SINUS TACHYCARDIA,1
IT,SKIN HAEMORRHAGE,1
IT,SKIN PAPILLOMA,1
IT,SKIN REACTION,1
IT,SKIN TOXICITY,1
IT,SKIN ULCER,1
IT,SKIN WOUND,1
IT,SLOW RESPONSE TO STIMULI,1
IT,SLUGGISHNESS,1
IT,SPINAL CORD COMPRESSION,1
IT,SPINAL PAIN,1
IT,SPLENOMEGALY,1
IT,SPONDYLITIS,1
IT,SPUTUM PURULENT,1
IT,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
IT,STAPHYLOCOCCAL SEPSIS,1
IT,STATUS EPILEPTICUS,1
IT,STENOSIS,1
IT,STREPTOCOCCAL INFECTION,1
IT,STUPOR,1
IT,SUBCUTANEOUS HAEMATOMA,1
IT,SUBDURAL HAEMORRHAGE,1
IT,SUBSTANCE ABUSE,1
IT,SUPRAVENTRICULAR TACHYCARDIA,1
IT,SYSTEMIC CANDIDA,1
IT,T-CELL LYMPHOMA,1
IT,THALAMUS HAEMORRHAGE,1
IT,THERAPEUTIC EMBOLISATION,1
IT,THERAPY CESSATION,1
IT,THINKING ABNORMAL,1
IT,THORACIC CAVITY DRAINAGE,1
IT,THROAT IRRITATION,1
IT,THROMBOPHLEBITIS SUPERFICIAL,1
IT,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
IT,THYROIDECTOMY,1
IT,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
IT,TOXIC SKIN ERUPTION,1
IT,TRACHEOSTOMY,1
IT,TRANSITIONAL CELL CARCINOMA,1
IT,TRANSPLANT REJECTION,1
IT,TRAUMATIC HAEMATOMA,1
IT,TREATMENT FAILURE,1
IT,TUMOUR FLARE,1
IT,TYPE I HYPERSENSITIVITY,1
IT,UNRESPONSIVE TO STIMULI,1
IT,URINARY CASTS,1
IT,URTICARIA PAPULAR,1
IT,VAGINAL HAEMORRHAGE,1
IT,VARICOSE VEIN,1
IT,VASCULAR COGNITIVE IMPAIRMENT,1
IT,VASCULAR COMPRESSION,1
IT,VASCULAR DEMENTIA,1
IT,VASCULAR ENCEPHALOPATHY,1
IT,VASCULAR PSEUDOANEURYSM,1
IT,VASCULAR PSEUDOANEURYSM RUPTURED,1
IT,VASODILATION PROCEDURE,1
IT,VENTRICULAR EXTRASYSTOLES,1
IT,VENTRICULAR FIBRILLATION,1
IT,VIROLOGIC FAILURE,1
IT,WATER INTOXICATION,1
IT,WOUND,1
IT,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
JP,PYREXIA,70
JP,PLATELET COUNT DECREASED,59
JP,ANAEMIA,49
JP,HEPATIC FUNCTION ABNORMAL,45
JP,NAUSEA,40
JP,PNEUMONIA,38
JP,WHITE BLOOD CELL COUNT DECREASED,36
JP,DIARRHOEA,33
JP,RENAL IMPAIRMENT,32
JP,INTERSTITIAL LUNG DISEASE,30
JP,SEPSIS,29
JP,DISSEMINATED INTRAVASCULAR COAGULATION,26
JP,FEBRILE NEUTROPENIA,26
JP,LIVER DISORDER,26
JP,RASH,26
JP,VOMITING,26
JP,CARDIAC FAILURE,25
JP,MALAISE,25
JP,CEREBRAL INFARCTION,24
JP,DECREASED APPETITE,24
JP,NEUTROPHIL COUNT DECREASED,24
JP,DEATH,23
JP,MALIGNANT NEOPLASM PROGRESSION,22
JP,PLEURAL EFFUSION,21
JP,HYPOKALAEMIA,20
JP,BLOOD PRESSURE DECREASED,19
JP,DRUG INEFFECTIVE,19
JP,ALANINE AMINOTRANSFERASE INCREASED,17
JP,NEUTROPENIA,17
JP,PNEUMONIA ASPIRATION,17
JP,RENAL FAILURE,17
JP,RHABDOMYOLYSIS,17
JP,ARTHRALGIA,16
JP,ASPARTATE AMINOTRANSFERASE INCREASED,16
JP,BLOOD CREATININE INCREASED,16
JP,HYPERTENSION,16
JP,CONSTIPATION,15
JP,GASTROINTESTINAL HAEMORRHAGE,15
JP,LOSS OF CONSCIOUSNESS,15
JP,DYSPNOEA,14
JP,HAEMOGLOBIN DECREASED,14
JP,OEDEMA PERIPHERAL,14
JP,SEPTIC SHOCK,14
JP,THROMBOCYTOPENIA,14
JP,BLOOD UREA INCREASED,13
JP,C-REACTIVE PROTEIN INCREASED,13
JP,CEREBRAL HAEMORRHAGE,13
JP,DEHYDRATION,13
JP,DRUG ERUPTION,13
JP,ABDOMINAL PAIN,12
JP,ALTERED STATE OF CONSCIOUSNESS,12
JP,DIZZINESS,12
JP,DRUG-INDUCED LIVER INJURY,12
JP,INFECTION,12
JP,PRURITUS,12
JP,SOMNOLENCE,12
JP,DELIRIUM,11
JP,ERYTHEMA,11
JP,PLASMA CELL MYELOMA,11
JP,STEVENS-JOHNSON SYNDROME,11
JP,URINARY TRACT INFECTION,11
JP,WHITE BLOOD CELL COUNT INCREASED,11
JP,CYTOMEGALOVIRUS INFECTION,10
JP,CYTOMEGALOVIRUS TEST POSITIVE,10
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,10
JP,HYPONATRAEMIA,10
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,10
JP,OEDEMA,10
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,9
JP,HYPERURICAEMIA,9
JP,HYPOALBUMINAEMIA,9
JP,PNEUMONIA BACTERIAL,9
JP,RENAL DISORDER,9
JP,SEIZURE,9
JP,STAPHYLOCOCCAL SEPSIS,9
JP,ASCITES,8
JP,FEELING ABNORMAL,8
JP,GASTRIC ULCER HAEMORRHAGE,8
JP,HERPES ZOSTER,8
JP,HYPOGLYCAEMIA,8
JP,ILEUS,8
JP,LYMPHOCYTE COUNT DECREASED,8
JP,MELAENA,8
JP,RESPIRATORY FAILURE,8
JP,VENTRICULAR TACHYCARDIA,8
JP,ARRHYTHMIA,7
JP,BACK PAIN,7
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,7
JP,CARDIAC ARREST,7
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,7
JP,DEVICE RELATED INFECTION,7
JP,DIABETES MELLITUS,7
JP,DISEASE PROGRESSION,7
JP,ELECTROCARDIOGRAM QT PROLONGED,7
JP,FALL,7
JP,GRAFT VERSUS HOST DISEASE,7
JP,INSOMNIA,7
JP,JAUNDICE,7
JP,PAIN,7
JP,PANCREATITIS ACUTE,7
JP,PANCYTOPENIA,7
JP,PULMONARY HYPERTENSION,7
JP,THROMBOTIC MICROANGIOPATHY,7
JP,UPPER RESPIRATORY TRACT INFLAMMATION,7
JP,ABDOMINAL DISTENSION,6
JP,ACUTE KIDNEY INJURY,6
JP,ACUTE RESPIRATORY FAILURE,6
JP,ATRIAL FIBRILLATION,6
JP,BLOOD BILIRUBIN INCREASED,6
JP,CLOSTRIDIUM DIFFICILE COLITIS,6
JP,CONDITION AGGRAVATED,6
JP,GASTRIC ANTRAL VASCULAR ECTASIA,6
JP,GASTRIC POLYPS,6
JP,GASTRIC ULCER,6
JP,GENERALISED OEDEMA,6
JP,HEADACHE,6
JP,HYPERGLYCAEMIA,6
JP,HYPOCALCAEMIA,6
JP,LUNG NEOPLASM MALIGNANT,6
JP,MUSCLE SPASMS,6
JP,NASOPHARYNGITIS,6
JP,PULMONARY ALVEOLAR HAEMORRHAGE,6
JP,PYELONEPHRITIS,6
JP,ASTHENIA,5
JP,AUTOIMMUNE HEPATITIS,5
JP,BONE MARROW FAILURE,5
JP,BRONCHITIS,5
JP,CHOLANGITIS,5
JP,COUGH,5
JP,DEPRESSION,5
JP,ENTEROCOLITIS,5
JP,ERYTHEMA MULTIFORME,5
JP,HALLUCINATION,5
JP,HEPATIC FAILURE,5
JP,HYPERCALCAEMIA,5
JP,HYPOAESTHESIA,5
JP,INTESTINAL OBSTRUCTION,5
JP,IRON DEFICIENCY ANAEMIA,5
JP,LEUKOPENIA,5
JP,LIVER FUNCTION TEST ABNORMAL,5
JP,LONG QT SYNDROME,5
JP,MYELODYSPLASTIC SYNDROME,5
JP,OROPHARYNGEAL PAIN,5
JP,PALPITATIONS,5
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,5
JP,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,5
JP,PULMONARY EMBOLISM,5
JP,RASH GENERALISED,5
JP,RECTAL CANCER,5
JP,RENAL INFARCT,5
JP,RHEUMATOID ARTHRITIS,5
JP,SHOCK,5
JP,SPINAL COMPRESSION FRACTURE,5
JP,STOMATITIS,5
JP,TORSADE DE POINTES,5
JP,ACUTE GRAFT VERSUS HOST DISEASE,4
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,4
JP,ANASTOMOTIC STENOSIS,4
JP,BACTERIAL INFECTION,4
JP,BLISTER,4
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,4
JP,BRAIN STEM HAEMORRHAGE,4
JP,BRONCHOPULMONARY ASPERGILLOSIS,4
JP,CARDIAC FAILURE ACUTE,4
JP,CATARACT,4
JP,CHILLS,4
JP,COLITIS,4
JP,CYTOMEGALOVIRUS VIRAEMIA,4
JP,DISORIENTATION,4
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
JP,EPISTAXIS,4
JP,GASTRIC CANCER,4
JP,HAEMATOCHEZIA,4
JP,HALLUCINATION_ VISUAL,4
JP,HEPATIC CIRRHOSIS,4
JP,HEPATIC ENCEPHALOPATHY,4
JP,HEPATIC ENZYME INCREASED,4
JP,HEPATITIS FULMINANT,4
JP,HYPERBILIRUBINAEMIA,4
JP,HYPERKALAEMIA,4
JP,HYPOPROTEINAEMIA,4
JP,HYPOXIA,4
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,4
JP,LACUNAR INFARCTION,4
JP,MULTI-ORGAN FAILURE,4
JP,NEUTROPHIL COUNT INCREASED,4
JP,OVERDOSE,4
JP,PERITONITIS,4
JP,PLEURISY,4
JP,PNEUMOTHORAX,4
JP,RESTLESSNESS,4
JP,SHOCK HAEMORRHAGIC,4
JP,TACHYCARDIA,4
JP,THIRST,4
JP,TOXICITY TO VARIOUS AGENTS,4
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,4
JP,UPPER RESPIRATORY TRACT INFECTION,4
JP,WEIGHT INCREASED,4
JP,ABNORMAL BEHAVIOUR,3
JP,ACUTE MYOCARDIAL INFARCTION,3
JP,AMMONIA INCREASED,3
JP,ANTICONVULSANT DRUG LEVEL INCREASED,3
JP,ANTIPHOSPHOLIPID SYNDROME,3
JP,APPENDICITIS,3
JP,BLOOD GLUCOSE INCREASED,3
JP,BLOOD POTASSIUM INCREASED,3
JP,BLOOD PRESSURE INCREASED,3
JP,BLOOD PRESSURE SYSTOLIC INCREASED,3
JP,BRADYCARDIA,3
JP,BRAIN OEDEMA,3
JP,CANCER PAIN,3
JP,CARDIO-RESPIRATORY ARREST,3
JP,CELLULITIS,3
JP,CHEST PAIN,3
JP,CHOLELITHIASIS,3
JP,CHRONIC GRAFT VERSUS HOST DISEASE,3
JP,CIRCULATORY COLLAPSE,3
JP,COAGULOPATHY,3
JP,COMA,3
JP,CONCOMITANT DISEASE AGGRAVATED,3
JP,CONJUNCTIVITIS,3
JP,CYSTITIS,3
JP,CYSTITIS HAEMORRHAGIC,3
JP,DEEP VEIN THROMBOSIS,3
JP,DEMENTIA,3
JP,DRY MOUTH,3
JP,DRY SKIN,3
JP,DYSGEUSIA,3
JP,EMBOLIC STROKE,3
JP,FACE OEDEMA,3
JP,FATIGUE,3
JP,FEMORAL NECK FRACTURE,3
JP,FUNGAL INFECTION,3
JP,GAIT DISTURBANCE,3
JP,GASTROINTESTINAL PERFORATION,3
JP,GENERAL PHYSICAL HEALTH DETERIORATION,3
JP,HAEMATURIA,3
JP,HAEMOPTYSIS,3
JP,HEART RATE DECREASED,3
JP,HENOCH-SCHONLEIN PURPURA,3
JP,HEPATOCELLULAR CARCINOMA,3
JP,HYPERNATRAEMIA,3
JP,HYPOPHAGIA,3
JP,HYPOTENSION,3
JP,HYPOTHYROIDISM,3
JP,IDIOPATHIC PULMONARY FIBROSIS,3
JP,INFLAMMATION,3
JP,INJECTION SITE ERYTHEMA,3
JP,INTESTINAL ISCHAEMIA,3
JP,LARGE INTESTINE PERFORATION,3
JP,LUNG DISORDER,3
JP,LUPUS-LIKE SYNDROME,3
JP,LYMPHOMA,3
JP,MALLORY-WEISS SYNDROME,3
JP,MEGACOLON,3
JP,METABOLIC ACIDOSIS,3
JP,MUSCULAR WEAKNESS,3
JP,MUSCULOSKELETAL STIFFNESS,3
JP,NEUROGENIC BLADDER,3
JP,NEUROPATHY PERIPHERAL,3
JP,OLIGURIA,3
JP,OSTEONECROSIS,3
JP,OXYGEN SATURATION DECREASED,3
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
JP,PANCREATIC CARCINOMA,3
JP,PANCREATITIS,3
JP,PHARYNGITIS,3
JP,PNEUMONIA STREPTOCOCCAL,3
JP,PORTAL VEIN THROMBOSIS,3
JP,PRODUCT USE ISSUE,3
JP,PROTEINURIA,3
JP,PSEUDOMEMBRANOUS COLITIS,3
JP,PULMONARY CONGESTION,3
JP,PULMONARY OEDEMA,3
JP,PUSTULAR PSORIASIS,3
JP,RASH MACULO-PAPULAR,3
JP,RED BLOOD CELL COUNT DECREASED,3
JP,RENAL FAILURE ACUTE,3
JP,RESPIRATORY ARREST,3
JP,RESPIRATORY DISORDER,3
JP,ROAD TRAFFIC ACCIDENT,3
JP,SINUSITIS,3
JP,STAPHYLOCOCCAL INFECTION,3
JP,SUBDURAL HAEMATOMA,3
JP,TINNITUS,3
JP,TOXIC ENCEPHALOPATHY,3
JP,TRANSFUSION,3
JP,TREMOR,3
JP,TUBULOINTERSTITIAL NEPHRITIS,3
JP,TUMOUR LYSIS SYNDROME,3
JP,VENTRICULAR FIBRILLATION,3
JP,ABDOMINAL DISCOMFORT,2
JP,ABDOMINAL PAIN UPPER,2
JP,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,2
JP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,2
JP,ACUTE MYELOID LEUKAEMIA,2
JP,AGEUSIA,2
JP,ALOPECIA,2
JP,AMNESIA,2
JP,AMYLASE INCREASED,2
JP,ANAPHYLACTIC REACTION,2
JP,ANAPHYLACTIC SHOCK,2
JP,ANAPHYLACTOID REACTION,2
JP,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,2
JP,ANXIETY,2
JP,AORTIC VALVE INCOMPETENCE,2
JP,ASPERGILLUS INFECTION,2
JP,ASPIRATION,2
JP,ASTHMA,2
JP,ATRIAL FLUTTER,2
JP,BEHCET^S SYNDROME,2
JP,BENIGN PROSTATIC HYPERPLASIA,2
JP,BLAST CELL COUNT INCREASED,2
JP,BLOOD ALBUMIN DECREASED,2
JP,BLOOD CALCIUM DECREASED,2
JP,BLOOD SODIUM INCREASED,2
JP,BLOOD URIC ACID INCREASED,2
JP,BODY TEMPERATURE DECREASED,2
JP,BREAST CANCER,2
JP,BRONCHOPNEUMONIA,2
JP,CARDIAC FAILURE CHRONIC,2
JP,CARDIAC FAILURE CONGESTIVE,2
JP,CARDIAC TAMPONADE,2
JP,CENTRAL VENOUS PRESSURE INCREASED,2
JP,CEREBRAL ARTERY EMBOLISM,2
JP,CHRONIC KIDNEY DISEASE,2
JP,COGNITIVE DISORDER,2
JP,CONVULSION,2
JP,CYTOPENIA,2
JP,DECUBITUS ULCER,2
JP,DELUSION,2
JP,DIABETIC KETOACIDOSIS,2
JP,DIABETIC NEUROPATHY,2
JP,DISSEMINATED TUBERCULOSIS,2
JP,DISTURBANCE IN ATTENTION,2
JP,DNA ANTIBODY POSITIVE,2
JP,DRUG EFFECT INCOMPLETE,2
JP,DUODENAL ULCER HAEMORRHAGE,2
JP,DYSPHAGIA,2
JP,DYSPNOEA EXERTIONAL,2
JP,EATING DISORDER,2
JP,ENCEPHALITIS,2
JP,ENTERITIS INFECTIOUS,2
JP,ENTEROCOLITIS HAEMORRHAGIC,2
JP,EOSINOPHILIA,2
JP,EOSINOPHILIC PNEUMONIA,2
JP,EOSINOPHILIC PUSTULAR FOLLICULITIS,2
JP,EYELID EROSION,2
JP,FAECES DISCOLOURED,2
JP,FAECES SOFT,2
JP,FEEDING DISORDER,2
JP,FEMUR FRACTURE,2
JP,FLUID OVERLOAD,2
JP,FLUID RETENTION,2
JP,FOLATE DEFICIENCY,2
JP,FOREIGN BODY,2
JP,GALLBLADDER CANCER STAGE IV,2
JP,GANGRENE,2
JP,GASTRIC MUCOSAL LESION,2
JP,GASTRITIS,2
JP,GASTROINTESTINAL MUCOSAL DISORDER,2
JP,GENERALISED ERYTHEMA,2
JP,GRAFT VERSUS HOST DISEASE IN SKIN,2
JP,HAEMATEMESIS,2
JP,HAEMATOCRIT DECREASED,2
JP,HAEMOBILIA,2
JP,HAEMOLYTIC ANAEMIA,2
JP,HAEMORRHAGE,2
JP,HAEMORRHAGIC CEREBRAL INFARCTION,2
JP,HYDRONEPHROSIS,2
JP,HYPERAMMONAEMIA,2
JP,HYPERCAPNIA,2
JP,HYPERLIPIDAEMIA,2
JP,HYPOCOMPLEMENTAEMIA,2
JP,HYPOMAGNESAEMIA,2
JP,ILIUM FRACTURE,2
JP,IMMUNE-MEDIATED NECROTISING MYOPATHY,2
JP,IMPETIGO,2
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
JP,INFECTIOUS PLEURAL EFFUSION,2
JP,INFLUENZA,2
JP,INFUSION RELATED REACTION,2
JP,INJECTION SITE PRURITUS,2
JP,INTENTIONAL PRODUCT MISUSE,2
JP,INTERVERTEBRAL DISC PROTRUSION,2
JP,INTESTINAL PERFORATION,2
JP,INTRA-ABDOMINAL HAEMORRHAGE,2
JP,ISCHAEMIC HEPATITIS,2
JP,JAUNDICE CHOLESTATIC,2
JP,LACTIC ACIDOSIS,2
JP,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,2
JP,LOWER GASTROINTESTINAL HAEMORRHAGE,2
JP,LUNG ABSCESS,2
JP,LUNG INFECTION,2
JP,LUPUS NEPHRITIS,2
JP,LYMPHADENITIS,2
JP,LYMPHADENOPATHY,2
JP,LYMPHANGIOSIS CARCINOMATOSA,2
JP,LYMPHOPENIA,2
JP,MALABSORPTION,2
JP,MALNUTRITION,2
JP,MENINGITIS BACTERIAL,2
JP,MENINGITIS LISTERIA,2
JP,METASTASES TO CENTRAL NERVOUS SYSTEM,2
JP,METASTASES TO LIVER,2
JP,METASTASES TO MENINGES,2
JP,MITRAL VALVE INCOMPETENCE,2
JP,MOUTH HAEMORRHAGE,2
JP,MUCORMYCOSIS,2
JP,MUCOUS MEMBRANE DISORDER,2
JP,MYALGIA,2
JP,MYCOBACTERIUM AVIUM COMPLEX INFECTION,2
JP,MYOCARDIAL INFARCTION,2
JP,NON-HODGKIN^S LYMPHOMA,2
JP,NON-SMALL CELL LUNG CANCER,2
JP,OBLITERATIVE BRONCHIOLITIS,2
JP,OCULAR HYPERAEMIA,2
JP,OESOPHAGEAL CARCINOMA,2
JP,OESOPHAGEAL RUPTURE,2
JP,OESOPHAGITIS,2
JP,ORAL CANDIDIASIS,2
JP,ORGANISING PNEUMONIA,2
JP,OSTEOPOROSIS,2
JP,PERIARTHRITIS,2
JP,PERICARDITIS,2
JP,PETECHIAE,2
JP,PNEUMOCONIOSIS,2
JP,PNEUMONIA CYTOMEGALOVIRAL,2
JP,PNEUMONIA STAPHYLOCOCCAL,2
JP,PNEUMONITIS,2
JP,POLLAKIURIA,2
JP,PRESCRIBED UNDERDOSE,2
JP,PROTEIN-LOSING GASTROENTEROPATHY,2
JP,PROTHROMBIN TIME PROLONGED,2
JP,PSEUDOMONAL SEPSIS,2
JP,PSYCHIATRIC SYMPTOM,2
JP,PULMONARY FIBROSIS,2
JP,PULMONARY HAEMORRHAGE,2
JP,PULMONARY MASS,2
JP,RADICULOPATHY,2
JP,RELAPSING FEVER,2
JP,RESPIRATORY DEPRESSION,2
JP,RIB FRACTURE,2
JP,RIGHT VENTRICULAR FAILURE,2
JP,SALIVARY HYPERSECRETION,2
JP,SERONEGATIVE ARTHRITIS,2
JP,SINUS NODE DYSFUNCTION,2
JP,SINUS TACHYCARDIA,2
JP,STRESS CARDIOMYOPATHY,2
JP,STRESS FRACTURE,2
JP,STUPOR,2
JP,SUBARACHNOID HAEMORRHAGE,2
JP,SUICIDAL IDEATION,2
JP,SUICIDE ATTEMPT,2
JP,THERAPEUTIC RESPONSE DECREASED,2
JP,THERAPY CESSATION,2
JP,TONSILLITIS,2
JP,TUBERCULOUS PLEURISY,2
JP,URINARY RETENTION,2
JP,URINE OUTPUT DECREASED,2
JP,URTICARIA,2
JP,VENOOCCLUSIVE LIVER DISEASE,2
JP,VERTIGO,2
JP,VIRAL INFECTION,2
JP,ABDOMINAL ABSCESS,1
JP,ABDOMINAL ADHESIONS,1
JP,ABDOMINAL REBOUND TENDERNESS,1
JP,ABNORMAL FAECES,1
JP,ABNORMAL SENSATION IN EYE,1
JP,ACCIDENTAL OVERDOSE,1
JP,ACIDOSIS HYPERCHLORAEMIC,1
JP,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
JP,ACTIVITIES OF DAILY LIVING IMPAIRED,1
JP,ACUTE CORONARY SYNDROME,1
JP,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
JP,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
JP,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
JP,ACUTE HEPATIC FAILURE,1
JP,ACUTE MYELOMONOCYTIC LEUKAEMIA,1
JP,ACUTE PRERENAL FAILURE,1
JP,ADENOCARCINOMA GASTRIC,1
JP,ADENOCARCINOMA OF COLON,1
JP,AGGRESSION,1
JP,AGITATION,1
JP,AKATHISIA,1
JP,ALLERGIC EOSINOPHILIA,1
JP,ALVEOLAR LUNG DISEASE,1
JP,ALVEOLITIS ALLERGIC,1
JP,AMOEBIC COLITIS,1
JP,ANAEMIA MACROCYTIC,1
JP,ANAL FISSURE,1
JP,ANEURYSM RUPTURED,1
JP,ANGINA PECTORIS,1
JP,ANGINA UNSTABLE,1
JP,ANGULAR CHEILITIS,1
JP,ANOGENITAL WARTS,1
JP,ANTICONVULSANT DRUG LEVEL DECREASED,1
JP,ANTITHROMBIN III DECREASED,1
JP,AORTIC ANEURYSM,1
JP,APHTHOUS ULCER,1
JP,APLASTIC ANAEMIA,1
JP,APNOEA,1
JP,APPENDICECTOMY,1
JP,ARTERIOSCLEROSIS,1
JP,ARTERIOSCLEROSIS CORONARY ARTERY,1
JP,ARTERIOVENOUS MALFORMATION,1
JP,ARTHRITIS,1
JP,ARTHROPOD STING,1
JP,ASTEATOSIS,1
JP,ATELECTASIS,1
JP,ATRIAL THROMBOSIS,1
JP,ATRIOVENTRICULAR BLOCK COMPLETE,1
JP,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
JP,ATYPICAL FRACTURE,1
JP,ATYPICAL MYCOBACTERIAL INFECTION,1
JP,BACTERAEMIA,1
JP,BACTERIAL TEST POSITIVE,1
JP,BASAL CELL CARCINOMA,1
JP,BASILAR ARTERY OCCLUSION,1
JP,BILE DUCT CANCER,1
JP,BILE DUCT STONE,1
JP,BILIARY TRACT DISORDER,1
JP,BILIRUBIN CONJUGATED INCREASED,1
JP,BLOOD CALCIUM INCREASED,1
JP,BLOOD CREATINE INCREASED,1
JP,BLOOD CREATININE DECREASED,1
JP,BLOOD OSMOLARITY DECREASED,1
JP,BLOOD PRESSURE DIASTOLIC DECREASED,1
JP,BLOOD PRESSURE DIASTOLIC INCREASED,1
JP,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
JP,BLOOD THYROID STIMULATING HORMONE DECREASED,1
JP,BLOOD URINE,1
JP,BONE MARROW INFILTRATION,1
JP,BOWEL MOVEMENT IRREGULARITY,1
JP,BRACHIAL PLEXOPATHY,1
JP,BRADYKINESIA,1
JP,BRAIN ABSCESS,1
JP,BRAIN NATRIURETIC PEPTIDE ABNORMAL,1
JP,BRAIN NATRIURETIC PEPTIDE INCREASED,1
JP,BRAIN NEOPLASM,1
JP,CACHEXIA,1
JP,CALCULUS URETERIC,1
JP,CARBON MONOXIDE POISONING,1
JP,CARCINOEMBRYONIC ANTIGEN INCREASED,1
JP,CARDIAC AMYLOIDOSIS,1
JP,CARDIAC PACEMAKER INSERTION,1
JP,CARDIOGENIC SHOCK,1
JP,CAROTID ARTERY DISSECTION,1
JP,CATHETERISATION CARDIAC,1
JP,CEREBRAL VENTRICULAR RUPTURE,1
JP,CHEILITIS,1
JP,CHEST DISCOMFORT,1
JP,CHEST WALL ABSCESS,1
JP,CHEYNE-STOKES RESPIRATION,1
JP,CHOLANGIOCARCINOMA,1
JP,CHOLANGITIS ACUTE,1
JP,CHOLECYSTITIS,1
JP,CHOLECYSTITIS ACUTE,1
JP,CHOLECYSTOCHOLANGITIS,1
JP,CHRONIC GASTRITIS,1
JP,CLONUS,1
JP,COAGULATION TEST ABNORMAL,1
JP,COLONIC ABSCESS,1
JP,COLORECTAL CANCER,1
JP,COMPLEX PARTIAL SEIZURES,1
JP,CONDUCTION DISORDER,1
JP,CONJUNCTIVAL HYPERAEMIA,1
JP,CONJUNCTIVITIS ALLERGIC,1
JP,CONTRAST MEDIA ALLERGY,1
JP,CORONARY ARTERY STENOSIS,1
JP,CYTOKINE RELEASE SYNDROME,1
JP,CYTOMEGALOVIRUS ENTEROCOLITIS,1
JP,DEAFNESS,1
JP,DECREASED IMMUNE RESPONSIVENESS,1
JP,DERMATITIS ACNEIFORM,1
JP,DERMATITIS EXFOLIATIVE,1
JP,DERMATITIS PSORIASIFORM,1
JP,DIABETES MELLITUS INADEQUATE CONTROL,1
JP,DIALYSIS,1
JP,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
JP,DISCOMFORT,1
JP,DISEASE RECURRENCE,1
JP,DISLOCATION OF VERTEBRA,1
JP,DISUSE SYNDROME,1
JP,DIVERTICULAR PERFORATION,1
JP,DIVERTICULITIS,1
JP,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
JP,DOPAMINE DYSREGULATION SYNDROME,1
JP,DRUG LEVEL INCREASED,1
JP,DRY EYE,1
JP,DUODENAL ULCER,1
JP,DYSKINESIA,1
JP,DYSLALIA,1
JP,DYSPHONIA,1
JP,DYSURIA,1
JP,ECZEMA,1
JP,EFFUSION,1
JP,ELECTROCARDIOGRAM ABNORMAL,1
JP,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
JP,ELECTROLYTE DEPLETION,1
JP,ELECTROLYTE IMBALANCE,1
JP,EMBOLIC CEREBRAL INFARCTION,1
JP,ENANTHEMA,1
JP,ENCEPHALITIS VIRAL,1
JP,ENCEPHALOPATHY,1
JP,ENDOCARDITIS,1
JP,ENDOMETRIAL ATROPHY,1
JP,ENDOMETRITIS,1
JP,ENGRAFTMENT SYNDROME,1
JP,ENTEROCOCCAL BACTERAEMIA,1
JP,ENTEROCOCCAL SEPSIS,1
JP,ENTEROCOLITIS VIRAL,1
JP,EOSINOPHIL COUNT DECREASED,1
JP,EPIDERMAL NECROSIS,1
JP,EPIDIDYMITIS,1
JP,EPILEPSY,1
JP,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
JP,EPSTEIN-BARR VIRUS INFECTION,1
JP,ERECTILE DYSFUNCTION,1
JP,ERYTHEMA NODOSUM,1
JP,ESCHERICHIA INFECTION,1
JP,ESCHERICHIA SEPSIS,1
JP,ESCHERICHIA TEST POSITIVE,1
JP,EXCORIATION,1
JP,EXTENSOR PLANTAR RESPONSE,1
JP,EXTRAPYRAMIDAL DISORDER,1
JP,EXTRASYSTOLES,1
JP,EYE DISCHARGE,1
JP,EYELID PTOSIS,1
JP,FACIAL BONES FRACTURE,1
JP,FAECALOMA,1
JP,FAMILIAL MEDITERRANEAN FEVER,1
JP,FANCONI SYNDROME,1
JP,FEELING COLD,1
JP,FEELING HOT,1
JP,FIBRIN D DIMER INCREASED,1
JP,FULL BLOOD COUNT DECREASED,1
JP,GALLBLADDER DISORDER,1
JP,GASTRECTOMY,1
JP,GASTRIC HAEMORRHAGE,1
JP,GASTRIC ULCER PERFORATION,1
JP,GASTROENTERITIS,1
JP,GASTROENTERITIS ESCHERICHIA COLI,1
JP,GASTROINTESTINAL CARCINOMA,1
JP,GASTROINTESTINAL DISORDER,1
JP,GASTROINTESTINAL HYPOMOTILITY,1
JP,GASTROINTESTINAL TRACT MUCOSAL DISCOLOURATION,1
JP,GASTROOESOPHAGEAL REFLUX DISEASE,1
JP,GAZE PALSY,1
JP,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
JP,GENITAL CANDIDIASIS,1
JP,GENITAL HAEMORRHAGE,1
JP,GLIOMA,1
JP,GLOMERULAR FILTRATION RATE DECREASED,1
JP,GLOMERULAR FILTRATION RATE INCREASED,1
JP,GLUCOSE TOLERANCE IMPAIRED,1
JP,GOITRE,1
JP,GOODPASTURE^S SYNDROME,1
JP,GRAFT VERSUS HOST DISEASE IN LIVER,1
JP,GRANULOCYTE COUNT DECREASED,1
JP,GRIP STRENGTH DECREASED,1
JP,HAEMATOMA,1
JP,HAEMATOTOXICITY,1
JP,HAEMODIALYSIS COMPLICATION,1
JP,HAEMOGLOBIN INCREASED,1
JP,HAEMOPHILUS INFECTION,1
JP,HAEMORRHAGE INTRACRANIAL,1
JP,HAEMORRHAGE SUBCUTANEOUS,1
JP,HAEMORRHAGIC ASCITES,1
JP,HAEMORRHAGIC INFARCTION,1
JP,HAEMOSIDEROSIS,1
JP,HAIR DISORDER,1
JP,HALLUCINATION_ AUDITORY,1
JP,HEAT ILLNESS,1
JP,HEMIANOPIA,1
JP,HEMIPLEGIA,1
JP,HEPATIC CANCER RECURRENT,1
JP,HEPATIC MASS,1
JP,HEPATIC STEATOSIS,1
JP,HEPATITIS B REACTIVATION,1
JP,HEPATITIS C,1
JP,HEPATITIS E,1
JP,HEPATOBILIARY DISEASE,1
JP,HEPATOPULMONARY SYNDROME,1
JP,HERPES VIRUS INFECTION,1
JP,HERPES ZOSTER DISSEMINATED,1
JP,HERPES ZOSTER OTICUS,1
JP,HISTIOCYTOSIS HAEMATOPHAGIC,1
JP,HOT FLUSH,1
JP,HYDROCEPHALUS,1
JP,HYPERAMYLASAEMIA,1
JP,HYPERGASTRINAEMIA,1
JP,HYPERKERATOSIS,1
JP,HYPERSENSITIVITY,1
JP,HYPERTHYROIDISM,1
JP,HYPOCOAGULABLE STATE,1
JP,HYPOGAMMAGLOBULINAEMIA,1
JP,HYPOGEUSIA,1
JP,HYPOPHOSPHATAEMIA,1
JP,HYPOPITUITARISM,1
JP,HYPOTHERMIA,1
JP,HYPOVOLAEMIC SHOCK,1
JP,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
JP,IGA NEPHROPATHY,1
JP,IIIRD NERVE PARALYSIS,1
JP,ILEAL PERFORATION,1
JP,ILEAL ULCER,1
JP,ILEUS PARALYTIC,1
JP,IMPAIRED GASTRIC EMPTYING,1
JP,IMPULSE-CONTROL DISORDER,1
JP,INCISION SITE HAEMATOMA,1
JP,INCOHERENT,1
JP,INCONTINENCE,1
JP,INFECTED DERMAL CYST,1
JP,INFECTIVE SPONDYLITIS,1
JP,INFECTIVE THROMBOSIS,1
JP,INGROWING NAIL,1
JP,INGUINAL HERNIA REPAIR,1
JP,INJECTION SITE EXTRAVASATION,1
JP,INJECTION SITE INDURATION,1
JP,INJECTION SITE RASH,1
JP,INTENTIONAL SELF-INJURY,1
JP,INTERCAPILLARY GLOMERULOSCLEROSIS,1
JP,INTERNAL HERNIA,1
JP,INTERNATIONAL NORMALISED RATIO INCREASED,1
JP,INTERVERTEBRAL DISC DEGENERATION,1
JP,INTESTINAL DILATATION,1
JP,INTESTINAL HAEMATOMA,1
JP,INTESTINAL PSEUDO-OBSTRUCTION,1
JP,INTESTINAL SEPSIS,1
JP,IRON OVERLOAD,1
JP,ISCHAEMIA,1
JP,ISCHAEMIC STROKE,1
JP,JEJUNAL PERFORATION,1
JP,KLEBSIELLA SEPSIS,1
JP,LABORATORY TEST ABNORMAL,1
JP,LACERATION,1
JP,LARGE INTESTINAL OBSTRUCTION,1
JP,LARGE INTESTINAL STENOSIS,1
JP,LARGE INTESTINE EROSION,1
JP,LARGE INTESTINE POLYP,1
JP,LARYNGEAL CANCER,1
JP,LARYNGEAL STENOSIS,1
JP,LEFT VENTRICULAR HYPERTROPHY,1
JP,LEUKODERMA,1
JP,LICHENIFICATION,1
JP,LIMB DISCOMFORT,1
JP,LIMBIC ENCEPHALITIS,1
JP,LIP AND/OR ORAL CAVITY CANCER,1
JP,LIP EROSION,1
JP,LIP ERYTHEMA,1
JP,LIP SWELLING,1
JP,LIPASE INCREASED,1
JP,LISTLESS,1
JP,LIVER ABSCESS,1
JP,LIVER INJURY,1
JP,LOBAR PNEUMONIA,1
JP,LOGORRHOEA,1
JP,LOW BIRTH WEIGHT BABY,1
JP,LUNG CONSOLIDATION,1
JP,LUNG CYST,1
JP,LUNG INFILTRATION,1
JP,LYMPHOCYTE STIMULATION TEST POSITIVE,1
JP,LYMPHOCYTIC INFILTRATION,1
JP,LYMPHOPROLIFERATIVE DISORDER,1
JP,MANIA,1
JP,MASTITIS,1
JP,MENINGITIS,1
JP,MENINGOENCEPHALITIS HERPETIC,1
JP,MENTAL DISORDER,1
JP,MESENTERIC PANNICULITIS,1
JP,METASTASES TO BONE,1
JP,METASTASES TO LYMPH NODES,1
JP,METASTATIC RENAL CELL CARCINOMA,1
JP,MONOCYTE COUNT INCREASED,1
JP,MONONEUROPATHY MULTIPLEX,1
JP,MONOPLEGIA,1
JP,MOUTH ULCERATION,1
JP,MOVEMENT DISORDER,1
JP,MUCOSAL EXCORIATION,1
JP,MULTI-ORGAN DISORDER,1
JP,MUSCLE ATROPHY,1
JP,MUSCLE HAEMORRHAGE,1
JP,MUSCLE RIGIDITY,1
JP,MUSCULOSKELETAL PAIN,1
JP,MYASTHENIA GRAVIS,1
JP,MYCOSIS FUNGOIDES,1
JP,MYOCARDIAL ISCHAEMIA,1
JP,MYOCLONUS,1
JP,MYOPATHY,1
JP,NARCOLEPSY,1
JP,NASAL CONGESTION,1
JP,NASAL SINUS CANCER,1
JP,NECK PAIN,1
JP,NECROTISING COLITIS,1
JP,NEOPLASM MALIGNANT,1
JP,NEPHROGENIC ANAEMIA,1
JP,NEPHROGENIC DIABETES INSIPIDUS,1
JP,NEPHROLITHIASIS,1
JP,NEPHROTIC SYNDROME,1
JP,NERVOUS SYSTEM DISORDER,1
JP,NEURALGIA,1
JP,NEUROLEPTIC MALIGNANT SYNDROME,1
JP,NEUROMUSCULAR BLOCK PROLONGED,1
JP,NEUTROPHIL PERCENTAGE INCREASED,1
JP,NODAL MARGINAL ZONE B-CELL LYMPHOMA,1
JP,OBSTRUCTION GASTRIC,1
JP,OCCULT BLOOD POSITIVE,1
JP,OCULOMUCOCUTANEOUS SYNDROME,1
JP,OESOPHAGEAL CANDIDIASIS,1
JP,OESOPHAGEAL DISORDER,1
JP,OESOPHAGEAL FISTULA,1
JP,OESOPHAGEAL HAEMORRHAGE,1
JP,OESOPHAGEAL MUCOSA ERYTHEMA,1
JP,OESOPHAGEAL OEDEMA,1
JP,OESOPHAGEAL PERFORATION,1
JP,OESOPHAGEAL STENOSIS,1
JP,OESOPHAGEAL VARICES HAEMORRHAGE,1
JP,OPHTHALMIC HERPES SIMPLEX,1
JP,ORAL DISCOMFORT,1
JP,ORAL HERPES,1
JP,ORAL MUCOSA EROSION,1
JP,OROPHARYNGEAL CANCER,1
JP,ORTHOSTATIC HYPOTENSION,1
JP,OSTEITIS,1
JP,OSTEOARTHRITIS,1
JP,OSTEOMYELITIS,1
JP,OSTEONECROSIS OF JAW,1
JP,OSTEOSCLEROSIS,1
JP,OTITIS MEDIA,1
JP,PAIN IN EXTREMITY,1
JP,PALATAL DYSPLASIA,1
JP,PALLOR,1
JP,PANCREATIC CARCINOMA METASTATIC,1
JP,PAPULE,1
JP,PARALYSIS,1
JP,PARANASAL SINUS NEOPLASM,1
JP,PAROSMIA,1
JP,PATELLA FRACTURE,1
JP,PATHOGEN RESISTANCE,1
JP,PENILE OEDEMA,1
JP,PENILE SWELLING,1
JP,PERFORMANCE STATUS DECREASED,1
JP,PERICARDIAL EFFUSION,1
JP,PERICARDIAL HAEMORRHAGE,1
JP,PERINEAL ABSCESS,1
JP,PERIPHERAL SENSORY NEUROPATHY,1
JP,PERIPHERAL SWELLING,1
JP,PERITONEAL ADHESIONS,1
JP,PERITONEAL DISORDER,1
JP,PERIVENTRICULAR LEUKOMALACIA,1
JP,PETIT MAL EPILEPSY,1
JP,PHLEBITIS,1
JP,PLASMABLASTIC LYMPHOMA,1
JP,PLASMACYTOMA,1
JP,PNEUMOTHORAX TRAUMATIC,1
JP,POLYDIPSIA,1
JP,POLYMYALGIA RHEUMATICA,1
JP,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
JP,POLYURIA,1
JP,POST HERPETIC NEURALGIA,1
JP,POST TRANSPLANT DISTAL LIMB SYNDROME,1
JP,PRECURSOR B-LYMPHOBLASTIC LYMPHOMA RECURRENT,1
JP,PREMATURE LABOUR,1
JP,PRERENAL FAILURE,1
JP,PRESCRIBED OVERDOSE,1
JP,PRINZMETAL ANGINA,1
JP,PROCTALGIA,1
JP,PRODUCT USE IN UNAPPROVED INDICATION,1
JP,PROSTATITIS,1
JP,PROTEIN URINE PRESENT,1
JP,PROTEUS TEST POSITIVE,1
JP,PRURITUS ALLERGIC,1
JP,PSEUDOMONAS INFECTION,1
JP,PSORIASIS,1
JP,PULMONARY ARTERY THROMBOSIS,1
JP,PULMONARY CAVITATION,1
JP,PULMONARY CONTUSION,1
JP,PULMONARY TUBERCULOSIS,1
JP,PUNCTURE SITE HAEMORRHAGE,1
JP,PUTAMEN HAEMORRHAGE,1
JP,PYOMYOSITIS,1
JP,PYURIA,1
JP,RADIATION PNEUMONITIS,1
JP,RASH ERYTHEMATOUS,1
JP,RASH PUSTULAR,1
JP,RASH VESICULAR,1
JP,RENAL ATROPHY,1
JP,RENAL CELL CARCINOMA,1
JP,RENAL CYST,1
JP,RENAL FAILURE CHRONIC,1
JP,RENAL HAEMORRHAGE,1
JP,RENAL TUBULAR ACIDOSIS,1
JP,RENAL TUBULAR DISORDER,1
JP,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
JP,RETINAL DETACHMENT,1
JP,RETINAL HAEMORRHAGE,1
JP,RETINAL TEAR,1
JP,RETROPERITONEAL ABSCESS,1
JP,RETROPERITONEAL CANCER,1
JP,RHINORRHOEA,1
JP,ROSEOLOVIRUS TEST POSITIVE,1
JP,SALIVA DISCOLOURATION,1
JP,SALMONELLA BACTERAEMIA,1
JP,SCAR,1
JP,SCHIZOPHRENIA,1
JP,SCLERODERMA,1
JP,SCREAMING,1
JP,SCROTAL OEDEMA,1
JP,SCROTAL SWELLING,1
JP,SEBORRHOEIC DERMATITIS,1
JP,SEDATION,1
JP,SEROTONIN SYNDROME,1
JP,SKIN ABRASION,1
JP,SKIN CANDIDA,1
JP,SKIN DEGENERATIVE DISORDER,1
JP,SKIN EROSION,1
JP,SKIN EXFOLIATION,1
JP,SKIN GRAFT,1
JP,SKIN INDURATION,1
JP,SKIN IRRITATION,1
JP,SKIN MASS,1
JP,SMALL CELL LUNG CANCER METASTATIC,1
JP,SMALL INTESTINAL HAEMORRHAGE,1
JP,SMALL INTESTINAL STENOSIS,1
JP,SPEECH DISORDER,1
JP,SPINAL CORD COMPRESSION,1
JP,SPLENIC INFARCTION,1
JP,SPLENIC VEIN THROMBOSIS,1
JP,SQUAMOUS CELL CARCINOMA OF LUNG,1
JP,STAPHYLOCOCCAL BACTERAEMIA,1
JP,STATUS EPILEPTICUS,1
JP,SUBCUTANEOUS ABSCESS,1
JP,SUBDURAL HAEMORRHAGE,1
JP,SWELLING,1
JP,SYNCOPE,1
JP,TACHYCARDIA PAROXYSMAL,1
JP,TACHYPNOEA,1
JP,TAKAYASU^S ARTERITIS,1
JP,TELANGIECTASIA,1
JP,TENDON RUPTURE,1
JP,TENOSYNOVITIS,1
JP,TETANY,1
JP,THROMBOSIS IN DEVICE,1
JP,THROMBOSIS MESENTERIC VESSEL,1
JP,THROMBOTIC CEREBRAL INFARCTION,1
JP,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
JP,THYROID ATROPHY,1
JP,TIBIA FRACTURE,1
JP,TONGUE HAEMORRHAGE,1
JP,TONSILLAR HYPERTROPHY,1
JP,TOXIC EPIDERMAL NECROLYSIS,1
JP,TOXIC SKIN ERUPTION,1
JP,TRACHEAL HAEMORRHAGE,1
JP,TRANSAMINASES INCREASED,1
JP,TRANSIENT ISCHAEMIC ATTACK,1
JP,TRAUMATIC HAEMORRHAGE,1
JP,TRAUMATIC HAEMOTHORAX,1
JP,TRI-IODOTHYRONINE FREE DECREASED,1
JP,ULCER,1
JP,UNEVALUABLE EVENT,1
JP,UPPER AIRWAY OBSTRUCTION,1
JP,URETERIC STENOSIS,1
JP,URINARY TRACT INFECTION PSEUDOMONAL,1
JP,URINE KETONE BODY PRESENT,1
JP,URINE OSMOLARITY INCREASED,1
JP,URINE SODIUM INCREASED,1
JP,UTERINE HAEMORRHAGE,1
JP,VARICES OESOPHAGEAL,1
JP,VASCULAR CALCIFICATION,1
JP,VENOOCCLUSIVE DISEASE,1
JP,VENOUS THROMBOSIS,1
JP,VENTRICULAR EXTRASYSTOLES,1
JP,VENTRICULAR FLUTTER,1
JP,VIRAL HAEMORRHAGIC CYSTITIS,1
JP,VISION BLURRED,1
JP,VISUAL IMPAIRMENT,1
JP,VITAMIN B1 DEFICIENCY,1
JP,VITH NERVE PARALYSIS,1
JP,VITREOUS HAEMORRHAGE,1
JP,VITREOUS OPACITIES,1
JP,VULVAR EROSION,1
JP,VULVOVAGINAL CANDIDIASIS,1
JP,VULVOVAGINAL WARTS,1
JP,WALKING DISABILITY,1
JP,WEIGHT DECREASED,1
JP,WHEEZING,1
JP,WOUND HAEMORRHAGE,1
JP,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
JO,GASTRIC VARICES HAEMORRHAGE,1
JO,INTESTINAL VARICES HAEMORRHAGE,1
JO,INVASIVE DUCTAL BREAST CARCINOMA,1
KZ,ADENOCARCINOMA GASTRIC,1
KZ,ASTHMA,1
KZ,DEEP VEIN THROMBOSIS,1
KZ,HAEMOTHORAX,1
KZ,LUNG NEOPLASM,1
KZ,PULMONARY TUBERCULOSIS,1
KE,RENAL FAILURE ACUTE,5
KE,ANAEMIA,3
KE,DEATH,2
KE,ENCEPHALITIS,2
KE,HYPERKALAEMIA,2
KE,MENINGITIS CRYPTOCOCCAL,2
KE,ABDOMINAL DISTENSION,1
KE,ABDOMINAL PAIN,1
KE,CACHEXIA,1
KE,CONSTIPATION,1
KE,DECREASED APPETITE,1
KE,DIARRHOEA,1
KE,DIZZINESS,1
KE,EXTRAPULMONARY TUBERCULOSIS,1
KE,FATIGUE,1
KE,GASTROENTERITIS,1
KE,HAEMOGLOBIN DECREASED,1
KE,HAEMORRHAGE,1
KE,HYPOKALAEMIA,1
KE,LEUKOPENIA,1
KE,LIVER ABSCESS,1
KE,MENINGITIS BACTERIAL,1
KE,MENINGITIS TUBERCULOUS,1
KE,MYELITIS TRANSVERSE,1
KE,NAUSEA,1
KE,NEUROPATHY PERIPHERAL,1
KE,NEUTROPENIA,1
KE,OESOPHAGEAL CANDIDIASIS,1
KE,OESOPHAGEAL IRRITATION,1
KE,ORAL CANDIDIASIS,1
KE,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
KE,PNEUMONIA,1
KE,PULMONARY TUBERCULOSIS,1
KE,RASH,1
KE,SEPSIS,1
KE,THROMBOCYTOPENIA,1
KE,TINNITUS,1
KE,VOMITING,1
KR,GASTRIC HAEMORRHAGE,6
KR,GASTROOESOPHAGEAL REFLUX DISEASE,4
KR,ANAEMIA,2
KR,DYSPEPSIA,2
KR,PYELONEPHRITIS ACUTE,2
KR,BENIGN GASTRIC NEOPLASM,1
KR,CARDIAC DEATH,1
KR,CEREBROVASCULAR ACCIDENT,1
KR,CONSTIPATION,1
KR,DELIRIUM,1
KR,DYSPHAGIA,1
KR,EPISTAXIS,1
KR,FLUID RETENTION,1
KR,HAEMOPTYSIS,1
KR,HAEMORRHAGE INTRACRANIAL,1
KR,HYPERTENSION,1
KR,INSOMNIA,1
KR,LIVER FUNCTION TEST INCREASED,1
KR,LUNG ADENOCARCINOMA,1
KR,MUSCLE HAEMORRHAGE,1
KR,MYALGIA,1
KR,MYOCARDIAL INFARCTION,1
KR,NEUTROPHIL COUNT DECREASED,1
KR,PERINEAL ERYTHEMA,1
KR,PLATELET COUNT DECREASED,1
KR,PNEUMONIA,1
KR,PNEUMONITIS,1
KR,PULMONARY EMBOLISM,1
KR,REGURGITATION,1
KR,RENAL CYST INFECTION,1
KW,ANAEMIA,3
KW,RHABDOMYOLYSIS,3
KW,ACUTE KIDNEY INJURY,2
KW,ANURIA,2
KW,ASPARTATE AMINOTRANSFERASE INCREASED,1
KW,BLOOD BILIRUBIN INCREASED,1
KW,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
KW,DRUG INEFFECTIVE,1
KW,DRUG LEVEL INCREASED,1
KW,FATIGUE,1
KW,MYALGIA,1
LA,DYSPNOEA,3
LA,HYPOKALAEMIA,3
LA,DIARRHOEA,1
LA,TOXIC EPIDERMAL NECROLYSIS,1
LV,DYSPNOEA,2
LV,GASTROINTESTINAL HAEMORRHAGE,2
LV,CHEST DISCOMFORT,1
LV,CHILLS,1
LV,CHOLANGIOCARCINOMA,1
LV,EPISTAXIS,1
LV,HEADACHE,1
LV,HYDROTHORAX,1
LV,HYPERHIDROSIS,1
LV,HYPERTENSIVE CRISIS,1
LV,ILEAL ULCER,1
LV,INFUSION SITE PAIN,1
LV,LIP OEDEMA,1
LV,MYALGIA,1
LV,NAUSEA,1
LV,OEDEMA MOUTH,1
LV,OEDEMA PERIPHERAL,1
LV,PALLOR,1
LV,PULMONARY EMBOLISM,1
LV,PYELONEPHRITIS CHRONIC,1
LV,PYREXIA,1
LV,RECTAL HAEMORRHAGE,1
LV,RENAL PAIN,1
LV,TRANSAMINASES INCREASED,1
LV,UTERINE HAEMORRHAGE,1
LV,VOMITING,1
LB,FATIGUE,3
LB,BACK PAIN,2
LB,BLOOD URIC ACID INCREASED,2
LB,GENERAL PHYSICAL HEALTH DETERIORATION,2
LB,HYPERTENSION,2
LB,LINEAR IGA DISEASE,2
LB,OEDEMA,2
LB,PAIN,2
LB,ABDOMINAL PAIN UPPER,1
LB,ASTHENIA,1
LB,BARRETT^S OESOPHAGUS,1
LB,BILE DUCT STONE,1
LB,BLISTER,1
LB,BLOOD PRESSURE ORTHOSTATIC ABNORMAL,1
LB,CARDIAC ARREST,1
LB,CEREBRAL ARTERY EMBOLISM,1
LB,CEREBROVASCULAR ACCIDENT,1
LB,CERVICAL RADICULOPATHY,1
LB,CHOLECYSTECTOMY,1
LB,DEATH,1
LB,DEHYDRATION,1
LB,DERMATITIS BULLOUS,1
LB,DRUG INEFFECTIVE,1
LB,EAR INFECTION,1
LB,EAR PAIN,1
LB,ENDOSCOPY UPPER GASTROINTESTINAL TRACT,1
LB,ERYTHEMA,1
LB,GASTRIC DISORDER,1
LB,GENERALISED OEDEMA,1
LB,GYNAECOMASTIA,1
LB,HAEMATOCRIT DECREASED,1
LB,HEADACHE,1
LB,HEPATIC FAILURE,1
LB,HERNIA HIATUS REPAIR,1
LB,HIATUS HERNIA,1
LB,HYPERPHOSPHATAEMIA,1
LB,HYPERSENSITIVITY,1
LB,HYPOAESTHESIA,1
LB,HYPONATRAEMIA,1
LB,HYPOTENSION,1
LB,INFLUENZA,1
LB,LOSS OF CONSCIOUSNESS,1
LB,LYMPHOPENIA,1
LB,MENINGITIS LISTERIA,1
LB,METASTATIC RENAL CELL CARCINOMA,1
LB,MOBILITY DECREASED,1
LB,MYOCARDIAL INFARCTION,1
LB,NAUSEA,1
LB,NEURALGIA,1
LB,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
LB,OEDEMA PERIPHERAL,1
LB,OESOPHAGEAL HYPOMOTILITY,1
LB,PALPITATIONS,1
LB,PANCREATIC MASS,1
LB,PLASMA CELL MYELOMA,1
LB,PLASMA CELL MYELOMA RECURRENT,1
LB,PLATELET COUNT DECREASED,1
LB,PYREXIA,1
LB,RED BLOOD CELL COUNT DECREASED,1
LB,RENAL FAILURE,1
LB,RENAL PAIN,1
LB,SCAB,1
LB,SKIN EROSION,1
LB,SPINAL FRACTURE,1
LB,STAPHYLOCOCCAL INFECTION,1
LB,TYMPANIC MEMBRANE PERFORATION,1
LB,URINE OUTPUT DECREASED,1
LB,VERTIGO,1
LB,WHITE BLOOD CELL COUNT DECREASED,1
LB,WHITE BLOOD CELL COUNT INCREASED,1
LS,LARYNGITIS,3
LS,PULMONARY TUBERCULOSIS,3
LS,RESPIRATORY DISTRESS,3
LS,HYPOKALAEMIA,2
LS,AIDS RELATED COMPLICATION,1
LS,ANAEMIA,1
LS,CARDIAC FAILURE CONGESTIVE,1
LS,DEAFNESS,1
LS,ELECTROCARDIOGRAM QT PROLONGED,1
LS,GASTROENTERITIS,1
LS,HAEMOGLOBIN DECREASED,1
LS,HYPOVOLAEMIC SHOCK,1
LS,INTENTIONAL PRODUCT USE ISSUE,1
LS,PNEUMONIA,1
LS,PULMONARY OEDEMA,1
LS,RENAL FAILURE,1
LS,RESPIRATORY FAILURE,1
LS,SUDDEN DEATH,1
LY,ACUTE RESPIRATORY DISTRESS SYNDROME,1
LY,LOWER RESPIRATORY TRACT INFECTION,1
LY,UPPER RESPIRATORY TRACT CONGESTION,1
LT,CHEST X-RAY ABNORMAL,1
LT,OSTEOARTHRITIS,1
LT,PLEOMORPHIC ADENOMA,1
LT,POLYARTHRITIS,1
LU,DYSPNOEA,2
LU,ABDOMINAL PAIN,1
LU,ARRHYTHMIA,1
LU,DIARRHOEA,1
LU,ENCEPHALOPATHY,1
LU,GENERAL PHYSICAL HEALTH DETERIORATION,1
LU,GRANULOMA,1
LU,HAEMATEMESIS,1
LU,HEPATIC FAILURE,1
LU,HOT FLUSH,1
LU,INTERVERTEBRAL DISC PROTRUSION,1
LU,MUSCLE SPASMS,1
LU,MYOCARDIAL INFARCTION,1
LU,PNEUMONIA,1
LU,PRURITUS,1
LU,PULMONARY MASS,1
LU,RASH ERYTHEMATOUS,1
LU,RHABDOMYOLYSIS,1
LU,SARCOIDOSIS,1
MK,ERYTHEMA,1
MK,INJECTION SITE ERYTHEMA,1
MK,MULTI-ORGAN FAILURE,1
MK,SKIN NECROSIS,1
MW,ANAEMIA,1
MY,DYSPNOEA,5
MY,PNEUMONIA,4
MY,PYREXIA,4
MY,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,3
MY,DIARRHOEA,3
MY,NAUSEA,3
MY,ABDOMINAL PAIN,2
MY,ABDOMINAL PAIN UPPER,2
MY,ACUTE PULMONARY OEDEMA,2
MY,ANAEMIA,2
MY,ARTHRALGIA,2
MY,BLOOD ALKALINE PHOSPHATASE INCREASED,2
MY,BONE PAIN,2
MY,CARDIAC FAILURE,2
MY,CONSTIPATION,2
MY,DECREASED APPETITE,2
MY,DISEASE PROGRESSION,2
MY,DYSPHAGIA,2
MY,FLUID OVERLOAD,2
MY,HEPATIC ENZYME ABNORMAL,2
MY,INFECTION,2
MY,LETHARGY,2
MY,MYALGIA,2
MY,PLEURAL EFFUSION,2
MY,RASH,2
MY,SEPTIC SHOCK,2
MY,TUBERCULOSIS,2
MY,ABDOMINAL DISCOMFORT,1
MY,ABDOMINAL RIGIDITY,1
MY,ACUTE ABDOMEN,1
MY,ACUTE CORONARY SYNDROME,1
MY,ACUTE GRAFT VERSUS HOST DISEASE,1
MY,ACUTE KIDNEY INJURY,1
MY,ACUTE MYOCARDIAL INFARCTION,1
MY,ADENOCARCINOMA OF COLON,1
MY,ALANINE AMINOTRANSFERASE INCREASED,1
MY,ANEURYSM,1
MY,ANGIOEDEMA,1
MY,AORTIC ANEURYSM,1
MY,AORTIC ARTERIOSCLEROSIS,1
MY,APHTHOUS ULCER,1
MY,ASPARTATE AMINOTRANSFERASE INCREASED,1
MY,ATRIAL FIBRILLATION,1
MY,BLOOD BILIRUBIN INCREASED,1
MY,BLOOD CREATININE INCREASED,1
MY,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MY,BREAST CANCER,1
MY,BRONCHOSPASM,1
MY,CARDIAC ARREST,1
MY,CARDIOMEGALY,1
MY,CENTRAL NERVOUS SYSTEM LESION,1
MY,CHEST DISCOMFORT,1
MY,CHRONIC GASTRITIS,1
MY,CHRONIC KIDNEY DISEASE,1
MY,CHRONIC MYELOID LEUKAEMIA,1
MY,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
MY,CIRCUMORAL OEDEMA,1
MY,COMPRESSION FRACTURE,1
MY,CONJUNCTIVITIS,1
MY,CORONARY ARTERY DISEASE,1
MY,CREPITATIONS,1
MY,DEEP VEIN THROMBOSIS,1
MY,DEVICE RELATED INFECTION,1
MY,DEVICE RELATED SEPSIS,1
MY,DIZZINESS,1
MY,DRUG INTOLERANCE,1
MY,END STAGE RENAL DISEASE,1
MY,EOSINOPHIL COUNT DECREASED,1
MY,ERYTHEMA MULTIFORME,1
MY,EYE SWELLING,1
MY,FLANK PAIN,1
MY,FLATULENCE,1
MY,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
MY,GASTROINTESTINAL HAEMORRHAGE,1
MY,GENERAL PHYSICAL HEALTH DETERIORATION,1
MY,GLOMERULAR FILTRATION RATE DECREASED,1
MY,HAEMODIALYSIS,1
MY,HAEMOGLOBIN DECREASED,1
MY,HAEMORRHOIDAL HAEMORRHAGE,1
MY,HEPARIN-INDUCED THROMBOCYTOPENIA,1
MY,HYPERSENSITIVITY,1
MY,HYPOGLYCAEMIA,1
MY,HYPOKALAEMIA,1
MY,HYPORESPONSIVE TO STIMULI,1
MY,INTERVERTEBRAL DISCITIS,1
MY,INTESTINAL ISCHAEMIA,1
MY,LIPASE INCREASED,1
MY,LIVER FUNCTION TEST ABNORMAL,1
MY,LUNG INFECTION,1
MY,LYMPHOCYTE COUNT DECREASED,1
MY,MALAISE,1
MY,MALIGNANT HYPERTENSION,1
MY,MALIGNANT NEOPLASM PROGRESSION,1
MY,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
MY,MEAN CELL HAEMOGLOBIN DECREASED,1
MY,MEAN CELL VOLUME ABNORMAL,1
MY,METASTASES TO LIVER,1
MY,METASTASES TO LUNG,1
MY,MOUTH ULCERATION,1
MY,MUCOSAL INFLAMMATION,1
MY,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
MY,MUSCULAR WEAKNESS,1
MY,MUSCULOSKELETAL CHEST PAIN,1
MY,MYOCARDIAL INFARCTION,1
MY,MYOCARDIAL ISCHAEMIA,1
MY,NEPHROGENIC ANAEMIA,1
MY,NEUTROPENIC SEPSIS,1
MY,NEUTROPHIL COUNT INCREASED,1
MY,NODULE,1
MY,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
MY,PERIORBITAL OEDEMA,1
MY,PERIPHERAL VASCULAR DISORDER,1
MY,PHOTOPHOBIA,1
MY,PLASMA CELL MYELOMA,1
MY,RASH MACULO-PAPULAR,1
MY,RECTAL TENESMUS,1
MY,RED BLOOD CELL COUNT INCREASED,1
MY,RED CELL DISTRIBUTION WIDTH INCREASED,1
MY,REFUSAL OF TREATMENT BY PATIENT,1
MY,RENAL CELL CARCINOMA,1
MY,RESPIRATORY DISTRESS,1
MY,RESPIRATORY FAILURE,1
MY,RHINORRHOEA,1
MY,ROAD TRAFFIC ACCIDENT,1
MY,SECOND PRIMARY MALIGNANCY,1
MY,SEPSIS,1
MY,SKIN FISSURES,1
MY,SOFT TISSUE INJURY,1
MY,STAPHYLOCOCCAL INFECTION,1
MY,SWELLING FACE,1
MY,THROMBOCYTOPENIA,1
MY,THROMBOPHLEBITIS,1
MY,URINARY TRACT INFECTION,1
MY,URTICARIA,1
MY,VASCULITIS,1
MY,VISION BLURRED,1
MY,VOMITING,1
MY,WEIGHT DECREASED,1
MT,ATRIAL FIBRILLATION,2
MT,COUGH,2
MT,DIZZINESS,2
MT,HEPATIC ENCEPHALOPATHY,2
MT,PAIN,2
MT,SYNCOPE,2
MT,ABSCESS RUPTURE,1
MT,ACUTE KIDNEY INJURY,1
MT,ANAEMIA,1
MT,ANAL ATRESIA,1
MT,ANTINUCLEAR ANTIBODY INCREASED,1
MT,ARRHYTHMIA,1
MT,ASCITES,1
MT,BALANCE DISORDER,1
MT,CAMPYLOBACTER TEST POSITIVE,1
MT,CHILLS,1
MT,CROHN^S DISEASE,1
MT,DELIRIUM,1
MT,DISEASE RECURRENCE,1
MT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
MT,DRUG LEVEL DECREASED,1
MT,DRUG SPECIFIC ANTIBODY PRESENT,1
MT,DRUG WITHDRAWAL SYNDROME,1
MT,DYSSTASIA,1
MT,EMBOLISM,1
MT,FAECAL CALPROTECTIN INCREASED,1
MT,FAECES DISCOLOURED,1
MT,FATIGUE,1
MT,FEELING OF DESPAIR,1
MT,GASTROINTESTINAL HAEMORRHAGE,1
MT,HAEMOGLOBIN DECREASED,1
MT,HEPATIC FUNCTION ABNORMAL,1
MT,HIP FRACTURE,1
MT,HYPERHIDROSIS,1
MT,HYPOTENSION,1
MT,INTESTINAL ISCHAEMIA,1
MT,LABORATORY TEST ABNORMAL,1
MT,LARGE INTESTINE POLYP,1
MT,LIVER ABSCESS,1
MT,LOSS OF CONSCIOUSNESS,1
MT,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
MT,MESENTERIC VEIN THROMBOSIS,1
MT,MOBILITY DECREASED,1
MT,NAUSEA,1
MT,OEDEMA,1
MT,OESOPHAGEAL VARICES HAEMORRHAGE,1
MT,ORAL CANDIDIASIS,1
MT,OSTEOPOROSIS,1
MT,PETECHIAE,1
MT,PORTAL VEIN THROMBOSIS,1
MT,POST PROCEDURAL COMPLICATION,1
MT,PULMONARY EMBOLISM,1
MT,PYREXIA,1
MT,SEPSIS,1
MT,SPINAL FRACTURE,1
MT,TRISOMY 21,1
MT,UPPER LIMB FRACTURE,1
MU,PARONYCHIA,1
MU,PYOGENIC GRANULOMA,1
MX,DIARRHOEA,36
MX,FALL,32
MX,FATIGUE,31
MX,PRODUCT USE ISSUE,28
MX,ASTHENIA,27
MX,ARTHRALGIA,25
MX,VOMITING,23
MX,DIZZINESS,22
MX,GAIT DISTURBANCE,22
MX,MALAISE,22
MX,PAIN IN EXTREMITY,22
MX,COUGH,20
MX,HEADACHE,20
MX,PNEUMONIA,20
MX,WEIGHT DECREASED,20
MX,NAUSEA,19
MX,PAIN,19
MX,PYREXIA,19
MX,DECREASED APPETITE,18
MX,DRUG INEFFECTIVE,18
MX,DYSPNOEA,18
MX,URINARY TRACT INFECTION,18
MX,FEELING ABNORMAL,17
MX,DEPRESSION,16
MX,DRUG PRESCRIBING ERROR,16
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,15
MX,ANXIETY,14
MX,BACK PAIN,14
MX,BLOOD GLUCOSE INCREASED,14
MX,BLOOD PRESSURE INCREASED,14
MX,BONE PAIN,14
MX,CHEST PAIN,14
MX,HYPERTENSION,14
MX,PLATELET COUNT DECREASED,14
MX,ABDOMINAL PAIN,13
MX,CONSTIPATION,13
MX,GENERAL PHYSICAL HEALTH DETERIORATION,13
MX,INFLUENZA,13
MX,ABDOMINAL PAIN UPPER,12
MX,ANAEMIA,12
MX,BACTERAEMIA,12
MX,DEHYDRATION,12
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,12
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,12
MX,HAEMOGLOBIN DECREASED,11
MX,MEMORY IMPAIRMENT,11
MX,ARRHYTHMIA,10
MX,DYSPEPSIA,10
MX,GASTRITIS,10
MX,INSOMNIA,10
MX,TREMOR,10
MX,WEIGHT INCREASED,10
MX,CEREBROVASCULAR ACCIDENT,9
MX,DIABETES MELLITUS,9
MX,HYPOAESTHESIA,9
MX,MOBILITY DECREASED,9
MX,OEDEMA PERIPHERAL,9
MX,PERIPHERAL SWELLING,9
MX,ABDOMINAL DISCOMFORT,8
MX,AMNESIA,8
MX,CONTUSION,8
MX,DISORIENTATION,8
MX,PARAESTHESIA,8
MX,RENAL FAILURE,8
MX,VISUAL IMPAIRMENT,8
MX,ABDOMINAL DISTENSION,7
MX,BURNING SENSATION,7
MX,DEPRESSED MOOD,7
MX,DYSPHONIA,7
MX,FEELING OF DESPAIR,7
MX,FLUID RETENTION,7
MX,HYPOTENSION,7
MX,INFARCTION,7
MX,INFLAMMATION,7
MX,MUSCLE SPASMS,7
MX,PRURITUS,7
MX,SEPTIC SHOCK,7
MX,SOMNOLENCE,7
MX,TACHYCARDIA,7
MX,THROMBOSIS,7
MX,VISION BLURRED,7
MX,ABASIA,6
MX,BURKHOLDERIA CEPACIA COMPLEX INFECTION,6
MX,COGNITIVE DISORDER,6
MX,COLITIS,6
MX,DRY SKIN,6
MX,EPISTAXIS,6
MX,ERYTHEMA,6
MX,HEPATIC FUNCTION ABNORMAL,6
MX,HYPOACUSIS,6
MX,LIMB INJURY,6
MX,MUCOSAL INFLAMMATION,6
MX,PRODUCT QUALITY ISSUE,6
MX,PRODUCT USE IN UNAPPROVED INDICATION,6
MX,RASH,6
MX,STOMATITIS,6
MX,STRESS,6
MX,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,6
MX,THROMBOCYTOPENIA,6
MX,URTICARIA,6
MX,WHITE BLOOD CELL COUNT DECREASED,6
MX,ALOPECIA,5
MX,APATHY,5
MX,ASPHYXIA,5
MX,BLOOD GLUCOSE DECREASED,5
MX,BLOOD PRESSURE DECREASED,5
MX,CARDIAC FAILURE,5
MX,CATARACT,5
MX,CHOLELITHIASIS,5
MX,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
MX,CONCOMITANT DISEASE AGGRAVATED,5
MX,CONDITION AGGRAVATED,5
MX,DEATH,5
MX,FEELING COLD,5
MX,GASTROINTESTINAL HAEMORRHAGE,5
MX,HAEMORRHAGE,5
MX,HEPATIC FAILURE,5
MX,HYPERBILIRUBINAEMIA,5
MX,LOCAL SWELLING,5
MX,LOSS OF CONSCIOUSNESS,5
MX,MYOCARDIAL INFARCTION,5
MX,OEDEMA,5
MX,ORAL CANDIDIASIS,5
MX,PRESCRIBED UNDERDOSE,5
MX,RENAL DISORDER,5
MX,SEIZURE,5
MX,SKIN DISCOLOURATION,5
MX,SKIN EXFOLIATION,5
MX,SPEECH DISORDER,5
MX,TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,5
MX,VITAMIN B12 DEFICIENCY,5
MX,ANGINA PECTORIS,4
MX,APRAXIA,4
MX,ASCITES,4
MX,ASTHMA,4
MX,BLISTER,4
MX,CARDIAC DISORDER,4
MX,DISEASE PROGRESSION,4
MX,DRUG DOSE OMISSION,4
MX,DRUG INTOLERANCE,4
MX,DYSPNOEA EXERTIONAL,4
MX,FAECES DISCOLOURED,4
MX,GALLBLADDER DISORDER,4
MX,GASTROOESOPHAGEAL REFLUX DISEASE,4
MX,HAEMORRHOIDS,4
MX,HEMIPLEGIA,4
MX,INCOHERENT,4
MX,INDIFFERENCE,4
MX,INJURY,4
MX,IRRITABILITY,4
MX,JOINT INJURY,4
MX,JOINT SWELLING,4
MX,LIMB DISCOMFORT,4
MX,LIVER DISORDER,4
MX,MICTURITION URGENCY,4
MX,MULTIPLE SCLEROSIS RELAPSE,4
MX,MUSCLE RIGIDITY,4
MX,MUSCULOSKELETAL PAIN,4
MX,MYALGIA,4
MX,NASOPHARYNGITIS,4
MX,OROPHARYNGEAL PAIN,4
MX,OSTEOPOROSIS,4
MX,PALPITATIONS,4
MX,PHLEBITIS,4
MX,POLLAKIURIA,4
MX,PULMONARY EMBOLISM,4
MX,PULMONARY OEDEMA,4
MX,RENAL PAIN,4
MX,SYNCOPE,4
MX,TINNITUS,4
MX,UNEVALUABLE EVENT,4
MX,UPPER GASTROINTESTINAL HAEMORRHAGE,4
MX,VITAMIN B12 ABNORMAL,4
MX,ABNORMAL BEHAVIOUR,3
MX,ACNE,3
MX,AGITATION,3
MX,ARTERIAL OCCLUSIVE DISEASE,3
MX,BLOOD BILIRUBIN INCREASED,3
MX,BLOOD GLUCOSE FLUCTUATION,3
MX,BLOOD PRESSURE ABNORMAL,3
MX,BRONCHITIS,3
MX,CARDIO-RESPIRATORY ARREST,3
MX,CARDIOVASCULAR DISORDER,3
MX,CEREBRAL HAEMORRHAGE,3
MX,CEREBRAL INFARCTION,3
MX,CHEST DISCOMFORT,3
MX,CHILLS,3
MX,DECREASED ACTIVITY,3
MX,DECREASED IMMUNE RESPONSIVENESS,3
MX,DERMATITIS ATOPIC,3
MX,DISCOMFORT,3
MX,DISEASE RECURRENCE,3
MX,DRUG DEPENDENCE,3
MX,DRY MOUTH,3
MX,DYSGEUSIA,3
MX,EAR DISCOMFORT,3
MX,EPILEPSY,3
MX,EXPOSURE DURING PREGNANCY,3
MX,FACE OEDEMA,3
MX,FEAR,3
MX,FEEDING DISORDER,3
MX,FLATULENCE,3
MX,GASTRIC ULCER,3
MX,GASTROINTESTINAL NEOPLASM,3
MX,GENERALISED OEDEMA,3
MX,GINGIVAL BLEEDING,3
MX,HAEMATEMESIS,3
MX,HAEMATOMA,3
MX,HEAD DISCOMFORT,3
MX,HERPES ZOSTER,3
MX,HIATUS HERNIA,3
MX,HICCUPS,3
MX,HIP FRACTURE,3
MX,HYPERKERATOSIS,3
MX,HYPOTHERMIA,3
MX,INCORRECT DOSE ADMINISTERED,3
MX,JAUNDICE,3
MX,LOCALISED INFECTION,3
MX,LOWER LIMB FRACTURE,3
MX,MALNUTRITION,3
MX,MASTICATION DISORDER,3
MX,MENINGITIS TUBERCULOUS,3
MX,METASTASES TO BONE,3
MX,MULTI-ORGAN FAILURE,3
MX,MULTIPLE SCLEROSIS,3
MX,MUSCULAR WEAKNESS,3
MX,MUSCULOSKELETAL DISORDER,3
MX,MUSCULOSKELETAL STIFFNESS,3
MX,NEUTROPENIA,3
MX,NUTRITIONAL CONDITION ABNORMAL,3
MX,ODYNOPHAGIA,3
MX,ORAL DISCOMFORT,3
MX,ORAL PAIN,3
MX,PAIN OF SKIN,3
MX,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
MX,PANCREATITIS,3
MX,PANCYTOPENIA,3
MX,PERITONITIS,3
MX,PETIT MAL EPILEPSY,3
MX,PHARYNGITIS,3
MX,PLEURAL EFFUSION,3
MX,PRURITUS GENERALISED,3
MX,RASH MACULAR,3
MX,RECTAL HAEMORRHAGE,3
MX,RENAL FAILURE ACUTE,3
MX,RESPIRATORY FAILURE,3
MX,RESTLESSNESS,3
MX,RIGHT VENTRICULAR FAILURE,3
MX,SEPSIS,3
MX,SEROTONIN SYNDROME,3
MX,SKIN BURNING SENSATION,3
MX,SKIN FISSURES,3
MX,SKIN IRRITATION,3
MX,SPINAL COLUMN INJURY,3
MX,SWELLING,3
MX,SWELLING FACE,3
MX,TENSION,3
MX,THYROID DISORDER,3
MX,TONGUE DISCOMFORT,3
MX,TRANSFUSION,3
MX,ULCER,3
MX,UPPER LIMB FRACTURE,3
MX,ABDOMINAL INFECTION,2
MX,ABORTION SPONTANEOUS,2
MX,ACUTE KIDNEY INJURY,2
MX,ACUTE MYOCARDIAL INFARCTION,2
MX,ACUTE RESPIRATORY DISTRESS SYNDROME,2
MX,ANAL INCONTINENCE,2
MX,ANGINA UNSTABLE,2
MX,ANIMAL BITE,2
MX,ANURIA,2
MX,APHTHOUS ULCER,2
MX,APPENDICITIS,2
MX,APPLICATION SITE IRRITATION,2
MX,ARTHRITIS,2
MX,ATONIC SEIZURES,2
MX,BACK INJURY,2
MX,BENIGN EAR NEOPLASM,2
MX,BLINDNESS UNILATERAL,2
MX,BLOOD ALBUMIN DECREASED,2
MX,BLOOD CREATININE INCREASED,2
MX,BLOOD PRESSURE FLUCTUATION,2
MX,BLOOD TRIGLYCERIDES INCREASED,2
MX,BLOOD UREA INCREASED,2
MX,BODY TEMPERATURE INCREASED,2
MX,BONE MARROW FAILURE,2
MX,BRADYCARDIA,2
MX,BREAST CANCER,2
MX,BRONCHIECTASIS,2
MX,CARDIAC ARREST,2
MX,CEREBROVASCULAR DISORDER,2
MX,CHOKING,2
MX,COMA,2
MX,CONVULSION,2
MX,CROHN^S DISEASE,2
MX,CYANOSIS,2
MX,DEAFNESS,2
MX,DERMATITIS INFECTED,2
MX,DIABETES MELLITUS INADEQUATE CONTROL,2
MX,DIABETIC COMPLICATION,2
MX,DIABETIC NEUROPATHY,2
MX,DISSEMINATED INTRAVASCULAR COAGULATION,2
MX,DRUG HYPERSENSITIVITY,2
MX,DRY EYE,2
MX,DYSSTASIA,2
MX,EAR INFECTION,2
MX,EAR PAIN,2
MX,EMBOLISM,2
MX,ENCEPHALOPATHY,2
MX,ERUCTATION,2
MX,EXPIRED PRODUCT ADMINISTERED,2
MX,EYE DISORDER,2
MX,EYE INFECTION,2
MX,EYE PAIN,2
MX,EYELID OEDEMA,2
MX,FACE INJURY,2
MX,FACIAL BONES FRACTURE,2
MX,FIBROMYALGIA,2
MX,FOOD ALLERGY,2
MX,FRACTURE,2
MX,GASTROINTESTINAL INFLAMMATION,2
MX,HAEMATURIA,2
MX,HALLUCINATION,2
MX,HALLUCINATION_ VISUAL,2
MX,HEAD INJURY,2
MX,HEARING IMPAIRED,2
MX,HEPATIC CIRRHOSIS,2
MX,HEPATIC ENCEPHALOPATHY,2
MX,HEPATIC FIBROSIS,2
MX,HEPATOTOXICITY,2
MX,HERNIA,2
MX,HOSPITALISATION,2
MX,HOT FLUSH,2
MX,HUMERUS FRACTURE,2
MX,HYPERAESTHESIA,2
MX,HYPERGLYCAEMIA,2
MX,HYPERTONIA,2
MX,HYPOAESTHESIA ORAL,2
MX,HYPOALBUMINAEMIA,2
MX,HYPOGLYCAEMIA,2
MX,HYPOKALAEMIA,2
MX,HYPOPHAGIA,2
MX,INCONTINENCE,2
MX,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
MX,INTERVERTEBRAL DISC PROTRUSION,2
MX,INTRAOCULAR PRESSURE INCREASED,2
MX,KNEE DEFORMITY,2
MX,LIGAMENT RUPTURE,2
MX,LIGAMENT SPRAIN,2
MX,LIVER INJURY,2
MX,LOWER GASTROINTESTINAL HAEMORRHAGE,2
MX,LUNG DISORDER,2
MX,LYMPHADENOPATHY,2
MX,LYMPHOCYTE COUNT DECREASED,2
MX,MALIGNANT NEOPLASM PROGRESSION,2
MX,METASTASES TO LIVER,2
MX,METASTASES TO SPLEEN,2
MX,MOUTH HAEMORRHAGE,2
MX,MOUTH ULCERATION,2
MX,MUCOSAL ATROPHY,2
MX,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
MX,NEOPLASM,2
MX,NEOPLASM MALIGNANT,2
MX,NEOPLASM PROGRESSION,2
MX,NERVOUS SYSTEM DISORDER,2
MX,NEUROTOXICITY,2
MX,OESOPHAGEAL PAIN,2
MX,ORAL DISORDER,2
MX,OROPHARYNGEAL DISCOMFORT,2
MX,OSTEOARTHRITIS,2
MX,OXYGEN CONSUMPTION INCREASED,2
MX,PALLOR,2
MX,PHARYNGEAL ULCERATION,2
MX,PLATELET COUNT ABNORMAL,2
MX,PNEUMOTHORAX,2
MX,PRODUCT COLOUR ISSUE,2
MX,PULMONARY ARTERIAL HYPERTENSION,2
MX,PULMONARY PAIN,2
MX,RASH PRURITIC,2
MX,RENAL IMPAIRMENT,2
MX,RESPIRATORY DISORDER,2
MX,RHEUMATIC DISORDER,2
MX,RHINITIS ALLERGIC,2
MX,SKIN LESION,2
MX,SKIN SWELLING,2
MX,SKIN ULCER,2
MX,SLEEP DISORDER,2
MX,SQUAMOUS CELL CARCINOMA OF SKIN,2
MX,SUFFOCATION FEELING,2
MX,SUICIDAL IDEATION,2
MX,SUTURE RELATED COMPLICATION,2
MX,SYSTEMIC LUPUS ERYTHEMATOSUS,2
MX,THROAT TIGHTNESS,2
MX,TONGUE MOVEMENT DISTURBANCE,2
MX,TOXICITY TO VARIOUS AGENTS,2
MX,TRANSAMINASES INCREASED,2
MX,TRANSIENT ISCHAEMIC ATTACK,2
MX,TRISMUS,2
MX,TUBERCULOSIS,2
MX,UTERINE HAEMORRHAGE,2
MX,VARICOSE VEIN,2
MX,VERTIGO,2
MX,VISUAL ACUITY REDUCED,2
MX,WHITE BLOOD CELL COUNT INCREASED,2
MX,ABDOMINAL ADHESIONS,1
MX,ABDOMINAL PAIN LOWER,1
MX,ABSCESS,1
MX,ACCIDENT,1
MX,ACID PEPTIC DISEASE,1
MX,ACTIVITIES OF DAILY LIVING IMPAIRED,1
MX,ACUTE GRAFT VERSUS HOST DISEASE,1
MX,ACUTE HEPATIC FAILURE,1
MX,ACUTE RESPIRATORY FAILURE,1
MX,ACUTE SINUSITIS,1
MX,ADRENAL SUPPRESSION,1
MX,ADVERSE EVENT,1
MX,AGEUSIA,1
MX,AMOEBIASIS,1
MX,ANAL HAEMORRHAGE,1
MX,ANEURYSM,1
MX,ANGIOEDEMA,1
MX,ANHEDONIA,1
MX,ANIMAL SCRATCH,1
MX,ANTEROGRADE AMNESIA,1
MX,ANTICOAGULATION DRUG LEVEL INCREASED,1
MX,ANTIPHOSPHOLIPID SYNDROME,1
MX,AORTIC DISORDER,1
MX,APHAGIA,1
MX,APHASIA,1
MX,APHONIA,1
MX,APHTHOUS STOMATITIS,1
MX,APLASTIC ANAEMIA,1
MX,APPARENT DEATH,1
MX,APPLICATION SITE BURN,1
MX,APPLICATION SITE EXFOLIATION,1
MX,APPLICATION SITE INJURY,1
MX,APPLICATION SITE LACERATION,1
MX,APPLICATION SITE PAIN,1
MX,APPLICATION SITE PRURITUS,1
MX,APPLICATION SITE SCAR,1
MX,ARTERIAL DISORDER,1
MX,ARTERIOSCLEROSIS,1
MX,ARTHRITIS INFECTIVE,1
MX,ARTHROFIBROSIS,1
MX,ARTHROPATHY,1
MX,ATELECTASIS,1
MX,ATRIAL FIBRILLATION,1
MX,ATRIAL FLUTTER,1
MX,ATYPICAL PNEUMONIA,1
MX,BACK DISORDER,1
MX,BACTERIAL INFECTION,1
MX,BALANCE DISORDER,1
MX,BENIGN BREAST NEOPLASM,1
MX,BILE DUCT STONE,1
MX,BLAST CELL COUNT INCREASED,1
MX,BLEPHAROSPASM,1
MX,BLINDNESS,1
MX,BLOOD CHOLESTEROL INCREASED,1
MX,BLOOD CREATINE INCREASED,1
MX,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
MX,BLOOD CULTURE POSITIVE,1
MX,BLOOD DISORDER,1
MX,BLOOD GLUCOSE ABNORMAL,1
MX,BLOOD PH INCREASED,1
MX,BLOOD POTASSIUM DECREASED,1
MX,BLOOD POTASSIUM INCREASED,1
MX,BLOOD PRESSURE DIASTOLIC INCREASED,1
MX,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
MX,BLOOD PRESSURE SYSTOLIC INCREASED,1
MX,BLOOD SODIUM DECREASED,1
MX,BLOOD TEST ABNORMAL,1
MX,BLOOD URIC ACID INCREASED,1
MX,BLOODY DISCHARGE,1
MX,BODY HEIGHT BELOW NORMAL,1
MX,BONE CANCER,1
MX,BONE DEFORMITY,1
MX,BONE MARROW DISORDER,1
MX,BOWEL MOVEMENT IRREGULARITY,1
MX,BRAIN HYPOXIA,1
MX,BRAIN OEDEMA,1
MX,BREAST CANCER FEMALE,1
MX,BREAST DISCOMFORT,1
MX,BREAST MASS,1
MX,BRONCHIAL DISORDER,1
MX,CAFE AU LAIT SPOTS,1
MX,CANDIDA INFECTION,1
MX,CAPILLARY NAIL REFILL TEST ABNORMAL,1
MX,CARDIAC FAILURE CHRONIC,1
MX,CARDIAC HYPERTROPHY,1
MX,CARDIAC MURMUR,1
MX,CARDIOGENIC SHOCK,1
MX,CARDIOMEGALY,1
MX,CARDIOMYOPATHY,1
MX,CAROTID ARTERY CALCIFICATION,1
MX,CAROTID ARTERY THROMBOSIS,1
MX,CARTILAGE INJURY,1
MX,CATARRH,1
MX,CENTRAL NERVOUS SYSTEM LESION,1
MX,CEREBELLAR EMBOLISM,1
MX,CEREBRAL ARTERY EMBOLISM,1
MX,CEREBRAL ATROPHY,1
MX,CEREBRAL ISCHAEMIA,1
MX,CEREBRAL THROMBOSIS,1
MX,CHANGE IN SEIZURE PRESENTATION,1
MX,CHEST X-RAY ABNORMAL,1
MX,CHOLECYSTITIS,1
MX,CHONDROPATHY,1
MX,CHRONIC KIDNEY DISEASE,1
MX,CHRONIC RESPIRATORY FAILURE,1
MX,CHRONIC RIGHT VENTRICULAR FAILURE,1
MX,CLOSTRIDIUM DIFFICILE INFECTION,1
MX,COAGULATION TIME PROLONGED,1
MX,COLON CANCER,1
MX,COMMUNICATION DISORDER,1
MX,COMPLEX PARTIAL SEIZURES,1
MX,CONGENITAL ANOMALY,1
MX,CONGENITAL JOINT MALFORMATION,1
MX,CONJUNCTIVITIS,1
MX,CONTRAINDICATED PRODUCT ADMINISTERED,1
MX,CONVULSIONS LOCAL,1
MX,CYSTITIS ESCHERICHIA,1
MX,CYSTITIS NONINFECTIVE,1
MX,CYTOKINE RELEASE SYNDROME,1
MX,DAYDREAMING,1
MX,DEMENTIA ALZHEIMER^S TYPE,1
MX,DENTAL DISCOMFORT,1
MX,DEPRESSION SUICIDAL,1
MX,DERMATITIS,1
MX,DERMATITIS ACNEIFORM,1
MX,DEVICE RELATED INFECTION,1
MX,DIABETIC FOOT,1
MX,DIABETIC NEPHROPATHY,1
MX,DIAPHRAGMATIC DISORDER,1
MX,DIAPHRAGMATIC SPASM,1
MX,DISEASE SUSCEPTIBILITY,1
MX,DISLOCATION OF VERTEBRA,1
MX,DISSEMINATED TUBERCULOSIS,1
MX,DISTRACTIBILITY,1
MX,DIVERTICULITIS,1
MX,DROWNING,1
MX,DRUG ADMINISTRATION ERROR,1
MX,DRUG DISPENSING ERROR,1
MX,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
MX,DYSCHEZIA,1
MX,DYSGRAPHIA,1
MX,DYSKINESIA,1
MX,DYSPHAGIA,1
MX,DYSPHEMIA,1
MX,DYSURIA,1
MX,EAR CONGESTION,1
MX,EAR DISORDER,1
MX,EARLY SATIETY,1
MX,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
MX,EATING DISORDER,1
MX,ECCHYMOSIS,1
MX,ECZEMA,1
MX,EJECTION FRACTION DECREASED,1
MX,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
MX,EMOTIONAL DISORDER,1
MX,ENTEROCOCCAL INFECTION,1
MX,ENTEROCOLITIS INFECTIOUS,1
MX,ENTEROCUTANEOUS FISTULA,1
MX,ERYTHEMA OF EYELID,1
MX,ESCHERICHIA TEST POSITIVE,1
MX,EXCESSIVE CERUMEN PRODUCTION,1
MX,EXCORIATION,1
MX,EXTRASYSTOLES,1
MX,EXTREMITY CONTRACTURE,1
MX,EYE SWELLING,1
MX,EYELID BLEEDING,1
MX,FACIAL PARALYSIS,1
MX,FAECAL INCONTINENCE,1
MX,FAECAL VOLUME INCREASED,1
MX,FEBRILE NEUTROPENIA,1
MX,FEELING DRUNK,1
MX,FEELING HOT,1
MX,FEELING OF BODY TEMPERATURE CHANGE,1
MX,FEMORAL NECK FRACTURE,1
MX,FEMUR FRACTURE,1
MX,FIBULA FRACTURE,1
MX,FOETAL DEATH,1
MX,FOREIGN BODY SENSATION IN EYES,1
MX,GAIT INABILITY,1
MX,GALLBLADDER PAIN,1
MX,GANGRENE,1
MX,GASTRIC CANCER,1
MX,GASTRIC DILATATION,1
MX,GASTRIC DISORDER,1
MX,GASTRIC HAEMORRHAGE,1
MX,GASTRIC INFECTION,1
MX,GASTRIC ULCER PERFORATION,1
MX,GASTROENTERITIS,1
MX,GASTROINTESTINAL STROMAL TUMOUR,1
MX,GENERAL PHYSICAL CONDITION ABNORMAL,1
MX,GENITAL BURNING SENSATION,1
MX,GENITAL PAIN,1
MX,GINGIVAL DISCOMFORT,1
MX,GINGIVAL INJURY,1
MX,GINGIVAL PAIN,1
MX,GINGIVAL ULCERATION,1
MX,GLAUCOMA,1
MX,GLOSSODYNIA,1
MX,GLUCOSE TOLERANCE IMPAIRED,1
MX,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
MX,GRAFT VERSUS HOST DISEASE IN SKIN,1
MX,GRANULOMATOSIS WITH POLYANGIITIS,1
MX,GRIP STRENGTH DECREASED,1
MX,H1N1 INFLUENZA,1
MX,HAEMATOCHEZIA,1
MX,HAEMODYNAMIC INSTABILITY,1
MX,HAEMOGLOBIN INCREASED,1
MX,HAEMOLYTIC ANAEMIA,1
MX,HAEMORRHOIDAL HAEMORRHAGE,1
MX,HAEMOTHORAX,1
MX,HALLUCINATION_ AUDITORY,1
MX,HEAD TITUBATION,1
MX,HEART RATE INCREASED,1
MX,HELICOBACTER INFECTION,1
MX,HEMIPARESIS,1
MX,HEPATIC ADENOMA,1
MX,HEPATIC CANCER,1
MX,HEPATIC CONGESTION,1
MX,HEPATIC LESION,1
MX,HEPATIC MASS,1
MX,HEPATIC STEATOSIS,1
MX,HEPATIC VEIN THROMBOSIS,1
MX,HEPATITIS,1
MX,HEPATOCELLULAR CARCINOMA,1
MX,HEPATORENAL SYNDROME,1
MX,HERPES VIRUS INFECTION,1
MX,HODGKIN^S DISEASE,1
MX,HORDEOLUM,1
MX,HYPERACUSIS,1
MX,HYPERAEMIA,1
MX,HYPERHIDROSIS,1
MX,HYPERSENSITIVITY,1
MX,HYPERSOMNIA,1
MX,HYPERTENSIVE CRISIS,1
MX,HYPERTRIGLYCERIDAEMIA,1
MX,HYPOCALCAEMIA,1
MX,HYPOKINESIA,1
MX,HYPOMAGNESAEMIA,1
MX,HYPONATRAEMIA,1
MX,HYPOTHYROIDISM,1
MX,HYPOTONIA,1
MX,HYPOVOLAEMIC SHOCK,1
MX,HYPOXIA,1
MX,ILEUS PARALYTIC,1
MX,IMMUNODEFICIENCY,1
MX,INCORRECT DRUG ADMINISTRATION DURATION,1
MX,INCREASED UPPER AIRWAY SECRETION,1
MX,INCREASED VISCOSITY OF BRONCHIAL SECRETION,1
MX,INDURATION,1
MX,INFECTION,1
MX,INFLAMMATORY BOWEL DISEASE,1
MX,INFUSION RELATED REACTION,1
MX,INGUINAL HERNIA,1
MX,INTELLECTUAL DISABILITY,1
MX,INTENTIONAL OVERDOSE,1
MX,INTENTIONAL PRODUCT MISUSE,1
MX,INTENTIONAL PRODUCT USE ISSUE,1
MX,INTENTIONAL SELF-INJURY,1
MX,INTERSTITIAL LUNG DISEASE,1
MX,INTESTINAL ADENOCARCINOMA,1
MX,INTESTINAL OBSTRUCTION,1
MX,INTRA-ABDOMINAL FLUID COLLECTION,1
MX,IRON DEFICIENCY ANAEMIA,1
MX,IRREGULAR BREATHING,1
MX,JAW DISORDER,1
MX,JOINT DISLOCATION,1
MX,KIDNEY INFECTION,1
MX,LACERATION,1
MX,LACRIMAL DISORDER,1
MX,LARGE INTESTINE PERFORATION,1
MX,LAZINESS,1
MX,LEUKAEMIA CUTIS,1
MX,LEUKAEMIA MONOCYTIC,1
MX,LEUKAEMIC INFILTRATION BRAIN,1
MX,LEUKOCYTOSIS,1
MX,LEUKOPENIA,1
MX,LIMB DEFORMITY,1
MX,LIMB IMMOBILISATION,1
MX,LIP DISCOLOURATION,1
MX,LIP DRY,1
MX,LIP OEDEMA,1
MX,LIVER FUNCTION TEST ABNORMAL,1
MX,LIVER TRANSPLANT REJECTION,1
MX,LOCALISED INTRAABDOMINAL FLUID COLLECTION,1
MX,LOCALISED OEDEMA,1
MX,LOOSE TOOTH,1
MX,LOSS OF CONTROL OF LEGS,1
MX,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
MX,LOWER EXTREMITY MASS,1
MX,LOWER RESPIRATORY TRACT INFECTION,1
MX,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,1
MX,LUMBAR SPINAL STENOSIS,1
MX,LUNG INFECTION,1
MX,LYMPHATIC OBSTRUCTION,1
MX,LYMPHOEDEMA,1
MX,LYMPHOPROLIFERATIVE DISORDER,1
MX,MACULAR DEGENERATION,1
MX,MACULOPATHY,1
MX,MASS,1
MX,MASTECTOMY,1
MX,MELAENA,1
MX,MELANOCYTIC NAEVUS,1
MX,MENTAL DISORDER,1
MX,METASTASES TO LUNG,1
MX,MICROANGIOPATHY,1
MX,MIGRAINE,1
MX,MONOPLEGIA,1
MX,MOUTH INJURY,1
MX,MOVEMENT DISORDER,1
MX,MULTIPLE FRACTURES,1
MX,MUSCLE INJURY,1
MX,MYCOBACTERIAL INFECTION,1
MX,MYELOFIBROSIS,1
MX,MYOSITIS,1
MX,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
MX,NAIL DISCOLOURATION,1
MX,NAIL DISORDER,1
MX,NASAL CONGESTION,1
MX,NECK PAIN,1
MX,NEPHROPATHY TOXIC,1
MX,NERVE COMPRESSION,1
MX,NERVOUSNESS,1
MX,NEURODEGENERATIVE DISORDER,1
MX,NEUROLOGICAL DECOMPENSATION,1
MX,NEUROPATHY PERIPHERAL,1
MX,NEUTROPHIL COUNT DECREASED,1
MX,NO ADVERSE EVENT,1
MX,NO THERAPEUTIC RESPONSE,1
MX,OBSTRUCTIVE AIRWAYS DISORDER,1
MX,OCULAR DISCOMFORT,1
MX,OCULAR HYPERAEMIA,1
MX,OCULAR ICTERUS,1
MX,OESOPHAGEAL VARICES HAEMORRHAGE,1
MX,OESOPHAGITIS,1
MX,ONCOLOGIC COMPLICATION,1
MX,ONYCHOMADESIS,1
MX,OPEN ANGLE GLAUCOMA,1
MX,ORAL FUNGAL INFECTION,1
MX,ORAL HERPES,1
MX,ORAL INFECTION,1
MX,OVERDOSE,1
MX,OVERWEIGHT,1
MX,OXYGEN CONSUMPTION DECREASED,1
MX,OXYGEN SATURATION DECREASED,1
MX,PACKED RED BLOOD CELL TRANSFUSION,1
MX,PAIN IN JAW,1
MX,PANCREATIC CARCINOMA,1
MX,PAPULE,1
MX,PARAESTHESIA ORAL,1
MX,PARALYSIS,1
MX,PARKINSON^S DISEASE,1
MX,PAROSMIA,1
MX,PEMPHIGOID,1
MX,PENILE HAEMORRHAGE,1
MX,PENILE PAIN,1
MX,PERFORMANCE STATUS DECREASED,1
MX,PERIPHERAL COLDNESS,1
MX,PERIPHERAL VASCULAR DISORDER,1
MX,PERITONITIS BACTERIAL,1
MX,PETECHIAE,1
MX,PHARYNGEAL ERYTHEMA,1
MX,PITUITARY TUMOUR BENIGN,1
MX,PLASMA CELL MYELOMA,1
MX,PNEUMONIA FUNGAL,1
MX,POISONING,1
MX,POLYMYOSITIS,1
MX,POOR PERIPHERAL CIRCULATION,1
MX,PORTAL HYPERTENSION,1
MX,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
MX,PREGNANCY,1
MX,PRIMARY MYELOFIBROSIS,1
MX,PROCEDURAL COMPLICATION,1
MX,PROCEDURAL PAIN,1
MX,PRODUCT ADHESION ISSUE,1
MX,PRODUCTIVE COUGH,1
MX,PROSOPAGNOSIA,1
MX,PROSTATIC DISORDER,1
MX,PSORIASIS,1
MX,PSORIATIC ARTHROPATHY,1
MX,PULMONARY CONGESTION,1
MX,PULMONARY FIBROSIS,1
MX,PULMONARY HAEMORRHAGE,1
MX,PULMONARY TUBERCULOSIS,1
MX,PURULENT DISCHARGE,1
MX,RADIUS FRACTURE,1
MX,RASH GENERALISED,1
MX,RASH PAPULAR,1
MX,RASH VESICULAR,1
MX,RED BLOOD CELL COUNT DECREASED,1
MX,RED BLOOD CELL MORPHOLOGY ABNORMAL,1
MX,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
MX,REFLUX GASTRITIS,1
MX,RENAL CELL CARCINOMA,1
MX,RENAL CYST,1
MX,RESPIRATORY TRACT INFECTION,1
MX,RETINAL DETACHMENT,1
MX,RETINAL DISORDER,1
MX,RETINAL THICKENING,1
MX,RETINOPATHY,1
MX,RHABDOMYOLYSIS,1
MX,RHINITIS,1
MX,RHINORRHOEA,1
MX,RIGHT VENTRICULAR HYPERTROPHY,1
MX,ROAD TRAFFIC ACCIDENT,1
MX,SALIVA ALTERED,1
MX,SALIVARY HYPERSECRETION,1
MX,SALPINGO-OOPHORITIS,1
MX,SCAB,1
MX,SCAR PAIN,1
MX,SCOLIOSIS,1
MX,SENILE DEMENTIA,1
MX,SERUM SICKNESS,1
MX,SHOCK,1
MX,SINGLE FUNCTIONAL KIDNEY,1
MX,SINUS ARRHYTHMIA,1
MX,SJOGREN^S SYNDROME,1
MX,SKIN ATROPHY,1
MX,SKIN FRAGILITY,1
MX,SKIN HAEMORRHAGE,1
MX,SKIN INDURATION,1
MX,SKIN TEST POSITIVE,1
MX,SKIN WOUND,1
MX,SNEEZING,1
MX,SOMNAMBULISM,1
MX,SPINAL CORD OPERATION,1
MX,SPINAL DEFORMITY,1
MX,SPINAL DISORDER,1
MX,SPINAL PAIN,1
MX,STAPHYLOCOCCUS TEST POSITIVE,1
MX,STENOSIS,1
MX,SUBILEUS,1
MX,SUPERFICIAL VEIN PROMINENCE,1
MX,SWEAT GLAND DISORDER,1
MX,TACHYPNOEA,1
MX,TENDON RUPTURE,1
MX,TERMINAL STATE,1
MX,THERAPY CESSATION,1
MX,THERAPY NON-RESPONDER,1
MX,THIRST,1
MX,THROAT IRRITATION,1
MX,THROAT LESION,1
MX,THROMBOCYTOPENIC PURPURA,1
MX,THROMBOCYTOSIS,1
MX,THROMBOPHLEBITIS,1
MX,THROMBOSIS IN DEVICE,1
MX,THROMBOSIS MESENTERIC VESSEL,1
MX,THYROID ADENOMA,1
MX,TONGUE DISORDER,1
MX,TONGUE DRY,1
MX,TONGUE INJURY,1
MX,TONGUE OEDEMA,1
MX,TONSILLAR HYPERTROPHY,1
MX,TONSILLITIS,1
MX,TREATMENT NONCOMPLIANCE,1
MX,TRIGGER FINGER,1
MX,TUBERCULOSIS LIVER,1
MX,TYMPANIC MEMBRANE PERFORATION,1
MX,ULNA FRACTURE,1
MX,UMBILICAL HERNIA,1
MX,UNDERDOSE,1
MX,URINARY BLADDER ABSCESS,1
MX,URINARY RETENTION,1
MX,URINE ANALYSIS ABNORMAL,1
MX,URINE FLOW DECREASED,1
MX,UTERINE INFLAMMATION,1
MX,VAGINAL DISCHARGE,1
MX,VAGINAL HAEMORRHAGE,1
MX,VAGINAL INFECTION,1
MX,VAGINAL MUCOSAL BLISTERING,1
MX,VARICELLA,1
MX,VARICELLA ZOSTER VIRUS INFECTION,1
MX,VASCULAR RUPTURE,1
MX,VASCULITIS,1
MX,VEIN DISORDER,1
MX,VENOUS OCCLUSION,1
MX,VENOUS THROMBOSIS,1
MX,VIRAL INFECTION,1
MX,VIRAL LOAD INCREASED,1
MX,VULVOVAGINAL DRYNESS,1
MX,WRONG DRUG ADMINISTERED,1
MA,DERMATITIS BULLOUS,3
MA,BLISTER,2
MA,PRURITUS,2
MA,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
MA,ANAEMIA,1
MA,HAEMORRHAGIC CYST,1
MA,HYPERSENSITIVITY VASCULITIS,1
NL,DEATH,61
NL,NAUSEA,36
NL,MALAISE,32
NL,PYREXIA,28
NL,VOMITING,26
NL,ABDOMINAL PAIN,25
NL,PNEUMONIA,22
NL,DIARRHOEA,20
NL,FATIGUE,20
NL,DYSPNOEA,19
NL,PROSTATE CANCER METASTATIC,19
NL,DEHYDRATION,18
NL,TOXICITY TO VARIOUS AGENTS,18
NL,DIZZINESS,17
NL,WEIGHT DECREASED,17
NL,FALL,16
NL,MALIGNANT NEOPLASM PROGRESSION,16
NL,ANAEMIA,15
NL,PAIN,15
NL,RESPIRATORY FAILURE,15
NL,DECREASED APPETITE,14
NL,PAIN IN EXTREMITY,14
NL,TERMINAL STATE,14
NL,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,13
NL,BACK PAIN,13
NL,LOSS OF CONSCIOUSNESS,13
NL,ARTHRALGIA,12
NL,HYPOTENSION,12
NL,ANGIOEDEMA,11
NL,ANTICHOLINERGIC SYNDROME,11
NL,CARDIAC DISORDER,11
NL,DELIRIUM,11
NL,RHABDOMYOLYSIS,11
NL,ACUTE KIDNEY INJURY,10
NL,HOT FLUSH,10
NL,PULMONARY EMBOLISM,10
NL,RENAL IMPAIRMENT,10
NL,SEPSIS,10
NL,SOMNOLENCE,10
NL,SUICIDE ATTEMPT,10
NL,APHASIA,9
NL,ASTHENIA,9
NL,ATRIAL FIBRILLATION,9
NL,DISEASE PROGRESSION,9
NL,GENERAL PHYSICAL HEALTH DETERIORATION,9
NL,HEADACHE,9
NL,METASTASIS,9
NL,MUSCLE SPASMS,9
NL,RENAL FAILURE,9
NL,TREMOR,9
NL,ASCITES,8
NL,CARDIAC FAILURE,8
NL,COMA,8
NL,DRUG INEFFECTIVE,8
NL,HYPOGLYCAEMIA,8
NL,LACTIC ACIDOSIS,8
NL,MEMORY IMPAIRMENT,8
NL,METASTASES TO BONE,8
NL,MYOCARDIAL INFARCTION,8
NL,OVERDOSE,8
NL,PALPITATIONS,8
NL,PRURITUS,8
NL,SPEECH DISORDER,8
NL,VISION BLURRED,8
NL,BLOOD CREATININE INCREASED,7
NL,BULBAR PALSY,7
NL,GAIT DISTURBANCE,7
NL,HAEMODYNAMIC INSTABILITY,7
NL,HAEMOGLOBIN DECREASED,7
NL,LIVER FUNCTION TEST ABNORMAL,7
NL,MUSCLE RUPTURE,7
NL,PLEURAL EFFUSION,7
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,7
NL,VENTRICULAR TACHYCARDIA,7
NL,ALOPECIA,6
NL,ARTHROPATHY,6
NL,CHEST PAIN,6
NL,CONDITION AGGRAVATED,6
NL,CONFUSIONAL STATE,6
NL,CONSTIPATION,6
NL,DYSKINESIA,6
NL,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,6
NL,GASTROINTESTINAL DISORDER,6
NL,HEPATIC ENZYME INCREASED,6
NL,HYPOKALAEMIA,6
NL,OEDEMA,6
NL,OEDEMA PERIPHERAL,6
NL,ON AND OFF PHENOMENON,6
NL,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,6
NL,SYNCOPE,6
NL,TINNITUS,6
NL,URINARY TRACT INFECTION,6
NL,ANXIETY,5
NL,BONE PAIN,5
NL,CEREBRAL HAEMORRHAGE,5
NL,CHOLELITHIASIS,5
NL,DEPRESSED LEVEL OF CONSCIOUSNESS,5
NL,FLUID RETENTION,5
NL,INFECTION,5
NL,INTENTIONAL OVERDOSE,5
NL,INTERNATIONAL NORMALISED RATIO INCREASED,5
NL,MOBILITY DECREASED,5
NL,MULTI-ORGAN FAILURE,5
NL,NEUTROPENIA,5
NL,PAIN IN JAW,5
NL,PANCREATITIS,5
NL,PARKINSON^S DISEASE,5
NL,PNEUMONITIS,5
NL,RASH,5
NL,SUICIDAL IDEATION,5
NL,THROMBOCYTOPENIA,5
NL,ANAPHYLACTIC SHOCK,4
NL,ARRHYTHMIA,4
NL,ASPARTATE AMINOTRANSFERASE INCREASED,4
NL,BALANCE DISORDER,4
NL,BLOOD PRESSURE DECREASED,4
NL,BLOOD PRESSURE INCREASED,4
NL,CEREBRAL INFARCTION,4
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
NL,COUGH,4
NL,DEAFNESS UNILATERAL,4
NL,DYSPHAGIA,4
NL,EPILEPSY,4
NL,ERYTHEMA,4
NL,EXPOSURE DURING PREGNANCY,4
NL,FOETAL GROWTH RESTRICTION,4
NL,GASTRIC DISORDER,4
NL,GASTROENTERITIS,4
NL,HALLUCINATION,4
NL,HEART RATE DECREASED,4
NL,HIP FRACTURE,4
NL,HYPERHIDROSIS,4
NL,HYPERTENSION,4
NL,HYPOAESTHESIA,4
NL,HYPOCALCAEMIA,4
NL,HYPONATRAEMIA,4
NL,INJECTION SITE PAIN,4
NL,LUNG DISORDER,4
NL,MUSCULAR WEAKNESS,4
NL,MUSCULOSKELETAL PAIN,4
NL,MYALGIA,4
NL,NEUROPATHY PERIPHERAL,4
NL,NON-HODGKIN^S LYMPHOMA,4
NL,PERICARDIAL EFFUSION,4
NL,PLASMA CELL MYELOMA,4
NL,POISONING,4
NL,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,4
NL,PRODUCT USE ISSUE,4
NL,PROSTATE CANCER,4
NL,SLEEP DISORDER,4
NL,SPINAL COMPRESSION FRACTURE,4
NL,STOMA SITE DISCHARGE,4
NL,STOMA SITE PAIN,4
NL,TRANSIENT ISCHAEMIC ATTACK,4
NL,TUBULOINTERSTITIAL NEPHRITIS,4
NL,URINARY RETENTION,4
NL,UROSEPSIS,4
NL,ABDOMINAL DISCOMFORT,3
NL,ACUTE MYOCARDIAL INFARCTION,3
NL,ADRENAL INSUFFICIENCY,3
NL,ANGINA PECTORIS,3
NL,BILIARY COLIC,3
NL,BLOOD ALKALINE PHOSPHATASE INCREASED,3
NL,BLOOD GLUCOSE INCREASED,3
NL,BRADYKINESIA,3
NL,BREAST CANCER,3
NL,BREAST RECONSTRUCTION,3
NL,C-REACTIVE PROTEIN INCREASED,3
NL,CATARACT,3
NL,CEREBROVASCULAR ACCIDENT,3
NL,CIRCULATORY COLLAPSE,3
NL,COLON CANCER,3
NL,DEPRESSED MOOD,3
NL,DEPRESSION,3
NL,DEVICE DISLOCATION,3
NL,DIABETES MELLITUS,3
NL,DISORIENTATION,3
NL,DRUG ERUPTION,3
NL,DYSARTHRIA,3
NL,DYSTONIA,3
NL,EATING DISORDER,3
NL,EMBOLISM,3
NL,ENTERITIS,3
NL,FEBRILE NEUTROPENIA,3
NL,FEELING ABNORMAL,3
NL,FEELING COLD,3
NL,FEMUR FRACTURE,3
NL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
NL,GASTRIC HAEMORRHAGE,3
NL,GOUT,3
NL,GROIN PAIN,3
NL,GYNAECOMASTIA,3
NL,HAEMORRHAGE,3
NL,HEAD INJURY,3
NL,HEART RATE INCREASED,3
NL,HEPATIC FAILURE,3
NL,HEPATITIS,3
NL,HEPATITIS TOXIC,3
NL,HYPERKALAEMIA,3
NL,HYPERKINESIA,3
NL,HYPERSENSITIVITY,3
NL,HYPERSOMNIA,3
NL,HYPOMAGNESAEMIA,3
NL,ILEUS,3
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
NL,INCORRECT DOSE ADMINISTERED,3
NL,INFLUENZA,3
NL,INJECTION SITE MASS,3
NL,INJECTION SITE REACTION,3
NL,INTENTIONAL PRODUCT MISUSE,3
NL,INTENTIONAL PRODUCT USE ISSUE,3
NL,JOINT SWELLING,3
NL,LIVER DISORDER,3
NL,LOCAL SWELLING,3
NL,MOOD SWINGS,3
NL,MUSCLE RIGIDITY,3
NL,MYASTHENIA GRAVIS,3
NL,MYASTHENIA GRAVIS CRISIS,3
NL,NEOPLASM MALIGNANT,3
NL,NERVOUSNESS,3
NL,NIGHT SWEATS,3
NL,OSTEOPOROSIS,3
NL,PANCREATIC CARCINOMA,3
NL,PANCYTOPENIA,3
NL,PERICARDITIS,3
NL,PREMATURE DELIVERY,3
NL,PUBIS FRACTURE,3
NL,RASH ERYTHEMATOUS,3
NL,RECTAL HAEMORRHAGE,3
NL,RENAL FAILURE ACUTE,3
NL,RESTLESSNESS,3
NL,SENSE OF OPPRESSION,3
NL,SKIN EXFOLIATION,3
NL,SWELLING,3
NL,TENSION,3
NL,THINKING ABNORMAL,3
NL,VAGINAL HAEMORRHAGE,3
NL,VISUAL IMPAIRMENT,3
NL,WEIGHT INCREASED,3
NL,WOUND,3
NL,ABDOMINAL DISTENSION,2
NL,ABDOMINAL PAIN UPPER,2
NL,ABNORMAL BEHAVIOUR,2
NL,ABNORMAL DREAMS,2
NL,ACUTE CORONARY SYNDROME,2
NL,ACUTE HEPATIC FAILURE,2
NL,ALANINE AMINOTRANSFERASE INCREASED,2
NL,AMNESIA,2
NL,ANAPHYLACTIC REACTION,2
NL,ARTERIAL THROMBOSIS,2
NL,AUTOIMMUNE HAEMOLYTIC ANAEMIA,2
NL,AUTOIMMUNE HEPATITIS,2
NL,BACK DISORDER,2
NL,BACTERIAL INFECTION,2
NL,BLINDNESS,2
NL,BLINDNESS UNILATERAL,2
NL,BLISTER,2
NL,BLISTER INFECTED,2
NL,BLOOD BILIRUBIN INCREASED,2
NL,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
NL,BLOOD PRESSURE FLUCTUATION,2
NL,BLOOD TEST ABNORMAL,2
NL,BLOOD UREA INCREASED,2
NL,BLOOD URINE PRESENT,2
NL,BONE MARROW FAILURE,2
NL,BREAST CANCER METASTATIC,2
NL,BREATH SOUNDS ABNORMAL,2
NL,CACHEXIA,2
NL,CANDIDA INFECTION,2
NL,CARDIAC ARREST,2
NL,CARDIAC ASTHMA,2
NL,CARDIOVERSION,2
NL,CELLULITIS,2
NL,CHEST DISCOMFORT,2
NL,CHILLS,2
NL,CHOLECYSTITIS,2
NL,CLOSTRIDIUM DIFFICILE INFECTION,2
NL,COCCYDYNIA,2
NL,COLITIS,2
NL,CONTUSION,2
NL,COORDINATION ABNORMAL,2
NL,CROHN^S DISEASE,2
NL,CRYING,2
NL,CYSTITIS,2
NL,DEEP VEIN THROMBOSIS,2
NL,DERMATITIS,2
NL,DEVICE KINK,2
NL,DRUG DOSE OMISSION,2
NL,DRUG EFFECT DELAYED,2
NL,DRUG EFFECT INCOMPLETE,2
NL,DRUG LEVEL INCREASED,2
NL,DYSPHONIA,2
NL,DYSURIA,2
NL,ECZEMA,2
NL,EMOTIONAL DISORDER,2
NL,ENDOMETRIOSIS,2
NL,EOSINOPHILIA,2
NL,EPISTAXIS,2
NL,EXTRASYSTOLES,2
NL,FACE OEDEMA,2
NL,FACIAL PAIN,2
NL,FAECES DISCOLOURED,2
NL,FEAR,2
NL,FLUID INTAKE REDUCED,2
NL,FOETAL EXPOSURE DURING PREGNANCY,2
NL,FREQUENT BOWEL MOVEMENTS,2
NL,GASTROINTESTINAL HAEMORRHAGE,2
NL,GASTROINTESTINAL INFLAMMATION,2
NL,HAEMOLYTIC ANAEMIA,2
NL,HAEMORRHAGIC DIATHESIS,2
NL,HALLUCINATION_ VISUAL,2
NL,HEPATIC ENZYME ABNORMAL,2
NL,HEPATIC STEATOSIS,2
NL,HERPES VIRUS INFECTION,2
NL,HOSPITALISATION,2
NL,HYPERGLYCAEMIA,2
NL,HYPERTHYROIDISM,2
NL,HYPOACUSIS,2
NL,HYPOVOLAEMIC SHOCK,2
NL,HYPOXIA,2
NL,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
NL,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
NL,INFECTED BITES,2
NL,INFLAMMATION,2
NL,INFLUENZA LIKE ILLNESS,2
NL,INFUSION RELATED REACTION,2
NL,INJECTION SITE PRURITUS,2
NL,INTERSTITIAL LUNG DISEASE,2
NL,INVASIVE DUCTAL BREAST CARCINOMA,2
NL,IRON DEFICIENCY ANAEMIA,2
NL,ISCHAEMIC STROKE,2
NL,KNEE ARTHROPLASTY,2
NL,LARGE INTESTINE PERFORATION,2
NL,LEUKOCYTOCLASTIC VASCULITIS,2
NL,LEUKOCYTOSIS,2
NL,LIP SWELLING,2
NL,LIVER ABSCESS,2
NL,LIVER INJURY,2
NL,LOCALISED INFECTION,2
NL,LOWER RESPIRATORY TRACT INFECTION,2
NL,LUNG CANCER METASTATIC,2
NL,MALNUTRITION,2
NL,MATERNAL EXPOSURE DURING PREGNANCY,2
NL,MELAENA,2
NL,MENINGIOMA,2
NL,METABOLIC ALKALOSIS,2
NL,METASTASES TO PELVIS,2
NL,MIGRAINE,2
NL,MONOPLEGIA,2
NL,MOUTH SWELLING,2
NL,MULTIPLE SCLEROSIS RELAPSE,2
NL,MUSCLE DISORDER,2
NL,MUSCLE TIGHTNESS,2
NL,MUTISM,2
NL,MYELODYSPLASTIC SYNDROME,2
NL,NEOPLASM PROGRESSION,2
NL,NEURALGIA,2
NL,NOCTURIA,2
NL,OBESITY,2
NL,OESOPHAGEAL STENOSIS,2
NL,ORTHOSTATIC HYPOTENSION,2
NL,OSTEOARTHRITIS,2
NL,OSTEONECROSIS OF JAW,2
NL,OXYGEN SATURATION DECREASED,2
NL,PANIC ATTACK,2
NL,PARAPLEGIA,2
NL,PELVIC PAIN,2
NL,PERITONITIS,2
NL,PLATELET COUNT DECREASED,2
NL,PREGNANCY,2
NL,PRESYNCOPE,2
NL,PROCEDURAL PAIN,2
NL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
NL,PROTEINURIA,2
NL,PSEUDOMONAL SEPSIS,2
NL,PULMONARY HAEMORRHAGE,2
NL,PURPURA,2
NL,REGURGITATION,2
NL,RESPIRATORY DISTRESS,2
NL,RETINAL INFARCTION,2
NL,RHEUMATOID ARTHRITIS,2
NL,RHINITIS,2
NL,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,2
NL,SINUS TACHYCARDIA,2
NL,SKIN REACTION,2
NL,SPINAL FRACTURE,2
NL,STEVENS-JOHNSON SYNDROME,2
NL,STOMA SITE HYPERSENSITIVITY,2
NL,STOMA SITE INFLAMMATION,2
NL,TOOTH INJURY,2
NL,TOXIC SKIN ERUPTION,2
NL,URTICARIA,2
NL,VENOOCCLUSIVE DISEASE,2
NL,ABASIA,1
NL,ABDOMINAL HERNIA,1
NL,ABDOMINAL LYMPHADENOPATHY,1
NL,ABDOMINAL PAIN LOWER,1
NL,ABDOMINAL RIGIDITY,1
NL,ABDOMINAL SEPSIS,1
NL,ABDOMINAL TENDERNESS,1
NL,ABNORMAL FAECES,1
NL,ABORTION SPONTANEOUS,1
NL,ABSCESS,1
NL,ABSCESS JAW,1
NL,ABSCESS ORAL,1
NL,ACIDOSIS,1
NL,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,1
NL,ADENOCARCINOMA,1
NL,ADENOCARCINOMA OF COLON,1
NL,ADENOCARCINOMA PANCREAS,1
NL,ADRENALECTOMY,1
NL,ADVERSE DRUG REACTION,1
NL,AFFECT LABILITY,1
NL,ALVEOLITIS ALLERGIC,1
NL,AMYLASE INCREASED,1
NL,AMYOTROPHIC LATERAL SCLEROSIS,1
NL,ANAL ABSCESS,1
NL,ANASTOMOTIC LEAK,1
NL,ANEURYSM RUPTURED,1
NL,ANGINA UNSTABLE,1
NL,ANGIOPATHY,1
NL,ANTINUCLEAR ANTIBODY POSITIVE,1
NL,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
NL,AORTIC DISSECTION,1
NL,AORTIC RUPTURE,1
NL,AORTIC STENOSIS,1
NL,APATHY,1
NL,APHAGIA,1
NL,APPENDICITIS,1
NL,APRAXIA,1
NL,ARTERIOSPASM CORONARY,1
NL,ARTHRITIS,1
NL,ASOCIAL BEHAVIOUR,1
NL,ASPIRATION,1
NL,ATELECTASIS,1
NL,ATRIAL TACHYCARDIA,1
NL,ATRIOVENTRICULAR BLOCK COMPLETE,1
NL,AURA,1
NL,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
NL,BASAL CELL CARCINOMA,1
NL,BASEDOW^S DISEASE,1
NL,BENIGN PROSTATIC HYPERPLASIA,1
NL,BILIARY TRACT DISORDER,1
NL,BILIRUBIN CONJUGATED INCREASED,1
NL,BLADDER CANCER,1
NL,BLADDER PAIN,1
NL,BLEEDING VARICOSE VEIN,1
NL,BLINDNESS TRANSIENT,1
NL,BLOOD BLISTER,1
NL,BLOOD GLUCOSE ABNORMAL,1
NL,BLOOD GLUCOSE FLUCTUATION,1
NL,BLOOD INSULIN INCREASED,1
NL,BLOOD LACTATE DEHYDROGENASE ABNORMAL,1
NL,BLOOD POTASSIUM INCREASED,1
NL,BLOOD PRESSURE ABNORMAL,1
NL,BLOOD PRESSURE SYSTOLIC INCREASED,1
NL,BONE FISTULA,1
NL,BONE SCAN ABNORMAL,1
NL,BOREDOM,1
NL,BRADYCARDIA,1
NL,BRAIN HERNIATION,1
NL,BRAIN NEOPLASM,1
NL,BRAIN NEOPLASM MALIGNANT,1
NL,BREAST PAIN,1
NL,BREAST PROSTHESIS IMPLANTATION,1
NL,BRONCHIOLOALVEOLAR CARCINOMA,1
NL,BRONCHOPULMONARY ASPERGILLOSIS,1
NL,BURNING SENSATION,1
NL,CAESAREAN SECTION,1
NL,CALCULUS URINARY,1
NL,CAMPYLOBACTER GASTROENTERITIS,1
NL,CAPILLARY LEAK SYNDROME,1
NL,CARDIAC FAILURE CONGESTIVE,1
NL,CARDIAC MURMUR,1
NL,CARDIAC OPERATION,1
NL,CARDIOMYOPATHY,1
NL,CARDIOVASCULAR DISORDER,1
NL,CAROTID ARTERY STENOSIS,1
NL,CATHETER SITE HAEMORRHAGE,1
NL,CEREBELLAR INFARCTION,1
NL,CEREBELLAR ISCHAEMIA,1
NL,CEREBRAL ENDOVASCULAR ANEURYSM REPAIR,1
NL,CEREBRAL ISCHAEMIA,1
NL,CHEST WALL OPERATION,1
NL,CHOKING,1
NL,CHOLANGITIS,1
NL,CHOLANGITIS SUPPURATIVE,1
NL,CHOLECYSTITIS ACUTE,1
NL,CHOLESTASIS,1
NL,CHROMATURIA,1
NL,COGNITIVE DISORDER,1
NL,COLD SWEAT,1
NL,COLITIS MICROSCOPIC,1
NL,COLON ADENOMA,1
NL,COLON CANCER METASTATIC,1
NL,COLORECTAL ADENOCARCINOMA,1
NL,COMMINUTED FRACTURE,1
NL,COMPARTMENT SYNDROME,1
NL,COMPLETED SUICIDE,1
NL,COMPUTERISED TOMOGRAM ABNORMAL,1
NL,CONCOMITANT DISEASE AGGRAVATED,1
NL,CONCOMITANT DISEASE PROGRESSION,1
NL,CONJUNCTIVAL HAEMORRHAGE,1
NL,CONTRAINDICATED PRODUCT ADMINISTERED,1
NL,CONVULSION,1
NL,CORONARY ARTERY DISEASE,1
NL,CORONARY ARTERY OCCLUSION,1
NL,CORONARY ARTERY STENOSIS,1
NL,CYST,1
NL,CYSTITIS NONINFECTIVE,1
NL,CYTOKINE RELEASE SYNDROME,1
NL,DEAFNESS,1
NL,DEFAECATION URGENCY,1
NL,DELUSION,1
NL,DEMENTIA ALZHEIMER^S TYPE,1
NL,DENTAL CARIES,1
NL,DERMATITIS ALLERGIC,1
NL,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,1
NL,DEVICE ALARM ISSUE,1
NL,DEVICE ISSUE,1
NL,DEVICE LEAKAGE,1
NL,DEVICE OCCLUSION,1
NL,DEVICE RELATED INFECTION,1
NL,DIFFUSE LARGE B-CELL LYMPHOMA,1
NL,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
NL,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
NL,DRUG DISPENSING ERROR,1
NL,DRUG EFFECT DECREASED,1
NL,DRUG HYPERSENSITIVITY,1
NL,DRUG LEVEL ABOVE THERAPEUTIC,1
NL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
NL,DRY EYE,1
NL,DRY MOUTH,1
NL,DRY SKIN,1
NL,DUODENAL ULCER,1
NL,DYSCHEZIA,1
NL,DYSGEUSIA,1
NL,DYSPNOEA EXERTIONAL,1
NL,DYSPRAXIA,1
NL,DYSSTASIA,1
NL,EAR HAEMORRHAGE,1
NL,ELECTROCARDIOGRAM ABNORMAL,1
NL,ELECTROENCEPHALOGRAM ABNORMAL,1
NL,ELECTROLYTE IMBALANCE,1
NL,EMBOLISM ARTERIAL,1
NL,EMOTIONAL DISTRESS,1
NL,ENCEPHALITIS,1
NL,ENTEROVESICAL FISTULA,1
NL,EOSINOPHIL COUNT DECREASED,1
NL,EPSTEIN-BARR VIRUS INFECTION,1
NL,ERECTION INCREASED,1
NL,ERYSIPELAS,1
NL,ESCHERICHIA URINARY TRACT INFECTION,1
NL,EUTHANASIA,1
NL,EXERCISE LACK OF,1
NL,EXOPHTHALMOS,1
NL,EXTREMITY NECROSIS,1
NL,EYE CONTUSION,1
NL,EYE DISORDER,1
NL,FACIAL BONES FRACTURE,1
NL,FACIAL PARALYSIS,1
NL,FAECAL VOMITING,1
NL,FAECES SOFT,1
NL,FALLOPIAN TUBE CYST,1
NL,FEEDING DISORDER,1
NL,FEELING HOT,1
NL,FIBROMA,1
NL,FOETAL DEATH,1
NL,FRACTURE,1
NL,FRACTURE PAIN,1
NL,FREEZING PHENOMENON,1
NL,FUNCTIONAL RESIDUAL CAPACITY ABNORMAL,1
NL,GALACTORRHOEA,1
NL,GALLBLADDER OPERATION,1
NL,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
NL,GASTRIC BANDING,1
NL,GASTRIC PERFORATION,1
NL,GASTRIC ULCER HAEMORRHAGE,1
NL,GASTRITIS,1
NL,GASTRITIS EROSIVE,1
NL,GASTROENTERITIS VIRAL,1
NL,GASTROINTESTINAL COMPLICATION ASSOCIATED WITH DEVICE,1
NL,GASTROINTESTINAL HYPOMOTILITY,1
NL,GASTROINTESTINAL MOTILITY DISORDER,1
NL,GASTROINTESTINAL NECROSIS,1
NL,GASTROINTESTINAL PAIN,1
NL,GASTROINTESTINAL SOUNDS ABNORMAL,1
NL,GENERALISED ERYTHEMA,1
NL,GENERALISED TONIC-CLONIC SEIZURE,1
NL,GENITAL HAEMORRHAGE,1
NL,GLOMERULONEPHRITIS,1
NL,GLOSSOPHARYNGEAL NERVE DISORDER,1
NL,GRAFT VERSUS HOST DISEASE,1
NL,GRANULOMATOSIS WITH POLYANGIITIS,1
NL,GUILLAIN-BARRE SYNDROME,1
NL,HAEMATOCHEZIA,1
NL,HAEMATOCRIT DECREASED,1
NL,HAEMATURIA,1
NL,HAEMATURIA TRAUMATIC,1
NL,HAEMODIALYSIS,1
NL,HAEMOLYSIS,1
NL,HAEMORRHAGE INTRACRANIAL,1
NL,HAEMORRHAGIC STROKE,1
NL,HAEMORRHOIDS,1
NL,HEART VALVE REPLACEMENT,1
NL,HEPATECTOMY,1
NL,HEPATIC FUNCTION ABNORMAL,1
NL,HEPATIC MASS,1
NL,HEPATIC NECROSIS,1
NL,HEPATITIS ALCOHOLIC,1
NL,HEPATOMEGALY,1
NL,HERNIA,1
NL,HISTIOCYTOSIS HAEMATOPHAGIC,1
NL,HORMONE-DEPENDENT PROSTATE CANCER,1
NL,HORMONE-REFRACTORY PROSTATE CANCER,1
NL,HOSPICE CARE,1
NL,HYPERCALCAEMIA,1
NL,HYPERCAPNIA,1
NL,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
NL,HYPERSENSITIVITY VASCULITIS,1
NL,HYPOGEUSIA,1
NL,HYPOKINESIA,1
NL,HYPOPHAGIA,1
NL,HYPOPHOSPHATAEMIA,1
NL,HYPOPHYSITIS,1
NL,HYPOTHERMIA,1
NL,HYSTERECTOMY,1
NL,ILEAL ULCER,1
NL,ILEUS PARALYTIC,1
NL,IMMUNODEFICIENCY,1
NL,IMPAIRED HEALING,1
NL,IMPLANTABLE DEFIBRILLATOR INSERTION,1
NL,INCONTINENCE,1
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NL,INFECTION SUSCEPTIBILITY INCREASED,1
NL,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,1
NL,INGROWING NAIL,1
NL,INGUINAL HERNIA,1
NL,INGUINAL MASS,1
NL,INJECTION SITE ERYTHEMA,1
NL,INJECTION SITE INDURATION,1
NL,INJECTION SITE INFECTION,1
NL,INJECTION SITE INFLAMMATION,1
NL,INJECTION SITE NODULE,1
NL,INTESTINAL DILATATION,1
NL,INTESTINAL ISCHAEMIA,1
NL,INTESTINAL OBSTRUCTION,1
NL,INTESTINAL STENOSIS,1
NL,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
NL,ISCHAEMIA,1
NL,ISCHAEMIC CEREBRAL INFARCTION,1
NL,JOINT DISLOCATION,1
NL,JOINT INJURY,1
NL,JUVENILE IDIOPATHIC ARTHRITIS,1
NL,KIDNEY TRANSPLANT REJECTION,1
NL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
NL,LACRIMATION INCREASED,1
NL,LASER THERAPY,1
NL,LEPTOSPIROSIS,1
NL,LEUKOPENIA,1
NL,LICHEN PLANUS,1
NL,LIMB DISCOMFORT,1
NL,LIP BLISTER,1
NL,LIVER FUNCTION TEST INCREASED,1
NL,LOSS OF CONTROL OF LEGS,1
NL,LOSS OF LIBIDO,1
NL,LOWER URINARY TRACT SYMPTOMS,1
NL,LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,1
NL,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,1
NL,LUNG CONSOLIDATION,1
NL,LUNG INFECTION,1
NL,LUNG INFILTRATION,1
NL,LUNG NEOPLASM MALIGNANT,1
NL,LUPUS-LIKE SYNDROME,1
NL,LYMPHADENECTOMY,1
NL,LYMPHORRHOEA,1
NL,MALIGNANT ASCITES,1
NL,MALIGNANT MELANOMA,1
NL,MASTECTOMY,1
NL,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
NL,MEDIASTINAL SHIFT,1
NL,MEDICAL DEVICE DISCOMFORT,1
NL,MEDICATION ERROR,1
NL,MENINGITIS ASEPTIC,1
NL,MENINGOCOCCAL SEPSIS,1
NL,MENTAL IMPAIRMENT,1
NL,METABOLIC ACIDOSIS,1
NL,METABOLIC DISORDER,1
NL,METASTASES TO LIVER,1
NL,METASTASES TO LUNG,1
NL,METASTASES TO SKIN,1
NL,METASTASES TO SPINE,1
NL,METASTATIC GASTRIC CANCER,1
NL,METASTATIC RENAL CELL CARCINOMA,1
NL,METHAEMOGLOBINAEMIA,1
NL,METRORRHAGIA,1
NL,MICTURITION FREQUENCY DECREASED,1
NL,MONOCYTE COUNT INCREASED,1
NL,MONOPARESIS,1
NL,MORPHOEA,1
NL,MOTOR DYSFUNCTION,1
NL,MOUTH ULCERATION,1
NL,MOVEMENT DISORDER,1
NL,MUCOSAL INFLAMMATION,1
NL,MUCOUS MEMBRANE DISORDER,1
NL,MULTIPLE SCLEROSIS,1
NL,MUSCULOSKELETAL CHEST PAIN,1
NL,MUSCULOSKELETAL DISCOMFORT,1
NL,MUSCULOSKELETAL DISORDER,1
NL,MUSCULOSKELETAL STIFFNESS,1
NL,MYOCARDIAL DEPRESSION,1
NL,NAIL DYSTROPHY,1
NL,NASAL DISCOMFORT,1
NL,NASAL DISORDER,1
NL,NECK PAIN,1
NL,NECROSIS,1
NL,NEOPLASM,1
NL,NEPHROLITHIASIS,1
NL,NEPHROTIC SYNDROME,1
NL,NEUTROPHIL PERCENTAGE DECREASED,1
NL,NO ADVERSE EVENT,1
NL,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
NL,NOSOCOMIAL INFECTION,1
NL,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
NL,OCULAR RETROBULBAR HAEMORRHAGE,1
NL,OESOPHAGEAL CANDIDIASIS,1
NL,OESOPHAGITIS,1
NL,OOPHORECTOMY,1
NL,ORAL CANDIDIASIS,1
NL,ORAL MUCOSAL ERYTHEMA,1
NL,ORAL NEOPLASM,1
NL,OROPHARYNGEAL PAIN,1
NL,OROPHARYNGEAL SWELLING,1
NL,ORTHOPNOEA,1
NL,OSTEOMYELITIS,1
NL,OSTEONECROSIS,1
NL,OVERWEIGHT,1
NL,PANCREATIC DISORDER,1
NL,PARAESTHESIA,1
NL,PARANOIA,1
NL,PARAPSORIASIS,1
NL,PAROSMIA,1
NL,PARVOVIRUS INFECTION,1
NL,PATHOLOGICAL FRACTURE,1
NL,PATIENT-DEVICE INCOMPATIBILITY,1
NL,PELVIC FRACTURE,1
NL,PENILE PAIN,1
NL,PERFORMANCE STATUS DECREASED,1
NL,PERIPHERAL MOTOR NEUROPATHY,1
NL,PERIPHERAL SWELLING,1
NL,PHARYNGEAL DISORDER,1
NL,PHARYNGEAL INFLAMMATION,1
NL,PHARYNGEAL OEDEMA,1
NL,PIGMENTATION DISORDER,1
NL,PNEUMONIA ESCHERICHIA,1
NL,POLLAKIURIA,1
NL,POLYARTHRITIS,1
NL,POLYDIPSIA,1
NL,POLYNEUROPATHY,1
NL,POOR QUALITY SLEEP,1
NL,POST PROCEDURAL COMPLICATION,1
NL,POST-TRAUMATIC STRESS DISORDER,1
NL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
NL,POSTOPERATIVE WOUND INFECTION,1
NL,PREGNANCY ON CONTRACEPTIVE,1
NL,PREMATURE BABY,1
NL,PROCTALGIA,1
NL,PRODUCT USE IN UNAPPROVED INDICATION,1
NL,PROSTATIC SPECIFIC ANTIGEN DECREASED,1
NL,PROSTATISM,1
NL,PROTEIN TOTAL INCREASED,1
NL,PROTHROMBIN TIME RATIO INCREASED,1
NL,PROTHROMBIN TIME SHORTENED,1
NL,PSORIASIS,1
NL,PSORIATIC ARTHROPATHY,1
NL,PSYCHOTIC DISORDER,1
NL,PULMONARY ARTERIAL HYPERTENSION,1
NL,PULMONARY HYPERTENSION,1
NL,PULMONARY MASS,1
NL,PULMONARY SEPSIS,1
NL,PULPITIS DENTAL,1
NL,PYRAMIDAL TRACT SYNDROME,1
NL,RADICULAR SYNDROME,1
NL,RASH PAPULAR,1
NL,RASH PRURITIC,1
NL,RASH PUSTULAR,1
NL,RED BLOOD CELL COUNT DECREASED,1
NL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
NL,RED CELL DISTRIBUTION WIDTH INCREASED,1
NL,RENAL CANCER,1
NL,RENAL CELL CARCINOMA,1
NL,RENAL DISORDER,1
NL,RESPIRATORY RATE INCREASED,1
NL,RESPIRATORY TRACT INFECTION,1
NL,RESPIRATORY TRACT INFECTION FUNGAL,1
NL,RESTLESS LEGS SYNDROME,1
NL,RETINAL DETACHMENT,1
NL,RHEUMATIC DISORDER,1
NL,RHINORRHOEA,1
NL,RHONCHI,1
NL,RIB FRACTURE,1
NL,RIGHT VENTRICULAR HYPERTROPHY,1
NL,SACCADIC EYE MOVEMENT,1
NL,SALIVARY HYPERSECRETION,1
NL,SCAPULA FRACTURE,1
NL,SCAR,1
NL,SCARLET FEVER,1
NL,SCREAMING,1
NL,SCROTAL CYST,1
NL,SCROTAL PAIN,1
NL,SECOND PRIMARY MALIGNANCY,1
NL,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
NL,SEDATION,1
NL,SEIZURE,1
NL,SENSORY LOSS,1
NL,SEROTONIN SYNDROME,1
NL,SERUM FERRITIN DECREASED,1
NL,SERUM FERRITIN INCREASED,1
NL,SERUM SICKNESS,1
NL,SHOCK,1
NL,SINUSITIS,1
NL,SKIN ABRASION,1
NL,SKIN BURNING SENSATION,1
NL,SKIN CANCER,1
NL,SKIN DISCOLOURATION,1
NL,SKIN INFECTION,1
NL,SKIN LESION,1
NL,SKIN ULCER,1
NL,SLEEP APNOEA SYNDROME,1
NL,SMALL INTESTINAL RESECTION,1
NL,SMALL INTESTINE CARCINOMA,1
NL,SMOOTH MUSCLE ANTIBODY POSITIVE,1
NL,SPINAL CORD COMPRESSION,1
NL,SPINAL CORD INJURY,1
NL,SPLENIC HAEMORRHAGE,1
NL,SPLENOMEGALY,1
NL,SPONTANEOUS HAEMATOMA,1
NL,SQUAMOUS CELL CARCINOMA,1
NL,SQUAMOUS CELL CARCINOMA OF LUNG,1
NL,STAPHYLOCOCCAL INFECTION,1
NL,STAPHYLOCOCCAL SEPSIS,1
NL,STATUS EPILEPTICUS,1
NL,STOMA SITE ERYTHEMA,1
NL,STOMA SITE EXTRAVASATION,1
NL,STRABISMUS,1
NL,STRESS,1
NL,STRESS FRACTURE,1
NL,SURGERY,1
NL,SUSPECTED COUNTERFEIT PRODUCT,1
NL,SWOLLEN TONGUE,1
NL,SYSTEMIC LUPUS ERYTHEMATOSUS,1
NL,SYSTEMIC SCLEROSIS,1
NL,TACHYPNOEA,1
NL,TENDON RUPTURE,1
NL,THERAPEUTIC RESPONSE UNEXPECTED,1
NL,THROMBOPHLEBITIS SUPERFICIAL,1
NL,THROMBOSIS,1
NL,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
NL,THYROID DISORDER,1
NL,TIBIA FRACTURE,1
NL,TONGUE DISORDER,1
NL,TONSILLAR INFLAMMATION,1
NL,TONSILLITIS,1
NL,TOOTH DISORDER,1
NL,TOOTHACHE,1
NL,TOXIC EPIDERMAL NECROLYSIS,1
NL,TRANSFUSION,1
NL,TRANSURETHRAL PROSTATECTOMY,1
NL,TYPE 2 DIABETES MELLITUS,1
NL,UHTHOFF^S PHENOMENON,1
NL,UNEVALUABLE EVENT,1
NL,UPPER GASTROINTESTINAL HAEMORRHAGE,1
NL,URETEROLITHIASIS,1
NL,URINARY BLADDER HAEMORRHAGE,1
NL,URINARY TRACT INFLAMMATION,1
NL,URINE OUTPUT DECREASED,1
NL,VACCINATION FAILURE,1
NL,VAGINAL ULCERATION,1
NL,VASCULAR DEMENTIA,1
NL,VASCULAR OCCLUSION,1
NL,VENTRICULAR EXTRASYSTOLES,1
NL,VERTIGO POSITIONAL,1
NL,VIRAL INFECTION,1
NL,VITAMIN D DEFICIENCY,1
NL,VITH NERVE PARALYSIS,1
NL,VOMITING PROJECTILE,1
NL,VULVOVAGINAL INFLAMMATION,1
NL,VULVOVAGINAL PAIN,1
NL,WALKING DISABILITY,1
NL,WEIGHT ABNORMAL,1
NL,WHEELCHAIR USER,1
NL,WHITE BLOOD CELL COUNT DECREASED,1
NL,WOUND COMPLICATION,1
NL,WOUND INFECTION,1
NL,WRIST FRACTURE,1
NL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NZ,HYPONATRAEMIA,17
NZ,PYREXIA,14
NZ,FATIGUE,13
NZ,DYSPNOEA,12
NZ,CONFUSIONAL STATE,11
NZ,MALAISE,11
NZ,PAIN,10
NZ,ACUTE KIDNEY INJURY,9
NZ,DEATH,9
NZ,CEREBROVASCULAR ACCIDENT,8
NZ,FALL,8
NZ,HYPOMAGNESAEMIA,8
NZ,PNEUMONIA,8
NZ,SEPSIS,8
NZ,ABDOMINAL PAIN,7
NZ,ANAEMIA,7
NZ,ASTHENIA,7
NZ,CHEST PAIN,7
NZ,CHILLS,7
NZ,DIARRHOEA,7
NZ,GAIT DISTURBANCE,7
NZ,HYPOKALAEMIA,7
NZ,NAUSEA,7
NZ,RENAL IMPAIRMENT,7
NZ,VOMITING,7
NZ,ARTHRALGIA,6
NZ,CARDIAC FAILURE,6
NZ,DEPRESSION,6
NZ,DRUG INEFFECTIVE,6
NZ,FEBRILE NEUTROPENIA,6
NZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
NZ,LOWER RESPIRATORY TRACT INFECTION,6
NZ,MYALGIA,6
NZ,RASH,6
NZ,SYNCOPE,6
NZ,ARTHRITIS,5
NZ,BLOOD CREATININE INCREASED,5
NZ,BODY TEMPERATURE INCREASED,5
NZ,CONSTIPATION,5
NZ,COUGH,5
NZ,DYSPHAGIA,5
NZ,GASTROINTESTINAL HAEMORRHAGE,5
NZ,GENERAL PHYSICAL HEALTH DETERIORATION,5
NZ,HEADACHE,5
NZ,HEPATIC FAILURE,5
NZ,HYPOCALCAEMIA,5
NZ,LIVER FUNCTION TEST ABNORMAL,5
NZ,SUICIDAL IDEATION,5
NZ,WEIGHT DECREASED,5
NZ,WHITE BLOOD CELL COUNT INCREASED,5
NZ,ABDOMINAL DISTENSION,4
NZ,ACUTE MYOCARDIAL INFARCTION,4
NZ,ALANINE AMINOTRANSFERASE INCREASED,4
NZ,ANXIETY,4
NZ,ASPARTATE AMINOTRANSFERASE INCREASED,4
NZ,ATRIAL FIBRILLATION,4
NZ,CARDIAC ARREST,4
NZ,CELLULITIS,4
NZ,DISEASE PROGRESSION,4
NZ,DIZZINESS,4
NZ,HAEMOGLOBIN DECREASED,4
NZ,HEMIPARESIS,4
NZ,HYPOTENSION,4
NZ,INFECTION,4
NZ,JOINT EFFUSION,4
NZ,LOSS OF CONSCIOUSNESS,4
NZ,MELAENA,4
NZ,METASTASES TO BONE,4
NZ,MYOCARDIAL INFARCTION,4
NZ,NEUROPATHY PERIPHERAL,4
NZ,NEUTROPHIL COUNT INCREASED,4
NZ,PRODUCT USE ISSUE,4
NZ,PRURITUS,4
NZ,RENAL FAILURE,4
NZ,SUPRAVENTRICULAR TACHYCARDIA,4
NZ,TACHYCARDIA,4
NZ,TREATMENT FAILURE,4
NZ,URINARY TRACT INFECTION,4
NZ,ABDOMINAL PAIN UPPER,3
NZ,ALOPECIA,3
NZ,ANAPHYLACTIC REACTION,3
NZ,ASTHMA,3
NZ,BLOOD ALKALINE PHOSPHATASE INCREASED,3
NZ,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
NZ,BLOOD PRESSURE INCREASED,3
NZ,BRONCHITIS,3
NZ,C-REACTIVE PROTEIN INCREASED,3
NZ,CARDIAC FAILURE CONGESTIVE,3
NZ,CARPAL TUNNEL SYNDROME,3
NZ,CHEST DISCOMFORT,3
NZ,COLITIS ISCHAEMIC,3
NZ,DECREASED APPETITE,3
NZ,DEMYELINATION,3
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,3
NZ,FLAT AFFECT,3
NZ,GOUT,3
NZ,HAEMATOCHEZIA,3
NZ,HEPATIC ENZYME INCREASED,3
NZ,HYPERKALAEMIA,3
NZ,HYPERTENSION,3
NZ,INFLUENZA LIKE ILLNESS,3
NZ,JAUNDICE,3
NZ,LIVER INJURY,3
NZ,MULTI-ORGAN FAILURE,3
NZ,MYOCARDITIS,3
NZ,OROPHARYNGEAL PAIN,3
NZ,PAIN IN EXTREMITY,3
NZ,PALPITATIONS,3
NZ,PERIPHERAL SWELLING,3
NZ,PLATELET COUNT DECREASED,3
NZ,POLYARTHRITIS,3
NZ,PROSTATISM,3
NZ,PULMONARY EMBOLISM,3
NZ,RASH ERYTHEMATOUS,3
NZ,RECTAL HAEMORRHAGE,3
NZ,RHEUMATIC DISORDER,3
NZ,SOMNOLENCE,3
NZ,TUBULOINTERSTITIAL NEPHRITIS,3
NZ,URTICARIA,3
NZ,ABDOMINAL TENDERNESS,2
NZ,ACCELERATED HYPERTENSION,2
NZ,ACTIVITIES OF DAILY LIVING IMPAIRED,2
NZ,ACUTE HEPATIC FAILURE,2
NZ,ADENOCARCINOMA OF COLON,2
NZ,ADVERSE DRUG REACTION,2
NZ,AFFECTIVE DISORDER,2
NZ,ANGINA UNSTABLE,2
NZ,ANTIBIOTIC LEVEL ABOVE THERAPEUTIC,2
NZ,ASCITES,2
NZ,ATELECTASIS,2
NZ,BALANCE DISORDER,2
NZ,BLOOD PARATHYROID HORMONE DECREASED,2
NZ,BRADYCARDIA,2
NZ,CANDIDA INFECTION,2
NZ,CANDIDA SEPSIS,2
NZ,CEREBRAL HAEMORRHAGE,2
NZ,CHOLECYSTITIS,2
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
NZ,COLITIS,2
NZ,CONVULSION,2
NZ,CREPITATIONS,2
NZ,DEHYDRATION,2
NZ,DELIRIUM,2
NZ,DIABETES MELLITUS,2
NZ,DIABETIC FOOT INFECTION,2
NZ,DIALYSIS,2
NZ,DISEASE RECURRENCE,2
NZ,DUODENAL ULCER,2
NZ,DYSPHONIA,2
NZ,EMBOLISM VENOUS,2
NZ,EMOTIONAL DISTRESS,2
NZ,ENCEPHALOPATHY,2
NZ,EOSINOPHIL COUNT INCREASED,2
NZ,ERYTHEMA,2
NZ,FLUSHING,2
NZ,GASTROINTESTINAL HYPOMOTILITY,2
NZ,GASTROOESOPHAGEAL REFLUX DISEASE,2
NZ,GLOMERULAR FILTRATION RATE DECREASED,2
NZ,HAEMATOCRIT DECREASED,2
NZ,HAEMOPTYSIS,2
NZ,HAEMORRHAGE INTRACRANIAL,2
NZ,HEART RATE IRREGULAR,2
NZ,HEPATIC CIRRHOSIS,2
NZ,HYPOXIA,2
NZ,IMPAIRED WORK ABILITY,2
NZ,INFLAMMATION,2
NZ,INFLUENZA,2
NZ,INTERSTITIAL LUNG DISEASE,2
NZ,INTESTINAL OBSTRUCTION,2
NZ,JOINT SWELLING,2
NZ,KNEE ARTHROPLASTY,2
NZ,LOCAL SWELLING,2
NZ,LUNG INFILTRATION,2
NZ,MALIGNANT MELANOMA,2
NZ,MEMORY IMPAIRMENT,2
NZ,MENTAL DISORDER,2
NZ,METASTASES TO LIVER,2
NZ,METASTASES TO LUNG,2
NZ,METASTATIC MALIGNANT MELANOMA,2
NZ,MOBILITY DECREASED,2
NZ,MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED,2
NZ,MONOCYTOSIS,2
NZ,MUSCLE RIGIDITY,2
NZ,MUSCULOSKELETAL STIFFNESS,2
NZ,MYELODYSPLASTIC SYNDROME,2
NZ,MYOCARDIAL ISCHAEMIA,2
NZ,NECK PAIN,2
NZ,NEUTROPENIA,2
NZ,NEUTROPHIL COUNT DECREASED,2
NZ,NEUTROPHILIA,2
NZ,OBESITY,2
NZ,OESOPHAGITIS,2
NZ,ORTHOSTATIC HYPOTENSION,2
NZ,OSTEONECROSIS,2
NZ,OSTEONECROSIS OF JAW,2
NZ,OTOTOXICITY,2
NZ,OVERDOSE,2
NZ,PANCYTOPENIA,2
NZ,PHARYNGITIS,2
NZ,PLASMA CELL MYELOMA,2
NZ,PLATELET COUNT INCREASED,2
NZ,PNEUMONIA ASPIRATION,2
NZ,PORTAL VEIN THROMBOSIS,2
NZ,PSYCHOTIC DISORDER,2
NZ,PULMONARY MASS,2
NZ,PULMONARY OEDEMA,2
NZ,RASH MACULAR,2
NZ,RENAL FAILURE ACUTE,2
NZ,RESPIRATORY FAILURE,2
NZ,RHABDOMYOLYSIS,2
NZ,RHINITIS,2
NZ,SCHIZOPHRENIA,2
NZ,SEIZURE,2
NZ,SKIN INFECTION,2
NZ,SLEEP APNOEA SYNDROME,2
NZ,STAPHYLOCOCCAL ABSCESS,2
NZ,STRESS,2
NZ,SUICIDE ATTEMPT,2
NZ,TOXICITY TO VARIOUS AGENTS,2
NZ,TYPE 2 DIABETES MELLITUS,2
NZ,UPPER GASTROINTESTINAL HAEMORRHAGE,2
NZ,URINARY RETENTION,2
NZ,WHEEZING,2
NZ,WITHDRAWAL SYNDROME,2
NZ,ABDOMINAL DISCOMFORT,1
NZ,ABNORMAL BEHAVIOUR,1
NZ,ACUTE LEFT VENTRICULAR FAILURE,1
NZ,ACUTE PULMONARY OEDEMA,1
NZ,ACUTE RESPIRATORY DISTRESS SYNDROME,1
NZ,ADRENAL INSUFFICIENCY,1
NZ,ADULT T-CELL LYMPHOMA/LEUKAEMIA STAGE IV,1
NZ,AGEUSIA,1
NZ,AGGRESSION,1
NZ,AGITATION,1
NZ,AMNESIA,1
NZ,ANAL CHLAMYDIA INFECTION,1
NZ,ANAPHYLACTIC SHOCK,1
NZ,ANEURYSM,1
NZ,ANGER,1
NZ,ANGIOEDEMA,1
NZ,ANKLE FRACTURE,1
NZ,ANOSMIA,1
NZ,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,1
NZ,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
NZ,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
NZ,AORTIC ARTERIOSCLEROSIS,1
NZ,AORTIC DILATATION,1
NZ,APATHY,1
NZ,ARTERIAL HAEMORRHAGE,1
NZ,ARTHRODESIS,1
NZ,ARTHROPATHY,1
NZ,ASPIRATION,1
NZ,ATYPICAL FEMUR FRACTURE,1
NZ,B-CELL LYMPHOMA,1
NZ,BACK PAIN,1
NZ,BASAL GANGLIA HAEMORRHAGE,1
NZ,BILIARY SEPSIS,1
NZ,BLADDER DISORDER,1
NZ,BLINDNESS UNILATERAL,1
NZ,BLISTER,1
NZ,BLOOD BILIRUBIN INCREASED,1
NZ,BLOOD CREATININE ABNORMAL,1
NZ,BLOOD CULTURE POSITIVE,1
NZ,BLOOD GLUCOSE INCREASED,1
NZ,BLOOD IMMUNOGLOBULIN E INCREASED,1
NZ,BLOOD PRESSURE ABNORMAL,1
NZ,BLOOD PRESSURE DECREASED,1
NZ,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
NZ,BLOOD PRESSURE ORTHOSTATIC DECREASED,1
NZ,BLOOD SODIUM INCREASED,1
NZ,BONE PAIN,1
NZ,BREAST CANCER METASTATIC,1
NZ,BREAST RECONSTRUCTION,1
NZ,BRONCHOSPASM,1
NZ,BURNING SENSATION,1
NZ,C-REACTIVE PROTEIN ABNORMAL,1
NZ,CALCULUS URINARY,1
NZ,CARDIAC DISORDER,1
NZ,CARDIO-RESPIRATORY ARREST,1
NZ,CARDIOMEGALY,1
NZ,CARDIOMYOPATHY,1
NZ,CAROTID ARTERY STENOSIS,1
NZ,CEREBRAL INFARCTION,1
NZ,CEREBRAL THROMBOSIS,1
NZ,CHOKING,1
NZ,CHONDROCALCINOSIS PYROPHOSPHATE,1
NZ,CIRCULATORY COLLAPSE,1
NZ,COAGULOPATHY,1
NZ,COGNITIVE DISORDER,1
NZ,COLON CANCER,1
NZ,COLONOSCOPY,1
NZ,COMA SCALE ABNORMAL,1
NZ,CONDITION AGGRAVATED,1
NZ,CONGESTIVE CARDIOMYOPATHY,1
NZ,CONTRAINDICATED DRUG PRESCRIBED,1
NZ,CONTUSION,1
NZ,CROHN^S DISEASE,1
NZ,CYANOSIS,1
NZ,DEAFNESS,1
NZ,DELUSION,1
NZ,DEMENTIA,1
NZ,DEMENTIA ALZHEIMER^S TYPE,1
NZ,DEPRESSED MOOD,1
NZ,DERMATITIS,1
NZ,DERMATITIS BULLOUS,1
NZ,DERMATITIS PSORIASIFORM,1
NZ,DIABETES MELLITUS INADEQUATE CONTROL,1
NZ,DIABETIC FOOT,1
NZ,DIVERTICULITIS,1
NZ,DIVERTICULUM,1
NZ,DRUG DOSE OMISSION,1
NZ,DRUG EFFECT DECREASED,1
NZ,DRUG EFFECT INCOMPLETE,1
NZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
NZ,DRUG SCREEN NEGATIVE,1
NZ,DRUG SPECIFIC ANTIBODY PRESENT,1
NZ,DUODENAL ULCER HAEMORRHAGE,1
NZ,DYSAESTHESIA,1
NZ,DYSPNOEA AT REST,1
NZ,DYSPNOEA EXERTIONAL,1
NZ,DYSURIA,1
NZ,EFFUSION,1
NZ,EJECTION FRACTION DECREASED,1
NZ,ELECTROCARDIOGRAM ABNORMAL,1
NZ,ELECTROCARDIOGRAM QT PROLONGED,1
NZ,ELEVATED MOOD,1
NZ,EMOTIONAL POVERTY,1
NZ,EOSINOPHILIA,1
NZ,EUPHORIC MOOD,1
NZ,EXTRAMEDULLARY HAEMOPOIESIS,1
NZ,EYE IRRITATION,1
NZ,EYE PRURITUS,1
NZ,EYE SWELLING,1
NZ,EYELID OEDEMA,1
NZ,FANCONI SYNDROME,1
NZ,FEAR,1
NZ,FEEDING DISORDER,1
NZ,FEELING ABNORMAL,1
NZ,FEELING OF BODY TEMPERATURE CHANGE,1
NZ,FIBROUS HISTIOCYTOMA,1
NZ,FLATULENCE,1
NZ,FLUID RETENTION,1
NZ,GASTRIC CYST,1
NZ,GASTRIC DISORDER,1
NZ,GASTRIC ULCER PERFORATION,1
NZ,GASTRITIS,1
NZ,GASTROENTERITIS,1
NZ,GASTROENTERITIS AEROMONAS,1
NZ,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
NZ,GENERAL PHYSICAL CONDITION ABNORMAL,1
NZ,GLOMERULONEPHRITIS MEMBRANOUS,1
NZ,GLOSSITIS,1
NZ,GLUCOSE TOLERANCE IMPAIRED,1
NZ,GLYCOSURIA,1
NZ,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
NZ,GONORRHOEA,1
NZ,GRAND MAL CONVULSION,1
NZ,GRANULOCYTES ABNORMAL,1
NZ,GRANULOMA,1
NZ,GROIN PAIN,1
NZ,HAEMARTHROSIS,1
NZ,HAEMATEMESIS,1
NZ,HAEMATOCRIT INCREASED,1
NZ,HAEMOGLOBIN ABNORMAL,1
NZ,HAEMOGLOBIN INCREASED,1
NZ,HAEMORRHAGE,1
NZ,HALLUCINATION,1
NZ,HAND DEFORMITY,1
NZ,HEART RATE INCREASED,1
NZ,HEPATIC ENCEPHALOPATHY,1
NZ,HEPATOCELLULAR CARCINOMA,1
NZ,HEPATOTOXICITY,1
NZ,HERPES ZOSTER,1
NZ,HIP ARTHROPLASTY,1
NZ,HYPERGLYCAEMIA,1
NZ,HYPERHIDROSIS,1
NZ,HYPERLIPIDAEMIA,1
NZ,HYPERSENSITIVITY,1
NZ,HYPERTHYROIDISM,1
NZ,HYPERTONIA,1
NZ,HYPOAESTHESIA,1
NZ,HYPOGLYCAEMIA,1
NZ,HYPOPHAGIA,1
NZ,HYPOVOLAEMIA,1
NZ,ILEUS PARALYTIC,1
NZ,IMPAIRED HEALING,1
NZ,IMPLANT SITE EROSION,1
NZ,IMPULSIVE BEHAVIOUR,1
NZ,INCOHERENT,1
NZ,INCREASED APPETITE,1
NZ,INFUSION RELATED REACTION,1
NZ,INGUINAL HERNIA,1
NZ,INTENTIONAL DRUG MISUSE,1
NZ,INTENTIONAL OVERDOSE,1
NZ,INTENTIONAL PRODUCT MISUSE,1
NZ,INTERNAL FIXATION OF FRACTURE,1
NZ,INTERNATIONAL NORMALISED RATIO INCREASED,1
NZ,INTERVERTEBRAL DISC DISORDER,1
NZ,INTESTINAL PERFORATION,1
NZ,IRRITABILITY,1
NZ,ISCHAEMIC STROKE,1
NZ,JOINT ARTHROPLASTY,1
NZ,JOINT INJECTION,1
NZ,LARGE INTESTINE PERFORATION,1
NZ,LEFT VENTRICULAR DYSFUNCTION,1
NZ,LEFT VENTRICULAR FAILURE,1
NZ,LISTERIOSIS,1
NZ,LIVER TRANSPLANT,1
NZ,LOBAR PNEUMONIA,1
NZ,LOCALISED INFECTION,1
NZ,LUMBAR VERTEBRAL FRACTURE,1
NZ,LUNG DISORDER,1
NZ,LUNG NEOPLASM MALIGNANT,1
NZ,LUPUS-LIKE SYNDROME,1
NZ,LYMPHADENOPATHY,1
NZ,MALABSORPTION,1
NZ,MALLORY-WEISS SYNDROME,1
NZ,MANIA,1
NZ,MARROW HYPERPLASIA,1
NZ,MASTECTOMY,1
NZ,MEDICATION ERROR,1
NZ,MELANOCYTIC NAEVUS,1
NZ,MENORRHAGIA,1
NZ,MENTAL IMPAIRMENT,1
NZ,METASTASES TO LYMPH NODES,1
NZ,METASTASES TO MUSCLE,1
NZ,METASTASES TO PERITONEUM,1
NZ,METASTASES TO SKIN,1
NZ,METASTASES TO SPINE,1
NZ,METASTASES TO THE MEDIASTINUM,1
NZ,METASTATIC NEOPLASM,1
NZ,MICTURITION URGENCY,1
NZ,MIGRAINE,1
NZ,MIXED LIVER INJURY,1
NZ,MOVEMENT DISORDER,1
NZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
NZ,MULTIPLE SCLEROSIS RELAPSE,1
NZ,MUSCLE INJURY,1
NZ,MUSCLE TWITCHING,1
NZ,MUSCULOSKELETAL PAIN,1
NZ,MYCOBACTERIAL INFECTION,1
NZ,MYELOFIBROSIS,1
NZ,MYELOPATHY,1
NZ,NASAL POLYPS,1
NZ,NASAL SEPTUM DEVIATION,1
NZ,NEGATIVE THOUGHTS,1
NZ,NEPHRITIS,1
NZ,NEPHROTIC SYNDROME,1
NZ,NERVE ROOT COMPRESSION,1
NZ,NERVOUS SYSTEM DISORDER,1
NZ,NERVOUSNESS,1
NZ,NEUROLEPTIC MALIGNANT SYNDROME,1
NZ,NEUTROPENIC SEPSIS,1
NZ,NEUTROPHIL HYPERSEGMENTED MORPHOLOGY PRESENT,1
NZ,NIGHTMARE,1
NZ,NO ADVERSE EVENT,1
NZ,OCCULT BLOOD POSITIVE,1
NZ,OEDEMA PERIPHERAL,1
NZ,OESOPHAGEAL MOTILITY DISORDER,1
NZ,OESOPHAGEAL PAIN,1
NZ,OESOPHAGITIS CHEMICAL,1
NZ,OESOPHAGITIS ULCERATIVE,1
NZ,OPTIC NEUROPATHY,1
NZ,ORAL DISCOMFORT,1
NZ,ORGAN FAILURE,1
NZ,ORGANISING PNEUMONIA,1
NZ,OSTEOARTHRITIS,1
NZ,OSTEOMYELITIS,1
NZ,OVARIAN CYST RUPTURED,1
NZ,OXYGEN SATURATION DECREASED,1
NZ,PAIN IN JAW,1
NZ,PANCREATITIS,1
NZ,PARAESTHESIA,1
NZ,PATHOLOGICAL FRACTURE,1
NZ,PEMPHIGOID,1
NZ,PERICARDITIS,1
NZ,PERIODONTAL DISEASE,1
NZ,PERIORBITAL OEDEMA,1
NZ,PERIPHERAL CIRCULATORY FAILURE,1
NZ,PERIPHERAL ISCHAEMIA,1
NZ,PHARYNGEAL OEDEMA,1
NZ,PLATELET TOXICITY,1
NZ,PLEURAL EFFUSION,1
NZ,PNEUMOCOCCAL SEPSIS,1
NZ,PNEUMOCYSTIS JIROVECI INFECTION,1
NZ,PNEUMONITIS,1
NZ,POLYPECTOMY,1
NZ,POST-INJECTION DELIRIUM SEDATION SYNDROME,1
NZ,POST-TRAUMATIC PAIN,1
NZ,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
NZ,PRODUCT BLISTER PACKAGING ISSUE,1
NZ,PRODUCT QUALITY ISSUE,1
NZ,PRODUCT SUBSTITUTION ISSUE,1
NZ,PRODUCTIVE COUGH,1
NZ,PROSTATE CANCER METASTATIC,1
NZ,PROSTATOMEGALY,1
NZ,PROTEIN C INCREASED,1
NZ,PULMONARY HAEMORRHAGE,1
NZ,PULMONARY HYPERTENSION,1
NZ,PULMONARY SARCOIDOSIS,1
NZ,QUALITY OF LIFE DECREASED,1
NZ,RASH PRURITIC,1
NZ,RASH PUSTULAR,1
NZ,REACTION TO DRUG EXCIPIENTS,1
NZ,RECTAL ADENOCARCINOMA,1
NZ,RECTAL CANCER,1
NZ,RED BLOOD CELL COUNT DECREASED,1
NZ,RESPIRATORY DISTRESS,1
NZ,RESPIRATORY MONILIASIS,1
NZ,RESPIRATORY RATE INCREASED,1
NZ,RESPIRATORY TRACT INFECTION,1
NZ,RESTLESSNESS,1
NZ,RETCHING,1
NZ,RETINAL HAEMORRHAGE,1
NZ,RETROPERITONEAL HAEMORRHAGE,1
NZ,RHEUMATOID ARTHRITIS,1
NZ,RHINORRHOEA,1
NZ,ROTATOR CUFF SYNDROME,1
NZ,SALIVARY HYPERSECRETION,1
NZ,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
NZ,SEDATION,1
NZ,SENSATION OF FOREIGN BODY,1
NZ,SKIN DISORDER,1
NZ,SOFT TISSUE INJURY,1
NZ,SOFT TISSUE SWELLING,1
NZ,SPEECH DISORDER,1
NZ,SPINAL FUSION SURGERY,1
NZ,SPINAL OSTEOARTHRITIS,1
NZ,SPLENECTOMY,1
NZ,SPLENOMEGALY,1
NZ,SPONTANEOUS HAEMORRHAGE,1
NZ,SPUTUM CULTURE POSITIVE,1
NZ,SQUAMOUS CELL CARCINOMA OF SKIN,1
NZ,STAPHYLOCOCCAL INFECTION,1
NZ,STEM CELL TRANSPLANT,1
NZ,STENT PLACEMENT,1
NZ,STREPTOCOCCAL INFECTION,1
NZ,STREPTOCOCCAL SEPSIS,1
NZ,STREPTOCOCCUS TEST POSITIVE,1
NZ,STRIDOR,1
NZ,SUBARACHNOID HAEMORRHAGE,1
NZ,SUDDEN DEATH,1
NZ,SUTURE RUPTURE,1
NZ,SWELLING,1
NZ,SWELLING FACE,1
NZ,SWOLLEN TONGUE,1
NZ,SYNOVITIS,1
NZ,T-CELL LYMPHOMA STAGE IV,1
NZ,TACHYARRHYTHMIA,1
NZ,TEMPORAL ARTERITIS,1
NZ,TENDON RUPTURE,1
NZ,THERAPEUTIC RESPONSE DECREASED,1
NZ,THROAT TIGHTNESS,1
NZ,THROMBOPHLEBITIS,1
NZ,THYROID GLAND SCAN ABNORMAL,1
NZ,TINNITUS,1
NZ,TOOTH ABSCESS,1
NZ,TOOTH FRACTURE,1
NZ,TOOTH INFECTION,1
NZ,TRANSIENT ISCHAEMIC ATTACK,1
NZ,TROPONIN INCREASED,1
NZ,TUMOUR LYSIS SYNDROME,1
NZ,ULCERATIVE KERATITIS,1
NZ,UNDERDOSE,1
NZ,UNEVALUABLE EVENT,1
NZ,UNRESPONSIVE TO STIMULI,1
NZ,URINARY INCONTINENCE,1
NZ,URINE OUTPUT INCREASED,1
NZ,UROSEPSIS,1
NZ,UVEITIS,1
NZ,VAGINAL HAEMORRHAGE,1
NZ,VASOGENIC CEREBRAL OEDEMA,1
NZ,VIITH NERVE PARALYSIS,1
NZ,VIRAL INFECTION,1
NZ,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
NZ,VISION BLURRED,1
NZ,VITREOUS DETACHMENT,1
NZ,WEIGHT INCREASED,1
NZ,WEIGHT LOSS POOR,1
NZ,WOUND DECOMPOSITION,1
NZ,WRIST DEFORMITY,1
NG,ARTHRALGIA,1
NG,ASTHENIA,1
NG,DEATH,1
NG,FATIGUE,1
NG,INSOMNIA,1
NG,OEDEMA PERIPHERAL,1
NG,PAIN,1
NG,PERIPHERAL SWELLING,1
NG,SWELLING FACE,1
NO,HYPOMAGNESAEMIA,17
NO,TORSADE DE POINTES,16
NO,CARDIAC ARREST,15
NO,LOSS OF CONSCIOUSNESS,12
NO,DIARRHOEA,10
NO,SEIZURE,9
NO,NAUSEA,8
NO,ACUTE KIDNEY INJURY,7
NO,CYANOSIS,7
NO,DEHYDRATION,7
NO,VENTRICULAR ARRHYTHMIA,6
NO,STRESS,5
NO,VOMITING,4
NO,ALANINE AMINOTRANSFERASE INCREASED,3
NO,AMMONIA INCREASED,3
NO,AMYLASE INCREASED,3
NO,BLOOD BILIRUBIN INCREASED,3
NO,BLOOD LACTIC ACID INCREASED,3
NO,DERMATITIS ALLERGIC,3
NO,DYSPNOEA,3
NO,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,3
NO,HEADACHE,3
NO,HYPOGLYCAEMIA,3
NO,INTERNATIONAL NORMALISED RATIO INCREASED,3
NO,MULTIPLE SCLEROSIS,3
NO,PYREXIA,3
NO,C-REACTIVE PROTEIN INCREASED,2
NO,CHILLS,2
NO,FATIGUE,2
NO,LISTLESS,2
NO,NEUTROPENIA,2
NO,PAIN,2
NO,PNEUMONIA,2
NO,PNEUMONITIS,2
NO,RENAL FAILURE,2
NO,RESPIRATORY FAILURE,2
NO,VERTIGO,2
NO,ABDOMINAL PAIN,1
NO,ACCIDENTAL OVERDOSE,1
NO,AGGRESSION,1
NO,AGRANULOCYTOSIS,1
NO,ARTHRALGIA,1
NO,ATELECTASIS,1
NO,BASEDOW^S DISEASE,1
NO,BLOOD CREATININE INCREASED,1
NO,BLOOD PRESSURE INCREASED,1
NO,BLOOD PRESSURE SYSTOLIC DECREASED,1
NO,BLOOD UREA INCREASED,1
NO,CARDIAC FAILURE,1
NO,CERVICAL DYSPLASIA,1
NO,DEATH,1
NO,DEMYELINATION,1
NO,DEPENDENT PERSONALITY DISORDER,1
NO,DEPRESSION,1
NO,DRUG HYPERSENSITIVITY,1
NO,ERYTHEMA,1
NO,EYE HAEMORRHAGE,1
NO,FEELING HOT,1
NO,FEMUR FRACTURE,1
NO,GLOMERULAR FILTRATION RATE DECREASED,1
NO,HYPERSENSITIVITY,1
NO,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
NO,INTRAOCULAR PRESSURE INCREASED,1
NO,MEDICATION ERROR,1
NO,MYALGIA,1
NO,NEUROPATHY PERIPHERAL,1
NO,OLIGURIA,1
NO,OPTIC NEURITIS,1
NO,OSTEITIS,1
NO,OSTEOMYELITIS,1
NO,OSTEONECROSIS OF JAW,1
NO,PALPITATIONS,1
NO,PAPILLOEDEMA,1
NO,PAPILLOMA VIRAL INFECTION,1
NO,PNEUMONIA ASPIRATION,1
NO,PNEUMOTHORAX,1
NO,PRODUCT USE ISSUE,1
NO,PROTEIN URINE PRESENT,1
NO,PRURITUS,1
NO,RADIAL NERVE INJURY,1
NO,RASH,1
NO,RENAL FAILURE CHRONIC,1
NO,RESPIRATORY RATE INCREASED,1
NO,SELF INJURIOUS BEHAVIOUR,1
NO,SENSORY LOSS,1
NO,SEPSIS,1
NO,SINUS TACHYCARDIA,1
NO,SKIN REACTION,1
NO,SUICIDAL IDEATION,1
NO,TROPONIN I INCREASED,1
NO,URINARY CASTS PRESENT,1
NO,VISUAL FIELD DEFECT,1
OM,MELAENA,2
OM,ATRIAL FIBRILLATION,1
OM,DEATH,1
OM,DYSPNOEA,1
OM,HEPARIN-INDUCED THROMBOCYTOPENIA,1
OM,HYPOTENSION,1
OM,HYPOXIA,1
OM,JUGULAR VEIN THROMBOSIS,1
OM,LOCAL SWELLING,1
OM,MUCOSAL HAEMORRHAGE,1
OM,OXYGEN SATURATION ABNORMAL,1
OM,PERIPHERAL ISCHAEMIA,1
OM,PNEUMONIA ASPIRATION,1
OM,PULMONARY ARTERY THROMBOSIS,1
OM,PYREXIA,1
OM,RESPIRATORY FAILURE,1
OM,SEPSIS,1
OM,SHOCK,1
OM,SKIN DISCOLOURATION,1
OM,VENA CAVA THROMBOSIS,1
PK,PYREXIA,2
PK,SHOCK,2
PK,ABDOMINAL PAIN,1
PK,ACUTE KIDNEY INJURY,1
PK,BLOOD GLUCOSE INCREASED,1
PK,BONE MARROW FAILURE,1
PK,CHROMATURIA,1
PK,DIARRHOEA,1
PK,DYSPNOEA,1
PK,FATIGUE,1
PK,HAEMOPTYSIS,1
PK,HAEMORRHAGE,1
PK,HEPATITIS B,1
PK,HYPOAESTHESIA,1
PK,HYPOTENSION,1
PK,JAUNDICE,1
PK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
PK,ODYNOPHAGIA,1
PK,PAIN IN EXTREMITY,1
PK,PANCYTOPENIA,1
PK,PERIPHERAL ISCHAEMIA,1
PK,PRODUCT USE IN UNAPPROVED INDICATION,1
PK,RASH ERYTHEMATOUS,1
PK,RASH GENERALISED,1
PK,RASH PRURITIC,1
PK,RENAL IMPAIRMENT,1
PK,SKIN DISCOLOURATION,1
PK,SKIN EXFOLIATION,1
PK,SKIN PAPILLOMA,1
PK,THROMBOCYTOPENIA,1
PK,TOXIC EPIDERMAL NECROLYSIS,1
PK,TREATMENT NONCOMPLIANCE,1
PK,UROSEPSIS,1
PK,VOMITING,1
PS,BLOOD GLUCOSE INCREASED,1
PS,BONE MARROW FAILURE,1
PS,DIABETES MELLITUS,1
PS,DIABETES MELLITUS INADEQUATE CONTROL,1
PA,MALAISE,4
PA,ASTHMATIC CRISIS,3
PA,HAEMOGLOBIN DECREASED,3
PA,PAIN,3
PA,AGITATION,2
PA,ARTHRALGIA,2
PA,ASTHENIA,2
PA,DIZZINESS,2
PA,GAIT DISTURBANCE,2
PA,HEADACHE,2
PA,HYPOAESTHESIA,2
PA,PYREXIA,2
PA,SERUM FERRITIN INCREASED,2
PA,STRESS,2
PA,ABDOMINAL DISCOMFORT,1
PA,ABDOMINAL PAIN UPPER,1
PA,ANAL ABSCESS,1
PA,ARTERIAL DISORDER,1
PA,ASTHMA,1
PA,ASTIGMATISM,1
PA,BACK PAIN,1
PA,BALANCE DISORDER,1
PA,BLOOD PRESSURE INCREASED,1
PA,BRONCHOSPASM,1
PA,CENTRAL NERVOUS SYSTEM LESION,1
PA,CEREBROVASCULAR ACCIDENT,1
PA,CHEST DISCOMFORT,1
PA,CHILLS,1
PA,CHOLECYSTITIS ACUTE,1
PA,COORDINATION ABNORMAL,1
PA,DEPRESSED MOOD,1
PA,DIABETES MELLITUS,1
PA,DIARRHOEA,1
PA,DISORIENTATION,1
PA,DYSPNOEA,1
PA,FALL,1
PA,FATIGUE,1
PA,FEMUR FRACTURE,1
PA,GLOMERULAR FILTRATION RATE DECREASED,1
PA,HAEMOGLOBIN ABNORMAL,1
PA,HIP FRACTURE,1
PA,HYPERGLYCAEMIA,1
PA,HYPERSENSITIVITY,1
PA,INSOMNIA,1
PA,INTERVERTEBRAL DISC PROTRUSION,1
PA,INTESTINAL FISTULA,1
PA,INTESTINAL STENOSIS,1
PA,LABORATORY TEST ABNORMAL,1
PA,LIMB DISCOMFORT,1
PA,MELANOCYTIC NAEVUS,1
PA,MEMORY IMPAIRMENT,1
PA,MIGRAINE,1
PA,MOVEMENT DISORDER,1
PA,MULTIPLE SCLEROSIS RELAPSE,1
PA,MYOCARDIAL INFARCTION,1
PA,MYOPIA,1
PA,NASOPHARYNGITIS,1
PA,NAUSEA,1
PA,PAIN IN EXTREMITY,1
PA,PNEUMONIA,1
PA,RENAL PAIN,1
PA,SALIVARY HYPERSECRETION,1
PA,SEIZURE,1
PA,SENSITIVITY TO WEATHER CHANGE,1
PA,SICKLE CELL ANAEMIA,1
PA,SINGLE FUNCTIONAL KIDNEY,1
PA,SPINAL FRACTURE,1
PA,SPINAL PAIN,1
PA,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PA,URINARY INCONTINENCE,1
PA,VAGINAL HAEMORRHAGE,1
PA,VIRAL INFECTION,1
PA,VISUAL IMPAIRMENT,1
PA,VOMITING,1
PA,WEIGHT DECREASED,1
PA,WHITE BLOOD CELL COUNT INCREASED,1
PY,ACUTE KIDNEY INJURY,1
PY,ANAEMIA,1
PY,ASCITES,1
PY,CARDIAC FAILURE,1
PY,ELECTROLYTE IMBALANCE,1
PY,GASTROINTESTINAL HAEMORRHAGE,1
PY,HYPERURICAEMIA,1
PY,HYPOTENSION,1
PY,HYPOVOLAEMIA,1
PY,LEUKOCYTOSIS,1
PY,NO THERAPEUTIC RESPONSE,1
PY,PERFORATION,1
PY,PYREXIA,1
PY,SEPSIS,1
PY,SEPTIC SHOCK,1
PE,DIZZINESS,4
PE,ANAEMIA,2
PE,CATARACT,2
PE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
PE,FALL,2
PE,FATIGUE,2
PE,NAUSEA,2
PE,PYREXIA,2
PE,RESPIRATORY FAILURE,2
PE,SEPSIS,2
PE,VOMITING,2
PE,ABDOMINAL PAIN,1
PE,ABORTION SPONTANEOUS,1
PE,APPENDICECTOMY,1
PE,BRONCHITIS,1
PE,CARDIAC ARREST,1
PE,CONTUSION,1
PE,DEEP VEIN THROMBOSIS,1
PE,DELIRIUM,1
PE,DEVICE RELATED INFECTION,1
PE,DISCOMFORT,1
PE,DRUG DOSE OMISSION,1
PE,DRUG INEFFECTIVE,1
PE,EXPOSURE DURING PREGNANCY,1
PE,EYE MOVEMENT DISORDER,1
PE,FEBRILE NEUTROPENIA,1
PE,FOETAL DEATH,1
PE,FRACTURE,1
PE,GASTRITIS,1
PE,GASTROENTERITIS,1
PE,HAEMORRHAGE INTRACRANIAL,1
PE,HIGH RISK PREGNANCY,1
PE,HYPERCALCAEMIA,1
PE,HYPERPHOSPHATAEMIA,1
PE,HYPOGLYCAEMIA,1
PE,INCORRECT DOSE ADMINISTERED,1
PE,INFECTED SKIN ULCER,1
PE,INGUINAL HERNIA,1
PE,INTERSTITIAL LUNG DISEASE,1
PE,INTERVERTEBRAL DISC PROTRUSION,1
PE,LARYNGOSPASM,1
PE,LOWER GASTROINTESTINAL HAEMORRHAGE,1
PE,LUNG CYST,1
PE,LUNG INFECTION,1
PE,MACULAR HOLE,1
PE,MALAISE,1
PE,MELAENA,1
PE,MUSCULAR WEAKNESS,1
PE,MYELODYSPLASTIC SYNDROME,1
PE,MYOSITIS,1
PE,NASOPHARYNGITIS,1
PE,NEUTROPENIC INFECTION,1
PE,PLEURAL EFFUSION,1
PE,PNEUMONITIS,1
PE,PSYCHOTIC DISORDER,1
PE,PULMONARY OEDEMA,1
PE,PULMONARY TUBERCULOSIS,1
PE,RASH PRURITIC,1
PE,RENAL TRANSPLANT,1
PE,SEPTIC SHOCK,1
PE,SOMNOLENCE,1
PE,STAPHYLOCOCCAL INFECTION,1
PE,WEIGHT DECREASED,1
PH,PERITONITIS,7
PH,PNEUMONIA,7
PH,CARDIO-RESPIRATORY ARREST,6
PH,PERITONEAL DIALYSIS COMPLICATION,4
PH,ANAEMIA,3
PH,ASTHENIA,3
PH,DEATH,3
PH,DYSPNOEA,3
PH,PEPTIC ULCER,3
PH,PYREXIA,3
PH,SEPTIC SHOCK,3
PH,UPPER GASTROINTESTINAL HAEMORRHAGE,3
PH,VOMITING,3
PH,ACUTE CORONARY SYNDROME,2
PH,ANGIODYSPLASIA,2
PH,DUODENAL ULCER,2
PH,GASTROINTESTINAL ULCER,2
PH,HAEMATOCHEZIA,2
PH,HEPATIC FAILURE,2
PH,HYPOVOLAEMIC SHOCK,2
PH,NEUTROPENIA,2
PH,NEUTROPHIL COUNT DECREASED,2
PH,RENAL FAILURE CHRONIC,2
PH,WHITE BLOOD CELL COUNT INCREASED,2
PH,ABDOMINAL DISTENSION,1
PH,ABDOMINAL MASS,1
PH,ABDOMINAL PAIN UPPER,1
PH,ABDOMINAL TENDERNESS,1
PH,ACUTE RESPIRATORY FAILURE,1
PH,AORTIC ARTERIOSCLEROSIS,1
PH,ARTHRALGIA,1
PH,ASCITES,1
PH,BLOOD ALBUMIN DECREASED,1
PH,BLOOD CALCIUM DECREASED,1
PH,BLOOD CREATININE INCREASED,1
PH,BLOOD PRESSURE ABNORMAL,1
PH,BLOOD SODIUM DECREASED,1
PH,CARDIAC ARREST,1
PH,CARDIAC FAILURE CONGESTIVE,1
PH,CEREBRAL INFARCTION,1
PH,CHEST PAIN,1
PH,CORONARY ARTERY DISEASE,1
PH,CREATININE RENAL CLEARANCE DECREASED,1
PH,DEAFNESS,1
PH,DEHYDRATION,1
PH,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PH,DIABETIC NEPHROPATHY,1
PH,DIAPHRAGMATIC DISORDER,1
PH,DIZZINESS,1
PH,DRUG HYPERSENSITIVITY,1
PH,DRUG-INDUCED LIVER INJURY,1
PH,ELECTROLYTE IMBALANCE,1
PH,EOSINOPHIL PERCENTAGE INCREASED,1
PH,FATIGUE,1
PH,GASTRITIS,1
PH,GASTROENTERITIS,1
PH,GASTROINTESTINAL DISORDER,1
PH,GASTROINTESTINAL STROMAL TUMOUR,1
PH,GENERAL PHYSICAL HEALTH DETERIORATION,1
PH,GLOMERULONEPHRITIS CHRONIC,1
PH,HAEMATOCRIT DECREASED,1
PH,HAEMOGLOBIN DECREASED,1
PH,HAEMOLYTIC ANAEMIA,1
PH,HEADACHE,1
PH,HEART RATE DECREASED,1
PH,HEPATIC MASS,1
PH,HYPOPNOEA,1
PH,IMPAIRED HEALING,1
PH,INSOMNIA,1
PH,INTESTINAL ISCHAEMIA,1
PH,JAUNDICE,1
PH,KIDNEY TRANSPLANT REJECTION,1
PH,LOSS OF CONSCIOUSNESS,1
PH,LUNG INFECTION,1
PH,LYMPHOCYTE PERCENTAGE DECREASED,1
PH,MASS,1
PH,METASTATIC NEOPLASM,1
PH,MULTI-ORGAN FAILURE,1
PH,MYALGIA,1
PH,NEPHROPATHY,1
PH,NEUTROPHIL PERCENTAGE INCREASED,1
PH,OESOPHAGITIS,1
PH,PALPITATIONS,1
PH,PANCREATITIS ACUTE,1
PH,PERITONITIS BACTERIAL,1
PH,PNEUMONIA ASPIRATION,1
PH,PRURITUS,1
PH,PULMONARY CONGESTION,1
PH,PULMONARY TUBERCULOSIS,1
PH,RECURRENT CANCER,1
PH,RED BLOOD CELL COUNT DECREASED,1
PH,REFLUX LARYNGITIS,1
PH,RENAL DISORDER,1
PH,RENAL TUBULAR NECROSIS,1
PH,RESPIRATORY ARREST,1
PH,RETROPERITONEAL LYMPHADENOPATHY,1
PH,SPLEEN TUBERCULOSIS,1
PH,STEVENS-JOHNSON SYNDROME,1
PH,SUBDURAL HAEMATOMA,1
PH,TINNITUS,1
PH,UNRESPONSIVE TO STIMULI,1
PH,URAEMIC ENCEPHALOPATHY,1
PH,URAEMIC GASTROPATHY,1
PH,VENTRICULAR ARRHYTHMIA,1
PH,VIRAL INFECTION,1
PH,VIRAL MYOCARDITIS,1
PH,WEIGHT DECREASED,1
PL,VOMITING,17
PL,PNEUMONIA,16
PL,NAUSEA,12
PL,TOXICITY TO VARIOUS AGENTS,11
PL,APHASIA,9
PL,ATAXIA,9
PL,CONSTIPATION,9
PL,DERMATITIS EXFOLIATIVE,9
PL,PULMONARY OEDEMA,9
PL,VERTIGO,9
PL,CARDIOPULMONARY FAILURE,8
PL,DRUG LEVEL INCREASED,8
PL,ERYTHEMA,8
PL,HEPATIC FAILURE,8
PL,RASH,8
PL,ANAEMIA,7
PL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,7
PL,NEPHRITIS,7
PL,SEPTIC SHOCK,7
PL,DRUG INEFFECTIVE,6
PL,HAEMATURIA,6
PL,HYPONATRAEMIA,6
PL,OVERDOSE,6
PL,CHEST PAIN,5
PL,DIZZINESS,5
PL,GENERAL PHYSICAL HEALTH DETERIORATION,5
PL,PNEUMONITIS,5
PL,RENAL FAILURE,5
PL,TOXIC EPIDERMAL NECROLYSIS,5
PL,BLOOD PRESSURE INCREASED,4
PL,DYSPNOEA,4
PL,LUNG CANCER METASTATIC,4
PL,ORTHOSTATIC HYPOTENSION,4
PL,PYREXIA,4
PL,STAPHYLOCOCCAL SEPSIS,4
PL,SUICIDE ATTEMPT,4
PL,ALANINE AMINOTRANSFERASE INCREASED,3
PL,ASPARTATE AMINOTRANSFERASE INCREASED,3
PL,ASPERGILLUS INFECTION,3
PL,ATRIAL FIBRILLATION,3
PL,BLOOD CREATININE INCREASED,3
PL,BRONCHITIS,3
PL,CATARACT,3
PL,DEPRESSED MOOD,3
PL,EXPOSURE DURING PREGNANCY,3
PL,INTENTIONAL OVERDOSE,3
PL,LEUKOPENIA,3
PL,LUPUS-LIKE SYNDROME,3
PL,MACROCYTOSIS,3
PL,PLASMA CELL MYELOMA,3
PL,RESTLESSNESS,3
PL,STAPHYLOCOCCAL INFECTION,3
PL,ACUTE KIDNEY INJURY,2
PL,ADENOCARCINOMA GASTRIC,2
PL,AGRANULOCYTOSIS,2
PL,ALOPECIA,2
PL,BALANCE DISORDER,2
PL,BLISTER,2
PL,BLOOD BILIRUBIN INCREASED,2
PL,CARDIOGENIC SHOCK,2
PL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
PL,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
PL,CONJUNCTIVITIS,2
PL,DEHYDRATION,2
PL,DIABETES MELLITUS,2
PL,DISEASE PROGRESSION,2
PL,ELECTROCARDIOGRAM QT PROLONGED,2
PL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
PL,GASTROINTESTINAL HAEMORRHAGE,2
PL,GASTROOESOPHAGEAL REFLUX DISEASE,2
PL,GENERALISED TONIC-CLONIC SEIZURE,2
PL,HEART RATE INCREASED,2
PL,HYPERTENSION,2
PL,HYPOAESTHESIA,2
PL,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
PL,LARYNGEAL SQUAMOUS CELL CARCINOMA,2
PL,OROPHARYNGEAL PAIN,2
PL,PANCYTOPENIA,2
PL,PELVIC ABSCESS,2
PL,PSYCHOMOTOR HYPERACTIVITY,2
PL,RECTAL ADENOCARCINOMA,2
PL,RESPIRATORY ARREST,2
PL,RETCHING,2
PL,SCAB,2
PL,THROMBOCYTOPENIA,2
PL,WHITE BLOOD CELL COUNT DECREASED,2
PL,ABDOMINAL PAIN,1
PL,ACROMEGALY,1
PL,ACUTE MYOCARDIAL INFARCTION,1
PL,ACUTE RESPIRATORY FAILURE,1
PL,ANAL ABSCESS,1
PL,ANGINA PECTORIS,1
PL,ANKLE FRACTURE,1
PL,APNOEA,1
PL,ARTHRALGIA,1
PL,ARTHROPOD BITE,1
PL,ATRIAL FLUTTER,1
PL,AXIAL SPONDYLOARTHRITIS,1
PL,BASAL CELL CARCINOMA,1
PL,BLOOD CORTICOTROPHIN DECREASED,1
PL,BLOOD CORTISOL DECREASED,1
PL,BLOOD FOLLICLE STIMULATING HORMONE DECREASED,1
PL,BLOOD GROWTH HORMONE ABNORMAL,1
PL,BLOOD GROWTH HORMONE INCREASED,1
PL,BLOOD PROLACTIN DECREASED,1
PL,BLOOD THYROID STIMULATING HORMONE DECREASED,1
PL,BONE MARROW FAILURE,1
PL,BRAIN DEATH,1
PL,BRAIN MALFORMATION,1
PL,BREAST CANCER,1
PL,BREAST CANCER METASTATIC,1
PL,BRONCHOPNEUMONIA,1
PL,CANDIDIASIS,1
PL,CARDIAC ARREST,1
PL,CARDIAC FAILURE CONGESTIVE,1
PL,CARDIO-RESPIRATORY ARREST,1
PL,CELLULITIS,1
PL,CHOLELITHIASIS,1
PL,CHRONIC KIDNEY DISEASE,1
PL,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
PL,CIRCULATORY COLLAPSE,1
PL,COMA,1
PL,CONDITION AGGRAVATED,1
PL,CONGENITAL JAW MALFORMATION,1
PL,CONGENITAL PYELOCALIECTASIS,1
PL,CONGENITAL TOXOPLASMOSIS,1
PL,CORONARY ARTERY DISEASE,1
PL,CYTOMEGALOVIRUS INFECTION,1
PL,DEATH,1
PL,DECUBITUS ULCER,1
PL,DIABETIC FOOT,1
PL,DIARRHOEA,1
PL,DIASTASIS RECTI ABDOMINIS,1
PL,DILATATION VENTRICULAR,1
PL,DIPLOPIA,1
PL,DISSEMINATED INTRAVASCULAR COAGULATION,1
PL,DISSEMINATED TUBERCULOSIS,1
PL,DIVERTICULAR PERFORATION,1
PL,DIVERTICULITIS,1
PL,DIVERTICULUM INTESTINAL,1
PL,DRUG INTOLERANCE,1
PL,DRUG RESISTANCE,1
PL,ELECTROCARDIOGRAM ABNORMAL,1
PL,ELECTROCARDIOGRAM QRS COMPLEX SHORTENED,1
PL,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
PL,ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL,1
PL,ELECTROCARDIOGRAM T WAVE INVERSION,1
PL,ENCEPHALITIS,1
PL,ENDOMETRIAL CANCER,1
PL,FEBRILE INFECTION,1
PL,FOETAL EXPOSURE DURING PREGNANCY,1
PL,GASTRIC MUCOSA ERYTHEMA,1
PL,GASTRIC MUCOSAL HYPERTROPHY,1
PL,GASTRIC ULCER HAEMORRHAGE,1
PL,GASTRITIS,1
PL,GASTRITIS EROSIVE,1
PL,GASTRITIS HAEMORRHAGIC,1
PL,GASTROINTESTINAL INFECTION,1
PL,GASTROINTESTINAL OEDEMA,1
PL,HAEMOPTYSIS,1
PL,HAEMORRHAGE,1
PL,HAEMORRHOIDS,1
PL,HELICOBACTER INFECTION,1
PL,HEMIPARESIS,1
PL,HEPATIC STEATOSIS,1
PL,HYDROCELE,1
PL,HYDRONEPHROSIS,1
PL,HYPERAEMIA,1
PL,HYPERCHOLESTEROLAEMIA,1
PL,HYPERGLYCAEMIA,1
PL,HYPOALBUMINAEMIA,1
PL,HYPOKALAEMIA,1
PL,IDIOPATHIC PULMONARY FIBROSIS,1
PL,ILL-DEFINED DISORDER,1
PL,IMPAIRED GASTRIC EMPTYING,1
PL,INCOHERENT,1
PL,INFLAMMATION,1
PL,INFUSION RELATED REACTION,1
PL,INSULIN-LIKE GROWTH FACTOR INCREASED,1
PL,KLEBSIELLA INFECTION,1
PL,KLEBSIELLA TEST POSITIVE,1
PL,KUSSMAUL RESPIRATION,1
PL,LACTIC ACIDOSIS,1
PL,LARGE CELL LUNG CANCER,1
PL,LARYNGEAL CANCER STAGE I,1
PL,LOSS OF CONSCIOUSNESS,1
PL,LOWER RESPIRATORY TRACT INFECTION,1
PL,LUNG INFECTION,1
PL,LUNG NEOPLASM MALIGNANT,1
PL,LYMPHOPENIA,1
PL,LYMPHORRHOEA,1
PL,MALNUTRITION,1
PL,MATERNAL EXPOSURE DURING PREGNANCY,1
PL,MOUTH HAEMORRHAGE,1
PL,MUCOSAL HAEMORRHAGE,1
PL,MULTI-ORGAN FAILURE,1
PL,MULTIPLE SCLEROSIS RELAPSE,1
PL,MUSCULOSKELETAL PAIN,1
PL,MYOCARDIAL INFARCTION,1
PL,MYOCARDIAL ISCHAEMIA,1
PL,NEOPLASM PROGRESSION,1
PL,NERVOUS SYSTEM DISORDER,1
PL,NEUTROPENIA,1
PL,NIKOLSKY^S SIGN,1
PL,NON-CARDIOGENIC PULMONARY OEDEMA,1
PL,NORMAL NEWBORN,1
PL,OBESITY,1
PL,OCULAR HYPERAEMIA,1
PL,OESOPHAGEAL ATRESIA,1
PL,OESOPHAGITIS,1
PL,OESTRADIOL DECREASED,1
PL,OVARIAN CANCER,1
PL,OXYGEN SATURATION DECREASED,1
PL,PARAPARESIS,1
PL,PERIPHERAL ARTERY OCCLUSION,1
PL,PERIPHERAL ARTERY STENOSIS,1
PL,PERIPHERAL ISCHAEMIA,1
PL,PERIRENAL HAEMATOMA,1
PL,PLASMAPHERESIS,1
PL,PLATELET COUNT INCREASED,1
PL,PNEUMOCOCCAL SEPSIS,1
PL,PNEUMONIA FUNGAL,1
PL,POISONING,1
PL,POLYNEUROPATHY,1
PL,POLYP,1
PL,PROSTATE CANCER METASTATIC,1
PL,PROTEINURIA,1
PL,PULMONARY EMBOLISM,1
PL,PULMONARY HAEMORRHAGE,1
PL,PULMONARY HYPERTENSION,1
PL,PULMONARY VASCULAR DISORDER,1
PL,PYURIA,1
PL,REGURGITATION,1
PL,RENAL IMPAIRMENT,1
PL,RENAL INJURY,1
PL,RESPIRATORY FAILURE,1
PL,SEPSIS,1
PL,SHOCK,1
PL,SPINAL COMPRESSION FRACTURE,1
PL,SPINAL FRACTURE,1
PL,SPINAL OSTEOARTHRITIS,1
PL,SPUTUM DISCOLOURED,1
PL,STEVENS-JOHNSON SYNDROME,1
PL,SUICIDAL IDEATION,1
PL,TACHYCARDIA,1
PL,THERAPEUTIC PRODUCT INEFFECTIVE,1
PL,THERAPEUTIC RESPONSE DECREASED,1
PL,THROAT LESION,1
PL,THROMBOPHLEBITIS SUPERFICIAL,1
PL,THROMBOSIS,1
PL,THROMBOTIC MICROANGIOPATHY,1
PL,TORTICOLLIS,1
PL,TOXOPLASMOSIS,1
PL,TROPONIN I INCREASED,1
PL,TUMOUR COMPRESSION,1
PL,UPPER RESPIRATORY TRACT INFECTION,1
PL,URINARY BLADDER HAEMORRHAGE,1
PL,URINARY TRACT INFECTION,1
PL,URINARY TRACT OBSTRUCTION,1
PL,WEIGHT DECREASED,1
PL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
PT,FATIGUE,15
PT,PRURITUS,15
PT,PYREXIA,15
PT,ANGIOEDEMA,14
PT,DECREASED APPETITE,13
PT,DIARRHOEA,13
PT,DYSPNOEA,13
PT,ASTHENIA,12
PT,DRUG HYPERSENSITIVITY,12
PT,DIZZINESS,11
PT,GENERALISED ERYTHEMA,11
PT,OEDEMA PERIPHERAL,11
PT,RASH,11
PT,ANAPHYLACTIC REACTION,10
PT,DRUG INEFFECTIVE,10
PT,NAUSEA,10
PT,VOMITING,10
PT,ANAEMIA,9
PT,CHRONIC PIGMENTED PURPURA,9
PT,ERYTHEMA,9
PT,FEBRILE NEUTROPENIA,9
PT,MALAISE,9
PT,PLEURAL EFFUSION,9
PT,PNEUMONIA,9
PT,RESPIRATORY TRACT INFECTION,9
PT,SEPTIC SHOCK,9
PT,THROMBOCYTOPENIA,9
PT,ARTHRALGIA,8
PT,HEADACHE,8
PT,COGNITIVE DISORDER,7
PT,DIABETES MELLITUS,7
PT,NEUTROPENIA,7
PT,SYNCOPE,7
PT,TREMOR,7
PT,ALOPECIA,6
PT,DEPRESSION,6
PT,DISEASE PROGRESSION,6
PT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,6
PT,EOSINOPHILIA,6
PT,EXPOSURE DURING PREGNANCY,6
PT,HYPOTENSION,6
PT,LIP OEDEMA,6
PT,PRE-ECLAMPSIA,6
PT,PRURITUS GENERALISED,6
PT,SEPSIS,6
PT,TOXICITY TO VARIOUS AGENTS,6
PT,URTICARIA,6
PT,ABNORMAL BEHAVIOUR,5
PT,APRAXIA,5
PT,CONFUSIONAL STATE,5
PT,CONJUNCTIVITIS,5
PT,DEATH,5
PT,DERMATITIS BULLOUS,5
PT,DISORIENTATION,5
PT,FACE OEDEMA,5
PT,HYPERHIDROSIS,5
PT,LIVE BIRTH,5
PT,NEUROPATHY PERIPHERAL,5
PT,PANCYTOPENIA,5
PT,PERICARDIAL EFFUSION,5
PT,PLASMA CELL MYELOMA,5
PT,PRODUCT USE ISSUE,5
PT,SKIN EXFOLIATION,5
PT,TACHYCARDIA,5
PT,TYPE IV HYPERSENSITIVITY REACTION,5
PT,ACTIVITIES OF DAILY LIVING IMPAIRED,4
PT,ACUTE KIDNEY INJURY,4
PT,ANGINA UNSTABLE,4
PT,ATRIAL FIBRILLATION,4
PT,BONE PAIN,4
PT,CARDIAC FAILURE,4
PT,CEREBROVASCULAR ACCIDENT,4
PT,CHORIORETINITIS,4
PT,CONJUNCTIVAL HYPERAEMIA,4
PT,CONSTIPATION,4
PT,EJECTION FRACTION DECREASED,4
PT,FOETAL EXPOSURE DURING PREGNANCY,4
PT,GAIT DISTURBANCE,4
PT,GASTROINTESTINAL HAEMORRHAGE,4
PT,HYPERGLYCAEMIA,4
PT,HYPERREFLEXIA,4
PT,LEUKOPENIA,4
PT,LYMPHADENOPATHY,4
PT,MYOCLONUS,4
PT,OESOPHAGEAL ATRESIA,4
PT,ONYCHOLYSIS,4
PT,PAIN,4
PT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
PT,PARAESTHESIA,4
PT,PARAPARESIS,4
PT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
PT,PREMATURE BABY,4
PT,RASH PRURITIC,4
PT,RENAL FAILURE,4
PT,RHINORRHOEA,4
PT,SKIN LESION,4
PT,TERATOGENICITY,4
PT,VISION BLURRED,4
PT,WEIGHT DECREASED,4
PT,BLOOD BILIRUBIN INCREASED,3
PT,BONE MARROW TOXICITY,3
PT,BRADYPHRENIA,3
PT,BRONCHOPULMONARY ASPERGILLOSIS,3
PT,CONCOMITANT DISEASE AGGRAVATED,3
PT,CONTUSION,3
PT,DEHYDRATION,3
PT,DISTURBANCE IN ATTENTION,3
PT,DRUG RESISTANCE,3
PT,DYSARTHRIA,3
PT,ERYSIPELAS,3
PT,FACIAL PARALYSIS,3
PT,FALL,3
PT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
PT,GENERALISED OEDEMA,3
PT,HYPERTENSION,3
PT,HYPERTHYROIDISM,3
PT,HYPOAESTHESIA,3
PT,HYPOKALAEMIA,3
PT,LOSS OF CONSCIOUSNESS,3
PT,MOVEMENT DISORDER,3
PT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
PT,MYALGIA,3
PT,NORMOCHROMIC NORMOCYTIC ANAEMIA,3
PT,OCULAR TOXICITY,3
PT,OEDEMA,3
PT,OVERDOSE,3
PT,PERSEVERATION,3
PT,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
PT,RASH MACULO-PAPULAR,3
PT,RESPIRATORY FAILURE,3
PT,SLEEP DISORDER,3
PT,THROAT TIGHTNESS,3
PT,TOXIC SKIN ERUPTION,3
PT,TRANSFUSION,3
PT,ABDOMINAL DISTENSION,2
PT,ABDOMINAL PAIN,2
PT,ABDOMINAL PAIN UPPER,2
PT,ACUTE CORONARY SYNDROME,2
PT,ACUTE PULMONARY OEDEMA,2
PT,ADENOCARCINOMA GASTRIC,2
PT,AGGRESSION,2
PT,ALTERED STATE OF CONSCIOUSNESS,2
PT,ANGULAR CHEILITIS,2
PT,ASPERGILLUS INFECTION,2
PT,ATAXIA,2
PT,BLINDNESS,2
PT,BLINDNESS TRANSIENT,2
PT,BLISTER,2
PT,BLOOD CHOLESTEROL INCREASED,2
PT,BLOOD CREATININE INCREASED,2
PT,BLOOD PRESSURE DECREASED,2
PT,BLOOD PRESSURE INCREASED,2
PT,BRADYCARDIA,2
PT,BRAIN DEATH,2
PT,BREAST CANCER,2
PT,BREAST NEOPLASM,2
PT,C-REACTIVE PROTEIN INCREASED,2
PT,CANDIDURIA,2
PT,CENTRAL NERVOUS SYSTEM LESION,2
PT,CHROMATURIA,2
PT,COLITIS ISCHAEMIC,2
PT,COLITIS MICROSCOPIC,2
PT,COORDINATION ABNORMAL,2
PT,COUGH,2
PT,DEMENTIA,2
PT,DERMATITIS ACNEIFORM,2
PT,DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV,2
PT,DRY MOUTH,2
PT,DYSPEPSIA,2
PT,DYSPHONIA,2
PT,ELECTROLYTE IMBALANCE,2
PT,EMBOLIC STROKE,2
PT,EPISTAXIS,2
PT,FEELING ABNORMAL,2
PT,FLATULENCE,2
PT,FLUSHING,2
PT,GASTROINTESTINAL DISORDER,2
PT,GASTROINTESTINAL NECROSIS,2
PT,GINGIVAL BLEEDING,2
PT,HAEMATOMA,2
PT,HAEMATOTOXICITY,2
PT,HAEMATURIA,2
PT,HAEMOGLOBIN DECREASED,2
PT,HALLUCINATION_ VISUAL,2
PT,HEART RATE INCREASED,2
PT,HEPATITIS ACUTE,2
PT,HEPATOTOXICITY,2
PT,HIATUS HERNIA,2
PT,HYPOAESTHESIA ORAL,2
PT,HYPOTHYROIDISM,2
PT,HYPOVOLAEMIC SHOCK,2
PT,INFECTION,2
PT,IRRITABILITY,2
PT,ISCHAEMIC STROKE,2
PT,LEUKOCYTOSIS,2
PT,LUNG INFECTION,2
PT,MEMORY IMPAIRMENT,2
PT,MULTIPLE SCLEROSIS RELAPSE,2
PT,MUSCLE SPASMS,2
PT,MUSCULAR WEAKNESS,2
PT,NECROTISING FASCIITIS,2
PT,OESOPHAGEAL HAEMORRHAGE,2
PT,OESOPHAGITIS,2
PT,OPPORTUNISTIC INFECTION,2
PT,ORAL CANDIDIASIS,2
PT,ORAL MUCOSAL BLISTERING,2
PT,OROPHARYNGEAL PAIN,2
PT,PALLOR,2
PT,PERIPHERAL SWELLING,2
PT,PETECHIAE,2
PT,PNEUMOTHORAX,2
PT,PRODUCT QUALITY ISSUE,2
PT,PRODUCTIVE COUGH,2
PT,PRURITUS GENITAL,2
PT,PULMONARY EMBOLISM,2
PT,PULMONARY OEDEMA,2
PT,RASH GENERALISED,2
PT,REACTION TO DRUG EXCIPIENTS,2
PT,RENAL CELL CARCINOMA,2
PT,RENAL IMPAIRMENT,2
PT,SOMNOLENCE,2
PT,STOMATITIS,2
PT,STRONGYLOIDIASIS,2
PT,SWELLING,2
PT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
PT,THROMBOSIS,2
PT,URINARY RETENTION,2
PT,URINARY TRACT INFECTION,2
PT,VERTIGO,2
PT,VIITH NERVE PARALYSIS,2
PT,WHEEZING,2
PT,ABDOMINAL DISCOMFORT,1
PT,ABDOMINAL TENDERNESS,1
PT,ABNORMAL DREAMS,1
PT,ACUTE AORTIC SYNDROME,1
PT,ACUTE HEPATIC FAILURE,1
PT,ACUTE MYELOID LEUKAEMIA,1
PT,ACUTE MYOCARDIAL INFARCTION,1
PT,ACUTE RESPIRATORY DISTRESS SYNDROME,1
PT,ADDISON^S DISEASE,1
PT,ADMINISTRATION RELATED REACTION,1
PT,ADRENAL DISORDER,1
PT,ADRENAL INSUFFICIENCY,1
PT,ALANINE AMINOTRANSFERASE INCREASED,1
PT,APHTHOUS STOMATITIS,1
PT,APLASTIC ANAEMIA,1
PT,ARTHRITIS,1
PT,ASCITES,1
PT,ASPARTATE AMINOTRANSFERASE INCREASED,1
PT,ATELECTASIS,1
PT,B-CELL LYMPHOMA,1
PT,BACTERIAL SEPSIS,1
PT,BALANCE DISORDER,1
PT,BASAL CELL CARCINOMA,1
PT,BASILAR ARTERY STENOSIS,1
PT,BASILAR ARTERY THROMBOSIS,1
PT,BICYTOPENIA,1
PT,BLADDER DISORDER,1
PT,BLISTER INFECTED,1
PT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PT,BLOOD TRIGLYCERIDES INCREASED,1
PT,BODY TEMPERATURE INCREASED,1
PT,BONE MARROW FAILURE,1
PT,BONE TUBERCULOSIS,1
PT,BOWEL MOVEMENT IRREGULARITY,1
PT,BRUXISM,1
PT,BURNING SENSATION,1
PT,CACHEXIA,1
PT,CARDIAC ARREST,1
PT,CARDIAC DISORDER,1
PT,CARDIAC FAILURE ACUTE,1
PT,CHEST PAIN,1
PT,CHEST X-RAY ABNORMAL,1
PT,CLEAR CELL RENAL CELL CARCINOMA,1
PT,CLOSTRIDIUM DIFFICILE COLITIS,1
PT,CONDITION AGGRAVATED,1
PT,CONGESTIVE CARDIOMYOPATHY,1
PT,CONVULSION,1
PT,CORNEAL DEGENERATION,1
PT,CORNEAL EROSION,1
PT,CREATININE RENAL CLEARANCE DECREASED,1
PT,CROHN^S DISEASE,1
PT,CUSHINGOID,1
PT,CYANOSIS,1
PT,CYSTITIS,1
PT,DEFICIENCY OF BILE SECRETION,1
PT,DEMYELINATION,1
PT,DEPENDENT RUBOR,1
PT,DEPRESSED MOOD,1
PT,DERMAL CYST,1
PT,DERMATOPHYTOSIS,1
PT,DERMATOSIS,1
PT,DERMOID CYST,1
PT,DEVICE OCCLUSION,1
PT,DIABETES MELLITUS INADEQUATE CONTROL,1
PT,DIASTOLIC DYSFUNCTION,1
PT,DIET REFUSAL,1
PT,DIVERTICULAR PERFORATION,1
PT,DRUG ADMINISTRATION ERROR,1
PT,DRUG LEVEL INCREASED,1
PT,DRY EYE,1
PT,DUODENAL PERFORATION,1
PT,DYSKINESIA,1
PT,EAR PAIN,1
PT,ECCHYMOSIS,1
PT,ELECTROCARDIOGRAM ABNORMAL,1
PT,EMPYEMA,1
PT,EYE MOVEMENT DISORDER,1
PT,EYE PAIN,1
PT,EYELID PTOSIS,1
PT,FACIAL BONES FRACTURE,1
PT,FACIAL PAIN,1
PT,FAECAL VOLUME INCREASED,1
PT,FAECES DISCOLOURED,1
PT,FEMUR FRACTURE,1
PT,FUNCTIONAL GASTROINTESTINAL DISORDER,1
PT,GASTRIC CANCER,1
PT,GASTRIC ULCER,1
PT,GASTRITIS,1
PT,GASTROINTESTINAL TOXICITY,1
PT,GASTROOESOPHAGEAL REFLUX DISEASE,1
PT,GAZE PALSY,1
PT,GENERALISED TONIC-CLONIC SEIZURE,1
PT,GINGIVAL PAIN,1
PT,GLIOBLASTOMA,1
PT,GROWTH OF EYELASHES,1
PT,GUILLAIN-BARRE SYNDROME,1
PT,HAEMATEMESIS,1
PT,HAEMODIALYSIS,1
PT,HAEMOLYTIC ANAEMIA,1
PT,HAEMORRHAGE,1
PT,HAEMORRHAGIC STROKE,1
PT,HAIR GROWTH ABNORMAL,1
PT,HALLUCINATION_ AUDITORY,1
PT,HEMIPARESIS,1
PT,HEMIPLEGIA,1
PT,HEPATIC CIRRHOSIS,1
PT,HEPATIC CYST INFECTION,1
PT,HEPATIC ENZYME INCREASED,1
PT,HEPATITIS,1
PT,HEPATITIS TOXIC,1
PT,HEPATOCELLULAR INJURY,1
PT,HERNIA OBSTRUCTIVE,1
PT,HERPES ZOSTER DISSEMINATED,1
PT,HIGH DENSITY LIPOPROTEIN INCREASED,1
PT,HYPERACUSIS,1
PT,HYPERCALCAEMIA,1
PT,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
PT,HYPERSENSITIVITY,1
PT,HYPERSENSITIVITY VASCULITIS,1
PT,HYPERTHERMIA,1
PT,HYPERVOLAEMIA,1
PT,HYPOFIBRINOGENAEMIA,1
PT,HYPONATRAEMIA,1
PT,ILEUS PARALYTIC,1
PT,INCOHERENT,1
PT,INFECTED SKIN ULCER,1
PT,INFLAMMATION,1
PT,INFLUENZA LIKE ILLNESS,1
PT,INFUSION RELATED REACTION,1
PT,INGROWING NAIL,1
PT,INJECTION SITE PAIN,1
PT,INJECTION SITE PAPULE,1
PT,INSOMNIA,1
PT,INTENTIONAL PRODUCT MISUSE,1
PT,INTENTIONAL PRODUCT USE ISSUE,1
PT,INTERMITTENT CLAUDICATION,1
PT,INTERNATIONAL NORMALISED RATIO INCREASED,1
PT,INTESTINAL HAEMORRHAGE,1
PT,INTESTINAL ISCHAEMIA,1
PT,INTESTINAL OBSTRUCTION,1
PT,INTESTINAL POLYP,1
PT,INTESTINAL TRANSIT TIME DECREASED,1
PT,INTRA-ABDOMINAL HAEMATOMA,1
PT,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,1
PT,INTRAVASCULAR HAEMOLYSIS,1
PT,JAUNDICE,1
PT,JC VIRUS INFECTION,1
PT,JOINT STIFFNESS,1
PT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
PT,LACRIMATION INCREASED,1
PT,LACTIC ACIDOSIS,1
PT,LEUKOCYTOCLASTIC VASCULITIS,1
PT,LEUKOCYTURIA,1
PT,LIGAMENT SPRAIN,1
PT,LIMB INJURY,1
PT,LINEAR IGA DISEASE,1
PT,LIPASE INCREASED,1
PT,LIVER FUNCTION TEST ABNORMAL,1
PT,LIVER FUNCTION TEST INCREASED,1
PT,LIVER INJURY,1
PT,LOWER LIMB FRACTURE,1
PT,LYMPHOCYTE COUNT DECREASED,1
PT,LYMPHOPENIA,1
PT,MATERNAL DRUGS AFFECTING FOETUS,1
PT,MATERNAL EXPOSURE DURING PREGNANCY,1
PT,MECHANICAL VENTILATION,1
PT,MEDICATION RESIDUE PRESENT,1
PT,MEGACOLON,1
PT,MELAENA,1
PT,MENINGITIS CRYPTOCOCCAL,1
PT,METABOLIC ACIDOSIS,1
PT,METASTATIC GLIOMA,1
PT,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,1
PT,MICTURITION FREQUENCY DECREASED,1
PT,MIGRAINE,1
PT,MITRAL VALVE INCOMPETENCE,1
PT,MOBILITY DECREASED,1
PT,MONOPARESIS,1
PT,MULTI-ORGAN FAILURE,1
PT,MUSCLE CONTRACTURE,1
PT,MUSCLE RIGIDITY,1
PT,MUSCULOSKELETAL DISORDER,1
PT,MUSCULOSKELETAL STIFFNESS,1
PT,MUTISM,1
PT,MYDRIASIS,1
PT,MYELITIS TRANSVERSE,1
PT,MYELOFIBROSIS,1
PT,MYOCARDIAL INFARCTION,1
PT,MYOCARDIAL ISCHAEMIA,1
PT,MYOCLONIC EPILEPSY,1
PT,MYOGLOBIN BLOOD INCREASED,1
PT,MYOPATHY,1
PT,NAIL DISORDER,1
PT,NASAL DISORDER,1
PT,NASOPHARYNGITIS,1
PT,NEPHRITIS ALLERGIC,1
PT,NEPHROLITHIASIS,1
PT,NERVE INJURY,1
PT,NEUROLOGICAL SYMPTOM,1
PT,NEUROPSYCHIATRIC LUPUS,1
PT,NODULE,1
PT,NORMOCHROMIC ANAEMIA,1
PT,ODYNOPHAGIA,1
PT,OESOPHAGEAL ULCER,1
PT,OPTIC NEURITIS,1
PT,OPTIC NEUROPATHY,1
PT,ORAL DISCOMFORT,1
PT,ORAL MUCOSA EROSION,1
PT,ORAL PAIN,1
PT,ORGANISING PNEUMONIA,1
PT,OSTEITIS,1
PT,OSTEOLYSIS,1
PT,OXYGEN SATURATION DECREASED,1
PT,PAIN IN EXTREMITY,1
PT,PALPITATIONS,1
PT,PANCREATITIS,1
PT,PANCREATITIS ACUTE,1
PT,PANCREATOLITHIASIS,1
PT,PAPULE,1
PT,PARAESTHESIA ORAL,1
PT,PARALYSIS,1
PT,PARANASAL CYST,1
PT,PARESIS,1
PT,PARONYCHIA,1
PT,PAROPHTHALMIA,1
PT,PAROTID GLAND ENLARGEMENT,1
PT,PAROTID GLAND HAEMORRHAGE,1
PT,PERIPHERAL MOTOR NEUROPATHY,1
PT,PERITONITIS,1
PT,PLATELET COUNT INCREASED,1
PT,PLATELET TRANSFUSION,1
PT,PNEUMONIA BACTERIAL,1
PT,PNEUMONITIS,1
PT,PORTAL VEIN THROMBOSIS,1
PT,POST PROCEDURAL COMPLICATION,1
PT,POSTOPERATIVE WOUND INFECTION,1
PT,PRESCRIBED OVERDOSE,1
PT,PROCTALGIA,1
PT,PRODUCT SUBSTITUTION ISSUE,1
PT,PRODUCT USE IN UNAPPROVED INDICATION,1
PT,PROSTATE CANCER,1
PT,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
PT,PROTEINURIA,1
PT,PSORIASIS,1
PT,PSYCHOMOTOR RETARDATION,1
PT,PULMONARY CONGESTION,1
PT,PULMONARY TUBERCULOSIS,1
PT,PUPILS UNEQUAL,1
PT,PURPURA,1
PT,PYELONEPHRITIS,1
PT,PYOGENIC GRANULOMA,1
PT,RASH ERYTHEMATOUS,1
PT,RASH MACULAR,1
PT,RASH MORBILLIFORM,1
PT,RASH VESICULAR,1
PT,RECTAL HAEMORRHAGE,1
PT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PT,REFLEXES ABNORMAL,1
PT,RENAL COLIC,1
PT,RENAL FAILURE ACUTE,1
PT,RENAL INJURY,1
PT,RENAL TRANSPLANT,1
PT,RENAL TUBULAR DISORDER,1
PT,RESPIRATORY DEPRESSION,1
PT,RESPIRATORY DISTRESS,1
PT,RETINAL VEIN THROMBOSIS,1
PT,RETROPERITONEAL HAEMATOMA,1
PT,RHABDOMYOLYSIS,1
PT,RHEUMATOID ARTHRITIS,1
PT,ROAD TRAFFIC ACCIDENT,1
PT,SALIVARY GLAND PAIN,1
PT,SALMONELLOSIS,1
PT,SKIN DISCOLOURATION,1
PT,SKIN INFECTION,1
PT,SKIN MASS,1
PT,SKIN TEST POSITIVE,1
PT,SKIN ULCER,1
PT,SMALL INTESTINE CARCINOMA,1
PT,SPINAL OPERATION,1
PT,STRESS,1
PT,STRIDOR,1
PT,SUBDURAL HAEMATOMA,1
PT,SUBDURAL HAEMORRHAGE,1
PT,SUDDEN DEATH,1
PT,SUICIDAL IDEATION,1
PT,SYNOVITIS,1
PT,SYSTOLIC DYSFUNCTION,1
PT,THERAPY NON-RESPONDER,1
PT,THERMOHYPOAESTHESIA,1
PT,THROAT IRRITATION,1
PT,THYROIDECTOMY,1
PT,TINNITUS,1
PT,TOOTHACHE,1
PT,TRANSAMINASES INCREASED,1
PT,TRIGEMINAL NEURALGIA,1
PT,TUBULOINTERSTITIAL NEPHRITIS,1
PT,ULCER,1
PT,URINE ODOUR ABNORMAL,1
PT,VARICES OESOPHAGEAL,1
PT,VASCULITIS,1
PT,VIRAL LOAD INCREASED,1
PT,VISUAL ACUITY REDUCED,1
PT,VISUAL IMPAIRMENT,1
PT,VULVOVAGINAL PRURITUS,1
PT,WHITE BLOOD CELL COUNT INCREASED,1
PT,WOUND NECROSIS,1
PT,YELLOW SKIN,1
PR,INJECTION SITE PAIN,30
PR,NASOPHARYNGITIS,19
PR,PAIN,19
PR,ARTHRALGIA,16
PR,HAEMOGLOBIN DECREASED,13
PR,FATIGUE,11
PR,PAIN IN EXTREMITY,11
PR,ABDOMINAL PAIN UPPER,10
PR,ASTHENIA,10
PR,BURNING SENSATION,10
PR,DIARRHOEA,10
PR,HEADACHE,10
PR,DECREASED APPETITE,9
PR,INFLAMMATION,8
PR,PYREXIA,8
PR,DEPRESSION,7
PR,DIZZINESS,7
PR,MALAISE,7
PR,NAUSEA,7
PR,WEIGHT DECREASED,7
PR,ASTHMA,6
PR,BACK PAIN,6
PR,DYSPNOEA,6
PR,GASTRITIS,6
PR,PRURITUS,6
PR,URINARY TRACT INFECTION,6
PR,VOMITING,6
PR,ABDOMINAL DISCOMFORT,5
PR,ABDOMINAL PAIN,5
PR,DRUG INEFFECTIVE,5
PR,HEPATIC ENZYME INCREASED,5
PR,HYPERSENSITIVITY,5
PR,INJECTION SITE ERYTHEMA,5
PR,INJECTION SITE PRURITUS,5
PR,PSORIASIS,5
PR,ALOPECIA,4
PR,ANAEMIA,4
PR,ANXIETY,4
PR,CATARACT,4
PR,HYPERTENSION,4
PR,INFLUENZA,4
PR,INSOMNIA,4
PR,PERIPHERAL SWELLING,4
PR,RASH,4
PR,ARTHRITIS,3
PR,ASPHYXIA,3
PR,BACTERIAL INFECTION,3
PR,BRONCHITIS,3
PR,CARPAL TUNNEL SYNDROME,3
PR,CHEST PAIN,3
PR,COUGH,3
PR,CROHN^S DISEASE,3
PR,GAIT DISTURBANCE,3
PR,GASTROINTESTINAL INFLAMMATION,3
PR,GASTROOESOPHAGEAL REFLUX DISEASE,3
PR,HIATUS HERNIA,3
PR,HYPERCHOLESTEROLAEMIA,3
PR,MENISCUS INJURY,3
PR,MUSCULOSKELETAL STIFFNESS,3
PR,NEPHROLITHIASIS,3
PR,OROPHARYNGEAL PAIN,3
PR,RASH MACULAR,3
PR,RECTAL HAEMORRHAGE,3
PR,RESPIRATORY TRACT CONGESTION,3
PR,TACHYCARDIA,3
PR,THYROID DISORDER,3
PR,URTICARIA,3
PR,VAGINAL INFECTION,3
PR,ABSCESS,2
PR,ANAL ABSCESS,2
PR,ANKLE FRACTURE,2
PR,ARTHROPATHY,2
PR,BLOOD GLUCOSE INCREASED,2
PR,BONE PAIN,2
PR,CHIKUNGUNYA VIRUS INFECTION,2
PR,CHILLS,2
PR,CHOLELITHIASIS,2
PR,COLON CANCER,2
PR,CONTUSION,2
PR,DEHYDRATION,2
PR,DIVERTICULUM,2
PR,DRUG PRESCRIBING ERROR,2
PR,DRY SKIN,2
PR,DYSGEUSIA,2
PR,DYSPHONIA,2
PR,FEELING ABNORMAL,2
PR,FEELING HOT,2
PR,FIBROMYALGIA,2
PR,GASTROINTESTINAL DISORDER,2
PR,HAEMATOMA,2
PR,HYPERHIDROSIS,2
PR,HYPOGLYCAEMIA,2
PR,INCORRECT DOSE ADMINISTERED,2
PR,INFECTION,2
PR,INTERVERTEBRAL DISC DEGENERATION,2
PR,INTERVERTEBRAL DISC PROTRUSION,2
PR,INTESTINAL OBSTRUCTION,2
PR,LACERATION,2
PR,LIMB INJURY,2
PR,LUNG DISORDER,2
PR,MIGRAINE,2
PR,MOBILITY DECREASED,2
PR,MUSCLE SPASMS,2
PR,MUSCULOSKELETAL DISORDER,2
PR,MUSCULOSKELETAL PAIN,2
PR,NASAL CONGESTION,2
PR,NECK PAIN,2
PR,NERVOUSNESS,2
PR,NEUROPATHY PERIPHERAL,2
PR,PHARYNGITIS,2
PR,PNEUMONIA,2
PR,POST PROCEDURAL COMPLICATION,2
PR,PRODUCTIVE COUGH,2
PR,PRURITUS GENERALISED,2
PR,PULMONARY MASS,2
PR,PULMONARY OEDEMA,2
PR,RHEUMATOID ARTHRITIS,2
PR,SUBCUTANEOUS ABSCESS,2
PR,SWELLING FACE,2
PR,TENDON RUPTURE,2
PR,VAGINAL HAEMORRHAGE,2
PR,VISUAL IMPAIRMENT,2
PR,WHITE BLOOD CELL COUNT DECREASED,2
PR,ABDOMINAL ADHESIONS,1
PR,ABDOMINAL DISTENSION,1
PR,ABSCESS BACTERIAL,1
PR,ACNE,1
PR,ADVERSE DRUG REACTION,1
PR,ADVERSE EVENT,1
PR,ANAL INFLAMMATION,1
PR,ANAPHYLACTIC REACTION,1
PR,ANORECTAL DISCOMFORT,1
PR,APHASIA,1
PR,APPENDICEAL MUCOCOELE,1
PR,APPENDICITIS,1
PR,ARTHROPOD BITE,1
PR,ASPIRATION,1
PR,BACTERIAL TEST,1
PR,BLADDER PROLAPSE,1
PR,BLINDNESS,1
PR,BLINDNESS TRANSIENT,1
PR,BLOOD BLISTER,1
PR,BLOOD CALCIUM DECREASED,1
PR,BLOOD CHOLESTEROL ABNORMAL,1
PR,BLOOD CHOLESTEROL DECREASED,1
PR,BLOOD CHOLESTEROL INCREASED,1
PR,BLOOD PRESSURE INCREASED,1
PR,BONE DISORDER,1
PR,BURSITIS,1
PR,CANDIDA INFECTION,1
PR,CARDIOVASCULAR DISORDER,1
PR,CEREBRAL DISORDER,1
PR,CHRONIC GASTRITIS,1
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
PR,COLITIS ULCERATIVE,1
PR,CONJUNCTIVITIS,1
PR,CORONARY VEIN STENOSIS,1
PR,CYST,1
PR,DEAFNESS BILATERAL,1
PR,DEEP VEIN THROMBOSIS,1
PR,DERMATITIS INFECTED,1
PR,DIABETIC NEUROPATHY,1
PR,DISCOMFORT,1
PR,DRUG EFFECT INCOMPLETE,1
PR,DRY EYE,1
PR,DRY MOUTH,1
PR,DYSMENORRHOEA,1
PR,EATING DISORDER,1
PR,EMPHYSEMA,1
PR,ENDOTRACHEAL INTUBATION COMPLICATION,1
PR,ERYTHEMA,1
PR,EXOSTOSIS,1
PR,EYE OPERATION,1
PR,EYELID PTOSIS,1
PR,FALL,1
PR,FEAR OF INJECTION,1
PR,FEEDING DISORDER,1
PR,FEELING COLD,1
PR,FINGER DEFORMITY,1
PR,FLATULENCE,1
PR,FLUID RETENTION,1
PR,FORMICATION,1
PR,FUNGAL INFECTION,1
PR,GALLBLADDER DISORDER,1
PR,GASTRIC ULCER,1
PR,GASTROENTERITIS VIRAL,1
PR,GENERALISED OEDEMA,1
PR,GINGIVAL DISCOMFORT,1
PR,GLUCOSE TOLERANCE IMPAIRED,1
PR,GROIN ABSCESS,1
PR,HAEMATOCHEZIA,1
PR,HAEMATURIA,1
PR,HAEMOGLOBIN ABNORMAL,1
PR,HAEMORRHAGE,1
PR,HAEMORRHAGE INTRACRANIAL,1
PR,HAEMORRHOIDS,1
PR,HAIR GROWTH ABNORMAL,1
PR,HEAD DISCOMFORT,1
PR,HEPATIC STEATOSIS,1
PR,HORMONE LEVEL ABNORMAL,1
PR,HOT FLUSH,1
PR,HYPOPHAGIA,1
PR,ILEAL STENOSIS,1
PR,ILEAL ULCER,1
PR,IMMUNODEFICIENCY,1
PR,IMPAIRED HEALING,1
PR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
PR,INFECTED FISTULA,1
PR,INJECTION SITE DISCOLOURATION,1
PR,INJECTION SITE DISCOMFORT,1
PR,INJECTION SITE HAEMATOMA,1
PR,INJECTION SITE HYPERSENSITIVITY,1
PR,INJECTION SITE INDURATION,1
PR,INJECTION SITE RASH,1
PR,INJECTION SITE REACTION,1
PR,INJECTION SITE SWELLING,1
PR,INJECTION SITE URTICARIA,1
PR,INJECTION SITE WARMTH,1
PR,INJURY ASSOCIATED WITH DEVICE,1
PR,INTENTIONAL PRODUCT MISUSE,1
PR,INTESTINAL INFARCTION,1
PR,INTESTINAL SCARRING,1
PR,JAW DISORDER,1
PR,JOINT DESTRUCTION,1
PR,JOINT DISLOCATION,1
PR,JOINT INJURY,1
PR,JOINT RANGE OF MOTION DECREASED,1
PR,JOINT SWELLING,1
PR,LABORATORY TEST ABNORMAL,1
PR,LARGE INTESTINAL STENOSIS,1
PR,LIGAMENT SPRAIN,1
PR,LIGHT CHAIN ANALYSIS INCREASED,1
PR,LIVER DISORDER,1
PR,LOCAL SWELLING,1
PR,LOCALISED INFECTION,1
PR,LOSS OF CONSCIOUSNESS,1
PR,LOWER EXTREMITY MASS,1
PR,MEMORY IMPAIRMENT,1
PR,MENISCUS OPERATION,1
PR,MONOCLONAL IMMUNOGLOBULIN PRESENT,1
PR,MUCOUS MEMBRANE DISORDER,1
PR,MUSCULAR WEAKNESS,1
PR,MUSCULOSKELETAL DISCOMFORT,1
PR,MYALGIA,1
PR,MYOCARDIAL INFARCTION,1
PR,NAIL DISORDER,1
PR,NASAL ABSCESS,1
PR,NERVE COMPRESSION,1
PR,NERVE INJURY,1
PR,NODULE,1
PR,ODYNOPHAGIA,1
PR,OEDEMA PERIPHERAL,1
PR,ONYCHOMYCOSIS,1
PR,ORAL DISCOMFORT,1
PR,ORAL FUNGAL INFECTION,1
PR,ORAL PAIN,1
PR,OSTEONECROSIS,1
PR,OSTEOPOROSIS,1
PR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
PR,PAROSMIA,1
PR,PATELLA FRACTURE,1
PR,PHARYNGEAL INFLAMMATION,1
PR,PHARYNGEAL NEOPLASM,1
PR,PLATELET DISORDER,1
PR,PLEURAL EFFUSION,1
PR,POLYP,1
PR,POST PROCEDURAL CELLULITIS,1
PR,POST PROCEDURAL FISTULA,1
PR,POST PROCEDURAL HYPOTHYROIDISM,1
PR,POST PROCEDURAL INFECTION,1
PR,POSTOPERATIVE WOUND INFECTION,1
PR,PROCEDURAL PAIN,1
PR,PROTEIN TOTAL ABNORMAL,1
PR,PROTEIN TOTAL DECREASED,1
PR,PRURITUS ALLERGIC,1
PR,PULMONARY HYPERTENSION,1
PR,PURULENT DISCHARGE,1
PR,RASH PAPULAR,1
PR,RASH PRURITIC,1
PR,RASH PUSTULAR,1
PR,RENAL CANCER,1
PR,RESPIRATORY ARREST,1
PR,RESPIRATORY DISTRESS,1
PR,RHEUMATOID FACTOR INCREASED,1
PR,SCIATICA,1
PR,SEIZURE,1
PR,SINUSITIS,1
PR,SKIN DISCOLOURATION,1
PR,SKIN DISORDER,1
PR,SKIN HYPERTROPHY,1
PR,SKIN MASS,1
PR,SOMNOLENCE,1
PR,STAPHYLOCOCCAL ABSCESS,1
PR,STOMA SITE DISCHARGE,1
PR,STOMA SITE ERYTHEMA,1
PR,STRESS,1
PR,SUICIDAL IDEATION,1
PR,SUTURE REMOVAL,1
PR,TEMPERATURE INTOLERANCE,1
PR,TESTICULAR SWELLING,1
PR,THROAT IRRITATION,1
PR,THROMBOSIS,1
PR,THYROID CANCER,1
PR,THYROID PAIN,1
PR,TONGUE DISCOMFORT,1
PR,TONGUE DISORDER,1
PR,TOOTH INFECTION,1
PR,TOOTHACHE,1
PR,TRACHEAL OEDEMA,1
PR,UNEVALUABLE EVENT,1
PR,URINARY TRACT INFECTION BACTERIAL,1
PR,VAGINAL ABSCESS,1
PR,VERTIGO POSITIONAL,1
PR,VIRAL INFECTION,1
PR,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
PR,VISION BLURRED,1
PR,WEIGHT INCREASED,1
PR,WHITE BLOOD CELL COUNT INCREASED,1
PR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
QA,RHABDOMYOLYSIS,7
QA,UROSEPSIS,4
QA,ESCHERICHIA INFECTION,3
QA,DYSPNOEA,2
QA,LETHARGY,2
QA,MUSCULAR WEAKNESS,2
QA,MYALGIA,2
QA,DEATH,1
RO,ACUTE MYOCARDIAL INFARCTION,3
RO,DRUG RESISTANCE,3
RO,VASCULAR STENT THROMBOSIS,3
RO,ANAEMIA,2
RO,ANGINA PECTORIS,2
RO,CELLULITIS,2
RO,NEUTROPENIA,2
RO,VOMITING,2
RO,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
RO,ACUTE RESPIRATORY FAILURE,1
RO,AMYLASE INCREASED,1
RO,ANGIOEDEMA,1
RO,BLOOD CHROMOGRANIN A INCREASED,1
RO,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
RO,BLOOD CREATININE INCREASED,1
RO,BONE MARROW TOXICITY,1
RO,CARDIAC FAILURE,1
RO,CATARACT,1
RO,CHOLECYSTITIS ACUTE,1
RO,CLOSTRIDIUM DIFFICILE COLITIS,1
RO,DIARRHOEA,1
RO,DRUG INEFFECTIVE,1
RO,DYSPNOEA,1
RO,EJECTION FRACTION DECREASED,1
RO,GASTROINTESTINAL HAEMORRHAGE,1
RO,HAEMATEMESIS,1
RO,HAEMOLYSIS,1
RO,HERPES ZOSTER,1
RO,HIATUS HERNIA,1
RO,HYPERAMYLASAEMIA,1
RO,HYPERLIPASAEMIA,1
RO,ILEUS PARALYTIC,1
RO,INFECTIVE MYOSITIS,1
RO,LATENT TUBERCULOSIS,1
RO,LUNG INFECTION,1
RO,MELAENA,1
RO,NASOPHARYNGITIS,1
RO,NAUSEA,1
RO,NEUROPATHY PERIPHERAL,1
RO,OEDEMA PERIPHERAL,1
RO,OESOPHAGITIS,1
RO,OVERDOSE,1
RO,PNEUMONIA,1
RO,POLYCYTHAEMIA,1
RO,PULMONARY FIBROSIS,1
RO,PUSTULAR PSORIASIS,1
RO,PYREXIA,1
RO,RENAL FAILURE CHRONIC,1
RO,STOMATITIS HAEMORRHAGIC,1
RO,SYSTOLIC DYSFUNCTION,1
RO,THROMBOCYTOPENIA,1
RO,THROMBOSIS,1
RO,TOXICITY TO VARIOUS AGENTS,1
RO,TUBERCULOSIS,1
RO,UPPER GASTROINTESTINAL HAEMORRHAGE,1
RO,URINARY RETENTION,1
RO,URINARY TRACT INFECTION,1
RO,URINARY TRACT INFECTION BACTERIAL,1
RO,VASCULAR STENT OCCLUSION,1
RO,VENTRICULAR DYSKINESIA,1
RU,BLOOD PRESSURE INCREASED,14
RU,CONTUSION,13
RU,MYOCARDIAL INFARCTION,13
RU,CHEST PAIN,9
RU,DYSPNOEA,8
RU,VASCULAR STENT THROMBOSIS,8
RU,COUGH,7
RU,DYSPNOEA EXERTIONAL,7
RU,PNEUMONIA,7
RU,ANAEMIA,6
RU,EPISTAXIS,6
RU,NAUSEA,6
RU,PULMONARY OEDEMA,6
RU,ANGINA PECTORIS,5
RU,ANGINA UNSTABLE,5
RU,BLOOD PRESSURE DECREASED,5
RU,DEEP VEIN THROMBOSIS,5
RU,ERYTHEMA,5
RU,PRODUCT USE ISSUE,5
RU,PYREXIA,5
RU,WEIGHT INCREASED,5
RU,ABDOMINAL PAIN UPPER,4
RU,ACUTE MYOCARDIAL INFARCTION,4
RU,ASTHENIA,4
RU,DIARRHOEA,4
RU,DIZZINESS,4
RU,GASTRITIS,4
RU,HEADACHE,4
RU,PANCREATITIS CHRONIC,4
RU,THROMBOCYTOPENIA,4
RU,CARDIAC ARREST,3
RU,CEREBROVASCULAR ACCIDENT,3
RU,CONDITION AGGRAVATED,3
RU,CORONARY ARTERY DISEASE,3
RU,DECREASED APPETITE,3
RU,DISORIENTATION,3
RU,HAEMORRHOIDAL HAEMORRHAGE,3
RU,HEART RATE DECREASED,3
RU,HERPES ZOSTER,3
RU,HYPERTHERMIA,3
RU,LEUKOPENIA,3
RU,LOSS OF CONSCIOUSNESS,3
RU,OEDEMA PERIPHERAL,3
RU,TACHYCARDIA,3
RU,THROMBOSIS,3
RU,VASCULAR STENT OCCLUSION,3
RU,ACUTE CORONARY SYNDROME,2
RU,ALANINE AMINOTRANSFERASE INCREASED,2
RU,ASPARTATE AMINOTRANSFERASE INCREASED,2
RU,BLOOD BILIRUBIN INCREASED,2
RU,BLOOD GLUCOSE INCREASED,2
RU,BLOOD PRESSURE ABNORMAL,2
RU,CALCULUS URINARY,2
RU,CARDIAC FAILURE,2
RU,CARDIOGENIC SHOCK,2
RU,COLITIS ULCERATIVE,2
RU,DEATH,2
RU,DEVICE OCCLUSION,2
RU,DRUG INEFFECTIVE,2
RU,DUODENAL ULCER,2
RU,ENDOCARDITIS,2
RU,FALL,2
RU,GASTRIC CANCER,2
RU,GENERAL PHYSICAL HEALTH DETERIORATION,2
RU,HAEMATOTOXICITY,2
RU,HEART RATE INCREASED,2
RU,HEPATIC PAIN,2
RU,HYPERAEMIA,2
RU,HYPERTENSION,2
RU,HYPOAESTHESIA,2
RU,HYPOTENSION,2
RU,INSOMNIA,2
RU,INTENTIONAL PRODUCT MISUSE,2
RU,ISCHAEMIC STROKE,2
RU,LACRIMATION INCREASED,2
RU,LYMPHADENOPATHY,2
RU,NASOPHARYNGITIS,2
RU,NEPHRITIS,2
RU,NEUTROPENIA,2
RU,PLEURAL EFFUSION,2
RU,PLEURISY,2
RU,PULMONARY EMBOLISM,2
RU,RIB FRACTURE,2
RU,ROAD TRAFFIC ACCIDENT,2
RU,STEVENS-JOHNSON SYNDROME,2
RU,VASCULAR STENT STENOSIS,2
RU,VOMITING,2
RU,WEIGHT DECREASED,2
RU,ABDOMINAL DISCOMFORT,1
RU,ABDOMINAL DISTENSION,1
RU,ABORTION THREATENED,1
RU,ABSCESS,1
RU,ABSCESS LIMB,1
RU,ACUTE KIDNEY INJURY,1
RU,ACUTE LEUKAEMIA,1
RU,ALTERED STATE OF CONSCIOUSNESS,1
RU,ALVEOLITIS,1
RU,ANXIETY,1
RU,AORTIC THROMBOSIS,1
RU,APATHY,1
RU,APHASIA,1
RU,APNOEA,1
RU,APPENDICITIS,1
RU,ARRHYTHMIA,1
RU,ARTERIOSCLEROSIS,1
RU,ARTHRALGIA,1
RU,ASCITES,1
RU,ASTHMA,1
RU,ATRIAL FLUTTER,1
RU,BLOOD CREATININE INCREASED,1
RU,BLOOD GLUCOSE DECREASED,1
RU,BLOOD LACTATE DEHYDROGENASE INCREASED,1
RU,BLOOD URINE PRESENT,1
RU,BREAST INFLAMMATION,1
RU,BREAST NEOPLASM,1
RU,BRONCHOSPASM,1
RU,BURNING SENSATION,1
RU,CALCULUS URETERIC,1
RU,CANDIDA INFECTION,1
RU,CARDIOMYOPATHY,1
RU,CAROTID ARTERY STENOSIS,1
RU,CHRONIC GASTRITIS,1
RU,CHRONIC HEPATITIS,1
RU,CHRONIC KIDNEY DISEASE,1
RU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
RU,CIRCULATORY COLLAPSE,1
RU,CLEAR CELL RENAL CELL CARCINOMA,1
RU,COLITIS,1
RU,COLON CANCER,1
RU,CONCOMITANT DISEASE PROGRESSION,1
RU,CONVERSION DISORDER,1
RU,CORONARY ARTERY OCCLUSION,1
RU,CORONARY ARTERY STENOSIS,1
RU,CORONARY ARTERY THROMBOSIS,1
RU,CUSHING^S SYNDROME,1
RU,CYSTITIS,1
RU,CYSTITIS HAEMORRHAGIC,1
RU,CYTOGENETIC ANALYSIS ABNORMAL,1
RU,CYTOKINE RELEASE SYNDROME,1
RU,DEVICE RELATED INFECTION,1
RU,DIABETES MELLITUS,1
RU,DIPLOPIA,1
RU,DISEASE PROGRESSION,1
RU,DIZZINESS POSTURAL,1
RU,DRUG RESISTANCE,1
RU,DYSGEUSIA,1
RU,DYSPNOEA AT REST,1
RU,EAR HAEMORRHAGE,1
RU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
RU,ENCEPHALOPATHY,1
RU,EPSTEIN-BARR VIRAEMIA,1
RU,ERYSIPELAS,1
RU,ESCHERICHIA INFECTION,1
RU,ESCHERICHIA SEPSIS,1
RU,EUPHORIC MOOD,1
RU,EYE OEDEMA,1
RU,FACE OEDEMA,1
RU,FEAR,1
RU,FEBRILE NEUTROPENIA,1
RU,GASTRIC POLYPS,1
RU,GASTRITIS EROSIVE,1
RU,GASTROINTESTINAL POLYP HAEMORRHAGE,1
RU,GLOMERULONEPHRITIS MEMBRANOUS,1
RU,GOUT,1
RU,HAEMATOCHEZIA,1
RU,HAEMATURIA,1
RU,HAEMOGLOBIN DECREASED,1
RU,HAEMOPTYSIS,1
RU,HAEMORRHAGE,1
RU,HAEMORRHAGIC DISORDER,1
RU,HENOCH-SCHONLEIN PURPURA,1
RU,HEPATIC CIRRHOSIS,1
RU,HEPATIC FAILURE,1
RU,HEPATIC FUNCTION ABNORMAL,1
RU,HEPATITIS,1
RU,HEPATITIS TOXIC,1
RU,HEPATOSPLENOMEGALY,1
RU,HIP FRACTURE,1
RU,HODGKIN^S DISEASE,1
RU,HYDROCEPHALUS,1
RU,HYDROTHORAX,1
RU,HYPERSENSITIVITY,1
RU,HYPOXIA,1
RU,INCORRECT DRUG ADMINISTRATION DURATION,1
RU,INFLAMMATION,1
RU,INFLUENZA,1
RU,INTENTIONAL PRODUCT USE ISSUE,1
RU,INTERNAL HAEMORRHAGE,1
RU,INTESTINAL HAEMORRHAGE,1
RU,INTESTINAL OBSTRUCTION,1
RU,JAUNDICE CHOLESTATIC,1
RU,KIDNEY TRANSPLANT REJECTION,1
RU,LEUKAEMIA RECURRENT,1
RU,LEUKOCYTOSIS,1
RU,LIP SWELLING,1
RU,LUNG NEOPLASM MALIGNANT,1
RU,LYMPHADENITIS,1
RU,LYMPHATIC SYSTEM NEOPLASM,1
RU,LYMPHOCYTE COUNT INCREASED,1
RU,MANTLE CELL LYMPHOMA REFRACTORY,1
RU,MARROW HYPERPLASIA,1
RU,MESENTERIC ARTERY THROMBOSIS,1
RU,METASTASES TO PLEURA,1
RU,MOUTH ULCERATION,1
RU,MUSCULOSKELETAL CHEST PAIN,1
RU,MYOCARDIAL ISCHAEMIA,1
RU,NASAL INJURY,1
RU,NEOPLASM,1
RU,NEPHROPATHY,1
RU,NERVOUSNESS,1
RU,OEDEMA,1
RU,OROPHARYNGEAL SPASM,1
RU,OVERDOSE,1
RU,PANIC ATTACK,1
RU,PERINEAL CELLULITIS,1
RU,PERIPHERAL ARTERY THROMBOSIS,1
RU,PHOTOPHOBIA,1
RU,POST PROCEDURAL HAEMORRHAGE,1
RU,POSTOPERATIVE WOUND INFECTION,1
RU,PROCALCITONIN INCREASED,1
RU,PROCTITIS,1
RU,PROTEINURIA,1
RU,PRURITUS,1
RU,PULMONARY ARTERIAL HYPERTENSION,1
RU,PULMONARY ARTERIAL PRESSURE INCREASED,1
RU,PULMONARY THROMBOSIS,1
RU,PULMONARY TUBERCULOSIS,1
RU,PURPURA,1
RU,PYELONEPHRITIS,1
RU,RASH,1
RU,RASH ERYTHEMATOUS,1
RU,RENAL FAILURE,1
RU,RENAL IMPAIRMENT,1
RU,RENAL PAIN,1
RU,RHABDOMYOLYSIS,1
RU,SALIVARY GLAND CALCULUS,1
RU,SCROTAL ABSCESS,1
RU,SECOND PRIMARY MALIGNANCY,1
RU,SEIZURE,1
RU,SEPSIS,1
RU,SEPTIC SHOCK,1
RU,SHOCK HAEMORRHAGIC,1
RU,SHUNT THROMBOSIS,1
RU,SIALOADENITIS,1
RU,SKIN ULCER,1
RU,SNEEZING,1
RU,THROMBOSIS IN DEVICE,1
RU,TINNITUS,1
RU,TOE AMPUTATION,1
RU,TOOTH FRACTURE,1
RU,TRANSAMINASES INCREASED,1
RU,TRANSPLANT,1
RU,TRAUMATIC HAEMORRHAGE,1
RU,TREMOR,1
RU,ULCER HAEMORRHAGE,1
RU,URTICARIA,1
RU,UTERINE HAEMORRHAGE,1
RU,VENOUS THROMBOSIS,1
RU,VENTRICULAR FIBRILLATION,1
RU,WOUND ABSCESS,1
RU,YELLOW SKIN,1
VC,PULMONARY EMBOLISM,1
VC,TREATMENT NONCOMPLIANCE,1
WS,ASTHENIA,1
WS,GASTROINTESTINAL HAEMORRHAGE,1
SA,VOMITING,3
SA,HAEMOPTYSIS,2
SA,ACUTE KIDNEY INJURY,1
SA,AGGRESSION,1
SA,ANASTOMOTIC STENOSIS,1
SA,BLOOD PRESSURE INCREASED,1
SA,CHEST DISCOMFORT,1
SA,CHEST PAIN,1
SA,COUGH,1
SA,CYTOMEGALOVIRUS TEST POSITIVE,1
SA,DUODENAL PERFORATION,1
SA,DYSPNOEA,1
SA,EPISTAXIS,1
SA,FEBRILE NEUTROPENIA,1
SA,HEADACHE,1
SA,HEPATIC ARTERY STENOSIS,1
SA,HEPATIC ARTERY THROMBOSIS,1
SA,HEPATIC ENZYME INCREASED,1
SA,HERPES ZOSTER,1
SA,HYPERGLYCAEMIA,1
SA,HYPOCHROMIC ANAEMIA,1
SA,MOOD SWINGS,1
SA,NEUTROPENIA,1
SA,TRANSAMINASES INCREASED,1
SA,TUBULOINTERSTITIAL NEPHRITIS,1
SA,WHITE BLOOD CELL COUNT DECREASED,1
SN,ABORTION SPONTANEOUS,1
SN,EXPOSURE DURING PREGNANCY,1
SN,FOETAL DEATH,1
RS,FALL,1
RS,HAEMATOMA,1
SG,DIARRHOEA,9
SG,PERIORBITAL OEDEMA,9
SG,ANAEMIA,8
SG,DYSPNOEA,8
SG,PNEUMONIA,8
SG,RASH,8
SG,DERMATITIS EXFOLIATIVE,7
SG,RASH MACULO-PAPULAR,7
SG,EYE SWELLING,6
SG,STEVENS-JOHNSON SYNDROME,6
SG,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
SG,HYPOKALAEMIA,5
SG,MYOSITIS,5
SG,NAUSEA,5
SG,SEPSIS,5
SG,VOMITING,5
SG,ABDOMINAL DISTENSION,4
SG,ACUTE KIDNEY INJURY,4
SG,CARDIAC FAILURE CONGESTIVE,4
SG,DECREASED APPETITE,4
SG,DYSPHAGIA,4
SG,FACE OEDEMA,4
SG,FALL,4
SG,GASTRITIS,4
SG,LIP SWELLING,4
SG,ABDOMINAL PAIN,3
SG,COLITIS,3
SG,DERMATOSIS,3
SG,DRUG ERUPTION,3
SG,DUODENAL ULCER,3
SG,ERYTHEMA DYSCHROMICUM PERSTANS,3
SG,FATIGUE,3
SG,FLATULENCE,3
SG,GASTROOESOPHAGEAL REFLUX DISEASE,3
SG,HAEMORRHOIDS,3
SG,HYPERSENSITIVITY VASCULITIS,3
SG,HYPONATRAEMIA,3
SG,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
SG,PYREXIA,3
SG,RASH ERYTHEMATOUS,3
SG,SYNCOPE,3
SG,TRANSAMINASES INCREASED,3
SG,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
SG,ANGIOEDEMA,2
SG,ASTHENIA,2
SG,BACK PAIN,2
SG,BLOOD CREATININE INCREASED,2
SG,BONE MARROW FAILURE,2
SG,BRONCHITIS,2
SG,CHEST PAIN,2
SG,DEHYDRATION,2
SG,DERMATITIS EXFOLIATIVE GENERALISED,2
SG,DISEASE PROGRESSION,2
SG,DYSPNOEA EXERTIONAL,2
SG,FANCONI SYNDROME,2
SG,GASTROINTESTINAL DISORDER,2
SG,GASTROINTESTINAL HAEMORRHAGE,2
SG,GENITAL ULCERATION,2
SG,HYPERGLYCAEMIA,2
SG,HYPOMAGNESAEMIA,2
SG,HYPOTENSION,2
SG,LARYNGEAL OEDEMA,2
SG,LOCAL SWELLING,2
SG,LOWER RESPIRATORY TRACT INFECTION,2
SG,MALAISE,2
SG,MOUTH ULCERATION,2
SG,MYALGIA,2
SG,PANCREATITIS,2
SG,PERIPHERAL SWELLING,2
SG,PNEUMONITIS,2
SG,PRODUCT USE IN UNAPPROVED INDICATION,2
SG,PROTEINURIA,2
SG,PULMONARY OEDEMA,2
SG,RASH GENERALISED,2
SG,RASH PUSTULAR,2
SG,RENAL FAILURE ACUTE,2
SG,RENAL IMPAIRMENT,2
SG,SWELLING,2
SG,SWELLING FACE,2
SG,TOXIC EPIDERMAL NECROLYSIS,2
SG,TUBULOINTERSTITIAL NEPHRITIS,2
SG,URINARY TRACT INFECTION,2
SG,WEIGHT INCREASED,2
SG,ACUTE MYOCARDIAL INFARCTION,1
SG,ADENOCARCINOMA OF COLON,1
SG,ANAPHYLACTIC REACTION,1
SG,ANGINA UNSTABLE,1
SG,APLASIA PURE RED CELL,1
SG,ARTHRALGIA,1
SG,ASPARTATE AMINOTRANSFERASE INCREASED,1
SG,BLOOD BILIRUBIN INCREASED,1
SG,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
SG,BLOOD PRESSURE ABNORMAL,1
SG,BLOOD URIC ACID DECREASED,1
SG,BRAIN CONTUSION,1
SG,CAMPYLOBACTER GASTROENTERITIS,1
SG,CAMPYLOBACTER INFECTION,1
SG,CARDIAC DISORDER,1
SG,CARDIAC FAILURE,1
SG,CELLULITIS,1
SG,CEREBRAL HAEMORRHAGE,1
SG,CHEST DISCOMFORT,1
SG,CHILLS,1
SG,CONFUSIONAL STATE,1
SG,CORONARY ARTERY DISEASE,1
SG,CORONARY ARTERY OCCLUSION,1
SG,DEAFNESS BILATERAL,1
SG,DEATH,1
SG,DEMYELINATION,1
SG,DENGUE FEVER,1
SG,DERMATITIS ACNEIFORM,1
SG,DERMATITIS BULLOUS,1
SG,DIASTOLIC DYSFUNCTION,1
SG,DIZZINESS,1
SG,DRUG ADMINISTRATION ERROR,1
SG,DRUG INTOLERANCE,1
SG,DUODENAL ULCER PERFORATION,1
SG,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
SG,ELECTROLYTE IMBALANCE,1
SG,ENCEPHALOPATHY,1
SG,ENTEROCOLITIS INFECTIOUS,1
SG,EPIGASTRIC DISCOMFORT,1
SG,EYE OEDEMA,1
SG,EYE PRURITUS,1
SG,FAECAL INCONTINENCE,1
SG,FAECES DISCOLOURED,1
SG,FLUID OVERLOAD,1
SG,FLUSHING,1
SG,FUNGAL INFECTION,1
SG,GASTRIC CANCER,1
SG,GASTROENTERITIS,1
SG,GASTROINTESTINAL TOXICITY,1
SG,GENERAL PHYSICAL HEALTH DETERIORATION,1
SG,GENERALISED OEDEMA,1
SG,GLOMERULONEPHRITIS,1
SG,GRAVITATIONAL OEDEMA,1
SG,HAEMATOCHEZIA,1
SG,HEPATITIS E,1
SG,HEPATOCELLULAR CARCINOMA,1
SG,HUNGER,1
SG,HYPERCALCAEMIA,1
SG,HYPOCALCAEMIA,1
SG,HYPOPHOSPHATAEMIA,1
SG,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
SG,INFECTION,1
SG,INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS,1
SG,JOINT CREPITATION,1
SG,JOINT EFFUSION,1
SG,JOINT RANGE OF MOTION DECREASED,1
SG,JOINT SWELLING,1
SG,LACERATION,1
SG,LACTIC ACIDOSIS,1
SG,LATENT TUBERCULOSIS,1
SG,LETHARGY,1
SG,LEUKOPENIA,1
SG,LIVER DISORDER,1
SG,LIVER FUNCTION TEST ABNORMAL,1
SG,MENTAL STATUS CHANGES,1
SG,METABOLIC ACIDOSIS,1
SG,MUSCULOSKELETAL CHEST PAIN,1
SG,MYASTHENIA GRAVIS CRISIS,1
SG,MYOCARDIAL INFARCTION,1
SG,MYOCARDIAL ISCHAEMIA,1
SG,NASAL OEDEMA,1
SG,NEUTROPENIC SEPSIS,1
SG,NON-CARDIAC CHEST PAIN,1
SG,OCCULT BLOOD POSITIVE,1
SG,OEDEMA PERIPHERAL,1
SG,OESOPHAGEAL CANDIDIASIS,1
SG,ORAL CANDIDIASIS,1
SG,ORBITAL OEDEMA,1
SG,OROPHARYNGEAL PAIN,1
SG,ORTHOPNOEA,1
SG,PALPABLE PURPURA,1
SG,PANCREATIC CARCINOMA,1
SG,PANCREATITIS ACUTE,1
SG,PERIPHERAL VASCULAR DISORDER,1
SG,PERITONITIS,1
SG,PLASMA CELL MYELOMA,1
SG,PNEUMONIA INFLUENZAL,1
SG,PRURITUS,1
SG,PULMONARY CONGESTION,1
SG,PULMONARY EMBOLISM,1
SG,RALES,1
SG,RASH MACULAR,1
SG,RASH PAPULAR,1
SG,RASH PRURITIC,1
SG,RECTAL HAEMORRHAGE,1
SG,RECTOSIGMOID CANCER,1
SG,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
SG,REGURGITATION,1
SG,RENAL FAILURE,1
SG,RENAL TUBULAR INJURY,1
SG,RHABDOMYOLYSIS,1
SG,SEIZURE,1
SG,SEPTIC SHOCK,1
SG,SKULL FRACTURED BASE,1
SG,SPINAL OSTEOARTHRITIS,1
SG,SUBARACHNOID HAEMORRHAGE,1
SG,SUBCLAVIAN VEIN THROMBOSIS,1
SG,SUBDURAL HAEMORRHAGE,1
SG,SYNOVITIS,1
SG,SYSTEMIC IMMUNE ACTIVATION,1
SG,THROAT IRRITATION,1
SG,THROMBOCYTOPENIA,1
SG,THROMBOPHLEBITIS,1
SG,THROMBOTIC MICROANGIOPATHY,1
SG,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
SG,TOXICITY TO VARIOUS AGENTS,1
SG,TUMOUR LYSIS SYNDROME,1
SG,URINARY INCONTINENCE,1
SG,URTICARIA,1
SG,VASCULAR STENT THROMBOSIS,1
SG,VASCULITIS,1
SG,VENTRICULAR FIBRILLATION,1
SG,VENTRICULAR TACHYCARDIA,1
SG,VITAMIN D DEFICIENCY,1
SK,LOW BIRTH WEIGHT BABY,4
SK,PREMATURE BABY,4
SK,DIARRHOEA,3
SK,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,3
SK,ABNORMAL LOSS OF WEIGHT,2
SK,CARDIOPULMONARY FAILURE,2
SK,COLITIS MICROSCOPIC,2
SK,FATIGUE,2
SK,FOETAL EXPOSURE DURING PREGNANCY,2
SK,GASTRITIS EROSIVE,2
SK,HYPERKALAEMIA,2
SK,MATERNAL EXPOSURE DURING PREGNANCY,2
SK,ACUTE KIDNEY INJURY,1
SK,ANGINA UNSTABLE,1
SK,BRONCHITIS,1
SK,BRONCHOPNEUMONIA,1
SK,CANDIDA TEST POSITIVE,1
SK,CARDIAC FAILURE,1
SK,DECREASED APPETITE,1
SK,DERMATITIS ACNEIFORM,1
SK,DRUG INEFFECTIVE,1
SK,DRY MOUTH,1
SK,DYSPNOEA,1
SK,ECZEMA,1
SK,ERYTHEMA ANNULARE,1
SK,GASTRIC HAEMORRHAGE,1
SK,GASTROINTESTINAL CANDIDIASIS,1
SK,GASTROINTESTINAL TELANGIECTASIA,1
SK,HAEMOPTYSIS,1
SK,HEADACHE,1
SK,HODGKIN^S DISEASE,1
SK,INFUSION RELATED REACTION,1
SK,LEUKOCYTOSIS,1
SK,MATERNAL EXPOSURE DURING BREAST FEEDING,1
SK,MEGACOLON,1
SK,NORMAL NEWBORN,1
SK,PLASMA CELL MYELOMA,1
SK,PREMATURE RUPTURE OF MEMBRANES,1
SK,PRESCRIBED UNDERDOSE,1
SK,RASH,1
SK,RENAL COLIC,1
SK,TACHYCARDIA,1
SK,THROMBOCYTOPENIA,1
SK,UHTHOFF^S PHENOMENON,1
SK,UPPER GASTROINTESTINAL HAEMORRHAGE,1
SK,URINARY TRACT INFECTION,1
SK,WEIGHT DECREASED,1
SI,RESTLESSNESS,7
SI,CONFUSIONAL STATE,6
SI,HALLUCINATION,5
SI,PARANOIA,5
SI,BACK PAIN,4
SI,DEATH,4
SI,DIZZINESS,3
SI,INSOMNIA,3
SI,AGGRESSION,2
SI,ANXIETY,2
SI,COGNITIVE DISORDER,2
SI,CONSTIPATION,2
SI,DELIRIUM,2
SI,DISORIENTATION,2
SI,HALLUCINATION_ VISUAL,2
SI,PSYCHOMOTOR HYPERACTIVITY,2
SI,URINARY INCONTINENCE,2
SI,ABDOMINAL PAIN,1
SI,ABNORMAL BEHAVIOUR,1
SI,ACUTE MYOCARDIAL INFARCTION,1
SI,ALANINE AMINOTRANSFERASE INCREASED,1
SI,ANAPHYLACTIC REACTION,1
SI,ANGIOPATHY,1
SI,ASPARTATE AMINOTRANSFERASE INCREASED,1
SI,ATRIAL FIBRILLATION,1
SI,CARDIAC FAILURE,1
SI,CARDIOMEGALY,1
SI,CRYSTAL URINE PRESENT,1
SI,CYCLOTHYMIC DISORDER,1
SI,DEPRESSED MOOD,1
SI,DEPRESSION,1
SI,DIASTOLIC DYSFUNCTION,1
SI,DRUG INEFFECTIVE,1
SI,DRUG LEVEL INCREASED,1
SI,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
SI,FALL,1
SI,FEAR,1
SI,GASTROOESOPHAGEAL REFLUX DISEASE,1
SI,HALLUCINATION_ OLFACTORY,1
SI,HEADACHE,1
SI,HYPEROXALURIA,1
SI,HYPOCITRATURIA,1
SI,HYPOMANIA,1
SI,HYPOTONIA,1
SI,INFUSION RELATED REACTION,1
SI,ISCHAEMIC STROKE,1
SI,KIDNEY SMALL,1
SI,LEFT VENTRICULAR HYPERTROPHY,1
SI,MOOD ALTERED,1
SI,MUSCULAR WEAKNESS,1
SI,MUSCULOSKELETAL PAIN,1
SI,MYELOPROLIFERATIVE DISORDER,1
SI,NEOPLASM,1
SI,NEPHROANGIOSCLEROSIS,1
SI,NEPHROLITHIASIS,1
SI,PAIN IN EXTREMITY,1
SI,PROTEINURIA,1
SI,RENAL CYST,1
SI,RENAL FAILURE,1
SI,RENAL HYPERTENSION,1
SI,RETINOPATHY HYPERTENSIVE,1
SI,SOMNOLENCE,1
SI,SPINAL PAIN,1
SI,SUICIDE ATTEMPT,1
SI,TACHYCARDIA,1
SI,URINARY TRACT INFECTION,1
SI,URINARY TRACT OBSTRUCTION,1
SI,VISION BLURRED,1
SI,WALKING AID USER,1
ZA,DEATH,3
ZA,ACUTE MYOCARDIAL INFARCTION,2
ZA,ANAEMIA,2
ZA,BRONCHITIS,2
ZA,CARDIAC FAILURE,2
ZA,GASTRITIS,2
ZA,PAIN,2
ZA,URINARY TRACT INFECTION,2
ZA,ABDOMINAL PAIN,1
ZA,ABDOMINAL PAIN UPPER,1
ZA,ABNORMAL PRODUCT OF CONCEPTION,1
ZA,ACNE,1
ZA,ANGINA PECTORIS,1
ZA,ARRHYTHMIA,1
ZA,BACK PAIN,1
ZA,BLOOD PRESSURE DECREASED,1
ZA,BONE DENSITY DECREASED,1
ZA,BRADYCARDIA,1
ZA,CERVICAL RADICULOPATHY,1
ZA,CHEST PAIN,1
ZA,CHOLECYSTITIS,1
ZA,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
ZA,CONSTIPATION,1
ZA,CONTUSION,1
ZA,CORONARY ARTERY DISEASE,1
ZA,CORONARY ARTERY OCCLUSION,1
ZA,DECREASED APPETITE,1
ZA,DIVERTICULUM,1
ZA,DRUG HYPERSENSITIVITY,1
ZA,DRUG INEFFECTIVE,1
ZA,DRUG-INDUCED LIVER INJURY,1
ZA,DYSPEPSIA,1
ZA,DYSPNOEA,1
ZA,EXPOSURE DURING PREGNANCY,1
ZA,EYE PAIN,1
ZA,FEELING ABNORMAL,1
ZA,GAIT DISTURBANCE,1
ZA,GASTRITIS HAEMORRHAGIC,1
ZA,HAEMORRHAGE,1
ZA,HEADACHE,1
ZA,HEPATOTOXICITY,1
ZA,HOSPITALISATION,1
ZA,HYPERSPLENISM,1
ZA,HYPERTENSIVE CRISIS,1
ZA,HYPOAESTHESIA,1
ZA,HYPOKINESIA,1
ZA,HYPOPHAGIA,1
ZA,INFECTION,1
ZA,INFECTIVE MYOSITIS,1
ZA,INTESTINAL OBSTRUCTION,1
ZA,JOINT STIFFNESS,1
ZA,LARGE INTESTINE POLYP,1
ZA,MALAISE,1
ZA,MALIGNANT NEOPLASM PROGRESSION,1
ZA,MARROW HYPERPLASIA,1
ZA,METASTASES TO LIVER,1
ZA,MUSCULAR WEAKNESS,1
ZA,MYALGIA,1
ZA,NAUSEA,1
ZA,NO THERAPEUTIC RESPONSE,1
ZA,NODULE,1
ZA,NON-HODGKIN^S LYMPHOMA,1
ZA,PARALYSIS,1
ZA,PILOERECTION,1
ZA,PLEURAL EFFUSION,1
ZA,PNEUMONIA,1
ZA,PNEUMONIA HAEMOPHILUS,1
ZA,PYELONEPHRITIS,1
ZA,PYREXIA,1
ZA,SPLENOMEGALY,1
ZA,THERAPEUTIC RESPONSE DECREASED,1
ZA,VOMITING,1
ZA,WEIGHT DECREASED,1
ZA,WHITE BLOOD CELL COUNT DECREASED,1
ES,PYREXIA,99
ES,ASTHENIA,89
ES,DIARRHOEA,87
ES,ACUTE KIDNEY INJURY,83
ES,ANAEMIA,79
ES,VOMITING,77
ES,HYPOMAGNESAEMIA,70
ES,PNEUMONIA,69
ES,NAUSEA,66
ES,NEUTROPENIA,62
ES,CONDITION AGGRAVATED,61
ES,DYSPNOEA,61
ES,DIZZINESS,58
ES,FEBRILE NEUTROPENIA,58
ES,FATIGUE,57
ES,HYPOCALCAEMIA,57
ES,SOMNOLENCE,55
ES,CARDIAC FAILURE,54
ES,HYPONATRAEMIA,53
ES,RENAL FAILURE,53
ES,HYPOTENSION,50
ES,HEADACHE,48
ES,RESPIRATORY FAILURE,47
ES,RESPIRATORY TRACT INFECTION,46
ES,DRUG INEFFECTIVE,45
ES,THROMBOCYTOPENIA,44
ES,TOXICITY TO VARIOUS AGENTS,44
ES,URINARY TRACT INFECTION,43
ES,ABDOMINAL PAIN,42
ES,PAIN IN EXTREMITY,41
ES,SEPTIC SHOCK,41
ES,ATRIAL FIBRILLATION,40
ES,CONFUSIONAL STATE,40
ES,FALL,40
ES,MALAISE,39
ES,TREMOR,38
ES,HYPERTENSION,36
ES,HEPATOTOXICITY,34
ES,HYPERKALAEMIA,34
ES,HYPOKALAEMIA,33
ES,PAIN,32
ES,DECREASED APPETITE,31
ES,DISORIENTATION,31
ES,PANCYTOPENIA,31
ES,SEPSIS,31
ES,ARTHRALGIA,30
ES,CONSTIPATION,30
ES,HEPATIC ENCEPHALOPATHY,30
ES,RENAL FAILURE ACUTE,30
ES,CARDIO-RESPIRATORY ARREST,29
ES,INSOMNIA,29
ES,SYNCOPE,29
ES,DEPRESSION,28
ES,ERYTHEMA,28
ES,PRURITUS,28
ES,TRANSAMINASES INCREASED,27
ES,DEATH,26
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,26
ES,RASH,26
ES,GAIT DISTURBANCE,24
ES,MYALGIA,24
ES,TORSADE DE POINTES,23
ES,TOXIC EPIDERMAL NECROLYSIS,23
ES,GASTROINTESTINAL HAEMORRHAGE,22
ES,RENAL IMPAIRMENT,22
ES,URTICARIA,22
ES,WEIGHT DECREASED,22
ES,OEDEMA PERIPHERAL,21
ES,PARAESTHESIA,21
ES,HEPATIC FAILURE,20
ES,PLEURAL EFFUSION,20
ES,PULMONARY EMBOLISM,20
ES,RHABDOMYOLYSIS,20
ES,TREATMENT NONCOMPLIANCE,20
ES,BACK PAIN,19
ES,EUPHORIC MOOD,19
ES,METABOLIC ACIDOSIS,19
ES,ABDOMINAL PAIN UPPER,18
ES,ELECTROCARDIOGRAM QT PROLONGED,18
ES,ERYTHRODERMIC PSORIASIS,18
ES,HEPATITIS,18
ES,MUSCLE SPASMS,18
ES,PLATELET COUNT DECREASED,18
ES,STUPOR,18
ES,VENTRICULAR FIBRILLATION,18
ES,HYPERTRANSAMINASAEMIA,17
ES,MUSCULAR WEAKNESS,17
ES,PANCREATITIS ACUTE,17
ES,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,16
ES,BONE PAIN,16
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,16
ES,DYSPHAGIA,16
ES,EOSINOPHILIA,16
ES,LEUKOPENIA,16
ES,LUNG INFILTRATION,16
ES,MUCOSAL INFLAMMATION,16
ES,CHEST PAIN,15
ES,CHOLESTASIS,15
ES,GENERAL PHYSICAL HEALTH DETERIORATION,15
ES,HYPOGLYCAEMIA,15
ES,LACTIC ACIDOSIS,15
ES,PALPITATIONS,15
ES,WERNICKE^S ENCEPHALOPATHY,15
ES,ACUTE MYELOID LEUKAEMIA,14
ES,DEHYDRATION,14
ES,DISEASE PROGRESSION,14
ES,EPISTAXIS,14
ES,HEPATITIS CHOLESTATIC,14
ES,HYPERREFLEXIA,14
ES,OVERDOSE,14
ES,PNEUMONITIS,14
ES,PRODUCT USE ISSUE,14
ES,RECTAL HAEMORRHAGE,14
ES,TOXIC SKIN ERUPTION,14
ES,ANXIETY,13
ES,CEREBRAL VASOCONSTRICTION,13
ES,GASTROENTERITIS,13
ES,HAEMOGLOBIN DECREASED,13
ES,HYPERSENSITIVITY VASCULITIS,13
ES,HYPOAESTHESIA,13
ES,INJECTION SITE ERYTHEMA,13
ES,INTERSTITIAL LUNG DISEASE,13
ES,MALIGNANT NEOPLASM PROGRESSION,13
ES,MANIA,13
ES,MULTI-ORGAN FAILURE,13
ES,PANCREATITIS,13
ES,RHEUMATOID ARTHRITIS,13
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,13
ES,ASCITES,12
ES,BLOOD PRESSURE INCREASED,12
ES,CHILLS,12
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,12
ES,DYSPEPSIA,12
ES,HAEMATURIA,12
ES,HALLUCINATION_ VISUAL,12
ES,HYPERHIDROSIS,12
ES,INJECTION SITE PAIN,12
ES,JAUNDICE,12
ES,LOSS OF CONSCIOUSNESS,12
ES,NEUROTOXICITY,12
ES,SKIN ULCER,12
ES,SUBDURAL HAEMATOMA,12
ES,TRANSIENT ISCHAEMIC ATTACK,12
ES,ANURIA,11
ES,APHASIA,11
ES,BLOOD CREATININE INCREASED,11
ES,BRADYCARDIA,11
ES,CELLULITIS,11
ES,CEREBROVASCULAR ACCIDENT,11
ES,COUGH,11
ES,DEEP VEIN THROMBOSIS,11
ES,FEELING ABNORMAL,11
ES,HYPERBILIRUBINAEMIA,11
ES,HYPOPHOSPHATAEMIA,11
ES,HYPOVOLAEMIC SHOCK,11
ES,INFECTION,11
ES,LEUKOCYTOSIS,11
ES,LOWER GASTROINTESTINAL HAEMORRHAGE,11
ES,RESPIRATORY DISTRESS,11
ES,STEVENS-JOHNSON SYNDROME,11
ES,VENTRICULAR TACHYCARDIA,11
ES,ABDOMINAL DISTENSION,10
ES,ACUTE CORONARY SYNDROME,10
ES,ACUTE RESPIRATORY FAILURE,10
ES,BIPOLAR I DISORDER,10
ES,DISCOMFORT,10
ES,DYSARTHRIA,10
ES,FAECALOMA,10
ES,INFLUENZA,10
ES,INTERNATIONAL NORMALISED RATIO INCREASED,10
ES,MUSCULOSKELETAL PAIN,10
ES,PSYCHOMOTOR HYPERACTIVITY,10
ES,SEDATION,10
ES,STOMATITIS,10
ES,ABDOMINAL DISCOMFORT,9
ES,ACUTE MYOCARDIAL INFARCTION,9
ES,AGITATION,9
ES,ASPHYXIA,9
ES,ATAXIA,9
ES,CATARACT,9
ES,CHOLELITHIASIS,9
ES,COGNITIVE DISORDER,9
ES,DELIRIUM,9
ES,DIABETES MELLITUS,9
ES,DIABETES MELLITUS INADEQUATE CONTROL,9
ES,FEELING HOT,9
ES,HYPERGLYCAEMIA,9
ES,INFLAMMATION,9
ES,INJECTION SITE HAEMATOMA,9
ES,ISCHAEMIC STROKE,9
ES,LARGE INTESTINAL ULCER,9
ES,MOUTH ULCERATION,9
ES,NERVOUSNESS,9
ES,RIGHT HEMISPHERE DEFICIT SYNDROME,9
ES,TACHYCARDIA,9
ES,TETANY,9
ES,ACUTE HEPATIC FAILURE,8
ES,ACUTE PULMONARY OEDEMA,8
ES,ANGINA PECTORIS,8
ES,ANGIOEDEMA,8
ES,CHOLECYSTITIS,8
ES,DRY MOUTH,8
ES,ENCEPHALITIS,8
ES,GASTROINTESTINAL DISORDER,8
ES,HAEMORRHAGE INTRACRANIAL,8
ES,HEPATIC CIRRHOSIS,8
ES,HEPATIC NECROSIS,8
ES,HYPERSENSITIVITY,8
ES,HYPERTHYROIDISM,8
ES,HYPOCOAGULABLE STATE,8
ES,INTESTINAL OBSTRUCTION,8
ES,LYMPHOPENIA,8
ES,MENTAL DISORDER,8
ES,MOBILITY DECREASED,8
ES,NEUROPATHY PERIPHERAL,8
ES,OEDEMA,8
ES,PERIPHERAL SWELLING,8
ES,PERITONITIS,8
ES,PLASMA CELL MYELOMA,8
ES,SKIN TEST POSITIVE,8
ES,URINARY TRACT DISCOMFORT,8
ES,VISUAL IMPAIRMENT,8
ES,ALOPECIA,7
ES,ANAPHYLACTIC SHOCK,7
ES,ARTHROPATHY,7
ES,ASTHMA,7
ES,BLOOD HIV RNA INCREASED,7
ES,BRONCHITIS,7
ES,CEREBELLAR ATAXIA,7
ES,CEREBRAL HAEMORRHAGE,7
ES,CHRONIC KIDNEY DISEASE,7
ES,COAGULOPATHY,7
ES,CYTOMEGALOVIRUS INFECTION,7
ES,DIVERTICULITIS,7
ES,DRUG ERUPTION,7
ES,DRUG INTOLERANCE,7
ES,ENCEPHALOPATHY,7
ES,EPILEPSY,7
ES,EYE MOVEMENT DISORDER,7
ES,EYELID OEDEMA,7
ES,FEMUR FRACTURE,7
ES,FLANK PAIN,7
ES,GASTRITIS,7
ES,HEMIANOPIA,7
ES,HEPATITIS ACUTE,7
ES,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
ES,INHIBITORY DRUG INTERACTION,7
ES,LIVER DISORDER,7
ES,LUPUS-LIKE SYNDROME,7
ES,LYMPHADENOPATHY,7
ES,METABOLIC ENCEPHALOPATHY,7
ES,METASTASES TO BONE,7
ES,NASAL CONGESTION,7
ES,ODYNOPHAGIA,7
ES,OSTEONECROSIS,7
ES,OSTEONECROSIS OF JAW,7
ES,PRODUCT USE IN UNAPPROVED INDICATION,7
ES,PSORIATIC ARTHROPATHY,7
ES,PSYCHOTIC DISORDER,7
ES,RASH ERYTHEMATOUS,7
ES,URINARY RETENTION,7
ES,VISION BLURRED,7
ES,ABDOMINAL WALL HAEMATOMA,6
ES,ACUTE PSYCHOSIS,6
ES,AGGRESSION,6
ES,AGRANULOCYTOSIS,6
ES,ALLERGY TEST POSITIVE,6
ES,AMNESIA,6
ES,ARRHYTHMIA,6
ES,ATYPICAL FEMUR FRACTURE,6
ES,BACTERAEMIA,6
ES,BLOOD CHOLESTEROL INCREASED,6
ES,BURNING SENSATION,6
ES,CARDIAC FAILURE CONGESTIVE,6
ES,CHEST DISCOMFORT,6
ES,CHRONIC GASTRITIS,6
ES,COLITIS ISCHAEMIC,6
ES,CONTUSION,6
ES,CRANIOCEREBRAL INJURY,6
ES,CROHN^S DISEASE,6
ES,DEVICE RELATED INFECTION,6
ES,DRUG-INDUCED LIVER INJURY,6
ES,FACE OEDEMA,6
ES,HAEMATEMESIS,6
ES,HAEMATOCHEZIA,6
ES,HALLUCINATION,6
ES,HEPATOCELLULAR CARCINOMA,6
ES,HYPERTENSIVE CRISIS,6
ES,INTENTIONAL OVERDOSE,6
ES,INTESTINAL PERFORATION,6
ES,METABOLIC SYNDROME,6
ES,MUSCULOSKELETAL STIFFNESS,6
ES,NASOPHARYNGITIS,6
ES,OCCUPATIONAL EXPOSURE TO PRODUCT,6
ES,PNEUMONIA ASPIRATION,6
ES,POLYNEUROPATHY,6
ES,PRESYNCOPE,6
ES,PRURITUS GENERALISED,6
ES,SCIATICA,6
ES,SEROTONIN SYNDROME,6
ES,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,6
ES,SUICIDAL IDEATION,6
ES,TACHYPNOEA,6
ES,VENTRICULAR EXTRASYSTOLES,6
ES,ABASIA,5
ES,ADENOCARCINOMA PANCREAS,5
ES,AGEUSIA,5
ES,ALANINE AMINOTRANSFERASE INCREASED,5
ES,ALTERED STATE OF CONSCIOUSNESS,5
ES,ANKYLOSING SPONDYLITIS,5
ES,ASPARTATE AMINOTRANSFERASE INCREASED,5
ES,ASPIRATION,5
ES,ASPIRATION BRONCHIAL,5
ES,ATELECTASIS,5
ES,BLINDNESS,5
ES,BONE MARROW FAILURE,5
ES,BRAIN OEDEMA,5
ES,BRONCHOSPASM,5
ES,CARDIAC FAILURE ACUTE,5
ES,CARDIOGENIC SHOCK,5
ES,CEREBRAL HAEMATOMA,5
ES,CHOLANGITIS,5
ES,COLITIS,5
ES,COMPLETED SUICIDE,5
ES,CYANOSIS,5
ES,DEPRESSED MOOD,5
ES,DIABETIC KETOACIDOSIS,5
ES,DYSKINESIA,5
ES,DYSURIA,5
ES,ELECTROLYTE IMBALANCE,5
ES,ENTERITIS,5
ES,ERECTILE DYSFUNCTION,5
ES,FLUSHING,5
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
ES,HAEMOPTYSIS,5
ES,HAEMORRHOIDS,5
ES,HEPATITIS TOXIC,5
ES,HIATUS HERNIA,5
ES,HYPERCALCAEMIA,5
ES,HYPOXIA,5
ES,INCORRECT DOSE ADMINISTERED,5
ES,INJECTION SITE PRURITUS,5
ES,INJECTION SITE REACTION,5
ES,INTERVERTEBRAL DISC PROTRUSION,5
ES,IRON DEFICIENCY ANAEMIA,5
ES,LIVER INJURY,5
ES,MEDICATION ERROR,5
ES,MELAENA,5
ES,MUSCLE HAEMORRHAGE,5
ES,MYOPATHY,5
ES,NECK PAIN,5
ES,NEPHROPATHY TOXIC,5
ES,OESOPHAGITIS,5
ES,PALLOR,5
ES,PERICARDIAL EFFUSION,5
ES,PERICARDITIS,5
ES,PERITONITIS BACTERIAL,5
ES,PNEUMOTHORAX,5
ES,PORTAL VEIN THROMBOSIS,5
ES,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,5
ES,PSORIASIS,5
ES,PSYCHOTIC BEHAVIOUR,5
ES,RASH PUSTULAR,5
ES,SEIZURE,5
ES,SKIN EXFOLIATION,5
ES,SKIN LESION,5
ES,SKIN TOXICITY,5
ES,SPONTANEOUS HAEMATOMA,5
ES,SPRUE-LIKE ENTEROPATHY,5
ES,STATUS EPILEPTICUS,5
ES,SUBSTANCE-INDUCED MOOD DISORDER,5
ES,THROMBOTIC MICROANGIOPATHY,5
ES,TYPE I HYPERSENSITIVITY,5
ES,UPPER RESPIRATORY TRACT INFECTION,5
ES,WITHDRAWAL SYNDROME,5
ES,ABNORMAL BEHAVIOUR,4
ES,ANAEMIA MEGALOBLASTIC,4
ES,APPENDICITIS,4
ES,ATRIOVENTRICULAR BLOCK,4
ES,BLOOD PRESSURE DECREASED,4
ES,BLOOD TRIGLYCERIDES INCREASED,4
ES,BRADYPHRENIA,4
ES,CARDIAC ARREST,4
ES,CARDIOMEGALY,4
ES,CHOLECYSTITIS ACUTE,4
ES,CLOSTRIDIUM DIFFICILE COLITIS,4
ES,COLITIS ULCERATIVE,4
ES,COLON CANCER,4
ES,DEMENTIA,4
ES,DERMATITIS BULLOUS,4
ES,DIPLOPIA,4
ES,DRUG EFFECT INCOMPLETE,4
ES,DRUG HYPERSENSITIVITY,4
ES,DRUG LEVEL INCREASED,4
ES,DYSLIPIDAEMIA,4
ES,ERYTHEMA MULTIFORME,4
ES,FANCONI SYNDROME,4
ES,FEELING COLD,4
ES,FLATULENCE,4
ES,GASTRIC DISORDER,4
ES,GASTRIC ULCER,4
ES,GASTROINTESTINAL TOXICITY,4
ES,HAEMOLYTIC URAEMIC SYNDROME,4
ES,HAEMORRHAGE,4
ES,HEART RATE INCREASED,4
ES,HEPATIC ENZYME INCREASED,4
ES,HEPATIC FUNCTION ABNORMAL,4
ES,HEPATIC STEATOSIS,4
ES,HEPATITIS C,4
ES,HERPES ZOSTER,4
ES,HIP FRACTURE,4
ES,HYPERNATRAEMIA,4
ES,HYPOPARATHYROIDISM,4
ES,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,4
ES,INJECTION SITE WARMTH,4
ES,INTESTINAL ISCHAEMIA,4
ES,IRRITABILITY,4
ES,KLEBSIELLA INFECTION,4
ES,LINEAR IGA DISEASE,4
ES,LIP SWELLING,4
ES,METASTASES TO LIVER,4
ES,MITRAL VALVE INCOMPETENCE,4
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
ES,MYELODYSPLASTIC SYNDROME,4
ES,MYOCARDIAL ISCHAEMIA,4
ES,NEOPLASM PROGRESSION,4
ES,NEPHROLITHIASIS,4
ES,NEPHROPATHY,4
ES,NERVOUS SYSTEM DISORDER,4
ES,NODAL RHYTHM,4
ES,NYSTAGMUS,4
ES,OESOPHAGEAL CANDIDIASIS,4
ES,OLIGURIA,4
ES,OROPHARYNGEAL PAIN,4
ES,OVERLAP SYNDROME,4
ES,PEMPHIGOID,4
ES,PERICARDIAL HAEMORRHAGE,4
ES,PETECHIAE,4
ES,PHARYNGITIS,4
ES,PNEUMONIA PNEUMOCOCCAL,4
ES,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
ES,PRODUCT QUALITY ISSUE,4
ES,PRODUCTIVE COUGH,4
ES,PROSTATE CANCER,4
ES,PSEUDOMONAS INFECTION,4
ES,PULMONARY HYPERTENSION,4
ES,RENAL DISORDER,4
ES,RENAL TUBULAR DISORDER,4
ES,RENAL TUBULAR NECROSIS,4
ES,RESTLESSNESS,4
ES,SENSITISATION,4
ES,SHOCK,4
ES,SPINAL FRACTURE,4
ES,STRESS CARDIOMYOPATHY,4
ES,SUDDEN DEATH,4
ES,SUICIDE ATTEMPT,4
ES,SUPERIOR VENA CAVA SYNDROME,4
ES,SWOLLEN TONGUE,4
ES,TINNITUS,4
ES,TOOTHACHE,4
ES,TRANSFUSION,4
ES,TREATMENT FAILURE,4
ES,TUBERCULOSIS,4
ES,TYPE IV HYPERSENSITIVITY REACTION,4
ES,VITAMIN B12 DECREASED,4
ES,WEIGHT INCREASED,4
ES,ABORTION SPONTANEOUS,3
ES,ACTIVITIES OF DAILY LIVING IMPAIRED,3
ES,ACUTE INTERSTITIAL PNEUMONITIS,3
ES,ACUTE PRERENAL FAILURE,3
ES,ADRENAL INSUFFICIENCY,3
ES,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,3
ES,ARTHRITIS,3
ES,B-CELL LYMPHOMA RECURRENT,3
ES,BALANCE DISORDER,3
ES,BASAL CELL CARCINOMA,3
ES,BICYTOPENIA,3
ES,BILE DUCT STENOSIS,3
ES,BLISTER,3
ES,BLOOD BILIRUBIN INCREASED,3
ES,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
ES,BLOOD LACTATE DEHYDROGENASE INCREASED,3
ES,BLOOD PRESSURE FLUCTUATION,3
ES,BREAST CANCER,3
ES,BRONCHIECTASIS,3
ES,BRONCHOPULMONARY ASPERGILLOSIS,3
ES,C-REACTIVE PROTEIN INCREASED,3
ES,CARDIAC DISORDER,3
ES,CARDIOACTIVE DRUG LEVEL INCREASED,3
ES,CARDIOVASCULAR DISORDER,3
ES,CEREBRAL INFARCTION,3
ES,CHOLURIA,3
ES,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
ES,CLUMSINESS,3
ES,CONGESTIVE CARDIOMYOPATHY,3
ES,CRYING,3
ES,DEAFNESS,3
ES,DECREASED IMMUNE RESPONSIVENESS,3
ES,DECUBITUS ULCER,3
ES,DERMATITIS,3
ES,DISEASE RECURRENCE,3
ES,DIVERTICULUM,3
ES,DUPUYTREN^S CONTRACTURE,3
ES,EMBOLISM,3
ES,EYE PAIN,3
ES,FLUID RETENTION,3
ES,GASTRIC PERFORATION,3
ES,GENERALISED ERYTHEMA,3
ES,GENERALISED OEDEMA,3
ES,GINGIVAL BLEEDING,3
ES,GINGIVAL PAIN,3
ES,GLOMERULAR FILTRATION RATE DECREASED,3
ES,GYNAECOMASTIA,3
ES,HAEMATOCRIT DECREASED,3
ES,HELICOBACTER INFECTION,3
ES,HEPATIC CYST,3
ES,HEPATIC NEOPLASM,3
ES,HERPES SIMPLEX,3
ES,HYPOGAMMAGLOBULINAEMIA,3
ES,HYPOVOLAEMIA,3
ES,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,3
ES,IMPAIRED HEALING,3
ES,INFUSION RELATED REACTION,3
ES,INJECTION SITE HAEMORRHAGE,3
ES,INJECTION SITE INFLAMMATION,3
ES,INJECTION SITE MASS,3
ES,INJECTION SITE URTICARIA,3
ES,INTENTIONAL PRODUCT MISUSE,3
ES,INTENTIONAL PRODUCT USE ISSUE,3
ES,INTERCEPTED DRUG ADMINISTRATION ERROR,3
ES,INTRAOCULAR PRESSURE INCREASED,3
ES,INTRAVENTRICULAR HAEMORRHAGE,3
ES,JOINT SWELLING,3
ES,KOUNIS SYNDROME,3
ES,LABORATORY TEST ABNORMAL,3
ES,LACUNAR INFARCTION,3
ES,LARYNGEAL PAIN,3
ES,LIP OEDEMA,3
ES,LOBAR PNEUMONIA,3
ES,LOWER RESPIRATORY TRACT INFECTION,3
ES,LUNG ADENOCARCINOMA,3
ES,MALLORY-WEISS SYNDROME,3
ES,MATERNAL EXPOSURE DURING PREGNANCY,3
ES,MENTAL IMPAIRMENT,3
ES,METABOLIC ALKALOSIS,3
ES,METABOLIC DISORDER,3
ES,METASTASES TO SPINE,3
ES,MIGRAINE,3
ES,MULTIPLE SCLEROSIS RELAPSE,3
ES,NEURALGIA,3
ES,NO ADVERSE EVENT,3
ES,NUCHAL RIGIDITY,3
ES,ORAL MUCOSA EROSION,3
ES,ORAL PAIN,3
ES,ORTHOPNOEA,3
ES,OSTEOARTHRITIS,3
ES,OSTEOPOROSIS,3
ES,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
ES,PANCREATIC CARCINOMA,3
ES,PAPULE,3
ES,PNEUMOCOCCAL SEPSIS,3
ES,PNEUMONIA STAPHYLOCOCCAL,3
ES,POISONING DELIBERATE,3
ES,POSTHAEMORRHAGIC HYDROCEPHALUS,3
ES,PREMATURE DELIVERY,3
ES,PROCTALGIA,3
ES,PULMONARY ALVEOLAR HAEMORRHAGE,3
ES,PULMONARY FIBROSIS,3
ES,PULMONARY OEDEMA,3
ES,PULMONARY TOXICITY,3
ES,RASH MACULO-PAPULAR,3
ES,RENAL CYST,3
ES,RENAL FAILURE CHRONIC,3
ES,RESPIRATORY ALKALOSIS,3
ES,RESPIRATORY DISORDER,3
ES,RHINITIS,3
ES,SPEECH DISORDER,3
ES,SUBARACHNOID HAEMORRHAGE,3
ES,SUPRAVENTRICULAR TACHYCARDIA,3
ES,SWELLING,3
ES,SWELLING FACE,3
ES,SYSTEMIC LUPUS ERYTHEMATOSUS,3
ES,TACHYARRHYTHMIA,3
ES,TENDON RUPTURE,3
ES,TRICUSPID VALVE INCOMPETENCE,3
ES,UPPER LIMB FRACTURE,3
ES,URINARY TRACT OBSTRUCTION,3
ES,UVEITIS,3
ES,VASCULITIS,3
ES,VERTIGO,3
ES,VIRAL INFECTION,3
ES,WHITE BLOOD CELL COUNT DECREASED,3
ES,WRONG PATIENT RECEIVED MEDICATION,3
ES,ABDOMINAL ABSCESS,2
ES,ABDOMINAL PAIN LOWER,2
ES,ABDOMINAL SEPSIS,2
ES,ABSCESS DRAINAGE,2
ES,ACNE,2
ES,ACQUIRED TRACHEO-OESOPHAGEAL FISTULA,2
ES,ACUTE ABDOMEN,2
ES,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,2
ES,ACUTE LYMPHOCYTIC LEUKAEMIA,2
ES,ACUTE RESPIRATORY DISTRESS SYNDROME,2
ES,ADENOCARCINOMA OF COLON,2
ES,AFFECT LABILITY,2
ES,ALANINE AMINOTRANSFERASE ABNORMAL,2
ES,AMPUTATION,2
ES,AMYLASE INCREASED,2
ES,ANGINA UNSTABLE,2
ES,ANGLE CLOSURE GLAUCOMA,2
ES,APATHY,2
ES,APLASIA,2
ES,ARRHYTHMIA SUPRAVENTRICULAR,2
ES,ASPARTATE AMINOTRANSFERASE ABNORMAL,2
ES,ATRIOVENTRICULAR BLOCK COMPLETE,2
ES,AUTOIMMUNE COLITIS,2
ES,AUTONOMIC NEUROPATHY,2
ES,BARRETT^S OESOPHAGUS,2
ES,BENIGN PROSTATIC HYPERPLASIA,2
ES,BILE DUCT STONE,2
ES,BILIARY ANASTOMOSIS,2
ES,BILIARY COLIC,2
ES,BILIARY TRACT INFECTION,2
ES,BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0,2
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,2
ES,BLOOD GLUCOSE ABNORMAL,2
ES,BLOOD GLUCOSE INCREASED,2
ES,BLOOD IRON DECREASED,2
ES,BLOOD LACTIC ACID INCREASED,2
ES,BLOOD PARATHYROID HORMONE INCREASED,2
ES,BLOOD POTASSIUM DECREASED,2
ES,BLOOD UREA INCREASED,2
ES,BODY TEMPERATURE INCREASED,2
ES,BONE MARROW TOXICITY,2
ES,BREAST CANCER METASTATIC,2
ES,BUNDLE BRANCH BLOCK LEFT,2
ES,CANDIDA INFECTION,2
ES,CARDIOMYOPATHY,2
ES,CEREBRAL ARTERY EMBOLISM,2
ES,CEREBRAL THROMBOSIS,2
ES,CHEST INJURY,2
ES,CHOKING SENSATION,2
ES,CHROMATURIA,2
ES,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,2
ES,CLEAR CELL RENAL CELL CARCINOMA,2
ES,COLITIS MICROSCOPIC,2
ES,COMA,2
ES,CONDUCT DISORDER,2
ES,CONJUNCTIVITIS,2
ES,CONVULSION,2
ES,CYCLIC VOMITING SYNDROME,2
ES,CYTOKINE RELEASE SYNDROME,2
ES,DELUSION,2
ES,DISSEMINATED INTRAVASCULAR COAGULATION,2
ES,DIVERTICULAR PERFORATION,2
ES,DIVERTICULUM INTESTINAL HAEMORRHAGIC,2
ES,DRUG ADMINISTRATION ERROR,2
ES,DRUG DOSE OMISSION,2
ES,DRUG EFFECT DECREASED,2
ES,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
ES,DRUG PRESCRIBING ERROR,2
ES,DUODENAL NEOPLASM,2
ES,DUODENAL ULCER,2
ES,DYSGEUSIA,2
ES,DYSPHONIA,2
ES,DYSPNOEA EXERTIONAL,2
ES,DYSTONIA,2
ES,EAR PAIN,2
ES,ECZEMA,2
ES,EJACULATION DELAYED,2
ES,EJECTION FRACTION DECREASED,2
ES,ELECTROCARDIOGRAM T WAVE INVERSION,2
ES,EMBOLIC STROKE,2
ES,EMOTIONAL DISORDER,2
ES,EMPHYSEMA,2
ES,EMPYEMA,2
ES,ENDOCARDITIS,2
ES,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,2
ES,EXCESSIVE CERUMEN PRODUCTION,2
ES,EXPOSURE DURING PREGNANCY,2
ES,EXPOSURE VIA FATHER,2
ES,EXTENSOR PLANTAR RESPONSE,2
ES,EYE DISORDER,2
ES,EYE OEDEMA,2
ES,FACIAL PARALYSIS,2
ES,FAECES DISCOLOURED,2
ES,FEELING OF DESPAIR,2
ES,FLUID INTAKE REDUCED,2
ES,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,2
ES,FOETAL EXPOSURE DURING PREGNANCY,2
ES,FOOD INTOLERANCE,2
ES,FRACTURE,2
ES,FRACTURE DELAYED UNION,2
ES,GANGRENE,2
ES,GASTROENTERITIS VIRAL,2
ES,GENERALISED TONIC-CLONIC SEIZURE,2
ES,GENITAL CANDIDIASIS,2
ES,GINGIVITIS,2
ES,GLIOBLASTOMA MULTIFORME,2
ES,GLOSSITIS,2
ES,GLOSSOPHARYNGEAL NERVE PARALYSIS,2
ES,GOITRE,2
ES,GOUT,2
ES,GOUTY TOPHUS,2
ES,GUILLAIN-BARRE SYNDROME,2
ES,HAEMANGIOMA,2
ES,HAEMATOMA,2
ES,HAEMATOTOXICITY,2
ES,HAEMODYNAMIC INSTABILITY,2
ES,HAEMORRHAGIC ANAEMIA,2
ES,HAEMOTHORAX,2
ES,HALLUCINATION_ AUDITORY,2
ES,HALLUCINATIONS_ MIXED,2
ES,HEART INJURY,2
ES,HEPATOMEGALY,2
ES,HERPES OPHTHALMIC,2
ES,HERPES SIMPLEX MENINGITIS,2
ES,HISTIOCYTOSIS HAEMATOPHAGIC,2
ES,HOT FLUSH,2
ES,HUMERUS FRACTURE,2
ES,HYPERKERATOSIS,2
ES,HYPERTRIGLYCERIDAEMIA,2
ES,HYPOACUSIS,2
ES,HYPOGLYCAEMIC COMA,2
ES,HYPOKINESIA,2
ES,HYPOTHERMIA,2
ES,IMMUNODEFICIENCY,2
ES,IMMUNOSUPPRESSION,2
ES,INFARCTION,2
ES,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
ES,INFLUENZA A VIRUS TEST POSITIVE,2
ES,INGUINAL HERNIA,2
ES,INJECTION SITE DISCOLOURATION,2
ES,INJECTION SITE RECALL REACTION,2
ES,INJECTION SITE ULCER,2
ES,INTENTION TREMOR,2
ES,INTERVERTEBRAL DISC DEGENERATION,2
ES,INTESTINAL RESECTION,2
ES,INTRA-ABDOMINAL HAEMATOMA,2
ES,INVASIVE DUCTAL BREAST CARCINOMA,2
ES,IRON DEFICIENCY,2
ES,ISCHAEMIC HEPATITIS,2
ES,JOINT DISLOCATION,2
ES,JUGULAR VEIN THROMBOSIS,2
ES,KETOACIDOSIS,2
ES,LACRIMATION INCREASED,2
ES,LEFT VENTRICULAR DYSFUNCTION,2
ES,LEFT VENTRICULAR HYPERTROPHY,2
ES,LIGAMENT SPRAIN,2
ES,LIMB DISCOMFORT,2
ES,LIPASE INCREASED,2
ES,LIPODYSTROPHY ACQUIRED,2
ES,LISTERIA ENCEPHALITIS,2
ES,LIVER FUNCTION TEST ABNORMAL,2
ES,LOGORRHOEA,2
ES,LUNG NEOPLASM,2
ES,LUNG NEOPLASM MALIGNANT,2
ES,MALNUTRITION,2
ES,MEDICATION RESIDUE PRESENT,2
ES,MENINGITIS ASEPTIC,2
ES,MESENTERIC VEIN THROMBOSIS,2
ES,METASTASES TO LUNG,2
ES,METASTASES TO MENINGES,2
ES,METASTASES TO PLEURA,2
ES,MICROCYTIC ANAEMIA,2
ES,MIXED LIVER INJURY,2
ES,MOOD DISORDER DUE TO A GENERAL MEDICAL CONDITION,2
ES,MOVEMENT DISORDER,2
ES,MUCOSAL EROSION,2
ES,MUSCLE RIGIDITY,2
ES,MYOCARDIAL INFARCTION,2
ES,MYOCARDITIS,2
ES,MYOCLONUS,2
ES,NECROSIS,2
ES,NECROTISING COLITIS,2
ES,NEUTROPENIC SEPSIS,2
ES,NIGHTMARE,2
ES,NON-SMALL CELL LUNG CANCER,2
ES,OCCUPATIONAL DERMATITIS,2
ES,OPHTHALMOPLEGIA,2
ES,OPTIC NEURITIS,2
ES,ORAL CANDIDIASIS,2
ES,ORAL DISCOMFORT,2
ES,ORAL HERPES,2
ES,ORAL INFECTION,2
ES,OSTEITIS,2
ES,OXYGEN SATURATION DECREASED,2
ES,PAIN IN JAW,2
ES,PALATAL OEDEMA,2
ES,PANCREATITIS NECROTISING,2
ES,PAPILLARY THYROID CANCER,2
ES,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,2
ES,PEMPHIGUS,2
ES,PENILE ERYTHEMA,2
ES,PERIPHERAL ISCHAEMIA,2
ES,PERSECUTORY DELUSION,2
ES,PHARYNGEAL INFLAMMATION,2
ES,PHLEBITIS,2
ES,PHOTOPHOBIA,2
ES,PNEUMOCOCCAL INFECTION,2
ES,PNEUMONIA HERPES VIRAL,2
ES,PNEUMONIA NECROTISING,2
ES,POLLAKIURIA,2
ES,POLYMYALGIA RHEUMATICA,2
ES,POLYURIA,2
ES,POOR PERIPHERAL CIRCULATION,2
ES,POOR QUALITY SLEEP,2
ES,PORTOPULMONARY HYPERTENSION,2
ES,POSTOPERATIVE WOUND INFECTION,2
ES,PRERENAL FAILURE,2
ES,PRESCRIBED OVERDOSE,2
ES,PRIAPISM,2
ES,PROCEDURAL PAIN,2
ES,PROCTITIS,2
ES,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
ES,PROTEINURIA,2
ES,PROTHROMBIN LEVEL DECREASED,2
ES,PRURITUS GENITAL,2
ES,PSEUDOMONAL SEPSIS,2
ES,PULMONARY HAEMORRHAGE,2
ES,PULMONARY TUBERCULOSIS,2
ES,PURPURA,2
ES,RASH MACULAR,2
ES,RASH PAPULAR,2
ES,RASH PRURITIC,2
ES,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
ES,REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA,2
ES,RENAL COLIC,2
ES,RENAL EMBOLISM,2
ES,RENAL TRANSPLANT FAILURE,2
ES,RESPIRATORY ACIDOSIS,2
ES,RESPIRATORY TRACT INFECTION VIRAL,2
ES,RETINAL DETACHMENT,2
ES,RETINAL VEIN THROMBOSIS,2
ES,RHINORRHOEA,2
ES,RIGHT VENTRICULAR FAILURE,2
ES,SCEDOSPORIUM INFECTION,2
ES,SCLERODERMA,2
ES,SECONDARY HYPERTHYROIDISM,2
ES,SENSITIVITY TO WEATHER CHANGE,2
ES,SHOCK HAEMORRHAGIC,2
ES,SINUS BRADYCARDIA,2
ES,SINUS NODE DYSFUNCTION,2
ES,SINUS TACHYCARDIA,2
ES,SINUSITIS,2
ES,SKIN DISCOLOURATION,2
ES,SKIN DISORDER,2
ES,SKIN REACTION,2
ES,SLEEP DISORDER,2
ES,SOFT TISSUE INFECTION,2
ES,SPINAL COLUMN STENOSIS,2
ES,SPINAL COMPRESSION FRACTURE,2
ES,SPINAL OSTEOARTHRITIS,2
ES,SPLENIC INFARCTION,2
ES,SPLENIC VEIN THROMBOSIS,2
ES,STAPHYLOCOCCAL BACTERAEMIA,2
ES,STOMA SITE HAEMORRHAGE,2
ES,SUPERINFECTION,2
ES,SUPERINFECTION BACTERIAL,2
ES,SURGERY,2
ES,SYNOVIAL CYST,2
ES,TACHYPHRENIA,2
ES,TEARFULNESS,2
ES,TENDON CALCIFICATION,2
ES,THROAT IRRITATION,2
ES,THROMBOCYTOSIS,2
ES,THROMBOPHLEBITIS,2
ES,THROMBOSIS,2
ES,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
ES,TOE AMPUTATION,2
ES,TONGUE PRURITUS,2
ES,TONSILLITIS,2
ES,TRANSPLANT DYSFUNCTION,2
ES,TRANSPLANT REJECTION,2
ES,TUBULOINTERSTITIAL NEPHRITIS,2
ES,TUMOUR LYSIS SYNDROME,2
ES,ULCER,2
ES,UNDERDOSE,2
ES,URINARY INCONTINENCE,2
ES,URINARY TRACT INFECTION ENTEROCOCCAL,2
ES,UROSEPSIS,2
ES,VAGUS NERVE PARALYSIS,2
ES,VIRAL DIARRHOEA,2
ES,VISUAL ACUITY REDUCED,2
ES,VOLVULUS,2
ES,WHEEZING,2
ES,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
ES,ABDOMINAL INFECTION,1
ES,ABDOMINAL MASS,1
ES,ABDOMINAL RIGIDITY,1
ES,ABDOMINAL SYMPTOM,1
ES,ABNORMAL SENSATION IN EYE,1
ES,ABORTION INDUCED,1
ES,ABSCESS JAW,1
ES,ABSCESS OF SALIVARY GLAND,1
ES,ACARODERMATITIS,1
ES,ACCIDENT,1
ES,ACCIDENTAL OVERDOSE,1
ES,ACQUIRED DIAPHRAGMATIC EVENTRATION,1
ES,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
ES,ACUTE GRAFT VERSUS HOST DISEASE,1
ES,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
ES,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
ES,ACUTE LEUKAEMIA,1
ES,ACUTE PHOSPHATE NEPHROPATHY,1
ES,ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME,1
ES,ACUTE SINUSITIS,1
ES,ADENOMA BENIGN,1
ES,ADRENAL DISORDER,1
ES,AFFECTIVE DISORDER,1
ES,AGITATED DEPRESSION,1
ES,AGNOSIA,1
ES,ALKALOSIS HYPOKALAEMIC,1
ES,AMAUROSIS,1
ES,AMAUROSIS FUGAX,1
ES,AMMONIA INCREASED,1
ES,AMYLOID RELATED IMAGING ABNORMALITIES,1
ES,ANAEMIA FOLATE DEFICIENCY,1
ES,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
ES,ANAEMIA MACROCYTIC,1
ES,ANAEMIA OF CHRONIC DISEASE,1
ES,ANAEMIA POSTOPERATIVE,1
ES,ANAL ABSCESS,1
ES,ANAL FISSURE,1
ES,ANAL INCONTINENCE,1
ES,ANAL SPHINCTER ATONY,1
ES,ANAL ULCER,1
ES,ANAPHYLACTIC REACTION,1
ES,ANAPHYLACTOID REACTION,1
ES,ANGER,1
ES,ANGIOGRAM CEREBRAL ABNORMAL,1
ES,ANGIOMYOLIPOMA,1
ES,ANHEDONIA,1
ES,ANION GAP INCREASED,1
ES,ANKLE FRACTURE,1
ES,ANOSMIA,1
ES,ANTICOAGULATION DRUG LEVEL ABNORMAL,1
ES,AORTIC ANEURYSM RUPTURE,1
ES,AORTIC ARTERIOSCLEROSIS,1
ES,AORTIC DILATATION,1
ES,AORTIC ELONGATION,1
ES,AORTIC STENOSIS,1
ES,AORTIC THROMBOSIS,1
ES,AORTIC VALVE INCOMPETENCE,1
ES,AORTIC VALVE SCLEROSIS,1
ES,AORTITIS,1
ES,APALLIC SYNDROME,1
ES,APHAGIA,1
ES,APHTHOUS ULCER,1
ES,APPENDICITIS PERFORATED,1
ES,APPLICATION SITE INJURY,1
ES,ARTERIAL OCCLUSIVE DISEASE,1
ES,ARTERIOSCLEROSIS CORONARY ARTERY,1
ES,ARTERIOSPASM CORONARY,1
ES,ARTHRITIS BACTERIAL,1
ES,ASPERGILLUS INFECTION,1
ES,ASPIRATION PLEURAL CAVITY,1
ES,ASTEATOSIS,1
ES,ASTERIXIS,1
ES,ATRIAL FLUTTER,1
ES,ATRIAL THROMBOSIS,1
ES,ATYPICAL PNEUMONIA,1
ES,AUTOIMMUNE DISORDER,1
ES,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
ES,AUTOIMMUNE HEPATITIS,1
ES,AUTOIMMUNE THYROIDITIS,1
ES,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
ES,AXILLARY PAIN,1
ES,BACILLUS BACTERAEMIA,1
ES,BACTERIURIA,1
ES,BASAL GANGLIA HAEMATOMA,1
ES,BASAL GANGLIA HAEMORRHAGE,1
ES,BED REST,1
ES,BENIGN NEOPLASM,1
ES,BILE DUCT OBSTRUCTION,1
ES,BILIARY DILATATION,1
ES,BILIARY DRAINAGE,1
ES,BILIARY NEOPLASM,1
ES,BILIARY SEPSIS,1
ES,BLADDER CANCER,1
ES,BLADDER DIVERTICULUM,1
ES,BLADDER PAIN,1
ES,BLADDER SPHINCTER ATONY,1
ES,BLEEDING VARICOSE VEIN,1
ES,BLINDNESS TRANSIENT,1
ES,BLOOD CALCIUM DECREASED,1
ES,BLOOD CHOLESTEROL DECREASED,1
ES,BLOOD CREATINE INCREASED,1
ES,BLOOD DISORDER,1
ES,BLOOD GLUCOSE DECREASED,1
ES,BLOOD GLUCOSE FLUCTUATION,1
ES,BLOOD IMMUNOGLOBULIN E INCREASED,1
ES,BLOOD IMMUNOGLOBULIN M INCREASED,1
ES,BLOOD KETONE BODY INCREASED,1
ES,BLOOD LACTATE DEHYDROGENASE ABNORMAL,1
ES,BLOOD PH DECREASED,1
ES,BLOOD STEM CELL HARVEST FAILURE,1
ES,BLOOD TEST ABNORMAL,1
LK,MYOPATHY,8
LK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
SE,FATIGUE,48
SE,TOXICITY TO VARIOUS AGENTS,43
SE,DIZZINESS,41
SE,DYSPNOEA,40
SE,VOMITING,33
SE,NAUSEA,32
SE,HEADACHE,30
SE,DIARRHOEA,26
SE,ABDOMINAL PAIN,24
SE,ARTHRALGIA,22
SE,HYPERHIDROSIS,22
SE,HYPONATRAEMIA,22
SE,MUSCLE SPASMS,22
SE,MUSCULAR WEAKNESS,20
SE,PYREXIA,20
SE,BACK PAIN,19
SE,CHILLS,18
SE,PAIN,18
SE,PARAESTHESIA,18
SE,ACUTE KIDNEY INJURY,17
SE,ANXIETY,17
SE,CHEST PAIN,17
SE,DRUG INEFFECTIVE,17
SE,HYPOTENSION,17
SE,PRURITUS,16
SE,RASH,16
SE,SUICIDE ATTEMPT,16
SE,TREMOR,16
SE,HYPOMAGNESAEMIA,15
SE,SUICIDAL IDEATION,15
SE,WEIGHT INCREASED,15
SE,ERYTHEMA,14
SE,MYALGIA,14
SE,DEPRESSION,13
SE,PALPITATIONS,13
SE,PERIPHERAL SWELLING,13
SE,AGITATION,12
SE,CHEST DISCOMFORT,12
SE,CONFUSIONAL STATE,12
SE,OSTEONECROSIS OF JAW,12
SE,PHARYNGEAL OEDEMA,12
SE,PNEUMONIA,12
SE,AGGRESSION,11
SE,C-REACTIVE PROTEIN INCREASED,11
SE,DYSKINESIA,11
SE,SWELLING,11
SE,ASTHENIA,10
SE,BREAST ENLARGEMENT,10
SE,CARDIAC FAILURE,10
SE,COUGH,10
SE,DRY EYE,10
SE,DYSURIA,10
SE,FALL,10
SE,GENERAL PHYSICAL HEALTH DETERIORATION,10
SE,RHABDOMYOLYSIS,10
SE,SYNCOPE,10
SE,TACHYCARDIA,10
SE,ABDOMINAL PAIN UPPER,9
SE,AMENORRHOEA,9
SE,BLOOD PROLACTIN INCREASED,9
SE,CONSTIPATION,9
SE,DEHYDRATION,9
SE,GALACTORRHOEA,9
SE,GASTROINTESTINAL HAEMORRHAGE,9
SE,HYPOKALAEMIA,9
SE,MEMORY IMPAIRMENT,9
SE,PULMONARY EMBOLISM,9
SE,SEPSIS,9
SE,SLEEP DISORDER,9
SE,URTICARIA,9
SE,ANAEMIA,8
SE,ATRIAL FIBRILLATION,8
SE,BALANCE DISORDER,8
SE,CARDIAC ARREST,8
SE,DRY MOUTH,8
SE,HYPERSENSITIVITY,8
SE,INFECTION,8
SE,OVERDOSE,8
SE,POLYNEUROPATHY,8
SE,VISUAL IMPAIRMENT,8
SE,ABDOMINAL DISCOMFORT,7
SE,ANALGESIC DRUG LEVEL INCREASED,7
SE,DECREASED APPETITE,7
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,7
SE,DISTURBANCE IN ATTENTION,7
SE,DYSPHAGIA,7
SE,GAIT DISTURBANCE,7
SE,JOINT SWELLING,7
SE,MALAISE,7
SE,NEUROLEPTIC MALIGNANT SYNDROME,7
SE,OROPHARYNGEAL PAIN,7
SE,OVARIAN GERM CELL CANCER STAGE II,7
SE,SOMNOLENCE,7
SE,WEIGHT DECREASED,7
SE,ALOPECIA,6
SE,ALTERED STATE OF CONSCIOUSNESS,6
SE,ANGIOEDEMA,6
SE,CEREBRAL HAEMORRHAGE,6
SE,DYSPEPSIA,6
SE,HEART RATE INCREASED,6
SE,MYOCARDIAL INFARCTION,6
SE,PAIN IN EXTREMITY,6
SE,TRANSAMINASES INCREASED,6
SE,URINARY INCONTINENCE,6
SE,URINARY TRACT INFECTION,6
SE,ANAL INCONTINENCE,5
SE,ASCITES,5
SE,BLOOD CREATININE INCREASED,5
SE,BLOOD PRESSURE INCREASED,5
SE,CIRCULATORY COLLAPSE,5
SE,DEATH,5
SE,DRUG EFFECT DECREASED,5
SE,DYSARTHRIA,5
SE,ELECTROCARDIOGRAM QT PROLONGED,5
SE,GENITAL NEOPLASM MALIGNANT FEMALE,5
SE,HAEMATURIA,5
SE,HAEMOGLOBIN DECREASED,5
SE,INSOMNIA,5
SE,INTENTIONAL SELF-INJURY,5
SE,INTERSTITIAL LUNG DISEASE,5
SE,LEUKOPENIA,5
SE,PSYCHOTIC DISORDER,5
SE,RENAL FAILURE,5
SE,RESPIRATORY DISORDER,5
SE,TINNITUS,5
SE,UPPER RESPIRATORY TRACT INFECTION,5
SE,WITHDRAWAL SYNDROME,5
SE,ABDOMINAL DISTENSION,4
SE,ABDOMINAL WALL HAEMATOMA,4
SE,ABNORMAL BEHAVIOUR,4
SE,ACIDOSIS,4
SE,ACNE,4
SE,ACUTE HEPATIC FAILURE,4
SE,ARRHYTHMIA,4
SE,BRADYCARDIA,4
SE,CEREBRAL INFARCTION,4
SE,CEREBROVASCULAR ACCIDENT,4
SE,COGNITIVE DISORDER,4
SE,COLON CANCER,4
SE,CONTUSION,4
SE,DRY SKIN,4
SE,DYSGEUSIA,4
SE,FEELING ABNORMAL,4
SE,FEELING HOT,4
SE,FLATULENCE,4
SE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
SE,GASTROINTESTINAL DISORDER,4
SE,HALLUCINATION,4
SE,HEPATIC CIRRHOSIS,4
SE,HEPATOTOXICITY,4
SE,HOT FLUSH,4
SE,HYPERCALCAEMIA,4
SE,HYPERKALAEMIA,4
SE,HYPERTENSION,4
SE,HYPOAESTHESIA,4
SE,HYPOCALCAEMIA,4
SE,INTENTIONAL OVERDOSE,4
SE,LACTOSE INTOLERANCE,4
SE,LIVER FUNCTION TEST ABNORMAL,4
SE,NECK PAIN,4
SE,NEUTROPENIA,4
SE,NEUTROPENIC SEPSIS,4
SE,OSTEONECROSIS,4
SE,PRODUCT USE IN UNAPPROVED INDICATION,4
SE,SEIZURE,4
SE,SUDDEN ONSET OF SLEEP,4
SE,THROMBOCYTOPENIA,4
SE,TRANSIENT ISCHAEMIC ATTACK,4
SE,URINARY RETENTION,4
SE,ADENOVIRUS INFECTION,3
SE,ALANINE AMINOTRANSFERASE INCREASED,3
SE,ATYPICAL FEMUR FRACTURE,3
SE,BASAL CELL CARCINOMA,3
SE,BLISTER,3
SE,BLOOD GLUCOSE INCREASED,3
SE,BONE PAIN,3
SE,BRAIN INJURY,3
SE,BREAST CANCER,3
SE,BURNING SENSATION,3
SE,CARDIAC FAILURE CONGESTIVE,3
SE,COLITIS ULCERATIVE,3
SE,CONDITION AGGRAVATED,3
SE,CONVULSION,3
SE,DEPRESSED MOOD,3
SE,DRUG ERUPTION,3
SE,ENCEPHALOPATHY,3
SE,EPISTAXIS,3
SE,EXPOSURE VIA FATHER,3
SE,FEELING COLD,3
SE,FOOD INTOLERANCE,3
SE,GASTRIC ULCER,3
SE,HEAD DISCOMFORT,3
SE,HEPATIC NEOPLASM,3
SE,INCORRECT DOSE ADMINISTERED,3
SE,INFLUENZA LIKE ILLNESS,3
SE,INTERVERTEBRAL DISC PROTRUSION,3
SE,ISCHAEMIC STROKE,3
SE,JOINT INSTABILITY,3
SE,LIBIDO DECREASED,3
SE,LIMB REDUCTION DEFECT,3
SE,LIP SWELLING,3
SE,LIVER DISORDER,3
SE,MALIGNANT NEOPLASM PROGRESSION,3
SE,MUSCULOSKELETAL STIFFNESS,3
SE,NASAL CONGESTION,3
SE,NEUTROPHIL COUNT DECREASED,3
SE,OCULAR HYPERAEMIA,3
SE,OEDEMA,3
SE,OEDEMA PERIPHERAL,3
SE,OESOPHAGITIS,3
SE,ORAL MUCOSAL BLISTERING,3
SE,PANIC ATTACK,3
SE,PATHOLOGICAL FRACTURE,3
SE,PERIODONTITIS,3
SE,PERIPHERAL COLDNESS,3
SE,POISONING,3
SE,POLLAKIURIA,3
SE,PORTAL VEIN THROMBOSIS,3
SE,RASH PRURITIC,3
SE,RENAL FAILURE ACUTE,3
SE,RESPIRATORY FAILURE,3
SE,RESTLESSNESS,3
SE,SINUSITIS,3
SE,SKIN DISORDER,3
SE,SKIN NECROSIS,3
SE,SKIN ULCER,3
SE,STOMATITIS,3
SE,SWELLING FACE,3
SE,TIC,3
SE,TUBULOINTERSTITIAL NEPHRITIS,3
SE,VASCULITIS,3
SE,VISUAL ACUITY REDUCED,3
SE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
SE,ADENOCARCINOMA OF COLON,2
SE,AGRANULOCYTOSIS,2
SE,AMNESIA,2
SE,ANAPHYLACTIC REACTION,2
SE,ANGER,2
SE,ANGINA PECTORIS,2
SE,ANOSMIA,2
SE,ARTERIOSCLEROSIS,2
SE,ARTHRITIS,2
SE,ATAXIA,2
SE,BACTERIAL INFECTION,2
SE,BLADDER NEOPLASM,2
SE,BLOOD ALKALINE PHOSPHATASE INCREASED,2
SE,BLOOD POTASSIUM INCREASED,2
SE,BLOOD PRESSURE DECREASED,2
SE,BLOOD TEST ABNORMAL,2
SE,BODY TEMPERATURE INCREASED,2
SE,BONE MARROW FAILURE,2
SE,CARDIAC DISORDER,2
SE,CATHETER SITE INFECTION,2
SE,COLITIS,2
SE,COORDINATION ABNORMAL,2
SE,CORONARY ARTERY STENOSIS,2
SE,DEEP VEIN THROMBOSIS,2
SE,DEVICE RELATED INFECTION,2
SE,DIABETES MELLITUS,2
SE,DISEASE PROGRESSION,2
SE,DIVERTICULUM,2
SE,DRUG ADMINISTRATION ERROR,2
SE,DRUG LEVEL INCREASED,2
SE,DYSPHONIA,2
SE,ELEVATED MOOD,2
SE,ERYSIPELAS,2
SE,EXOPHTHALMOS,2
SE,EXPOSURE DURING PREGNANCY,2
SE,EYE IRRITATION,2
SE,FAECES DISCOLOURED,2
SE,FEBRILE NEUTROPENIA,2
SE,FLUSHING,2
SE,FOETAL GROWTH RESTRICTION,2
SE,FORMICATION,2
SE,GINGIVAL DISORDER,2
SE,HAEMATEMESIS,2
SE,HALLUCINATION_ AUDITORY,2
SE,HALLUCINATION_ VISUAL,2
SE,HEART RATE IRREGULAR,2
SE,HEMIPARESIS,2
SE,HEPATIC ENZYME INCREASED,2
SE,HEPATIC FAILURE,2
SE,HEPATIC FUNCTION ABNORMAL,2
SE,HEPATIC STEATOSIS,2
SE,HEPATITIS ACUTE,2
SE,HEPATORENAL SYNDROME,2
SE,HIP FRACTURE,2
SE,HUNGER,2
SE,HYPERTHYROIDISM,2
SE,HYPOXIA,2
SE,ILEUS,2
SE,INGUINAL HERNIA,2
SE,INTRA-ABDOMINAL HAEMORRHAGE,2
SE,JAUNDICE,2
SE,LARGE INTESTINE PERFORATION,2
SE,LOCAL SWELLING,2
SE,LOSS OF CONSCIOUSNESS,2
SE,LOSS OF LIBIDO,2
SE,LUNG INFILTRATION,2
SE,LYMPHADENOPATHY,2
SE,MANIA,2
SE,MENINGIOMA,2
SE,MENTAL IMPAIRMENT,2
SE,METABOLIC ACIDOSIS,2
SE,METASTASES TO BONE,2
SE,MOOD SWINGS,2
SE,MUSCLE CONTRACTIONS INVOLUNTARY,2
SE,NAIL DISORDER,2
SE,NOCTURIA,2
SE,NODULE,2
SE,ORAL DISORDER,2
SE,ORAL PAIN,2
SE,OXYGEN SATURATION DECREASED,2
SE,PAIN IN JAW,2
SE,PANCREATITIS,2
SE,PANCYTOPENIA,2
SE,PEMPHIGOID,2
SE,PHOTOSENSITIVITY REACTION,2
SE,PLEURAL EFFUSION,2
SE,PNEUMOCOCCAL SEPSIS,2
SE,PNEUMOCYSTIS JIROVECII INFECTION,2
SE,PNEUMONIA BACTERIAL,2
SE,PNEUMONIA PNEUMOCOCCAL,2
SE,PNEUMONITIS,2
SE,POST PROCEDURAL HAEMORRHAGE,2
SE,PRESYNCOPE,2
SE,PRODUCT SUBSTITUTION ISSUE,2
SE,PRODUCT USE ISSUE,2
SE,PSORIATIC ARTHROPATHY,2
SE,PULMONARY FIBROSIS,2
SE,PULMONARY OEDEMA,2
SE,PYOGENIC GRANULOMA,2
SE,RADIUS FRACTURE,2
SE,RASH ERYTHEMATOUS,2
SE,READING DISORDER,2
SE,RECTAL ADENOMA,2
SE,RENAL IMPAIRMENT,2
SE,RESPIRATORY DEPRESSION,2
SE,RHEUMATOID ARTHRITIS,2
SE,RIGHT VENTRICULAR FAILURE,2
SE,SEDATION,2
SE,SEPTIC SHOCK,2
SE,SKIN REACTION,2
SE,SPEECH DISORDER,2
SE,STUPOR,2
SE,SUBARACHNOID HAEMORRHAGE,2
SE,SUBCUTANEOUS ABSCESS,2
SE,SUBDURAL HAEMATOMA,2
SE,SUBDURAL HAEMORRHAGE,2
SE,SUDDEN CARDIAC DEATH,2
SE,TACHYPNOEA,2
SE,TESTIS CANCER,2
SE,THROAT IRRITATION,2
SE,THROMBOSIS,2
SE,TOOTH INFECTION,2
SE,TORSADE DE POINTES,2
SE,TRANSFUSION,2
SE,TROPONIN INCREASED,2
SE,ULCER,2
SE,VENTRICULAR EXTRASYSTOLES,2
SE,VERTIGO,2
SE,VISION BLURRED,2
SE,WHEEZING,2
SE,ABDOMINAL OPERATION,1
SE,ABDOMINAL PAIN LOWER,1
SE,ABORTION SPONTANEOUS,1
SE,ABSCESS JAW,1
SE,ACCIDENT,1
SE,ACCIDENTAL OVERDOSE,1
SE,ACETABULUM FRACTURE,1
SE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
SE,ACUTE MYOCARDIAL INFARCTION,1
SE,ADENOCARCINOMA,1
SE,ADVERSE DRUG REACTION,1
SE,AGEUSIA,1
SE,ALCOHOL INTERACTION,1
SE,ALVEOLITIS,1
SE,ANAL ABSCESS,1
SE,ANGINA UNSTABLE,1
SE,ANURIA,1
SE,AORTIC VALVE INCOMPETENCE,1
SE,APATHY,1
SE,APHASIA,1
SE,APNOEA,1
SE,APPENDICITIS,1
SE,APPLICATION SITE PRURITUS,1
SE,APPLICATION SITE RASH,1
SE,APPLICATION SITE ULCER,1
SE,APRAXIA,1
SE,ARTHRITIS INFECTIVE,1
SE,ARTHRITIS REACTIVE,1
SE,ARTHROPATHY,1
SE,ASPARTATE AMINOTRANSFERASE INCREASED,1
SE,ASPHYXIA,1
SE,ATRIAL FLUTTER,1
SE,ATRIOVENTRICULAR BLOCK COMPLETE,1
SE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
SE,BACTERAEMIA,1
SE,BENIGN BREAST NEOPLASM,1
SE,BENIGN PROSTATIC HYPERPLASIA,1
SE,BLEPHARITIS,1
SE,BLOOD BILIRUBIN INCREASED,1
SE,BLOOD CORTISOL DECREASED,1
SE,BLOOD CREATINE INCREASED,1
SE,BLOOD GLUCOSE ABNORMAL,1
SE,BLOOD LACTIC ACID INCREASED,1
SE,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
SE,BLOOD THYROID STIMULATING HORMONE DECREASED,1
SE,BLOOD URIC ACID INCREASED,1
SE,BLOOD URINE PRESENT,1
SE,BLUE TOE SYNDROME,1
SE,BODY TEMPERATURE DECREASED,1
SE,BOWEL MOVEMENT IRREGULARITY,1
SE,BRAIN ABSCESS,1
SE,BRAIN OEDEMA,1
SE,BRAIN STEM INFARCTION,1
SE,BREAST DISORDER,1
SE,BREAST PAIN,1
SE,BRONCHIAL HYPERREACTIVITY,1
SE,BRONCHIAL OBSTRUCTION,1
SE,BRONCHOPNEUMONIA,1
SE,BUNDLE BRANCH BLOCK LEFT,1
SE,BURNING SENSATION MUCOSAL,1
SE,CALCIUM DEFICIENCY,1
SE,CARDIAC DISCOMFORT,1
SE,CARDIAC FIBRILLATION,1
SE,CARDIAC HYPERTROPHY,1
SE,CARDIAC PACEMAKER INSERTION,1
SE,CARDIO-RESPIRATORY ARREST,1
SE,CARDIOMYOPATHY,1
SE,CARDIOVASCULAR INSUFFICIENCY,1
SE,CAROTID ARTERY STENOSIS,1
SE,CATAPLEXY,1
SE,CATARACT,1
SE,CATARACT OPERATION,1
SE,CEREBELLAR ATAXIA,1
SE,CEREBELLAR INFARCTION,1
SE,CHEILITIS,1
SE,CHOLECYSTITIS,1
SE,CHOLELITHIASIS,1
SE,CHOLESTASIS,1
SE,COLD SWEAT,1
SE,COMPARTMENT SYNDROME,1
SE,COMPUTERISED TOMOGRAM ABNORMAL,1
SE,CONCUSSION,1
SE,CROHN^S DISEASE,1
SE,CUSHINGOID,1
SE,CUTANEOUS CALCIFICATION,1
SE,CUTANEOUS VASCULITIS,1
SE,CYANOSIS,1
SE,CYTOKINE RELEASE SYNDROME,1
SE,CYTOMEGALOVIRUS INFECTION,1
SE,DAYDREAMING,1
SE,DEAFNESS NEUROSENSORY,1
SE,DECREASED VIBRATORY SENSE,1
SE,DENTAL CARIES,1
SE,DEPRESSIVE SYMPTOM,1
SE,DERMATITIS PSORIASIFORM,1
SE,DIABETES MELLITUS INADEQUATE CONTROL,1
SE,DIARRHOEA INFECTIOUS,1
SE,DIPLOPIA,1
SE,DISORIENTATION,1
SE,DISSEMINATED INTRAVASCULAR COAGULATION,1
SE,DISSOCIATION,1
SE,DIVERTICULITIS,1
SE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
SE,DRUG DEPENDENCE,1
SE,DRUG EFFECT VARIABLE,1
SE,DRUG HYPERSENSITIVITY,1
SE,DRUG LEVEL FLUCTUATING,1
SE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
SE,DRUG SPECIFIC ANTIBODY,1
SE,DUODENAL ULCER,1
SE,DYSPAREUNIA,1
SE,DYSPHORIA,1
SE,DYSPNOEA EXERTIONAL,1
SE,EAR HAEMORRHAGE,1
SE,EAR PAIN,1
SE,EATING DISORDER,1
SE,ECCHYMOSIS,1
SE,ECZEMA NUMMULAR,1
SE,EJECTION FRACTION DECREASED,1
SE,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
SE,EMPYEMA,1
SE,ENTEROCOLITIS,1
SE,EOSINOPHILIA,1
SE,ERECTILE DYSFUNCTION,1
SE,ERUCTATION,1
SE,ERYTHEMA MULTIFORME,1
SE,ESCHERICHIA SEPSIS,1
SE,EXERCISE ELECTROCARDIOGRAM ABNORMAL,1
SE,EXTRA DOSE ADMINISTERED,1
SE,EXTRAPYRAMIDAL DISORDER,1
SE,EYE DISORDER,1
SE,EYE SWELLING,1
SE,EYELID PTOSIS,1
SE,FACE INJURY,1
SE,FACIAL ASYMMETRY,1
SE,FACIAL PAIN,1
SE,FACIAL PARESIS,1
SE,FAECAL INCONTINENCE,1
SE,FIBROMATOSIS,1
SE,FOOD INTERACTION,1
SE,FREQUENT BOWEL MOVEMENTS,1
SE,FUNGAL INFECTION,1
SE,FUNGAL SKIN INFECTION,1
SE,GANGRENE,1
SE,GASTRIC DISORDER,1
SE,GASTRIC HAEMORRHAGE,1
SE,GASTRITIS,1
SE,GASTROENTERITIS ESCHERICHIA COLI,1
SE,GASTROENTERITIS VIRAL,1
SE,GASTROINTESTINAL STROMAL TUMOUR,1
SE,GENERAL PHYSICAL CONDITION ABNORMAL,1
SE,GENERALISED ERYTHEMA,1
SE,GENERALISED TONIC-CLONIC SEIZURE,1
SE,GENITAL HAEMORRHAGE,1
SE,GENITAL RASH,1
SE,GINGIVAL BLISTER,1
SE,GOUT,1
SE,GRAFT ISCHAEMIA,1
SE,GRANULOMA ANNULARE,1
SE,GYNAECOMASTIA,1
SE,HAEMATOCHEZIA,1
SE,HAEMATOMA,1
SE,HAEMOGLOBIN ABNORMAL,1
SE,HAEMOLYSIS,1
SE,HAEMOPTYSIS,1
SE,HAEMORRHAGE,1
SE,HAEMORRHOIDAL HAEMORRHAGE,1
SE,HAEMOTHORAX,1
SE,HEARING IMPAIRED,1
SE,HEART RATE DECREASED,1
SE,HENOCH-SCHONLEIN PURPURA,1
SE,HEPATIC CANCER,1
SE,HEPATIC ENCEPHALOPATHY,1
SE,HEPATIC HAEMORRHAGE,1
SE,HEPATITIS C,1
SE,HERPES ZOSTER CUTANEOUS DISSEMINATED,1
SE,HERPES ZOSTER OTICUS,1
SE,HIRSUTISM,1
SE,HISTIOCYTOSIS HAEMATOPHAGIC,1
SE,HYDROTHORAX,1
SE,HYPERACUSIS,1
SE,HYPERAEMIA,1
SE,HYPERAESTHESIA,1
SE,HYPERBILIRUBINAEMIA,1
SE,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,1
SE,HYPERKINESIA,1
SE,HYPOACUSIS,1
SE,HYPOAESTHESIA ORAL,1
SE,HYPOALBUMINAEMIA,1
SE,HYPOCHROMIC ANAEMIA,1
SE,HYPOGEUSIA,1
SE,HYPOMANIA,1
SE,HYPOPNOEA,1
SE,HYPOSMIA,1
SE,HYPOTHERMIA,1
SE,HYPOTHYROIDISM,1
SE,ILEAL PERFORATION,1
SE,IMMUNODEFICIENCY,1
SE,IMPAIRED GASTRIC EMPTYING,1
SE,IMPAIRED HEALING,1
SE,IMPLANT SITE INFLAMMATION,1
SE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
SE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SE,INCREASED APPETITE,1
SE,INCREASED BRONCHIAL SECRETION,1
SE,INFECTED DERMAL CYST,1
SE,INFECTION SUSCEPTIBILITY INCREASED,1
SE,INFECTIOUS PLEURAL EFFUSION,1
SE,INFLAMMATORY BOWEL DISEASE,1
SE,INFUSION RELATED REACTION,1
SE,INFUSION SITE PAIN,1
SE,INITIAL INSOMNIA,1
SE,INJECTION SITE ERYTHEMA,1
SE,INJECTION SITE PAIN,1
SE,INTENTIONAL DRUG MISUSE,1
SE,INTENTIONAL PRODUCT MISUSE,1
SE,INTERNATIONAL NORMALISED RATIO INCREASED,1
SE,INTERVERTEBRAL DISC COMPRESSION,1
SE,INTERVERTEBRAL DISCITIS,1
SE,INTESTINAL HAEMORRHAGE,1
SE,INTESTINAL SEPSIS,1
SE,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
SE,IRON DEFICIENCY ANAEMIA,1
SE,IRRITABILITY,1
SE,ISCHAEMIA,1
SE,JOINT DISLOCATION,1
SE,KETOACIDOSIS,1
SE,KIDNEY TRANSPLANT REJECTION,1
SE,KNEE ARTHROPLASTY,1
SE,LABORATORY TEST ABNORMAL,1
SE,LACRIMAL DISORDER,1
SE,LACTIC ACIDOSIS,1
SE,LACUNAR INFARCTION,1
SE,LETHARGY,1
SE,LIMB DISCOMFORT,1
SE,LIP DISORDER,1
SE,LIP PRURITUS,1
SE,LIP SQUAMOUS CELL CARCINOMA,1
SE,LISTERIA SEPSIS,1
SE,LIVER INJURY,1
SE,LUNG DISORDER,1
SE,LYMPHOEDEMA,1
SE,LYMPHOMA,1
SE,MALIGNANT BREAST LUMP REMOVAL,1
SE,MALIGNANT MELANOMA IN SITU,1
SE,MASTICATION DISORDER,1
SE,MEDICAL DEVICE COMPLICATION,1
SE,MEDICATION RESIDUE PRESENT,1
SE,MENINGITIS BACTERIAL,1
SE,MENSTRUAL DISORDER,1
SE,MENTAL DISORDER,1
SE,METABOLIC DISORDER,1
SE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
SE,METASTASES TO THORAX,1
SE,MIDDLE INSOMNIA,1
SE,MIGRAINE,1
SE,MITRAL VALVE INCOMPETENCE,1
SE,MORBID THOUGHTS,1
SE,MOUTH SWELLING,1
SE,MUCOSAL DRYNESS,1
SE,MULTI-ORGAN FAILURE,1
SE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
SE,MUSCLE FATIGUE,1
SE,MUSCLE RIGIDITY,1
SE,MUSCLE TWITCHING,1
SE,MYOCARDIAL ISCHAEMIA,1
SE,MYOSITIS,1
SE,NASOPHARYNGITIS,1
SE,NEPHRITIS,1
SE,NEPHROLITHIASIS,1
SE,NEPHROPATHY TOXIC,1
SE,NERVOUS SYSTEM DISORDER,1
SE,NEURALGIA,1
SE,NEUROLOGICAL SYMPTOM,1
SE,NEUROPATHY PERIPHERAL,1
SE,NEUTROPHIL COUNT ABNORMAL,1
SE,NIGHTMARE,1
SE,NITRITE URINE PRESENT,1
SE,NON-CARDIAC CHEST PAIN,1
SE,OCULAR DISCOMFORT,1
SE,OESOPHAGEAL CANCER METASTATIC,1
SE,OLIGOMENORRHOEA,1
SE,OPTIC ISCHAEMIC NEUROPATHY,1
SE,OPTIC NERVE SHEATH HAEMORRHAGE,1
SE,OPTIC NEURITIS,1
SE,ORAL CANDIDIASIS,1
SE,ORAL CAVITY FISTULA,1
SE,ORAL MUCOSAL ERUPTION,1
SE,ORGAN FAILURE,1
SE,OSTEOMYELITIS ACUTE,1
SE,OSTEOPOROSIS,1
SE,OVARIAN CANCER STAGE II,1
SE,OVARIAN GERM CELL TERATOMA STAGE II,1
SE,PANCREATIC CARCINOMA METASTATIC,1
SE,PANCREATIC CYST RUPTURE,1
SE,PANIC DISORDER,1
SE,PARAESTHESIA ORAL,1
SE,PARALYSIS,1
SE,PARESIS,1
SE,PARKINSON^S DISEASE,1
SE,PENILE ULCERATION,1
SE,PENIS DISORDER,1
SE,PERFORMANCE STATUS DECREASED,1
SE,PERICARDIAL HAEMORRHAGE,1
SE,PERICARDITIS,1
SE,PERICARDITIS CONSTRICTIVE,1
SE,PERIPHERAL ISCHAEMIA,1
SE,PERIPROSTHETIC FRACTURE,1
SE,PERITONITIS,1
SE,PERIVASCULAR DERMATITIS,1
SE,PETECHIAE,1
SE,PETIT MAL EPILEPSY,1
SE,PIGMENTATION DISORDER,1
SE,PLASMA CELL MYELOMA,1
SE,PLATELET COUNT DECREASED,1
SE,PLEURISY,1
SE,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
SE,PNEUMONIA ASPIRATION,1
SE,POLYARTHRITIS,1
SE,POLYMYALGIA RHEUMATICA,1
SE,PORTAL HYPERTENSION,1
SE,POST PROCEDURAL COMPLICATION,1
SE,PREGNANCY,1
SE,PREMENSTRUAL SYNDROME,1
SE,PRESCRIBED OVERDOSE,1
SE,PRESCRIBED UNDERDOSE,1
SE,PROCEDURAL PAIN,1
SE,PRODUCT SUBSTITUTION,1
SE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
SE,PROTEINURIA,1
SE,PRURITUS GENERALISED,1
SE,PSORIASIS,1
SE,PSYCHIATRIC SYMPTOM,1
SE,PULMONARY AMYLOIDOSIS,1
SE,PULMONARY ARTERIAL PRESSURE INCREASED,1
SE,PULMONARY INFARCTION,1
SE,PULMONARY OIL MICROEMBOLISM,1
SE,PULMONARY THROMBOSIS,1
SE,PULSE ABSENT,1
SE,RASH MACULAR,1
SE,RASH MACULO-PAPULAR,1
SE,RECTAL ADENOCARCINOMA,1
SE,RECTAL HAEMORRHAGE,1
SE,RED BLOOD CELL COUNT DECREASED,1
SE,RED BLOOD CELL SEDIMENTATION RATE DECREASED,1
SE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
SE,REDUCED FACIAL EXPRESSION,1
SE,RENAL AMYLOIDOSIS,1
SE,RENAL TRANSPLANT FAILURE,1
SE,RESPIRATORY DISTRESS,1
SE,RESTLESS LEGS SYNDROME,1
SE,RETCHING,1
SE,RETINAL ANEURYSM,1
SE,RHINITIS,1
SE,RIB FRACTURE,1
SE,ROAD TRAFFIC ACCIDENT,1
SE,SALIVARY HYPERSECRETION,1
SE,SCIATICA,1
SE,SCRATCH,1
SE,SCREAMING,1
SE,SCROTAL OEDEMA,1
SE,SEBORRHOEA,1
SE,SELF INJURIOUS BEHAVIOUR,1
SE,SENSATION OF FOREIGN BODY,1
SE,SENSORY DISTURBANCE,1
SE,SEPTIC ARTHRITIS STAPHYLOCOCCAL,1
SE,SERUM FERRITIN INCREASED,1
SE,SKIN ATROPHY,1
SE,SKIN CANCER,1
SE,SOFT TISSUE HAEMORRHAGE,1
SE,SOLAR DERMATITIS,1
SE,SPINAL COMPRESSION FRACTURE,1
SE,SPINAL FRACTURE,1
SE,SPINAL OSTEOARTHRITIS,1
SE,SPLENIC INFARCTION,1
SE,SPONDYLITIS,1
SE,STAPHYLOCOCCAL ABSCESS,1
SE,STICKY SKIN,1
SE,STRESS,1
SE,STRESS CARDIOMYOPATHY,1
SE,STRESS FRACTURE,1
SE,SUDDEN HEARING LOSS,1
SE,SUICIDAL BEHAVIOUR,1
SE,SWOLLEN TONGUE,1
SE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
SE,SYSTOLIC DYSFUNCTION,1
SE,TEMPERATURE INTOLERANCE,1
SE,TEMPERATURE REGULATION DISORDER,1
SE,TENDON PAIN,1
SE,TENDON RUPTURE,1
SE,THALAMIC INFARCTION,1
SE,THERMAL BURN,1
SE,THIRST,1
SE,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
SE,TONGUE BLISTERING,1
SE,TONGUE DISCOLOURATION,1
SE,TONGUE PRURITUS,1
SE,TOOTH DEPOSIT,1
SE,TOOTH DISCOLOURATION,1
SE,TOOTH LOSS,1
SE,TOOTHACHE,1
SE,TORTICOLLIS,1
SE,TOXIC SKIN ERUPTION,1
SE,TUBERCULOSIS,1
SE,TUBERCULOUS PLEURISY,1
SE,TUMOUR FLARE,1
SE,TYPE 2 DIABETES MELLITUS,1
SE,URINARY TRACT DISORDER,1
SE,UTERINE HAEMORRHAGE,1
SE,UTERINE INFECTION,1
SE,VACCINATION SITE NECROSIS,1
SE,VAGINAL DISCHARGE,1
SE,VASCULITIS NECROTISING,1
SE,VENTRICULAR TACHYCARDIA,1
SE,VIITH NERVE PARALYSIS,1
SE,VITAMIN D DEFICIENCY,1
SE,VOCAL CORD DISORDER,1
SE,WHITE BLOOD CELL COUNT ABNORMAL,1
SE,WHITE BLOOD CELL COUNT DECREASED,1
SE,WHITE BLOOD CELL DISORDER,1
SE,WOUND HAEMORRHAGE,1
SE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
CH,ELECTROCARDIOGRAM QT PROLONGED,7
CH,EXPOSURE DURING PREGNANCY,7
CH,FALL,6
CH,HYPONATRAEMIA,6
CH,CEREBRAL HAEMORRHAGE,5
CH,DELIRIUM,5
CH,MUSCULAR WEAKNESS,5
CH,AGITATION,4
CH,ASTHENIA,4
CH,FATIGUE,4
CH,HALLUCINATION,4
CH,HEPATIC ENZYME INCREASED,4
CH,HEPATIC STEATOSIS,4
CH,HEPATOCELLULAR INJURY,4
CH,HYPOKALAEMIA,4
CH,NAUSEA,4
CH,BALANCE DISORDER,3
CH,BRADYCARDIA,3
CH,CARDIAC FAILURE,3
CH,DRUG-INDUCED LIVER INJURY,3
CH,LEUKOPENIA,3
CH,PARAESTHESIA,3
CH,PSEUDOLYMPHOMA,3
CH,REBOUND EFFECT,3
CH,THROMBOCYTOPENIA,3
CH,ABDOMINAL PAIN,2
CH,ABNORMAL LOSS OF WEIGHT,2
CH,ABORTION INDUCED,2
CH,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
CH,BACK PAIN,2
CH,BLOOD CREATININE INCREASED,2
CH,BONE DENSITY DECREASED,2
CH,C-REACTIVE PROTEIN INCREASED,2
CH,CARDIAC ARREST,2
CH,COMA,2
CH,COUGH,2
CH,DEPRESSION,2
CH,DRUG INEFFECTIVE,2
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CH,DRY MOUTH,2
CH,EXPOSURE DURING BREAST FEEDING,2
CH,GESTATIONAL HYPERTENSION,2
CH,HEADACHE,2
CH,HEPATITIS FULMINANT,2
CH,HYPERHIDROSIS,2
CH,HYPOCALCAEMIA,2
CH,HYPOGLYCAEMIA,2
CH,HYPOMAGNESAEMIA,2
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
CH,INGUINAL HERNIA,2
CH,LUMBAR VERTEBRAL FRACTURE,2
CH,MALAISE,2
CH,MALNUTRITION,2
CH,MATERNAL EXPOSURE DURING PREGNANCY,2
CH,MICROCYTIC ANAEMIA,2
CH,NORMAL NEWBORN,2
CH,PATHOLOGICAL FRACTURE,2
CH,PHOTOPHOBIA,2
CH,PNEUMONIA,2
CH,PRODUCT USE ISSUE,2
CH,PROLONGED LABOUR,2
CH,RASH MACULO-PAPULAR,2
CH,RED MAN SYNDROME,2
CH,RENAL FAILURE,2
CH,RENAL IMPAIRMENT,2
CH,SPINAL FRACTURE,2
CH,SUBDURAL HAEMATOMA,2
CH,THORACIC VERTEBRAL FRACTURE,2
CH,UROSEPSIS,2
CH,VERTIGO,2
CH,ABNORMAL SENSATION IN EYE,1
CH,ACUTE MYELOID LEUKAEMIA,1
CH,ACUTE RESPIRATORY DISTRESS SYNDROME,1
CH,ALANINE AMINOTRANSFERASE INCREASED,1
CH,ANAEMIA,1
CH,ANAPHYLACTIC SHOCK,1
CH,ANASTOMOTIC LEAK,1
CH,ANGIOEDEMA,1
CH,APRAXIA,1
CH,ARRHYTHMIA,1
CH,ARTHRALGIA,1
CH,ASPARTATE AMINOTRANSFERASE INCREASED,1
CH,BLADDER CANCER,1
CH,BLAST CELLS PRESENT,1
CH,BLOOD ALBUMIN DECREASED,1
CH,BLOOD GLUCOSE INCREASED,1
CH,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CH,BLOOD THYROID STIMULATING HORMONE INCREASED,1
CH,BLOOD URIC ACID INCREASED,1
CH,CEREBRAL ISCHAEMIA,1
CH,CEREBRAL MICROANGIOPATHY,1
CH,CHEST PAIN,1
CH,CHOLESTATIC LIVER INJURY,1
CH,CHRONIC GASTROINTESTINAL BLEEDING,1
CH,CLUSTER HEADACHE,1
CH,COGNITIVE DISORDER,1
CH,COLITIS,1
CH,CONFUSIONAL STATE,1
CH,CONGENITAL HAND MALFORMATION,1
CH,DECREASED APPETITE,1
CH,DERMATITIS ALLERGIC,1
CH,DEVICE RELATED INFECTION,1
CH,DISEASE RECURRENCE,1
CH,DISTURBANCE IN ATTENTION,1
CH,DIZZINESS,1
CH,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CH,DYSAESTHESIA,1
CH,ENTEROCOLITIS INFECTIOUS,1
CH,EVANS SYNDROME,1
CH,EXTRACORPOREAL MEMBRANE OXYGENATION,1
CH,EYE DISORDER,1
CH,EYELID OEDEMA,1
CH,EYELID PTOSIS,1
CH,FACIAL PAIN,1
CH,FACIAL PARESIS,1
CH,FOETAL EXPOSURE DURING PREGNANCY,1
CH,FOETAL MACROSOMIA,1
CH,FRACTURE,1
CH,GAIT DISTURBANCE,1
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CH,GASTRIC ANTRAL VASCULAR ECTASIA,1
CH,GASTRITIS,1
CH,GENERAL PHYSICAL HEALTH DETERIORATION,1
CH,GENERALISED TONIC-CLONIC SEIZURE,1
CH,GLOBULINS INCREASED,1
CH,GOUT,1
CH,GOUTY ARTHRITIS,1
CH,HAEMATOMA,1
CH,HAEMOGLOBIN DECREASED,1
CH,HAEMORRHAGE SUBCUTANEOUS,1
CH,HEMIPARESIS,1
CH,HEPATIC CANCER,1
CH,HEPATIC FAILURE,1
CH,HEPATITIS,1
CH,HORNER^S SYNDROME,1
CH,HYPERBILIRUBINAEMIA,1
CH,HYPERPHOSPHATAEMIA,1
CH,HYPERTONIA,1
CH,HYPOAESTHESIA,1
CH,HYPOCHROMIC ANAEMIA,1
CH,HYPOPHOSPHATAEMIA,1
CH,ILEAL STENOSIS,1
CH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CH,INFLAMMATION,1
CH,INFLAMMATORY MARKER INCREASED,1
CH,INVASIVE LOBULAR BREAST CARCINOMA,1
CH,IRON DEFICIENCY,1
CH,IRON DEFICIENCY ANAEMIA,1
CH,JOINT DISLOCATION,1
CH,LACRIMATION INCREASED,1
CH,LEUKOCYTOSIS,1
CH,LIMB MALFORMATION,1
CH,LIMB REDUCTION DEFECT,1
CH,LIPODYSTROPHY ACQUIRED,1
CH,LIVE BIRTH,1
CH,LIVER DISORDER,1
CH,LOSS OF CONSCIOUSNESS,1
CH,LYMPHOMA TRANSFORMATION,1
CH,MALIGNANT NEOPLASM PROGRESSION,1
CH,MELAENA,1
CH,MEMORY IMPAIRMENT,1
CH,MITOCHONDRIAL MYOPATHY,1
CH,MUSCLE SPASMS,1
CH,MYALGIA,1
CH,MYOCARDIAL INFARCTION,1
CH,MYOCLONUS,1
CH,NECK PAIN,1
CH,NEPHRITIS,1
CH,NERVOUS SYSTEM DISORDER,1
CH,NERVOUSNESS,1
CH,NIGHTMARE,1
CH,NITRITE URINE PRESENT,1
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CH,OEDEMA PERIPHERAL,1
CH,OSTEOPOROTIC FRACTURE,1
CH,OXYGEN SATURATION DECREASED,1
CH,PAIN,1
CH,PARAESTHESIA ORAL,1
CH,PAROTITIS,1
CH,PNEUMONIA CYTOMEGALOVIRAL,1
CH,PROSTATE CANCER,1
CH,PROTEIN TOTAL INCREASED,1
CH,PROTEINURIA,1
CH,PRURITUS,1
CH,PSORIASIS,1
CH,PYREXIA,1
CH,RASH GENERALISED,1
CH,RENAL ATROPHY,1
CH,RENAL FAILURE ACUTE,1
CH,RENAL FAILURE CHRONIC,1
CH,RIB FRACTURE,1
CH,SENSORY DISTURBANCE,1
CH,SEPSIS,1
CH,SEPTIC SHOCK,1
CH,SEROTONIN SYNDROME,1
CH,SKIN BURNING SENSATION,1
CH,SKIN PLAQUE,1
CH,SLEEP DISORDER,1
CH,SPINAL COMPRESSION FRACTURE,1
CH,SPINAL CORD COMPRESSION,1
CH,SUDDEN DEATH,1
CH,SYNCOPE,1
CH,TACHYCARDIA,1
CH,TACHYPNOEA,1
CH,THROMBOCYTOSIS,1
CH,TONGUE OEDEMA,1
CH,TOXIC EPIDERMAL NECROLYSIS,1
CH,TOXIC SKIN ERUPTION,1
CH,TRANSAMINASES INCREASED,1
CH,TREATMENT FAILURE,1
CH,TUBULOINTERSTITIAL NEPHRITIS,1
CH,URTICARIA,1
CH,VASCULITIS,1
CH,VIITH NERVE PARALYSIS,1
CH,VIRAL MUTATION IDENTIFIED,1
CH,VITAMIN D DEFICIENCY,1
CH,VOMITING,1
CH,XERODERMA,1
TW,EOSINOPHILIA,3
TW,PNEUMONIA,3
TW,ARRHYTHMIA,2
TW,ARTERIAL OCCLUSIVE DISEASE,2
TW,CHILLS,2
TW,DYSPNOEA,2
TW,HAEMORRHAGE,2
TW,HEART RATE INCREASED,2
TW,STENT PLACEMENT,2
TW,TREMOR,2
TW,ABDOMINAL DISTENSION,1
TW,ALTERED STATE OF CONSCIOUSNESS,1
TW,ASTHENIA,1
TW,BACILLUS BACTERAEMIA,1
TW,BACTERAEMIA,1
TW,CHRONIC SINUSITIS,1
TW,COUGH,1
TW,DEVICE RELATED THROMBOSIS,1
TW,DIZZINESS,1
TW,DRUG ABUSE,1
TW,IDIOPATHIC PULMONARY FIBROSIS,1
TW,INFECTION,1
TW,INTERSTITIAL LUNG DISEASE,1
TW,MOUTH ULCERATION,1
TW,NAUSEA,1
TW,OROPHARYNGEAL PAIN,1
TW,PAIN IN EXTREMITY,1
TW,PANCYTOPENIA,1
TW,PLATELET COUNT DECREASED,1
TW,PULMONARY EMBOLISM,1
TW,PYREXIA,1
TW,SEPSIS,1
TW,SEPTIC SHOCK,1
TW,SPUTUM DISCOLOURED,1
TW,VOMITING,1
TH,SEPTIC SHOCK,10
TH,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,8
TH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,7
TH,SEPSIS,6
TH,ACUTE HEPATIC FAILURE,5
TH,PNEUMONIA,5
TH,ANAEMIA,4
TH,DYSPNOEA,3
TH,FEBRILE NEUTROPENIA,3
TH,HYPOKALAEMIA,3
TH,NEUTROPENIA,3
TH,PYREXIA,3
TH,RASH,3
TH,RESPIRATORY FAILURE,3
TH,SKIN EXFOLIATION,3
TH,THROMBOCYTOPENIA,3
TH,ALANINE AMINOTRANSFERASE INCREASED,2
TH,ANGIOEDEMA,2
TH,ASPARTATE AMINOTRANSFERASE INCREASED,2
TH,ATRIAL FIBRILLATION,2
TH,DIARRHOEA,2
TH,FATIGUE,2
TH,GASTROINTESTINAL STROMAL TUMOUR,2
TH,HEPATIC FAILURE,2
TH,HEPATIC FUNCTION ABNORMAL,2
TH,HEPATITIS,2
TH,HYPERTENSION,2
TH,MALIGNANT NEOPLASM PROGRESSION,2
TH,RENAL FAILURE ACUTE,2
TH,TUMOUR LYSIS SYNDROME,2
TH,ACUTE KIDNEY INJURY,1
TH,ACUTE MYOCARDIAL INFARCTION,1
TH,ACUTE PULMONARY OEDEMA,1
TH,ARTHRITIS BACTERIAL,1
TH,ASTHMA,1
TH,BLOOD CREATININE INCREASED,1
TH,BLOOD PRESSURE DECREASED,1
TH,BLOOD PRESSURE FLUCTUATION,1
TH,BRONCHIECTASIS,1
TH,CARDIAC FAILURE,1
TH,CARDIAC FAILURE CONGESTIVE,1
TH,CELLULITIS,1
TH,CEREBRAL INFARCTION,1
TH,CEREBROVASCULAR ACCIDENT,1
TH,COLITIS,1
TH,CONFUSIONAL STATE,1
TH,CONJUNCTIVAL HYPERAEMIA,1
TH,CONJUNCTIVITIS,1
TH,DEEP VEIN THROMBOSIS,1
TH,DEHYDRATION,1
TH,DIARRHOEA INFECTIOUS,1
TH,DUODENAL ULCER HAEMORRHAGE,1
TH,EMPYEMA,1
TH,ENCEPHALOPATHY,1
TH,ENTEROCOLITIS,1
TH,ESCHERICHIA SEPSIS,1
TH,ESCHERICHIA TEST POSITIVE,1
TH,ESCHERICHIA URINARY TRACT INFECTION,1
TH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
TH,GASTRIC POLYPS,1
TH,GASTRITIS,1
TH,GASTROINTESTINAL DISORDER,1
TH,GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY,1
TH,HAEMATOCRIT DECREASED,1
TH,HAEMATURIA,1
TH,HAEMOPTYSIS,1
TH,HERPES VIRUS INFECTION,1
TH,HYPERCALCAEMIA,1
TH,HYPOMAGNESAEMIA,1
TH,HYPONATRAEMIA,1
TH,HYPOTENSION,1
TH,ILEAL ULCER,1
TH,INFLAMMATORY MYOFIBROBLASTIC TUMOUR,1
TH,INFUSION RELATED REACTION,1
TH,INTERNATIONAL NORMALISED RATIO INCREASED,1
TH,INTRAOCULAR PRESSURE INCREASED,1
TH,INVASIVE DUCTAL BREAST CARCINOMA,1
TH,IRON DEFICIENCY ANAEMIA,1
TH,ISCHAEMIC STROKE,1
TH,KIDNEY TRANSPLANT REJECTION,1
TH,LIP SWELLING,1
TH,LOSS OF CONSCIOUSNESS,1
TH,METHAEMOGLOBINAEMIA,1
TH,MUSCLE RIGIDITY,1
TH,MYALGIA,1
TH,MYOCARDIAL INFARCTION,1
TH,NECROTISING FASCIITIS,1
TH,NEUROPATHY PERIPHERAL,1
TH,NEUTROPENIC SEPSIS,1
TH,OEDEMA,1
TH,OVERDOSE,1
TH,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
TH,PANCREATIC CARCINOMA,1
TH,PANCREATITIS ACUTE,1
TH,PANOPHTHALMITIS,1
TH,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
TH,PNEUMONIA BACTERIAL,1
TH,POLYARTERITIS NODOSA,1
TH,PRURITUS,1
TH,PULMONARY HAEMORRHAGE,1
TH,PULMONARY HYPERTENSION,1
TH,PYOMYOSITIS,1
TH,RASH MACULO-PAPULAR,1
TH,RHINORRHOEA,1
TH,SCLERAL DISORDER,1
TH,SELF-MEDICATION,1
TH,SINUSITIS,1
TH,SINUSITIS FUNGAL,1
TH,SKIN HYPERPIGMENTATION,1
TH,SPINAL OSTEOARTHRITIS,1
TH,STEVENS-JOHNSON SYNDROME,1
TH,SUPERINFECTION,1
TH,SYSTEMIC MASTOCYTOSIS,1
TH,THERAPEUTIC RESPONSE INCREASED,1
TH,THERAPY NON-RESPONDER,1
TH,TOXIC EPIDERMAL NECROLYSIS,1
TH,UNDERDOSE,1
TH,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TH,URINARY TRACT INFECTION,1
TH,URTICARIA,1
TH,WHITE BLOOD CELL COUNT DECREASED,1
TN,DEATH,2
TN,DRUG HYPERSENSITIVITY,2
TN,HEPATITIS FULMINANT,2
TN,PANCREATITIS,2
TN,RASH MACULO-PAPULAR,2
TN,ABDOMINAL PAIN UPPER,1
TN,ACUTE HEPATIC FAILURE,1
TN,ALANINE AMINOTRANSFERASE INCREASED,1
TN,ASPARTATE AMINOTRANSFERASE INCREASED,1
TN,BACK PAIN,1
TN,BLOOD BILIRUBIN INCREASED,1
TN,BONE MARROW FAILURE,1
TN,CARDIAC ARREST,1
TN,CHEST PAIN,1
TN,CHROMATURIA,1
TN,CONDITION AGGRAVATED,1
TN,EMPHYSEMA,1
TN,EOSINOPHILIA,1
TN,ERYSIPELAS,1
TN,FACE OEDEMA,1
TN,FAECES DISCOLOURED,1
TN,GASTROINTESTINAL CARCINOMA,1
TN,HAEMATEMESIS,1
TN,HICCUPS,1
TN,HYPERLIPIDAEMIA,1
TN,HYPOCALCAEMIA,1
TN,HYPOPROTEINAEMIA,1
TN,JAUNDICE,1
TN,JAUNDICE CHOLESTATIC,1
TN,LACTIC ACIDOSIS,1
TN,PANCREATITIS ACUTE,1
TN,PRURITUS GENERALISED,1
TN,SEPTIC SHOCK,1
TN,STEVENS-JOHNSON SYNDROME,1
TN,SUDDEN DEATH,1
TN,URTICARIA,1
TN,VITAMIN B1 DEFICIENCY,1
TR,PANCREATITIS ACUTE,3
TR,ANAPHYLACTIC REACTION,2
TR,FATIGUE,2
TR,FEBRILE NEUTROPENIA,2
TR,GENERALISED TONIC-CLONIC SEIZURE,2
TR,HYPOCALCAEMIA,2
TR,HYPOGLYCAEMIA,2
TR,HYPOMAGNESAEMIA,2
TR,MANIA,2
TR,PANCREATITIS,2
TR,PARAESTHESIA,2
TR,ACUTE KIDNEY INJURY,1
TR,AGITATION,1
TR,ANXIETY,1
TR,CARDIAC FAILURE,1
TR,COLD SWEAT,1
TR,COLITIS,1
TR,CRYPTOCOCCAL CUTANEOUS INFECTION,1
TR,CYTOKINE STORM,1
TR,DEATH,1
TR,DEEP VEIN THROMBOSIS,1
TR,DERMATOPHYTOSIS,1
TR,DRUG INEFFECTIVE,1
TR,DRUG PROVOCATION TEST,1
TR,ERYTHEMA,1
TR,FALL,1
TR,GAIT DISTURBANCE,1
TR,HALLUCINATION_ VISUAL,1
TR,HEPATOMEGALY,1
TR,HOSTILITY,1
TR,HYPERKERATOSIS,1
TR,HYPERPARATHYROIDISM,1
TR,HYPERPARATHYROIDISM SECONDARY,1
TR,HYPERSENSITIVITY,1
TR,HYPERURICAEMIA,1
TR,HYPOMANIA,1
TR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
TR,KAPOSI^S SARCOMA,1
TR,LEUKOPENIA,1
TR,LOSS OF CONSCIOUSNESS,1
TR,LOWER RESPIRATORY TRACT INFECTION,1
TR,LYMPHOPENIA,1
TR,METABOLIC ENCEPHALOPATHY,1
TR,MUCOSAL INFLAMMATION,1
TR,MUSCLE SPASMS,1
TR,MUSCULAR WEAKNESS,1
TR,NEUTROPENIA,1
TR,PANCYTOPENIA,1
TR,PAPULE,1
TR,PNEUMONIA,1
TR,PNEUMOTHORAX,1
TR,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
TR,PRURITUS,1
TR,PYELONEPHRITIS ACUTE,1
TR,PYREXIA,1
TR,RESPIRATORY FAILURE,1
TR,SEPTIC SHOCK,1
TR,SKIN LESION,1
TR,SKIN MASS,1
TR,THERAPEUTIC PRODUCT CROSS-REACTIVITY,1
TR,THROMBOTIC MICROANGIOPATHY,1
TR,TRANSIENT ISCHAEMIC ATTACK,1
TR,TRANSPLANT REJECTION,1
TR,TRAUMATIC RENAL INJURY,1
TR,TYPE I HYPERSENSITIVITY,1
TR,URTICARIA,1
TR,VISION BLURRED,1
TR,WAXY FLEXIBILITY,1
UG,ABORTION SPONTANEOUS,1
UG,HEPATITIS ACUTE,1
UA,ACUTE CORONARY SYNDROME,3
UA,PULMONARY ARTERY THROMBOSIS,3
UA,ALOPECIA,1
UA,ASTHENIA,1
UA,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
UA,BLOOD PRESSURE INCREASED,1
UA,BODY TEMPERATURE INCREASED,1
UA,BURNING SENSATION,1
UA,CHEST PAIN,1
UA,COUGH,1
UA,CYTOTOXIC CARDIOMYOPATHY,1
UA,DIZZINESS,1
UA,DYSPNOEA AT REST,1
UA,ERYTHEMA,1
UA,EXERCISE TOLERANCE DECREASED,1
UA,EXOPHTHALMOS,1
UA,FATIGUE,1
UA,HEADACHE,1
UA,HYPERHIDROSIS,1
UA,OXYGEN SATURATION DECREASED,1
UA,PERIPHERAL SWELLING,1
UA,PHOTOSENSITIVITY REACTION,1
UA,PNEUMONIA,1
UA,PULMONARY TOXICITY,1
UA,RIGHT VENTRICULAR FAILURE,1
UA,SKIN HYPERPIGMENTATION,1
UA,THYROID DISORDER,1
UA,TREMOR,1
UA,TUMOUR LYSIS SYNDROME,1
UA,WEIGHT DECREASED,1
AE,CHORIORETINOPATHY,4
AE,DIZZINESS,4
AE,CONDITION AGGRAVATED,3
AE,DIPLOPIA,2
AE,NAUSEA,2
AE,ANGIOGRAM ABNORMAL,1
AE,ASTHENIA,1
AE,BLOOD CALCIUM DECREASED,1
AE,BLOOD CHLORIDE DECREASED,1
AE,BLOOD POTASSIUM DECREASED,1
AE,CONTUSION,1
AE,COUGH,1
AE,DIARRHOEA,1
AE,DRY MOUTH,1
AE,DYSPNOEA,1
AE,FUNDOSCOPY ABNORMAL,1
AE,HEART RATE INCREASED,1
AE,HYPERBILIRUBINAEMIA,1
AE,HYPOTENSION,1
AE,MACULAR SCAR,1
AE,MALAISE,1
AE,METAMORPHOPSIA,1
AE,OPTICAL COHERENCE TOMOGRAPHY ABNORMAL,1
AE,OXYGEN SATURATION DECREASED,1
AE,PANCREATITIS,1
AE,RASH,1
AE,RESPIRATORY RATE INCREASED,1
AE,SEPTIC SHOCK,1
AE,SKIN ULCER,1
AE,VISION BLURRED,1
AE,VISUAL ACUITY REDUCED,1
AE,VOMITING,1
GB,MALAISE,1118
GB,DYSPNOEA,945
GB,NAUSEA,813
GB,DIARRHOEA,809
GB,DIZZINESS,774
GB,VOMITING,732
GB,FATIGUE,684
GB,ACUTE KIDNEY INJURY,665
GB,CONFUSIONAL STATE,659
GB,HEADACHE,616
GB,MYALGIA,533
GB,HYPONATRAEMIA,493
GB,ABDOMINAL PAIN,484
GB,ARTHRALGIA,482
GB,PYREXIA,422
GB,FALL,414
GB,PAIN,410
GB,RASH,398
GB,DECREASED APPETITE,385
GB,TREMOR,373
GB,PAIN IN EXTREMITY,370
GB,LOWER RESPIRATORY TRACT INFECTION,360
GB,CHEST PAIN,359
GB,LETHARGY,356
GB,ASTHENIA,348
GB,ANXIETY,329
GB,INSOMNIA,317
GB,PNEUMONIA,307
GB,LIVER FUNCTION TEST ABNORMAL,306
GB,COUGH,305
GB,PRURITUS,303
GB,CONDITION AGGRAVATED,300
GB,PARAESTHESIA,297
GB,ABDOMINAL PAIN UPPER,294
GB,CONSTIPATION,293
GB,PALPITATIONS,285
GB,HYPERHIDROSIS,281
GB,ANAEMIA,280
GB,HYPOTENSION,274
GB,MUSCLE SPASMS,267
GB,MUSCULAR WEAKNESS,259
GB,DEPRESSION,258
GB,SEPSIS,253
GB,VISION BLURRED,252
GB,DRY MOUTH,250
GB,URINARY TRACT INFECTION,232
GB,BACK PAIN,231
GB,DEHYDRATION,227
GB,FEELING ABNORMAL,226
GB,RENAL FAILURE ACUTE,216
GB,SOMNOLENCE,216
GB,SYNCOPE,215
GB,BALANCE DISORDER,211
GB,JOINT SWELLING,204
GB,NEUTROPENIA,204
GB,TACHYCARDIA,201
GB,DRUG INEFFECTIVE,199
GB,HYPOMAGNESAEMIA,197
GB,AGITATION,195
GB,ALOPECIA,195
GB,PERIPHERAL SWELLING,195
GB,PULMONARY EMBOLISM,190
GB,CONTUSION,189
GB,ABDOMINAL DISTENSION,188
GB,WHEEZING,182
GB,RENAL IMPAIRMENT,180
GB,ERYTHEMA,178
GB,NEUTROPENIC SEPSIS,178
GB,HALLUCINATION,177
GB,LIP SWELLING,177
GB,SUICIDAL IDEATION,174
GB,SWELLING FACE,171
GB,TUBULOINTERSTITIAL NEPHRITIS,171
GB,WEIGHT DECREASED,171
GB,GASTROINTESTINAL HAEMORRHAGE,170
GB,THROMBOCYTOPENIA,168
GB,DYSPEPSIA,167
GB,HAEMATEMESIS,167
GB,ATRIAL FIBRILLATION,161
GB,HAEMOGLOBIN DECREASED,160
GB,BLISTER,159
GB,TOXICITY TO VARIOUS AGENTS,156
GB,HYPOAESTHESIA,154
GB,WHITE BLOOD CELL COUNT INCREASED,154
GB,HYPERSENSITIVITY,153
GB,SEIZURE,151
GB,VISUAL IMPAIRMENT,150
GB,ALANINE AMINOTRANSFERASE INCREASED,147
GB,LOSS OF CONSCIOUSNESS,147
GB,OEDEMA PERIPHERAL,146
GB,BRADYCARDIA,145
GB,CARDIAC ARREST,145
GB,INFECTION,143
GB,SWOLLEN TONGUE,143
GB,DYSPHAGIA,142
GB,DISTURBANCE IN ATTENTION,139
GB,HYPOCALCAEMIA,139
GB,OVERDOSE,134
GB,CIRCULATORY COLLAPSE,133
GB,HYPOKALAEMIA,132
GB,JAUNDICE,132
GB,CHILLS,129
GB,EPISTAXIS,129
GB,ABNORMAL LOSS OF WEIGHT,127
GB,SKIN EXFOLIATION,127
GB,HYPERTENSION,125
GB,INTERNATIONAL NORMALISED RATIO INCREASED,125
GB,CHEST DISCOMFORT,123
GB,GASTROOESOPHAGEAL REFLUX DISEASE,123
GB,ANAPHYLACTIC REACTION,122
GB,DEATH,122
GB,ABDOMINAL DISCOMFORT,121
GB,MUSCULOSKELETAL STIFFNESS,121
GB,GAIT DISTURBANCE,119
GB,HYPERKALAEMIA,119
GB,HEART RATE INCREASED,118
GB,PANCYTOPENIA,118
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,116
GB,MEMORY IMPAIRMENT,116
GB,DEPRESSED MOOD,115
GB,NIGHTMARE,115
GB,RHABDOMYOLYSIS,112
GB,TINNITUS,112
GB,ANGIOEDEMA,111
GB,ELECTROCARDIOGRAM QT PROLONGED,111
GB,AGGRESSION,110
GB,MOUTH ULCERATION,109
GB,RESPIRATORY FAILURE,109
GB,URTICARIA,108
GB,MOBILITY DECREASED,107
GB,OROPHARYNGEAL PAIN,107
GB,C-REACTIVE PROTEIN INCREASED,106
GB,DELIRIUM,106
GB,RASH GENERALISED,106
GB,RASH PRURITIC,106
GB,SLEEP DISORDER,106
GB,HYPOGLYCAEMIA,105
GB,DYSGEUSIA,104
GB,RECTAL HAEMORRHAGE,102
GB,WITHDRAWAL SYNDROME,102
GB,FLATULENCE,101
GB,FEBRILE NEUTROPENIA,99
GB,AMNESIA,98
GB,DISORIENTATION,97
GB,PULMONARY OEDEMA,95
GB,CHROMATURIA,94
GB,BURNING SENSATION,93
GB,LOCAL SWELLING,93
GB,CARDIAC FAILURE,92
GB,UNRESPONSIVE TO STIMULI,92
GB,CEREBROVASCULAR ACCIDENT,91
GB,RENAL FAILURE,91
GB,RESTLESSNESS,91
GB,DEEP VEIN THROMBOSIS,90
GB,INFLUENZA LIKE ILLNESS,90
GB,VERTIGO,90
GB,FAECES DISCOLOURED,89
GB,HAEMORRHAGE,89
GB,MUSCULOSKELETAL PAIN,88
GB,SPEECH DISORDER,88
GB,NEUTROPHIL COUNT INCREASED,87
GB,CLOSTRIDIUM DIFFICILE INFECTION,86
GB,CONVULSION,86
GB,MELAENA,86
GB,PLATELET COUNT DECREASED,85
GB,GASTROINTESTINAL DISORDER,84
GB,HEPATIC FUNCTION ABNORMAL,83
GB,CELLULITIS,82
GB,PHARYNGEAL OEDEMA,82
GB,DRY SKIN,81
GB,RASH ERYTHEMATOUS,81
GB,FEELING HOT,79
GB,PRODUCT USE ISSUE,79
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,78
GB,NEUTROPHIL COUNT DECREASED,78
GB,BONE PAIN,77
GB,DYSKINESIA,77
GB,GASTRITIS,77
GB,MENTAL IMPAIRMENT,77
GB,SWELLING,77
GB,EXPOSURE DURING PREGNANCY,76
GB,ORAL PAIN,76
GB,DRUG WITHDRAWAL SYNDROME,75
GB,GENERAL PHYSICAL HEALTH DETERIORATION,74
GB,NIGHT SWEATS,74
GB,PANCREATITIS,74
GB,NECK PAIN,73
GB,DYSARTHRIA,72
GB,PALLOR,72
GB,ARRHYTHMIA,71
GB,BLOOD CREATININE INCREASED,71
GB,DRUG HYPERSENSITIVITY,71
GB,HOT FLUSH,71
GB,RESTLESS LEGS SYNDROME,71
GB,WHITE BLOOD CELL COUNT DECREASED,71
GB,POLLAKIURIA,70
GB,BLOOD BILIRUBIN INCREASED,69
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,68
GB,MIGRAINE,68
GB,APHASIA,67
GB,FLUSHING,67
GB,PRURITUS GENERALISED,67
GB,SKIN DISCOLOURATION,67
GB,PARANOIA,66
GB,DRUG PRESCRIBING ERROR,65
GB,IRRITABILITY,65
GB,MYOCARDIAL INFARCTION,65
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,65
GB,BLOOD PRESSURE INCREASED,64
GB,INCORRECT DOSE ADMINISTERED,64
GB,PANIC ATTACK,64
GB,PERITONITIS,64
GB,PSORIASIS,63
GB,ACCIDENTAL OVERDOSE,62
GB,ASTHMA,62
GB,URINARY RETENTION,62
GB,CEREBRAL HAEMORRHAGE,61
GB,NEUROPATHY PERIPHERAL,61
GB,PLEURAL EFFUSION,61
GB,STEVENS-JOHNSON SYNDROME,61
GB,SUICIDE ATTEMPT,61
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,60
GB,PLATELET COUNT INCREASED,60
GB,PRESYNCOPE,60
GB,ABNORMAL DREAMS,59
GB,MENTAL DISORDER,59
GB,THIRST,59
GB,DYSPNOEA EXERTIONAL,58
GB,HAEMATURIA,58
GB,PRODUCTIVE COUGH,58
GB,SEROTONIN SYNDROME,58
GB,COORDINATION ABNORMAL,57
GB,DYSURIA,57
GB,WEIGHT INCREASED,57
GB,ABNORMAL BEHAVIOUR,56
GB,BLOOD PRESSURE DECREASED,56
GB,PARAESTHESIA ORAL,56
GB,TENDONITIS,56
GB,PNEUMONITIS,55
GB,ACUTE MYOCARDIAL INFARCTION,54
GB,OXYGEN SATURATION DECREASED,54
GB,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,54
GB,COGNITIVE DISORDER,53
GB,METABOLIC ACIDOSIS,53
GB,PRODUCT SUBSTITUTION ISSUE,53
GB,PSYCHOTIC DISORDER,53
GB,URINARY INCONTINENCE,53
GB,MYOCARDIAL ISCHAEMIA,52
GB,ANGINA PECTORIS,51
GB,DRUG LEVEL INCREASED,50
GB,DRY EYE,50
GB,JOINT STIFFNESS,50
GB,LEUKOPENIA,50
GB,MUSCLE TWITCHING,50
GB,RASH MACULO-PAPULAR,50
GB,VISUAL ACUITY REDUCED,50
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,49
GB,HYPOPHAGIA,49
GB,MUSCLE ATROPHY,49
GB,AGEUSIA,48
GB,EYE PAIN,48
GB,FOETAL EXPOSURE DURING PREGNANCY,48
GB,HYPOXIA,48
GB,MOOD SWINGS,48
GB,MUCOSAL INFLAMMATION,48
GB,PANCREATITIS ACUTE,48
GB,STOMATITIS,48
GB,UROSEPSIS,48
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,47
GB,ARTHRITIS,47
GB,DIPLOPIA,47
GB,DISCOMFORT,47
GB,OESOPHAGITIS,47
GB,PERIPHERAL COLDNESS,47
GB,DRUG INTOLERANCE,46
GB,GASTRIC ULCER,46
GB,GLOMERULAR FILTRATION RATE DECREASED,46
GB,HEPATITIS,46
GB,HYPOAESTHESIA ORAL,46
GB,CLOSTRIDIUM DIFFICILE COLITIS,45
GB,ORTHOSTATIC HYPOTENSION,45
GB,PULMONARY FIBROSIS,45
GB,TRANSIENT ISCHAEMIC ATTACK,45
GB,BLOOD GLUCOSE INCREASED,44
GB,ERYTHEMA MULTIFORME,44
GB,MUSCLE RIGIDITY,44
GB,PHOTOPHOBIA,44
GB,POLYURIA,44
GB,RASH MACULAR,44
GB,CHRONIC KIDNEY DISEASE,43
GB,ELECTROLYTE IMBALANCE,43
GB,NEUROLEPTIC MALIGNANT SYNDROME,43
GB,BODY TEMPERATURE INCREASED,42
GB,HAEMORRHAGE INTRACRANIAL,42
GB,HEART RATE IRREGULAR,42
GB,PRODUCT USE IN UNAPPROVED INDICATION,42
GB,THROAT TIGHTNESS,42
GB,HEPATIC FAILURE,41
GB,INFLAMMATION,41
GB,TOXIC EPIDERMAL NECROLYSIS,41
GB,ACUTE CORONARY SYNDROME,40
GB,DIABETIC KETOACIDOSIS,40
GB,OEDEMA,40
GB,DRUG-INDUCED LIVER INJURY,39
GB,EPILEPSY,39
GB,HYPERGLYCAEMIA,39
GB,HYPERSOMNIA,39
GB,INTENTIONAL OVERDOSE,39
GB,SKIN BURNING SENSATION,39
GB,SPUTUM DISCOLOURED,39
GB,THROAT IRRITATION,39
GB,ABNORMAL WEIGHT GAIN,38
GB,BLINDNESS,38
GB,BLOOD CALCIUM DECREASED,38
GB,DERMATITIS ALLERGIC,38
GB,HEPATIC STEATOSIS,38
GB,INTERSTITIAL LUNG DISEASE,38
GB,COLITIS,37
GB,CONTRAINDICATED DRUG ADMINISTERED,37
GB,DIABETES MELLITUS,37
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,37
GB,EMOTIONAL DISTRESS,37
GB,HIATUS HERNIA,37
GB,BLOOD MAGNESIUM DECREASED,36
GB,LIVER INJURY,36
GB,MOOD ALTERED,36
GB,PHOTOSENSITIVITY REACTION,36
GB,SKIN INFECTION,36
GB,TARDIVE DYSKINESIA,36
GB,UPPER RESPIRATORY TRACT INFECTION,36
GB,MOVEMENT DISORDER,35
GB,MYOCLONUS,35
GB,MYOPATHY,35
GB,OSTEOPENIA,35
GB,PHOTOPSIA,35
GB,PNEUMONIA ASPIRATION,35
GB,RHEUMATOID ARTHRITIS,35
GB,ABNORMAL FAECES,34
GB,DYSTONIA,34
GB,EAR PAIN,34
GB,EOSINOPHILIA,34
GB,ERECTILE DYSFUNCTION,34
GB,FACIAL PARALYSIS,34
GB,FEMUR FRACTURE,34
GB,FLUID RETENTION,34
GB,HAEMOPTYSIS,34
GB,HEPATOMEGALY,34
GB,TENDERNESS,34
GB,ASCITES,33
GB,BLOOD SODIUM DECREASED,33
GB,ELECTROCARDIOGRAM ABNORMAL,33
GB,HALLUCINATIONS_ MIXED,33
GB,HEMIPARESIS,33
GB,INFLAMMATORY MARKER INCREASED,33
GB,LIVER DISORDER,33
GB,LYMPHADENOPATHY,33
GB,PNEUMOTHORAX,33
GB,RENAL DISORDER,33
GB,EXTRAPYRAMIDAL DISORDER,32
GB,EYE SWELLING,32
GB,FEELING COLD,32
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,32
GB,LUNG INFECTION,32
GB,MUSCLE DISORDER,32
GB,NERVOUSNESS,32
GB,SEDATION,32
GB,SNEEZING,32
GB,TREATMENT FAILURE,32
GB,BREAST CANCER,31
GB,CYANOSIS,31
GB,DELUSION,31
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,31
GB,DERMATITIS EXFOLIATIVE,31
GB,LIMB DISCOMFORT,31
GB,LIVER FUNCTION TEST INCREASED,31
GB,MULTI-ORGAN FAILURE,31
GB,PARALYSIS,31
GB,SCHIZOPHRENIA,31
GB,SPLENOMEGALY,31
GB,ARTERIOSCLEROSIS CORONARY ARTERY,30
GB,BLOOD POTASSIUM DECREASED,30
GB,DERMATITIS,30
GB,DISEASE PROGRESSION,30
GB,DRUG DISPENSING ERROR,30
GB,DYSPHONIA,30
GB,GINGIVAL BLEEDING,30
GB,INTENTIONAL SELF-INJURY,30
GB,IRRITABLE BOWEL SYNDROME,30
GB,MATERNAL EXPOSURE DURING PREGNANCY,30
GB,ORAL CANDIDIASIS,30
GB,ORAL HERPES,30
GB,SALIVARY HYPERSECRETION,30
GB,ABDOMINAL TENDERNESS,29
GB,BASAL CELL CARCINOMA,29
GB,CRYING,29
GB,EYE IRRITATION,29
GB,HALLUCINATION_ VISUAL,29
GB,IMMUNOSUPPRESSION,29
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,29
GB,LACTIC ACIDOSIS,29
GB,MANIA,29
GB,PSYCHOMOTOR HYPERACTIVITY,29
GB,EMOTIONAL DISORDER,28
GB,FEMORAL NECK FRACTURE,28
GB,IMPAIRED HEALING,28
GB,JAUNDICE CHOLESTATIC,28
GB,MALIGNANT NEOPLASM PROGRESSION,28
GB,MEDICATION ERROR,28
GB,NEURALGIA,28
GB,ANTIPSYCHOTIC DRUG LEVEL INCREASED,27
GB,CROHN^S DISEASE,27
GB,DIVERTICULITIS,27
GB,DYSSTASIA,27
GB,EOSINOPHIL COUNT INCREASED,27
GB,FEELING OF BODY TEMPERATURE CHANGE,27
GB,GASTRIC HAEMORRHAGE,27
GB,HAEMORRHOIDS,27
GB,HEART RATE DECREASED,27
GB,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,27
GB,INHIBITORY DRUG INTERACTION,27
GB,MASS,27
GB,METABOLIC ALKALOSIS,27
GB,MOUTH SWELLING,27
GB,NASOPHARYNGITIS,27
GB,PAIN IN JAW,27
GB,CHOLESTASIS,26
GB,COLITIS ULCERATIVE,26
GB,DIZZINESS POSTURAL,26
GB,DRUG DOSE OMISSION,26
GB,GLOSSODYNIA,26
GB,HAEMATOMA,26
GB,HEAD DISCOMFORT,26
GB,INTERNATIONAL NORMALISED RATIO ABNORMAL,26
GB,ISCHAEMIC STROKE,26
GB,OESOPHAGEAL ULCER,26
GB,OSTEONECROSIS OF JAW,26
GB,PARKINSONISM,26
GB,SELF-INJURIOUS IDEATION,26
GB,TEARFULNESS,26
GB,ATRIAL FLUTTER,25
GB,BRAIN OEDEMA,25
GB,CANDIDA INFECTION,25
GB,CARDIAC DISORDER,25
GB,DRY THROAT,25
GB,HALLUCINATION_ AUDITORY,25
GB,HYPOPHOSPHATAEMIA,25
GB,OCULAR HYPERAEMIA,25
GB,PSYCHIATRIC SYMPTOM,25
GB,RETCHING,25
GB,SUBDURAL HAEMATOMA,25
GB,TONGUE DISCOLOURATION,25
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,24
GB,ASPARTATE AMINOTRANSFERASE INCREASED,24
GB,CARDIAC FAILURE CONGESTIVE,24
GB,DRUG ABUSE,24
GB,ERUCTATION,24
GB,FEAR,24
GB,GASTRIC DISORDER,24
GB,LARGE INTESTINE PERFORATION,24
GB,LUNG DISORDER,24
GB,LYMPHOEDEMA,24
GB,MUSCULOSKELETAL CHEST PAIN,24
GB,PELVIC PAIN,24
GB,PRESCRIBED OVERDOSE,24
GB,SKIN DISORDER,24
GB,TETANY,24
GB,TREATMENT NONCOMPLIANCE,24
GB,VIITH NERVE PARALYSIS,24
GB,WEIGHT BEARING DIFFICULTY,24
GB,ACUTE HEPATIC FAILURE,23
GB,AGITATED DEPRESSION,23
GB,BLOOD POTASSIUM INCREASED,23
GB,BREAST PAIN,23
GB,DUODENITIS,23
GB,ECZEMA,23
GB,FLUID OVERLOAD,23
GB,HEPATOTOXICITY,23
GB,LUNG NEOPLASM MALIGNANT,23
GB,OBESITY,23
GB,PAIN OF SKIN,23
GB,PANIC REACTION,23
GB,PETECHIAE,23
GB,PRODUCT PACKAGING CONFUSION,23
GB,PURPURA,23
GB,SKIN ULCER,23
GB,TROPONIN INCREASED,23
GB,VENTRICULAR FIBRILLATION,23
GB,BLOOD ELECTROLYTES ABNORMAL,22
GB,BODY TEMPERATURE DECREASED,22
GB,CARDIOMYOPATHY,22
GB,CHOLELITHIASIS,22
GB,DRUG ADMINISTRATION ERROR,22
GB,FLUID INTAKE REDUCED,22
GB,GASTROENTERITIS,22
GB,HIP FRACTURE,22
GB,HYPOKINESIA,22
GB,INJECTION SITE PAIN,22
GB,INTESTINAL DILATATION,22
GB,MICTURITION URGENCY,22
GB,MUSCLE TIGHTNESS,22
GB,MYOCARDITIS,22
GB,RESPIRATORY TRACT INFECTION,22
GB,SENSORY LOSS,22
GB,SKIN WRINKLING,22
GB,STRESS FRACTURE,22
GB,TENSION HEADACHE,22
GB,TOOTH DISORDER,22
GB,VENTRICULAR TACHYCARDIA,22
GB,VULVOVAGINAL PAIN,22
GB,ADVERSE DRUG REACTION,21
GB,ANGER,21
GB,COLD SWEAT,21
GB,COMA SCALE ABNORMAL,21
GB,CONTRAINDICATED PRODUCT ADMINISTERED,21
GB,EYELID OEDEMA,21
GB,GENERALISED TONIC-CLONIC SEIZURE,21
GB,GINGIVITIS,21
GB,HYPOTHYROIDISM,21
GB,LYMPHOCYTE COUNT DECREASED,21
GB,NAIL DISORDER,21
GB,OSTEOMYELITIS,21
GB,POOR QUALITY SLEEP,21
GB,RHINORRHOEA,21
GB,SENSORY DISTURBANCE,21
GB,SINUS TACHYCARDIA,21
GB,STRESS,21
GB,SUBARACHNOID HAEMORRHAGE,21
GB,TYPE 2 DIABETES MELLITUS,21
GB,URINE OUTPUT DECREASED,21
GB,ASPIRATION,20
GB,ATAXIA,20
GB,ATRIOVENTRICULAR BLOCK,20
GB,DEAFNESS,20
GB,DIABETES MELLITUS INADEQUATE CONTROL,20
GB,DROOLING,20
GB,DRUG ERUPTION,20
GB,FAECALOMA,20
GB,GASTROINTESTINAL MOTILITY DISORDER,20
GB,INCONTINENCE,20
GB,INFLUENZA,20
GB,INFUSION RELATED REACTION,20
GB,LEFT VENTRICULAR DYSFUNCTION,20
GB,MOTOR DYSFUNCTION,20
GB,MUSCULOSKELETAL DISCOMFORT,20
GB,OBSTRUCTIVE AIRWAYS DISORDER,20
GB,PROCTALGIA,20
GB,PYELONEPHRITIS,20
GB,RASH VESICULAR,20
GB,RED BLOOD CELL SEDIMENTATION RATE INCREASED,20
GB,SEPTIC SHOCK,20
GB,SKIN FISSURES,20
GB,SKIN HAEMORRHAGE,20
GB,ANAL HAEMORRHAGE,19
GB,EYE PRURITUS,19
GB,FOOD INTERACTION,19
GB,GASTROINTESTINAL PAIN,19
GB,GINGIVAL PAIN,19
GB,HEPATIC ENZYME INCREASED,19
GB,HERPES ZOSTER,19
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,19
GB,INFLAMMATORY BOWEL DISEASE,19
GB,SCAB,19
GB,SKIN ATROPHY,19
GB,THINKING ABNORMAL,19
GB,THROMBOSIS,19
GB,TRANSAMINASES INCREASED,19
GB,VAGINAL DISCHARGE,19
GB,VITREOUS FLOATERS,19
GB,ABASIA,18
GB,ACUTE INTERSTITIAL PNEUMONITIS,18
GB,ACUTE PSYCHOSIS,18
GB,AMYLASE INCREASED,18
GB,APATHY,18
GB,ATRIOVENTRICULAR BLOCK COMPLETE,18
GB,BLOOD CREATINE INCREASED,18
GB,BRUXISM,18
GB,COMPLETED SUICIDE,18
GB,DERMATITIS BULLOUS,18
GB,DEVICE RELATED INFECTION,18
GB,DISSOCIATION,18
GB,ENCEPHALITIS,18
GB,GASTROINTESTINAL CARCINOMA,18
GB,GOUT,18
GB,HEPATIC CIRRHOSIS,18
GB,HYDROCEPHALUS,18
GB,HYPERVENTILATION,18
GB,MASTICATION DISORDER,18
GB,NEUTROPHILIA,18
GB,NON-CARDIAC CHEST PAIN,18
GB,ORAL DISCOMFORT,18
GB,PLEURITIC PAIN,18
GB,POTENTIATING DRUG INTERACTION,18
GB,PREMATURE BABY,18
GB,PRODUCT QUALITY ISSUE,18
GB,QUALITY OF LIFE DECREASED,18
GB,RHINITIS,18
GB,STEATORRHOEA,18
GB,VAGINAL HAEMORRHAGE,18
GB,VIRAL INFECTION,18
GB,VULVOVAGINAL CANDIDIASIS,18
GB,ATYPICAL FEMUR FRACTURE,17
GB,COGWHEEL RIGIDITY,17
GB,CORONARY ARTERY STENOSIS,17
GB,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,17
GB,DRUG WITHDRAWAL SYNDROME NEONATAL,17
GB,DUODENAL ULCER,17
GB,HERNIA,17
GB,HYPERAESTHESIA,17
GB,HYPOGEUSIA,17
GB,HYPOTONIA,17
GB,INCREASED APPETITE,17
GB,IRON DEFICIENCY ANAEMIA,17
GB,MICROCYTIC ANAEMIA,17
GB,MYDRIASIS,17
GB,NEOPLASM MALIGNANT,17
GB,NOCTURIA,17
GB,NYSTAGMUS,17
GB,OSTEOARTHRITIS,17
GB,OSTEONECROSIS,17
GB,OSTEOPOROSIS,17
GB,PAROSMIA,17
GB,PERICARDIAL EFFUSION,17
GB,PULMONARY HYPERTENSION,17
GB,RASH PUSTULAR,17
GB,STATUS EPILEPTICUS,17
GB,THERAPEUTIC RESPONSE UNEXPECTED,17
GB,VENTRICULAR DYSFUNCTION,17
GB,ANAL INCONTINENCE,16
GB,BACTERAEMIA,16
GB,BRONCHOPNEUMONIA,16
GB,CARDIOVASCULAR DISORDER,16
GB,CEREBRAL INFARCTION,16
GB,CHOKING,16
GB,CHOLECYSTITIS ACUTE,16
GB,COMMUNICATION DISORDER,16
GB,COMPARTMENT SYNDROME,16
GB,DILATATION INTRAHEPATIC DUCT ACQUIRED,16
GB,GROIN PAIN,16
GB,HEPATITIS ACUTE,16
GB,HYPERCALCAEMIA,16
GB,HYPOTHERMIA,16
GB,INJURY,16
GB,LONG QT SYNDROME,16
GB,MIGRAINE WITH AURA,16
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,16
GB,NASAL CONGESTION,16
GB,NASAL DRYNESS,16
GB,NEPHROLITHIASIS,16
GB,PEMPHIGOID,16
GB,PERIORBITAL OEDEMA,16
GB,RASH PAPULAR,16
GB,RESPIRATORY ARREST,16
GB,RESPIRATORY RATE INCREASED,16
GB,SMALL INTESTINAL OBSTRUCTION,16
GB,SUBDURAL HAEMORRHAGE,16
GB,TENDON RUPTURE,16
GB,TONGUE BITING,16
GB,ABDOMINAL PAIN LOWER,15
GB,ACIDOSIS,15
GB,APHAGIA,15
GB,ARTERIOSCLEROSIS,15
GB,BLADDER DISORDER,15
GB,BLINDNESS TRANSIENT,15
GB,BLOOD CHOLESTEROL INCREASED,15
GB,BLOOD URINE PRESENT,15
GB,BODY TEMPERATURE ABNORMAL,15
GB,BURSITIS,15
GB,COAGULOPATHY,15
GB,DENTAL CARIES,15
GB,FACIAL PAIN,15
GB,FAECAL INCONTINENCE,15
GB,FLANK PAIN,15
GB,FRACTURE,15
GB,FREQUENT BOWEL MOVEMENTS,15
GB,GASTROINTESTINAL STOMA COMPLICATION,15
GB,HAEMOLYSIS,15
GB,INTESTINAL ISCHAEMIA,15
GB,LAZINESS,15
GB,MENSTRUAL DISORDER,15
GB,METASTASES TO LIVER,15
GB,NEPHROPATHY TOXIC,15
GB,NON-SMALL CELL LUNG CANCER,15
GB,PANCREATIC PSEUDOCYST,15
GB,PENIS DISORDER,15
GB,PLASMA CELL MYELOMA,15
GB,PLEUROTHOTONUS,15
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,15
GB,STRIDOR,15
GB,VASCULITIS,15
GB,APRAXIA,14
GB,ARTHROPATHY,14
GB,BLINDNESS UNILATERAL,14
GB,BLOOD PHOSPHORUS DECREASED,14
GB,BLOOD TRIGLYCERIDES INCREASED,14
GB,BONE DISORDER,14
GB,BONE MARROW FAILURE,14
GB,BREAST SWELLING,14
GB,CONGENITAL THROMBOCYTOPENIA,14
GB,DIARRHOEA HAEMORRHAGIC,14
GB,DIVERTICULUM,14
GB,EYE DISCHARGE,14
GB,FEEDING DISORDER,14
GB,GASTRIC PH DECREASED,14
GB,HAIR COLOUR CHANGES,14
GB,HAIR TEXTURE ABNORMAL,14
GB,INTESTINAL PERFORATION,14
GB,ISCHAEMIA,14
GB,KETOACIDOSIS,14
GB,LIBIDO INCREASED,14
GB,LIP BLISTER,14
GB,LUNG CONSOLIDATION,14
GB,MUSCLE STRAIN,14
GB,MYOSITIS,14
GB,OTITIS EXTERNA,14
GB,PERICARDITIS,14
GB,POOR VENOUS ACCESS,14
GB,PULMONARY CONGESTION,14
GB,REACTION TO DRUG EXCIPIENTS,14
GB,SUBILEUS,14
GB,SYSTEMIC LUPUS ERYTHEMATOSUS,14
GB,TOOTH ABSCESS,14
GB,TORSADE DE POINTES,14
GB,UNEVALUABLE EVENT,14
GB,VENOOCCLUSIVE LIVER DISEASE,14
GB,VITAMIN D DEFICIENCY,14
GB,VULVOVAGINAL PRURITUS,14
GB,ADVERSE EVENT,13
GB,ANOSMIA,13
GB,BILIARY SEPSIS,13
GB,BLOOD GLUCOSE ABNORMAL,13
GB,BLOOD LACTIC ACID INCREASED,13
GB,BLOOD UREA INCREASED,13
GB,BRAIN INJURY,13
GB,CAMPYLOBACTER INFECTION,13
GB,CARDIOMEGALY,13
GB,CATARACT,13
GB,CHANGE OF BOWEL HABIT,13
GB,CONJUNCTIVITIS,13
GB,DEPERSONALISATION,13
GB,DRUG DISPENSED TO WRONG PATIENT,13
GB,DYSPHEMIA,13
GB,EXTRASYSTOLES,13
GB,FAECES PALE,13
GB,GASTROENTERITIS NOROVIRUS,13
GB,GINGIVAL SWELLING,13
GB,HAEMATOCHEZIA,13
GB,HEMIPLEGIA,13
GB,HEPATIC ENCEPHALOPATHY,13
GB,HEPATIC ENZYME ABNORMAL,13
GB,HEPATITIS CHOLESTATIC,13
GB,HOSPITALISATION,13
GB,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,13
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,13
GB,INTELLECTUAL DISABILITY,13
GB,LIP ULCERATION,13
GB,LOCALISED INFECTION,13
GB,LOSS OF LIBIDO,13
GB,MACROCYTOSIS,13
GB,MACULAR HOLE,13
GB,ORAL DISORDER,13
GB,RECTAL DISCHARGE,13
GB,RED BLOOD CELL COUNT DECREASED,13
GB,SINUSITIS,13
GB,SKIN LESION,13
GB,SLOW SPEECH,13
GB,TENDON DISORDER,13
GB,ABULIA,12
GB,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,12
GB,AMYLOIDOSIS,12
GB,APPETITE DISORDER,12
GB,ARTERIOSPASM CORONARY,12
GB,BARRETT^S OESOPHAGUS,12
GB,BLOOD COUNT ABNORMAL,12
GB,EMBOLISM,12
GB,EYE DISORDER,12
GB,FORMICATION,12
GB,GENERALISED OEDEMA,12
GB,H1N1 INFLUENZA,12
GB,HAEMORRHAGIC DIATHESIS,12
GB,HYDRONEPHROSIS,12
GB,HYPEROSMOLAR STATE,12
GB,HYPERTONIA,12
GB,HYPOPARATHYROIDISM SECONDARY,12
GB,HYPOVENTILATION,12
GB,LEUKOCYTOSIS,12
GB,LOOSE TOOTH,12
GB,LYMPHOMA,12
GB,METASTATIC NEOPLASM,12
GB,MUCOSAL ULCERATION,12
GB,OLIGURIA,12
GB,OROPHARYNGEAL SWELLING,12
GB,PAPULE,12
GB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,12
GB,PSORIATIC ARTHROPATHY,12
GB,RENAL TUBULAR ACIDOSIS,12
GB,RESPIRATION ABNORMAL,12
GB,SCREAMING,12
GB,SINUS BRADYCARDIA,12
GB,SKIN STRIAE,12
GB,SKIN WARM,12
GB,SPINAL PAIN,12
GB,STAPHYLOCOCCAL SCALDED SKIN SYNDROME,12
GB,SUPRAVENTRICULAR TACHYCARDIA,12
GB,TESTICULAR PAIN,12
GB,THERAPEUTIC RESPONSE DECREASED,12
GB,THERAPY CESSATION,12
GB,TONGUE ULCERATION,12
GB,TOOTH INFECTION,12
GB,TRANSFUSION,12
GB,USE OF ACCESSORY RESPIRATORY MUSCLES,12
GB,VASCULITIC RASH,12
GB,VULVOVAGINAL DRYNESS,12
GB,WOUND SECRETION,12
GB,ACUTE MYELOID LEUKAEMIA,11
GB,AGRANULOCYTOSIS,11
GB,ALTERED STATE OF CONSCIOUSNESS,11
GB,ALVEOLITIS ALLERGIC,11
GB,ATYPICAL FRACTURE,11
GB,BACK INJURY,11
GB,BIPOLAR I DISORDER,11
GB,BLADDER CANCER,11
GB,BLOOD DISORDER,11
GB,BRAIN COMPRESSION,11
GB,BRONCHIECTASIS,11
GB,CARDIAC FAILURE ACUTE,11
GB,CEREBRAL ARTERIOSCLEROSIS,11
GB,CEREBRAL HAEMATOMA,11
GB,CHOLECYSTITIS,11
GB,COELIAC DISEASE,11
GB,CREPITATIONS,11
GB,CYSTITIS,11
GB,DRUG DEPENDENCE,11
GB,DUODENAL STENOSIS,11
GB,DUODENAL ULCER HAEMORRHAGE,11
GB,DUODENAL ULCER PERFORATION,11
GB,ESCHERICHIA INFECTION,11
GB,EXERCISE TOLERANCE DECREASED,11
GB,FANCONI SYNDROME,11
GB,FEELING DRUNK,11
GB,FEELING JITTERY,11
GB,FURUNCLE,11
GB,GRANULOMA ANNULARE,11
GB,HAEMATOCRIT DECREASED,11
GB,HAEMORRHAGIC STROKE,11
GB,HEPATIC PAIN,11
GB,HUMERUS FRACTURE,11
GB,HYPERACUSIS,11
GB,HYPOVOLAEMIA,11
GB,IMPAIRED QUALITY OF LIFE,11
GB,INCOHERENT,11
GB,INDURATION,11
GB,INJECTION SITE ERYTHEMA,11
GB,JOINT DISLOCATION,11
GB,KIDNEY INFECTION,11
GB,LACRIMATION INCREASED,11
GB,LARYNGOSPASM,11
GB,MACULAR DEGENERATION,11
GB,MACULAR DETACHMENT,11
GB,MEDICATION MONITORING ERROR,11
GB,MELANOCYTIC NAEVUS,11
GB,OESOPHAGEAL CARCINOMA,11
GB,ONYCHOCLASIS,11
GB,ORAL MUCOSAL BLISTERING,11
GB,PHARYNGITIS,11
GB,POSTOPERATIVE WOUND INFECTION,11
GB,PREMATURE LABOUR,11
GB,PROSTATE CANCER METASTATIC,11
GB,PULSELESS ELECTRICAL ACTIVITY,11
GB,RETINOPATHY,11
GB,SEPSIS NEONATAL,11
GB,SKIN DEPIGMENTATION,11
GB,SKIN MASS,11
GB,SKIN PLAQUE,11
GB,SKIN REACTION,11
GB,SKIN SWELLING,11
GB,STAPHYLOCOCCAL INFECTION,11
GB,SUDDEN DEATH,11
GB,TACHYPHRENIA,11
GB,TACHYPNOEA,11
GB,TETANUS,11
GB,TRISMUS,11
GB,URETERIC OBSTRUCTION,11
GB,URINE FLOW DECREASED,11
GB,UVEITIS,11
GB,VENTRICULAR ARRHYTHMIA,11
GB,VITREOUS DETACHMENT,11
GB,VULVOVAGINAL DISCOMFORT,11
GB,ABDOMINAL SEPSIS,10
GB,ABSCESS,10
GB,ACNE,10
GB,ADRENAL INSUFFICIENCY,10
GB,ALVEOLAR PROTEINOSIS,10
GB,ANAL PRURITUS,10
GB,ANAPHYLACTOID REACTION,10
GB,ANGIOPATHY,10
GB,APHONIA,10
GB,BLOOD ALBUMIN DECREASED,10
GB,BLOODY DISCHARGE,10
GB,BOWEL MOVEMENT IRREGULARITY,10
GB,BREAST TENDERNESS,10
GB,BRONCHIAL IRRITATION,10
GB,CHAPPED LIPS,10
GB,CHEILITIS,10
GB,CONGESTIVE CARDIOMYOPATHY,10
GB,DERMATITIS CONTACT,10
GB,DIALYSIS,10
GB,DIFFUSE LARGE B-CELL LYMPHOMA,10
GB,DIVERTICULAR PERFORATION,10
GB,EAR INFECTION,10
GB,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,10
GB,EYE HAEMORRHAGE,10
GB,EYE INFECTION,10
GB,EYE MOVEMENT DISORDER,10
GB,FOETAL GROWTH RESTRICTION,10
GB,FOOT FRACTURE,10
GB,HAND-EYE COORDINATION IMPAIRED,10
GB,HYPERBILIRUBINAEMIA,10
GB,HYPERCHLORHYDRIA,10
GB,HYPERPROTEINAEMIA,10
GB,IMPAIRED DRIVING ABILITY,10
GB,INTRAOCULAR PRESSURE INCREASED,10
GB,INVASIVE DUCTAL BREAST CARCINOMA,10
GB,LACERATION,10
GB,LIP DISCOLOURATION,10
GB,LIP DRY,10
GB,LUNG CANCER METASTATIC,10
GB,MAGNESIUM DEFICIENCY,10
GB,MALABSORPTION,10
GB,MEAN CELL VOLUME INCREASED,10
GB,MENOPAUSAL SYMPTOMS,10
GB,METASTASES TO LUNG,10
GB,MUCOSAL DRYNESS,10
GB,MUSCLE CONTRACTIONS INVOLUNTARY,10
GB,MYELODYSPLASTIC SYNDROME,10
GB,MYELOFIBROSIS,10
GB,NEOPLASM PROGRESSION,10
GB,NON-SMALL CELL LUNG CANCER METASTATIC,10
GB,PANCREATIC CARCINOMA,10
GB,PARTIAL SEIZURES,10
GB,PHARYNGEAL HAEMORRHAGE,10
GB,REACTION TO EXCIPIENT,10
GB,SECOND PRIMARY MALIGNANCY,10
GB,SEIZURE LIKE PHENOMENA,10
GB,SKIN EROSION,10
GB,SKIN HYPERPIGMENTATION,10
GB,SOMNAMBULISM,10
GB,SWEAT DISCOLOURATION,10
GB,TEMPORAL ARTERITIS,10
GB,THROMBOTIC MICROANGIOPATHY,10
GB,TONGUE BLISTERING,10
GB,TONGUE DISCOMFORT,10
GB,TOOTH INJURY,10
GB,TRICHORRHEXIS,10
GB,VASCULAR PAIN,10
GB,VENTRICULAR EXTRASYSTOLES,10
GB,VITH NERVE PARALYSIS,10
GB,ABDOMINAL WALL HAEMATOMA,9
GB,ABNORMAL SENSATION IN EYE,9
GB,AKATHISIA,9
GB,AMENORRHOEA,9
GB,AORTIC ARTERIOSCLEROSIS,9
GB,ARTHROPOD STING,9
GB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,9
GB,BINGE EATING,9
GB,BLISTER RUPTURE,9
GB,BREAST DISCOMFORT,9
GB,BRONCHOPULMONARY ASPERGILLOSIS,9
GB,BUNDLE BRANCH BLOCK LEFT,9
GB,C-REACTIVE PROTEIN DECREASED,9
GB,COMA,9
GB,CORONARY ARTERY THROMBOSIS,9
GB,DISABILITY,9
GB,DISINHIBITION,9
GB,DISSEMINATED INTRAVASCULAR COAGULATION,9
GB,ENDOCARDITIS,9
GB,FEELING OF DESPAIR,9
GB,GENERALISED ERYTHEMA,9
GB,HAEMOGLOBIN INCREASED,9
GB,HEAD TITUBATION,9
GB,HEPATORENAL SYNDROME,9
GB,HICCUPS,9
GB,INCORRECT DRUG ADMINISTRATION DURATION,9
GB,INCREASED TENDENCY TO BRUISE,9
GB,INFUSION SITE PAIN,9
GB,INJECTION SITE SWELLING,9
GB,INTERNATIONAL NORMALISED RATIO DECREASED,9
GB,INTESTINAL OBSTRUCTION,9
GB,JOINT LOCK,9
GB,LARYNGEAL OEDEMA,9
GB,LEUKOENCEPHALOPATHY,9
GB,LIVE BIRTH,9
GB,LOCALISED INTRAABDOMINAL FLUID COLLECTION,9
GB,MACROGLOSSIA,9
GB,MENINGITIS ASEPTIC,9
GB,METASTASES TO CENTRAL NERVOUS SYSTEM,9
GB,METASTATIC MALIGNANT MELANOMA,9
GB,MOUTH HAEMORRHAGE,9
GB,MULTIPLE SCLEROSIS RELAPSE,9
US,DRUG INEFFECTIVE,4802
US,FATIGUE,4437
US,NAUSEA,4179
US,DIARRHOEA,4047
US,DYSPNOEA,3234
US,HEADACHE,3030
US,PAIN,2910
US,DIZZINESS,2625
US,VOMITING,2197
US,FALL,2180
US,ARTHRALGIA,2154
US,ASTHENIA,2143
US,MALAISE,2105
US,DRUG DOSE OMISSION,2047
US,PNEUMONIA,2025
US,WEIGHT DECREASED,1827
US,PAIN IN EXTREMITY,1792
US,COUGH,1714
US,DEATH,1685
US,RASH,1668
US,BACK PAIN,1561
US,INSOMNIA,1521
US,DECREASED APPETITE,1370
US,INJECTION SITE PAIN,1356
US,CONSTIPATION,1355
US,PRURITUS,1353
US,ABDOMINAL PAIN UPPER,1328
US,ABDOMINAL PAIN,1273
US,ANXIETY,1256
US,FEELING ABNORMAL,1251
US,DEPRESSION,1243
US,ANAEMIA,1200
US,MUSCLE SPASMS,1188
US,PYREXIA,1178
US,WEIGHT INCREASED,1177
US,CHEST PAIN,1105
US,GASTROOESOPHAGEAL REFLUX DISEASE,1100
US,HYPERTENSION,1083
US,GAIT DISTURBANCE,1078
US,ABDOMINAL DISCOMFORT,1070
US,URINARY TRACT INFECTION,1051
US,CONDITION AGGRAVATED,1028
US,PERIPHERAL SWELLING,1020
US,GASTROINTESTINAL HAEMORRHAGE,1013
US,NASOPHARYNGITIS,942
US,DEHYDRATION,885
US,PRODUCT USE ISSUE,867
US,HYPOAESTHESIA,865
US,DYSPEPSIA,852
US,MEMORY IMPAIRMENT,840
US,ALOPECIA,826
US,SOMNOLENCE,821
US,SINUSITIS,796
US,TREMOR,787
US,PARAESTHESIA,778
US,PRODUCT QUALITY ISSUE,776
US,MYALGIA,751
US,HYPOTENSION,741
US,BRONCHITIS,726
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,722
US,OEDEMA PERIPHERAL,700
US,DRUG HYPERSENSITIVITY,692
US,CONFUSIONAL STATE,689
US,CONTUSION,686
US,INCORRECT DOSE ADMINISTERED,681
US,MUSCULAR WEAKNESS,673
US,BLOOD PRESSURE INCREASED,668
US,ARTHRITIS,655
US,BLOOD GLUCOSE INCREASED,650
US,VISION BLURRED,626
US,NEUROPATHY PERIPHERAL,622
US,INTENTIONAL PRODUCT MISUSE,620
US,JOINT SWELLING,619
US,OROPHARYNGEAL PAIN,614
US,ABDOMINAL DISTENSION,613
US,MYOCARDIAL INFARCTION,609
US,CEREBROVASCULAR ACCIDENT,606
US,INFLUENZA,595
US,ATRIAL FIBRILLATION,592
US,HYPERSENSITIVITY,588
US,BALANCE DISORDER,579
US,HAEMOGLOBIN DECREASED,578
US,DRY MOUTH,574
US,HYPERHIDROSIS,571
US,ACUTE KIDNEY INJURY,565
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,565
US,DYSGEUSIA,554
US,CARDIAC FAILURE CONGESTIVE,549
US,PSORIASIS,544
US,ERYTHEMA,537
US,INJECTION SITE ERYTHEMA,529
US,PULMONARY EMBOLISM,524
US,CHEST DISCOMFORT,515
US,DYSPHAGIA,513
US,DEEP VEIN THROMBOSIS,512
US,RHEUMATOID ARTHRITIS,509
US,WHITE BLOOD CELL COUNT DECREASED,509
US,CHILLS,504
US,EPISTAXIS,498
US,SEPSIS,492
US,DYSPHONIA,491
US,URTICARIA,491
US,CROHN^S DISEASE,486
US,MUSCULOSKELETAL PAIN,485
US,INFECTION,484
US,FLUSHING,482
US,ASTHMA,481
US,THROMBOSIS,481
US,LOSS OF CONSCIOUSNESS,477
US,INJECTION SITE BRUISING,476
US,PLATELET COUNT DECREASED,476
US,RENAL FAILURE,461
US,VISUAL IMPAIRMENT,454
US,FLATULENCE,447
US,PALPITATIONS,446
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,446
US,OSTEOARTHRITIS,443
US,DISEASE PROGRESSION,441
US,INFLUENZA LIKE ILLNESS,436
US,COMPLETED SUICIDE,423
US,MUSCULOSKELETAL STIFFNESS,411
US,MIGRAINE,407
US,OSTEOPOROSIS,406
US,SYNCOPE,406
US,DRUG EFFECT INCOMPLETE,402
US,DRY SKIN,398
US,SEIZURE,398
US,BURNING SENSATION,389
US,DRUG EFFECT DECREASED,387
US,CATARACT,385
US,HAEMORRHAGE,380
US,TOXICITY TO VARIOUS AGENTS,380
US,STOMATITIS,374
US,SWELLING,373
US,HEART RATE INCREASED,370
US,UPPER RESPIRATORY TRACT INFECTION,366
US,HOT FLUSH,365
US,DIABETES MELLITUS,363
US,RHINORRHOEA,363
US,NECK PAIN,362
US,BONE PAIN,354
US,NASAL CONGESTION,351
US,THERAPEUTIC RESPONSE UNEXPECTED,350
US,FLUID RETENTION,349
US,INJECTION SITE PRURITUS,344
US,RECTAL HAEMORRHAGE,343
US,INJECTION SITE HAEMORRHAGE,342
US,THROMBOCYTOPENIA,342
US,AMNESIA,338
US,UNEVALUABLE EVENT,330
US,PRODUCTIVE COUGH,328
US,STRESS,327
US,INJURY,326
US,CARDIAC DISORDER,324
US,PLASMA CELL MYELOMA,318
US,BLOOD CHOLESTEROL INCREASED,317
US,CELLULITIS,315
US,RESPIRATORY FAILURE,315
US,ARTHROPATHY,313
US,HERPES ZOSTER,307
US,RASH PRURITIC,307
US,ADVERSE EVENT,306
US,HOSPITALISATION,303
US,MALIGNANT NEOPLASM PROGRESSION,303
US,MULTIPLE SCLEROSIS RELAPSE,300
US,HAEMATOCHEZIA,299
US,PRODUCT USE IN UNAPPROVED INDICATION,298
US,NERVOUSNESS,295
US,OVERDOSE,288
US,POLLAKIURIA,288
US,WHEEZING,288
US,HEPATIC ENZYME INCREASED,283
US,PLEURAL EFFUSION,282
US,BLOOD POTASSIUM DECREASED,279
US,BLISTER,278
US,DRUG INTOLERANCE,278
US,GASTRIC DISORDER,278
US,HALLUCINATION,277
US,GASTROINTESTINAL DISORDER,276
US,THROAT IRRITATION,276
US,OEDEMA,274
US,SLEEP APNOEA SYNDROME,273
US,SWELLING FACE,273
US,NEUTROPENIA,269
US,INJECTION SITE SWELLING,267
US,UNDERDOSE,267
US,FEELING HOT,264
US,VERTIGO,263
US,LETHARGY,261
US,NEPHROLITHIASIS,261
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,259
US,INCORRECT DRUG ADMINISTRATION DURATION,257
US,MOBILITY DECREASED,255
US,THERAPY CESSATION,255
US,DEVICE ISSUE,253
US,STAPHYLOCOCCAL INFECTION,253
US,DYSPNOEA EXERTIONAL,250
US,SKIN DISCOLOURATION,249
US,IRRITABILITY,248
US,SLEEP DISORDER,247
US,INTENTIONAL PRODUCT USE ISSUE,241
US,OXYGEN SATURATION DECREASED,240
US,ADVERSE DRUG REACTION,239
US,SUICIDAL IDEATION,239
US,CLOSTRIDIUM DIFFICILE INFECTION,235
US,BLOOD CREATININE INCREASED,234
US,AGITATION,233
US,CHOLELITHIASIS,232
US,SKIN EXFOLIATION,232
US,NIGHT SWEATS,231
US,INJECTION SITE REACTION,228
US,PANCYTOPENIA,226
US,ABASIA,225
US,EMOTIONAL DISTRESS,225
US,PANCREATITIS,224
US,CYSTITIS,223
US,HIATUS HERNIA,221
US,LOCAL SWELLING,220
US,DEVICE MALFUNCTION,219
US,FIBROMYALGIA,219
US,DISTURBANCE IN ATTENTION,218
US,HAEMATURIA,218
US,DYSURIA,217
US,DIVERTICULITIS,216
US,IMPAIRED HEALING,212
US,ACTIVITIES OF DAILY LIVING IMPAIRED,210
US,INTERVERTEBRAL DISC PROTRUSION,209
US,GASTRITIS,208
US,TRANSIENT ISCHAEMIC ATTACK,207
US,DRUG WITHDRAWAL SYNDROME,206
US,ORAL PAIN,205
US,CARDIAC ARREST,204
US,FULL BLOOD COUNT DECREASED,204
US,BONE DISORDER,203
US,RED BLOOD CELL COUNT DECREASED,203
US,PULMONARY OEDEMA,202
US,WHITE BLOOD CELL COUNT INCREASED,201
US,HYPOKALAEMIA,200
US,NO ADVERSE EVENT,200
US,BLOOD PRESSURE DECREASED,197
US,COLITIS,197
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,197
US,DRY EYE,197
US,HEAD INJURY,197
US,HAEMOPTYSIS,196
US,HAEMORRHOIDS,193
US,PRODUCT SUBSTITUTION ISSUE,191
US,RENAL IMPAIRMENT,191
US,TREATMENT NONCOMPLIANCE,191
US,RENAL DISORDER,190
US,UPPER GASTROINTESTINAL HAEMORRHAGE,190
US,HIP FRACTURE,189
US,TACHYCARDIA,189
US,INTESTINAL OBSTRUCTION,188
US,LUNG DISORDER,188
US,TINNITUS,188
US,MENTAL STATUS CHANGES,187
US,RENAL FAILURE ACUTE,186
US,DRUG ADMINISTRATION ERROR,185
US,HYPONATRAEMIA,185
US,INTENTIONAL DRUG MISUSE,185
US,ROAD TRAFFIC ACCIDENT,185
US,BLOOD GLUCOSE DECREASED,184
US,SPEECH DISORDER,184
US,LIMB DISCOMFORT,183
US,GENERAL PHYSICAL HEALTH DETERIORATION,181
US,URINARY INCONTINENCE,181
US,BODY HEIGHT DECREASED,179
US,FUNGAL INFECTION,179
US,DEPRESSED MOOD,175
US,INTERVERTEBRAL DISC DEGENERATION,175
US,RIB FRACTURE,173
US,DISCOMFORT,171
US,PAIN IN JAW,171
US,EXPIRED PRODUCT ADMINISTERED,169
US,EYE PAIN,168
US,HYPOACUSIS,168
US,FOOT FRACTURE,166
US,HYPOXIA,166
US,PRE-EXISTING CONDITION IMPROVED,166
US,FEBRILE NEUTROPENIA,165
US,THERAPEUTIC RESPONSE DECREASED,164
US,DISORIENTATION,163
US,RASH ERYTHEMATOUS,163
US,TYPE 2 DIABETES MELLITUS,162
US,HYPOTHYROIDISM,161
US,CORONARY ARTERY DISEASE,160
US,EYE IRRITATION,160
US,DYSARTHRIA,159
US,LYMPHADENOPATHY,159
US,CARDIAC FAILURE,158
US,GALLBLADDER DISORDER,158
US,OSTEOPENIA,158
US,FAECES DISCOLOURED,156
US,HYPERSOMNIA,155
US,HYPOPHAGIA,154
US,NEURALGIA,154
US,PRURITUS GENERALISED,154
US,URINARY RETENTION,154
US,SINUS DISORDER,153
US,ACUTE RESPIRATORY FAILURE,152
US,ROTATOR CUFF SYNDROME,152
US,CHRONIC KIDNEY DISEASE,151
US,ERUCTATION,151
US,HAEMORRHAGIC ANAEMIA,150
US,VISUAL ACUITY REDUCED,150
US,VITAMIN D DEFICIENCY,149
US,ALANINE AMINOTRANSFERASE INCREASED,148
US,GLOSSODYNIA,148
US,JOINT INJURY,148
US,SWOLLEN TONGUE,148
US,ASPARTATE AMINOTRANSFERASE INCREASED,147
US,BACK DISORDER,147
US,LACERATION,147
US,SURGERY,147
US,CRYING,146
US,CARPAL TUNNEL SYNDROME,145
US,PANIC ATTACK,145
US,CANDIDA INFECTION,144
US,COGNITIVE DISORDER,144
US,RASH GENERALISED,144
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,143
US,OCULAR HYPERAEMIA,143
US,BLOOD URINE PRESENT,142
US,LIMB INJURY,142
US,PSORIATIC ARTHROPATHY,142
US,ARRHYTHMIA,141
US,DYSSTASIA,141
US,MUSCULOSKELETAL DISCOMFORT,141
US,PULMONARY HYPERTENSION,141
US,CHROMATURIA,140
US,FEMUR FRACTURE,140
US,INTERNAL HAEMORRHAGE,139
US,SPINAL FRACTURE,139
US,DYSKINESIA,138
US,MOVEMENT DISORDER,138
US,RESTLESS LEGS SYNDROME,138
US,VIRAL INFECTION,138
US,ACNE,137
US,HERNIA,137
US,NEOPLASM MALIGNANT,137
US,RETCHING,137
US,WITHDRAWAL SYNDROME,137
US,BLOOD COUNT ABNORMAL,136
US,EYE SWELLING,136
US,FREQUENT BOWEL MOVEMENTS,136
US,LUNG INFECTION,136
US,COAGULOPATHY,135
US,RASH MACULAR,135
US,JOINT STIFFNESS,134
US,SMALL INTESTINAL OBSTRUCTION,134
US,EAR INFECTION,133
US,GLAUCOMA,133
US,IRRITABLE BOWEL SYNDROME,133
US,SEPTIC SHOCK,133
US,FEELING COLD,132
US,VAGINAL HAEMORRHAGE,132
US,HYPERLIPIDAEMIA,131
US,SPINAL OSTEOARTHRITIS,131
US,GASTROENTERITIS VIRAL,130
US,LABORATORY TEST ABNORMAL,130
US,INFLAMMATION,129
US,IRON DEFICIENCY ANAEMIA,129
US,LACRIMATION INCREASED,129
US,DRUG PRESCRIBING ERROR,128
US,UPPER LIMB FRACTURE,128
US,COLITIS ULCERATIVE,127
US,GOUT,127
US,INJECTION SITE RASH,127
US,MEDICATION ERROR,127
US,INJECTION SITE MASS,126
US,LEUKOPENIA,126
US,LIVER DISORDER,126
US,SKIN ULCER,126
US,MULTIPLE FRACTURES,125
US,HEART RATE DECREASED,124
US,ABNORMAL BEHAVIOUR,123
US,BREAST CANCER,123
US,FLUID OVERLOAD,123
US,LIP SWELLING,123
US,LOCALISED INFECTION,123
US,LUNG NEOPLASM MALIGNANT,123
US,MALABSORPTION,123
US,TUBULOINTERSTITIAL NEPHRITIS,123
US,POOR QUALITY SLEEP,122
US,INFUSION RELATED REACTION,121
US,SNEEZING,121
US,ANKLE FRACTURE,120
US,EYE DISORDER,120
US,ANGINA PECTORIS,119
US,MOOD SWINGS,119
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,119
US,TOOTH DISORDER,119
US,CEREBRAL HAEMORRHAGE,118
US,MUSCULOSKELETAL CHEST PAIN,118
US,RESTLESSNESS,118
US,SKIN LESION,118
US,HAEMATEMESIS,117
US,MENTAL DISORDER,117
US,PULMONARY MASS,117
US,CHOKING,116
US,EXOSTOSIS,116
US,WOUND,116
US,FEELING JITTERY,115
US,HAEMATOCRIT DECREASED,115
US,BLOOD SODIUM DECREASED,114
US,NIGHTMARE,114
US,SKIN DISORDER,114
US,LOWER GASTROINTESTINAL HAEMORRHAGE,113
US,RESPIRATORY TRACT CONGESTION,113
US,RESPIRATORY TRACT INFECTION,113
US,AGEUSIA,112
US,EXTRA DOSE ADMINISTERED,112
US,PERICARDIAL EFFUSION,112
US,BLOOD MAGNESIUM DECREASED,111
US,CONVULSION,111
US,INCREASED TENDENCY TO BRUISE,111
US,KIDNEY INFECTION,111
US,NEOPLASM PROGRESSION,111
US,PRODUCT ADHESION ISSUE,111
US,SINUS CONGESTION,111
US,CORONARY ARTERY OCCLUSION,110
US,DEAFNESS,110
US,EAR PAIN,110
US,GASTRIC ULCER,110
US,LIVER FUNCTION TEST ABNORMAL,110
US,ACUTE MYOCARDIAL INFARCTION,109
US,MUSCLE TWITCHING,109
US,RASH PAPULAR,109
US,CARDIO-RESPIRATORY ARREST,108
US,HYPERGLYCAEMIA,108
US,HYPOGLYCAEMIA,108
US,INTERNATIONAL NORMALISED RATIO INCREASED,108
US,MOOD ALTERED,108
US,PHARYNGEAL OEDEMA,108
US,APHASIA,106
US,SCIATICA,106
US,THYROID DISORDER,106
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,105
US,THROAT TIGHTNESS,105
US,ABNORMAL DREAMS,104
US,ANGER,104
US,BURSITIS,104
US,HAEMATOMA,104
US,UNRESPONSIVE TO STIMULI,104
US,EATING DISORDER,103
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,103
US,HYPERKALAEMIA,103
US,SPINAL COLUMN STENOSIS,103
US,TOOTHACHE,103
US,ULCER,103
US,HEAD DISCOMFORT,102
US,HEPATIC STEATOSIS,102
US,ORAL DISCOMFORT,102
US,ASCITES,101
US,BLINDNESS,101
US,RHABDOMYOLYSIS,101
US,DELIRIUM,100
US,FEEDING DISORDER,100
US,HEPATIC CIRRHOSIS,100
US,MENTAL IMPAIRMENT,100
US,INJECTION SITE URTICARIA,99
US,LEUKOCYTOSIS,99
US,NERVE INJURY,99
US,PRESYNCOPE,99
US,SPLENOMEGALY,99
US,BLOOD TRIGLYCERIDES INCREASED,98
US,DIVERTICULUM,98
US,RESPIRATORY DISTRESS,98
US,SEASONAL ALLERGY,98
US,DEMENTIA,97
US,MULTIPLE SCLEROSIS,97
US,OSTEOMYELITIS,97
US,OSTEONECROSIS OF JAW,97
US,SKIN BURNING SENSATION,97
US,THINKING ABNORMAL,97
US,APPLICATION SITE ERYTHEMA,96
US,HEART RATE IRREGULAR,96
US,IMPAIRED GASTRIC EMPTYING,96
US,PRODUCT PHYSICAL ISSUE,96
US,BLOOD PRESSURE ABNORMAL,95
US,ENCEPHALOPATHY,95
US,LOWER LIMB FRACTURE,95
US,ORAL CANDIDIASIS,95
US,SKIN CANCER,95
US,DIPLOPIA,94
US,NEUTROPHIL COUNT DECREASED,93
US,ABDOMINAL PAIN LOWER,92
US,ABNORMAL LOSS OF WEIGHT,92
US,ANAPHYLACTIC REACTION,92
US,BRADYCARDIA,92
US,LARGE INTESTINE POLYP,92
US,RESPIRATORY DISORDER,92
US,VITAMIN D DECREASED,92
US,BLOOD IRON DECREASED,91
US,ELECTROCARDIOGRAM QT PROLONGED,90
US,PROCEDURAL PAIN,90
US,APHONIA,89
US,AGGRESSION,88
US,BASAL CELL CARCINOMA,88
US,CLOSTRIDIUM DIFFICILE COLITIS,88
US,HAIR TEXTURE ABNORMAL,88
US,WRIST FRACTURE,88
US,EYE PRURITUS,87
US,HYPOMAGNESAEMIA,87
US,KNEE ARTHROPLASTY,87
US,NODULE,87
US,OESOPHAGITIS,87
US,ACCIDENTAL EXPOSURE TO PRODUCT,86
US,CHOLECYSTECTOMY,86
US,EMOTIONAL DISORDER,86
US,FEAR,86
US,INTENTIONAL OVERDOSE,86
US,JOINT DISLOCATION,86
US,PULMONARY ARTERIAL HYPERTENSION,86
US,DENTAL CARIES,85
US,HAIR COLOUR CHANGES,85
US,ILL-DEFINED DISORDER,85
US,INCREASED APPETITE,85
US,PRESCRIBED OVERDOSE,85
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,85
US,LARYNGITIS,84
US,UPPER-AIRWAY COUGH SYNDROME,84
US,BLOOD POTASSIUM INCREASED,83
US,LIGAMENT SPRAIN,83
US,SUICIDE ATTEMPT,83
US,PNEUMONIA ASPIRATION,82
US,ATELECTASIS,81
US,DRY THROAT,81
US,HYPOAESTHESIA ORAL,81
US,MUSCLE TIGHTNESS,81
US,TREATMENT FAILURE,81
US,INCORRECT PRODUCT STORAGE,80
US,MANIA,80
US,MASS,80
US,PELVIC PAIN,80
US,BLOOD TESTOSTERONE DECREASED,79
US,MELAENA,79
US,MICTURITION URGENCY,79
US,NERVE COMPRESSION,79
US,NERVOUS SYSTEM DISORDER,79
US,PNEUMONITIS,79
US,PROSTATE CANCER,79
US,SCAR,79
US,BLOOD ALKALINE PHOSPHATASE INCREASED,78
US,PANCREATITIS ACUTE,78
US,PULMONARY THROMBOSIS,78
US,SUBDURAL HAEMATOMA,78
US,ANGIOEDEMA,77
US,MUSCULOSKELETAL DISORDER,77
US,PRODUCT TASTE ABNORMAL,77
US,RENAL CYST,77
US,TENDERNESS,77
US,BLOOD UREA INCREASED,76
US,CHOLECYSTITIS CHRONIC,76
US,COLD SWEAT,76
US,HEPATIC FAILURE,76
US,PAIN OF SKIN,76
US,BACTERIAL INFECTION,75
US,DEVICE RELATED INFECTION,75
US,EXPOSURE DURING PREGNANCY,75
US,INJECTION SITE WARMTH,75
US,OBESITY,75
US,SYSTEMIC LUPUS ERYTHEMATOSUS,75
US,TRANSFUSION,75
US,APPLICATION SITE PRURITUS,74
US,BARRETT^S OESOPHAGUS,74
US,CYST,74
US,MOUTH ULCERATION,74
US,NOCTURIA,74
US,THIRST,74
US,BLOOD GLUCOSE ABNORMAL,73
US,EYE INFECTION,73
US,INJECTION SITE NODULE,73
US,MACULAR DEGENERATION,73
US,MUCOSAL INFLAMMATION,73
US,ORTHOSTATIC HYPOTENSION,73
US,PLATELET COUNT INCREASED,73
US,SEDATION,73
US,SEROTONIN SYNDROME,73
US,TOOTH FRACTURE,73
US,CHOLECYSTITIS,72
US,DISABILITY,72
US,EMPHYSEMA,72
US,FLANK PAIN,72
US,HYPOCALCAEMIA,72
US,INCONTINENCE,72
US,TOOTH ABSCESS,72
US,BLADDER DISORDER,71
US,CARDIOMEGALY,71
US,HAEMORRHAGE INTRACRANIAL,71
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,71
US,PNEUMOTHORAX,71
US,PULMONARY FIBROSIS,71
US,ANHEDONIA,70
US,ECZEMA,70
US,GAIT INABILITY,70
US,HEPATITIS C,70
US,IMPAIRED WORK ABILITY,70
US,METASTASES TO BONE,70
US,PALLOR,70
US,TOOTH LOSS,70
US,DERMATITIS,69
US,HUNGER,69
US,LYMPHOCYTE COUNT DECREASED,69
US,SPINAL COMPRESSION FRACTURE,69
US,TENDONITIS,69
US,BLOOD PRESSURE FLUCTUATION,68
US,BONE DENSITY DECREASED,68
US,MIDDLE INSOMNIA,68
US,SENSORY DISTURBANCE,68
US,APHAGIA,67
US,CARDIOMYOPATHY,67
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,67
US,DIABETIC KETOACIDOSIS,67
US,PELVIC FRACTURE,67
US,PERIPHERAL COLDNESS,67
US,POLYP,67
US,POST PROCEDURAL COMPLICATION,67
US,SPINAL DISORDER,67
US,DRUG DISPENSING ERROR,66
US,GINGIVAL BLEEDING,66
US,SKIN FISSURES,66
US,EYE HAEMORRHAGE,65
US,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,65
US,PULMONARY CONGESTION,65
US,SKIN IRRITATION,65
US,SQUAMOUS CELL CARCINOMA,65
US,ACCIDENTAL OVERDOSE,64
US,JOINT RANGE OF MOTION DECREASED,64
US,LIVER FUNCTION TEST INCREASED,64
US,LOWER RESPIRATORY TRACT INFECTION,64
US,MENISCUS INJURY,64
US,METABOLIC ACIDOSIS,64
US,PHOTOSENSITIVITY REACTION,64
US,SCOLIOSIS,64
US,SPUTUM DISCOLOURED,64
US,BLOOD CALCIUM DECREASED,63
US,CENTRAL NERVOUS SYSTEM LESION,63
US,GASTROENTERITIS,63
US,HEARING IMPAIRED,63
US,PSYCHOMOTOR HYPERACTIVITY,63
US,BACK INJURY,62
US,BIPOLAR DISORDER,62
US,BLOOD TEST ABNORMAL,62
US,HAEMORRHAGIC STROKE,62
US,IMMUNE SYSTEM DISORDER,62
US,PARKINSON^S DISEASE,62
US,PHARYNGITIS,62
US,ATRIAL FLUTTER,61
US,DISEASE RECURRENCE,61
US,EAR DISCOMFORT,61
US,ERECTILE DYSFUNCTION,61
US,HEPATIC ENCEPHALOPATHY,61
US,HYPOKINESIA,61
US,ORAL HERPES,61
US,ORAL MUCOSAL BLISTERING,61
US,APPLICATION SITE PAIN,60
US,INTERSTITIAL LUNG DISEASE,60
US,MALIGNANT MELANOMA,60
US,MALNUTRITION,60
US,MEDICATION RESIDUE PRESENT,60
US,ORAL DISORDER,60
US,PSYCHOTIC DISORDER,60
US,ABSCESS,59
US,BLOOD BILIRUBIN INCREASED,59
US,HAND FRACTURE,59
US,PHOTOPHOBIA,59
US,SINUS TACHYCARDIA,59
US,TOOTH INFECTION,59
US,WEIGHT FLUCTUATION,59
US,BLINDNESS UNILATERAL,58
US,DEVICE DISLOCATION,58
US,DIABETIC NEUROPATHY,58
US,GINGIVAL PAIN,58
US,GROIN PAIN,58
US,HYPERCALCAEMIA,58
US,MYELODYSPLASTIC SYNDROME,58
US,THROMBOPHLEBITIS SUPERFICIAL,58
US,WALKING AID USER,58
US,ASPIRATION,57
US,DEVICE USE ERROR,57
US,DRUG DEPENDENCE,57
US,FOOT DEFORMITY,57
US,HAEMORRHOIDAL HAEMORRHAGE,57
US,HIP ARTHROPLASTY,57
US,HYPERCHLORHYDRIA,57
US,RESPIRATORY ARREST,57
US,SQUAMOUS CELL CARCINOMA OF SKIN,57
US,TENDON RUPTURE,57
US,GASTRIC HAEMORRHAGE,56
US,HAIR DISORDER,56
US,ONYCHOCLASIS,56
US,PANCREATIC CARCINOMA,56
US,PARAESTHESIA ORAL,56
US,PRESCRIBED UNDERDOSE,56
US,SJOGREN^S SYNDROME,56
US,SKIN ABRASION,56
US,SPINAL PAIN,56
US,GASTROINTESTINAL PAIN,55
US,INCREASED UPPER AIRWAY SECRETION,55
US,LUNG INFILTRATION,55
US,MITRAL VALVE INCOMPETENCE,55
US,POST PROCEDURAL HAEMORRHAGE,55
US,RENAL CANCER,55
US,RENAL FAILURE CHRONIC,55
US,SECRETION DISCHARGE,55
US,SPINAL OPERATION,55
US,COELIAC DISEASE,54
US,COMA,54
US,END STAGE RENAL DISEASE,54
US,HALLUCINATION_ VISUAL,54
US,HEMIPARESIS,54
US,PARANOIA,54
US,BREAST PAIN,53
US,COORDINATION ABNORMAL,53
US,DECUBITUS ULCER,53
US,ECCHYMOSIS,53
US,IMPAIRED DRIVING ABILITY,53
US,INJECTION SITE DISCOLOURATION,53
US,INJECTION SITE INDURATION,53
US,PSYCHOLOGICAL TRAUMA,53
US,SKIN HAEMORRHAGE,53
US,TEMPERATURE INTOLERANCE,53
US,AMMONIA INCREASED,52
US,BODY TEMPERATURE INCREASED,52
US,DIZZINESS POSTURAL,52
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,52
US,JAUNDICE,52
US,METASTASES TO LIVER,52
US,RENAL PAIN,52
US,SCAB,52
US,SLUGGISHNESS,52
US,VITREOUS FLOATERS,52
US,BOWEL MOVEMENT IRREGULARITY,51
US,FURUNCLE,51
US,LUMBAR SPINAL STENOSIS,51
US,MENORRHAGIA,51
US,THERAPY NON-RESPONDER,51
US,WOUND INFECTION,51
US,BACTERAEMIA,50
US,DECREASED INTEREST,50
US,DIABETES MELLITUS INADEQUATE CONTROL,50
US,ACCIDENT,49
US,DEVICE FAILURE,49
US,FEELING DRUNK,49
US,FRACTURE,49
US,GENERALISED OEDEMA,49
US,HYPERAESTHESIA,49
US,HYPERCHOLESTEROLAEMIA,49
US,ISCHAEMIC STROKE,49
US,NAIL DISORDER,49
US,PROCTALGIA,49
US,REGURGITATION,49
US,TONGUE DISORDER,49
US,AFFECT LABILITY,48
US,BEDRIDDEN,48
US,BONE LESION,48
US,CARDIAC MURMUR,48
US,DRUG LEVEL INCREASED,48
US,FAILURE TO THRIVE,48
US,IMMUNODEFICIENCY,48
US,INITIAL INSOMNIA,48
US,PROSTATOMEGALY,48
US,SINUS HEADACHE,48
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,47
US,CARDIOVASCULAR DISORDER,47
US,DEPRESSED LEVEL OF CONSCIOUSNESS,47
US,HEPATITIS,47
US,INTERVERTEBRAL DISC DISORDER,47
US,JOINT EFFUSION,47
US,MADAROSIS,47
US,MUSCLE SPASTICITY,47
US,MUSCLE STRAIN,47
US,NASAL DISCOMFORT,47
US,TOOTH EXTRACTION,47
US,ANAL INCONTINENCE,46
US,AORTIC ANEURYSM,46
US,ARTERIOSCLEROSIS,46
US,BLOOD GLUCOSE FLUCTUATION,46
US,EJECTION FRACTION DECREASED,46
US,HUMERUS FRACTURE,46
US,INJECTION SITE EXTRAVASATION,46
US,URINE OUTPUT DECREASED,46
US,ABDOMINAL HERNIA,45
US,ARTERIAL OCCLUSIVE DISEASE,45
US,FACIAL PAIN,45
US,ILEUS,45
US,RASH MACULO-PAPULAR,45
US,ULCER HAEMORRHAGE,45
US,ACUTE HEPATIC FAILURE,44
US,ANORECTAL DISCOMFORT,44
US,APPLICATION SITE RASH,44
US,BONE LOSS,44
US,DRUG EFFECT DELAYED,44
US,ELECTROLYTE IMBALANCE,44
US,GASTROINTESTINAL INFECTION,44
US,HAIR GROWTH ABNORMAL,44
US,HEPATOMEGALY,44
US,INJURY ASSOCIATED WITH DEVICE,44
US,LYMPHOEDEMA,44
US,NASAL DRYNESS,44
US,PARANASAL SINUS DISCOMFORT,44
US,PARANASAL SINUS HYPERSECRETION,44
US,POOR QUALITY DRUG ADMINISTERED,44
US,SCRATCH,44
US,SKIN ATROPHY,44
US,TONGUE DISCOLOURATION,44
US,VITAMIN B12 DEFICIENCY,44
US,ABDOMINAL TENDERNESS,43
US,ARTHROPOD BITE,43
US,ATAXIA,43
US,BILIARY DYSKINESIA,43
US,COMPRESSION FRACTURE,43
US,CONCUSSION,43
US,DERMATITIS CONTACT,43
US,PHARYNGITIS STREPTOCOCCAL,43
US,TRANSAMINASES INCREASED,43
US,TRIGGER FINGER,43
US,UTERINE LEIOMYOMA,43
US,COLON CANCER,42
US,DELUSION,42
US,FORMICATION,42
US,GASTROINTESTINAL SOUNDS ABNORMAL,42
US,GLUCOSE TOLERANCE IMPAIRED,42
US,MULTIPLE ALLERGIES,42
US,PULMONARY FUNCTION TEST DECREASED,42
US,SHOCK,42
US,TIBIA FRACTURE,42
US,ABDOMINAL ADHESIONS,41
US,BENIGN PROSTATIC HYPERPLASIA,41
US,BREAST MASS,41
US,CALCIUM DEFICIENCY,41
US,CARDIAC FLUTTER,41
US,DROOLING,41
US,EYE DISCHARGE,41
US,HYSTERECTOMY,41
US,INJECTION SITE PAPULE,41
US,INTESTINAL PERFORATION,41
US,OESOPHAGEAL DISORDER,41
US,PERITONITIS,41
US,PETECHIAE,41
US,PLEURISY,41
US,SKIN MASS,41
US,SOMNAMBULISM,41
US,VENTRICULAR TACHYCARDIA,41
US,ADRENAL INSUFFICIENCY,40
US,CYTOPENIA,40
US,DIALYSIS,40
US,DIARRHOEA HAEMORRHAGIC,40
US,ESSENTIAL HYPERTENSION,40
US,FISTULA,40
US,GENERALISED TONIC-CLONIC SEIZURE,40
US,MAJOR DEPRESSION,40
US,MOUTH HAEMORRHAGE,40
US,OESOPHAGEAL PAIN,40
US,QUALITY OF LIFE DECREASED,40
US,RENAL CELL CARCINOMA,40
US,RHINITIS ALLERGIC,40
US,RIGHT VENTRICULAR FAILURE,40
US,SENSORY LOSS,40
US,STENT PLACEMENT,40
US,UROSEPSIS,40
US,WRONG DRUG ADMINISTERED,40
US,ABNORMAL FAECES,39
US,APPETITE DISORDER,39
US,BLOOD CALCIUM INCREASED,39
US,DECREASED ACTIVITY,39
US,FIBULA FRACTURE,39
US,HYPERKERATOSIS,39
US,OSTEONECROSIS,39
US,PATHOLOGICAL FRACTURE,39
US,POST PROCEDURAL INFECTION,39
US,PYELONEPHRITIS,39
US,SPINAL CORD COMPRESSION,39
US,SUPRAVENTRICULAR TACHYCARDIA,39
US,BREAST CANCER METASTATIC,38
US,CATARACT OPERATION,38
US,CYSTIC FIBROSIS,38
US,ELECTROCARDIOGRAM ABNORMAL,38
US,GOITRE,38
US,HICCUPS,38
US,HYDRONEPHROSIS,38
US,MOTOR DYSFUNCTION,38
US,PERONEAL NERVE PALSY,38
US,PERSONALITY CHANGE,38
US,DEFORMITY,37
US,DEMENTIA ALZHEIMER^S TYPE,37
US,NO THERAPEUTIC RESPONSE,37
US,NON-CARDIAC CHEST PAIN,37
US,SKIN INFECTION,37
US,UTERINE PERFORATION,37
US,ARTERIOSCLEROSIS CORONARY ARTERY,36
US,CHRONIC SINUSITIS,36
US,ENERGY INCREASED,36
US,FAECAL INCONTINENCE,36
US,GASTRIC ULCER HAEMORRHAGE,36
US,GASTROINTESTINAL INFLAMMATION,36
US,HEPATIC CANCER,36
US,INFUSION SITE PAIN,36
US,INTERNATIONAL NORMALISED RATIO DECREASED,36
US,INTESTINAL STENOSIS,36
US,INTRAMEDULLARY ROD INSERTION,36
US,INTRAOCULAR PRESSURE INCREASED,36
US,LYMPHOMA,36
US,MUSCLE ATROPHY,36
US,ONYCHOMYCOSIS,36
US,OSTEOSCLEROSIS,36
US,PAROSMIA,36
US,PRODUCT ODOUR ABNORMAL,36
US,RED BLOOD CELL SEDIMENTATION RATE INCREASED,36
US,SKIN REACTION,36
US,SPINAL FUSION SURGERY,36
US,URINE ODOUR ABNORMAL,36
US,ACUTE MYELOID LEUKAEMIA,35
US,BLADDER CANCER,35
US,BLOOD CHOLESTEROL ABNORMAL,35
US,EYELID OEDEMA,35
US,FOREIGN BODY,35
US,FUNGAL SKIN INFECTION,35
US,GASTROINTESTINAL MOTILITY DISORDER,35
US,GRIP STRENGTH DECREASED,35
US,HELICOBACTER INFECTION,35
US,HYPERTHYROIDISM,35
US,METASTASES TO CENTRAL NERVOUS SYSTEM,35
US,METASTASES TO LUNG,35
US,MULTI-ORGAN FAILURE,35
US,MYDRIASIS,35
US,OESOPHAGEAL STENOSIS,35
US,PIGMENTATION DISORDER,35
US,SINUS BRADYCARDIA,35
US,STRESS FRACTURE,35
US,SYNOVIAL CYST,35
US,UMBILICAL HERNIA,35
US,CAROTID ARTERY OCCLUSION,34
US,CARTILAGE ATROPHY,34
US,COLITIS ISCHAEMIC,34
US,CONTRAINDICATED PRODUCT ADMINISTERED,34
US,DERMATITIS ALLERGIC,34
US,DEVICE LEAKAGE,34
US,DRUG-INDUCED LIVER INJURY,34
US,HAEMORRHAGIC DIATHESIS,34
US,LACTIC ACIDOSIS,34
US,NEUTROPHIL COUNT INCREASED,34
US,OCULAR DISCOMFORT,34
US,PROCEDURAL COMPLICATION,34
US,RENAL INJURY,34
US,SECOND PRIMARY MALIGNANCY,34
US,TRICUSPID VALVE INCOMPETENCE,34
US,YELLOW SKIN,34
US,ANAL FISTULA,33
US,BREATH SOUNDS ABNORMAL,33
US,DIVERTICULUM INTESTINAL,33
US,DRUG ABUSE,33
US,ENTERITIS,33
US,EYELID PTOSIS,33
US,HYPOTHERMIA,33
US,RHINITIS,33
US,SUNBURN,33
US,THYROID MASS,33
US,TONGUE ULCERATION,33
US,TROPONIN INCREASED,33
US,VENTRICULAR EXTRASYSTOLES,33
US,WOUND COMPLICATION,33
US,APPENDICITIS,32
US,BILE DUCT OBSTRUCTION,32
US,BRAIN NEOPLASM,32
US,CARDIAC PACEMAKER INSERTION,32
US,DEVICE BREAKAGE,32
US,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,32
US,DRUG SCREEN POSITIVE,32
US,FOOD POISONING,32
US,FOREIGN BODY SENSATION IN EYES,32
US,LEUKAEMIA,32
US,ODYNOPHAGIA,32
US,PARALYSIS,32
US,PROTEINURIA,32
US,SENSATION OF FOREIGN BODY,32
US,STREPTOCOCCAL INFECTION,32
US,APATHY,31
US,BLOOD BLISTER,31
US,BREAST CANCER FEMALE,31
US,BRONCHOSPASM,31
US,CATAPLEXY,31
US,CHOKING SENSATION,31
US,ENURESIS,31
US,GASTRITIS EROSIVE,31
US,HYPERBILIRUBINAEMIA,31
US,HYPOVOLAEMIA,31
US,INGUINAL HERNIA,31
US,INJECTION SITE VESICLES,31
US,INTENTIONAL UNDERDOSE,31
US,LACTOSE INTOLERANCE,31
US,LEFT VENTRICULAR HYPERTROPHY,31
US,LIVER INJURY,31
US,OVARIAN CYST,31
US,POLYURIA,31
US,SEXUAL DYSFUNCTION,31
UM,DRUG INEFFECTIVE,1
UM,FATIGUE,1
UM,FRUSTRATION TOLERANCE DECREASED,1
UM,NEGATIVE THOUGHTS,1
UY,DIARRHOEA,2
UY,PYREXIA,2
UY,SEPSIS,2
UY,ABDOMINAL DISTENSION,1
UY,ABDOMINAL HERNIA OBSTRUCTIVE,1
UY,ABDOMINAL PAIN,1
UY,ANTI-TRANSGLUTAMINASE ANTIBODY INCREASED,1
UY,CELLULITIS,1
UY,CHEST PAIN,1
UY,CHILLS,1
UY,DECREASED APPETITE,1
UY,DISEASE PROGRESSION,1
UY,DRUG DOSE OMISSION,1
UY,DYSPNOEA,1
UY,ENTEROCOCCUS TEST POSITIVE,1
UY,FATIGUE,1
UY,FEELING HOT,1
UY,FREQUENT BOWEL MOVEMENTS,1
UY,FUNGAL PERITONITIS,1
UY,GAIT DISTURBANCE,1
UY,GASTROINTESTINAL HAEMORRHAGE,1
UY,HAEMATOCHEZIA,1
UY,HAEMATURIA,1
UY,HYPERAESTHESIA,1
UY,HYPERKERATOSIS,1
UY,IMMUNODEFICIENCY,1
UY,INFLUENZA,1
UY,KLEBSIELLA TEST POSITIVE,1
UY,LEUKOPENIA,1
UY,MUSCLE CONTRACTURE,1
UY,NECK PAIN,1
UY,NEPHROLITHIASIS,1
UY,OEDEMA PERIPHERAL,1
UY,PAIN,1
UY,PAIN IN EXTREMITY,1
UY,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
UY,PERITONITIS BACTERIAL,1
UY,PNEUMONIA,1
UY,PNEUMONIA PNEUMOCOCCAL,1
UY,RESPIRATORY FAILURE,1
UY,RETINAL VEIN THROMBOSIS,1
UY,SKIN EXFOLIATION,1
UY,SKIN LESION,1
UY,TENDONITIS,1
UY,TONSILLITIS STREPTOCOCCAL,1
UY,UNEVALUABLE EVENT,1
UY,URINARY TRACT INFECTION,1
UY,VISION BLURRED,1
UY,VOMITING,1
UY,WEIGHT DECREASED,1
UY,WITHDRAWAL BLEED,1
UY,WOUND HAEMORRHAGE,1
VE,MALAISE,12
VE,SEIZURE,9
VE,DIZZINESS,8
VE,PAIN,8
VE,FATIGUE,7
VE,PAIN IN EXTREMITY,7
VE,SEPSIS,7
VE,ARTHRALGIA,6
VE,DYSPNOEA,6
VE,HEADACHE,6
VE,VOMITING,6
VE,FALL,5
VE,PYREXIA,5
VE,ABASIA,4
VE,ABDOMINAL PAIN UPPER,4
VE,ANXIETY,4
VE,BLOOD PRESSURE INCREASED,4
VE,CHIKUNGUNYA VIRUS INFECTION,4
VE,FEELING ABNORMAL,4
VE,INFLUENZA,4
VE,NAUSEA,4
VE,RASH,4
VE,BLOOD CREATININE INCREASED,3
VE,BRONCHITIS,3
VE,CEREBROVASCULAR ACCIDENT,3
VE,DEATH,3
VE,DEPRESSED MOOD,3
VE,DIARRHOEA,3
VE,DISCOMFORT,3
VE,GENERAL PHYSICAL HEALTH DETERIORATION,3
VE,HAEMOGLOBIN DECREASED,3
VE,HYPERTENSIVE CRISIS,3
VE,HYPOKINESIA,3
VE,INFLAMMATION,3
VE,MOBILITY DECREASED,3
VE,MUSCLE SPASMS,3
VE,MYOCARDIAL INFARCTION,3
VE,OSTEOPOROSIS,3
VE,SOMNOLENCE,3
VE,SPINAL COLUMN INJURY,3
VE,TUBERCULIN TEST POSITIVE,3
VE,ASTHENIA,2
VE,ASTHMA,2
VE,BLOOD CHOLESTEROL ABNORMAL,2
VE,BLOOD DISORDER,2
VE,BRONCHIAL DISORDER,2
VE,CARDIAC FAILURE,2
VE,CARDIOVASCULAR DISORDER,2
VE,CEREBROVASCULAR DISORDER,2
VE,CHOLELITHIASIS,2
VE,DECREASED APPETITE,2
VE,DEVICE DISLOCATION,2
VE,DEVICE RELATED INFECTION,2
VE,DRUG INTOLERANCE,2
VE,HAEMATOLOGY TEST ABNORMAL,2
VE,HEPATIC NEOPLASM,2
VE,HYPERSENSITIVITY,2
VE,INCREASED BRONCHIAL SECRETION,2
VE,INFARCTION,2
VE,INJURY,2
VE,JOINT DISLOCATION,2
VE,MUSCLE RIGIDITY,2
VE,MYOCARDIAL ISCHAEMIA,2
VE,PNEUMONIA,2
VE,RENAL DISORDER,2
VE,RHEUMATOID ARTHRITIS,2
VE,SPINAL CORD COMPRESSION,2
VE,TINNITUS,2
VE,TONIC CLONIC MOVEMENTS,2
VE,TREMOR,2
VE,VIRAL INFECTION,2
VE,WEIGHT INCREASED,2
VE,ABDOMINAL DISTENSION,1
VE,ABDOMINAL INFECTION,1
VE,ABNORMAL BEHAVIOUR,1
VE,ABSCESS LIMB,1
VE,ALLERGIC COUGH,1
VE,ANAEMIA,1
VE,ANAL FISTULA,1
VE,ANGINA PECTORIS,1
VE,AORTIC ANEURYSM,1
VE,APPARENT DEATH,1
VE,APPENDICITIS,1
VE,APPENDIX DISORDER,1
VE,ARRHYTHMIA,1
VE,ASPHYXIA,1
VE,ASTHMATIC CRISIS,1
VE,BACK PAIN,1
VE,BALANCE DISORDER,1
VE,BILE DUCT OBSTRUCTION,1
VE,BLINDNESS,1
VE,BLINDNESS UNILATERAL,1
VE,BLOOD CHOLESTEROL INCREASED,1
VE,BLOOD GLUCOSE DECREASED,1
VE,BLOOD GLUCOSE INCREASED,1
VE,BLOOD POTASSIUM DECREASED,1
VE,BLOOD PRESSURE ABNORMAL,1
VE,BLOOD PRESSURE FLUCTUATION,1
VE,BLOOD PRESSURE SYSTOLIC INCREASED,1
VE,BLOOD TRIGLYCERIDES ABNORMAL,1
VE,BLOOD TRIGLYCERIDES INCREASED,1
VE,BONE CYST,1
VE,BONE DISORDER,1
VE,BONE PAIN,1
VE,BREAST CANCER RECURRENT,1
VE,BULIMIA NERVOSA,1
VE,CEREBRAL DISORDER,1
VE,CERVIX CANCER METASTATIC,1
VE,CERVIX CARCINOMA,1
VE,CHEST PAIN,1
VE,CHILLS,1
VE,CHOKING,1
VE,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
VE,CHRONIC SINUSITIS,1
VE,CLUMSINESS,1
VE,CONTUSION,1
VE,CONVULSION,1
VE,CORONARY ARTERY OCCLUSION,1
VE,CYST,1
VE,DAYDREAMING,1
VE,DECREASED IMMUNE RESPONSIVENESS,1
VE,DEHYDRATION,1
VE,DEMENTIA,1
VE,DEPRESSION,1
VE,DEVICE MALFUNCTION,1
VE,DIABETES MELLITUS INADEQUATE CONTROL,1
VE,DIET REFUSAL,1
VE,DISEASE PROGRESSION,1
VE,DISEASE RECURRENCE,1
VE,DIVERTICULITIS,1
VE,DRUG INEFFECTIVE,1
VE,DRUG-INDUCED LIVER INJURY,1
VE,DYSKINESIA,1
VE,DYSLIPIDAEMIA,1
VE,DYSPEPSIA,1
VE,DYSPHEMIA,1
VE,DYSURIA,1
VE,EATING DISORDER,1
VE,EMOTIONAL DISORDER,1
VE,EMPYEMA,1
VE,ENDOCARDITIS BACTERIAL,1
VE,EPISTAXIS,1
VE,ESCHERICHIA TEST POSITIVE,1
VE,EXPOSURE DURING PREGNANCY,1
VE,EYE HAEMORRHAGE,1
VE,FEELING COLD,1
VE,FEMUR FRACTURE,1
VE,FLATULENCE,1
VE,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
VE,FOOD INTOLERANCE,1
VE,GALLBLADDER DISORDER,1
VE,GASTRIC ULCER,1
VE,GASTRIC ULCER HAEMORRHAGE,1
VE,GASTRITIS,1
VE,GASTROINTESTINAL HAEMORRHAGE,1
VE,GASTROINTESTINAL INFECTION,1
VE,GLOBULINS INCREASED,1
VE,GRIP STRENGTH DECREASED,1
VE,HAEMORRHOIDS,1
VE,HEART RATE INCREASED,1
VE,HEPATIC ENZYME INCREASED,1
VE,HEPATITIS C,1
VE,HERNIA,1
VE,HIATUS HERNIA,1
VE,HYPERCHOLESTEROLAEMIA,1
VE,HYPERGLYCAEMIA,1
VE,HYPERHIDROSIS,1
VE,HYPERTENSION,1
VE,HYPERTENSIVE EMERGENCY,1
VE,HYPERTENSIVE HEART DISEASE,1
VE,HYPERTRIGLYCERIDAEMIA,1
VE,HYPOAESTHESIA,1
VE,HYPOAESTHESIA EYE,1
VE,HYPOAESTHESIA ORAL,1
VE,IMMUNE SYSTEM DISORDER,1
VE,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
VE,IMMUNOSUPPRESSION,1
VE,INCORRECT DOSE ADMINISTERED,1
VE,INFECTION,1
VE,INFECTION PARASITIC,1
VE,INGUINAL HERNIA,1
VE,INSOMNIA,1
VE,INTERVERTEBRAL DISC DISPLACEMENT,1
VE,INTERVERTEBRAL DISC PROTRUSION,1
VE,INTESTINAL OBSTRUCTION,1
VE,JOINT SWELLING,1
VE,LABORATORY TEST ABNORMAL,1
VE,LARGE INTESTINE BENIGN NEOPLASM,1
VE,LIMB DISCOMFORT,1
VE,LIP DRY,1
VE,LIVER INJURY,1
VE,LUNG DISORDER,1
VE,MENISCUS INJURY,1
VE,MENSTRUATION IRREGULAR,1
VE,MENTAL DISORDER,1
VE,MENTAL RETARDATION,1
VE,METASTASES TO LIVER,1
VE,METASTASES TO STOMACH,1
VE,METASTASIS,1
VE,MICTURITION DISORDER,1
VE,MIGRAINE,1
VE,MUSCLE TIGHTNESS,1
VE,MUSCULOSKELETAL PAIN,1
VE,MYALGIA,1
VE,MYOFASCIAL PAIN SYNDROME,1
VE,NERVE COMPRESSION,1
VE,NERVOUSNESS,1
VE,NEUROPATHY PERIPHERAL,1
VE,OBSTRUCTIVE UROPATHY,1
VE,OESOPHAGEAL CANDIDIASIS,1
VE,ORAL DISORDER,1
VE,ORGAN FAILURE,1
VE,OSTEOARTHRITIS,1
VE,OVARIAN DYSGERMINOMA STAGE UNSPECIFIED,1
VE,PELVIC MASS,1
VE,PELVIC PAIN,1
VE,PERIPHERAL SWELLING,1
VE,PLATELET COUNT DECREASED,1
VE,PLATELET COUNT INCREASED,1
VE,PLEURAL EFFUSION,1
VE,PNEUMONITIS,1
VE,POLLAKIURIA,1
VE,POLYDIPSIA,1
VE,PRODUCT USE IN UNAPPROVED INDICATION,1
VE,PRODUCT USE ISSUE,1
VE,PROSTATE CANCER,1
VE,PROTEIN-LOSING GASTROENTEROPATHY,1
VE,PRURITUS,1
VE,PULMONARY FIBROSIS,1
VE,PULMONARY OEDEMA,1
VE,PYELOCALIECTASIS,1
VE,RECTAL ABSCESS,1
VE,RECURRENT CANCER,1
VE,RENAL FAILURE,1
VE,RESPIRATORY ARREST,1
VE,RESPIRATORY DISORDER,1
VE,RESPIRATORY TRACT INFECTION,1
VE,RIB DEFORMITY,1
VE,ROAD TRAFFIC ACCIDENT,1
VE,SCOLIOSIS,1
VE,SICKLE CELL ANAEMIA WITH CRISIS,1
VE,SKIN ULCER,1
VE,SPEECH DISORDER,1
VE,SPINAL DEFORMITY,1
VE,SPINAL DISORDER,1
VE,SPINAL FRACTURE,1
VE,STRESS,1
VE,SWELLING,1
VE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
VE,TACHYCARDIA,1
VE,TENDON RUPTURE,1
VE,THROMBOSIS,1
VE,TONSILLITIS,1
VE,TOOTHACHE,1
VE,TUBERCULOSIS,1
VE,UPPER LIMB FRACTURE,1
VE,URETHRAL OBSTRUCTION,1
VE,UROSEPSIS,1
VE,VAGINAL HAEMORRHAGE,1
VE,VASCULAR ACCESS SITE OCCLUSION,1
VE,VERTIGO,1
VE,VISION BLURRED,1
VE,VISUAL ACUITY REDUCED,1
VE,WEIGHT DECREASED,1
VE,WHITE BLOOD CELL COUNT INCREASED,1
VE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
VE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
VN,CELLULITIS,2
VN,LIMB INJURY,2
VN,SEPTIC SHOCK,2
VN,ASTHENIA,1
VN,CATARACT,1
VN,FATIGUE,1
VN,HEPATIC ENZYME INCREASED,1
VN,NEUTROPHIL COUNT DECREASED,1
VN,PNEUMONIA,1
VN,RESPIRATORY FAILURE,1
VN,SEBORRHOEIC DERMATITIS,1
VN,SEPSIS,1
VN,THROMBOCYTOSIS,1
VN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
VI,COUGH,1
VI,DRUG EFFECT DECREASED,1
VI,HAEMATEMESIS,1
